data_1x52_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x52 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.9 85.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.434 0.561 . . . . 0.0 112.291 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.11 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.3 1.44 . . . . 0.0 112.812 -169.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.06 -49.74 32.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -55.31 -51.21 67.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.714 0.805 . . . . 0.0 110.205 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.9 -42.21 88.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 119.223 0.92 . . . . 0.0 111.2 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -59.85 -47.75 84.47 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.85 1.659 . . . . 0.0 109.075 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.64 95.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.095 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.6 -43.9 80.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.269 0.94 . . . . 0.0 110.164 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.54 -48.38 60.62 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.522 1.129 . . . . 0.0 111.029 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.05 -41.11 95.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -57.43 -60.0 4.3 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.22 1.408 . . . . 0.0 110.32 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -35.94 74.94 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.59 -56.36 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -37.78 88.77 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.142 0.577 . . . . 0.0 109.933 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.52 -36.53 69.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.332 0.969 . . . . 0.0 111.725 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -67.98 -61.26 1.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -64.97 -85.55 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.47 1.908 . . . . 0.0 112.44 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.21 93.87 47.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.29 1.436 . . . . 0.0 109.929 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.45 -5.36 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.894 1.729 . . . . 0.0 112.087 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.75 -33.07 60.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.134 0.879 . . . . 0.0 110.039 165.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -97.33 7.72 46.0 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.18 90.68 2.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.253 1.842 . . . . 0.0 110.347 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -93.3 137.28 32.77 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.495 0.718 . . . . 0.0 109.756 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.56 164.94 28.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.77 0.795 . . . . 0.0 112.017 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.58 126.69 0.85 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -170.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -35.66 -53.66 0.7 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.907 2.083 . . . . 0.0 112.422 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.05 83.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.037 0.935 . . . . 0.0 111.767 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -59.04 -57.23 13.98 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 t -49.64 -43.87 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.26 -31.99 69.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.805 1.184 . . . . 0.0 111.727 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -44.71 30.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.617 1.567 . . . . 0.0 110.477 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.51 67.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.925 -1.11 . . . . 0.0 112.37 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.52 -41.93 92.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.549 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.02 -35.4 69.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.25 0.932 . . . . 0.0 111.544 172.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.61 -2.81 40.8 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.847 1.259 . . . . 0.0 112.706 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.6 mmt 51.96 14.91 0.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.462 1.905 . . . . 0.0 113.148 -170.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.53 -4.97 58.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.143 -0.973 . . . . 0.0 112.362 -162.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -76.55 108.72 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -169.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.4 -62.48 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.557 -1.202 . . . . 0.0 107.849 168.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.4 m -139.01 133.69 32.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 tp -110.51 124.25 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.3 1.84 . . . . 0.0 108.582 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -101.67 137.56 39.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.591 1.556 . . . . 0.0 107.806 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 tt -151.94 139.75 13.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 134.24 50.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 166.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -34.52 69.45 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.6 -25.22 62.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.743 1.156 . . . . 0.0 113.212 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.72 -37.06 19.78 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.531 1.059 . . . . 0.0 110.378 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -56.55 -19.55 16.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.682 1.193 . . . . 0.0 112.352 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.66 49.72 2.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.626 -1.297 . . . . 0.0 108.863 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -62.09 151.59 35.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.882 0.873 . . . . 0.0 109.617 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -69.22 -42.81 75.2 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.217 0.607 . . . . 0.0 112.415 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.17 119.15 19.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.5 -49.43 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 117.532 -1.223 . . . . 0.0 110.676 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.04 -52.38 66.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.366 1.439 . . . . 0.0 110.945 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -52.94 -53.12 54.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 110.809 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -55.89 -52.7 63.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -46.47 -50.6 16.69 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 126.256 1.822 . . . . 0.0 110.575 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.13 -57.3 11.62 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.972 0.909 . . . . 0.0 110.048 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -56.18 -51.68 67.14 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.152 -0.928 . . . . 0.0 112.113 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.12 -38.61 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 120.058 1.299 . . . . 0.0 110.824 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -60.22 -52.58 64.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.356 1.062 . . . . 0.0 109.026 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.12 -44.17 92.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.006 0.922 . . . . 0.0 111.205 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -53.29 -57.42 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.263 1.025 . . . . 0.0 110.138 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -34.73 78.63 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -16.82 63.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.028 . . . . 0.0 112.809 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.35 -37.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 O-C-N 120.472 -1.393 . . . . 0.0 109.135 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.98 -39.44 92.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.306 0.957 . . . . 0.0 108.899 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -57.25 -36.13 70.58 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.274 0.63 . . . . 0.0 111.269 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -87.62 13.37 10.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.856 1.262 . . . . 0.0 112.065 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.26 19.34 4.89 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.887 2.475 . . . . 0.0 114.535 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.33 170.03 50.84 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.282 0.946 . . . . 0.0 110.956 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -92.99 153.4 18.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.293 1.437 . . . . 0.0 108.691 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.6 142.1 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.333 1.453 . . . . 0.0 107.73 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -134.5 122.4 22.39 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.537 1.535 . . . . 0.0 108.011 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.75 105.55 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 10.2 m-85 -88.49 155.42 19.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -172.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 m -103.84 147.32 27.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.318 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 t -60.64 -35.85 77.19 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.149 0.906 . . . . 0.0 108.809 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.13 -56.25 16.18 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.976 1.71 . . . . 0.0 111.514 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -66.46 145.21 55.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.79 -26.46 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.586 0.63 . . . . 0.0 111.247 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 p -56.38 -17.98 9.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.184 0.994 . . . . 0.0 112.664 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.91 -55.58 4.08 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 125.348 1.452 . . . . 0.0 110.449 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.06 -29.19 67.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.312 1.056 . . . . 0.0 111.103 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -60.81 -58.13 9.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.48 -28.06 63.07 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.391 1.077 . . . . 0.0 112.238 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 m -56.34 -34.35 66.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.25 1.02 . . . . 0.0 113.196 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -64.44 -9.17 16.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.822 1.249 . . . . 0.0 111.755 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.1 mt -131.03 32.88 4.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.816 2.846 . . . . 0.0 108.711 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p 56.99 18.4 3.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.003 2.121 . . . . 0.0 114.482 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.64 69.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.801 2.143 . . . . 0.0 113.072 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.48 121.82 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.791 1.796 . . . . 0.0 110.59 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 179.48 8.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.506 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.67 145.44 12.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.903 1.281 . . . . 0.0 110.502 169.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.44 146.34 7.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.529 1.531 . . . . 0.0 106.898 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.46 145.57 44.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.452 0.701 . . . . 0.0 109.725 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -77.6 -24.6 49.62 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.689 1.596 . . . . 0.0 111.913 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -148.22 154.83 42.88 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 126.2 1.8 . . . . 0.0 106.324 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.34 114.75 3.56 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 123.163 2.576 . . . . 0.0 107.586 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.055 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt . . . . . 0 C--O 1.237 0.395 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.7 76.3 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.982 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.95 -23.99 61.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.496 1.044 . . . . 0.0 112.231 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.79 -43.44 22.98 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.71 93.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.009 0.924 . . . . 0.0 110.54 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 t -69.03 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.197 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -53.38 -44.1 68.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.077 1.762 . . . . 0.0 109.87 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.61 -46.32 79.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.794 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.1 -45.32 79.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.38 0.991 . . . . 0.0 111.106 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.26 -54.38 44.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.33 1.852 . . . . 0.0 108.465 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -66.39 -38.15 86.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.819 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -58.22 -59.7 4.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 110.285 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -61.71 -31.04 71.17 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -50.37 -62.94 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -58.9 -38.75 79.62 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.29 -30.32 59.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.983 1.265 . . . . 0.0 112.23 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -35.45 11.31 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.463 -0.773 . . . . 0.0 111.945 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -76.88 -56.42 4.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.207 1.003 . . . . 0.0 112.857 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.27 81.06 7.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.606 1.963 . . . . 0.0 108.891 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.11 -14.03 39.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.126 2.551 . . . . 0.0 112.762 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.41 -20.98 61.64 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.104 -0.998 . . . . 0.0 111.301 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -101.08 11.35 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 123.835 0.854 . . . . 0.0 112.665 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.26 91.03 2.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.43 1.014 . . . . 0.0 109.837 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.33 144.5 25.32 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.64 164.66 29.59 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.57 130.8 2.86 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 -171.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.0 tp -43.95 -47.6 8.51 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.27 -46.73 89.12 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.307 1.043 . . . . 0.0 111.618 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.14 -58.4 8.69 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.532 1.06 . . . . 0.0 108.412 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 t -53.08 -36.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.684 1.194 . . . . 0.0 111.637 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.04 -21.62 66.29 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.02 . . . . 0.0 112.767 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -87.6 -43.49 11.94 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 125.836 1.654 . . . . 0.0 110.459 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.87 -36.55 65.22 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.251 -0.906 . . . . 0.0 111.898 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.89 -45.18 87.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.576 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -60.0 -28.75 67.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.388 0.994 . . . . 0.0 113.132 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -0.11 29.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.186 1.394 . . . . 0.0 111.829 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.1 mmt 52.26 23.31 2.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.309 2.244 . . . . 0.0 112.775 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.92 -8.26 22.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.333 1.053 . . . . 0.0 112.694 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.3 mt -70.5 117.48 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.05 -61.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.57 1.148 . . . . 0.0 108.518 165.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.7 m -138.0 139.84 39.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 80' ' ' VAL . 12.1 tp -110.53 133.4 53.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.186 1.794 . . . . 0.0 108.107 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.62 134.47 51.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.199 1.799 . . . . 0.0 107.326 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.53 142.83 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -72.7 131.73 42.75 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.58 -32.85 65.62 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 123.05 0.54 . . . . 0.0 111.537 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.52 -41.87 22.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.6 -40.24 35.08 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.114 0.966 . . . . 0.0 108.998 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.32 -20.05 10.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.372 0.669 . . . . 0.0 111.694 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -118.61 21.27 12.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.847 2.059 . . . . 0.0 111.773 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -55.07 144.85 22.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.369 0.986 . . . . 0.0 111.421 -168.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.21 -21.78 56.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.99 108.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.0 -26.09 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 111.592 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.36 -54.39 12.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.16 0.891 . . . . 0.0 111.195 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.0 m -53.86 -49.03 69.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.145 1.778 . . . . 0.0 109.635 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.91 -47.28 71.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.089 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -50.13 -43.5 51.91 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.886 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.79 -56.74 18.27 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.271 1.028 . . . . 0.0 108.671 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -54.4 -55.61 26.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.757 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 m -64.96 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.901 1.228 . . . . 0.0 111.666 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -62.11 -53.36 56.49 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.0 tp -58.06 -43.28 86.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.197 0.999 . . . . 0.0 111.461 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 49.3 t -57.08 -33.02 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.094 0.958 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.24 -35.1 15.51 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.478 -0.764 . . . . 0.0 112.073 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 t -64.93 -16.3 63.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.069 1.747 . . . . 0.0 111.643 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.06 -35.3 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 119.513 -1.992 . . . . 0.0 109.679 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.85 -39.5 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.654 1.115 . . . . 0.0 110.37 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -48.93 -43.18 39.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.479 1.112 . . . . 0.0 110.325 171.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -94.37 17.65 12.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.161 1.384 . . . . 0.0 111.054 -168.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 27.69 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.57 2.348 . . . . 0.0 113.658 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.48 -170.79 46.72 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.127 0.87 . . . . 0.0 111.293 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -124.93 156.34 38.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.136 2.174 . . . . 0.0 109.14 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.66 140.92 44.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.969 0.89 . . . . 0.0 108.826 -173.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -137.07 120.81 17.37 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.25 109.93 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 -175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -89.66 138.12 31.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 t -69.07 122.43 18.71 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 p -55.88 -15.0 2.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.226 1.41 . . . . 0.0 113.38 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.95 -33.93 44.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.158 0.89 . . . . 0.0 111.297 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -67.44 151.49 47.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.78 -18.18 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.752 -0.592 . . . . 0.0 111.905 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.7 p -68.04 -27.9 66.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.105 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.07 -26.32 72.66 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.66 1.118 . . . . 0.0 110.756 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.49 -49.86 37.05 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.289 1.045 . . . . 0.0 108.811 165.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -61.14 -35.65 77.65 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.203 -0.936 . . . . 0.0 111.885 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 tp -70.64 -29.79 66.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.646 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 t -52.94 -41.47 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.984 1.314 . . . . 0.0 110.973 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.0 4.03 0.73 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.017 2.127 . . . . 0.0 114.115 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -137.81 27.98 2.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.539 2.736 . . . . 0.0 108.793 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p 66.29 2.08 2.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.249 2.62 . . . . 0.0 114.801 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.34 73.32 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 128.32 2.867 . . . . 0.0 113.94 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.56 132.67 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.016 1.908 . . . . 0.0 109.904 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.93 168.56 24.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.519 1.127 . . . . 0.0 110.269 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.06 145.28 23.91 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.309 0.958 . . . . 0.0 111.137 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.1 mt -83.95 148.87 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 127.029 2.132 . . . . 0.0 106.687 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.56 147.38 42.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.118 0.967 . . . . 0.0 111.718 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mtt85 -70.34 -32.09 69.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 168.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -151.23 154.0 33.32 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 118.245 0.475 . . . . 0.0 110.356 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.3 113.44 3.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.783 2.988 . . . . 0.0 109.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.499 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.07 -54.43 46.02 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.637 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.72 -40.37 54.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.537 1.135 . . . . 0.0 112.447 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.39 -47.61 34.74 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.962 0.801 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -48.68 76.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.946 0.873 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.23 -42.5 66.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 124.7 1.2 . . . . 0.0 109.606 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -57.13 -50.04 74.03 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.909 1.231 . . . . 0.0 109.533 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.64 98.52 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.855 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.91 -47.93 81.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.865 1.211 . . . . 0.0 110.233 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.18 -51.95 65.77 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 126.701 2.0 . . . . 0.0 109.477 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.03 -42.15 73.31 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -173.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.98 -56.82 11.88 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.198 0.999 . . . . 0.0 108.567 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -44.89 89.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 124.123 0.889 . . . . 0.0 112.247 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.08 -57.73 4.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ttp -66.27 -33.14 75.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.374 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.18 -50.94 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.732 1.606 . . . . 0.0 110.814 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -65.33 -40.16 93.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.221 0.208 . . . . 0.0 110.562 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -78.88 -57.95 3.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 111.41 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -149.97 76.9 8.63 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.431 2.292 . . . . 0.0 108.29 -167.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.81 -5.94 14.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.749 2.299 . . . . 0.0 112.151 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -27.19 2.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.003 2.121 . . . . 0.0 110.99 163.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -110.22 0.8 18.32 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.208 1.403 . . . . 0.0 113.922 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.74 95.21 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -93.55 133.62 36.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -140.38 159.91 41.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.16 0.981 . . . . 0.0 113.522 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 135.94 0.69 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.8 tp -44.97 -49.8 10.96 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.801 1.641 . . . . 0.0 112.27 -169.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -56.16 -43.27 78.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.432 1.493 . . . . 0.0 110.367 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -66.69 -57.82 6.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.18 -36.65 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.218 -0.926 . . . . 0.0 111.924 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -56.4 -38.84 72.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.914 0.885 . . . . 0.0 112.21 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -47.11 53.29 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.155 1.382 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.77 -32.83 69.64 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.577 -0.702 . . . . 0.0 112.537 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -65.53 -43.61 89.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.906 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.64 -28.16 66.98 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.04 0.836 . . . . 0.0 112.548 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.18 -6.12 57.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.46 0.704 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 60.26 9.5 1.96 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.624 1.97 . . . . 0.0 112.491 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.56 -7.19 59.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.167 -0.958 . . . . 0.0 113.027 -162.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.0 114.35 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 119.167 0.894 . . . . 0.0 108.86 -170.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.74 -52.37 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.166 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.6 m -140.99 132.93 27.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.27 132.71 53.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.467 2.307 . . . . 0.0 106.797 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -110.96 126.68 55.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.16 1.784 . . . . 0.0 106.918 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.11 136.31 29.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 118.931 0.787 . . . . 0.0 109.469 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -65.75 138.55 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.55 -39.35 70.5 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 122.928 0.491 . . . . 0.0 110.208 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -60.65 -16.7 41.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.39 -42.59 10.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.875 1.216 . . . . 0.0 110.091 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -50.28 -32.56 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.554 1.142 . . . . 0.0 112.379 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.55 38.85 4.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.511 1.924 . . . . 0.0 109.709 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.97 151.82 17.62 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -68.73 -41.49 78.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.583 0.753 . . . . 0.0 111.785 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 23.9 t70 -75.89 120.48 21.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.191 1.396 . . . . 0.0 108.23 -172.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.84 -39.44 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.404 -174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -60.27 4.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.976 0.807 . . . . 0.0 109.289 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 89.1 m -58.93 -51.24 70.88 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.089 0.956 . . . . 0.0 110.061 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -52.62 -52.31 56.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.017 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.3 t -52.2 -46.87 65.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 119.227 0.922 . . . . 0.0 109.245 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -51.73 -50.73 59.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.106 0.866 . . . . 0.0 109.668 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -57.82 -60.4 3.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.722 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 m -61.94 -37.84 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.328 1.422 . . . . 0.0 111.151 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -57.55 -53.16 61.34 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.809 1.644 . . . . 0.0 108.721 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.72 -46.63 88.53 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.808 0.843 . . . . 0.0 111.252 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.67 -49.88 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 124.311 1.045 . . . . 0.0 109.348 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.02 -37.8 78.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -64.65 -30.49 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.76 0.824 . . . . 0.0 111.856 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.28 -39.77 79.46 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 O-C-N 120.952 -1.092 . . . . 0.0 109.623 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.01 -46.69 89.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.985 0.811 . . . . 0.0 110.114 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -59.14 -31.27 68.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.979 0.512 . . . . 0.0 112.189 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.81 26.6 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.829 1.252 . . . . 0.0 111.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.64 6.75 2.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.872 2.869 . . . . 0.0 115.225 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.99 -176.18 47.91 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.177 0.899 . . . . 0.0 112.015 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -123.42 157.5 33.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.897 1.679 . . . . 0.0 109.935 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.3 t -122.66 139.66 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 108.232 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -129.36 121.45 27.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.1 mm -100.74 109.34 25.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 5.6 m-85 -89.62 156.76 18.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 108.697 -177.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -104.76 139.4 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 t -62.4 9.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.691 2.396 . . . . 0.0 114.155 170.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -129.3 -14.47 4.27 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.27 1.828 . . . . 0.0 113.689 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.457 ' HD1' ' CB ' ' A' ' 99' ' ' SER . 3.5 t-80 -87.69 148.38 24.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.565 1.075 . . . . 0.0 109.214 -174.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.6 p -57.02 -32.63 40.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 O-C-N 121.721 -0.612 . . . . 0.0 110.129 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.457 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . 16.0 m -65.3 -27.36 68.56 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.307 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.65 -53.8 25.99 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 167.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.34 -31.33 67.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.29 1.045 . . . . 0.0 112.196 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.96 -47.53 65.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.953 0.901 . . . . 0.0 109.697 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.86 -31.91 65.28 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 122.948 0.499 . . . . 0.0 111.39 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -58.33 -33.88 70.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.648 1.179 . . . . 0.0 112.926 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.14 -6.77 14.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.452 1.501 . . . . 0.0 112.053 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.0 mt -129.7 23.04 5.42 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.537 2.735 . . . . 0.0 108.218 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p 77.57 -12.12 1.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.263 3.425 . . . . 0.0 114.122 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.36 15.76 46.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.962 2.22 . . . . 0.0 113.133 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.17 133.48 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 118.933 1.366 . . . . 0.0 108.962 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.09 13.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.669 1.188 . . . . 0.0 110.05 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.18 142.01 9.82 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.241 0.928 . . . . 0.0 110.918 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -83.88 141.84 14.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.203 1.401 . . . . 0.0 107.715 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 mt -112.9 139.91 48.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.311 1.045 . . . . 0.0 111.249 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -66.86 -25.54 66.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.052 1.741 . . . . 0.0 112.374 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -151.61 157.47 34.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.507 1.523 . . . . 0.0 107.254 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.69 128.92 15.81 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.992 1.795 . . . . 0.0 108.384 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tptm . . . . . 0 C--O 1.232 0.147 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.95 80.54 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.524 0.73 . . . . 0.0 110.007 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.14 69.14 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.416 1.007 . . . . 0.0 113.367 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.67 -39.27 18.11 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 119.423 1.011 . . . . 0.0 111.115 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -50.42 68.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.881 2.072 . . . . 0.0 108.139 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.44 -51.52 48.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 126.013 1.725 . . . . 0.0 109.677 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.06 -45.01 67.92 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.558 1.072 . . . . 0.0 109.769 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.72 71.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 123.854 0.721 . . . . 0.0 111.383 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -55.74 -46.75 77.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.977 1.262 . . . . 0.0 111.361 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.04 -46.53 88.0 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.543 1.537 . . . . 0.0 110.073 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.72 -35.65 65.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.135 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -61.46 -57.39 12.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.444 2.298 . . . . 0.0 109.995 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -58.79 -35.4 72.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.739 0.7 . . . . 0.0 112.073 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -50.0 -53.65 25.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -59.86 -44.44 94.13 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.57 0.623 . . . . 0.0 110.286 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.1 -25.31 45.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.056 0.844 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -86.65 -62.35 1.53 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -68.11 -59.39 3.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.927 1.291 . . . . 0.0 113.826 -168.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.98 80.63 47.93 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 124.975 1.31 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.48 -7.65 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.273 1.982 . . . . 0.0 113.752 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.99 -55.24 25.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.889 1.222 . . . . 0.0 108.195 164.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -76.08 10.97 1.63 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.278 0.945 . . . . 0.0 112.526 -168.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.3 96.51 4.46 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.77 1.228 . . . . 0.0 109.69 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -93.37 140.64 29.34 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.27 159.67 41.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 142.13 0.73 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 tp -45.24 -51.81 10.31 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.361 1.464 . . . . 0.0 112.673 -165.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -49.59 75.89 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.648 1.579 . . . . 0.0 110.272 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.12 -56.44 22.22 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -49.22 -40.59 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.666 1.186 . . . . 0.0 112.29 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -59.61 -35.65 74.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.688 1.586 . . . . 0.0 111.56 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -49.32 16.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.236 1.415 . . . . 0.0 109.348 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.36 71.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.748 -0.595 . . . . 0.0 111.126 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.93 -50.37 69.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.5 0.72 . . . . 0.0 109.114 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.88 -16.01 47.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.891 1.277 . . . . 0.0 114.355 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.17 -10.51 54.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.806 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 51.91 52.45 14.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.164 1.385 . . . . 0.0 109.573 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.76 -18.73 5.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.334 2.254 . . . . 0.0 111.528 -171.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.48 117.61 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.7 -57.65 2.68 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.459 1.103 . . . . 0.0 108.973 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -129.98 126.42 37.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 108.099 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.52 137.2 47.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.874 2.07 . . . . 0.0 106.958 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.23 126.17 50.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.486 1.914 . . . . 0.0 107.076 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.83 141.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.3 m -71.22 134.13 46.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.268 1.027 . . . . 0.0 108.682 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.19 -35.0 66.76 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.055 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.04 -22.27 10.28 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.64 -45.41 9.87 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 120.85 -1.157 . . . . 0.0 110.081 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -54.85 -20.49 8.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.284 1.434 . . . . 0.0 113.592 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 20.74 7.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.706 1.603 . . . . 0.0 112.085 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -51.39 144.57 9.79 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.732 1.613 . . . . 0.0 111.526 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -51.32 -52.06 48.8 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 112.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.06 108.66 9.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 126.257 1.823 . . . . 0.0 107.713 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.44 -33.62 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.759 -174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.13 -63.28 1.29 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.803 1.183 . . . . 0.0 111.363 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 m -55.42 -45.73 76.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.768 1.227 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -56.83 -48.85 77.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.818 1.19 . . . . 0.0 110.619 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.4 m -57.09 -31.04 64.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.546 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -64.28 -58.54 6.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 120.303 1.41 . . . . 0.0 108.94 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -53.46 -53.34 52.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.023 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.78 -38.77 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.345 0.975 . . . . 0.0 110.93 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -63.65 -46.83 83.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.304 0.502 . . . . 0.0 110.486 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 tp -70.05 -34.96 73.9 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.382 0.673 . . . . 0.0 110.921 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.61 -48.51 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.67 94.38 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.949 0.9 . . . . 0.0 110.621 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -70.66 -25.38 62.97 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.546 1.538 . . . . 0.0 111.631 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.85 -42.26 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 120.702 -1.249 . . . . 0.0 108.466 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -63.72 -40.06 95.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.814 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -50.57 -49.0 57.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.071 0.851 . . . . 0.0 109.49 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -84.8 26.06 0.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.011 2.124 . . . . 0.0 110.763 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.04 22.12 12.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.534 2.734 . . . . 0.0 115.311 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.64 159.41 23.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 122.581 1.101 . . . . 0.0 113.243 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -82.5 163.55 21.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.191 2.197 . . . . 0.0 110.693 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -127.92 153.54 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 120.706 -1.246 . . . . 0.0 108.945 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.1 mmt-85 -141.0 131.88 25.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.692 1.997 . . . . 0.0 106.113 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.6 mm -118.4 107.48 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.86 155.02 19.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -103.11 145.8 29.36 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.7 t -60.55 -34.96 74.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.833 0.708 . . . . 0.0 110.542 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.19 -25.06 67.57 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.347 1.459 . . . . 0.0 112.809 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -83.39 147.62 27.79 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.496 0.718 . . . . 0.0 109.948 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -37.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.982 0.513 . . . . 0.0 110.36 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.6 m -71.04 -20.36 62.39 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.405 1.082 . . . . 0.0 111.838 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.48 -44.54 33.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.84 -34.97 73.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.715 0.758 . . . . 0.0 110.296 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -66.1 -55.65 15.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 111.068 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.61 -30.96 67.65 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.559 1.072 . . . . 0.0 111.803 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 t -60.15 -33.45 72.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.286 1.034 . . . . 0.0 112.128 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -58.76 -21.64 56.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.884 0.765 . . . . 0.0 111.303 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.4 mt -112.27 29.8 7.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.644 2.378 . . . . 0.0 109.412 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.94 0.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.523 2.729 . . . . 0.0 114.427 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.34 13.81 65.07 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 128.87 3.128 . . . . 0.0 113.618 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.2 133.13 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.502 2.151 . . . . 0.0 109.739 171.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.17 172.76 17.63 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.775 0.83 . . . . 0.0 110.439 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.44 146.86 22.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.091 -1.006 . . . . 0.0 110.614 173.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.2 mt -84.02 141.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 107.304 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.4 141.97 47.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.01 0.924 . . . . 0.0 108.589 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -66.93 -40.48 87.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.32 0.648 . . . . 0.0 110.37 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -136.0 156.82 76.83 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.547 1.539 . . . . 0.0 107.725 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 114.48 3.87 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.845 2.364 . . . . 0.0 108.294 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.142 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -33.53 74.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.901 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.5 -11.62 61.04 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.717 2.053 . . . . 0.0 112.741 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.87 -61.74 3.91 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 165.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.79 -43.61 98.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.886 1.274 . . . . 0.0 112.459 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.47 -41.0 80.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 124.0 0.92 . . . . 0.0 109.907 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.41 83.55 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.433 1.015 . . . . 0.0 109.353 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.33 75.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.051 0.541 . . . . 0.0 110.866 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.01 -46.0 89.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.575 0.75 . . . . 0.0 110.456 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -57.2 -52.62 64.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 124.405 1.082 . . . . 0.0 108.765 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -42.15 94.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.219 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.63 -55.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.443 1.497 . . . . 0.0 110.12 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -58.42 -35.54 72.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 118.9 0.773 . . . . 0.0 112.086 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -53.65 -56.34 18.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.61 -35.81 78.91 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.851 0.75 . . . . 0.0 111.703 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.36 -28.76 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.137 1.335 . . . . 0.0 111.462 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -90.44 -55.96 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.258 0.623 . . . . 0.0 110.827 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.56 -53.8 51.55 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.903 0.774 . . . . 0.0 112.756 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.87 76.41 11.55 Favored Pre-proline 0 N--CA 1.446 -0.654 0 C-N-CA 125.301 1.441 . . . . 0.0 109.059 -172.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -12.44 29.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.531 2.154 . . . . 0.0 112.41 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -61.88 -19.84 63.08 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.893 -1.129 . . . . 0.0 111.729 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -110.25 6.64 22.71 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.24 1.416 . . . . 0.0 113.118 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.85 95.68 3.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.3 m-85 -93.29 139.92 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -140.23 156.8 46.35 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 119.382 0.992 . . . . 0.0 112.882 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.24 132.7 1.65 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.73 -51.08 4.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.028 1.731 . . . . 0.0 112.276 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -59.13 -49.46 77.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.472 1.109 . . . . 0.0 110.264 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.87 -55.07 38.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.3 t -53.58 -40.14 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.41 -0.806 . . . . 0.0 111.451 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.34 -41.49 76.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.27 0.941 . . . . 0.0 110.964 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -44.91 83.31 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.082 -1.011 . . . . 0.0 109.647 176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.89 -31.75 72.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -62.72 -45.8 91.08 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.269 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.88 -25.1 66.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.61 -5.6 57.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.771 0.828 . . . . 0.0 111.541 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 58.31 19.96 6.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.509 1.524 . . . . 0.0 111.897 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.14 -5.72 15.86 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.201 -163.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.47 109.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.83 -45.97 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.231 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -146.22 133.46 20.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.06 123.74 50.23 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.347 1.859 . . . . 0.0 106.488 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.29 126.28 46.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 106.719 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -137.02 139.57 44.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.38 131.9 44.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.73 -34.2 67.27 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.99 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.58 -35.83 14.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.471 1.487 . . . . 0.0 113.591 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.8 mt -81.08 -42.43 21.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.023 0.829 . . . . 0.0 110.553 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -55.41 -28.91 57.15 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.069 -1.019 . . . . 0.0 112.218 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -106.45 16.62 24.45 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 127.533 2.333 . . . . 0.0 110.924 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -50.77 139.15 17.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.114 1.324 . . . . 0.0 111.254 -162.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -35.37 74.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.593 1.157 . . . . 0.0 111.74 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.16 119.91 20.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.509 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.405 1.002 . . . . 0.0 109.948 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -56.97 -45.05 83.16 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.637 1.175 . . . . 0.0 111.281 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -51.29 -48.79 62.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.065 1.302 . . . . 0.0 111.817 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -13.62 15.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.243 -1.36 . . . . 0.0 113.961 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -75.2 -63.47 1.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.684 1.584 . . . . 0.0 108.556 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -49.56 -53.86 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.828 -0.606 . . . . 0.0 112.039 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.59 -36.31 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.76 1.164 . . . . 0.0 111.544 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -64.78 -47.34 78.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 122.028 -0.42 . . . . 0.0 110.941 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.48 -46.63 89.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.712 0.805 . . . . 0.0 110.243 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.13 -39.09 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.506 1.123 . . . . 0.0 110.618 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.23 -43.05 58.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.568 -1.333 . . . . 0.0 110.883 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 t -64.36 -28.26 69.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.454 0.57 . . . . 0.0 111.151 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -65.15 -36.49 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 120.199 -1.563 . . . . 0.0 110.474 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -63.64 -45.62 89.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.365 1.439 . . . . 0.0 109.843 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.41 -37.36 64.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.363 1.065 . . . . 0.0 110.398 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -93.14 20.35 6.98 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.57 1.548 . . . . 0.0 111.215 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.12 27.47 16.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.27 2.228 . . . . 0.0 114.001 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.79 163.06 24.47 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -86.59 145.97 26.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.659 1.583 . . . . 0.0 109.124 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.86 139.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -128.3 121.22 28.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.76 122.09 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -94.46 128.41 41.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 117.4 5.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -58.81 -24.71 62.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.297 1.439 . . . . 0.0 112.415 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.07 -26.16 65.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 111.717 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -81.61 147.32 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.468 1.907 . . . . 0.0 109.436 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.05 -16.06 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.261 1.025 . . . . 0.0 112.262 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -60.19 -35.98 76.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.432 -1.417 . . . . 0.0 111.42 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.92 97.23 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -72.46 -38.24 68.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.11 0.964 . . . . 0.0 111.639 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -57.17 -51.32 69.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.36 -0.838 . . . . 0.0 109.343 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.59 -30.96 71.98 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.7 t -58.04 -37.3 74.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.445 1.898 . . . . 0.0 111.249 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -52.2 -33.45 40.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.61 1.164 . . . . 0.0 110.871 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.7 mt -105.49 31.29 5.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.674 2.79 . . . . 0.0 109.997 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 p 75.11 -14.93 0.71 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.871 2.868 . . . . 0.0 113.479 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.0 14.75 58.8 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.292 2.377 . . . . 0.0 113.13 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.54 132.68 27.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 120.096 1.948 . . . . 0.0 108.976 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.97 175.1 14.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.359 1.063 . . . . 0.0 109.823 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.53 144.46 15.43 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 86.2 mt -83.9 143.11 12.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 40' ' ' PHE . 13.5 mt -117.09 151.51 36.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 0.0 110.653 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -63.88 -51.91 62.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.735 170.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.08 154.73 80.48 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.256 1.423 . . . . 0.0 110.479 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.24 106.66 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.165 3.243 . . . . 0.0 108.733 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 80.7 t . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 122.705 0.402 . . . . 0.0 110.071 -163.595 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -25.72 66.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.175 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.95 65.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 121.566 1.985 . . . . 0.0 112.056 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.04 16.66 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 172.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.24 -50.31 73.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.289 0.636 . . . . 0.0 111.038 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.99 -47.88 88.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.314 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -55.58 26.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.297 1.408 . . . . 0.0 109.113 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.61 -28.05 66.85 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 127.288 2.235 . . . . 0.0 112.524 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.1 -45.93 17.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.828 1.251 . . . . 0.0 110.218 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -54.45 -48.69 71.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.284 1.834 . . . . 0.0 109.276 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.32 -40.24 67.6 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.183 1.393 . . . . 0.0 109.531 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -59.2 -54.39 47.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.782 1.233 . . . . 0.0 109.891 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -58.28 -38.24 76.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.361 0.665 . . . . 0.0 112.175 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' HZ3' ' CD2' ' A' ' 34' ' ' HIS . 2.0 ttpp -50.85 -57.2 9.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mmm -59.53 -39.06 82.7 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.4 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -53.36 -25.95 17.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.759 1.224 . . . . 0.0 112.054 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -96.28 -51.63 4.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.167 1.787 . . . . 0.0 111.504 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' CD2' ' HZ3' ' A' ' 30' ' ' LYS . 95.1 m-70 -71.75 -64.77 0.86 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.105 -0.997 . . . . 0.0 111.61 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -134.32 81.68 48.96 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.06 -14.42 43.37 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.45 2.1 . . . . 0.0 111.999 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.94 -23.75 7.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.621 1.568 . . . . 0.0 112.087 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -106.21 13.97 28.19 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.896 1.278 . . . . 0.0 111.995 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.72 90.96 2.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.107 1.322 . . . . 0.0 110.728 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -93.64 138.75 31.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 109.25 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -139.41 158.75 43.6 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.711 0.767 . . . . 0.0 111.308 171.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 134.76 1.33 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -172.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -44.33 -48.05 9.62 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 124.484 1.114 . . . . 0.0 110.84 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -60.7 -44.1 96.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.664 1.186 . . . . 0.0 111.365 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.83 -58.68 6.07 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 t -53.69 -38.8 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.699 0.8 . . . . 0.0 112.195 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.36 -36.94 74.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.749 1.159 . . . . 0.0 110.934 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -46.82 63.2 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.97 0.908 . . . . 0.0 109.557 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.59 -35.59 81.0 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -62.2 -44.51 96.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.47 -22.0 66.83 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.44 59.21 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.668 0.787 . . . . 0.0 111.375 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 28.0 mtt 52.06 44.52 29.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.362 1.465 . . . . 0.0 109.581 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.93 -9.95 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.246 2.219 . . . . 0.0 111.903 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.8 mt -80.08 105.95 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.22 -53.07 54.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.812 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 m -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.654 1.181 . . . . 0.0 108.292 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -109.77 137.87 46.96 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.386 1.874 . . . . 0.0 108.029 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.39 128.97 55.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.053 1.741 . . . . 0.0 107.725 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -144.95 143.47 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.402 1.001 . . . . 0.0 110.393 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.17 142.91 50.67 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.366 1.066 . . . . 0.0 109.724 170.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -56.5 -42.65 78.7 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.05 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.27 -20.81 7.74 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.6 -45.33 8.54 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.872 0.869 . . . . 0.0 109.202 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -51.32 -29.93 16.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.842 1.257 . . . . 0.0 112.276 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.91 31.35 5.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 110.841 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -51.68 148.01 5.94 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.666 0.666 . . . . 0.0 111.518 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -68.46 -31.29 70.48 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.413 1.485 . . . . 0.0 112.832 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.57 118.3 28.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.6 -30.63 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.34 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 -54.05 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.9 1.682 . . . . 0.0 109.891 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.4 m -58.2 -51.46 69.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.334 1.854 . . . . 0.0 110.756 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -58.26 -48.9 78.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.351 0.978 . . . . 0.0 110.242 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 m -55.14 -35.41 64.67 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.141 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -60.76 -51.82 67.71 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.46 1.027 . . . . 0.0 111.015 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -60.66 -51.45 69.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.181 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.83 -37.46 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.089 0.859 . . . . 0.0 110.971 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -57.82 -53.8 54.07 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.943 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.08 -48.21 82.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.315 1.009 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.54 -47.34 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.545 1.138 . . . . 0.0 110.526 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.522 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 5.3 m-20 -68.08 -43.22 79.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.653 -0.654 . . . . 0.0 110.555 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -72.85 -30.38 63.96 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.038 0.935 . . . . 0.0 110.324 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.29 -42.47 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.85 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 7.0 mtmp? -65.4 -39.24 91.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.898 0.772 . . . . 0.0 111.216 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.37 -25.61 66.87 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.933 -0.479 . . . . 0.0 111.561 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -100.71 44.1 1.03 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.45 5.04 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.447 3.099 . . . . 0.0 116.97 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.75 -174.47 48.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.486 1.517 . . . . 0.0 113.958 -171.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -130.79 149.33 52.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.802 2.441 . . . . 0.0 110.57 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.85 147.12 16.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.264 1.426 . . . . 0.0 108.826 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -147.21 126.59 13.13 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.849 2.06 . . . . 0.0 107.187 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -116.04 123.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.01 164.48 13.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.54 1.536 . . . . 0.0 108.331 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 136.75 42.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 162.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.8 t -51.61 -28.59 14.69 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.118 0.967 . . . . 0.0 111.47 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.18 -26.6 66.71 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 126.649 1.98 . . . . 0.0 113.613 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.405 ' HD1' ' CB ' ' A' ' 99' ' ' SER . 6.4 t-80 -84.03 158.85 21.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.669 0.788 . . . . 0.0 110.913 -165.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.44 -40.76 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 118.947 0.794 . . . . 0.0 109.321 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.405 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . 1.6 m -60.06 -23.32 63.67 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.863 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.69 -53.05 10.33 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.955 1.74 . . . . 0.0 110.97 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.19 -27.36 69.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.653 1.727 . . . . 0.0 112.071 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.55 -46.12 73.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.467 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.26 -34.64 78.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.747 -0.596 . . . . 0.0 111.022 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -57.91 -38.42 75.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.923 1.689 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -55.42 -23.38 24.6 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.344 -0.847 . . . . 0.0 111.085 173.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.53 30.81 7.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.763 2.825 . . . . 0.0 110.238 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.2 p 66.41 19.76 10.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.096 1.358 . . . . 0.0 113.969 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.44 15.65 52.94 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.355 2.407 . . . . 0.0 114.533 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.01 124.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.15 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.52 146.67 8.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.31 -0.869 . . . . 0.0 110.829 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.4 mt -83.83 152.45 3.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.38 145.74 42.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.783 0.801 . . . . 0.0 109.781 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -64.5 -46.71 81.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.982 1.313 . . . . 0.0 109.906 165.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -138.14 152.85 72.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.428 1.491 . . . . 0.0 108.747 -169.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 124.27 10.62 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.165 2.577 . . . . 0.0 109.105 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.3 74.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.459 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -56.62 17.24 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.646 1.112 . . . . 0.0 110.928 -172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.3 93.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -50.84 40.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.95 1.3 . . . . 0.0 109.003 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.0 -41.68 83.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 125.204 1.402 . . . . 0.0 109.949 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -59.0 -44.01 91.6 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 119.118 0.872 . . . . 0.0 109.205 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.0 87.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.968 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tp -64.16 -48.68 75.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.437 1.017 . . . . 0.0 110.571 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -53.28 -50.94 63.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.338 1.455 . . . . 0.0 109.099 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -66.36 -46.89 75.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.413 2.285 . . . . 0.0 109.416 -171.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -54.81 -56.21 21.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.476 1.51 . . . . 0.0 110.375 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.44 -30.68 70.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -50.76 -62.73 1.42 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.659 0.599 . . . . 0.0 109.486 169.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -29.49 70.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.048 -0.977 . . . . 0.0 111.613 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.25 -29.58 58.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.102 1.319 . . . . 0.0 111.76 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -92.31 -50.06 5.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.971 0.908 . . . . 0.0 110.367 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -73.37 -48.11 36.76 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -168.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.81 81.1 8.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.803 1.241 . . . . 0.0 109.062 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.83 -12.07 33.6 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.992 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -20.04 10.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 111.604 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -111.7 2.57 17.28 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.831 1.252 . . . . 0.0 113.106 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.06 88.48 2.91 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.583 1.083 . . . . 0.0 108.608 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -93.78 134.33 36.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.555 0.742 . . . . 0.0 109.011 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -140.74 164.79 29.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.396 0.617 . . . . 0.0 112.619 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.35 126.14 0.51 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -168.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 tp -37.14 -50.04 0.92 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.202 2.201 . . . . 0.0 110.785 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.64 -51.89 52.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 128.671 2.788 . . . . 0.0 114.084 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.22 -50.4 68.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.601 1.191 . . . . 0.0 107.959 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.76 -31.95 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.333 1.053 . . . . 0.0 111.131 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.86 -19.66 65.06 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.933 1.293 . . . . 0.0 112.713 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.74 -42.4 34.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 119.519 -1.988 . . . . 0.0 109.458 165.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.47 71.07 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -60.47 -43.83 96.52 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 119.11 0.868 . . . . 0.0 108.869 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -66.3 -11.17 49.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.57 -5.43 45.91 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.445 1.498 . . . . 0.0 112.078 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 29.1 mmt 55.49 14.15 1.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.85 . . . . 0.0 113.092 -166.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.92 -9.64 53.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.87 -1.144 . . . . 0.0 112.909 -162.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.2 mt -72.54 110.6 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.33 -60.19 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.577 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.2 m -144.79 141.79 29.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -110.06 133.98 52.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 107.773 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.34 119.49 35.87 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.6 1.56 . . . . 0.0 107.128 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 tt -138.85 141.2 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.02 144.47 55.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -59.54 -38.41 80.98 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.094 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -16.53 27.98 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.62 -40.42 9.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.94 1.245 . . . . 0.0 110.042 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.01 -19.19 17.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.72 0.808 . . . . 0.0 111.986 167.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -122.58 21.0 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.973 2.909 . . . . 0.0 111.372 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -56.73 151.96 13.17 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.571 0.749 . . . . 0.0 110.989 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -63.78 -47.18 81.98 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.179 0.591 . . . . 0.0 111.86 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.79 122.73 24.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.83 -32.09 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.684 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.82 -57.78 5.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.919 1.691 . . . . 0.0 110.494 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -53.04 -52.07 59.68 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.037 0.935 . . . . 0.0 109.532 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -57.01 -46.19 82.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.696 -0.628 . . . . 0.0 111.552 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 m -52.72 -42.56 64.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.859 0.754 . . . . 0.0 110.911 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -57.99 -52.6 64.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.918 0.887 . . . . 0.0 109.036 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -60.47 -53.14 61.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.272 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -61.22 -36.78 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.838 1.199 . . . . 0.0 110.758 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -53.15 34.09 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.34 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.05 -37.08 81.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.736 0.698 . . . . 0.0 111.482 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.75 -53.4 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 109.922 168.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -58.81 -47.39 84.94 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.872 1.269 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.8 m -63.0 -33.14 74.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.195 1.798 . . . . 0.0 112.014 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.13 -35.64 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 120.602 -1.311 . . . . 0.0 110.62 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.98 -34.51 77.91 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.47 0.577 . . . . 0.0 109.701 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.37 -34.75 78.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.713 0.688 . . . . 0.0 110.374 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -79.23 3.01 19.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.916 1.287 . . . . 0.0 112.101 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.59 24.53 10.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.381 2.272 . . . . 0.0 113.696 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.24 166.09 29.38 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.4 m -92.56 157.02 16.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.109 0.957 . . . . 0.0 111.126 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.08 147.72 17.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.968 1.707 . . . . 0.0 107.23 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -132.94 121.48 22.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.18 108.11 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -89.19 156.13 18.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.2 m -103.12 136.12 43.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 t -52.55 -39.5 61.53 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 124.7 1.25 . . . . 0.0 111.895 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.44 -23.58 63.7 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.849 -1.157 . . . . 0.0 113.481 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -85.81 148.98 25.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.182 0.993 . . . . 0.0 109.646 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.47 -17.55 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.922 -1.112 . . . . 0.0 111.697 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 p -57.16 -34.98 68.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.711 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.71 -44.4 57.04 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.31 -38.3 71.08 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.9 0.85 . . . . 0.0 110.916 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -76.8 -37.21 56.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.188 -0.945 . . . . 0.0 112.128 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.41 -32.04 73.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.563 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -56.11 -40.72 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.853 1.661 . . . . 0.0 111.287 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -58.24 -15.71 11.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 112.071 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.36 37.42 4.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 129.073 2.949 . . . . 0.0 108.901 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p 66.54 9.51 6.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.728 2.011 . . . . 0.0 114.72 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.26 15.7 65.93 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.119 2.295 . . . . 0.0 113.385 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.7 111.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.049 0.925 . . . . 0.0 108.708 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.66 174.12 10.93 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.638 1.575 . . . . 0.0 109.258 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.23 146.45 8.94 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.873 -1.142 . . . . 0.0 110.251 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 80.6 mt -83.8 152.01 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.232 1.413 . . . . 0.0 107.916 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 mt -117.16 138.45 51.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.996 0.919 . . . . 0.0 110.691 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -60.99 -42.08 97.74 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.035 1.334 . . . . 0.0 110.119 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -139.07 157.1 71.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 125.721 1.609 . . . . 0.0 107.941 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.0 125.07 12.56 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.83 2.354 . . . . 0.0 108.807 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.207 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.01 80.81 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 123.809 0.693 . . . . 0.0 110.363 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.58 -24.5 67.58 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.98 -43.19 74.43 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.48 -51.44 60.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 127.415 2.286 . . . . 0.0 110.528 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.71 -50.42 80.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 119.094 0.861 . . . . 0.0 109.3 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -60.47 -41.93 95.2 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.86 -0.525 . . . . 0.0 110.906 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.42 -48.67 80.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.92 -44.85 94.06 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.136 -0.978 . . . . 0.0 110.184 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.49 -50.8 72.43 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.186 1.795 . . . . 0.0 109.866 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.04 -42.28 80.78 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.083 1.49 . . . . 0.0 108.455 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.42 -58.45 7.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.653 1.181 . . . . 0.0 109.496 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.63 -40.34 75.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.563 0.345 . . . . 0.0 111.626 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.93 -44.2 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.928 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -35.58 62.44 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 119.127 0.876 . . . . 0.0 109.334 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -54.06 -33.41 57.39 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.658 1.117 . . . . 0.0 112.168 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -70.63 -56.84 5.53 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.945 1.698 . . . . 0.0 110.695 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -94.38 -52.93 4.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.395 1.478 . . . . 0.0 113.409 -160.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -138.09 71.69 47.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.713 1.605 . . . . 0.0 107.521 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.35 -10.64 26.82 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 112.488 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.08 -24.04 16.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.334 2.254 . . . . 0.0 111.571 167.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -104.46 10.96 35.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.443 1.097 . . . . 0.0 112.063 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.36 96.66 3.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.841 1.2 . . . . 0.0 108.512 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 49' ' ' ALA . 2.3 m-30 -93.92 133.19 37.61 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.951 0.9 . . . . 0.0 108.893 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -139.78 160.56 39.6 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.41 133.98 0.52 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -167.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 tp -40.45 -52.89 2.72 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 126.258 1.823 . . . . 0.0 111.576 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -54.56 -46.0 73.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.621 1.568 . . . . 0.0 111.983 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.1 -59.85 4.46 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.69 -39.48 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.596 1.158 . . . . 0.0 112.332 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -54.68 -39.23 67.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.333 1.053 . . . . 0.0 111.505 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.94 -53.21 22.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.799 1.24 . . . . 0.0 110.539 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . . . -55.93 -36.02 67.27 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -58.74 -47.29 85.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.66 -33.8 75.79 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.98 -9.24 57.6 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.164 0.586 . . . . 0.0 111.682 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 44.7 mtt 55.4 24.42 6.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 127.494 2.318 . . . . 0.0 111.839 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.86 -13.97 49.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.747 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 mt -66.39 106.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.568 1.147 . . . . 0.0 109.03 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.77 -57.05 4.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.5 m -134.99 131.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.81 132.08 54.47 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.834 2.054 . . . . 0.0 106.522 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 118.88 31.5 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 tt -136.23 139.95 44.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.668 1.122 . . . . 0.0 109.222 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.37 133.12 54.62 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -38.57 75.55 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.247 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.32 -20.48 28.95 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 113.948 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.22 -43.53 10.93 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -50.73 -31.41 16.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 112.157 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.09 46.96 2.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.178 2.191 . . . . 0.0 108.431 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.38 152.52 33.86 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.294 0.638 . . . . 0.0 110.393 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.21 -33.38 63.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.447 1.499 . . . . 0.0 112.874 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -83.61 119.73 25.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.684 1.129 . . . . 0.0 108.858 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -51.85 -44.38 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 117.829 -1.082 . . . . 0.0 112.787 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.02 69.37 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.857 1.662 . . . . 0.0 111.644 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.1 -46.11 82.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.23 1.012 . . . . 0.0 108.748 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -53.87 -50.02 67.22 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.345 0.975 . . . . 0.0 109.417 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 t -52.04 -44.07 64.06 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.11 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -57.65 -55.4 35.28 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.493 1.042 . . . . 0.0 109.349 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -56.45 -50.88 70.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.29 -36.9 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.369 0.986 . . . . 0.0 111.251 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -49.67 75.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.812 0.733 . . . . 0.0 109.044 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 tp -56.21 -51.13 69.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.891 0.877 . . . . 0.0 109.594 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.6 t -54.0 -47.63 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.588 0.755 . . . . 0.0 111.406 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.91 -54.39 22.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.29 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 -11.74 61.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.585 0.754 . . . . 0.0 112.089 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.83 -39.32 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 O-C-N 120.312 -1.493 . . . . 0.0 109.714 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -61.26 -47.78 84.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.036 1.289 . . . . 0.0 108.589 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -51.92 -47.94 64.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.46 1.104 . . . . 0.0 110.086 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -82.25 9.94 7.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.894 0.877 . . . . 0.0 112.264 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 87.91 4.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 130.221 3.408 . . . . 0.0 114.486 166.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.18 162.47 40.42 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.893 -1.129 . . . . 0.0 113.246 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.8 m -87.0 130.4 34.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.501 2.32 . . . . 0.0 109.128 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.04 145.46 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.469 171.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -131.89 132.79 43.93 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 127.163 2.185 . . . . 0.0 106.374 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -118.62 113.42 41.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -90.57 140.35 29.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.076 1.751 . . . . 0.0 109.73 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 m -87.47 130.5 34.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.467 0.707 . . . . 0.0 111.243 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -51.23 -42.01 60.7 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.575 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -70.32 -17.65 63.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.968 1.707 . . . . 0.0 113.511 -171.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -93.95 150.15 20.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.204 1.401 . . . . 0.0 110.093 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.89 -31.44 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -53.71 -23.01 10.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.408 0.683 . . . . 0.0 111.311 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 -53.06 5.87 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 118.243 -1.309 . . . . 0.0 112.377 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.74 -29.56 70.19 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.246 1.523 . . . . 0.0 110.69 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.4 -55.26 14.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.498 1.519 . . . . 0.0 110.14 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.29 -37.03 76.68 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 119.449 1.022 . . . . 0.0 110.914 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -58.1 -35.23 71.12 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 111.795 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -60.5 -25.56 66.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.544 -0.722 . . . . 0.0 111.741 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -102.71 20.03 18.06 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.675 2.39 . . . . 0.0 109.656 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.277 17.5 p 78.09 0.92 2.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.471 3.508 . . . . 0.0 113.71 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.88 22.15 62.02 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 127.056 2.265 . . . . 0.0 112.289 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.81 109.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.904 1.352 . . . . 0.0 108.016 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.15 176.36 9.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.513 1.525 . . . . 0.0 111.437 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.37 146.67 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.897 171.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.56 143.76 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 C-N-CA 126.319 1.848 . . . . 0.0 107.634 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.23 129.32 55.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 124.298 0.999 . . . . 0.0 109.631 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -54.0 -41.14 67.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.49 1.516 . . . . 0.0 110.467 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.67 154.76 75.14 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.847 1.659 . . . . 0.0 107.788 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.54 106.6 1.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.044 3.163 . . . . 0.0 108.478 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.567 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.45 98.73 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.325 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.11 -19.42 65.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.008 1.731 . . . . 0.0 112.761 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.83 -53.86 5.17 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 120.958 -1.088 . . . . 0.0 110.46 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.73 -51.71 66.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.943 0.897 . . . . 0.0 110.827 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.88 -48.63 78.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 126.192 1.797 . . . . 0.0 110.576 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -54.55 -48.94 71.43 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 119.56 1.073 . . . . 0.0 109.67 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -42.42 99.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.013 0.82 . . . . 0.0 111.813 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.33 -48.8 78.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.002 0.819 . . . . 0.0 110.716 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -61.47 -52.99 62.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.167 1.787 . . . . 0.0 109.342 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.2 -37.77 86.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.161 0.984 . . . . 0.0 108.886 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -58.94 -57.06 14.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.231 1.012 . . . . 0.0 110.341 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.89 -32.55 72.0 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.94 -59.25 3.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.16 -39.18 85.53 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.978 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.09 -20.27 51.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.857 0.753 . . . . 0.0 111.977 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -96.13 -53.36 3.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.532 1.133 . . . . 0.0 111.551 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -63.65 -66.36 0.55 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.521 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -145.11 80.83 10.9 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 109.616 -172.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.04 -6.52 8.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.228 2.619 . . . . 0.0 114.532 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.37 -25.07 33.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.091 0.86 . . . . 0.0 111.756 165.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -106.91 14.46 26.52 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.441 1.096 . . . . 0.0 112.015 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.56 92.71 3.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.305 0.957 . . . . 0.0 109.214 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.41 ' CD2' ' HB1' ' A' ' 49' ' ' ALA . 2.4 m-30 -93.75 132.78 37.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -139.9 163.48 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.497 0.719 . . . . 0.0 109.948 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 123.78 0.93 Allowed Glycine 0 C--N 1.331 0.269 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 -170.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.77 -46.8 2.75 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.726 1.611 . . . . 0.0 111.939 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.15 -55.57 26.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.765 2.826 . . . . 0.0 110.698 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.06 -57.42 13.16 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -50.92 -41.94 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.384 1.473 . . . . 0.0 111.835 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -56.8 -33.5 66.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.494 1.117 . . . . 0.0 111.488 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -77.3 -42.42 36.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 110.498 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HB1' ' CD2' ' A' ' 40' ' ' PHE . . . -65.6 -32.21 73.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.243 -0.911 . . . . 0.0 112.126 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -57.09 -51.33 69.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.1 -31.23 70.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -9.22 58.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.875 0.87 . . . . 0.0 111.319 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.2 mmt 62.27 21.44 12.49 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 110.948 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.4 -16.21 29.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 112.343 -168.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 mt -70.63 113.71 7.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -80.08 -55.41 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -137.95 128.87 27.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -110.61 131.1 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.96 2.104 . . . . 0.0 108.757 -175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.16 124.65 52.01 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 108.077 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.05 144.15 27.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 119.785 1.175 . . . . 0.0 108.382 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.29 136.5 53.55 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.39 -35.61 63.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.861 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.71 -16.0 55.41 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.36 1.436 . . . . 0.0 114.287 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.43 -40.8 9.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.607 1.163 . . . . 0.0 109.811 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -52.17 -29.31 21.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.237 1.015 . . . . 0.0 112.55 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 51.07 1.92 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.081 2.552 . . . . 0.0 108.159 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -57.98 148.25 26.57 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.314 -0.866 . . . . 0.0 109.954 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.79 -39.09 87.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.86 117.2 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.587 1.155 . . . . 0.0 108.641 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.51 -33.09 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.267 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.03 60.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 120.782 1.628 . . . . 0.0 109.762 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -59.21 -48.52 81.31 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 111.105 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -52.82 -50.92 62.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.292 0.951 . . . . 0.0 109.873 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -51.71 -42.04 61.94 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -56.8 -55.77 30.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.036 1.289 . . . . 0.0 110.341 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -57.3 -55.04 39.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.147 0.904 . . . . 0.0 111.014 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 t -51.43 -54.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.9 1.28 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -64.52 -40.25 95.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 tp -67.65 -41.39 83.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.413 0.552 . . . . 0.0 111.621 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.44 -48.95 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.622 1.169 . . . . 0.0 108.925 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -42.36 98.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.1 0.96 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 m -66.37 -32.19 73.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.478 1.911 . . . . 0.0 111.956 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.15 -38.03 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 120.34 -1.475 . . . . 0.0 110.467 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -61.77 -44.5 96.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.961 0.801 . . . . 0.0 109.819 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -54.41 -38.03 65.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.229 1.012 . . . . 0.0 110.268 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -93.93 16.82 13.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.842 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 89.77 1.47 0.23 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 128.977 2.911 . . . . 0.0 114.277 168.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.76 152.57 22.52 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.732 1.151 . . . . 0.0 112.775 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -80.35 152.2 29.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.891 2.076 . . . . 0.0 108.491 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.75 139.51 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -130.63 121.67 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.06 108.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 147.85 23.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.188 1.395 . . . . 0.0 109.532 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.98 136.26 45.1 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 171.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.8 t -71.56 4.93 2.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.542 0.737 . . . . 0.0 111.795 167.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.8 mt -121.47 -0.8 9.71 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.614 1.965 . . . . 0.0 112.607 -168.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.472 ' HD1' ' HB2' ' A' ' 99' ' ' SER . 9.7 t-80 -106.3 159.56 16.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.333 2.253 . . . . 0.0 110.357 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.472 ' HB2' ' HD1' ' A' ' 97' ' ' HIS . 17.7 m -58.76 -27.46 64.98 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.277 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.87 -54.72 7.97 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-O 119.004 -0.886 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.96 -31.94 73.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.073 0.937 . . . . 0.0 111.721 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.08 -46.15 90.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.989 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.53 -37.89 87.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.318 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.4 m -57.62 -29.15 64.29 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.566 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -66.41 -17.23 64.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 112.856 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -122.59 48.34 1.78 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.797 2.439 . . . . 0.0 107.251 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.5 p 63.03 4.47 1.55 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.69 1.996 . . . . 0.0 114.665 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.27 65.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.144 2.307 . . . . 0.0 112.904 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.7 p -154.32 113.19 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 118.866 1.333 . . . . 0.0 109.668 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.88 176.61 9.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 112.015 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.08 147.47 9.63 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.179 -1.576 . . . . 0.0 111.231 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -85.72 141.46 14.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.524 1.53 . . . . 0.0 107.68 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.0 mt -108.47 138.7 44.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.832 0.853 . . . . 0.0 109.683 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -52.04 -52.6 49.93 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.911 1.685 . . . . 0.0 109.752 168.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.02 159.34 71.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 127.448 2.299 . . . . 0.0 107.382 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.81 142.27 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.631 1.554 . . . . 0.0 109.514 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.528 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.77 79.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.965 0.348 . . . . 0.0 110.514 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.15 97.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.503 1.121 . . . . 0.0 112.466 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.49 63.63 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -50.76 54.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.26 1.424 . . . . 0.0 107.856 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.03 -51.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 110.39 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -60.32 -37.97 82.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.403 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.78 -35.48 74.93 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.219 0.918 . . . . 0.0 111.321 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tp -60.8 -49.07 78.96 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.056 0.844 . . . . 0.0 109.314 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -54.17 -56.81 14.64 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.52 1.128 . . . . 0.0 108.635 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -56.82 -43.46 81.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.084 0.865 . . . . 0.0 109.552 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.92 -54.55 40.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.835 0.854 . . . . 0.0 110.882 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.15 -35.73 77.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.795 0.725 . . . . 0.0 112.922 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -47.73 -59.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 108.206 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -62.23 -38.92 91.04 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.552 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.25 -29.28 57.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.044 1.293 . . . . 0.0 111.309 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -94.61 -47.08 6.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -69.39 -58.27 4.22 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.552 0.614 . . . . 0.0 111.658 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -144.92 79.33 12.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 C-N-CA 124.315 1.046 . . . . 0.0 109.369 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.65 -10.49 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.289 1.993 . . . . 0.0 114.571 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.22 -21.02 61.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.3 1.409 . . . . 0.0 111.23 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -102.97 12.33 36.21 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.824 1.193 . . . . 0.0 112.46 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.03 93.6 2.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.922 1.237 . . . . 0.0 109.064 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -97.34 138.26 35.08 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.468 0.707 . . . . 0.0 109.934 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -140.3 159.08 42.98 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.31 131.69 0.81 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 tp -43.27 -50.51 6.52 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.999 1.72 . . . . 0.0 112.968 -166.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.471 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -52.78 -55.81 20.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.528 1.931 . . . . 0.0 109.952 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -56.84 -57.14 13.78 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 t -47.96 -46.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.975 1.71 . . . . 0.0 111.675 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.36 -43.43 75.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.757 1.162 . . . . 0.0 110.382 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -64.32 -40.51 96.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.067 -1.021 . . . . 0.0 110.349 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.91 75.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.424 -0.797 . . . . 0.0 112.781 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -68.46 -42.57 78.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.49 -19.98 65.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.943 1.697 . . . . 0.0 113.118 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.58 -13.6 54.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.479 1.111 . . . . 0.0 111.897 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 57.36 24.86 10.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.469 1.908 . . . . 0.0 111.553 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.62 -15.06 31.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.438 -1.268 . . . . 0.0 111.891 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.07 107.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.505 1.048 . . . . 0.0 108.663 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.84 -48.45 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 172.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -143.78 134.31 24.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.4 tp -110.15 133.95 52.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.863 2.065 . . . . 0.0 107.314 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 124.61 48.54 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.108 1.763 . . . . 0.0 108.175 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 tt -138.64 134.97 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -62.32 125.88 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.743 1.217 . . . . 0.0 107.88 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -57.12 -32.41 66.32 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.017 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -54.13 -25.85 24.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.117 1.326 . . . . 0.0 113.44 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 mt -86.59 -42.15 13.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.51 1.124 . . . . 0.0 109.603 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -52.1 -27.58 14.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.262 1.425 . . . . 0.0 112.481 170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 34.78 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 110.591 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -55.7 146.81 20.05 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.016 -0.428 . . . . 0.0 111.185 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -25.21 64.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.37 120.67 31.69 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.61 -36.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.052 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -56.36 15.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.995 1.725 . . . . 0.0 109.888 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -53.68 -56.11 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.386 1.874 . . . . 0.0 110.232 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.09 -49.88 72.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.943 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -53.32 -41.82 66.07 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.94 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -57.39 -51.76 68.1 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.038 0.836 . . . . 0.0 110.383 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -60.79 -54.44 45.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.286 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.74 -31.79 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.581 1.082 . . . . 0.0 110.758 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -61.08 -58.21 9.32 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 109.075 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.371 1.068 . . . . 0.0 111.689 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.55 -46.22 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.13 . . . . 0.0 110.485 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.14 -37.87 69.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 0.0 111.46 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.2 t -67.01 -38.58 86.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.211 1.804 . . . . 0.0 110.859 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -55.38 -39.59 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 121.557 -0.715 . . . . 0.0 110.659 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.95 -39.3 87.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.794 0.724 . . . . 0.0 110.848 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.58 -28.55 69.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.686 0.794 . . . . 0.0 111.022 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -91.59 12.98 19.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.093 1.757 . . . . 0.0 110.732 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.11 26.4 15.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.471 . . . . 0.0 114.928 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.05 159.9 25.76 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.308 -0.87 . . . . 0.0 111.162 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -93.93 157.22 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.899 1.68 . . . . 0.0 110.184 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.54 148.37 25.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.1 0.96 . . . . 0.0 109.112 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.5 mmt-85 -141.83 121.68 13.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.37 112.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.12 124.57 34.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 96' ' ' LEU . 15.1 m -74.02 139.9 45.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.771 0.26 . . . . 0.0 111.034 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 t -61.39 10.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.261 2.625 . . . . 0.0 115.065 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 94' ' ' SER 0.455 0.2 OUTLIER -118.75 3.63 11.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.61 2.364 . . . . 0.0 113.665 -179.767 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.421 ' HD1' ' HB2' ' A' ' 99' ' ' SER . 2.1 t-80 -114.28 139.41 49.44 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.331 1.452 . . . . 0.0 110.886 -169.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 p -56.2 -28.93 26.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.688 0.795 . . . . 0.0 110.841 172.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.421 ' HB2' ' HD1' ' A' ' 97' ' ' HIS . 17.1 m -64.64 -27.72 69.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.726 -0.609 . . . . 0.0 111.529 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.64 52.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.67 -26.89 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.567 0.684 . . . . 0.0 112.002 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.47 -41.37 47.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.303 1.441 . . . . 0.0 110.381 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.38 -26.91 68.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 0.0 112.427 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 t -41.24 -54.9 2.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.176 2.19 . . . . 0.0 110.843 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -61.53 -5.23 1.67 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.638 1.975 . . . . 0.0 113.784 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 mt -131.66 33.97 3.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.784 2.433 . . . . 0.0 109.323 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.8 p 64.37 12.08 6.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.293 1.837 . . . . 0.0 113.671 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.4 17.19 68.24 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.996 2.236 . . . . 0.0 114.182 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.05 115.08 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.919 1.86 . . . . 0.0 108.856 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.97 15.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.343 1.057 . . . . 0.0 111.432 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.71 144.61 13.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.258 -1.526 . . . . 0.0 110.547 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.7 mt -84.12 144.29 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.162 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 mt -114.23 146.03 40.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.609 0.764 . . . . 0.0 109.512 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -71.26 -42.84 68.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.685 1.194 . . . . 0.0 110.43 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -129.34 157.39 76.35 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.113 1.365 . . . . 0.0 108.069 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 107.11 1.78 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.824 2.349 . . . . 0.0 106.888 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 tttt . . . . . 0 C--O 1.231 0.099 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.37 -45.83 46.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.795 1.238 . . . . 0.0 111.111 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.25 -32.33 73.94 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.799 0.84 . . . . 0.0 113.227 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.85 77.21 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.19 -51.92 65.86 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.533 1.133 . . . . 0.0 109.519 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.61 -42.35 81.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 124.467 1.107 . . . . 0.0 110.962 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -59.32 -49.59 77.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.659 1.118 . . . . 0.0 109.211 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.5 76.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.236 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.86 -50.24 74.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 110.375 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -62.31 -33.33 74.45 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.447 1.099 . . . . 0.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -43.72 32.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.665 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.79 -58.03 10.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.279 1.432 . . . . 0.0 110.775 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -54.55 -39.21 67.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.212 0.914 . . . . 0.0 112.294 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -45.44 -58.29 3.46 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.341 1.056 . . . . 0.0 108.939 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.77 80.3 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 117.871 -1.062 . . . . 0.0 111.329 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.18 -29.63 46.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.772 1.624 . . . . 0.0 111.498 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.78 -51.15 5.22 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.923 . . . . 0.0 110.878 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -75.96 -33.07 59.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -171.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -168.26 76.76 0.85 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.931 1.693 . . . . 0.0 110.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.8 -10.77 26.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.483 2.122 . . . . 0.0 114.107 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.93 -19.67 61.01 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.888 -1.133 . . . . 0.0 111.43 168.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -98.45 4.68 48.4 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.342 0.974 . . . . 0.0 112.989 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.81 95.87 2.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.85 1.205 . . . . 0.0 109.67 -176.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.425 ' CD2' ' HB1' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.1 141.39 28.47 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.019 1.328 . . . . 0.0 109.119 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -140.58 160.04 40.88 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.187 0.903 . . . . 0.0 113.07 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.66 131.49 2.66 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.7 tp -44.0 -45.94 8.09 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.688 1.595 . . . . 0.0 111.094 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -58.82 -45.76 89.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.049 1.339 . . . . 0.0 111.953 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -64.08 -59.05 4.93 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -49.64 -42.24 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.468 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -53.6 -40.64 65.85 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.46 1.104 . . . . 0.0 110.905 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.13 -48.08 25.45 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 126.1 1.76 . . . . 0.0 109.746 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 40' ' ' PHE . . . -54.52 -36.15 63.94 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.563 -1.336 . . . . 0.0 112.533 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -68.23 -40.97 81.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.392 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.36 -29.53 69.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.242 1.017 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 -7.0 51.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 111.172 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.8 mmt 54.21 24.69 5.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.688 1.995 . . . . 0.0 111.131 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.5 23.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.615 1.166 . . . . 0.0 111.839 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.54 118.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -97.23 -30.31 13.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.57 0.544 . . . . 0.0 110.946 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 m -139.33 132.77 30.2 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tp -109.87 133.82 52.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.76 125.03 53.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.083 1.753 . . . . 0.0 106.404 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 tt -140.83 148.14 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.7 t -67.92 144.26 55.31 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.09 -32.04 69.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.405 165.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.77 -24.73 64.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.433 1.47 . . . . 0.0 113.401 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.45 -45.62 11.67 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.905 1.282 . . . . 0.0 108.941 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.75 -26.49 34.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.234 1.413 . . . . 0.0 114.234 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 23.33 9.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.698 1.599 . . . . 0.0 110.807 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -55.63 147.45 18.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.916 0.886 . . . . 0.0 111.193 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -61.25 -45.14 95.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.929 1.291 . . . . 0.0 113.419 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -76.46 113.54 14.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 t -57.53 -32.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 117.514 -1.231 . . . . 0.0 111.139 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 -56.41 10.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 121.043 1.747 . . . . 0.0 110.506 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.9 m -50.81 -57.02 9.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.192 1.397 . . . . 0.0 110.786 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.59 -52.38 59.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.956 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.5 m -54.97 -43.13 73.23 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 117.056 -1.45 . . . . 0.0 111.162 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -51.99 -54.13 33.41 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 121.682 2.037 . . . . 0.0 110.032 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -57.99 -49.81 75.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.994 0.517 . . . . 0.0 111.466 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.85 -51.65 69.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.91 1.684 . . . . 0.0 110.983 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -63.88 -40.07 95.67 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.29 -43.84 89.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.05 -44.65 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.334 1.053 . . . . 0.0 109.704 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.57 -44.35 71.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.117 0.967 . . . . 0.0 111.22 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -66.06 -34.92 79.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.155 1.782 . . . . 0.0 110.626 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 t -59.09 -40.56 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.632 1.106 . . . . 0.0 109.952 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -69.68 -40.89 76.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.317 0.962 . . . . 0.0 110.029 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.04 -38.42 70.54 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.2 16.95 5.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.44 2.296 . . . . 0.0 112.193 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.07 10.18 3.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.024 2.93 . . . . 0.0 115.032 168.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.3 158.69 31.63 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.946 -1.096 . . . . 0.0 112.856 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.9 m -81.22 154.26 26.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.315 1.846 . . . . 0.0 109.655 172.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.68 145.55 25.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.037 0.935 . . . . 0.0 108.499 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -136.29 121.67 19.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 mm -112.78 107.74 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.67 155.19 19.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.637 1.175 . . . . 0.0 107.858 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -95.14 129.7 42.15 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -44.33 -46.5 9.31 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.875 1.27 . . . . 0.0 111.062 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.531 ' H ' HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -63.58 -17.41 62.81 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.488 1.515 . . . . 0.0 114.735 -173.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -75.93 155.35 35.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 108.759 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.93 -26.94 21.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.98 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -74.83 -18.03 60.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.563 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.93 -49.1 50.47 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 123.106 2.685 . . . . 0.0 107.865 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.57 -33.92 76.67 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.6 -45.22 91.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.89 -34.32 77.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.814 0.846 . . . . 0.0 110.907 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 m -56.48 -33.59 66.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.401 1.081 . . . . 0.0 113.602 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -60.51 -20.48 60.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.056 -1.028 . . . . 0.0 111.288 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.8 mt -117.72 25.6 10.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 129.313 3.045 . . . . 0.0 108.8 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 p 70.5 11.43 7.34 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.832 2.453 . . . . 0.0 113.807 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.49 76.55 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.955 2.217 . . . . 0.0 113.242 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.33 122.89 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.115 1.457 . . . . 0.0 110.409 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.98 173.97 13.68 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 110.989 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.93 145.97 14.13 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.648 -1.283 . . . . 0.0 111.375 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.53 143.92 10.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.383 1.873 . . . . 0.0 107.615 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 mt -117.53 143.44 46.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 110.793 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -62.13 -32.47 73.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.321 1.848 . . . . 0.0 111.716 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.41 161.85 28.46 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 127.26 2.224 . . . . 0.0 107.414 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 107.95 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.274 2.65 . . . . 0.0 109.205 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? . . . . . 0 C--O 1.232 0.181 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.8 -43.98 66.3 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 111.55 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.47 -21.67 63.69 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.11 -44.43 54.16 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.53 -43.83 97.84 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.298 0.639 . . . . 0.0 110.353 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.6 t -58.17 -51.92 65.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 118.117 -0.945 . . . . 0.0 109.366 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -39.22 84.74 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.881 1.219 . . . . 0.0 110.024 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.94 -55.89 28.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.46 0.704 . . . . 0.0 110.916 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.08 -41.74 79.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.539 1.063 . . . . 0.0 111.673 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.23 -50.09 75.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 126.533 1.933 . . . . 0.0 109.173 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.0 -39.82 87.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.07 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.95 -57.22 12.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.324 1.85 . . . . 0.0 110.24 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -55.78 -38.62 70.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.343 0.657 . . . . 0.0 112.428 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -44.65 -60.18 2.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.226 0.61 . . . . 0.0 110.099 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -34.68 78.89 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.656 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.67 -30.2 54.83 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.035 1.289 . . . . 0.0 111.519 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -85.63 -65.39 1.02 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.41 0.684 . . . . 0.0 110.34 167.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.52 -38.64 84.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -161.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.99 77.87 3.93 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.59 -5.76 13.74 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.794 1.663 . . . . 0.0 113.299 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -60.19 -19.47 54.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.616 -1.302 . . . . 0.0 111.094 166.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -107.95 9.7 28.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.207 1.403 . . . . 0.0 112.603 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 92.24 2.93 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 120.198 1.363 . . . . 0.0 108.774 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -94.0 137.77 32.84 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.67 160.26 40.29 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 139.11 1.13 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -39.58 -52.45 2.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.53 1.932 . . . . 0.0 112.026 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -59.64 -44.55 93.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.643 1.977 . . . . 0.0 111.748 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -64.4 -57.26 9.8 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -46.44 -42.6 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.262 1.425 . . . . 0.0 111.686 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -53.44 -43.64 68.22 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.301 0.955 . . . . 0.0 111.391 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.73 -42.21 74.28 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.565 1.146 . . . . 0.0 110.292 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.0 96.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -66.11 -36.69 83.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.15 0.281 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.35 -38.4 77.15 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.123 -0.986 . . . . 0.0 111.632 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -3.59 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.299 1.44 . . . . 0.0 111.512 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.7 mmt 63.4 4.39 1.7 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 113.08 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.24 48.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -158.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.9 mt -74.25 110.18 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -168.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.71 -54.23 17.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -146.35 136.32 23.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.455 1.502 . . . . 0.0 107.653 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -110.0 142.36 41.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.468 1.907 . . . . 0.0 107.666 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.1 119.52 25.51 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.72 149.77 22.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 120.135 1.334 . . . . 0.0 108.051 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 3.9 t -66.51 144.06 56.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -60.33 -36.46 78.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.357 166.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 6.5 pt-20 -56.04 -31.66 63.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.741 1.61 . . . . 0.0 113.65 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 mt -81.71 -42.08 20.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 109.41 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -52.73 -24.99 9.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 113.997 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.55 27.09 6.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.657 1.583 . . . . 0.0 110.819 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -53.52 142.99 20.79 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.716 0.769 . . . . 0.0 111.62 -172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -58.78 -39.82 82.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.366 2.267 . . . . 0.0 113.144 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -85.9 114.9 23.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 t -39.6 -41.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.743 1.617 . . . . 0.0 111.491 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -35.11 62.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.803 1.183 . . . . 0.0 114.065 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -74.36 -45.82 44.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -52.77 -50.9 62.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.3 p -53.17 -46.38 68.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.472 0.709 . . . . 0.0 110.292 -168.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -53.64 -55.58 24.66 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.496 1.918 . . . . 0.0 109.909 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -59.19 -59.37 5.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.621 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.53 -36.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.825 1.648 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -57.37 11.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.134 1.374 . . . . 0.0 109.286 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -62.27 -36.78 83.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.297 0.639 . . . . 0.0 111.829 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 t -60.24 -50.48 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.319 1.448 . . . . 0.0 109.012 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.26 -36.72 80.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.504 0.721 . . . . 0.0 110.214 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 t -65.45 -35.0 79.61 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.26 1.424 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.71 -35.53 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 119.422 1.01 . . . . 0.0 110.188 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -69.16 -33.88 74.1 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.38 -25.39 67.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.0 110.914 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -99.09 11.86 37.76 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 127.185 2.194 . . . . 0.0 111.508 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.51 33.37 23.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.398 1.479 . . . . 0.0 113.212 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.75 153.46 20.92 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.204 0.911 . . . . 0.0 111.057 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -74.99 151.12 38.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.031 0.932 . . . . 0.0 108.955 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -121.16 142.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.92 1.288 . . . . 0.0 107.6 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -133.16 120.88 21.78 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.6 mm -94.49 125.21 47.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.42 166.57 13.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.102 0.864 . . . . 0.0 108.788 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.03 110.08 21.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 166.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 t -43.71 -34.3 1.47 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.851 1.26 . . . . 0.0 112.16 173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.604 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -65.83 -36.14 82.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.862 2.465 . . . . 0.0 113.748 -176.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -72.78 160.3 32.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.133 1.773 . . . . 0.0 111.236 -172.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -36.65 48.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.702 -0.624 . . . . 0.0 110.171 172.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -66.66 -16.73 64.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.483 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.14 10.39 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 171.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.11 -36.96 63.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.949 0.9 . . . . 0.0 110.273 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.04 -63.73 1.2 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.662 169.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.69 -34.15 64.79 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.319 1.418 . . . . 0.0 111.662 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.0 66.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.077 1.351 . . . . 0.0 112.476 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.45 -28.6 68.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 111.055 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.9 mt -104.48 31.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.418 2.287 . . . . 0.0 109.371 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p 69.05 -0.37 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.273 2.229 . . . . 0.0 114.049 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.33 58.88 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.961 2.696 . . . . 0.0 112.538 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.17 118.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.843 1.322 . . . . 0.0 110.306 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.44 9.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.404 1.481 . . . . 0.0 112.567 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.16 149.45 17.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 110.772 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.13 144.82 9.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.671 1.988 . . . . 0.0 107.029 167.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.29 136.41 53.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -60.25 -39.0 85.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.979 0.912 . . . . 0.0 110.802 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.31 157.81 75.88 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 128.448 2.699 . . . . 0.0 107.101 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.5 124.69 13.22 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.961 1.774 . . . . 0.0 107.805 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.0 t . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 171.817 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 mttt . . . . . 0 C--O 1.235 0.302 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.24 79.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.465 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.59 65.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.285 1.034 . . . . 0.0 113.441 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.2 -34.54 54.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.05 -50.5 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.562 0.681 . . . . 0.0 109.783 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.07 -53.54 41.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 125.828 1.651 . . . . 0.0 109.726 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -59.42 -36.29 75.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.425 1.011 . . . . 0.0 110.326 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.39 94.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.368 0.985 . . . . 0.0 110.995 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.48 -44.82 89.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.035 1.288 . . . . 0.0 110.82 173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -60.6 -47.62 85.38 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.526 1.53 . . . . 0.0 110.289 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -73.3 -35.99 66.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.875 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.61 -59.58 5.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.824 1.65 . . . . 0.0 110.791 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 -37.73 66.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -51.56 -53.1 41.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.703 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -34.08 77.34 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 118.152 -0.928 . . . . 0.0 111.533 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.59 -33.65 64.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.976 1.262 . . . . 0.0 110.514 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -76.78 -62.45 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -75.56 -34.56 60.71 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -160.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -157.91 81.48 3.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.987 1.715 . . . . 0.0 109.763 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 -14.03 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.684 2.256 . . . . 0.0 113.916 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.74 -15.28 39.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.657 -1.277 . . . . 0.0 111.871 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -107.52 8.9 29.59 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.957 0.903 . . . . 0.0 112.488 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.29 86.74 2.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.789 1.177 . . . . 0.0 108.837 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -93.19 144.9 24.84 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.54 164.94 28.81 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.42 134.95 0.57 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 tp -43.05 -47.29 5.88 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.857 1.663 . . . . 0.0 111.806 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -55.72 -43.33 76.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 112.189 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -55.65 13.03 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.72 -42.11 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 111.711 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.26 -24.79 68.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.377 1.471 . . . . 0.0 111.492 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -72.4 -70.31 0.35 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 116.005 -1.95 . . . . 0.0 107.104 161.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.28 -31.19 8.48 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 122.92 2.6 . . . . 0.0 116.135 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.06 -49.21 32.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.416 1.486 . . . . 0.0 112.209 167.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -48.0 -42.15 27.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 128.323 2.649 . . . . 0.0 110.176 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.07 -0.44 57.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.666 1.186 . . . . 0.0 111.116 -169.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 mmt 54.0 31.69 14.05 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.559 1.543 . . . . 0.0 110.425 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.81 -7.81 36.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.094 -166.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -83.08 114.81 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 119.679 1.127 . . . . 0.0 108.043 -166.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.37 -54.79 6.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.337 1.455 . . . . 0.0 108.478 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.6 m -146.52 138.14 24.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.339 1.455 . . . . 0.0 107.336 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.69 139.57 44.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 106.95 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.87 124.17 42.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.048 1.739 . . . . 0.0 106.555 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.7 tt -137.52 142.13 37.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.18 131.06 45.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -53.8 -33.85 57.32 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 117.564 -1.208 . . . . 0.0 111.522 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.84 -37.72 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.944 1.702 . . . . 0.0 112.873 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.48 -42.75 67.72 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.92 0.867 . . . . 0.0 109.752 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.69 -12.14 15.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.057 0.943 . . . . 0.0 112.572 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -123.44 19.96 9.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.898 2.479 . . . . 0.0 111.497 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -61.12 152.93 27.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.353 1.073 . . . . 0.0 111.949 -168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -77.57 -33.76 53.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.903 2.481 . . . . 0.0 112.399 -172.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 50.4 t0 -80.14 120.0 23.68 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.95 -29.98 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.605 0.639 . . . . 0.0 110.455 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.7 -56.05 18.67 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 119.863 -1.773 . . . . 0.0 111.513 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 54.9 m -56.21 -57.44 12.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.938 1.295 . . . . 0.0 108.826 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -54.25 -49.2 70.08 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.412 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.5 m -53.94 -41.17 67.46 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.079 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -57.42 -48.94 77.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.987 1.267 . . . . 0.0 109.812 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -61.91 -56.12 22.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.048 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.85 -36.6 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.532 1.06 . . . . 0.0 110.161 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -57.74 -59.9 4.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.65 0.78 . . . . 0.0 109.486 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 tp -56.07 -44.17 78.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 111.46 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -53.15 -52.16 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.777 1.231 . . . . 0.0 109.991 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -32.73 63.33 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.16 -0.962 . . . . 0.0 112.303 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -62.23 -37.87 87.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.432 1.493 . . . . 0.0 110.985 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.55 -33.34 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.11 0.868 . . . . 0.0 110.008 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -70.48 -29.69 66.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.246 1.385 . . . . 0.0 112.222 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.06 -47.97 75.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -74.69 17.27 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.64 1.976 . . . . 0.0 112.44 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.89 56.46 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.145 2.578 . . . . 0.0 112.369 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.97 155.19 18.49 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.882 1.706 . . . . 0.0 109.822 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.1 m -75.99 148.81 37.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.452 -1.028 . . . . 0.0 110.078 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.0 129.72 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 109.016 169.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -119.64 121.53 39.48 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.42 120.25 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -88.42 162.49 16.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -104.27 113.28 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 117.374 -1.298 . . . . 0.0 107.674 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 t -56.11 -30.0 61.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.662 1.119 . . . . 0.0 112.476 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.598 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.06 -38.88 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.025 1.73 . . . . 0.0 111.251 -178.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -75.32 142.02 43.29 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 126.792 2.037 . . . . 0.0 110.655 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.04 -18.34 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.25 1.02 . . . . 0.0 113.331 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.0 m -61.7 -26.46 68.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.501 1.046 . . . . 0.0 111.165 172.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.16 -55.5 29.12 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -56.78 -36.11 69.48 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.06 0.93 . . . . 0.0 112.797 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -67.26 -45.64 76.04 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.576 -0.702 . . . . 0.0 110.184 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.92 -37.09 83.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.942 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.7 m -62.32 -28.54 69.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.563 1.074 . . . . 0.0 112.431 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -69.88 3.89 2.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.086 0.954 . . . . 0.0 112.904 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.8 mt -136.52 33.27 2.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.055 2.942 . . . . 0.0 107.645 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.263 3.2 p 59.74 11.15 2.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.312 2.645 . . . . 0.0 114.845 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.96 17.86 80.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 128.054 2.74 . . . . 0.0 113.03 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.37 120.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 119.706 1.753 . . . . 0.0 108.949 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.47 175.35 10.63 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.933 0.893 . . . . 0.0 109.566 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.85 146.71 11.26 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.614 -1.304 . . . . 0.0 109.454 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.56 139.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.9 mt -106.07 141.27 37.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -50.02 -61.21 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.943 2.097 . . . . 0.0 108.752 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -130.62 159.46 70.88 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 127.49 2.316 . . . . 0.0 109.278 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 106.68 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.855 2.37 . . . . 0.0 109.577 -176.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 170.696 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.61 -44.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.398 0.679 . . . . 0.0 111.427 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.19 83.06 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.134 1.373 . . . . 0.0 112.84 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.31 -40.22 98.72 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -45.19 78.39 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.39 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.6 t -54.92 -42.13 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.642 0.777 . . . . 0.0 109.481 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -51.19 70.99 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.35 80.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.737 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.82 -48.37 79.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.739 1.154 . . . . 0.0 110.907 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.28 -53.4 54.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.557 1.543 . . . . 0.0 109.306 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -66.42 -37.8 86.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.264 1.826 . . . . 0.0 109.169 -171.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -65.1 -56.09 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 111.19 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.88 -37.47 74.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.951 0.796 . . . . 0.0 112.235 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.91 -55.24 12.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.719 0.808 . . . . 0.0 109.731 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -64.11 -34.88 79.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.836 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.11 -17.59 27.87 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.158 0.89 . . . . 0.0 111.86 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -96.55 -57.81 2.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 110.622 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -70.43 -44.48 67.79 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -165.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.33 77.93 6.56 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 119.229 0.922 . . . . 0.0 110.094 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -65.07 -8.76 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.268 1.979 . . . . 0.0 114.208 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.27 -17.86 32.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.91 1.232 . . . . 0.0 111.279 164.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -108.42 11.26 27.11 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.311 1.444 . . . . 0.0 112.784 174.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.55 89.83 2.64 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.876 1.216 . . . . 0.0 108.934 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -93.81 140.19 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.743 0.817 . . . . 0.0 108.834 -175.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -139.79 158.53 43.95 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.778 0.431 . . . . 0.0 111.214 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 131.72 0.79 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.0 tp -41.21 -49.75 3.58 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.054 2.141 . . . . 0.0 111.456 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.39 -56.76 15.42 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.526 1.931 . . . . 0.0 110.638 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -59.21 -51.06 71.62 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.16 -42.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.984 1.313 . . . . 0.0 111.962 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -61.06 -30.02 70.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 120.254 1.388 . . . . 0.0 111.261 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -75.0 -45.76 39.74 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 120.098 -1.626 . . . . 0.0 110.579 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.67 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.77 -1.206 . . . . 0.0 111.94 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.45 -52.2 66.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.221 1.409 . . . . 0.0 109.062 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.37 -37.21 72.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.972 0.805 . . . . 0.0 111.65 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.48 -5.01 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.706 0.802 . . . . 0.0 111.282 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.2 mmt 53.97 26.25 6.17 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.195 1.798 . . . . 0.0 111.854 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.11 -11.15 36.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.886 -164.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.39 118.19 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -169.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -84.28 -50.09 8.17 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 167.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.3 m -131.99 131.63 42.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 tp -110.15 130.81 55.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.234 1.814 . . . . 0.0 107.579 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 131.7 54.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.194 1.797 . . . . 0.0 106.468 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.49 146.62 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.39 0.541 . . . . 0.0 109.751 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.16 134.16 51.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 166.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -52.0 -36.6 50.42 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.144 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.61 -33.1 59.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.935 1.243 . . . . 0.0 113.242 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.94 -39.99 20.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.901 0.773 . . . . 0.0 109.347 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -57.57 -16.99 11.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.142 0.977 . . . . 0.0 112.555 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 39.83 3.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.721 2.008 . . . . 0.0 109.241 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -58.5 152.8 17.3 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.625 -0.672 . . . . 0.0 109.535 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -67.73 -55.0 14.8 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.105 1.362 . . . . 0.0 111.725 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -63.6 120.1 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.55 -42.09 80.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.558 1.143 . . . . 0.0 111.521 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.38 -34.3 61.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.95 0.795 . . . . 0.0 111.694 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.0 m -70.92 -45.65 63.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.234 175.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -51.64 -53.47 38.34 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.502 1.046 . . . . 0.0 109.075 167.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.3 t -52.1 -40.44 61.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.98 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -58.8 -57.35 13.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 120.206 1.367 . . . . 0.0 109.725 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -54.18 -50.37 67.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.527 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.37 -38.0 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 118.363 0.528 . . . . 0.0 111.045 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -58.93 -50.75 72.87 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.91 -42.73 97.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.957 0.903 . . . . 0.0 111.226 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -49.89 -52.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.547 1.139 . . . . 0.0 109.571 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.606 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 23.7 t70 -65.52 -43.12 91.03 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.436 0.694 . . . . 0.0 111.243 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -37.44 79.01 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.871 1.668 . . . . 0.0 111.769 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.82 -33.89 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.629 1.104 . . . . 0.0 110.115 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.606 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 5.7 mtmp? -75.57 -33.35 60.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.853 1.206 . . . . 0.0 111.402 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -56.56 -43.44 79.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -77.53 21.78 0.26 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.482 1.913 . . . . 0.0 111.721 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.73 9.05 0.53 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.794 3.238 . . . . 0.0 115.834 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.48 176.04 52.51 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.79 1.216 . . . . 0.0 112.209 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -108.05 149.36 28.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.173 2.189 . . . . 0.0 109.493 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.9 146.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.269 1.428 . . . . 0.0 107.407 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -139.28 121.75 16.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.32 115.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.19 173.74 7.99 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.365 1.466 . . . . 0.0 108.398 -175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -103.8 132.72 49.79 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -43.21 31.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.343 1.457 . . . . 0.0 111.907 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.603 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -71.05 -20.39 62.38 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.096 2.158 . . . . 0.0 112.953 -174.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.61 158.11 34.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.097 -1.002 . . . . 0.0 109.38 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 p -57.58 -37.87 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 m -64.52 -24.15 67.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.279 1.032 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.59 -41.96 28.11 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.67 -41.64 81.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.18 0.99 . . . . 0.0 109.584 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -68.91 -43.74 74.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.544 0.737 . . . . 0.0 111.643 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.48 -31.45 72.67 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.311 0.505 . . . . 0.0 110.172 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.03 -39.59 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.66 1.184 . . . . 0.0 112.637 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -56.54 -14.74 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.594 1.158 . . . . 0.0 112.111 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.1 mt -128.29 33.86 4.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.182 2.993 . . . . 0.0 108.757 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 65.58 10.6 6.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.761 1.624 . . . . 0.0 114.119 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.43 15.11 70.13 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.432 1.968 . . . . 0.0 115.118 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.38 129.65 9.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 119.229 1.515 . . . . 0.0 109.157 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.35 175.91 13.39 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 109.396 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.36 145.07 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.53 -0.731 . . . . 0.0 110.526 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 77.0 mt -83.82 135.35 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.2 mt -105.02 141.23 36.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp-105 -56.54 -56.31 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.708 1.603 . . . . 0.0 109.138 171.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -124.71 157.14 66.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 125.959 1.704 . . . . 0.0 108.493 -172.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.49 115.2 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.359 2.04 . . . . 0.0 107.269 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.535 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -42.03 92.8 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.204 0.456 . . . . 0.0 109.9 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -9.77 34.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.171 1.388 . . . . 0.0 112.88 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.3 -42.68 4.22 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 120.153 1.342 . . . . 0.0 110.988 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.36 -57.37 12.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.59 1.556 . . . . 0.0 108.804 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.98 -50.53 19.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 125.685 1.594 . . . . 0.0 110.407 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -58.15 -50.47 73.4 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.265 0.939 . . . . 0.0 109.58 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.63 75.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.667 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.0 -49.84 64.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.571 1.532 . . . . 0.0 110.451 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.7 -49.12 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.583 1.553 . . . . 0.0 109.178 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -69.48 -34.59 74.55 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.237 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -62.25 -58.54 7.35 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 127.049 2.14 . . . . 0.0 109.647 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -54.43 -39.63 67.54 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.361 0.664 . . . . 0.0 112.248 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -49.9 -48.59 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.475 0.31 . . . . 0.0 111.211 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.2 mtp -71.45 -35.91 71.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.964 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -55.71 -26.97 47.93 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.447 1.021 . . . . 0.0 111.476 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -92.94 -36.39 12.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.73 1.612 . . . . 0.0 112.861 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -86.03 -64.05 1.22 Allowed 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.295 1.038 . . . . 0.0 112.0 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -142.6 80.93 13.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.711 1.604 . . . . 0.0 107.513 -170.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.6 -13.1 38.55 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.769 2.313 . . . . 0.0 112.552 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.8 -20.15 14.01 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 111.892 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -103.27 1.83 33.43 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 124.354 1.062 . . . . 0.0 113.543 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.41 90.69 2.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 120.058 1.299 . . . . 0.0 109.915 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.4 ' CD2' ' HB1' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.37 140.43 29.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.052 0.941 . . . . 0.0 108.966 -173.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -139.95 160.16 40.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.32 143.45 1.39 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.5 tp -46.64 -49.89 18.46 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.326 1.45 . . . . 0.0 112.356 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -46.41 90.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.682 0.793 . . . . 0.0 109.72 -175.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.5 -56.43 18.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.53 -43.3 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.904 1.282 . . . . 0.0 111.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.39 -40.81 68.56 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.577 1.08 . . . . 0.0 110.645 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.19 -46.48 33.78 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.505 1.522 . . . . 0.0 109.838 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.4 ' HB1' ' CD2' ' A' ' 40' ' ' PHE . . . -54.71 -37.54 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.995 -1.065 . . . . 0.0 111.941 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -66.73 -44.34 81.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.391 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.0 -34.63 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.789 1.177 . . . . 0.0 111.758 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.7 -7.15 36.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.978 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mmt 51.29 39.53 24.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.846 2.459 . . . . 0.0 109.362 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.0 -10.5 13.93 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.386 1.074 . . . . 0.0 112.923 -164.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.35 111.13 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.49 -59.27 3.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.2 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.421 ' CG2' ' HE ' ' A' ' 91' ' ' ARG . 53.4 m -146.07 134.73 22.22 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.69 140.96 41.36 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 126.712 2.005 . . . . 0.0 107.201 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.41 129.79 56.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.978 2.111 . . . . 0.0 106.468 176.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.28 131.6 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -63.58 129.97 42.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.73 -33.94 36.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.235 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.32 -22.06 62.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.35 1.432 . . . . 0.0 112.871 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.02 -40.49 11.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.241 1.016 . . . . 0.0 109.191 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -54.23 -21.06 8.09 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 20.05 7.3 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.934 1.243 . . . . 0.0 112.062 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -49.8 145.07 5.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.154 1.382 . . . . 0.0 112.908 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -46.65 89.45 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.05 110.33 5.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.69 -36.47 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.851 -172.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.78 65.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.02 1.282 . . . . 0.0 112.575 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.14 -48.72 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.289 1.036 . . . . 0.0 108.506 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 -55.02 -49.95 70.25 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.394 0.678 . . . . 0.0 109.994 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.2 p -54.61 -43.75 72.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.44 0.696 . . . . 0.0 110.276 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -54.72 -57.34 11.87 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.061 1.344 . . . . 0.0 108.772 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -55.7 -53.19 59.63 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.7 -38.53 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 118.91 0.777 . . . . 0.0 110.281 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -57.57 -52.35 65.76 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.545 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.73 -43.74 98.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.431 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -52.47 -50.43 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.501 1.121 . . . . 0.0 109.758 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.23 96.74 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.146 0.578 . . . . 0.0 109.961 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.8 m -64.7 -30.6 71.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.992 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.66 -44.77 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.138 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -64.01 -34.26 77.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.292 0.951 . . . . 0.0 110.419 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.35 -35.73 81.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.568 0.622 . . . . 0.0 110.454 174.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -91.51 24.29 3.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.9 1.68 . . . . 0.0 111.394 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 28.91 12.84 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.094 1.758 . . . . 0.0 113.861 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.85 145.52 17.82 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 170.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 m -78.06 154.98 30.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.266 1.026 . . . . 0.0 109.017 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.96 149.29 17.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.924 1.29 . . . . 0.0 107.561 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.421 ' HE ' ' CG2' ' A' ' 57' ' ' THR . 21.4 mmt180 -137.46 121.31 17.58 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 mm -90.66 119.4 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 m-85 -89.91 125.12 35.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -62.93 109.63 1.52 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 166.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -56.74 -27.41 59.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.455 1.502 . . . . 0.0 112.836 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.616 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -67.03 -32.13 73.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.852 2.461 . . . . 0.0 111.758 -178.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -71.56 158.5 36.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.626 1.97 . . . . 0.0 110.632 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -19.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.071 -1.018 . . . . 0.0 111.536 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -72.87 -23.32 60.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.177 -1.577 . . . . 0.0 111.003 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.33 -43.05 26.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.637 1.108 . . . . 0.0 110.436 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -52.2 -47.83 65.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.355 1.078 . . . . 0.0 109.876 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.63 -42.26 91.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.167 0.587 . . . . 0.0 111.245 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.12 -33.74 75.04 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 119.018 0.826 . . . . 0.0 111.392 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 m -59.59 -36.54 76.45 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.224 1.409 . . . . 0.0 111.68 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -58.19 -20.65 42.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.711 0.804 . . . . 0.0 112.167 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.48 21.86 15.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.706 2.402 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 p 74.16 -1.68 3.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.551 2.74 . . . . 0.0 113.893 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.42 62.36 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 127.238 2.352 . . . . 0.0 113.462 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.79 133.14 26.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.903 1.852 . . . . 0.0 108.88 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.63 177.35 10.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 110.684 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.83 149.49 16.46 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.797 -1.19 . . . . 0.0 109.738 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.46 142.87 12.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.3 mt -108.97 146.14 34.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 109.202 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -59.04 -44.28 91.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.968 169.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -142.88 161.71 47.48 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.391 1.476 . . . . 0.0 109.344 -169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.09 114.04 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 tptp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.99 95.76 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.918 1.287 . . . . 0.0 112.015 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -18.59 65.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.766 0.827 . . . . 0.0 111.382 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.44 51.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -60.66 -50.72 72.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.594 1.158 . . . . 0.0 110.717 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.77 -50.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.213 1.005 . . . . 0.0 110.392 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -53.53 -49.31 67.88 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.057 0.543 . . . . 0.0 110.862 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.05 99.1 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.297 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.67 -45.28 92.53 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.37 1.441 . . . . 0.0 109.71 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.162 0.985 . . . . 0.0 111.399 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.12 -45.88 46.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.26 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.56 -58.38 6.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.908 1.283 . . . . 0.0 110.267 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.49 -37.8 88.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.864 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -55.97 12.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 ttp -68.64 -30.24 68.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.862 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.25 -44.72 92.36 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 120.473 1.488 . . . . 0.0 111.386 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -65.22 -24.17 67.27 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.744 1.618 . . . . 0.0 111.901 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -117.96 -41.59 2.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -162.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -155.7 83.71 3.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.332 1.853 . . . . 0.0 108.995 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.91 -7.57 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.92 2.413 . . . . 0.0 113.605 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.53 -21.44 52.38 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.889 -1.132 . . . . 0.0 111.579 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -103.4 9.23 37.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.006 1.276 . . . . 0.0 112.707 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.15 92.74 2.82 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.411 1.084 . . . . 0.0 109.427 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -93.23 145.59 24.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.06 1.344 . . . . 0.0 107.658 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -140.78 163.56 32.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.25 139.43 1.12 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -43.27 -51.0 6.43 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.176 2.19 . . . . 0.0 112.201 -172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -52.82 18.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.011 2.124 . . . . 0.0 111.526 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.5 -53.14 25.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -50.5 -44.54 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.876 1.27 . . . . 0.0 111.061 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -53.25 -38.43 63.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.634 1.173 . . . . 0.0 111.65 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -78.63 -43.35 26.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 126.051 1.741 . . . . 0.0 110.632 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -30.69 71.36 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 118.497 -1.281 . . . . 0.0 110.629 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.29 -36.69 82.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.473 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -52.52 -35.33 53.09 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.057 0.943 . . . . 0.0 111.503 168.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.54 59.35 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.352 1.461 . . . . 0.0 112.538 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.8 mmt 56.07 39.1 30.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.645 0.778 . . . . 0.0 110.905 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.97 -7.14 14.57 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.116 0.966 . . . . 0.0 112.198 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -78.44 105.19 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.07 -54.89 6.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 123.699 0.624 . . . . 0.0 109.754 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -135.83 124.65 23.99 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -171.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.8 tp -109.07 132.37 54.18 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 107.788 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.59 119.5 35.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.782 1.633 . . . . 0.0 107.66 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.42 141.24 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 137.16 57.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -59.2 -37.66 77.97 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.84 -30.89 62.17 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.686 1.195 . . . . 0.0 112.77 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -82.87 -42.08 18.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.613 1.097 . . . . 0.0 109.618 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -56.74 -18.85 14.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.389 0.675 . . . . 0.0 112.597 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 23.9 9.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.775 2.83 . . . . 0.0 109.881 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -56.45 140.38 46.06 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.689 0.677 . . . . 0.0 110.0 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -59.65 -35.84 75.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.484 1.114 . . . . 0.0 112.638 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -79.68 125.14 29.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 108.61 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.69 -38.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 116.846 -1.55 . . . . 0.0 111.167 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.74 -52.07 41.84 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.921 2.146 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -56.88 -52.42 65.21 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.409 1.884 . . . . 0.0 108.262 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -52.25 -46.48 65.8 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.726 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 p -53.8 -44.16 69.92 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.926 0.89 . . . . 0.0 110.364 -173.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -57.66 -55.48 34.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.273 1.429 . . . . 0.0 108.689 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -57.57 -51.41 69.6 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.587 -1.196 . . . . 0.0 112.629 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.2 -37.63 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.765 1.166 . . . . 0.0 110.937 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.9 mtt-85 -60.17 -51.06 71.19 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.073 0.949 . . . . 0.0 110.238 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.67 -42.83 95.11 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 122.893 0.477 . . . . 0.0 111.221 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.68 -48.55 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.02 0.928 . . . . 0.0 109.986 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.29 -49.13 78.81 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.251 1.02 . . . . 0.0 110.666 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -71.82 -23.54 61.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.683 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.72 -41.67 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 120.058 1.299 . . . . 0.0 108.465 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -65.14 -38.21 89.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.804 1.184 . . . . 0.0 110.327 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.18 -32.67 64.56 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.531 0.605 . . . . 0.0 110.82 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -98.87 24.26 7.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.436 2.294 . . . . 0.0 111.04 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 61.6 19.4 10.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.834 2.054 . . . . 0.0 114.185 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.46 146.71 19.1 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 122.277 0.932 . . . . 0.0 110.792 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.57 149.58 48.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.202 2.201 . . . . 0.0 109.534 170.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.0 t -117.33 150.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.14 1.376 . . . . 0.0 108.861 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -138.54 138.05 37.62 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.679 1.992 . . . . 0.0 106.648 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.72 104.26 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 -170.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.4 m-85 -90.02 124.88 35.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -70.09 128.48 36.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -60.71 10.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.828 2.451 . . . . 0.0 116.148 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.8 mt -129.22 -18.9 3.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.952 2.101 . . . . 0.0 111.393 -175.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -69.67 157.54 37.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.164 1.385 . . . . 0.0 110.532 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.76 -39.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.478 0.581 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 m -63.83 -32.3 73.77 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.198 -0.938 . . . . 0.0 110.489 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -65.93 -50.41 52.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.942 1.258 . . . . 0.0 110.333 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.04 -26.75 65.13 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.298 1.049 . . . . 0.0 112.028 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.62 -46.24 89.16 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.12 -0.988 . . . . 0.0 108.84 170.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -60.61 -25.74 66.48 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.488 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t -50.69 -44.08 57.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.572 . . . . 0.0 111.826 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.15 0.56 0.91 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.435 1.094 . . . . 0.0 113.398 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.65 32.75 3.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.742 2.417 . . . . 0.0 108.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p 65.32 -3.45 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.787 2.435 . . . . 0.0 114.174 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.35 18.6 64.08 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.522 2.487 . . . . 0.0 112.884 -170.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.43 129.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 119.638 1.719 . . . . 0.0 110.804 167.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.66 173.49 13.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.456 1.102 . . . . 0.0 109.782 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.09 15.87 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.8 -1.187 . . . . 0.0 110.424 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -98.33 140.5 18.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 126.578 1.951 . . . . 0.0 108.048 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.43 145.39 33.06 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.429 0.691 . . . . 0.0 111.266 -175.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -66.25 -39.81 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.928 1.291 . . . . 0.0 110.787 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.55 155.08 57.03 Favored Pre-proline 0 N--CA 1.453 -0.286 0 C-N-CA 123.748 0.819 . . . . 0.0 109.464 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.32 146.4 62.77 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.661 2.24 . . . . 0.0 109.601 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 125.887 1.675 . . . . 0.0 106.741 -170.173 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tptm . . . . . 0 N--CA 1.462 0.143 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -25.82 68.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.892 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.17 63.41 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 119.616 1.098 . . . . 0.0 111.491 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.98 -53.0 43.75 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 170.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.21 -58.98 5.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.047 0.939 . . . . 0.0 110.71 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.51 -41.61 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 117.417 -1.278 . . . . 0.0 111.606 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -55.03 -48.35 73.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.802 1.637 . . . . 0.0 109.235 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.61 88.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.892 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.27 -46.9 88.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.064 1.302 . . . . 0.0 110.086 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -56.52 -53.94 51.66 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.75 1.22 . . . . 0.0 109.054 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -66.52 -41.7 88.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.156 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.36 -57.73 10.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.302 1.041 . . . . 0.0 110.933 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.59 -41.25 89.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.166 0.439 . . . . 0.0 111.772 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -50.74 -51.97 45.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 tpp -61.03 -41.04 95.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.714 0.806 . . . . 0.0 111.731 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.44 -29.51 61.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.064 1.746 . . . . 0.0 111.469 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -80.59 -59.37 2.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.993 1.317 . . . . 0.0 108.94 173.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -71.02 -51.64 24.23 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -166.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.13 78.67 9.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.883 1.273 . . . . 0.0 108.305 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.57 -9.19 12.72 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.823 2.349 . . . . 0.0 114.137 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.62 -16.75 51.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 0.0 111.142 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -107.82 9.15 28.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 112.179 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.76 89.57 2.96 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.788 1.235 . . . . 0.0 107.947 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -94.11 133.36 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.028 -172.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -140.25 161.29 38.03 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.32 137.91 0.46 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -168.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 tp -37.16 -53.9 1.02 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.741 2.016 . . . . 0.0 112.862 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -59.56 -49.4 77.9 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.703 1.201 . . . . 0.0 110.943 -174.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -56.24 -58.67 6.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 t -48.93 -45.27 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.474 1.109 . . . . 0.0 112.317 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -58.24 -40.62 82.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.113 1.324 . . . . 0.0 111.205 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -37.85 85.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.63 1.172 . . . . 0.0 109.695 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.25 -35.26 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.17 -38.74 92.36 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.11 -3.6 7.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.745 1.618 . . . . 0.0 114.745 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.61 -5.73 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 112.041 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 mmt 63.26 4.59 1.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.078 2.151 . . . . 0.0 112.596 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.68 -10.15 59.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.033 -164.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.96 115.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.28 -65.17 1.04 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 m -125.83 132.64 52.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.91 132.84 53.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.265 1.826 . . . . 0.0 107.127 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 120.95 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.707 1.603 . . . . 0.0 106.961 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.54 145.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.02 142.32 58.46 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.718 0.807 . . . . 0.0 109.58 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.97 -42.34 89.7 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.09 -33.34 39.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.99 -43.29 30.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.912 0.778 . . . . 0.0 110.124 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.25 -23.75 16.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.65 1.18 . . . . 0.0 113.624 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.16 27.27 5.66 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.722 1.609 . . . . 0.0 111.29 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -54.43 149.22 10.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.33 1.452 . . . . 0.0 112.687 -174.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -58.58 -26.39 63.57 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.768 2.027 . . . . 0.0 114.51 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -105.21 114.4 28.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -53.13 -39.25 32.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.234 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -34.87 61.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.065 1.302 . . . . 0.0 111.974 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 m -65.95 -53.49 38.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -52.43 -50.51 62.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p -56.85 -36.8 70.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.481 0.582 . . . . 0.0 111.523 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.74 -53.73 53.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.92 0.782 . . . . 0.0 109.73 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -59.03 -53.76 54.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.05 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 m -63.55 -35.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.528 1.058 . . . . 0.0 110.451 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -61.67 -56.07 23.68 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -54.72 -41.31 70.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.82 -50.93 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.993 0.917 . . . . 0.0 110.695 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.37 -46.16 67.61 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.626 0.77 . . . . 0.0 110.022 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.4 m -66.29 -23.8 66.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.395 1.478 . . . . 0.0 112.323 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.95 -38.38 82.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.917 0.78 . . . . 0.0 110.071 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.54 -43.47 89.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.909 0.777 . . . . 0.0 109.493 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.32 -44.41 95.49 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.529 0.518 . . . . 0.0 110.073 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -70.91 6.42 1.55 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 112.231 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.83 54.89 0.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 130.479 3.512 . . . . 0.0 113.093 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.89 163.43 17.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.522 1.058 . . . . 0.0 113.871 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -82.2 146.31 29.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.465 2.306 . . . . 0.0 109.571 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.14 144.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.443 1.497 . . . . 0.0 107.923 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -133.38 121.61 22.56 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.96 110.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.94 124.77 35.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 m -70.04 116.87 10.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -58.61 -17.03 18.7 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.78 -41.52 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.497 1.119 . . . . 0.0 112.181 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.77 153.42 41.86 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 109.591 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.55 -26.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.556 -0.715 . . . . 0.0 111.629 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 p -58.31 -27.51 64.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.221 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.22 -53.0 19.9 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 124.176 0.893 . . . . 0.0 111.034 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -38.93 74.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.653 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.47 -58.31 9.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.219 1.408 . . . . 0.0 109.661 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -56.37 -29.06 60.94 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.61 0.641 . . . . 0.0 111.402 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.02 -36.5 65.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.591 1.557 . . . . 0.0 112.593 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.53 -32.53 68.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.141 0.976 . . . . 0.0 110.705 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -99.79 21.86 11.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.204 2.201 . . . . 0.0 109.692 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p 68.99 9.39 7.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.664 2.386 . . . . 0.0 114.257 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.35 18.97 78.81 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.204 1.859 . . . . 0.0 113.504 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.13 122.02 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.992 1.396 . . . . 0.0 108.977 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.7 170.06 19.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 110.043 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.9 153.68 39.41 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.619 -0.676 . . . . 0.0 110.777 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.9 mt -84.11 141.76 14.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.664 1.585 . . . . 0.0 107.327 168.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.2 mt -109.36 145.08 36.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.161 0.981 . . . . 0.0 110.167 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -65.68 -38.63 89.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.018 1.327 . . . . 0.0 111.223 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -143.55 157.57 58.78 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 127.309 2.244 . . . . 0.0 106.76 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.13 128.0 15.09 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.883 1.722 . . . . 0.0 108.384 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 174.856 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.84 94.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.716 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.24 87.39 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.218 0.917 . . . . 0.0 112.353 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.41 61.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 119.292 0.951 . . . . 0.0 111.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -67.12 -44.32 80.2 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.5 -1.0 . . . . 0.0 109.841 172.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.59 -45.93 82.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -60.75 -48.15 83.11 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.924 0.784 . . . . 0.0 109.993 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.21 80.2 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.46 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -64.76 -50.71 65.75 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.504 1.047 . . . . 0.0 110.435 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -33.81 76.24 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.201 1.0 . . . . 0.0 110.388 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.51 -44.61 67.25 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.209 1.404 . . . . 0.0 110.148 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -58.93 -52.81 64.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.433 1.093 . . . . 0.0 109.944 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.21 -38.81 87.92 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.042 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -45.19 -52.63 9.17 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mmt -63.76 -47.76 79.69 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.198 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.55 -35.38 60.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.362 0.983 . . . . 0.0 111.541 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -78.9 -56.62 4.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.162 0.985 . . . . 0.0 109.569 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -76.46 -70.15 0.47 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.121 1.368 . . . . 0.0 113.307 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.51 71.63 66.03 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.52 -14.35 44.43 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.655 -170.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.03 -21.09 58.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.775 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -100.59 14.17 32.27 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.133 1.373 . . . . 0.0 113.864 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.33 110.05 12.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.327 1.051 . . . . 0.0 108.757 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.6 m-85 -107.62 130.79 54.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.554 1.142 . . . . 0.0 108.468 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.29 156.6 46.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.728 1.149 . . . . 0.0 114.1 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.97 140.04 0.19 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.633 1.111 . . . . 0.0 110.526 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -47.5 -49.81 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.439 1.096 . . . . 0.0 112.461 -162.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -58.95 -32.7 69.86 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.799 1.64 . . . . 0.0 112.632 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -71.16 -63.31 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -50.74 -41.12 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 0.0 112.233 -170.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -44.68 -49.71 10.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.074 1.75 . . . . 0.0 111.089 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -71.54 -41.92 68.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 109.851 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -66.73 -29.34 69.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.304 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.09 -37.33 78.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.3 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.91 -7.26 10.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.6 0.15 30.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.696 1.599 . . . . 0.0 112.571 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 55.96 8.2 0.35 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 127.025 2.13 . . . . 0.0 112.727 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -18.64 60.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.845 -1.16 . . . . 0.0 112.102 -162.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.28 115.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.82 -55.81 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 165.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -132.72 135.48 45.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 tp -110.25 133.18 53.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.953 2.101 . . . . 0.0 106.547 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 129.37 55.5 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.525 1.93 . . . . 0.0 107.115 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -143.56 136.39 24.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 119.014 0.824 . . . . 0.0 109.585 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.23 128.24 35.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 168.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -34.07 69.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.564 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -43.85 -39.7 4.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.659 1.184 . . . . 0.0 113.473 170.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 mt -77.07 -42.93 36.28 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.486 1.114 . . . . 0.0 109.571 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.53 -20.09 11.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.952 1.301 . . . . 0.0 112.877 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 30.35 4.73 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 119.96 -1.712 . . . . 0.0 110.014 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -56.18 149.39 16.14 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.255 0.55 . . . . 0.0 110.98 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -32.47 65.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.463 1.105 . . . . 0.0 112.439 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.9 113.6 20.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.38 -36.56 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.579 -168.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.61 59.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.596 1.089 . . . . 0.0 112.196 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.1 m -55.7 -52.61 63.28 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.081 1.352 . . . . 0.0 108.406 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -53.07 -53.58 48.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.586 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -53.12 -44.81 67.96 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.19 0.596 . . . . 0.0 109.949 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -54.93 -53.87 49.98 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.062 0.945 . . . . 0.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -57.96 -57.37 13.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.197 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.64 -30.41 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.218 0.917 . . . . 0.0 111.102 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -66.25 -59.8 3.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.918 0.887 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 tp -52.74 -39.57 62.26 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.512 0.725 . . . . 0.0 111.445 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.48 -53.25 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.333 1.053 . . . . 0.0 110.235 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.55 -36.03 80.18 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.167 -0.333 . . . . 0.0 111.249 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -69.4 -24.47 63.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.055 0.942 . . . . 0.0 112.435 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.85 -43.85 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -61.16 -43.32 99.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.355 0.98 . . . . 0.0 110.926 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.6 -44.09 62.72 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.345 1.458 . . . . 0.0 110.124 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -85.32 25.44 1.01 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.689 1.195 . . . . 0.0 111.037 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.31 20.57 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.28 2.232 . . . . 0.0 114.064 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.64 -176.44 50.97 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 120.969 -1.082 . . . . 0.0 112.683 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 m -122.05 152.35 39.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.141 2.576 . . . . 0.0 108.499 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.73 124.14 56.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 47.8 mmt-85 -116.17 121.33 41.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -102.68 108.07 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.32 124.0 34.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -71.7 123.57 22.85 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -49.69 -42.73 46.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.329 1.851 . . . . 0.0 112.501 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.67 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.6 -37.21 67.81 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.191 1.796 . . . . 0.0 112.304 -174.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -72.74 152.09 41.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.994 1.318 . . . . 0.0 110.391 -167.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.54 -32.48 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.297 0.639 . . . . 0.0 111.595 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.5 m -65.07 -33.99 77.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.035 -1.041 . . . . 0.0 111.781 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.4 -49.55 77.29 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.1 -38.79 92.35 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.407 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -59.75 -47.26 86.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.21 -29.33 70.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.286 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.5 m -59.82 -34.27 72.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.641 1.11 . . . . 0.0 112.56 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.67 -3.93 7.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.71 1.204 . . . . 0.0 112.428 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -127.47 23.03 6.39 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.354 2.662 . . . . 0.0 108.679 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.7 p 69.75 1.3 3.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 128.449 2.7 . . . . 0.0 114.194 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.61 17.43 70.82 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.299 1.904 . . . . 0.0 113.224 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.03 129.83 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 120.165 1.982 . . . . 0.0 108.879 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.59 173.98 13.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.016 0.926 . . . . 0.0 110.291 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.46 153.92 25.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.193 -0.942 . . . . 0.0 110.874 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.6 mt -99.66 144.94 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.319 1.848 . . . . 0.0 107.911 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 mt -116.99 131.31 56.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.595 0.758 . . . . 0.0 111.721 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -53.54 -36.93 62.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.643 1.977 . . . . 0.0 111.865 173.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -149.07 157.53 39.81 Favored Pre-proline 0 N--CA 1.444 -0.737 0 C-N-CA 126.621 1.968 . . . . 0.0 106.358 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.43 144.08 66.04 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.233 1.956 . . . . 0.0 109.37 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.33 -41.03 83.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.266 0.626 . . . . 0.0 109.949 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 -26.35 67.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.994 0.815 . . . . 0.0 112.975 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.54 -38.73 86.75 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.674 1.125 . . . . 0.0 111.093 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.67 -52.63 56.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.678 170.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.02 -49.02 75.04 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 125.117 1.367 . . . . 0.0 110.034 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -49.98 69.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.03 78.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.752 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -64.98 -52.48 55.98 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.253 1.388 . . . . 0.0 110.285 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.61 -43.97 85.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.358 1.063 . . . . 0.0 109.262 -173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.5 -34.54 63.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.811 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.82 -55.08 25.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.629 1.572 . . . . 0.0 109.847 173.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.75 -39.07 73.33 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -53.76 -50.09 66.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.164 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -32.15 72.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.564 1.075 . . . . 0.0 111.3 175.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 tp -55.52 -36.17 66.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.182 1.356 . . . . 0.0 110.665 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -74.22 -57.14 4.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 111.079 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -76.69 -58.78 3.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -166.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -136.91 73.67 52.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.998 1.719 . . . . 0.0 108.283 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.26 -14.13 42.1 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.135 2.557 . . . . 0.0 113.476 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -64.73 -13.73 55.89 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.56 -1.337 . . . . 0.0 111.631 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -103.18 -0.25 30.77 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.377 1.071 . . . . 0.0 112.8 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.08 91.17 3.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.299 0.954 . . . . 0.0 108.816 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -93.35 137.75 32.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.688 1.195 . . . . 0.0 108.707 -175.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -140.33 159.6 41.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.07 134.45 0.63 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.1 tp -42.16 -51.8 4.54 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.473 1.509 . . . . 0.0 112.447 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -56.96 -42.53 80.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.84 1.656 . . . . 0.0 111.708 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -65.25 -55.94 15.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.11 -41.92 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.358 1.063 . . . . 0.0 112.332 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -55.52 -40.38 71.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.245 0.929 . . . . 0.0 110.731 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -71.66 -41.13 69.13 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.681 1.593 . . . . 0.0 110.919 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.01 -30.24 69.44 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.179 -0.95 . . . . 0.0 112.085 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.19 -44.15 97.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.38 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.23 -33.33 69.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.253 0.933 . . . . 0.0 112.876 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.6 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.05 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 mmt 47.46 36.61 5.26 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.925 2.09 . . . . 0.0 110.467 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.64 -20.55 13.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.642 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.66 113.97 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.31 -42.1 14.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 124.122 0.889 . . . . 0.0 110.177 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.2 m -141.64 124.72 16.3 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 tp -110.07 125.51 53.03 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 127.121 2.168 . . . . 0.0 108.814 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -108.02 126.95 53.33 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.993 1.717 . . . . 0.0 107.857 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -143.17 142.53 25.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.33 133.43 54.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 168.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.2 -39.91 73.18 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.352 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -49.58 -36.46 24.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.592 1.542 . . . . 0.0 113.803 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.3 mt -78.04 -38.56 44.31 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.825 1.193 . . . . 0.0 110.258 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -56.6 -30.25 63.02 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.318 1.047 . . . . 0.0 111.457 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 42.2 3.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.774 2.429 . . . . 0.0 109.055 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -60.99 146.9 45.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.31 -35.74 78.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.162 0.985 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -87.04 114.96 24.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.98 1.312 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.74 -34.61 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.626 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.21 11.77 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 120.093 1.315 . . . . 0.0 110.527 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -62.52 -45.21 94.05 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.637 1.175 . . . . 0.0 110.464 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -51.61 -44.97 63.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.965 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 p -51.61 -46.08 63.46 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.319 0.509 . . . . 0.0 110.083 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.41 -46.23 90.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 109.562 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -59.64 -61.39 2.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.01 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.74 -36.99 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.832 1.196 . . . . 0.0 110.857 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.11 -49.3 78.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.235 1.014 . . . . 0.0 111.297 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.1 -43.15 96.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.132 0.573 . . . . 0.0 109.928 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.33 -55.38 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.761 1.225 . . . . 0.0 110.164 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -39.63 94.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.703 0.801 . . . . 0.0 110.652 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 t -67.14 -36.79 82.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.504 1.122 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.82 -40.24 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.313 0.96 . . . . 0.0 109.273 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -65.29 -41.46 94.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.218 0.917 . . . . 0.0 110.904 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.2 -39.87 73.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.075 0.398 . . . . 0.0 110.501 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -75.39 -2.84 30.42 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 112.92 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 80.51 26.47 0.29 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.72 2.808 . . . . 0.0 113.941 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.75 143.71 16.82 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.499 1.523 . . . . 0.0 112.319 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.0 m -74.77 131.91 41.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.152 2.181 . . . . 0.0 109.778 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.7 t -93.99 148.43 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.989 0.916 . . . . 0.0 109.148 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -140.36 122.01 15.27 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.212 1.805 . . . . 0.0 108.085 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.27 109.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.9 m-85 -89.23 124.33 34.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.9 t -69.75 127.78 34.12 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -31.58 62.84 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.105 0.478 . . . . 0.0 110.355 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.91 -4.78 22.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.839 1.655 . . . . 0.0 113.642 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -109.66 143.42 39.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.867 1.667 . . . . 0.0 110.348 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -22.38 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.757 -0.59 . . . . 0.0 112.154 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -64.8 -20.53 66.43 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.596 -1.315 . . . . 0.0 111.174 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.0 -32.76 13.48 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 119.539 1.063 . . . . 0.0 112.271 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.25 -39.69 79.84 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.137 0.968 . . . . 0.0 108.855 168.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.06 -52.36 56.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.649 1.18 . . . . 0.0 110.763 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.32 -30.88 63.13 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.352 0.978 . . . . 0.0 111.713 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.8 t -52.44 -39.93 61.62 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.679 1.592 . . . . 0.0 112.362 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.29 -25.84 59.9 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.466 1.106 . . . . 0.0 111.145 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.1 mt -109.4 23.27 14.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.991 2.116 . . . . 0.0 109.849 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.9 p 73.65 0.23 3.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.321 2.648 . . . . 0.0 113.745 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.14 21.09 63.5 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.402 1.953 . . . . 0.0 113.129 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.48 129.23 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.603 1.702 . . . . 0.0 109.12 171.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.31 177.41 11.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.768 1.227 . . . . 0.0 110.323 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.59 150.29 17.55 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.857 -1.152 . . . . 0.0 111.522 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.1 mt -83.76 141.07 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.03 144.19 43.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.602 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -65.57 -25.71 67.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.286 2.234 . . . . 0.0 112.273 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -159.86 161.39 26.47 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 127.141 2.177 . . . . 0.0 106.41 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.32 132.37 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.089 1.859 . . . . 0.0 109.563 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 80.5 t . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.27 64.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.679 -163.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.95 -36.43 62.83 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.183 0.902 . . . . 0.0 113.259 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.5 71.1 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 118.987 0.812 . . . . 0.0 111.863 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.66 -53.27 57.04 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.297 0.639 . . . . 0.0 109.328 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.51 -33.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.373 1.069 . . . . 0.0 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -62.96 -47.19 84.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.941 1.7 . . . . 0.0 110.513 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.67 -37.77 82.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.134 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -48.99 79.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.483 1.038 . . . . 0.0 110.111 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -57.52 -53.56 56.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.328 1.451 . . . . 0.0 108.443 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -38.93 83.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.147 0.904 . . . . 0.0 109.77 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.19 -53.13 61.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.815 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.59 -36.29 82.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -53.9 -55.24 28.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.041 0.937 . . . . 0.0 108.721 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 tpp -57.51 -38.81 75.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.8 0.44 . . . . 0.0 110.302 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.02 -19.59 66.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.119 1.768 . . . . 0.0 112.822 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -95.0 -34.89 12.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -90.08 -70.6 0.66 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.1 77.03 68.49 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 109.388 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.99 -8.98 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.597 2.198 . . . . 0.0 114.092 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -57.06 -22.97 43.27 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.046 1.294 . . . . 0.0 111.747 166.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -106.17 8.64 32.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 112.598 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.97 98.19 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.168 0.987 . . . . 0.0 109.521 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -100.46 141.74 32.91 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.384 1.074 . . . . 0.0 109.159 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.13 161.09 38.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.749 0.785 . . . . 0.0 112.95 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 148.21 0.68 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 125.242 1.401 . . . . 0.0 111.226 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 tp -49.69 -44.83 48.25 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.31 1.044 . . . . 0.0 110.972 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -61.06 -54.5 43.92 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.263 1.425 . . . . 0.0 111.289 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -61.77 -50.97 70.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 0.0 108.205 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.31 -38.88 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 111.906 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.04 -22.42 64.96 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.209 -0.932 . . . . 0.0 112.742 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -77.98 -43.34 29.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.72 1.145 . . . . 0.0 108.859 167.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.23 94.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.005 -0.434 . . . . 0.0 112.02 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.86 -33.53 76.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.503 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.65 -35.01 79.63 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.045 0.839 . . . . 0.0 112.365 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.79 -0.19 29.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 111.991 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 62.19 3.08 0.93 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.88 2.472 . . . . 0.0 114.417 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.72 -2.46 50.65 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.696 -1.252 . . . . 0.0 112.629 -162.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.41 110.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.58 -49.36 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 108.121 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -144.41 136.76 26.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 tp -109.42 142.1 40.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 125.24 47.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.479 1.911 . . . . 0.0 107.253 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 tt -141.26 143.26 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 119.191 0.905 . . . . 0.0 110.341 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.88 137.26 53.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -37.04 69.8 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.848 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.55 -18.69 42.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.5 -43.18 9.84 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.322 1.049 . . . . 0.0 109.449 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.09 -26.58 11.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 0.0 112.444 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.28 37.39 4.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.554 1.941 . . . . 0.0 110.33 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -56.05 145.79 24.59 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.582 0.753 . . . . 0.0 110.886 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -40.51 96.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.611 0.764 . . . . 0.0 112.699 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.35 120.64 21.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -55.67 -44.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.284 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.31 -53.55 42.22 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 120.223 1.374 . . . . 0.0 111.235 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -51.38 -53.32 37.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.763 1.625 . . . . 0.0 109.878 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -55.73 -48.57 74.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.513 0.597 . . . . 0.0 109.773 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -39.23 58.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.624 0.77 . . . . 0.0 110.802 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -62.44 -56.55 17.12 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.634 1.106 . . . . 0.0 109.049 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -55.19 -50.23 69.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.762 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.62 -40.82 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 119.432 1.014 . . . . 0.0 110.479 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -62.33 -52.76 62.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.18 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.79 -42.62 75.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.521 1.055 . . . . 0.0 111.126 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -58.07 -51.23 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.194 0.597 . . . . 0.0 110.315 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.47 -33.12 74.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.843 1.657 . . . . 0.0 111.085 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -71.49 -30.12 65.6 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.954 1.701 . . . . 0.0 110.866 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.23 -37.79 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.718 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -61.73 -46.01 91.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.159 1.345 . . . . 0.0 110.295 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.11 -43.73 87.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.428 0.691 . . . . 0.0 111.842 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -77.48 10.52 2.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.992 0.917 . . . . 0.0 111.247 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.44 19.21 11.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.499 3.119 . . . . 0.0 115.143 174.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.3 168.37 51.7 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.435 1.016 . . . . 0.0 111.918 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -83.42 159.45 21.78 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.904 1.682 . . . . 0.0 109.846 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.1 t -124.59 146.73 29.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.653 1.181 . . . . 0.0 109.127 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -143.85 121.28 11.68 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.26 0.624 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 mm -110.61 110.09 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.28 151.94 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.717 1.607 . . . . 0.0 108.985 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -103.08 132.27 49.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.338 0.655 . . . . 0.0 110.648 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.3 p -65.36 10.43 0.09 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.805 2.042 . . . . 0.0 114.715 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.28 0.71 10.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.394 1.877 . . . . 0.0 112.463 -166.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.667 ' CD2' ' HG ' ' A' ' 99' ' ' SER . 2.7 t60 -139.62 160.38 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.606 1.962 . . . . 0.0 107.041 -172.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.33 -24.69 28.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.326 0.65 . . . . 0.0 112.41 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.667 ' HG ' ' CD2' ' A' ' 97' ' ' HIS . 59.3 p -68.47 -31.99 71.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.722 -1.236 . . . . 0.0 110.285 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.32 -39.14 70.97 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -66.39 -28.96 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.143 1.472 . . . . 0.0 110.92 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.04 -51.23 26.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.251 1.021 . . . . 0.0 109.311 170.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.03 -28.8 68.04 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.818 1.19 . . . . 0.0 111.954 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -58.85 -36.15 74.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.565 1.146 . . . . 0.0 111.811 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -68.23 -0.68 4.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.1 1.76 . . . . 0.0 112.162 173.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.77 28.22 3.58 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.422 2.289 . . . . 0.0 108.79 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 p 70.87 2.38 4.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.829 2.051 . . . . 0.0 114.521 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.04 17.07 70.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 129.03 3.205 . . . . 0.0 114.238 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.66 134.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.299 1.55 . . . . 0.0 109.477 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.69 177.97 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.218 1.407 . . . . 0.0 110.488 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.3 144.35 10.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.465 1.03 . . . . 0.0 110.338 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.8 mt -84.11 144.84 9.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 125.081 1.352 . . . . 0.0 107.607 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.7 mt -117.71 139.25 51.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.145 0.978 . . . . 0.0 109.874 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.73 -24.24 65.35 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.093 1.357 . . . . 0.0 111.98 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -151.44 157.31 34.91 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.929 1.292 . . . . 0.0 108.799 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.91 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.414 2.743 . . . . 0.0 108.406 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.2 t . . . . . 0 C--O 1.237 0.414 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -171.828 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 -65.31 0.14 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 p -70.34 -179.71 2.13 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.96 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.51 -161.32 42.59 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -170.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 m 63.05 97.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.962 1.705 . . . . 0.0 110.943 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.7 m 35.2 90.68 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.548 1.939 . . . . 0.0 115.577 167.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.6 151.48 23.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 t -138.37 -174.61 3.86 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.115 1.366 . . . . 0.0 109.325 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.38 118.29 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.79 41.11 0.33 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.47 1.508 . . . . 0.0 112.33 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -55.72 138.04 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.768 0.827 . . . . 0.0 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -161.93 149.52 14.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.313 2.245 . . . . 0.0 106.263 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.14 156.85 36.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.805 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.47 -174.65 5.05 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.261 1.024 . . . . 0.0 109.339 166.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.33 131.14 49.77 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.085 0.954 . . . . 0.0 108.435 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.2 m -60.2 -38.08 82.2 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.261 0.937 . . . . 0.0 111.341 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.05 -52.08 66.46 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.706 1.139 . . . . 0.0 108.451 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.9 85.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.434 0.561 . . . . 0.0 112.291 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.11 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.3 1.44 . . . . 0.0 112.812 -169.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.06 -49.74 32.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -55.31 -51.21 67.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.714 0.805 . . . . 0.0 110.205 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.9 -42.21 88.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 119.223 0.92 . . . . 0.0 111.2 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -59.85 -47.75 84.47 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.85 1.659 . . . . 0.0 109.075 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.64 95.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.095 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.6 -43.9 80.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.269 0.94 . . . . 0.0 110.164 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.54 -48.38 60.62 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.522 1.129 . . . . 0.0 111.029 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.05 -41.11 95.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -57.43 -60.0 4.3 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.22 1.408 . . . . 0.0 110.32 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -35.94 74.94 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.59 -56.36 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -37.78 88.77 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.142 0.577 . . . . 0.0 109.933 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.52 -36.53 69.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.332 0.969 . . . . 0.0 111.725 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -67.98 -61.26 1.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -64.97 -85.55 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.47 1.908 . . . . 0.0 112.44 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.21 93.87 47.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.29 1.436 . . . . 0.0 109.929 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.45 -5.36 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.894 1.729 . . . . 0.0 112.087 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.75 -33.07 60.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.134 0.879 . . . . 0.0 110.039 165.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -97.33 7.72 46.0 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.18 90.68 2.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.253 1.842 . . . . 0.0 110.347 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -93.3 137.28 32.77 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.495 0.718 . . . . 0.0 109.756 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.56 164.94 28.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.77 0.795 . . . . 0.0 112.017 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.58 126.69 0.85 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -170.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -35.66 -53.66 0.7 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.907 2.083 . . . . 0.0 112.422 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.05 83.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.037 0.935 . . . . 0.0 111.767 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -59.04 -57.23 13.98 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 t -49.64 -43.87 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.26 -31.99 69.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.805 1.184 . . . . 0.0 111.727 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -44.71 30.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.617 1.567 . . . . 0.0 110.477 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -32.51 67.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.925 -1.11 . . . . 0.0 112.37 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.52 -41.93 92.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.549 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.02 -35.4 69.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.25 0.932 . . . . 0.0 111.544 172.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.61 -2.81 40.8 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.847 1.259 . . . . 0.0 112.706 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.6 mmt 51.96 14.91 0.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.462 1.905 . . . . 0.0 113.148 -170.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.53 -4.97 58.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.143 -0.973 . . . . 0.0 112.362 -162.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -76.55 108.72 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -169.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.4 -62.48 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.557 -1.202 . . . . 0.0 107.849 168.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.4 m -139.01 133.69 32.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 tp -110.51 124.25 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.3 1.84 . . . . 0.0 108.582 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -101.67 137.56 39.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.591 1.556 . . . . 0.0 107.806 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 tt -151.94 139.75 13.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 134.24 50.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 166.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -34.52 69.45 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.6 -25.22 62.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.743 1.156 . . . . 0.0 113.212 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.72 -37.06 19.78 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.531 1.059 . . . . 0.0 110.378 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -56.55 -19.55 16.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.682 1.193 . . . . 0.0 112.352 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.66 49.72 2.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.626 -1.297 . . . . 0.0 108.863 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -62.09 151.59 35.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.882 0.873 . . . . 0.0 109.617 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -69.22 -42.81 75.2 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.217 0.607 . . . . 0.0 112.415 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.17 119.15 19.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.5 -49.43 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 117.532 -1.223 . . . . 0.0 110.676 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.04 -52.38 66.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.366 1.439 . . . . 0.0 110.945 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -52.94 -53.12 54.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 110.809 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -55.89 -52.7 63.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -46.47 -50.6 16.69 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 126.256 1.822 . . . . 0.0 110.575 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.13 -57.3 11.62 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.972 0.909 . . . . 0.0 110.048 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -56.18 -51.68 67.14 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.152 -0.928 . . . . 0.0 112.113 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.12 -38.61 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 120.058 1.299 . . . . 0.0 110.824 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -60.22 -52.58 64.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.356 1.062 . . . . 0.0 109.026 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.12 -44.17 92.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.006 0.922 . . . . 0.0 111.205 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -53.29 -57.42 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.263 1.025 . . . . 0.0 110.138 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -34.73 78.63 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -16.82 63.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.028 . . . . 0.0 112.809 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.35 -37.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 O-C-N 120.472 -1.393 . . . . 0.0 109.135 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.98 -39.44 92.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.306 0.957 . . . . 0.0 108.899 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -57.25 -36.13 70.58 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.274 0.63 . . . . 0.0 111.269 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -87.62 13.37 10.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.856 1.262 . . . . 0.0 112.065 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.26 19.34 4.89 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.887 2.475 . . . . 0.0 114.535 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.33 170.03 50.84 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.282 0.946 . . . . 0.0 110.956 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -92.99 153.4 18.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.293 1.437 . . . . 0.0 108.691 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.6 142.1 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.333 1.453 . . . . 0.0 107.73 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -134.5 122.4 22.39 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.537 1.535 . . . . 0.0 108.011 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.75 105.55 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 10.2 m-85 -88.49 155.42 19.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -172.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 m -103.84 147.32 27.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.318 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 t -60.64 -35.85 77.19 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.149 0.906 . . . . 0.0 108.809 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.13 -56.25 16.18 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.976 1.71 . . . . 0.0 111.514 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -66.46 145.21 55.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.79 -26.46 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.586 0.63 . . . . 0.0 111.247 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 p -56.38 -17.98 9.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.184 0.994 . . . . 0.0 112.664 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.91 -55.58 4.08 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 125.348 1.452 . . . . 0.0 110.449 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.06 -29.19 67.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.312 1.056 . . . . 0.0 111.103 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -60.81 -58.13 9.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.48 -28.06 63.07 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.391 1.077 . . . . 0.0 112.238 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 m -56.34 -34.35 66.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.25 1.02 . . . . 0.0 113.196 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -64.44 -9.17 16.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.822 1.249 . . . . 0.0 111.755 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.1 mt -131.03 32.88 4.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.816 2.846 . . . . 0.0 108.711 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p 56.99 18.4 3.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.003 2.121 . . . . 0.0 114.482 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.64 69.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.801 2.143 . . . . 0.0 113.072 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.48 121.82 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.791 1.796 . . . . 0.0 110.59 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 179.48 8.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.506 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.67 145.44 12.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.903 1.281 . . . . 0.0 110.502 169.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.44 146.34 7.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.529 1.531 . . . . 0.0 106.898 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.46 145.57 44.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.452 0.701 . . . . 0.0 109.725 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -77.6 -24.6 49.62 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.689 1.596 . . . . 0.0 111.913 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -148.22 154.83 42.88 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 126.2 1.8 . . . . 0.0 106.324 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.34 114.75 3.56 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 123.163 2.576 . . . . 0.0 107.586 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.6 142.23 94.43 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.65 66.19 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.504 2.803 . . . . 0.0 112.32 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.9 m -139.78 5.47 2.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.398 1.879 . . . . 0.0 111.837 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.04 -177.64 54.21 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.964 0.802 . . . . 0.0 113.088 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.33 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.08 2.52 . . . . 0.0 110.896 -167.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -155.29 175.92 13.23 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 128.795 2.838 . . . . 0.0 105.462 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 t -141.95 169.65 17.2 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.059 0.933 . . . . 0.0 110.692 -172.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 C-N-CA 127.851 2.644 . . . . 0.0 106.847 169.491 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -155.85 171.72 19.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.269 1.828 . . . . 0.0 108.592 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -162.72 -173.09 3.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.729 2.412 . . . . 0.0 109.005 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.17 126.16 3.47 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.882 1.229 . . . . 0.0 111.806 165.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.1 p -153.12 142.48 21.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.782 0.833 . . . . 0.0 109.009 168.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 143.71 16.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.583 1.553 . . . . 0.0 109.585 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.05 159.24 14.25 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.969 0.795 . . . . 0.0 112.061 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.3 t -163.31 133.11 4.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.739 1.216 . . . . 0.0 109.489 165.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -138.2 161.53 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.78 1.632 . . . . 0.0 106.676 166.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.69 100.1 0.32 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.337 1.055 . . . . 0.0 109.767 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -117.89 151.39 37.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.082 0.953 . . . . 0.0 109.941 167.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.45 153.45 39.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.419 1.887 . . . . 0.0 107.528 167.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.58 179.26 4.32 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.834 1.254 . . . . 0.0 109.996 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 m -96.36 60.69 1.95 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.893 1.677 . . . . 0.0 108.259 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.66 109.63 4.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.0 m -54.47 -48.89 71.24 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.267 1.027 . . . . 0.0 111.29 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -66.71 -52.56 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.423 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.7 76.3 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.982 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.95 -23.99 61.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.496 1.044 . . . . 0.0 112.231 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.79 -43.44 22.98 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.71 93.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.009 0.924 . . . . 0.0 110.54 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 t -69.03 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.197 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -53.38 -44.1 68.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.077 1.762 . . . . 0.0 109.87 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.61 -46.32 79.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.794 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.1 -45.32 79.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.38 0.991 . . . . 0.0 111.106 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.26 -54.38 44.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.33 1.852 . . . . 0.0 108.465 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -66.39 -38.15 86.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.819 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -58.22 -59.7 4.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 110.285 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -61.71 -31.04 71.17 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -50.37 -62.94 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -58.9 -38.75 79.62 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.29 -30.32 59.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.983 1.265 . . . . 0.0 112.23 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -35.45 11.31 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.463 -0.773 . . . . 0.0 111.945 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -76.88 -56.42 4.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.207 1.003 . . . . 0.0 112.857 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.27 81.06 7.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.606 1.963 . . . . 0.0 108.891 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.11 -14.03 39.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.126 2.551 . . . . 0.0 112.762 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.41 -20.98 61.64 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.104 -0.998 . . . . 0.0 111.301 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -101.08 11.35 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 123.835 0.854 . . . . 0.0 112.665 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.26 91.03 2.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.43 1.014 . . . . 0.0 109.837 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.33 144.5 25.32 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.64 164.66 29.59 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.57 130.8 2.86 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 -171.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.0 tp -43.95 -47.6 8.51 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.27 -46.73 89.12 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.307 1.043 . . . . 0.0 111.618 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.14 -58.4 8.69 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.532 1.06 . . . . 0.0 108.412 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 t -53.08 -36.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.684 1.194 . . . . 0.0 111.637 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.04 -21.62 66.29 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.02 . . . . 0.0 112.767 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -87.6 -43.49 11.94 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 125.836 1.654 . . . . 0.0 110.459 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.87 -36.55 65.22 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.251 -0.906 . . . . 0.0 111.898 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.89 -45.18 87.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.576 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -60.0 -28.75 67.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.388 0.994 . . . . 0.0 113.132 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -0.11 29.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.186 1.394 . . . . 0.0 111.829 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.1 mmt 52.26 23.31 2.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.309 2.244 . . . . 0.0 112.775 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.92 -8.26 22.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.333 1.053 . . . . 0.0 112.694 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.3 mt -70.5 117.48 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.05 -61.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.57 1.148 . . . . 0.0 108.518 165.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.7 m -138.0 139.84 39.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.41 ' CD2' ' HA ' ' A' ' 80' ' ' VAL . 12.1 tp -110.53 133.4 53.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.186 1.794 . . . . 0.0 108.107 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.62 134.47 51.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.199 1.799 . . . . 0.0 107.326 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.53 142.83 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -72.7 131.73 42.75 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.58 -32.85 65.62 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 123.05 0.54 . . . . 0.0 111.537 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.52 -41.87 22.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.6 -40.24 35.08 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.114 0.966 . . . . 0.0 108.998 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.32 -20.05 10.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.372 0.669 . . . . 0.0 111.694 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -118.61 21.27 12.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.847 2.059 . . . . 0.0 111.773 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -55.07 144.85 22.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.369 0.986 . . . . 0.0 111.421 -168.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.21 -21.78 56.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.99 108.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.0 -26.09 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 111.592 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.36 -54.39 12.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.16 0.891 . . . . 0.0 111.195 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.0 m -53.86 -49.03 69.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.145 1.778 . . . . 0.0 109.635 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.91 -47.28 71.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.089 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -50.13 -43.5 51.91 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.886 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.79 -56.74 18.27 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.271 1.028 . . . . 0.0 108.671 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -54.4 -55.61 26.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.757 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 m -64.96 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.901 1.228 . . . . 0.0 111.666 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -62.11 -53.36 56.49 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.0 tp -58.06 -43.28 86.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.197 0.999 . . . . 0.0 111.461 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 49.3 t -57.08 -33.02 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.094 0.958 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.24 -35.1 15.51 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.478 -0.764 . . . . 0.0 112.073 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 t -64.93 -16.3 63.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.069 1.747 . . . . 0.0 111.643 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.06 -35.3 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 119.513 -1.992 . . . . 0.0 109.679 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.85 -39.5 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.654 1.115 . . . . 0.0 110.37 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -48.93 -43.18 39.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.479 1.112 . . . . 0.0 110.325 171.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -94.37 17.65 12.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.161 1.384 . . . . 0.0 111.054 -168.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 27.69 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.57 2.348 . . . . 0.0 113.658 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.48 -170.79 46.72 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.127 0.87 . . . . 0.0 111.293 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -124.93 156.34 38.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.136 2.174 . . . . 0.0 109.14 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.66 140.92 44.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.969 0.89 . . . . 0.0 108.826 -173.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -137.07 120.81 17.37 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.25 109.93 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 -175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -89.66 138.12 31.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 t -69.07 122.43 18.71 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 p -55.88 -15.0 2.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.226 1.41 . . . . 0.0 113.38 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.95 -33.93 44.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.158 0.89 . . . . 0.0 111.297 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -67.44 151.49 47.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.78 -18.18 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.752 -0.592 . . . . 0.0 111.905 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.7 p -68.04 -27.9 66.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.105 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.07 -26.32 72.66 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.66 1.118 . . . . 0.0 110.756 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.49 -49.86 37.05 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.289 1.045 . . . . 0.0 108.811 165.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -61.14 -35.65 77.65 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.203 -0.936 . . . . 0.0 111.885 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 tp -70.64 -29.79 66.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.646 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 t -52.94 -41.47 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.984 1.314 . . . . 0.0 110.973 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.0 4.03 0.73 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.017 2.127 . . . . 0.0 114.115 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -137.81 27.98 2.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.539 2.736 . . . . 0.0 108.793 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p 66.29 2.08 2.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.249 2.62 . . . . 0.0 114.801 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.34 73.32 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 128.32 2.867 . . . . 0.0 113.94 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.56 132.67 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.016 1.908 . . . . 0.0 109.904 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.93 168.56 24.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.519 1.127 . . . . 0.0 110.269 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.06 145.28 23.91 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.309 0.958 . . . . 0.0 111.137 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.1 mt -83.95 148.87 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 127.029 2.132 . . . . 0.0 106.687 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.56 147.38 42.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.118 0.967 . . . . 0.0 111.718 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mtt85 -70.34 -32.09 69.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 168.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -151.23 154.0 33.32 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 118.245 0.475 . . . . 0.0 110.356 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.3 113.44 3.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.783 2.988 . . . . 0.0 109.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.0 t -73.02 122.62 88.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.83 82.31 2.35 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.804 3.003 . . . . 0.0 111.682 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 m -140.43 -165.57 1.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.704 2.002 . . . . 0.0 107.845 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 127.86 2.56 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 172.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.24 155.74 63.67 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.152 1.901 . . . . 0.0 109.333 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 p -86.52 -66.28 0.92 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.124 1.369 . . . . 0.0 110.673 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.3 t -131.83 -179.32 5.32 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.686 1.995 . . . . 0.0 107.251 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.295 0 CA-C-O 117.519 -1.711 . . . . 0.0 110.087 -177.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.6 p -155.62 168.13 28.15 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.51 -170.72 0.1 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.299 0.64 . . . . 0.0 112.469 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.17 -163.87 16.41 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m 67.33 103.58 0.05 OUTLIER 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.442 1.897 . . . . 0.0 111.908 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 t -154.87 141.22 18.66 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.754 1.622 . . . . 0.0 107.371 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.24 140.82 3.09 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -166.1 135.55 3.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.68 72.43 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 110.964 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.45 11.53 13.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.738 2.415 . . . . 0.0 111.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -66.24 110.6 3.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.081 1.752 . . . . 0.0 110.009 -169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -148.97 -66.42 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.209 -0.932 . . . . 0.0 110.892 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.01 -163.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.101 1.36 . . . . 0.0 112.259 -157.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 m -141.35 170.9 14.86 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.175 1.79 . . . . 0.0 108.944 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t0 63.12 105.41 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 130.074 3.35 . . . . 0.0 110.471 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -42.16 -41.79 2.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.83 1.652 . . . . 0.0 114.503 -165.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -68.78 -51.94 35.68 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.806 -1.184 . . . . 0.0 110.153 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.07 -54.43 46.02 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.637 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.72 -40.37 54.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.537 1.135 . . . . 0.0 112.447 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.39 -47.61 34.74 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.962 0.801 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -48.68 76.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.946 0.873 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.23 -42.5 66.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 124.7 1.2 . . . . 0.0 109.606 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -57.13 -50.04 74.03 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.909 1.231 . . . . 0.0 109.533 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.64 98.52 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.855 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.91 -47.93 81.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.865 1.211 . . . . 0.0 110.233 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.18 -51.95 65.77 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 126.701 2.0 . . . . 0.0 109.477 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.03 -42.15 73.31 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -173.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.98 -56.82 11.88 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.198 0.999 . . . . 0.0 108.567 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -44.89 89.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 124.123 0.889 . . . . 0.0 112.247 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.08 -57.73 4.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ttp -66.27 -33.14 75.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.374 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.18 -50.94 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.732 1.606 . . . . 0.0 110.814 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -65.33 -40.16 93.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.221 0.208 . . . . 0.0 110.562 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -78.88 -57.95 3.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 111.41 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -149.97 76.9 8.63 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.431 2.292 . . . . 0.0 108.29 -167.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.81 -5.94 14.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.749 2.299 . . . . 0.0 112.151 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -27.19 2.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.003 2.121 . . . . 0.0 110.99 163.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -110.22 0.8 18.32 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.208 1.403 . . . . 0.0 113.922 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.74 95.21 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -93.55 133.62 36.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -140.38 159.91 41.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.16 0.981 . . . . 0.0 113.522 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 135.94 0.69 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.8 tp -44.97 -49.8 10.96 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.801 1.641 . . . . 0.0 112.27 -169.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -56.16 -43.27 78.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.432 1.493 . . . . 0.0 110.367 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -66.69 -57.82 6.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.18 -36.65 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.218 -0.926 . . . . 0.0 111.924 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -56.4 -38.84 72.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.914 0.885 . . . . 0.0 112.21 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -47.11 53.29 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.155 1.382 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.77 -32.83 69.64 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.577 -0.702 . . . . 0.0 112.537 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -65.53 -43.61 89.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.906 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.64 -28.16 66.98 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.04 0.836 . . . . 0.0 112.548 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.18 -6.12 57.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.46 0.704 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 60.26 9.5 1.96 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.624 1.97 . . . . 0.0 112.491 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.56 -7.19 59.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.167 -0.958 . . . . 0.0 113.027 -162.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.0 114.35 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 119.167 0.894 . . . . 0.0 108.86 -170.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.74 -52.37 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.166 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.6 m -140.99 132.93 27.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.27 132.71 53.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.467 2.307 . . . . 0.0 106.797 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -110.96 126.68 55.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.16 1.784 . . . . 0.0 106.918 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.11 136.31 29.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 118.931 0.787 . . . . 0.0 109.469 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -65.75 138.55 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.55 -39.35 70.5 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 122.928 0.491 . . . . 0.0 110.208 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -60.65 -16.7 41.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.39 -42.59 10.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.875 1.216 . . . . 0.0 110.091 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -50.28 -32.56 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.554 1.142 . . . . 0.0 112.379 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.55 38.85 4.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.511 1.924 . . . . 0.0 109.709 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.97 151.82 17.62 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -68.73 -41.49 78.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.583 0.753 . . . . 0.0 111.785 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 23.9 t70 -75.89 120.48 21.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.191 1.396 . . . . 0.0 108.23 -172.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.84 -39.44 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.404 -174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -60.27 4.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.976 0.807 . . . . 0.0 109.289 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 89.1 m -58.93 -51.24 70.88 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.089 0.956 . . . . 0.0 110.061 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -52.62 -52.31 56.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.017 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.3 t -52.2 -46.87 65.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 119.227 0.922 . . . . 0.0 109.245 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -51.73 -50.73 59.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.106 0.866 . . . . 0.0 109.668 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -57.82 -60.4 3.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.722 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 m -61.94 -37.84 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.328 1.422 . . . . 0.0 111.151 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -57.55 -53.16 61.34 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.809 1.644 . . . . 0.0 108.721 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.72 -46.63 88.53 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.808 0.843 . . . . 0.0 111.252 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.67 -49.88 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 124.311 1.045 . . . . 0.0 109.348 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.02 -37.8 78.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -64.65 -30.49 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.76 0.824 . . . . 0.0 111.856 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.28 -39.77 79.46 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 O-C-N 120.952 -1.092 . . . . 0.0 109.623 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.01 -46.69 89.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.985 0.811 . . . . 0.0 110.114 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -59.14 -31.27 68.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.979 0.512 . . . . 0.0 112.189 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.81 26.6 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.829 1.252 . . . . 0.0 111.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.64 6.75 2.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.872 2.869 . . . . 0.0 115.225 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.99 -176.18 47.91 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.177 0.899 . . . . 0.0 112.015 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -123.42 157.5 33.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.897 1.679 . . . . 0.0 109.935 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.3 t -122.66 139.66 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 108.232 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -129.36 121.45 27.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.1 mm -100.74 109.34 25.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 5.6 m-85 -89.62 156.76 18.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 108.697 -177.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -104.76 139.4 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 t -62.4 9.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.691 2.396 . . . . 0.0 114.155 170.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -129.3 -14.47 4.27 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.27 1.828 . . . . 0.0 113.689 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.457 ' HD1' ' CB ' ' A' ' 99' ' ' SER . 3.5 t-80 -87.69 148.38 24.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.565 1.075 . . . . 0.0 109.214 -174.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.6 p -57.02 -32.63 40.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 O-C-N 121.721 -0.612 . . . . 0.0 110.129 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.457 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . 16.0 m -65.3 -27.36 68.56 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.307 177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.65 -53.8 25.99 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 167.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.34 -31.33 67.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.29 1.045 . . . . 0.0 112.196 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.96 -47.53 65.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.953 0.901 . . . . 0.0 109.697 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.86 -31.91 65.28 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 122.948 0.499 . . . . 0.0 111.39 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -58.33 -33.88 70.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.648 1.179 . . . . 0.0 112.926 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.14 -6.77 14.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.452 1.501 . . . . 0.0 112.053 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.0 mt -129.7 23.04 5.42 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.537 2.735 . . . . 0.0 108.218 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p 77.57 -12.12 1.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.263 3.425 . . . . 0.0 114.122 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.36 15.76 46.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.962 2.22 . . . . 0.0 113.133 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.17 133.48 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 118.933 1.366 . . . . 0.0 108.962 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.09 13.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.669 1.188 . . . . 0.0 110.05 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.18 142.01 9.82 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.241 0.928 . . . . 0.0 110.918 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -83.88 141.84 14.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.203 1.401 . . . . 0.0 107.715 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 mt -112.9 139.91 48.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.311 1.045 . . . . 0.0 111.249 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -66.86 -25.54 66.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.052 1.741 . . . . 0.0 112.374 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -151.61 157.47 34.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.507 1.523 . . . . 0.0 107.254 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.69 128.92 15.81 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.992 1.795 . . . . 0.0 108.384 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t -78.88 129.39 73.62 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.85 104.87 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.869 2.379 . . . . 0.0 110.334 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.8 t -158.9 -74.98 0.08 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.35 170.49 34.74 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.7 169.64 15.59 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.945 2.43 . . . . 0.0 109.783 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.2 p -157.4 164.62 37.32 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.292 0.637 . . . . 0.0 110.095 171.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -167.38 -164.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.741 2.016 . . . . 0.0 108.384 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 117.62 -1.656 . . . . 0.0 110.683 178.055 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m 61.68 141.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.063 1.745 . . . . 0.0 109.73 -152.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -145.49 155.88 43.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.45 160.72 53.62 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.7 t -153.18 126.25 8.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t 61.12 -164.91 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.729 1.212 . . . . 0.0 112.812 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.2 -170.76 43.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 128.548 2.975 . . . . 0.0 107.655 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 154.66 41.18 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.619 1.209 . . . . 0.0 108.775 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.23 165.5 19.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.99 0.916 . . . . 0.0 110.845 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.3 146.53 43.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 161.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.5 p -140.57 162.42 35.42 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.978 0.911 . . . . 0.0 109.021 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -139.79 164.78 29.05 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 123.859 0.863 . . . . 0.0 109.084 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.63 -59.6 4.94 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 167.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t 47.03 83.52 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.35 1.86 . . . . 0.0 113.155 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.05 96.26 0.07 Allowed 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 126.7 2.0 . . . . 0.0 113.087 153.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 m -35.3 -50.68 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.808 2.043 . . . . 0.0 115.489 -162.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -65.97 -51.76 55.61 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.732 0.413 . . . . 0.0 110.216 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.95 80.54 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.524 0.73 . . . . 0.0 110.007 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.14 69.14 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.416 1.007 . . . . 0.0 113.367 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.67 -39.27 18.11 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 119.423 1.011 . . . . 0.0 111.115 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -50.42 68.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.881 2.072 . . . . 0.0 108.139 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.44 -51.52 48.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 126.013 1.725 . . . . 0.0 109.677 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.06 -45.01 67.92 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.558 1.072 . . . . 0.0 109.769 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.6 -50.72 71.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 123.854 0.721 . . . . 0.0 111.383 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -55.74 -46.75 77.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.977 1.262 . . . . 0.0 111.361 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.04 -46.53 88.0 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.543 1.537 . . . . 0.0 110.073 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.72 -35.65 65.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.135 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -61.46 -57.39 12.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.444 2.298 . . . . 0.0 109.995 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -58.79 -35.4 72.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.739 0.7 . . . . 0.0 112.073 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -50.0 -53.65 25.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -59.86 -44.44 94.13 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.57 0.623 . . . . 0.0 110.286 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.1 -25.31 45.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.056 0.844 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -86.65 -62.35 1.53 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -68.11 -59.39 3.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.927 1.291 . . . . 0.0 113.826 -168.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.98 80.63 47.93 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 124.975 1.31 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.48 -7.65 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.273 1.982 . . . . 0.0 113.752 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.99 -55.24 25.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.889 1.222 . . . . 0.0 108.195 164.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -76.08 10.97 1.63 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.278 0.945 . . . . 0.0 112.526 -168.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.3 96.51 4.46 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.77 1.228 . . . . 0.0 109.69 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -93.37 140.64 29.34 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.27 159.67 41.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 142.13 0.73 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 tp -45.24 -51.81 10.31 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.361 1.464 . . . . 0.0 112.673 -165.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -49.59 75.89 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.648 1.579 . . . . 0.0 110.272 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.12 -56.44 22.22 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -49.22 -40.59 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.666 1.186 . . . . 0.0 112.29 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -59.61 -35.65 74.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.688 1.586 . . . . 0.0 111.56 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -49.32 16.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.236 1.415 . . . . 0.0 109.348 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.36 71.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.748 -0.595 . . . . 0.0 111.126 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.93 -50.37 69.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.5 0.72 . . . . 0.0 109.114 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.88 -16.01 47.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.891 1.277 . . . . 0.0 114.355 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.17 -10.51 54.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.806 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 51.91 52.45 14.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.164 1.385 . . . . 0.0 109.573 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -124.76 -18.73 5.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.334 2.254 . . . . 0.0 111.528 -171.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.48 117.61 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.7 -57.65 2.68 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.459 1.103 . . . . 0.0 108.973 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -129.98 126.42 37.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 108.099 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tp -109.52 137.2 47.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.874 2.07 . . . . 0.0 106.958 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.23 126.17 50.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.486 1.914 . . . . 0.0 107.076 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.83 141.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.3 m -71.22 134.13 46.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.268 1.027 . . . . 0.0 108.682 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.19 -35.0 66.76 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.055 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.04 -22.27 10.28 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.64 -45.41 9.87 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 120.85 -1.157 . . . . 0.0 110.081 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -54.85 -20.49 8.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.284 1.434 . . . . 0.0 113.592 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 20.74 7.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.706 1.603 . . . . 0.0 112.085 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -51.39 144.57 9.79 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.732 1.613 . . . . 0.0 111.526 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -51.32 -52.06 48.8 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 112.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.06 108.66 9.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 126.257 1.823 . . . . 0.0 107.713 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.44 -33.62 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.759 -174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.13 -63.28 1.29 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.803 1.183 . . . . 0.0 111.363 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 m -55.42 -45.73 76.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.768 1.227 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -56.83 -48.85 77.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.818 1.19 . . . . 0.0 110.619 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.4 m -57.09 -31.04 64.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.546 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -64.28 -58.54 6.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 120.303 1.41 . . . . 0.0 108.94 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -53.46 -53.34 52.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.023 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.78 -38.77 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.345 0.975 . . . . 0.0 110.93 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -63.65 -46.83 83.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.304 0.502 . . . . 0.0 110.486 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 tp -70.05 -34.96 73.9 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.382 0.673 . . . . 0.0 110.921 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.61 -48.51 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.67 94.38 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.949 0.9 . . . . 0.0 110.621 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -70.66 -25.38 62.97 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.546 1.538 . . . . 0.0 111.631 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.85 -42.26 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 120.702 -1.249 . . . . 0.0 108.466 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -63.72 -40.06 95.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.814 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -50.57 -49.0 57.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.071 0.851 . . . . 0.0 109.49 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -84.8 26.06 0.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.011 2.124 . . . . 0.0 110.763 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.04 22.12 12.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.534 2.734 . . . . 0.0 115.311 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.64 159.41 23.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 122.581 1.101 . . . . 0.0 113.243 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -82.5 163.55 21.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.191 2.197 . . . . 0.0 110.693 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -127.92 153.54 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 120.706 -1.246 . . . . 0.0 108.945 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.1 mmt-85 -141.0 131.88 25.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.692 1.997 . . . . 0.0 106.113 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.6 mm -118.4 107.48 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.86 155.02 19.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -103.11 145.8 29.36 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.7 t -60.55 -34.96 74.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.833 0.708 . . . . 0.0 110.542 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.19 -25.06 67.57 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.347 1.459 . . . . 0.0 112.809 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -83.39 147.62 27.79 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.496 0.718 . . . . 0.0 109.948 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -37.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.982 0.513 . . . . 0.0 110.36 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.6 m -71.04 -20.36 62.39 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.405 1.082 . . . . 0.0 111.838 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.48 -44.54 33.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.84 -34.97 73.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.715 0.758 . . . . 0.0 110.296 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -66.1 -55.65 15.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 111.068 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.61 -30.96 67.65 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.559 1.072 . . . . 0.0 111.803 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 t -60.15 -33.45 72.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.286 1.034 . . . . 0.0 112.128 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -58.76 -21.64 56.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.884 0.765 . . . . 0.0 111.303 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.4 mt -112.27 29.8 7.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.644 2.378 . . . . 0.0 109.412 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.94 0.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.523 2.729 . . . . 0.0 114.427 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.34 13.81 65.07 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 128.87 3.128 . . . . 0.0 113.618 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.2 133.13 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.502 2.151 . . . . 0.0 109.739 171.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.17 172.76 17.63 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.775 0.83 . . . . 0.0 110.439 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.44 146.86 22.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.091 -1.006 . . . . 0.0 110.614 173.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.2 mt -84.02 141.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 107.304 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.4 141.97 47.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.01 0.924 . . . . 0.0 108.589 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -66.93 -40.48 87.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.32 0.648 . . . . 0.0 110.37 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -136.0 156.82 76.83 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.547 1.539 . . . . 0.0 107.725 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 114.48 3.87 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.845 2.364 . . . . 0.0 108.294 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.14 133.71 94.72 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.12 98.87 0.33 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.888 2.392 . . . . 0.0 109.017 170.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.4 m -161.33 -179.98 7.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.849 2.46 . . . . 0.0 107.593 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.0 29.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.53 -15.81 24.48 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.409 2.739 . . . . 0.0 113.523 -170.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.34 -21.67 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.093 0.86 . . . . 0.0 110.864 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 p -95.63 53.92 1.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.13 1.372 . . . . 0.0 111.811 -171.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 167.622 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -105.73 -1.24 24.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.895 1.278 . . . . 0.0 112.75 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 m -63.17 156.15 26.05 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.33 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.81 25.83 69.48 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.08 162.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.9 t -93.34 -97.57 0.14 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.416 1.608 . . . . 0.0 109.957 -173.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.3 m -61.85 144.28 55.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.842 1.257 . . . . 0.0 110.906 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.99 -178.15 40.24 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.791 -0.568 . . . . 0.0 111.883 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -120.1 120.11 35.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.464 1.106 . . . . 0.0 109.631 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -114.41 67.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 140.98 47.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.52 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 p -139.38 141.16 37.59 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.435 0.636 . . . . 0.0 110.716 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -126.5 103.04 7.39 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.91 1.684 . . . . 0.0 108.312 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.74 94.79 5.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.9 m -127.99 -8.24 5.46 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -163.14 141.5 8.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.76 1.164 . . . . 0.0 109.131 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -62.19 -43.14 99.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.375 1.443 . . . . 0.0 111.48 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -52.91 5.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -33.53 74.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.901 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.5 -11.62 61.04 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.717 2.053 . . . . 0.0 112.741 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.87 -61.74 3.91 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 165.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.79 -43.61 98.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.886 1.274 . . . . 0.0 112.459 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.47 -41.0 80.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 124.0 0.92 . . . . 0.0 109.907 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.41 83.55 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.433 1.015 . . . . 0.0 109.353 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.33 75.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.051 0.541 . . . . 0.0 110.866 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.01 -46.0 89.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.575 0.75 . . . . 0.0 110.456 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -57.2 -52.62 64.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 124.405 1.082 . . . . 0.0 108.765 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -42.15 94.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.219 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.63 -55.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.443 1.497 . . . . 0.0 110.12 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -58.42 -35.54 72.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 118.9 0.773 . . . . 0.0 112.086 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -53.65 -56.34 18.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.61 -35.81 78.91 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.851 0.75 . . . . 0.0 111.703 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.36 -28.76 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.137 1.335 . . . . 0.0 111.462 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -90.44 -55.96 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.258 0.623 . . . . 0.0 110.827 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.56 -53.8 51.55 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.903 0.774 . . . . 0.0 112.756 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.87 76.41 11.55 Favored Pre-proline 0 N--CA 1.446 -0.654 0 C-N-CA 125.301 1.441 . . . . 0.0 109.059 -172.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -12.44 29.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.531 2.154 . . . . 0.0 112.41 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -61.88 -19.84 63.08 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.893 -1.129 . . . . 0.0 111.729 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -110.25 6.64 22.71 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.24 1.416 . . . . 0.0 113.118 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.85 95.68 3.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.3 m-85 -93.29 139.92 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -140.23 156.8 46.35 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 119.382 0.992 . . . . 0.0 112.882 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.24 132.7 1.65 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.73 -51.08 4.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.028 1.731 . . . . 0.0 112.276 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -59.13 -49.46 77.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.472 1.109 . . . . 0.0 110.264 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.87 -55.07 38.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.3 t -53.58 -40.14 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.41 -0.806 . . . . 0.0 111.451 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.34 -41.49 76.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.27 0.941 . . . . 0.0 110.964 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -44.91 83.31 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.082 -1.011 . . . . 0.0 109.647 176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.89 -31.75 72.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -62.72 -45.8 91.08 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.269 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.88 -25.1 66.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.61 -5.6 57.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.771 0.828 . . . . 0.0 111.541 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 58.31 19.96 6.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.509 1.524 . . . . 0.0 111.897 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.14 -5.72 15.86 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.201 -163.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.47 109.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.83 -45.97 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.231 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -146.22 133.46 20.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.06 123.74 50.23 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.347 1.859 . . . . 0.0 106.488 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.29 126.28 46.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 106.719 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -137.02 139.57 44.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.38 131.9 44.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.73 -34.2 67.27 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.99 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.58 -35.83 14.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.471 1.487 . . . . 0.0 113.591 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.8 mt -81.08 -42.43 21.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.023 0.829 . . . . 0.0 110.553 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -55.41 -28.91 57.15 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.069 -1.019 . . . . 0.0 112.218 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -106.45 16.62 24.45 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 127.533 2.333 . . . . 0.0 110.924 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -50.77 139.15 17.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.114 1.324 . . . . 0.0 111.254 -162.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -35.37 74.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.593 1.157 . . . . 0.0 111.74 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.16 119.91 20.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.509 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.405 1.002 . . . . 0.0 109.948 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -56.97 -45.05 83.16 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.637 1.175 . . . . 0.0 111.281 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -51.29 -48.79 62.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.065 1.302 . . . . 0.0 111.817 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -13.62 15.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.243 -1.36 . . . . 0.0 113.961 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -75.2 -63.47 1.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.684 1.584 . . . . 0.0 108.556 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -49.56 -53.86 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.828 -0.606 . . . . 0.0 112.039 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.59 -36.31 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.76 1.164 . . . . 0.0 111.544 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -64.78 -47.34 78.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 122.028 -0.42 . . . . 0.0 110.941 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.48 -46.63 89.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.712 0.805 . . . . 0.0 110.243 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.13 -39.09 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.506 1.123 . . . . 0.0 110.618 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.23 -43.05 58.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.568 -1.333 . . . . 0.0 110.883 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 t -64.36 -28.26 69.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.454 0.57 . . . . 0.0 111.151 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -65.15 -36.49 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 120.199 -1.563 . . . . 0.0 110.474 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -63.64 -45.62 89.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.365 1.439 . . . . 0.0 109.843 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.41 -37.36 64.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.363 1.065 . . . . 0.0 110.398 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -93.14 20.35 6.98 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.57 1.548 . . . . 0.0 111.215 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.12 27.47 16.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.27 2.228 . . . . 0.0 114.001 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.79 163.06 24.47 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -86.59 145.97 26.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.659 1.583 . . . . 0.0 109.124 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.86 139.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -128.3 121.22 28.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.76 122.09 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -94.46 128.41 41.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 117.4 5.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -58.81 -24.71 62.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.297 1.439 . . . . 0.0 112.415 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.07 -26.16 65.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 111.717 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -81.61 147.32 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.468 1.907 . . . . 0.0 109.436 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.05 -16.06 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.261 1.025 . . . . 0.0 112.262 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -60.19 -35.98 76.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.432 -1.417 . . . . 0.0 111.42 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.92 97.23 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -72.46 -38.24 68.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.11 0.964 . . . . 0.0 111.639 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -57.17 -51.32 69.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.36 -0.838 . . . . 0.0 109.343 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.59 -30.96 71.98 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.7 t -58.04 -37.3 74.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.445 1.898 . . . . 0.0 111.249 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -52.2 -33.45 40.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.61 1.164 . . . . 0.0 110.871 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.7 mt -105.49 31.29 5.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.674 2.79 . . . . 0.0 109.997 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 p 75.11 -14.93 0.71 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.871 2.868 . . . . 0.0 113.479 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.0 14.75 58.8 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.292 2.377 . . . . 0.0 113.13 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.54 132.68 27.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 120.096 1.948 . . . . 0.0 108.976 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.97 175.1 14.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.359 1.063 . . . . 0.0 109.823 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.53 144.46 15.43 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 86.2 mt -83.9 143.11 12.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 40' ' ' PHE . 13.5 mt -117.09 151.51 36.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 0.0 110.653 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -63.88 -51.91 62.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.735 170.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.08 154.73 80.48 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.256 1.423 . . . . 0.0 110.479 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.24 106.66 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.165 3.243 . . . . 0.0 108.733 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 80.7 t -63.25 135.48 96.26 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.705 0.402 . . . . 0.0 110.071 -163.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.13 91.7 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.172 3.248 . . . . 0.0 109.885 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.0 m -150.22 -171.03 3.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.803 1.241 . . . . 0.0 109.417 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.13 -178.0 15.32 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.502 1.525 . . . . 0.0 110.324 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.3 163.25 39.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.861 2.374 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -135.67 -62.96 0.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.508 0.723 . . . . 0.0 109.601 163.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 m -66.6 175.8 2.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.021 1.328 . . . . 0.0 110.936 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.749 -1.584 . . . . 0.0 110.628 166.237 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.45 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.724 2.009 . . . . 0.0 112.303 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -139.44 115.08 10.01 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.905 1.282 . . . . 0.0 108.36 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.71 -167.11 34.15 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 168.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m 110.65 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.846 3.659 . . . . 0.0 107.621 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 83.1 p -153.25 176.41 11.99 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.255 0.622 . . . . 0.0 111.165 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.58 76.83 1.14 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -154.29 133.2 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.36 21.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.072 0.549 . . . . 0.0 110.929 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.29 134.98 49.96 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.959 -1.088 . . . . 0.0 111.49 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -132.53 -58.53 0.93 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.569 2.347 . . . . 0.0 110.819 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.42 91.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.888 2.475 . . . . 0.0 113.186 -170.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.74 156.37 30.63 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 164.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.64 -53.05 0.31 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.528 1.531 . . . . 0.0 110.119 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.15 176.25 4.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.206 0.602 . . . . 0.0 111.802 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -67.44 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.498 -1.376 . . . . 0.0 109.085 152.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -51.77 41.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -161.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -25.72 66.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.175 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.95 65.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 121.566 1.985 . . . . 0.0 112.056 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.04 16.66 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 172.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.24 -50.31 73.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.289 0.636 . . . . 0.0 111.038 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.99 -47.88 88.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.314 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -55.58 26.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.297 1.408 . . . . 0.0 109.113 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.61 -28.05 66.85 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 127.288 2.235 . . . . 0.0 112.524 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.1 -45.93 17.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.828 1.251 . . . . 0.0 110.218 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -54.45 -48.69 71.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.284 1.834 . . . . 0.0 109.276 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.32 -40.24 67.6 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.183 1.393 . . . . 0.0 109.531 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -59.2 -54.39 47.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.782 1.233 . . . . 0.0 109.891 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -58.28 -38.24 76.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.361 0.665 . . . . 0.0 112.175 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' HZ3' ' CD2' ' A' ' 34' ' ' HIS . 2.0 ttpp -50.85 -57.2 9.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mmm -59.53 -39.06 82.7 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.4 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -53.36 -25.95 17.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.759 1.224 . . . . 0.0 112.054 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -96.28 -51.63 4.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.167 1.787 . . . . 0.0 111.504 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.506 ' CD2' ' HZ3' ' A' ' 30' ' ' LYS . 95.1 m-70 -71.75 -64.77 0.86 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.105 -0.997 . . . . 0.0 111.61 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -134.32 81.68 48.96 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.06 -14.42 43.37 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.45 2.1 . . . . 0.0 111.999 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.94 -23.75 7.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.621 1.568 . . . . 0.0 112.087 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -106.21 13.97 28.19 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.896 1.278 . . . . 0.0 111.995 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.72 90.96 2.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.107 1.322 . . . . 0.0 110.728 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -93.64 138.75 31.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 109.25 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -139.41 158.75 43.6 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.711 0.767 . . . . 0.0 111.308 171.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 134.76 1.33 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -172.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -44.33 -48.05 9.62 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 124.484 1.114 . . . . 0.0 110.84 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -60.7 -44.1 96.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.664 1.186 . . . . 0.0 111.365 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.83 -58.68 6.07 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 t -53.69 -38.8 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.699 0.8 . . . . 0.0 112.195 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.36 -36.94 74.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.749 1.159 . . . . 0.0 110.934 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -46.82 63.2 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.97 0.908 . . . . 0.0 109.557 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.59 -35.59 81.0 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -62.2 -44.51 96.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.47 -22.0 66.83 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.44 59.21 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.668 0.787 . . . . 0.0 111.375 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 28.0 mtt 52.06 44.52 29.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.362 1.465 . . . . 0.0 109.581 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.93 -9.95 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.246 2.219 . . . . 0.0 111.903 -170.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.8 mt -80.08 105.95 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.22 -53.07 54.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.812 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 m -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.654 1.181 . . . . 0.0 108.292 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -109.77 137.87 46.96 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.386 1.874 . . . . 0.0 108.029 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.39 128.97 55.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.053 1.741 . . . . 0.0 107.725 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -144.95 143.47 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.402 1.001 . . . . 0.0 110.393 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.17 142.91 50.67 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.366 1.066 . . . . 0.0 109.724 170.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -56.5 -42.65 78.7 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.05 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.27 -20.81 7.74 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.6 -45.33 8.54 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.872 0.869 . . . . 0.0 109.202 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -51.32 -29.93 16.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.842 1.257 . . . . 0.0 112.276 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.91 31.35 5.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 110.841 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -51.68 148.01 5.94 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.666 0.666 . . . . 0.0 111.518 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -68.46 -31.29 70.48 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.413 1.485 . . . . 0.0 112.832 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.57 118.3 28.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.6 -30.63 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.34 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 -54.05 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.9 1.682 . . . . 0.0 109.891 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.4 m -58.2 -51.46 69.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.334 1.854 . . . . 0.0 110.756 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -58.26 -48.9 78.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.351 0.978 . . . . 0.0 110.242 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 m -55.14 -35.41 64.67 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.141 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -60.76 -51.82 67.71 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.46 1.027 . . . . 0.0 111.015 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -60.66 -51.45 69.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.181 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.83 -37.46 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.089 0.859 . . . . 0.0 110.971 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -57.82 -53.8 54.07 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.943 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.08 -48.21 82.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.315 1.009 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.54 -47.34 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.545 1.138 . . . . 0.0 110.526 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.522 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 5.3 m-20 -68.08 -43.22 79.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.653 -0.654 . . . . 0.0 110.555 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -72.85 -30.38 63.96 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.038 0.935 . . . . 0.0 110.324 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.29 -42.47 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.85 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 7.0 mtmp? -65.4 -39.24 91.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.898 0.772 . . . . 0.0 111.216 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.37 -25.61 66.87 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.933 -0.479 . . . . 0.0 111.561 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -100.71 44.1 1.03 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.45 5.04 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.447 3.099 . . . . 0.0 116.97 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.75 -174.47 48.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.486 1.517 . . . . 0.0 113.958 -171.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -130.79 149.33 52.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.802 2.441 . . . . 0.0 110.57 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.85 147.12 16.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.264 1.426 . . . . 0.0 108.826 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -147.21 126.59 13.13 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.849 2.06 . . . . 0.0 107.187 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -116.04 123.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.01 164.48 13.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.54 1.536 . . . . 0.0 108.331 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 136.75 42.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 162.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.8 t -51.61 -28.59 14.69 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.118 0.967 . . . . 0.0 111.47 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.18 -26.6 66.71 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 126.649 1.98 . . . . 0.0 113.613 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.405 ' HD1' ' CB ' ' A' ' 99' ' ' SER . 6.4 t-80 -84.03 158.85 21.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.669 0.788 . . . . 0.0 110.913 -165.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.44 -40.76 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 118.947 0.794 . . . . 0.0 109.321 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.405 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . 1.6 m -60.06 -23.32 63.67 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.863 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.69 -53.05 10.33 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.955 1.74 . . . . 0.0 110.97 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.19 -27.36 69.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.653 1.727 . . . . 0.0 112.071 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.55 -46.12 73.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.467 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 tp -63.26 -34.64 78.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.747 -0.596 . . . . 0.0 111.022 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -57.91 -38.42 75.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.923 1.689 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -55.42 -23.38 24.6 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.344 -0.847 . . . . 0.0 111.085 173.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.53 30.81 7.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.763 2.825 . . . . 0.0 110.238 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.2 p 66.41 19.76 10.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.096 1.358 . . . . 0.0 113.969 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.44 15.65 52.94 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.355 2.407 . . . . 0.0 114.533 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.01 124.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.15 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.52 146.67 8.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.31 -0.869 . . . . 0.0 110.829 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.4 mt -83.83 152.45 3.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.38 145.74 42.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.783 0.801 . . . . 0.0 109.781 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -64.5 -46.71 81.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.982 1.313 . . . . 0.0 109.906 165.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -138.14 152.85 72.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.428 1.491 . . . . 0.0 108.747 -169.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 124.27 10.62 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.165 2.577 . . . . 0.0 109.105 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.0 t -78.29 131.45 68.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.03 49.06 2.68 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.021 3.147 . . . . 0.0 111.764 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -152.88 89.3 1.38 Allowed 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -163.94 139.17 5.7 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.46 -35.45 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.656 2.237 . . . . 0.0 112.065 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 t -162.3 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.969 1.708 . . . . 0.0 108.507 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.9 m 68.08 -64.13 0.3 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.673 1.989 . . . . 0.0 111.113 -173.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 106.115 -2.794 . . . . 0.0 106.115 162.207 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m 64.55 -20.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.62 2.368 . . . . 0.0 115.975 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 47.93 65.22 1.36 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.392 2.277 . . . . 0.0 114.259 162.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.9 -162.43 46.71 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.7 m -165.74 -67.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.726 1.611 . . . . 0.0 108.869 167.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -159.67 159.64 33.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.367 2.667 . . . . 0.0 104.489 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.37 151.53 12.16 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.3 t -143.56 153.78 42.92 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.195 0.998 . . . . 0.0 108.94 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.71 156.52 9.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 127.204 2.202 . . . . 0.0 107.441 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.26 173.71 13.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.092 1.757 . . . . 0.0 109.251 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 m -156.85 106.22 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -156.89 0.59 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 154.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -51.72 112.76 0.82 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.343 0.974 . . . . 0.0 110.505 -172.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -107.08 140.63 39.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.09 154.12 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 160.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -53.22 -46.38 69.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.182 0.993 . . . . 0.0 110.945 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.29 -51.02 69.37 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.862 0.755 . . . . 0.0 109.364 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.3 74.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.459 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -56.62 17.24 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.646 1.112 . . . . 0.0 110.928 -172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.3 93.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -50.84 40.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.95 1.3 . . . . 0.0 109.003 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.0 -41.68 83.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 125.204 1.402 . . . . 0.0 109.949 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -59.0 -44.01 91.6 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 119.118 0.872 . . . . 0.0 109.205 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.0 87.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.968 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tp -64.16 -48.68 75.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.437 1.017 . . . . 0.0 110.571 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -53.28 -50.94 63.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.338 1.455 . . . . 0.0 109.099 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -66.36 -46.89 75.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.413 2.285 . . . . 0.0 109.416 -171.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -54.81 -56.21 21.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.476 1.51 . . . . 0.0 110.375 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.44 -30.68 70.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -50.76 -62.73 1.42 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.659 0.599 . . . . 0.0 109.486 169.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -29.49 70.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.048 -0.977 . . . . 0.0 111.613 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.25 -29.58 58.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.102 1.319 . . . . 0.0 111.76 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -92.31 -50.06 5.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.971 0.908 . . . . 0.0 110.367 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -73.37 -48.11 36.76 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -168.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.81 81.1 8.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.803 1.241 . . . . 0.0 109.062 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.83 -12.07 33.6 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.992 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -20.04 10.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 111.604 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -111.7 2.57 17.28 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.831 1.252 . . . . 0.0 113.106 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.06 88.48 2.91 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.583 1.083 . . . . 0.0 108.608 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -93.78 134.33 36.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.555 0.742 . . . . 0.0 109.011 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -140.74 164.79 29.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.396 0.617 . . . . 0.0 112.619 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.35 126.14 0.51 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -168.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 tp -37.14 -50.04 0.92 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.202 2.201 . . . . 0.0 110.785 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.64 -51.89 52.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 128.671 2.788 . . . . 0.0 114.084 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.22 -50.4 68.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.601 1.191 . . . . 0.0 107.959 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.76 -31.95 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.333 1.053 . . . . 0.0 111.131 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.86 -19.66 65.06 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.933 1.293 . . . . 0.0 112.713 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.74 -42.4 34.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 119.519 -1.988 . . . . 0.0 109.458 165.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.47 71.07 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -60.47 -43.83 96.52 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 119.11 0.868 . . . . 0.0 108.869 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -66.3 -11.17 49.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.57 -5.43 45.91 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.445 1.498 . . . . 0.0 112.078 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 29.1 mmt 55.49 14.15 1.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.85 . . . . 0.0 113.092 -166.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.92 -9.64 53.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.87 -1.144 . . . . 0.0 112.909 -162.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.2 mt -72.54 110.6 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.33 -60.19 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.577 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.2 m -144.79 141.79 29.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tp -110.06 133.98 52.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 107.773 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.34 119.49 35.87 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.6 1.56 . . . . 0.0 107.128 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 tt -138.85 141.2 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.02 144.47 55.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -59.54 -38.41 80.98 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.094 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -16.53 27.98 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.62 -40.42 9.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.94 1.245 . . . . 0.0 110.042 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.01 -19.19 17.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.72 0.808 . . . . 0.0 111.986 167.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -122.58 21.0 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.973 2.909 . . . . 0.0 111.372 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -56.73 151.96 13.17 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.571 0.749 . . . . 0.0 110.989 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -63.78 -47.18 81.98 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.179 0.591 . . . . 0.0 111.86 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.79 122.73 24.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.83 -32.09 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.684 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.82 -57.78 5.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.919 1.691 . . . . 0.0 110.494 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -53.04 -52.07 59.68 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.037 0.935 . . . . 0.0 109.532 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -57.01 -46.19 82.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.696 -0.628 . . . . 0.0 111.552 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 m -52.72 -42.56 64.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.859 0.754 . . . . 0.0 110.911 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -57.99 -52.6 64.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.918 0.887 . . . . 0.0 109.036 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -60.47 -53.14 61.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.272 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -61.22 -36.78 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.838 1.199 . . . . 0.0 110.758 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -53.15 34.09 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.34 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.05 -37.08 81.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.736 0.698 . . . . 0.0 111.482 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.0 t -53.75 -53.4 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 109.922 168.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -58.81 -47.39 84.94 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.872 1.269 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.8 m -63.0 -33.14 74.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.195 1.798 . . . . 0.0 112.014 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.13 -35.64 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 120.602 -1.311 . . . . 0.0 110.62 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.98 -34.51 77.91 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.47 0.577 . . . . 0.0 109.701 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.37 -34.75 78.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.713 0.688 . . . . 0.0 110.374 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -79.23 3.01 19.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.916 1.287 . . . . 0.0 112.101 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.59 24.53 10.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.381 2.272 . . . . 0.0 113.696 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.24 166.09 29.38 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.4 m -92.56 157.02 16.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.109 0.957 . . . . 0.0 111.126 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.08 147.72 17.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.968 1.707 . . . . 0.0 107.23 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -132.94 121.48 22.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.18 108.11 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -89.19 156.13 18.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.2 m -103.12 136.12 43.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 t -52.55 -39.5 61.53 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 124.7 1.25 . . . . 0.0 111.895 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.44 -23.58 63.7 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.849 -1.157 . . . . 0.0 113.481 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -85.81 148.98 25.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.182 0.993 . . . . 0.0 109.646 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.47 -17.55 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.922 -1.112 . . . . 0.0 111.697 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 p -57.16 -34.98 68.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.711 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.71 -44.4 57.04 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.31 -38.3 71.08 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.9 0.85 . . . . 0.0 110.916 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -76.8 -37.21 56.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.188 -0.945 . . . . 0.0 112.128 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.41 -32.04 73.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.563 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -56.11 -40.72 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.853 1.661 . . . . 0.0 111.287 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -58.24 -15.71 11.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 112.071 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.36 37.42 4.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 129.073 2.949 . . . . 0.0 108.901 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p 66.54 9.51 6.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.728 2.011 . . . . 0.0 114.72 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.26 15.7 65.93 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.119 2.295 . . . . 0.0 113.385 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.7 111.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.049 0.925 . . . . 0.0 108.708 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.66 174.12 10.93 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.638 1.575 . . . . 0.0 109.258 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.23 146.45 8.94 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.873 -1.142 . . . . 0.0 110.251 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 80.6 mt -83.8 152.01 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.232 1.413 . . . . 0.0 107.916 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 38.8 mt -117.16 138.45 51.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.996 0.919 . . . . 0.0 110.691 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -60.99 -42.08 97.74 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.035 1.334 . . . . 0.0 110.119 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -139.07 157.1 71.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 125.721 1.609 . . . . 0.0 107.941 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.0 125.07 12.56 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.83 2.354 . . . . 0.0 108.807 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t -78.45 129.09 75.74 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.53 87.29 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.46 2.107 . . . . 0.0 109.767 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 p -143.04 146.31 33.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 160.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.29 168.64 51.98 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.09 124.51 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.007 2.472 . . . . 0.0 108.664 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 t -153.22 89.89 1.39 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -153.91 92.47 1.55 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.426 -1.764 . . . . 0.0 110.316 -169.661 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.099 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -149.18 164.56 34.4 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -154.97 175.78 13.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.013 2.125 . . . . 0.0 106.663 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.68 89.43 1.9 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 t -149.07 -82.19 0.11 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m 47.55 46.16 17.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.334 1.054 . . . . 0.0 110.501 -170.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 165.7 33.31 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 m -153.52 139.59 18.31 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.41 142.5 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.26 85.05 1.45 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 p -136.64 94.77 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.71 1.204 . . . . 0.0 109.456 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.93 139.7 38.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 159.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -162.61 142.71 9.56 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.707 1.603 . . . . 0.0 107.685 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 t -155.06 -58.44 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.315 1.046 . . . . 0.0 108.191 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.79 163.02 14.91 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -91.2 -73.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -51.25 19.09 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.862 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.01 80.81 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 123.809 0.693 . . . . 0.0 110.363 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.58 -24.5 67.58 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.98 -43.19 74.43 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.48 -51.44 60.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 127.415 2.286 . . . . 0.0 110.528 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.71 -50.42 80.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 119.094 0.861 . . . . 0.0 109.3 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -60.47 -41.93 95.2 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.86 -0.525 . . . . 0.0 110.906 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.42 -48.67 80.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.92 -44.85 94.06 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.136 -0.978 . . . . 0.0 110.184 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.49 -50.8 72.43 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.186 1.795 . . . . 0.0 109.866 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.04 -42.28 80.78 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.083 1.49 . . . . 0.0 108.455 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.42 -58.45 7.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.653 1.181 . . . . 0.0 109.496 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.63 -40.34 75.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.563 0.345 . . . . 0.0 111.626 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.93 -44.2 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.928 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -35.58 62.44 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 119.127 0.876 . . . . 0.0 109.334 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -54.06 -33.41 57.39 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.658 1.117 . . . . 0.0 112.168 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -70.63 -56.84 5.53 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.945 1.698 . . . . 0.0 110.695 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -94.38 -52.93 4.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.395 1.478 . . . . 0.0 113.409 -160.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -138.09 71.69 47.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.713 1.605 . . . . 0.0 107.521 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.35 -10.64 26.82 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 112.488 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.08 -24.04 16.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.334 2.254 . . . . 0.0 111.571 167.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -104.46 10.96 35.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.443 1.097 . . . . 0.0 112.063 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.36 96.66 3.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.841 1.2 . . . . 0.0 108.512 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 49' ' ' ALA . 2.3 m-30 -93.92 133.19 37.61 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.951 0.9 . . . . 0.0 108.893 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -139.78 160.56 39.6 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.41 133.98 0.52 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -167.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 tp -40.45 -52.89 2.72 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 126.258 1.823 . . . . 0.0 111.576 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -54.56 -46.0 73.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.621 1.568 . . . . 0.0 111.983 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.1 -59.85 4.46 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.69 -39.48 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.596 1.158 . . . . 0.0 112.332 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -54.68 -39.23 67.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.333 1.053 . . . . 0.0 111.505 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.94 -53.21 22.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.799 1.24 . . . . 0.0 110.539 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . . . -55.93 -36.02 67.27 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -58.74 -47.29 85.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.66 -33.8 75.79 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.98 -9.24 57.6 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.164 0.586 . . . . 0.0 111.682 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 44.7 mtt 55.4 24.42 6.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 127.494 2.318 . . . . 0.0 111.839 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.86 -13.97 49.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.747 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 mt -66.39 106.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.568 1.147 . . . . 0.0 109.03 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.77 -57.05 4.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.5 m -134.99 131.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.81 132.08 54.47 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.834 2.054 . . . . 0.0 106.522 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 118.88 31.5 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 tt -136.23 139.95 44.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.668 1.122 . . . . 0.0 109.222 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.37 133.12 54.62 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -38.57 75.55 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.247 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.32 -20.48 28.95 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 113.948 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.22 -43.53 10.93 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -50.73 -31.41 16.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 112.157 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.09 46.96 2.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.178 2.191 . . . . 0.0 108.431 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.38 152.52 33.86 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.294 0.638 . . . . 0.0 110.393 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.21 -33.38 63.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.447 1.499 . . . . 0.0 112.874 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -83.61 119.73 25.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.684 1.129 . . . . 0.0 108.858 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -51.85 -44.38 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 117.829 -1.082 . . . . 0.0 112.787 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.02 69.37 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.857 1.662 . . . . 0.0 111.644 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.1 -46.11 82.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.23 1.012 . . . . 0.0 108.748 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -53.87 -50.02 67.22 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.345 0.975 . . . . 0.0 109.417 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 t -52.04 -44.07 64.06 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.11 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -57.65 -55.4 35.28 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.493 1.042 . . . . 0.0 109.349 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -56.45 -50.88 70.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.29 -36.9 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.369 0.986 . . . . 0.0 111.251 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -49.67 75.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.812 0.733 . . . . 0.0 109.044 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 tp -56.21 -51.13 69.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.891 0.877 . . . . 0.0 109.594 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.6 t -54.0 -47.63 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.588 0.755 . . . . 0.0 111.406 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.91 -54.39 22.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.29 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 -11.74 61.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.585 0.754 . . . . 0.0 112.089 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.83 -39.32 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 O-C-N 120.312 -1.493 . . . . 0.0 109.714 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -61.26 -47.78 84.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.036 1.289 . . . . 0.0 108.589 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -51.92 -47.94 64.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.46 1.104 . . . . 0.0 110.086 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -82.25 9.94 7.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.894 0.877 . . . . 0.0 112.264 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 87.91 4.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 130.221 3.408 . . . . 0.0 114.486 166.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.18 162.47 40.42 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.893 -1.129 . . . . 0.0 113.246 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.8 m -87.0 130.4 34.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.501 2.32 . . . . 0.0 109.128 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.04 145.46 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.469 171.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -131.89 132.79 43.93 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 127.163 2.185 . . . . 0.0 106.374 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -118.62 113.42 41.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -90.57 140.35 29.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.076 1.751 . . . . 0.0 109.73 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 m -87.47 130.5 34.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.467 0.707 . . . . 0.0 111.243 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -51.23 -42.01 60.7 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.575 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -70.32 -17.65 63.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.968 1.707 . . . . 0.0 113.511 -171.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -93.95 150.15 20.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.204 1.401 . . . . 0.0 110.093 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.89 -31.44 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -53.71 -23.01 10.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.408 0.683 . . . . 0.0 111.311 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 -53.06 5.87 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 118.243 -1.309 . . . . 0.0 112.377 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.74 -29.56 70.19 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.246 1.523 . . . . 0.0 110.69 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.4 -55.26 14.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.498 1.519 . . . . 0.0 110.14 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.29 -37.03 76.68 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 119.449 1.022 . . . . 0.0 110.914 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -58.1 -35.23 71.12 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 111.795 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -60.5 -25.56 66.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.544 -0.722 . . . . 0.0 111.741 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -102.71 20.03 18.06 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.675 2.39 . . . . 0.0 109.656 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.277 17.5 p 78.09 0.92 2.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.471 3.508 . . . . 0.0 113.71 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.88 22.15 62.02 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 127.056 2.265 . . . . 0.0 112.289 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.81 109.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.904 1.352 . . . . 0.0 108.016 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.15 176.36 9.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.513 1.525 . . . . 0.0 111.437 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.37 146.67 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.897 171.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.56 143.76 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 C-N-CA 126.319 1.848 . . . . 0.0 107.634 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.23 129.32 55.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 124.298 0.999 . . . . 0.0 109.631 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -54.0 -41.14 67.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.49 1.516 . . . . 0.0 110.467 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.67 154.76 75.14 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.847 1.659 . . . . 0.0 107.788 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.54 106.6 1.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.044 3.163 . . . . 0.0 108.478 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.14 137.16 97.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.35 90.3 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.276 2.651 . . . . 0.0 109.751 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -133.26 162.14 32.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.179 1.392 . . . . 0.0 108.577 165.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.75 169.56 22.78 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 161.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.39 158.59 2.49 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.588 2.858 . . . . 0.0 110.511 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.67 161.81 41.81 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.153 -0.967 . . . . 0.0 109.528 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 t -72.41 -166.83 0.28 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.302 1.041 . . . . 0.0 109.808 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 O-C-N 120.223 -1.548 . . . . 0.0 109.298 165.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -134.01 172.82 12.3 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 111.838 -167.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -139.87 169.79 17.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.204 1.802 . . . . 0.0 108.705 171.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.64 91.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.555 1.55 . . . . 0.0 113.482 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -55.05 -50.86 68.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.908 0.854 . . . . 0.0 109.411 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p 47.45 65.46 1.26 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.88 1.672 . . . . 0.0 112.474 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.0 147.48 41.4 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.8 m -68.4 -34.86 76.78 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.261 -0.876 . . . . 0.0 112.121 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 t 40.72 68.18 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.765 2.026 . . . . 0.0 111.049 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.71 -73.16 0.51 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.65 0.78 . . . . 0.0 109.359 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -74.41 177.04 6.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.606 1.162 . . . . 0.0 111.674 -174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -71.62 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.012 -0.994 . . . . 0.0 112.382 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 144.88 28.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 121.044 1.747 . . . . 0.0 110.801 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 t -140.31 -56.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.448 0.699 . . . . 0.0 109.926 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.19 160.58 23.5 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.462 -0.774 . . . . 0.0 110.685 -163.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -61.06 -51.73 67.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.926 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -58.08 -53.24 60.49 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.45 98.73 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.325 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.11 -19.42 65.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.008 1.731 . . . . 0.0 112.761 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.83 -53.86 5.17 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 120.958 -1.088 . . . . 0.0 110.46 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.73 -51.71 66.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.943 0.897 . . . . 0.0 110.827 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.88 -48.63 78.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 126.192 1.797 . . . . 0.0 110.576 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -54.55 -48.94 71.43 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 119.56 1.073 . . . . 0.0 109.67 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -42.42 99.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.013 0.82 . . . . 0.0 111.813 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.33 -48.8 78.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.002 0.819 . . . . 0.0 110.716 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -61.47 -52.99 62.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.167 1.787 . . . . 0.0 109.342 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.2 -37.77 86.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.161 0.984 . . . . 0.0 108.886 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -58.94 -57.06 14.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.231 1.012 . . . . 0.0 110.341 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.89 -32.55 72.0 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.94 -59.25 3.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.16 -39.18 85.53 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.978 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.09 -20.27 51.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.857 0.753 . . . . 0.0 111.977 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -96.13 -53.36 3.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.532 1.133 . . . . 0.0 111.551 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -63.65 -66.36 0.55 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.521 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -145.11 80.83 10.9 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 109.616 -172.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.04 -6.52 8.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.228 2.619 . . . . 0.0 114.532 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.37 -25.07 33.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.091 0.86 . . . . 0.0 111.756 165.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -106.91 14.46 26.52 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.441 1.096 . . . . 0.0 112.015 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.56 92.71 3.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.305 0.957 . . . . 0.0 109.214 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.41 ' CD2' ' HB1' ' A' ' 49' ' ' ALA . 2.4 m-30 -93.75 132.78 37.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -139.9 163.48 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.497 0.719 . . . . 0.0 109.948 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 123.78 0.93 Allowed Glycine 0 C--N 1.331 0.269 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 -170.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.77 -46.8 2.75 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.726 1.611 . . . . 0.0 111.939 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.15 -55.57 26.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.765 2.826 . . . . 0.0 110.698 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.06 -57.42 13.16 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -50.92 -41.94 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.384 1.473 . . . . 0.0 111.835 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -56.8 -33.5 66.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.494 1.117 . . . . 0.0 111.488 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -77.3 -42.42 36.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 110.498 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HB1' ' CD2' ' A' ' 40' ' ' PHE . . . -65.6 -32.21 73.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.243 -0.911 . . . . 0.0 112.126 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -57.09 -51.33 69.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.1 -31.23 70.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -9.22 58.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.875 0.87 . . . . 0.0 111.319 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.2 mmt 62.27 21.44 12.49 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 110.948 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.4 -16.21 29.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 112.343 -168.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 mt -70.63 113.71 7.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -80.08 -55.41 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -137.95 128.87 27.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -110.61 131.1 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.96 2.104 . . . . 0.0 108.757 -175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.16 124.65 52.01 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 108.077 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.05 144.15 27.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 119.785 1.175 . . . . 0.0 108.382 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.29 136.5 53.55 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.39 -35.61 63.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.861 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.71 -16.0 55.41 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.36 1.436 . . . . 0.0 114.287 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.43 -40.8 9.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.607 1.163 . . . . 0.0 109.811 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -52.17 -29.31 21.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.237 1.015 . . . . 0.0 112.55 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 51.07 1.92 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.081 2.552 . . . . 0.0 108.159 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -57.98 148.25 26.57 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.314 -0.866 . . . . 0.0 109.954 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.79 -39.09 87.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.86 117.2 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.587 1.155 . . . . 0.0 108.641 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.51 -33.09 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.267 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.03 60.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 120.782 1.628 . . . . 0.0 109.762 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -59.21 -48.52 81.31 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 111.105 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -52.82 -50.92 62.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.292 0.951 . . . . 0.0 109.873 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -51.71 -42.04 61.94 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -56.8 -55.77 30.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.036 1.289 . . . . 0.0 110.341 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -57.3 -55.04 39.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.147 0.904 . . . . 0.0 111.014 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 t -51.43 -54.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.9 1.28 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -64.52 -40.25 95.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 tp -67.65 -41.39 83.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.413 0.552 . . . . 0.0 111.621 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.44 -48.95 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.622 1.169 . . . . 0.0 108.925 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -42.36 98.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.1 0.96 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 m -66.37 -32.19 73.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.478 1.911 . . . . 0.0 111.956 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.15 -38.03 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 120.34 -1.475 . . . . 0.0 110.467 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -61.77 -44.5 96.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.961 0.801 . . . . 0.0 109.819 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -54.41 -38.03 65.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.229 1.012 . . . . 0.0 110.268 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -93.93 16.82 13.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.842 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 89.77 1.47 0.23 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 128.977 2.911 . . . . 0.0 114.277 168.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.76 152.57 22.52 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.732 1.151 . . . . 0.0 112.775 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -80.35 152.2 29.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.891 2.076 . . . . 0.0 108.491 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.75 139.51 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -130.63 121.67 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.06 108.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 147.85 23.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.188 1.395 . . . . 0.0 109.532 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.98 136.26 45.1 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 171.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.8 t -71.56 4.93 2.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.542 0.737 . . . . 0.0 111.795 167.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.8 mt -121.47 -0.8 9.71 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.614 1.965 . . . . 0.0 112.607 -168.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.472 ' HD1' ' HB2' ' A' ' 99' ' ' SER . 9.7 t-80 -106.3 159.56 16.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.333 2.253 . . . . 0.0 110.357 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.472 ' HB2' ' HD1' ' A' ' 97' ' ' HIS . 17.7 m -58.76 -27.46 64.98 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.277 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.87 -54.72 7.97 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-O 119.004 -0.886 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.96 -31.94 73.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.073 0.937 . . . . 0.0 111.721 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.08 -46.15 90.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.989 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.53 -37.89 87.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.318 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.4 m -57.62 -29.15 64.29 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.566 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -66.41 -17.23 64.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 112.856 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -122.59 48.34 1.78 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.797 2.439 . . . . 0.0 107.251 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.5 p 63.03 4.47 1.55 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.69 1.996 . . . . 0.0 114.665 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.27 65.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.144 2.307 . . . . 0.0 112.904 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.7 p -154.32 113.19 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 118.866 1.333 . . . . 0.0 109.668 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.88 176.61 9.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 112.015 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.08 147.47 9.63 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.179 -1.576 . . . . 0.0 111.231 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -85.72 141.46 14.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.524 1.53 . . . . 0.0 107.68 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.0 mt -108.47 138.7 44.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.832 0.853 . . . . 0.0 109.683 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -52.04 -52.6 49.93 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.911 1.685 . . . . 0.0 109.752 168.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.02 159.34 71.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 127.448 2.299 . . . . 0.0 107.382 -170.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.81 142.27 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.631 1.554 . . . . 0.0 109.514 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t -89.4 136.89 29.38 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.95 65.54 8.28 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.451 2.768 . . . . 0.0 112.454 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.9 m -132.09 3.35 4.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.267 1.427 . . . . 0.0 112.255 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 65.13 163.09 0.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.205 1.383 . . . . 0.0 111.935 -172.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.02 -177.51 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.184 2.589 . . . . 0.0 112.207 -174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 m -75.91 157.12 33.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 157.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t -118.89 -25.16 6.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.262 1.425 . . . . 0.0 110.166 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 O-C-N 120.549 -1.345 . . . . 0.0 111.028 172.542 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -87.86 -169.4 2.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.32 1.448 . . . . 0.0 110.449 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t 47.3 -145.65 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.525 2.33 . . . . 0.0 112.886 161.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.61 163.58 12.14 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 158.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -137.29 -6.76 1.78 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.326 1.05 . . . . 0.0 113.418 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -89.58 142.46 27.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.367 1.439 . . . . 0.0 109.18 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.18 99.75 0.65 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.674 1.13 . . . . 0.0 110.659 -165.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -131.61 -0.9 3.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 111.96 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.85 -168.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 169.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 45.23 60.69 2.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.44 1.896 . . . . 0.0 111.926 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -135.32 95.25 3.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -129.94 -95.58 0.39 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 159.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.62 168.98 17.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 110.656 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 m -73.63 -70.35 0.38 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.787 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 46.76 77.32 0.09 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.948 1.699 . . . . 0.0 111.878 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -49.64 -42.9 46.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.736 1.614 . . . . 0.0 112.995 -168.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -66.13 -52.71 45.89 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.174 0.897 . . . . 0.0 110.135 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.77 79.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.965 0.348 . . . . 0.0 110.514 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.15 97.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.503 1.121 . . . . 0.0 112.466 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.49 63.63 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -50.76 54.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.26 1.424 . . . . 0.0 107.856 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.03 -51.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 110.39 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -60.32 -37.97 82.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.403 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.78 -35.48 74.93 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.219 0.918 . . . . 0.0 111.321 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tp -60.8 -49.07 78.96 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.056 0.844 . . . . 0.0 109.314 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -54.17 -56.81 14.64 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.52 1.128 . . . . 0.0 108.635 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -56.82 -43.46 81.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.084 0.865 . . . . 0.0 109.552 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.92 -54.55 40.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.835 0.854 . . . . 0.0 110.882 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.15 -35.73 77.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.795 0.725 . . . . 0.0 112.922 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -47.73 -59.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 108.206 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -62.23 -38.92 91.04 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.552 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.25 -29.28 57.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.044 1.293 . . . . 0.0 111.309 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -94.61 -47.08 6.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -69.39 -58.27 4.22 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.552 0.614 . . . . 0.0 111.658 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -144.92 79.33 12.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 C-N-CA 124.315 1.046 . . . . 0.0 109.369 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.65 -10.49 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.289 1.993 . . . . 0.0 114.571 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.22 -21.02 61.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.3 1.409 . . . . 0.0 111.23 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -102.97 12.33 36.21 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.824 1.193 . . . . 0.0 112.46 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.03 93.6 2.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.922 1.237 . . . . 0.0 109.064 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -97.34 138.26 35.08 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.468 0.707 . . . . 0.0 109.934 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -140.3 159.08 42.98 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.31 131.69 0.81 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 tp -43.27 -50.51 6.52 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.999 1.72 . . . . 0.0 112.968 -166.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.471 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -52.78 -55.81 20.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.528 1.931 . . . . 0.0 109.952 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -56.84 -57.14 13.78 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 t -47.96 -46.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.975 1.71 . . . . 0.0 111.675 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.36 -43.43 75.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.757 1.162 . . . . 0.0 110.382 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -64.32 -40.51 96.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.067 -1.021 . . . . 0.0 110.349 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.91 75.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.424 -0.797 . . . . 0.0 112.781 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -68.46 -42.57 78.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.49 -19.98 65.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.943 1.697 . . . . 0.0 113.118 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.58 -13.6 54.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.479 1.111 . . . . 0.0 111.897 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 57.36 24.86 10.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.469 1.908 . . . . 0.0 111.553 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.62 -15.06 31.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.438 -1.268 . . . . 0.0 111.891 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.07 107.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.505 1.048 . . . . 0.0 108.663 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.84 -48.45 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 172.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -143.78 134.31 24.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.4 tp -110.15 133.95 52.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.863 2.065 . . . . 0.0 107.314 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 124.61 48.54 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.108 1.763 . . . . 0.0 108.175 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 tt -138.64 134.97 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -62.32 125.88 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.743 1.217 . . . . 0.0 107.88 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -57.12 -32.41 66.32 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.017 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -54.13 -25.85 24.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.117 1.326 . . . . 0.0 113.44 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 mt -86.59 -42.15 13.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.51 1.124 . . . . 0.0 109.603 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -52.1 -27.58 14.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.262 1.425 . . . . 0.0 112.481 170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 34.78 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 110.591 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -55.7 146.81 20.05 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.016 -0.428 . . . . 0.0 111.185 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -25.21 64.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.37 120.67 31.69 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.61 -36.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.052 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -56.36 15.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.995 1.725 . . . . 0.0 109.888 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -53.68 -56.11 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.386 1.874 . . . . 0.0 110.232 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.09 -49.88 72.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.943 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -53.32 -41.82 66.07 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.94 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -57.39 -51.76 68.1 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.038 0.836 . . . . 0.0 110.383 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -60.79 -54.44 45.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.286 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.74 -31.79 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.581 1.082 . . . . 0.0 110.758 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -61.08 -58.21 9.32 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 109.075 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.371 1.068 . . . . 0.0 111.689 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.55 -46.22 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.13 . . . . 0.0 110.485 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.14 -37.87 69.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 0.0 111.46 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.2 t -67.01 -38.58 86.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.211 1.804 . . . . 0.0 110.859 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -55.38 -39.59 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 121.557 -0.715 . . . . 0.0 110.659 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.95 -39.3 87.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.794 0.724 . . . . 0.0 110.848 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.58 -28.55 69.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.686 0.794 . . . . 0.0 111.022 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -91.59 12.98 19.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.093 1.757 . . . . 0.0 110.732 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.11 26.4 15.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.471 . . . . 0.0 114.928 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.05 159.9 25.76 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.308 -0.87 . . . . 0.0 111.162 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -93.93 157.22 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.899 1.68 . . . . 0.0 110.184 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.54 148.37 25.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.1 0.96 . . . . 0.0 109.112 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.5 mmt-85 -141.83 121.68 13.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.37 112.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.12 124.57 34.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 96' ' ' LEU . 15.1 m -74.02 139.9 45.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.771 0.26 . . . . 0.0 111.034 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 t -61.39 10.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.261 2.625 . . . . 0.0 115.065 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 94' ' ' SER 0.455 0.2 OUTLIER -118.75 3.63 11.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.61 2.364 . . . . 0.0 113.665 -179.767 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.421 ' HD1' ' HB2' ' A' ' 99' ' ' SER . 2.1 t-80 -114.28 139.41 49.44 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.331 1.452 . . . . 0.0 110.886 -169.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 p -56.2 -28.93 26.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.688 0.795 . . . . 0.0 110.841 172.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.421 ' HB2' ' HD1' ' A' ' 97' ' ' HIS . 17.1 m -64.64 -27.72 69.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.726 -0.609 . . . . 0.0 111.529 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.64 52.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.67 -26.89 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.567 0.684 . . . . 0.0 112.002 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.47 -41.37 47.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.303 1.441 . . . . 0.0 110.381 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.38 -26.91 68.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 0.0 112.427 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 t -41.24 -54.9 2.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.176 2.19 . . . . 0.0 110.843 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -61.53 -5.23 1.67 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.638 1.975 . . . . 0.0 113.784 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 mt -131.66 33.97 3.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.784 2.433 . . . . 0.0 109.323 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.8 p 64.37 12.08 6.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.293 1.837 . . . . 0.0 113.671 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.4 17.19 68.24 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.996 2.236 . . . . 0.0 114.182 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.05 115.08 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.919 1.86 . . . . 0.0 108.856 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.97 15.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.343 1.057 . . . . 0.0 111.432 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.71 144.61 13.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.258 -1.526 . . . . 0.0 110.547 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.7 mt -84.12 144.29 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.162 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 mt -114.23 146.03 40.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.609 0.764 . . . . 0.0 109.512 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -71.26 -42.84 68.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.685 1.194 . . . . 0.0 110.43 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -129.34 157.39 76.35 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.113 1.365 . . . . 0.0 108.069 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 107.11 1.78 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.824 2.349 . . . . 0.0 106.888 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.58 138.03 81.97 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 97.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.037 2.492 . . . . 0.0 109.563 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.91 -52.31 0.03 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.798 0.839 . . . . 0.0 110.791 166.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 150.69 167.94 15.03 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 127.241 2.353 . . . . 0.0 111.307 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.57 166.47 13.72 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.076 3.184 . . . . 0.0 111.262 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -149.62 102.66 3.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.9 m -129.99 177.71 7.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.568 1.947 . . . . 0.0 108.003 161.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 CA-C-O 117.473 -1.737 . . . . 0.0 108.859 178.033 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.0 p -62.44 -36.22 81.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.296 1.048 . . . . 0.0 112.294 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.6 m 51.5 -155.59 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.903 1.281 . . . . 0.0 111.579 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.8 -76.56 0.22 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 m 69.56 87.34 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 127.82 2.448 . . . . 0.0 109.877 -172.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.7 p -132.72 -160.23 1.03 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.148 1.779 . . . . 0.0 108.867 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.53 174.99 13.9 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.1 m -124.26 176.38 6.46 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.671 1.588 . . . . 0.0 107.031 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.88 53.42 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 123.064 1.412 . . . . 0.0 108.379 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.32 142.19 58.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.269 1.428 . . . . 0.0 111.05 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.1 p -143.02 156.02 44.76 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.006 0.923 . . . . 0.0 109.817 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -160.13 133.72 7.03 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 52.32 -167.89 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.542 0.737 . . . . 0.0 110.57 -172.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.8 t -148.05 -53.79 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.28 -166.34 0.22 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.29 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.1 m -91.8 -74.48 0.51 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 111.106 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -66.82 -44.07 82.11 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -171.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.37 -45.83 46.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.795 1.238 . . . . 0.0 111.111 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.25 -32.33 73.94 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.799 0.84 . . . . 0.0 113.227 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.85 77.21 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.19 -51.92 65.86 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.533 1.133 . . . . 0.0 109.519 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.61 -42.35 81.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 124.467 1.107 . . . . 0.0 110.962 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -59.32 -49.59 77.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.659 1.118 . . . . 0.0 109.211 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.5 76.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.236 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -60.86 -50.24 74.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 110.375 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -62.31 -33.33 74.45 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.447 1.099 . . . . 0.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -43.72 32.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.665 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.79 -58.03 10.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.279 1.432 . . . . 0.0 110.775 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -54.55 -39.21 67.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.212 0.914 . . . . 0.0 112.294 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -45.44 -58.29 3.46 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.341 1.056 . . . . 0.0 108.939 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.77 80.3 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 117.871 -1.062 . . . . 0.0 111.329 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.18 -29.63 46.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.772 1.624 . . . . 0.0 111.498 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.78 -51.15 5.22 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.923 . . . . 0.0 110.878 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -75.96 -33.07 59.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -171.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -168.26 76.76 0.85 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.931 1.693 . . . . 0.0 110.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.8 -10.77 26.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.483 2.122 . . . . 0.0 114.107 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.93 -19.67 61.01 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.888 -1.133 . . . . 0.0 111.43 168.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -98.45 4.68 48.4 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.342 0.974 . . . . 0.0 112.989 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.81 95.87 2.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.85 1.205 . . . . 0.0 109.67 -176.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.425 ' CD2' ' HB1' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.1 141.39 28.47 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.019 1.328 . . . . 0.0 109.119 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -140.58 160.04 40.88 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.187 0.903 . . . . 0.0 113.07 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.66 131.49 2.66 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.7 tp -44.0 -45.94 8.09 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.688 1.595 . . . . 0.0 111.094 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -58.82 -45.76 89.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.049 1.339 . . . . 0.0 111.953 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -64.08 -59.05 4.93 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -49.64 -42.24 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.468 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -53.6 -40.64 65.85 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.46 1.104 . . . . 0.0 110.905 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.13 -48.08 25.45 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 126.1 1.76 . . . . 0.0 109.746 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 40' ' ' PHE . . . -54.52 -36.15 63.94 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.563 -1.336 . . . . 0.0 112.533 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -68.23 -40.97 81.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.392 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.36 -29.53 69.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.242 1.017 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 -7.0 51.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 111.172 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.8 mmt 54.21 24.69 5.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.688 1.995 . . . . 0.0 111.131 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.5 23.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.615 1.166 . . . . 0.0 111.839 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.54 118.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -97.23 -30.31 13.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.57 0.544 . . . . 0.0 110.946 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 m -139.33 132.77 30.2 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tp -109.87 133.82 52.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.76 125.03 53.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.083 1.753 . . . . 0.0 106.404 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 tt -140.83 148.14 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.7 t -67.92 144.26 55.31 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.09 -32.04 69.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.405 165.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.77 -24.73 64.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.433 1.47 . . . . 0.0 113.401 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.45 -45.62 11.67 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.905 1.282 . . . . 0.0 108.941 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.75 -26.49 34.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.234 1.413 . . . . 0.0 114.234 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.35 23.33 9.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.698 1.599 . . . . 0.0 110.807 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -55.63 147.45 18.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.916 0.886 . . . . 0.0 111.193 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -61.25 -45.14 95.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.929 1.291 . . . . 0.0 113.419 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -76.46 113.54 14.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 t -57.53 -32.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 117.514 -1.231 . . . . 0.0 111.139 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 -56.41 10.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 121.043 1.747 . . . . 0.0 110.506 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.9 m -50.81 -57.02 9.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.192 1.397 . . . . 0.0 110.786 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.59 -52.38 59.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.956 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.5 m -54.97 -43.13 73.23 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 117.056 -1.45 . . . . 0.0 111.162 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -51.99 -54.13 33.41 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 121.682 2.037 . . . . 0.0 110.032 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -57.99 -49.81 75.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.994 0.517 . . . . 0.0 111.466 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.85 -51.65 69.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.91 1.684 . . . . 0.0 110.983 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -63.88 -40.07 95.67 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.29 -43.84 89.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.05 -44.65 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.334 1.053 . . . . 0.0 109.704 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.57 -44.35 71.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.117 0.967 . . . . 0.0 111.22 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -66.06 -34.92 79.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.155 1.782 . . . . 0.0 110.626 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 t -59.09 -40.56 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.632 1.106 . . . . 0.0 109.952 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -69.68 -40.89 76.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.317 0.962 . . . . 0.0 110.029 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.04 -38.42 70.54 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.2 16.95 5.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.44 2.296 . . . . 0.0 112.193 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.07 10.18 3.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.024 2.93 . . . . 0.0 115.032 168.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.3 158.69 31.63 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.946 -1.096 . . . . 0.0 112.856 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.9 m -81.22 154.26 26.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.315 1.846 . . . . 0.0 109.655 172.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.68 145.55 25.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.037 0.935 . . . . 0.0 108.499 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -136.29 121.67 19.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 mm -112.78 107.74 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.67 155.19 19.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.637 1.175 . . . . 0.0 107.858 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -95.14 129.7 42.15 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -44.33 -46.5 9.31 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.875 1.27 . . . . 0.0 111.062 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.531 ' H ' HD21 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -63.58 -17.41 62.81 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.488 1.515 . . . . 0.0 114.735 -173.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -75.93 155.35 35.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 108.759 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.93 -26.94 21.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.98 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -74.83 -18.03 60.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.563 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.93 -49.1 50.47 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 123.106 2.685 . . . . 0.0 107.865 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.57 -33.92 76.67 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.6 -45.22 91.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.89 -34.32 77.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.814 0.846 . . . . 0.0 110.907 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 m -56.48 -33.59 66.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.401 1.081 . . . . 0.0 113.602 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -60.51 -20.48 60.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.056 -1.028 . . . . 0.0 111.288 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.8 mt -117.72 25.6 10.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 129.313 3.045 . . . . 0.0 108.8 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 p 70.5 11.43 7.34 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.832 2.453 . . . . 0.0 113.807 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.49 76.55 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.955 2.217 . . . . 0.0 113.242 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.33 122.89 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.115 1.457 . . . . 0.0 110.409 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.98 173.97 13.68 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 110.989 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.93 145.97 14.13 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.648 -1.283 . . . . 0.0 111.375 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.53 143.92 10.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.383 1.873 . . . . 0.0 107.615 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.8 mt -117.53 143.44 46.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 110.793 -172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -62.13 -32.47 73.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.321 1.848 . . . . 0.0 111.716 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.41 161.85 28.46 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 127.26 2.224 . . . . 0.0 107.414 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 107.95 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.274 2.65 . . . . 0.0 109.205 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.4 t -59.93 127.48 85.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.75 87.81 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.439 2.76 . . . . 0.0 110.103 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 m -147.48 170.23 17.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.092 2.557 . . . . 0.0 107.504 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.96 119.18 5.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 163.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.47 162.26 39.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.161 1.907 . . . . 0.0 109.205 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t -161.37 122.03 2.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.0 m -64.86 168.25 6.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 152.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 157.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p -148.2 155.96 42.0 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.301 1.05 . . . . 0.0 110.49 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 m -137.91 177.36 7.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.753 1.621 . . . . 0.0 110.156 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.43 -177.79 15.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.489 2.471 . . . . 0.0 107.26 166.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m 38.05 78.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.506 1.923 . . . . 0.0 115.615 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 p -139.75 159.49 42.05 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.695 -0.628 . . . . 0.0 110.183 159.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 35.58 51.38 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.4 p -86.3 -154.67 0.22 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.673 1.189 . . . . 0.0 109.225 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -44.7 121.2 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.938 1.695 . . . . 0.0 110.551 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 84.18 6.38 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.72 0.808 . . . . 0.0 109.897 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.64 174.68 10.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.864 1.666 . . . . 0.0 107.857 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -149.32 -65.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 109.347 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.46 149.36 23.95 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.258 1.823 . . . . 0.0 109.299 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 m -141.74 -9.48 0.93 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.843 0.857 . . . . 0.0 112.726 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -163.12 168.87 20.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.551 1.941 . . . . 0.0 106.557 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.9 m -68.38 -59.31 3.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.779 1.232 . . . . 0.0 111.007 169.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -64.54 -51.76 61.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.8 -43.98 66.3 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 111.55 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.47 -21.67 63.69 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.11 -44.43 54.16 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.53 -43.83 97.84 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.298 0.639 . . . . 0.0 110.353 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.6 t -58.17 -51.92 65.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 118.117 -0.945 . . . . 0.0 109.366 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -39.22 84.74 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.881 1.219 . . . . 0.0 110.024 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.94 -55.89 28.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.46 0.704 . . . . 0.0 110.916 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.08 -41.74 79.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.539 1.063 . . . . 0.0 111.673 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.23 -50.09 75.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 126.533 1.933 . . . . 0.0 109.173 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.0 -39.82 87.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.07 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.95 -57.22 12.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.324 1.85 . . . . 0.0 110.24 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -55.78 -38.62 70.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.343 0.657 . . . . 0.0 112.428 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -44.65 -60.18 2.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.226 0.61 . . . . 0.0 110.099 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -34.68 78.89 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.656 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.67 -30.2 54.83 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.035 1.289 . . . . 0.0 111.519 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -85.63 -65.39 1.02 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.41 0.684 . . . . 0.0 110.34 167.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.52 -38.64 84.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -161.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.99 77.87 3.93 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.59 -5.76 13.74 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.794 1.663 . . . . 0.0 113.299 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -60.19 -19.47 54.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.616 -1.302 . . . . 0.0 111.094 166.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -107.95 9.7 28.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.207 1.403 . . . . 0.0 112.603 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 92.24 2.93 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 120.198 1.363 . . . . 0.0 108.774 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -94.0 137.77 32.84 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.67 160.26 40.29 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 139.11 1.13 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -39.58 -52.45 2.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.53 1.932 . . . . 0.0 112.026 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -59.64 -44.55 93.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.643 1.977 . . . . 0.0 111.748 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -64.4 -57.26 9.8 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -46.44 -42.6 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.262 1.425 . . . . 0.0 111.686 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -53.44 -43.64 68.22 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.301 0.955 . . . . 0.0 111.391 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.73 -42.21 74.28 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.565 1.146 . . . . 0.0 110.292 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.0 96.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -66.11 -36.69 83.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.15 0.281 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.35 -38.4 77.15 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.123 -0.986 . . . . 0.0 111.632 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -3.59 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.299 1.44 . . . . 0.0 111.512 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.7 mmt 63.4 4.39 1.7 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 113.08 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.24 48.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -158.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.9 mt -74.25 110.18 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -168.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.71 -54.23 17.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -146.35 136.32 23.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.455 1.502 . . . . 0.0 107.653 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -110.0 142.36 41.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.468 1.907 . . . . 0.0 107.666 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.1 119.52 25.51 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.72 149.77 22.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 120.135 1.334 . . . . 0.0 108.051 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 3.9 t -66.51 144.06 56.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -60.33 -36.46 78.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.357 166.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 6.5 pt-20 -56.04 -31.66 63.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.741 1.61 . . . . 0.0 113.65 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 mt -81.71 -42.08 20.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 109.41 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -52.73 -24.99 9.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 113.997 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.55 27.09 6.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.657 1.583 . . . . 0.0 110.819 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -53.52 142.99 20.79 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.716 0.769 . . . . 0.0 111.62 -172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -58.78 -39.82 82.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.366 2.267 . . . . 0.0 113.144 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -85.9 114.9 23.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 t -39.6 -41.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.743 1.617 . . . . 0.0 111.491 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -35.11 62.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.803 1.183 . . . . 0.0 114.065 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -74.36 -45.82 44.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -52.77 -50.9 62.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.3 p -53.17 -46.38 68.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.472 0.709 . . . . 0.0 110.292 -168.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -53.64 -55.58 24.66 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.496 1.918 . . . . 0.0 109.909 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -59.19 -59.37 5.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.621 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.53 -36.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.825 1.648 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -57.37 11.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.134 1.374 . . . . 0.0 109.286 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -62.27 -36.78 83.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.297 0.639 . . . . 0.0 111.829 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 t -60.24 -50.48 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.319 1.448 . . . . 0.0 109.012 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.26 -36.72 80.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.504 0.721 . . . . 0.0 110.214 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 t -65.45 -35.0 79.61 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.26 1.424 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.71 -35.53 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 119.422 1.01 . . . . 0.0 110.188 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -69.16 -33.88 74.1 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.38 -25.39 67.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.0 110.914 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -99.09 11.86 37.76 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 127.185 2.194 . . . . 0.0 111.508 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.51 33.37 23.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.398 1.479 . . . . 0.0 113.212 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.75 153.46 20.92 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.204 0.911 . . . . 0.0 111.057 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -74.99 151.12 38.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.031 0.932 . . . . 0.0 108.955 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -121.16 142.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.92 1.288 . . . . 0.0 107.6 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -133.16 120.88 21.78 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.6 mm -94.49 125.21 47.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.42 166.57 13.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.102 0.864 . . . . 0.0 108.788 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.03 110.08 21.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 166.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 t -43.71 -34.3 1.47 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.851 1.26 . . . . 0.0 112.16 173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.604 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -65.83 -36.14 82.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.862 2.465 . . . . 0.0 113.748 -176.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -72.78 160.3 32.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.133 1.773 . . . . 0.0 111.236 -172.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -36.65 48.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.702 -0.624 . . . . 0.0 110.171 172.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -66.66 -16.73 64.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.483 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.14 10.39 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 171.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.11 -36.96 63.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.949 0.9 . . . . 0.0 110.273 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.04 -63.73 1.2 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.662 169.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.69 -34.15 64.79 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.319 1.418 . . . . 0.0 111.662 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.0 66.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.077 1.351 . . . . 0.0 112.476 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.45 -28.6 68.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 111.055 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.9 mt -104.48 31.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.418 2.287 . . . . 0.0 109.371 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p 69.05 -0.37 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.273 2.229 . . . . 0.0 114.049 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.33 58.88 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.961 2.696 . . . . 0.0 112.538 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.17 118.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.843 1.322 . . . . 0.0 110.306 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.44 9.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.404 1.481 . . . . 0.0 112.567 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.16 149.45 17.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 110.772 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.13 144.82 9.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.671 1.988 . . . . 0.0 107.029 167.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.29 136.41 53.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -60.25 -39.0 85.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.979 0.912 . . . . 0.0 110.802 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.31 157.81 75.88 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 128.448 2.699 . . . . 0.0 107.101 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.5 124.69 13.22 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.961 1.774 . . . . 0.0 107.805 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.0 t -75.31 122.02 86.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.19 142.69 81.22 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.46 1.44 . . . . 0.0 109.349 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.6 p -163.57 168.99 19.32 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.09 165.81 24.31 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 162.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.42 166.61 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.663 2.909 . . . . 0.0 113.27 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.0 m -141.07 50.4 1.63 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.7 2.0 . . . . 0.0 109.628 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 t -128.63 -87.09 0.55 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 104.864 -3.294 . . . . 0.0 104.864 162.074 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -163.31 -49.34 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.315 1.046 . . . . 0.0 108.584 162.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t -143.89 -177.06 5.24 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.284 1.034 . . . . 0.0 109.326 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.07 179.17 18.11 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 125.993 1.759 . . . . 0.0 111.038 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -128.69 175.88 8.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 108.595 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -177.5 -172.42 0.37 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.183 2.993 . . . . 0.0 104.71 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.48 166.65 19.32 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 171.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -142.89 162.62 34.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.23 1.812 . . . . 0.0 106.655 -176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.0 t -131.94 91.07 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.37 166.12 23.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.167 1.787 . . . . 0.0 109.375 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -163.05 -172.18 2.94 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 107.281 163.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -156.4 168.95 25.75 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.682 1.593 . . . . 0.0 108.112 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.2 tp -149.98 134.55 17.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.782 0.833 . . . . 0.0 108.94 173.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.58 131.1 9.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 t70 58.87 -177.96 0.08 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 112.45 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -92.55 -53.18 4.3 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.112 -2.243 . . . . 0.0 111.48 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -69.11 -51.3 39.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.24 79.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.465 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.59 65.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.285 1.034 . . . . 0.0 113.441 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.2 -34.54 54.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.05 -50.5 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.562 0.681 . . . . 0.0 109.783 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.07 -53.54 41.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 125.828 1.651 . . . . 0.0 109.726 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -59.42 -36.29 75.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.425 1.011 . . . . 0.0 110.326 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.39 94.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.368 0.985 . . . . 0.0 110.995 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.48 -44.82 89.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.035 1.288 . . . . 0.0 110.82 173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -60.6 -47.62 85.38 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.526 1.53 . . . . 0.0 110.289 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -73.3 -35.99 66.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.875 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.61 -59.58 5.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.824 1.65 . . . . 0.0 110.791 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 -37.73 66.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -51.56 -53.1 41.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.703 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -34.08 77.34 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 118.152 -0.928 . . . . 0.0 111.533 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.59 -33.65 64.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.976 1.262 . . . . 0.0 110.514 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -76.78 -62.45 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -75.56 -34.56 60.71 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -160.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -157.91 81.48 3.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.987 1.715 . . . . 0.0 109.763 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 -14.03 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.684 2.256 . . . . 0.0 113.916 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.74 -15.28 39.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.657 -1.277 . . . . 0.0 111.871 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -107.52 8.9 29.59 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.957 0.903 . . . . 0.0 112.488 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.29 86.74 2.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.789 1.177 . . . . 0.0 108.837 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -93.19 144.9 24.84 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.54 164.94 28.81 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.42 134.95 0.57 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 tp -43.05 -47.29 5.88 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.857 1.663 . . . . 0.0 111.806 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -55.72 -43.33 76.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 112.189 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -55.65 13.03 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.72 -42.11 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 111.711 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.26 -24.79 68.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.377 1.471 . . . . 0.0 111.492 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -72.4 -70.31 0.35 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 116.005 -1.95 . . . . 0.0 107.104 161.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.28 -31.19 8.48 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 122.92 2.6 . . . . 0.0 116.135 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.06 -49.21 32.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.416 1.486 . . . . 0.0 112.209 167.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -48.0 -42.15 27.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 128.323 2.649 . . . . 0.0 110.176 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.07 -0.44 57.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.666 1.186 . . . . 0.0 111.116 -169.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 mmt 54.0 31.69 14.05 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.559 1.543 . . . . 0.0 110.425 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.81 -7.81 36.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.094 -166.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -83.08 114.81 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 119.679 1.127 . . . . 0.0 108.043 -166.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.37 -54.79 6.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.337 1.455 . . . . 0.0 108.478 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.6 m -146.52 138.14 24.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.339 1.455 . . . . 0.0 107.336 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.69 139.57 44.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 106.95 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.87 124.17 42.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.048 1.739 . . . . 0.0 106.555 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.7 tt -137.52 142.13 37.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.18 131.06 45.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -53.8 -33.85 57.32 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 117.564 -1.208 . . . . 0.0 111.522 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.84 -37.72 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.944 1.702 . . . . 0.0 112.873 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.48 -42.75 67.72 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.92 0.867 . . . . 0.0 109.752 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.69 -12.14 15.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.057 0.943 . . . . 0.0 112.572 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -123.44 19.96 9.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.898 2.479 . . . . 0.0 111.497 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -61.12 152.93 27.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.353 1.073 . . . . 0.0 111.949 -168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -77.57 -33.76 53.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.903 2.481 . . . . 0.0 112.399 -172.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 50.4 t0 -80.14 120.0 23.68 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.95 -29.98 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.605 0.639 . . . . 0.0 110.455 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.7 -56.05 18.67 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 119.863 -1.773 . . . . 0.0 111.513 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 54.9 m -56.21 -57.44 12.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.938 1.295 . . . . 0.0 108.826 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -54.25 -49.2 70.08 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.412 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.5 m -53.94 -41.17 67.46 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.079 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -57.42 -48.94 77.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.987 1.267 . . . . 0.0 109.812 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -61.91 -56.12 22.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.048 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.85 -36.6 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.532 1.06 . . . . 0.0 110.161 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -57.74 -59.9 4.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.65 0.78 . . . . 0.0 109.486 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 tp -56.07 -44.17 78.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 111.46 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -53.15 -52.16 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.777 1.231 . . . . 0.0 109.991 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -32.73 63.33 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.16 -0.962 . . . . 0.0 112.303 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -62.23 -37.87 87.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.432 1.493 . . . . 0.0 110.985 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.55 -33.34 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.11 0.868 . . . . 0.0 110.008 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -70.48 -29.69 66.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.246 1.385 . . . . 0.0 112.222 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.06 -47.97 75.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -74.69 17.27 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.64 1.976 . . . . 0.0 112.44 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.89 56.46 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.145 2.578 . . . . 0.0 112.369 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.97 155.19 18.49 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.882 1.706 . . . . 0.0 109.822 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.1 m -75.99 148.81 37.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.452 -1.028 . . . . 0.0 110.078 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.0 129.72 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 109.016 169.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -119.64 121.53 39.48 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.42 120.25 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -88.42 162.49 16.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -104.27 113.28 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 117.374 -1.298 . . . . 0.0 107.674 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 t -56.11 -30.0 61.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.662 1.119 . . . . 0.0 112.476 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.598 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.06 -38.88 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.025 1.73 . . . . 0.0 111.251 -178.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -75.32 142.02 43.29 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 126.792 2.037 . . . . 0.0 110.655 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.04 -18.34 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.25 1.02 . . . . 0.0 113.331 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.0 m -61.7 -26.46 68.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.501 1.046 . . . . 0.0 111.165 172.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.16 -55.5 29.12 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -56.78 -36.11 69.48 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.06 0.93 . . . . 0.0 112.797 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -67.26 -45.64 76.04 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.576 -0.702 . . . . 0.0 110.184 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.92 -37.09 83.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.942 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.7 m -62.32 -28.54 69.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.563 1.074 . . . . 0.0 112.431 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -69.88 3.89 2.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.086 0.954 . . . . 0.0 112.904 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.8 mt -136.52 33.27 2.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.055 2.942 . . . . 0.0 107.645 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.263 3.2 p 59.74 11.15 2.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.312 2.645 . . . . 0.0 114.845 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.96 17.86 80.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 128.054 2.74 . . . . 0.0 113.03 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.37 120.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 119.706 1.753 . . . . 0.0 108.949 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.47 175.35 10.63 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.933 0.893 . . . . 0.0 109.566 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.85 146.71 11.26 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.614 -1.304 . . . . 0.0 109.454 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.56 139.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.9 mt -106.07 141.27 37.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -50.02 -61.21 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.943 2.097 . . . . 0.0 108.752 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -130.62 159.46 70.88 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 127.49 2.316 . . . . 0.0 109.278 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 106.68 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.855 2.37 . . . . 0.0 109.577 -176.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.01 136.54 87.74 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.41 112.73 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.563 2.175 . . . . 0.0 108.532 169.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.69 -52.01 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.47 157.77 7.29 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.22 -24.34 32.26 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.027 1.818 . . . . 0.0 111.134 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 m 44.3 63.09 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.427 1.891 . . . . 0.0 111.05 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.4 m -53.23 148.09 9.04 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.512 1.525 . . . . 0.0 113.551 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.818 0 CA-C-O 117.907 -1.496 . . . . 0.0 111.566 -168.03 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.966 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 m -140.63 -13.15 0.99 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t 48.5 -129.89 1.81 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.95 1.25 . . . . 0.0 111.131 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.93 -151.03 45.21 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.802 1.668 . . . . 0.0 113.476 171.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t 95.46 20.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.671 2.788 . . . . 0.0 113.063 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -127.14 76.44 1.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.035 1.288 . . . . 0.0 110.6 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.97 175.32 42.0 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -103.94 160.39 14.86 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.324 1.05 . . . . 0.0 109.899 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.19 84.62 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.245 1.818 . . . . 0.0 106.228 165.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.89 156.0 26.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.742 0.817 . . . . 0.0 109.94 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.0 t -172.89 114.93 0.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -141.22 172.59 12.47 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.695 1.598 . . . . 0.0 109.151 171.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.89 -75.61 0.56 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.313 1.845 . . . . 0.0 108.244 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.9 t 72.34 -54.82 0.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.191 2.196 . . . . 0.0 110.775 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -150.17 156.25 41.27 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.818 1.247 . . . . 0.0 109.523 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -54.93 -56.06 23.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.988 1.715 . . . . 0.0 112.421 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -67.13 -48.44 68.07 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.61 -44.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.398 0.679 . . . . 0.0 111.427 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.19 83.06 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.134 1.373 . . . . 0.0 112.84 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.31 -40.22 98.72 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -45.19 78.39 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.39 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.6 t -54.92 -42.13 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.642 0.777 . . . . 0.0 109.481 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -51.19 70.99 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.35 80.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.737 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.82 -48.37 79.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.739 1.154 . . . . 0.0 110.907 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.28 -53.4 54.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.557 1.543 . . . . 0.0 109.306 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -66.42 -37.8 86.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.264 1.826 . . . . 0.0 109.169 -171.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -65.1 -56.09 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 111.19 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.88 -37.47 74.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.951 0.796 . . . . 0.0 112.235 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.91 -55.24 12.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.719 0.808 . . . . 0.0 109.731 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -64.11 -34.88 79.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.836 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.11 -17.59 27.87 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.158 0.89 . . . . 0.0 111.86 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -96.55 -57.81 2.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 110.622 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -70.43 -44.48 67.79 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -165.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.33 77.93 6.56 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 119.229 0.922 . . . . 0.0 110.094 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -65.07 -8.76 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.268 1.979 . . . . 0.0 114.208 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.27 -17.86 32.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.91 1.232 . . . . 0.0 111.279 164.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -108.42 11.26 27.11 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.311 1.444 . . . . 0.0 112.784 174.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.55 89.83 2.64 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.876 1.216 . . . . 0.0 108.934 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -93.81 140.19 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.743 0.817 . . . . 0.0 108.834 -175.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -139.79 158.53 43.95 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.778 0.431 . . . . 0.0 111.214 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 131.72 0.79 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.0 tp -41.21 -49.75 3.58 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.054 2.141 . . . . 0.0 111.456 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.39 -56.76 15.42 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.526 1.931 . . . . 0.0 110.638 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -59.21 -51.06 71.62 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.16 -42.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.984 1.313 . . . . 0.0 111.962 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -61.06 -30.02 70.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 120.254 1.388 . . . . 0.0 111.261 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -75.0 -45.76 39.74 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 120.098 -1.626 . . . . 0.0 110.579 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.67 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.77 -1.206 . . . . 0.0 111.94 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.45 -52.2 66.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.221 1.409 . . . . 0.0 109.062 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.37 -37.21 72.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.972 0.805 . . . . 0.0 111.65 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.48 -5.01 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.706 0.802 . . . . 0.0 111.282 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.2 mmt 53.97 26.25 6.17 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.195 1.798 . . . . 0.0 111.854 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.11 -11.15 36.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.886 -164.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.39 118.19 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -169.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -84.28 -50.09 8.17 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 167.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.3 m -131.99 131.63 42.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 tp -110.15 130.81 55.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.234 1.814 . . . . 0.0 107.579 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 131.7 54.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.194 1.797 . . . . 0.0 106.468 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.49 146.62 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.39 0.541 . . . . 0.0 109.751 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.16 134.16 51.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 166.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -52.0 -36.6 50.42 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.144 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.61 -33.1 59.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.935 1.243 . . . . 0.0 113.242 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.94 -39.99 20.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.901 0.773 . . . . 0.0 109.347 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -57.57 -16.99 11.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.142 0.977 . . . . 0.0 112.555 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 39.83 3.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.721 2.008 . . . . 0.0 109.241 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -58.5 152.8 17.3 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.625 -0.672 . . . . 0.0 109.535 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -67.73 -55.0 14.8 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.105 1.362 . . . . 0.0 111.725 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -63.6 120.1 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.55 -42.09 80.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.558 1.143 . . . . 0.0 111.521 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.38 -34.3 61.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.95 0.795 . . . . 0.0 111.694 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.0 m -70.92 -45.65 63.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.234 175.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -51.64 -53.47 38.34 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.502 1.046 . . . . 0.0 109.075 167.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.3 t -52.1 -40.44 61.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.98 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -58.8 -57.35 13.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 120.206 1.367 . . . . 0.0 109.725 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -54.18 -50.37 67.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.527 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.37 -38.0 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 118.363 0.528 . . . . 0.0 111.045 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -58.93 -50.75 72.87 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.91 -42.73 97.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.957 0.903 . . . . 0.0 111.226 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -49.89 -52.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.547 1.139 . . . . 0.0 109.571 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.606 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 23.7 t70 -65.52 -43.12 91.03 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.436 0.694 . . . . 0.0 111.243 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -37.44 79.01 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.871 1.668 . . . . 0.0 111.769 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.82 -33.89 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.629 1.104 . . . . 0.0 110.115 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.606 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 5.7 mtmp? -75.57 -33.35 60.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.853 1.206 . . . . 0.0 111.402 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -56.56 -43.44 79.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -77.53 21.78 0.26 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.482 1.913 . . . . 0.0 111.721 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.73 9.05 0.53 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.794 3.238 . . . . 0.0 115.834 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.48 176.04 52.51 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.79 1.216 . . . . 0.0 112.209 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -108.05 149.36 28.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.173 2.189 . . . . 0.0 109.493 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.9 146.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.269 1.428 . . . . 0.0 107.407 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -139.28 121.75 16.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.32 115.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.19 173.74 7.99 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.365 1.466 . . . . 0.0 108.398 -175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -103.8 132.72 49.79 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -43.21 31.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.343 1.457 . . . . 0.0 111.907 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.603 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -71.05 -20.39 62.38 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.096 2.158 . . . . 0.0 112.953 -174.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.61 158.11 34.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.097 -1.002 . . . . 0.0 109.38 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 p -57.58 -37.87 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 m -64.52 -24.15 67.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.279 1.032 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.59 -41.96 28.11 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.67 -41.64 81.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.18 0.99 . . . . 0.0 109.584 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -68.91 -43.74 74.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.544 0.737 . . . . 0.0 111.643 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.48 -31.45 72.67 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.311 0.505 . . . . 0.0 110.172 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.03 -39.59 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.66 1.184 . . . . 0.0 112.637 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -56.54 -14.74 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.594 1.158 . . . . 0.0 112.111 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.1 mt -128.29 33.86 4.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.182 2.993 . . . . 0.0 108.757 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 65.58 10.6 6.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.761 1.624 . . . . 0.0 114.119 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.43 15.11 70.13 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.432 1.968 . . . . 0.0 115.118 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.38 129.65 9.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 119.229 1.515 . . . . 0.0 109.157 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.35 175.91 13.39 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 109.396 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.36 145.07 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.53 -0.731 . . . . 0.0 110.526 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 77.0 mt -83.82 135.35 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.2 mt -105.02 141.23 36.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp-105 -56.54 -56.31 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.708 1.603 . . . . 0.0 109.138 171.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -124.71 157.14 66.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 125.959 1.704 . . . . 0.0 108.493 -172.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.49 115.2 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.359 2.04 . . . . 0.0 107.269 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.99 119.89 72.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.18 111.2 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -56.49 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.762 0.825 . . . . 0.0 110.035 -171.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.64 141.35 7.31 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.265 1.888 . . . . 0.0 110.292 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.34 -23.83 27.69 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.997 3.131 . . . . 0.0 113.632 -166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.0 m 48.8 65.81 1.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.73 1.612 . . . . 0.0 113.915 163.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.0 t -63.12 -10.16 13.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.414 2.286 . . . . 0.0 114.432 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 116.597 -2.224 . . . . 0.0 109.459 178.097 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m -136.93 165.47 25.91 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.538 1.535 . . . . 0.0 107.333 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -150.88 -83.88 0.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.45 10.96 71.41 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.778 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 p -67.19 87.93 0.17 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.989 2.115 . . . . 0.0 110.479 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.0 p -144.26 -167.73 2.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.889 0.876 . . . . 0.0 110.671 -171.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.63 -174.53 20.99 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -140.79 151.93 44.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.64 42.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.1 1.36 . . . . 0.0 108.573 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.08 159.85 5.41 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.648 1.179 . . . . 0.0 110.462 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.2 t -143.82 162.14 36.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.681 0.753 . . . . 0.0 109.82 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -143.05 168.02 20.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.237 2.215 . . . . 0.0 106.608 165.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.488 ' CD2' ' H ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -153.45 -166.53 2.44 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.187 0.595 . . . . 0.0 109.598 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.488 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 22.3 m 53.8 -142.69 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.335 1.854 . . . . 0.0 109.851 -159.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -40.02 103.35 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.004 2.522 . . . . 0.0 112.126 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -59.14 -33.41 70.86 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.512 1.125 . . . . 0.0 112.233 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -71.15 -52.39 19.52 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.925 0.784 . . . . 0.0 111.212 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -42.03 92.8 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.204 0.456 . . . . 0.0 109.9 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -9.77 34.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.171 1.388 . . . . 0.0 112.88 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.3 -42.68 4.22 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 120.153 1.342 . . . . 0.0 110.988 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.36 -57.37 12.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.59 1.556 . . . . 0.0 108.804 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.98 -50.53 19.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 125.685 1.594 . . . . 0.0 110.407 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -58.15 -50.47 73.4 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.265 0.939 . . . . 0.0 109.58 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.63 75.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.667 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.0 -49.84 64.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.571 1.532 . . . . 0.0 110.451 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.7 -49.12 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.583 1.553 . . . . 0.0 109.178 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -69.48 -34.59 74.55 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.237 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -62.25 -58.54 7.35 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 127.049 2.14 . . . . 0.0 109.647 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -54.43 -39.63 67.54 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.361 0.664 . . . . 0.0 112.248 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -49.9 -48.59 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.475 0.31 . . . . 0.0 111.211 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.2 mtp -71.45 -35.91 71.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.964 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -55.71 -26.97 47.93 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.447 1.021 . . . . 0.0 111.476 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -92.94 -36.39 12.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.73 1.612 . . . . 0.0 112.861 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -86.03 -64.05 1.22 Allowed 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.295 1.038 . . . . 0.0 112.0 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -142.6 80.93 13.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.711 1.604 . . . . 0.0 107.513 -170.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.6 -13.1 38.55 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.769 2.313 . . . . 0.0 112.552 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.8 -20.15 14.01 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 111.892 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -103.27 1.83 33.43 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 124.354 1.062 . . . . 0.0 113.543 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.41 90.69 2.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 120.058 1.299 . . . . 0.0 109.915 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.4 ' CD2' ' HB1' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.37 140.43 29.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.052 0.941 . . . . 0.0 108.966 -173.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -139.95 160.16 40.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.32 143.45 1.39 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.5 tp -46.64 -49.89 18.46 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.326 1.45 . . . . 0.0 112.356 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -46.41 90.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.682 0.793 . . . . 0.0 109.72 -175.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.5 -56.43 18.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -50.53 -43.3 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.904 1.282 . . . . 0.0 111.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.39 -40.81 68.56 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.577 1.08 . . . . 0.0 110.645 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.19 -46.48 33.78 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.505 1.522 . . . . 0.0 109.838 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.4 ' HB1' ' CD2' ' A' ' 40' ' ' PHE . . . -54.71 -37.54 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.995 -1.065 . . . . 0.0 111.941 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -66.73 -44.34 81.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.391 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.0 -34.63 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.789 1.177 . . . . 0.0 111.758 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.7 -7.15 36.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.978 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mmt 51.29 39.53 24.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.846 2.459 . . . . 0.0 109.362 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.0 -10.5 13.93 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.386 1.074 . . . . 0.0 112.923 -164.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.35 111.13 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.49 -59.27 3.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.2 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.421 ' CG2' ' HE ' ' A' ' 91' ' ' ARG . 53.4 m -146.07 134.73 22.22 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.69 140.96 41.36 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 126.712 2.005 . . . . 0.0 107.201 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.41 129.79 56.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.978 2.111 . . . . 0.0 106.468 176.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.28 131.6 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -63.58 129.97 42.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.73 -33.94 36.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.235 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.32 -22.06 62.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.35 1.432 . . . . 0.0 112.871 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.02 -40.49 11.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.241 1.016 . . . . 0.0 109.191 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -54.23 -21.06 8.09 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 20.05 7.3 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.934 1.243 . . . . 0.0 112.062 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -49.8 145.07 5.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.154 1.382 . . . . 0.0 112.908 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -46.65 89.45 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.05 110.33 5.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.69 -36.47 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.851 -172.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.78 65.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.02 1.282 . . . . 0.0 112.575 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.14 -48.72 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.289 1.036 . . . . 0.0 108.506 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 -55.02 -49.95 70.25 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.394 0.678 . . . . 0.0 109.994 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.2 p -54.61 -43.75 72.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.44 0.696 . . . . 0.0 110.276 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -54.72 -57.34 11.87 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.061 1.344 . . . . 0.0 108.772 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -55.7 -53.19 59.63 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.7 -38.53 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 118.91 0.777 . . . . 0.0 110.281 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -57.57 -52.35 65.76 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.545 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.73 -43.74 98.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.431 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -52.47 -50.43 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.501 1.121 . . . . 0.0 109.758 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.23 96.74 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.146 0.578 . . . . 0.0 109.961 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.8 m -64.7 -30.6 71.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.992 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.66 -44.77 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.138 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -64.01 -34.26 77.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.292 0.951 . . . . 0.0 110.419 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.35 -35.73 81.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.568 0.622 . . . . 0.0 110.454 174.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -91.51 24.29 3.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.9 1.68 . . . . 0.0 111.394 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 28.91 12.84 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.094 1.758 . . . . 0.0 113.861 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.85 145.52 17.82 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 170.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 m -78.06 154.98 30.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.266 1.026 . . . . 0.0 109.017 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.96 149.29 17.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.924 1.29 . . . . 0.0 107.561 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.421 ' HE ' ' CG2' ' A' ' 57' ' ' THR . 21.4 mmt180 -137.46 121.31 17.58 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 mm -90.66 119.4 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 m-85 -89.91 125.12 35.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -62.93 109.63 1.52 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 166.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -56.74 -27.41 59.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.455 1.502 . . . . 0.0 112.836 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.616 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -67.03 -32.13 73.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.852 2.461 . . . . 0.0 111.758 -178.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -71.56 158.5 36.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.626 1.97 . . . . 0.0 110.632 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -19.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.071 -1.018 . . . . 0.0 111.536 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -72.87 -23.32 60.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.177 -1.577 . . . . 0.0 111.003 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.33 -43.05 26.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.637 1.108 . . . . 0.0 110.436 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -52.2 -47.83 65.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.355 1.078 . . . . 0.0 109.876 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.63 -42.26 91.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.167 0.587 . . . . 0.0 111.245 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.12 -33.74 75.04 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 119.018 0.826 . . . . 0.0 111.392 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 m -59.59 -36.54 76.45 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.224 1.409 . . . . 0.0 111.68 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -58.19 -20.65 42.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.711 0.804 . . . . 0.0 112.167 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.48 21.86 15.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.706 2.402 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 p 74.16 -1.68 3.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.551 2.74 . . . . 0.0 113.893 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.42 62.36 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 127.238 2.352 . . . . 0.0 113.462 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.79 133.14 26.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.903 1.852 . . . . 0.0 108.88 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.63 177.35 10.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 110.684 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.83 149.49 16.46 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.797 -1.19 . . . . 0.0 109.738 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.46 142.87 12.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.3 mt -108.97 146.14 34.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 109.202 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -59.04 -44.28 91.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.968 169.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -142.88 161.71 47.48 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.391 1.476 . . . . 0.0 109.344 -169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.09 114.04 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.5 t -69.12 124.22 89.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.19 24.66 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.394 3.396 . . . . 0.0 113.635 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.0 t -149.83 121.23 7.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -166.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.41 178.61 43.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.6 11.04 3.05 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.671 4.247 . . . . 0.0 114.795 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.69 147.72 8.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.411 1.005 . . . . 0.0 110.117 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.0 p -143.94 99.02 3.32 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.853 0.861 . . . . 0.0 109.911 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.305 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.837 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.46 173.01 3.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.42 1.11 . . . . 0.0 111.352 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 t -150.47 -167.02 2.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.506 2.323 . . . . 0.0 106.544 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.38 81.65 0.16 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.21 102.36 2.45 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 172.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -156.24 112.88 3.11 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.56 155.48 26.7 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.4 m -147.64 127.62 13.62 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.6 94.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.07 140.39 28.04 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.034 0.934 . . . . 0.0 109.38 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 m -163.44 -178.04 5.64 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.221 3.008 . . . . 0.0 105.914 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 60.0 179.82 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 0.0 111.565 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.22 165.56 27.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.98 167.57 23.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.76 0.791 . . . . 0.0 109.68 160.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.1 160.64 23.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.351 1.06 . . . . 0.0 110.249 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 t -53.76 -44.85 70.34 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.111 0.564 . . . . 0.0 111.41 -168.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -70.94 -53.08 16.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.99 95.76 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.918 1.287 . . . . 0.0 112.015 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -18.59 65.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.766 0.827 . . . . 0.0 111.382 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.44 51.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -60.66 -50.72 72.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.594 1.158 . . . . 0.0 110.717 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.77 -50.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.213 1.005 . . . . 0.0 110.392 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -53.53 -49.31 67.88 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.057 0.543 . . . . 0.0 110.862 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.05 99.1 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.297 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.67 -45.28 92.53 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.37 1.441 . . . . 0.0 109.71 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.162 0.985 . . . . 0.0 111.399 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.12 -45.88 46.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.26 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.56 -58.38 6.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.908 1.283 . . . . 0.0 110.267 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.49 -37.8 88.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.864 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -55.97 12.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 ttp -68.64 -30.24 68.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.862 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.25 -44.72 92.36 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 120.473 1.488 . . . . 0.0 111.386 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -65.22 -24.17 67.27 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.744 1.618 . . . . 0.0 111.901 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -117.96 -41.59 2.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -162.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -155.7 83.71 3.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.332 1.853 . . . . 0.0 108.995 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.91 -7.57 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.92 2.413 . . . . 0.0 113.605 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.53 -21.44 52.38 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.889 -1.132 . . . . 0.0 111.579 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -103.4 9.23 37.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.006 1.276 . . . . 0.0 112.707 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.15 92.74 2.82 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.411 1.084 . . . . 0.0 109.427 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -93.23 145.59 24.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.06 1.344 . . . . 0.0 107.658 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -140.78 163.56 32.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.25 139.43 1.12 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -43.27 -51.0 6.43 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.176 2.19 . . . . 0.0 112.201 -172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -52.82 18.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.011 2.124 . . . . 0.0 111.526 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.5 -53.14 25.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -50.5 -44.54 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.876 1.27 . . . . 0.0 111.061 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -53.25 -38.43 63.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.634 1.173 . . . . 0.0 111.65 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -78.63 -43.35 26.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 126.051 1.741 . . . . 0.0 110.632 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.81 -30.69 71.36 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 118.497 -1.281 . . . . 0.0 110.629 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.29 -36.69 82.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.473 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -52.52 -35.33 53.09 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.057 0.943 . . . . 0.0 111.503 168.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.54 59.35 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.352 1.461 . . . . 0.0 112.538 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.8 mmt 56.07 39.1 30.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.645 0.778 . . . . 0.0 110.905 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.97 -7.14 14.57 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.116 0.966 . . . . 0.0 112.198 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -78.44 105.19 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.07 -54.89 6.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 123.699 0.624 . . . . 0.0 109.754 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -135.83 124.65 23.99 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -171.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.8 tp -109.07 132.37 54.18 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 107.788 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.59 119.5 35.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.782 1.633 . . . . 0.0 107.66 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.42 141.24 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 137.16 57.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -59.2 -37.66 77.97 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.84 -30.89 62.17 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.686 1.195 . . . . 0.0 112.77 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -82.87 -42.08 18.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.613 1.097 . . . . 0.0 109.618 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -56.74 -18.85 14.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.389 0.675 . . . . 0.0 112.597 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 23.9 9.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.775 2.83 . . . . 0.0 109.881 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -56.45 140.38 46.06 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.689 0.677 . . . . 0.0 110.0 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -59.65 -35.84 75.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.484 1.114 . . . . 0.0 112.638 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -79.68 125.14 29.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 108.61 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.69 -38.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 116.846 -1.55 . . . . 0.0 111.167 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.74 -52.07 41.84 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.921 2.146 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -56.88 -52.42 65.21 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.409 1.884 . . . . 0.0 108.262 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -52.25 -46.48 65.8 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.726 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 p -53.8 -44.16 69.92 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.926 0.89 . . . . 0.0 110.364 -173.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -57.66 -55.48 34.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.273 1.429 . . . . 0.0 108.689 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -57.57 -51.41 69.6 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.587 -1.196 . . . . 0.0 112.629 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.2 -37.63 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.765 1.166 . . . . 0.0 110.937 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.9 mtt-85 -60.17 -51.06 71.19 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.073 0.949 . . . . 0.0 110.238 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.67 -42.83 95.11 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 122.893 0.477 . . . . 0.0 111.221 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.68 -48.55 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.02 0.928 . . . . 0.0 109.986 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.29 -49.13 78.81 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.251 1.02 . . . . 0.0 110.666 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -71.82 -23.54 61.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.683 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.72 -41.67 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 120.058 1.299 . . . . 0.0 108.465 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -65.14 -38.21 89.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.804 1.184 . . . . 0.0 110.327 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.18 -32.67 64.56 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.531 0.605 . . . . 0.0 110.82 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -98.87 24.26 7.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.436 2.294 . . . . 0.0 111.04 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 61.6 19.4 10.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.834 2.054 . . . . 0.0 114.185 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.46 146.71 19.1 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 122.277 0.932 . . . . 0.0 110.792 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.57 149.58 48.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.202 2.201 . . . . 0.0 109.534 170.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.0 t -117.33 150.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.14 1.376 . . . . 0.0 108.861 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -138.54 138.05 37.62 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.679 1.992 . . . . 0.0 106.648 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.72 104.26 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 -170.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.4 m-85 -90.02 124.88 35.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -70.09 128.48 36.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -60.71 10.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.828 2.451 . . . . 0.0 116.148 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.8 mt -129.22 -18.9 3.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.952 2.101 . . . . 0.0 111.393 -175.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -69.67 157.54 37.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.164 1.385 . . . . 0.0 110.532 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.76 -39.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.478 0.581 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 m -63.83 -32.3 73.77 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.198 -0.938 . . . . 0.0 110.489 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -65.93 -50.41 52.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.942 1.258 . . . . 0.0 110.333 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.04 -26.75 65.13 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.298 1.049 . . . . 0.0 112.028 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.62 -46.24 89.16 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.12 -0.988 . . . . 0.0 108.84 170.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -60.61 -25.74 66.48 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.488 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t -50.69 -44.08 57.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.572 . . . . 0.0 111.826 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.15 0.56 0.91 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.435 1.094 . . . . 0.0 113.398 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.65 32.75 3.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.742 2.417 . . . . 0.0 108.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p 65.32 -3.45 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.787 2.435 . . . . 0.0 114.174 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.35 18.6 64.08 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.522 2.487 . . . . 0.0 112.884 -170.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.43 129.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 119.638 1.719 . . . . 0.0 110.804 167.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.66 173.49 13.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.456 1.102 . . . . 0.0 109.782 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.09 15.87 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.8 -1.187 . . . . 0.0 110.424 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -98.33 140.5 18.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 126.578 1.951 . . . . 0.0 108.048 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.6 mt -107.43 145.39 33.06 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.429 0.691 . . . . 0.0 111.266 -175.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -66.25 -39.81 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.928 1.291 . . . . 0.0 110.787 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.55 155.08 57.03 Favored Pre-proline 0 N--CA 1.453 -0.286 0 C-N-CA 123.748 0.819 . . . . 0.0 109.464 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.32 146.4 62.77 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.661 2.24 . . . . 0.0 109.601 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.46 132.22 21.26 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.887 1.675 . . . . 0.0 106.741 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.36 102.71 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.974 2.449 . . . . 0.0 109.186 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 t -170.6 -175.8 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.923 1.689 . . . . 0.0 108.162 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.63 164.43 18.09 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 161.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.87 175.39 6.45 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.565 2.843 . . . . 0.0 110.548 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -126.4 123.98 39.14 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.9 t 51.33 -103.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.096 1.358 . . . . 0.0 108.275 -157.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.97 0 CA-C-O 116.963 -2.021 . . . . 0.0 110.744 -178.152 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 p -160.34 148.7 16.72 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.02 0.928 . . . . 0.0 108.887 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -97.93 170.32 9.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.451 1.1 . . . . 0.0 109.758 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.49 -96.1 0.1 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 151.21 41.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.15 1.38 . . . . 0.0 110.287 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.2 m 62.09 -175.05 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.078 0.951 . . . . 0.0 112.87 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.65 -88.49 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 O-C-N 121.14 -0.975 . . . . 0.0 112.25 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -70.17 138.33 51.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.583 0.691 . . . . 0.0 109.856 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.36 99.37 9.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.7 62.24 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 t 51.23 -169.82 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.521 1.928 . . . . 0.0 111.651 -166.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -151.23 166.84 29.67 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 127.102 2.161 . . . . 0.0 106.902 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -145.77 154.35 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 159.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 m -151.19 -61.47 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.1 -1.0 . . . . 0.0 109.498 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.7 149.28 43.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -60.91 -44.21 97.5 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.17 0.896 . . . . 0.0 111.172 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -71.76 -49.16 41.51 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.629 0.649 . . . . 0.0 109.748 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -25.82 68.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.892 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.17 63.41 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 119.616 1.098 . . . . 0.0 111.491 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.98 -53.0 43.75 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 170.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.21 -58.98 5.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.047 0.939 . . . . 0.0 110.71 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.51 -41.61 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 117.417 -1.278 . . . . 0.0 111.606 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -55.03 -48.35 73.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.802 1.637 . . . . 0.0 109.235 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.61 88.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.892 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.27 -46.9 88.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.064 1.302 . . . . 0.0 110.086 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -56.52 -53.94 51.66 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.75 1.22 . . . . 0.0 109.054 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -66.52 -41.7 88.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.156 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.36 -57.73 10.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.302 1.041 . . . . 0.0 110.933 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.59 -41.25 89.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.166 0.439 . . . . 0.0 111.772 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -50.74 -51.97 45.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 tpp -61.03 -41.04 95.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.714 0.806 . . . . 0.0 111.731 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.44 -29.51 61.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.064 1.746 . . . . 0.0 111.469 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -80.59 -59.37 2.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.993 1.317 . . . . 0.0 108.94 173.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -71.02 -51.64 24.23 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -166.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.13 78.67 9.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.883 1.273 . . . . 0.0 108.305 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.57 -9.19 12.72 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.823 2.349 . . . . 0.0 114.137 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.62 -16.75 51.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 0.0 111.142 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -107.82 9.15 28.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 112.179 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.76 89.57 2.96 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.788 1.235 . . . . 0.0 107.947 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -94.11 133.36 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.028 -172.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -140.25 161.29 38.03 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.32 137.91 0.46 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -168.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 tp -37.16 -53.9 1.02 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.741 2.016 . . . . 0.0 112.862 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -59.56 -49.4 77.9 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.703 1.201 . . . . 0.0 110.943 -174.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -56.24 -58.67 6.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 t -48.93 -45.27 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.474 1.109 . . . . 0.0 112.317 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -58.24 -40.62 82.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.113 1.324 . . . . 0.0 111.205 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -37.85 85.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.63 1.172 . . . . 0.0 109.695 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.25 -35.26 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 174.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.17 -38.74 92.36 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.11 -3.6 7.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.745 1.618 . . . . 0.0 114.745 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.61 -5.73 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 112.041 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 mmt 63.26 4.59 1.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.078 2.151 . . . . 0.0 112.596 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.68 -10.15 59.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.033 -164.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.96 115.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.28 -65.17 1.04 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 m -125.83 132.64 52.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.91 132.84 53.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.265 1.826 . . . . 0.0 107.127 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 120.95 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.707 1.603 . . . . 0.0 106.961 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.54 145.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.02 142.32 58.46 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.718 0.807 . . . . 0.0 109.58 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.97 -42.34 89.7 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.09 -33.34 39.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.99 -43.29 30.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.912 0.778 . . . . 0.0 110.124 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.25 -23.75 16.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.65 1.18 . . . . 0.0 113.624 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.16 27.27 5.66 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.722 1.609 . . . . 0.0 111.29 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -54.43 149.22 10.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.33 1.452 . . . . 0.0 112.687 -174.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -58.58 -26.39 63.57 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.768 2.027 . . . . 0.0 114.51 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -105.21 114.4 28.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -53.13 -39.25 32.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.234 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -34.87 61.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.065 1.302 . . . . 0.0 111.974 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 m -65.95 -53.49 38.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -52.43 -50.51 62.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 p -56.85 -36.8 70.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.481 0.582 . . . . 0.0 111.523 -174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.74 -53.73 53.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.92 0.782 . . . . 0.0 109.73 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -59.03 -53.76 54.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.05 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 m -63.55 -35.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.528 1.058 . . . . 0.0 110.451 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -61.67 -56.07 23.68 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -54.72 -41.31 70.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.82 -50.93 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.993 0.917 . . . . 0.0 110.695 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.37 -46.16 67.61 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.626 0.77 . . . . 0.0 110.022 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.4 m -66.29 -23.8 66.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.395 1.478 . . . . 0.0 112.323 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.95 -38.38 82.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.917 0.78 . . . . 0.0 110.071 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.54 -43.47 89.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.909 0.777 . . . . 0.0 109.493 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.32 -44.41 95.49 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.529 0.518 . . . . 0.0 110.073 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -70.91 6.42 1.55 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 112.231 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.83 54.89 0.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 130.479 3.512 . . . . 0.0 113.093 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.89 163.43 17.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.522 1.058 . . . . 0.0 113.871 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -82.2 146.31 29.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.465 2.306 . . . . 0.0 109.571 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.14 144.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.443 1.497 . . . . 0.0 107.923 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -133.38 121.61 22.56 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.96 110.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.94 124.77 35.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 m -70.04 116.87 10.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -58.61 -17.03 18.7 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.78 -41.52 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.497 1.119 . . . . 0.0 112.181 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.77 153.42 41.86 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 109.591 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.55 -26.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.556 -0.715 . . . . 0.0 111.629 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 p -58.31 -27.51 64.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.221 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.22 -53.0 19.9 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 124.176 0.893 . . . . 0.0 111.034 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -38.93 74.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.653 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.47 -58.31 9.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.219 1.408 . . . . 0.0 109.661 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -56.37 -29.06 60.94 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.61 0.641 . . . . 0.0 111.402 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.02 -36.5 65.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.591 1.557 . . . . 0.0 112.593 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.53 -32.53 68.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.141 0.976 . . . . 0.0 110.705 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -99.79 21.86 11.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.204 2.201 . . . . 0.0 109.692 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p 68.99 9.39 7.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.664 2.386 . . . . 0.0 114.257 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.35 18.97 78.81 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.204 1.859 . . . . 0.0 113.504 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.13 122.02 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.992 1.396 . . . . 0.0 108.977 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.7 170.06 19.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 110.043 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.9 153.68 39.41 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.619 -0.676 . . . . 0.0 110.777 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.9 mt -84.11 141.76 14.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.664 1.585 . . . . 0.0 107.327 168.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.2 mt -109.36 145.08 36.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.161 0.981 . . . . 0.0 110.167 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -65.68 -38.63 89.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.018 1.327 . . . . 0.0 111.223 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -143.55 157.57 58.78 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 127.309 2.244 . . . . 0.0 106.76 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.13 128.0 15.09 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.883 1.722 . . . . 0.0 108.384 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.6 t -80.5 119.58 76.73 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 174.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 60.19 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.297 3.332 . . . . 0.0 112.087 -169.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.0 m -127.54 -18.48 4.38 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.024 2.13 . . . . 0.0 111.043 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.49 -178.57 31.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.681 0.657 . . . . 0.0 112.444 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.09 160.68 48.45 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.119 2.546 . . . . 0.0 108.809 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -81.99 -16.39 50.48 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.12 -0.988 . . . . 0.0 112.284 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.09 173.62 4.29 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.274 1.43 . . . . 0.0 108.39 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 105.904 -2.878 . . . . 0.0 105.904 165.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 m -149.38 -12.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.14 -0.933 . . . . 0.0 113.457 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p 51.56 -177.63 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.261 1.424 . . . . 0.0 111.783 -162.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.2 -177.17 30.96 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 121.082 -1.011 . . . . 0.0 113.19 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m 52.35 164.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.08 2.152 . . . . 0.0 113.662 -162.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -170.83 -174.25 1.52 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.447 2.699 . . . . 0.0 105.792 157.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.36 108.59 0.56 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -162.63 86.27 0.57 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.415 1.102 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.89 170.29 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.582 -1.324 . . . . 0.0 108.864 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.17 168.03 20.77 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.728 1.611 . . . . 0.0 107.972 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m -153.34 93.63 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.804 -1.185 . . . . 0.0 109.306 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 75.1 158.06 0.2 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 129.488 3.115 . . . . 0.0 111.081 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.99 150.08 33.34 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.468 1.507 . . . . 0.0 108.833 156.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -150.21 -66.12 0.2 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -55.91 136.44 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.859 1.264 . . . . 0.0 109.278 165.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 m -93.63 -47.55 6.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.859 1.263 . . . . 0.0 112.229 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -63.58 -52.04 62.72 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.336 -0.853 . . . . 0.0 108.954 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.84 94.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.716 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.24 87.39 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.218 0.917 . . . . 0.0 112.353 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.41 61.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 119.292 0.951 . . . . 0.0 111.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -67.12 -44.32 80.2 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.5 -1.0 . . . . 0.0 109.841 172.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.59 -45.93 82.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -60.75 -48.15 83.11 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.924 0.784 . . . . 0.0 109.993 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.21 80.2 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.46 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -64.76 -50.71 65.75 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.504 1.047 . . . . 0.0 110.435 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -33.81 76.24 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.201 1.0 . . . . 0.0 110.388 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.51 -44.61 67.25 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.209 1.404 . . . . 0.0 110.148 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -58.93 -52.81 64.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.433 1.093 . . . . 0.0 109.944 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.21 -38.81 87.92 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.042 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -45.19 -52.63 9.17 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mmt -63.76 -47.76 79.69 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.198 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.55 -35.38 60.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.362 0.983 . . . . 0.0 111.541 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -78.9 -56.62 4.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.162 0.985 . . . . 0.0 109.569 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -76.46 -70.15 0.47 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.121 1.368 . . . . 0.0 113.307 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.51 71.63 66.03 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.52 -14.35 44.43 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.655 -170.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.03 -21.09 58.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.775 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -100.59 14.17 32.27 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.133 1.373 . . . . 0.0 113.864 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.33 110.05 12.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.327 1.051 . . . . 0.0 108.757 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.6 m-85 -107.62 130.79 54.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.554 1.142 . . . . 0.0 108.468 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.29 156.6 46.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.728 1.149 . . . . 0.0 114.1 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.97 140.04 0.19 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.633 1.111 . . . . 0.0 110.526 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -47.5 -49.81 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.439 1.096 . . . . 0.0 112.461 -162.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -58.95 -32.7 69.86 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.799 1.64 . . . . 0.0 112.632 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -71.16 -63.31 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -50.74 -41.12 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 0.0 112.233 -170.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -44.68 -49.71 10.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.074 1.75 . . . . 0.0 111.089 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -71.54 -41.92 68.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 109.851 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -66.73 -29.34 69.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.304 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.09 -37.33 78.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.3 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.91 -7.26 10.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.6 0.15 30.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.696 1.599 . . . . 0.0 112.571 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 55.96 8.2 0.35 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 127.025 2.13 . . . . 0.0 112.727 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -18.64 60.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.845 -1.16 . . . . 0.0 112.102 -162.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.28 115.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.82 -55.81 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 165.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -132.72 135.48 45.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 tp -110.25 133.18 53.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.953 2.101 . . . . 0.0 106.547 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 129.37 55.5 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.525 1.93 . . . . 0.0 107.115 175.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -143.56 136.39 24.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 119.014 0.824 . . . . 0.0 109.585 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.23 128.24 35.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 168.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -34.07 69.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.564 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -43.85 -39.7 4.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.659 1.184 . . . . 0.0 113.473 170.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 mt -77.07 -42.93 36.28 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.486 1.114 . . . . 0.0 109.571 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.53 -20.09 11.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.952 1.301 . . . . 0.0 112.877 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 30.35 4.73 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 119.96 -1.712 . . . . 0.0 110.014 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -56.18 149.39 16.14 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.255 0.55 . . . . 0.0 110.98 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -32.47 65.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.463 1.105 . . . . 0.0 112.439 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.9 113.6 20.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.38 -36.56 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.579 -168.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.61 59.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.596 1.089 . . . . 0.0 112.196 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.1 m -55.7 -52.61 63.28 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.081 1.352 . . . . 0.0 108.406 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -53.07 -53.58 48.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.586 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -53.12 -44.81 67.96 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.19 0.596 . . . . 0.0 109.949 -171.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -54.93 -53.87 49.98 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.062 0.945 . . . . 0.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -57.96 -57.37 13.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.197 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.64 -30.41 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.218 0.917 . . . . 0.0 111.102 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -66.25 -59.8 3.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.918 0.887 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 tp -52.74 -39.57 62.26 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.512 0.725 . . . . 0.0 111.445 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.48 -53.25 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.333 1.053 . . . . 0.0 110.235 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.55 -36.03 80.18 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.167 -0.333 . . . . 0.0 111.249 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -69.4 -24.47 63.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.055 0.942 . . . . 0.0 112.435 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.85 -43.85 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -61.16 -43.32 99.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.355 0.98 . . . . 0.0 110.926 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.6 -44.09 62.72 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.345 1.458 . . . . 0.0 110.124 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -85.32 25.44 1.01 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.689 1.195 . . . . 0.0 111.037 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.31 20.57 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.28 2.232 . . . . 0.0 114.064 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.64 -176.44 50.97 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 120.969 -1.082 . . . . 0.0 112.683 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 m -122.05 152.35 39.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.141 2.576 . . . . 0.0 108.499 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.73 124.14 56.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 47.8 mmt-85 -116.17 121.33 41.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -102.68 108.07 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.32 124.0 34.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -71.7 123.57 22.85 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -49.69 -42.73 46.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.329 1.851 . . . . 0.0 112.501 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.67 ' CD2' ' H ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.6 -37.21 67.81 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.191 1.796 . . . . 0.0 112.304 -174.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -72.74 152.09 41.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.994 1.318 . . . . 0.0 110.391 -167.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.54 -32.48 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.297 0.639 . . . . 0.0 111.595 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.5 m -65.07 -33.99 77.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.035 -1.041 . . . . 0.0 111.781 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.4 -49.55 77.29 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.1 -38.79 92.35 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.407 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -59.75 -47.26 86.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.21 -29.33 70.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.286 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.5 m -59.82 -34.27 72.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.641 1.11 . . . . 0.0 112.56 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.67 -3.93 7.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.71 1.204 . . . . 0.0 112.428 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -127.47 23.03 6.39 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.354 2.662 . . . . 0.0 108.679 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.7 p 69.75 1.3 3.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 128.449 2.7 . . . . 0.0 114.194 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.61 17.43 70.82 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.299 1.904 . . . . 0.0 113.224 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.03 129.83 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 120.165 1.982 . . . . 0.0 108.879 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.59 173.98 13.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.016 0.926 . . . . 0.0 110.291 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.46 153.92 25.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.193 -0.942 . . . . 0.0 110.874 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.6 mt -99.66 144.94 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.319 1.848 . . . . 0.0 107.911 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.4 mt -116.99 131.31 56.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.595 0.758 . . . . 0.0 111.721 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -53.54 -36.93 62.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.643 1.977 . . . . 0.0 111.865 173.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -149.07 157.53 39.81 Favored Pre-proline 0 N--CA 1.444 -0.737 0 C-N-CA 126.621 1.968 . . . . 0.0 106.358 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.43 144.08 66.04 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.233 1.956 . . . . 0.0 109.37 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 93.8 t -94.9 124.11 55.49 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.7 120.14 6.98 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.298 1.999 . . . . 0.0 109.361 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -139.76 -77.12 0.33 Allowed 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.79 -169.25 40.06 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.26 155.54 56.19 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.063 1.842 . . . . 0.0 111.045 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -141.74 -38.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.352 1.461 . . . . 0.0 111.359 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.8 t -166.83 -35.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.968 0.804 . . . . 0.0 111.159 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 CA-C-O 116.561 -2.244 . . . . 0.0 112.567 170.753 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -67.33 162.84 21.95 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.733 0.778 . . . . 0.0 110.798 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -126.88 -179.97 5.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.386 1.874 . . . . 0.0 107.367 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.74 -80.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 p -157.46 20.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -163.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.49 82.93 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.066 -1.646 . . . . 0.0 110.195 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.29 47.42 0.4 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.665 0.65 . . . . 0.0 114.16 -172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -150.97 133.45 15.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.456 1.128 . . . . 0.0 109.445 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.22 132.65 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.406 1.082 . . . . 0.0 108.87 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 33.97 58.52 0.59 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 129.411 3.085 . . . . 0.0 114.826 169.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -124.74 171.88 9.75 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.521 0.728 . . . . 0.0 112.001 172.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -130.63 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.887 2.075 . . . . 0.0 108.202 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.8 tp -134.72 -52.86 0.81 Allowed 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.801 0.841 . . . . 0.0 108.887 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m 52.22 66.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.556 1.169 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -137.89 151.91 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 152.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -90.48 -41.17 11.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.884 0.766 . . . . 0.0 110.967 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.34 -52.24 24.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.33 -41.03 83.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.266 0.626 . . . . 0.0 109.949 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 -26.35 67.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.994 0.815 . . . . 0.0 112.975 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.54 -38.73 86.75 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.674 1.125 . . . . 0.0 111.093 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.67 -52.63 56.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.678 170.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.02 -49.02 75.04 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 125.117 1.367 . . . . 0.0 110.034 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -49.98 69.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.03 78.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.752 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -64.98 -52.48 55.98 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.253 1.388 . . . . 0.0 110.285 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.61 -43.97 85.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.358 1.063 . . . . 0.0 109.262 -173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.5 -34.54 63.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.811 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.82 -55.08 25.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.629 1.572 . . . . 0.0 109.847 173.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.75 -39.07 73.33 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -53.76 -50.09 66.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.164 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -32.15 72.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.564 1.075 . . . . 0.0 111.3 175.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 tp -55.52 -36.17 66.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.182 1.356 . . . . 0.0 110.665 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -74.22 -57.14 4.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 111.079 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -76.69 -58.78 3.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -166.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -136.91 73.67 52.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.998 1.719 . . . . 0.0 108.283 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.26 -14.13 42.1 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.135 2.557 . . . . 0.0 113.476 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -64.73 -13.73 55.89 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.56 -1.337 . . . . 0.0 111.631 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -103.18 -0.25 30.77 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.377 1.071 . . . . 0.0 112.8 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.08 91.17 3.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.299 0.954 . . . . 0.0 108.816 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -93.35 137.75 32.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.688 1.195 . . . . 0.0 108.707 -175.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -140.33 159.6 41.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.07 134.45 0.63 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.1 tp -42.16 -51.8 4.54 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.473 1.509 . . . . 0.0 112.447 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -56.96 -42.53 80.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.84 1.656 . . . . 0.0 111.708 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -65.25 -55.94 15.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.11 -41.92 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.358 1.063 . . . . 0.0 112.332 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -55.52 -40.38 71.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.245 0.929 . . . . 0.0 110.731 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -71.66 -41.13 69.13 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.681 1.593 . . . . 0.0 110.919 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.01 -30.24 69.44 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.179 -0.95 . . . . 0.0 112.085 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.19 -44.15 97.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.38 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.23 -33.33 69.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.253 0.933 . . . . 0.0 112.876 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.6 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.05 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 mmt 47.46 36.61 5.26 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.925 2.09 . . . . 0.0 110.467 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.64 -20.55 13.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.642 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.66 113.97 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.31 -42.1 14.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 124.122 0.889 . . . . 0.0 110.177 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.2 m -141.64 124.72 16.3 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 tp -110.07 125.51 53.03 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 127.121 2.168 . . . . 0.0 108.814 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -108.02 126.95 53.33 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.993 1.717 . . . . 0.0 107.857 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -143.17 142.53 25.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.33 133.43 54.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 168.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.2 -39.91 73.18 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.352 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -49.58 -36.46 24.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.592 1.542 . . . . 0.0 113.803 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.3 mt -78.04 -38.56 44.31 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.825 1.193 . . . . 0.0 110.258 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -56.6 -30.25 63.02 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.318 1.047 . . . . 0.0 111.457 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 42.2 3.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.774 2.429 . . . . 0.0 109.055 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -60.99 146.9 45.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.31 -35.74 78.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.162 0.985 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -87.04 114.96 24.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.98 1.312 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.74 -34.61 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.626 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.21 11.77 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 120.093 1.315 . . . . 0.0 110.527 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -62.52 -45.21 94.05 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.637 1.175 . . . . 0.0 110.464 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -51.61 -44.97 63.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.965 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 p -51.61 -46.08 63.46 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.319 0.509 . . . . 0.0 110.083 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.41 -46.23 90.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 109.562 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -59.64 -61.39 2.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.01 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.74 -36.99 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.832 1.196 . . . . 0.0 110.857 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.11 -49.3 78.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.235 1.014 . . . . 0.0 111.297 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.1 -43.15 96.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.132 0.573 . . . . 0.0 109.928 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.33 -55.38 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.761 1.225 . . . . 0.0 110.164 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -39.63 94.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.703 0.801 . . . . 0.0 110.652 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 t -67.14 -36.79 82.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.504 1.122 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.82 -40.24 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.313 0.96 . . . . 0.0 109.273 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -65.29 -41.46 94.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.218 0.917 . . . . 0.0 110.904 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.2 -39.87 73.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.075 0.398 . . . . 0.0 110.501 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -75.39 -2.84 30.42 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 112.92 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 80.51 26.47 0.29 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.72 2.808 . . . . 0.0 113.941 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.75 143.71 16.82 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.499 1.523 . . . . 0.0 112.319 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.0 m -74.77 131.91 41.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.152 2.181 . . . . 0.0 109.778 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.7 t -93.99 148.43 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.989 0.916 . . . . 0.0 109.148 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -140.36 122.01 15.27 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.212 1.805 . . . . 0.0 108.085 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.27 109.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.9 m-85 -89.23 124.33 34.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.9 t -69.75 127.78 34.12 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -31.58 62.84 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.105 0.478 . . . . 0.0 110.355 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.91 -4.78 22.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.839 1.655 . . . . 0.0 113.642 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -109.66 143.42 39.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.867 1.667 . . . . 0.0 110.348 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -22.38 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.757 -0.59 . . . . 0.0 112.154 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -64.8 -20.53 66.43 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.596 -1.315 . . . . 0.0 111.174 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.0 -32.76 13.48 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 119.539 1.063 . . . . 0.0 112.271 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.25 -39.69 79.84 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.137 0.968 . . . . 0.0 108.855 168.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.06 -52.36 56.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.649 1.18 . . . . 0.0 110.763 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.32 -30.88 63.13 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.352 0.978 . . . . 0.0 111.713 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.8 t -52.44 -39.93 61.62 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.679 1.592 . . . . 0.0 112.362 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.29 -25.84 59.9 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.466 1.106 . . . . 0.0 111.145 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.1 mt -109.4 23.27 14.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.991 2.116 . . . . 0.0 109.849 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.9 p 73.65 0.23 3.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.321 2.648 . . . . 0.0 113.745 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.14 21.09 63.5 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.402 1.953 . . . . 0.0 113.129 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.48 129.23 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.603 1.702 . . . . 0.0 109.12 171.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.31 177.41 11.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.768 1.227 . . . . 0.0 110.323 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.59 150.29 17.55 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.857 -1.152 . . . . 0.0 111.522 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.1 mt -83.76 141.07 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.03 144.19 43.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.602 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -65.57 -25.71 67.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.286 2.234 . . . . 0.0 112.273 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -159.86 161.39 26.47 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 127.141 2.177 . . . . 0.0 106.41 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.32 132.37 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.089 1.859 . . . . 0.0 109.563 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 80.5 t -87.51 131.46 43.84 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.0 111.74 2.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.143 2.562 . . . . 0.0 107.91 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -161.48 125.28 3.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.18 166.3 33.7 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.48 -65.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.363 2.709 . . . . 0.0 110.908 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.1 t -163.82 110.46 1.11 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m 56.4 -169.1 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.452 1.501 . . . . 0.0 111.829 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 116.289 -2.395 . . . . 0.0 111.265 174.478 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 t -143.43 99.23 3.39 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -119.6 26.1 9.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.683 1.193 . . . . 0.0 111.356 -167.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.23 -164.62 52.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -163.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.62 156.17 36.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 117.708 0.754 . . . . 0.0 109.548 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -148.8 179.56 7.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.201 1.001 . . . . 0.0 110.747 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.97 161.69 34.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.011 2.243 . . . . 0.0 108.869 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -153.17 148.43 26.91 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.29 106.44 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.696 0.798 . . . . 0.0 109.091 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.89 157.72 45.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 108.259 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -164.65 173.38 11.97 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.969 2.508 . . . . 0.0 107.13 171.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -38.03 0.39 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.772 -1.109 . . . . 0.0 112.296 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 43.3 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.022 2.529 . . . . 0.0 112.137 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 t -146.73 150.91 36.29 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 53.7 154.51 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 130.431 3.492 . . . . 0.0 115.577 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 m -76.71 -33.85 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.122 -0.986 . . . . 0.0 110.643 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -52.9 17.67 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.497 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.27 64.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.679 -163.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.95 -36.43 62.83 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.183 0.902 . . . . 0.0 113.259 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.5 71.1 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 118.987 0.812 . . . . 0.0 111.863 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.66 -53.27 57.04 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.297 0.639 . . . . 0.0 109.328 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.51 -33.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.373 1.069 . . . . 0.0 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -62.96 -47.19 84.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.941 1.7 . . . . 0.0 110.513 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.67 -37.77 82.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.134 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -48.99 79.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.483 1.038 . . . . 0.0 110.111 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -57.52 -53.56 56.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.328 1.451 . . . . 0.0 108.443 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -38.93 83.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.147 0.904 . . . . 0.0 109.77 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.19 -53.13 61.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.815 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.59 -36.29 82.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -53.9 -55.24 28.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.041 0.937 . . . . 0.0 108.721 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 tpp -57.51 -38.81 75.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.8 0.44 . . . . 0.0 110.302 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.02 -19.59 66.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.119 1.768 . . . . 0.0 112.822 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -95.0 -34.89 12.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -90.08 -70.6 0.66 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.1 77.03 68.49 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 109.388 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.99 -8.98 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.597 2.198 . . . . 0.0 114.092 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -57.06 -22.97 43.27 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.046 1.294 . . . . 0.0 111.747 166.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -106.17 8.64 32.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 112.598 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.97 98.19 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.168 0.987 . . . . 0.0 109.521 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -100.46 141.74 32.91 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.384 1.074 . . . . 0.0 109.159 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.13 161.09 38.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.749 0.785 . . . . 0.0 112.95 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 148.21 0.68 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 125.242 1.401 . . . . 0.0 111.226 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 tp -49.69 -44.83 48.25 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.31 1.044 . . . . 0.0 110.972 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -61.06 -54.5 43.92 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.263 1.425 . . . . 0.0 111.289 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -61.77 -50.97 70.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 0.0 108.205 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.31 -38.88 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 111.906 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.04 -22.42 64.96 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.209 -0.932 . . . . 0.0 112.742 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -77.98 -43.34 29.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.72 1.145 . . . . 0.0 108.859 167.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.23 94.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.005 -0.434 . . . . 0.0 112.02 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.86 -33.53 76.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.503 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.65 -35.01 79.63 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.045 0.839 . . . . 0.0 112.365 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.79 -0.19 29.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 111.991 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 62.19 3.08 0.93 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.88 2.472 . . . . 0.0 114.417 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.72 -2.46 50.65 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.696 -1.252 . . . . 0.0 112.629 -162.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.41 110.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.58 -49.36 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 108.121 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -144.41 136.76 26.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 tp -109.42 142.1 40.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 125.24 47.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.479 1.911 . . . . 0.0 107.253 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 tt -141.26 143.26 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 119.191 0.905 . . . . 0.0 110.341 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.88 137.26 53.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -37.04 69.8 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.848 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.55 -18.69 42.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.5 -43.18 9.84 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.322 1.049 . . . . 0.0 109.449 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.09 -26.58 11.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 0.0 112.444 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.28 37.39 4.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.554 1.941 . . . . 0.0 110.33 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -56.05 145.79 24.59 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.582 0.753 . . . . 0.0 110.886 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -40.51 96.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.611 0.764 . . . . 0.0 112.699 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.35 120.64 21.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -55.67 -44.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.284 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.31 -53.55 42.22 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 120.223 1.374 . . . . 0.0 111.235 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -51.38 -53.32 37.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.763 1.625 . . . . 0.0 109.878 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -55.73 -48.57 74.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.513 0.597 . . . . 0.0 109.773 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -39.23 58.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.624 0.77 . . . . 0.0 110.802 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -62.44 -56.55 17.12 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.634 1.106 . . . . 0.0 109.049 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -55.19 -50.23 69.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.762 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.62 -40.82 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 119.432 1.014 . . . . 0.0 110.479 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -62.33 -52.76 62.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.18 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.79 -42.62 75.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.521 1.055 . . . . 0.0 111.126 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -58.07 -51.23 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.194 0.597 . . . . 0.0 110.315 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.47 -33.12 74.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.843 1.657 . . . . 0.0 111.085 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -71.49 -30.12 65.6 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.954 1.701 . . . . 0.0 110.866 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.23 -37.79 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.718 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -61.73 -46.01 91.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.159 1.345 . . . . 0.0 110.295 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.11 -43.73 87.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.428 0.691 . . . . 0.0 111.842 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -77.48 10.52 2.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.992 0.917 . . . . 0.0 111.247 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.44 19.21 11.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.499 3.119 . . . . 0.0 115.143 174.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.3 168.37 51.7 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.435 1.016 . . . . 0.0 111.918 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -83.42 159.45 21.78 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.904 1.682 . . . . 0.0 109.846 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.1 t -124.59 146.73 29.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.653 1.181 . . . . 0.0 109.127 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -143.85 121.28 11.68 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.26 0.624 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 mm -110.61 110.09 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.28 151.94 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.717 1.607 . . . . 0.0 108.985 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -103.08 132.27 49.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.338 0.655 . . . . 0.0 110.648 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.3 p -65.36 10.43 0.09 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.805 2.042 . . . . 0.0 114.715 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.28 0.71 10.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.394 1.877 . . . . 0.0 112.463 -166.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.667 ' CD2' ' HG ' ' A' ' 99' ' ' SER . 2.7 t60 -139.62 160.38 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.606 1.962 . . . . 0.0 107.041 -172.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.33 -24.69 28.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.326 0.65 . . . . 0.0 112.41 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.667 ' HG ' ' CD2' ' A' ' 97' ' ' HIS . 59.3 p -68.47 -31.99 71.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.722 -1.236 . . . . 0.0 110.285 -176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.32 -39.14 70.97 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -66.39 -28.96 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.143 1.472 . . . . 0.0 110.92 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.04 -51.23 26.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.251 1.021 . . . . 0.0 109.311 170.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.03 -28.8 68.04 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.818 1.19 . . . . 0.0 111.954 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -58.85 -36.15 74.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.565 1.146 . . . . 0.0 111.811 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -68.23 -0.68 4.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.1 1.76 . . . . 0.0 112.162 173.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.77 28.22 3.58 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.422 2.289 . . . . 0.0 108.79 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 p 70.87 2.38 4.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.829 2.051 . . . . 0.0 114.521 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.04 17.07 70.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 129.03 3.205 . . . . 0.0 114.238 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.66 134.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.299 1.55 . . . . 0.0 109.477 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.69 177.97 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.218 1.407 . . . . 0.0 110.488 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.3 144.35 10.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.465 1.03 . . . . 0.0 110.338 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.8 mt -84.11 144.84 9.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 125.081 1.352 . . . . 0.0 107.607 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.7 mt -117.71 139.25 51.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.145 0.978 . . . . 0.0 109.874 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.73 -24.24 65.35 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.093 1.357 . . . . 0.0 111.98 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -151.44 157.31 34.91 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.929 1.292 . . . . 0.0 108.799 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.91 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.414 2.743 . . . . 0.0 108.406 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.2 t -76.12 117.76 66.36 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -171.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.45 121.14 8.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.132 1.888 . . . . 0.0 108.188 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -165.46 -161.05 0.5 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.531 2.732 . . . . 0.0 105.034 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.62 179.84 31.27 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.629 -1.295 . . . . 0.0 110.856 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 122.72 9.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.882 2.388 . . . . 0.0 109.42 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m -139.55 -18.41 0.97 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.822 1.249 . . . . 0.0 113.445 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 p -91.01 -29.18 17.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.868 1.213 . . . . 0.0 112.209 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.374 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -145.423 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.9 85.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.434 0.561 . . . . 0.0 112.291 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.11 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.3 1.44 . . . . 0.0 112.812 -169.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.06 -49.74 32.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -55.31 -51.21 67.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.714 0.805 . . . . 0.0 110.205 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.9 -42.21 88.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 119.223 0.92 . . . . 0.0 111.2 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -59.85 -47.75 84.47 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.85 1.659 . . . . 0.0 109.075 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.64 95.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.095 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.6 -43.9 80.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.269 0.94 . . . . 0.0 110.164 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.54 -48.38 60.62 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.522 1.129 . . . . 0.0 111.029 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.05 -41.11 95.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -57.43 -60.0 4.3 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.22 1.408 . . . . 0.0 110.32 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -35.94 74.94 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.59 -56.36 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.453 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -64.94 -37.78 88.77 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.142 0.577 . . . . 0.0 109.933 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.52 -36.53 69.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.332 0.969 . . . . 0.0 111.725 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -67.98 -61.26 1.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -64.97 -85.55 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.47 1.908 . . . . 0.0 112.44 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.21 93.87 47.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.29 1.436 . . . . 0.0 109.929 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -67.45 -5.36 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.894 1.729 . . . . 0.0 112.087 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.75 -33.07 60.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.134 0.879 . . . . 0.0 110.039 165.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -97.33 7.72 46.0 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -137.18 90.68 2.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.253 1.842 . . . . 0.0 110.347 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.7 m-30 -93.3 137.28 32.77 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.495 0.718 . . . . 0.0 109.756 -174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.56 164.94 28.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.77 0.795 . . . . 0.0 112.017 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.58 126.69 0.85 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -170.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -35.66 -53.66 0.7 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.907 2.083 . . . . 0.0 112.422 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.05 83.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.037 0.935 . . . . 0.0 111.767 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -59.04 -57.23 13.98 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 t -49.64 -43.87 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.26 -31.99 69.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.805 1.184 . . . . 0.0 111.727 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -44.71 30.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.617 1.567 . . . . 0.0 110.477 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -57.85 -32.51 67.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.925 -1.11 . . . . 0.0 112.37 172.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.52 -41.93 92.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.549 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.02 -35.4 69.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.25 0.932 . . . . 0.0 111.544 172.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.61 -2.81 40.8 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.847 1.259 . . . . 0.0 112.706 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.6 mmt 51.96 14.91 0.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.462 1.905 . . . . 0.0 113.148 -170.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.53 -4.97 58.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.143 -0.973 . . . . 0.0 112.362 -162.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -76.55 108.72 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -169.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.4 -62.48 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.557 -1.202 . . . . 0.0 107.849 168.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.4 m -139.01 133.69 32.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 111' ' ' ALA . 8.2 tp -110.51 124.25 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.3 1.84 . . . . 0.0 108.582 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -101.67 137.56 39.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.591 1.556 . . . . 0.0 107.806 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 tt -151.94 139.75 13.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 134.24 50.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 166.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -34.52 69.45 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.6 -25.22 62.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.743 1.156 . . . . 0.0 113.212 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.72 -37.06 19.78 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.531 1.059 . . . . 0.0 110.378 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -56.55 -19.55 16.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.682 1.193 . . . . 0.0 112.352 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.66 49.72 2.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.626 -1.297 . . . . 0.0 108.863 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -62.09 151.59 35.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.882 0.873 . . . . 0.0 109.617 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -69.22 -42.81 75.2 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.217 0.607 . . . . 0.0 112.415 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.17 119.15 19.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.5 -49.43 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 117.532 -1.223 . . . . 0.0 110.676 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.04 -52.38 66.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.366 1.439 . . . . 0.0 110.945 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -52.94 -53.12 54.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 110.809 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -55.89 -52.7 63.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -46.47 -50.6 16.69 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 126.256 1.822 . . . . 0.0 110.575 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.13 -57.3 11.62 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.972 0.909 . . . . 0.0 110.048 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -56.18 -51.68 67.14 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.152 -0.928 . . . . 0.0 112.113 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.12 -38.61 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 120.058 1.299 . . . . 0.0 110.824 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -60.22 -52.58 64.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.356 1.062 . . . . 0.0 109.026 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.12 -44.17 92.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.006 0.922 . . . . 0.0 111.205 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -53.29 -57.42 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.263 1.025 . . . . 0.0 110.138 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -34.73 78.63 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -16.82 63.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.028 . . . . 0.0 112.809 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.35 -37.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 O-C-N 120.472 -1.393 . . . . 0.0 109.135 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.98 -39.44 92.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.306 0.957 . . . . 0.0 108.899 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -57.25 -36.13 70.58 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.274 0.63 . . . . 0.0 111.269 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -87.62 13.37 10.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.856 1.262 . . . . 0.0 112.065 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.26 19.34 4.89 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.887 2.475 . . . . 0.0 114.535 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.33 170.03 50.84 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.282 0.946 . . . . 0.0 110.956 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -92.99 153.4 18.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.293 1.437 . . . . 0.0 108.691 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.6 142.1 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.333 1.453 . . . . 0.0 107.73 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -134.5 122.4 22.39 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.537 1.535 . . . . 0.0 108.011 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.75 105.55 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 10.2 m-85 -88.49 155.42 19.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -172.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 m -103.84 147.32 27.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.318 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 t -60.64 -35.85 77.19 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.149 0.906 . . . . 0.0 108.809 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.13 -56.25 16.18 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.976 1.71 . . . . 0.0 111.514 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -66.46 145.21 55.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.79 -26.46 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.586 0.63 . . . . 0.0 111.247 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 p -56.38 -17.98 9.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.184 0.994 . . . . 0.0 112.664 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.91 -55.58 4.08 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 125.348 1.452 . . . . 0.0 110.449 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.06 -29.19 67.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.312 1.056 . . . . 0.0 111.103 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -60.81 -58.13 9.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.48 -28.06 63.07 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.391 1.077 . . . . 0.0 112.238 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 m -56.34 -34.35 66.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.25 1.02 . . . . 0.0 113.196 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -64.44 -9.17 16.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.822 1.249 . . . . 0.0 111.755 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.1 mt -131.03 32.88 4.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.816 2.846 . . . . 0.0 108.711 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p 56.99 18.4 3.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.003 2.121 . . . . 0.0 114.482 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.64 69.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.801 2.143 . . . . 0.0 113.072 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.48 121.82 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.791 1.796 . . . . 0.0 110.59 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 179.48 8.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.506 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -161.67 145.44 12.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.903 1.281 . . . . 0.0 110.502 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.44 146.34 7.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.529 1.531 . . . . 0.0 106.898 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 117' ' ' VAL . 18.1 mt -117.46 145.57 44.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.452 0.701 . . . . 0.0 109.725 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -77.6 -24.6 49.62 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.689 1.596 . . . . 0.0 111.913 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -148.22 154.83 42.88 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 126.2 1.8 . . . . 0.0 106.324 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.34 114.75 3.56 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 123.163 2.576 . . . . 0.0 107.586 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 113' ' ' LEU . 55.7 t . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt . . . . . 0 C--O 1.237 0.395 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.7 76.3 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.982 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.95 -23.99 61.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.496 1.044 . . . . 0.0 112.231 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.79 -43.44 22.98 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.71 93.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.009 0.924 . . . . 0.0 110.54 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 t -69.03 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.197 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -53.38 -44.1 68.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.077 1.762 . . . . 0.0 109.87 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.563 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -65.61 -46.32 79.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.794 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.1 -45.32 79.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.38 0.991 . . . . 0.0 111.106 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.26 -54.38 44.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.33 1.852 . . . . 0.0 108.465 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -66.39 -38.15 86.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.819 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 90.8 t80 -58.22 -59.7 4.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 110.285 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -61.71 -31.04 71.17 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -50.37 -62.94 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -58.9 -38.75 79.62 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.29 -30.32 59.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.983 1.265 . . . . 0.0 112.23 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.16 -35.45 11.31 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.463 -0.773 . . . . 0.0 111.945 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -76.88 -56.42 4.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.207 1.003 . . . . 0.0 112.857 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.27 81.06 7.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.606 1.963 . . . . 0.0 108.891 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.11 -14.03 39.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.126 2.551 . . . . 0.0 112.762 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.41 -20.98 61.64 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.104 -0.998 . . . . 0.0 111.301 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -101.08 11.35 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 123.835 0.854 . . . . 0.0 112.665 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -146.26 91.03 2.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.43 1.014 . . . . 0.0 109.837 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 4.3 m-30 -92.33 144.5 25.32 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.64 164.66 29.59 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.57 130.8 2.86 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 -171.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.0 tp -43.95 -47.6 8.51 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.27 -46.73 89.12 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.307 1.043 . . . . 0.0 111.618 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.14 -58.4 8.69 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.532 1.06 . . . . 0.0 108.412 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 t -53.08 -36.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.684 1.194 . . . . 0.0 111.637 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.04 -21.62 66.29 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.02 . . . . 0.0 112.767 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -87.6 -43.49 11.94 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 125.836 1.654 . . . . 0.0 110.459 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -54.87 -36.55 65.22 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.251 -0.906 . . . . 0.0 111.898 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.89 -45.18 87.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.576 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -60.0 -28.75 67.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.388 0.994 . . . . 0.0 113.132 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -0.11 29.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.186 1.394 . . . . 0.0 111.829 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.1 mmt 52.26 23.31 2.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.309 2.244 . . . . 0.0 112.775 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -100.92 -8.26 22.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.333 1.053 . . . . 0.0 112.694 -161.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.3 mt -70.5 117.48 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.05 -61.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.57 1.148 . . . . 0.0 108.518 165.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.7 m -138.0 139.84 39.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 80' ' ' VAL . 12.1 tp -110.53 133.4 53.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.186 1.794 . . . . 0.0 108.107 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.563 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -109.62 134.47 51.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.199 1.799 . . . . 0.0 107.326 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.53 142.83 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -72.7 131.73 42.75 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.58 -32.85 65.62 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 123.05 0.54 . . . . 0.0 111.537 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.52 -41.87 22.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.6 -40.24 35.08 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.114 0.966 . . . . 0.0 108.998 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.32 -20.05 10.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.372 0.669 . . . . 0.0 111.694 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -118.61 21.27 12.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.847 2.059 . . . . 0.0 111.773 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -55.07 144.85 22.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.369 0.986 . . . . 0.0 111.421 -168.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.21 -21.78 56.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.99 108.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.0 -26.09 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 111.592 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.36 -54.39 12.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.16 0.891 . . . . 0.0 111.195 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.0 m -53.86 -49.03 69.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.145 1.778 . . . . 0.0 109.635 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.91 -47.28 71.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.089 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -50.13 -43.5 51.91 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.886 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.79 -56.74 18.27 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.271 1.028 . . . . 0.0 108.671 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -54.4 -55.61 26.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.757 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 m -64.96 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.901 1.228 . . . . 0.0 111.666 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -62.11 -53.36 56.49 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.0 tp -58.06 -43.28 86.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.197 0.999 . . . . 0.0 111.461 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 49.3 t -57.08 -33.02 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.094 0.958 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.24 -35.1 15.51 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.478 -0.764 . . . . 0.0 112.073 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 t -64.93 -16.3 63.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.069 1.747 . . . . 0.0 111.643 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.06 -35.3 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 119.513 -1.992 . . . . 0.0 109.679 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.85 -39.5 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.654 1.115 . . . . 0.0 110.37 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -48.93 -43.18 39.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.479 1.112 . . . . 0.0 110.325 171.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -94.37 17.65 12.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.161 1.384 . . . . 0.0 111.054 -168.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 27.69 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.57 2.348 . . . . 0.0 113.658 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.48 -170.79 46.72 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.127 0.87 . . . . 0.0 111.293 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -124.93 156.34 38.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.136 2.174 . . . . 0.0 109.14 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.66 140.92 44.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.969 0.89 . . . . 0.0 108.826 -173.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -137.07 120.81 17.37 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.25 109.93 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 -175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -89.66 138.12 31.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 t -69.07 122.43 18.71 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 p -55.88 -15.0 2.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.226 1.41 . . . . 0.0 113.38 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.95 -33.93 44.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.158 0.89 . . . . 0.0 111.297 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -67.44 151.49 47.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.78 -18.18 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.752 -0.592 . . . . 0.0 111.905 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.7 p -68.04 -27.9 66.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.105 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.07 -26.32 72.66 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.66 1.118 . . . . 0.0 110.756 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.49 -49.86 37.05 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.289 1.045 . . . . 0.0 108.811 165.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -61.14 -35.65 77.65 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.203 -0.936 . . . . 0.0 111.885 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -70.64 -29.79 66.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.646 172.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 t -52.94 -41.47 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.984 1.314 . . . . 0.0 110.973 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.0 4.03 0.73 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.017 2.127 . . . . 0.0 114.115 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -137.81 27.98 2.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.539 2.736 . . . . 0.0 108.793 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p 66.29 2.08 2.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.249 2.62 . . . . 0.0 114.801 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.34 73.32 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 128.32 2.867 . . . . 0.0 113.94 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.56 132.67 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.016 1.908 . . . . 0.0 109.904 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.93 168.56 24.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.519 1.127 . . . . 0.0 110.269 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.06 145.28 23.91 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.309 0.958 . . . . 0.0 111.137 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.1 mt -83.95 148.87 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 127.029 2.132 . . . . 0.0 106.687 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 49' ' ' ALA . 24.2 mt -117.56 147.38 42.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.118 0.967 . . . . 0.0 111.718 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mtt85 -70.34 -32.09 69.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 168.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 10.4 p90 -151.23 154.0 33.32 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 118.245 0.475 . . . . 0.0 110.356 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.3 113.44 3.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.783 2.988 . . . . 0.0 109.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.506 HG23 HD13 ' A' ' 113' ' ' LEU . 98.0 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.07 -54.43 46.02 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.637 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.72 -40.37 54.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.537 1.135 . . . . 0.0 112.447 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.39 -47.61 34.74 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.962 0.801 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -48.68 76.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.946 0.873 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.23 -42.5 66.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 124.7 1.2 . . . . 0.0 109.606 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -57.13 -50.04 74.03 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.909 1.231 . . . . 0.0 109.533 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.45 -43.64 98.52 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.855 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.91 -47.93 81.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.865 1.211 . . . . 0.0 110.233 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.18 -51.95 65.77 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 126.701 2.0 . . . . 0.0 109.477 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.03 -42.15 73.31 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -173.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.98 -56.82 11.88 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.198 0.999 . . . . 0.0 108.567 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -44.89 89.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 124.123 0.889 . . . . 0.0 112.247 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.08 -57.73 4.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ttp -66.27 -33.14 75.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.374 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.18 -50.94 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.732 1.606 . . . . 0.0 110.814 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -65.33 -40.16 93.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.221 0.208 . . . . 0.0 110.562 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.88 -57.95 3.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 111.41 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -149.97 76.9 8.63 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.431 2.292 . . . . 0.0 108.29 -167.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.81 -5.94 14.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.749 2.299 . . . . 0.0 112.151 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -27.19 2.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.003 2.121 . . . . 0.0 110.99 163.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HA ' HD12 ' A' ' 113' ' ' LEU . 76.1 mtp180 -110.22 0.8 18.32 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.208 1.403 . . . . 0.0 113.922 175.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.74 95.21 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.669 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.5 m-30 -93.55 133.62 36.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -140.38 159.91 41.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.16 0.981 . . . . 0.0 113.522 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 135.94 0.69 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.8 tp -44.97 -49.8 10.96 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.801 1.641 . . . . 0.0 112.27 -169.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -56.16 -43.27 78.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.432 1.493 . . . . 0.0 110.367 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -66.69 -57.82 6.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.18 -36.65 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.218 -0.926 . . . . 0.0 111.924 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -56.4 -38.84 72.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.914 0.885 . . . . 0.0 112.21 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -47.11 53.29 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.155 1.382 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -58.77 -32.83 69.64 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.577 -0.702 . . . . 0.0 112.537 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.53 -43.61 89.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.906 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.64 -28.16 66.98 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.04 0.836 . . . . 0.0 112.548 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.18 -6.12 57.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.46 0.704 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 60.26 9.5 1.96 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.624 1.97 . . . . 0.0 112.491 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.56 -7.19 59.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.167 -0.958 . . . . 0.0 113.027 -162.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.0 114.35 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 119.167 0.894 . . . . 0.0 108.86 -170.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.74 -52.37 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.166 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.6 m -140.99 132.93 27.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.27 132.71 53.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.467 2.307 . . . . 0.0 106.797 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.481 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -110.96 126.68 55.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.16 1.784 . . . . 0.0 106.918 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.11 136.31 29.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 118.931 0.787 . . . . 0.0 109.469 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -65.75 138.55 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.55 -39.35 70.5 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 122.928 0.491 . . . . 0.0 110.208 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -60.65 -16.7 41.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.39 -42.59 10.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.875 1.216 . . . . 0.0 110.091 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -50.28 -32.56 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.554 1.142 . . . . 0.0 112.379 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.55 38.85 4.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.511 1.924 . . . . 0.0 109.709 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.97 151.82 17.62 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -68.73 -41.49 78.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.583 0.753 . . . . 0.0 111.785 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 23.9 t70 -75.89 120.48 21.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.191 1.396 . . . . 0.0 108.23 -172.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.84 -39.44 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.404 -174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -60.27 4.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.976 0.807 . . . . 0.0 109.289 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 89.1 m -58.93 -51.24 70.88 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.089 0.956 . . . . 0.0 110.061 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -52.62 -52.31 56.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.017 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.3 t -52.2 -46.87 65.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 119.227 0.922 . . . . 0.0 109.245 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -51.73 -50.73 59.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.106 0.866 . . . . 0.0 109.668 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -57.82 -60.4 3.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.722 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 m -61.94 -37.84 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.328 1.422 . . . . 0.0 111.151 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -57.55 -53.16 61.34 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.809 1.644 . . . . 0.0 108.721 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.72 -46.63 88.53 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.808 0.843 . . . . 0.0 111.252 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 58' ' ' LEU . 41.6 t -54.67 -49.88 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 124.311 1.045 . . . . 0.0 109.348 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.02 -37.8 78.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -64.65 -30.49 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.76 0.824 . . . . 0.0 111.856 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.28 -39.77 79.46 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 O-C-N 120.952 -1.092 . . . . 0.0 109.623 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.01 -46.69 89.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.985 0.811 . . . . 0.0 110.114 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -59.14 -31.27 68.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.979 0.512 . . . . 0.0 112.189 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.81 26.6 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.829 1.252 . . . . 0.0 111.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.64 6.75 2.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.872 2.869 . . . . 0.0 115.225 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.99 -176.18 47.91 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.177 0.899 . . . . 0.0 112.015 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -123.42 157.5 33.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.897 1.679 . . . . 0.0 109.935 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.3 t -122.66 139.66 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 108.232 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -129.36 121.45 27.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.1 mm -100.74 109.34 25.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 5.6 m-85 -89.62 156.76 18.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 108.697 -177.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -104.76 139.4 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 t -62.4 9.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.691 2.396 . . . . 0.0 114.155 170.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -129.3 -14.47 4.27 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.27 1.828 . . . . 0.0 113.689 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -87.69 148.38 24.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.565 1.075 . . . . 0.0 109.214 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.6 p -57.02 -32.63 40.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 O-C-N 121.721 -0.612 . . . . 0.0 110.129 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.0 m -65.3 -27.36 68.56 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.307 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.65 -53.8 25.99 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 167.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.34 -31.33 67.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.29 1.045 . . . . 0.0 112.196 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.96 -47.53 65.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.953 0.901 . . . . 0.0 109.697 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.86 -31.91 65.28 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 122.948 0.499 . . . . 0.0 111.39 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -58.33 -33.88 70.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.648 1.179 . . . . 0.0 112.926 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.14 -6.77 14.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.452 1.501 . . . . 0.0 112.053 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.0 mt -129.7 23.04 5.42 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.537 2.735 . . . . 0.0 108.218 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p 77.57 -12.12 1.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.263 3.425 . . . . 0.0 114.122 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.36 15.76 46.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.962 2.22 . . . . 0.0 113.133 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.17 133.48 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 118.933 1.366 . . . . 0.0 108.962 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.09 13.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.669 1.188 . . . . 0.0 110.05 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.18 142.01 9.82 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.241 0.928 . . . . 0.0 110.918 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -83.88 141.84 14.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.203 1.401 . . . . 0.0 107.715 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.732 HD13 HG23 ' A' ' 117' ' ' VAL . 30.2 mt -112.9 139.91 48.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.311 1.045 . . . . 0.0 111.249 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -66.86 -25.54 66.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.052 1.741 . . . . 0.0 112.374 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -151.61 157.47 34.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.507 1.523 . . . . 0.0 107.254 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.69 128.92 15.81 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.992 1.795 . . . . 0.0 108.384 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.732 HG23 HD13 ' A' ' 113' ' ' LEU . 79.4 t . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tptm . . . . . 0 C--O 1.232 0.147 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.95 80.54 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.524 0.73 . . . . 0.0 110.007 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.14 69.14 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.416 1.007 . . . . 0.0 113.367 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.67 -39.27 18.11 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 119.423 1.011 . . . . 0.0 111.115 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -50.42 68.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.881 2.072 . . . . 0.0 108.139 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.44 -51.52 48.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 126.013 1.725 . . . . 0.0 109.677 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.06 -45.01 67.92 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.558 1.072 . . . . 0.0 109.769 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.6 -50.72 71.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 123.854 0.721 . . . . 0.0 111.383 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -55.74 -46.75 77.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.977 1.262 . . . . 0.0 111.361 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.04 -46.53 88.0 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.543 1.537 . . . . 0.0 110.073 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.72 -35.65 65.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.135 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 61.4 t80 -61.46 -57.39 12.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.444 2.298 . . . . 0.0 109.995 173.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -58.79 -35.4 72.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.739 0.7 . . . . 0.0 112.073 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -50.0 -53.65 25.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.482 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.1 mmt -59.86 -44.44 94.13 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.57 0.623 . . . . 0.0 110.286 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.1 -25.31 45.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.056 0.844 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -86.65 -62.35 1.53 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -68.11 -59.39 3.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.927 1.291 . . . . 0.0 113.826 -168.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.98 80.63 47.93 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 124.975 1.31 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.48 -7.65 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.273 1.982 . . . . 0.0 113.752 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.99 -55.24 25.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.889 1.222 . . . . 0.0 108.195 164.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -76.08 10.97 1.63 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.278 0.945 . . . . 0.0 112.526 -168.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -128.3 96.51 4.46 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.77 1.228 . . . . 0.0 109.69 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.73 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.37 140.64 29.34 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.27 159.67 41.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 142.13 0.73 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 tp -45.24 -51.81 10.31 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.361 1.464 . . . . 0.0 112.673 -165.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.434 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -57.56 -49.59 75.89 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.648 1.579 . . . . 0.0 110.272 -175.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.12 -56.44 22.22 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -49.22 -40.59 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.666 1.186 . . . . 0.0 112.29 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -59.61 -35.65 74.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.688 1.586 . . . . 0.0 111.56 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -49.32 16.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.236 1.415 . . . . 0.0 109.348 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.73 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -56.06 -39.36 71.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.748 -0.595 . . . . 0.0 111.126 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -54.93 -50.37 69.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.5 0.72 . . . . 0.0 109.114 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.88 -16.01 47.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.891 1.277 . . . . 0.0 114.355 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.17 -10.51 54.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.806 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 51.91 52.45 14.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.164 1.385 . . . . 0.0 109.573 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 115' ' ' PHE . . . -124.76 -18.73 5.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.334 2.254 . . . . 0.0 111.528 -171.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.48 117.61 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.7 -57.65 2.68 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.459 1.103 . . . . 0.0 108.973 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -129.98 126.42 37.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 108.099 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 HG22 ' A' ' 80' ' ' VAL . 9.3 tp -109.52 137.2 47.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.874 2.07 . . . . 0.0 106.958 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -119.23 126.17 50.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.486 1.914 . . . . 0.0 107.076 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.83 141.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.3 m -71.22 134.13 46.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.268 1.027 . . . . 0.0 108.682 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -56.19 -35.0 66.76 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.04 -22.27 10.28 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.64 -45.41 9.87 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 120.85 -1.157 . . . . 0.0 110.081 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -54.85 -20.49 8.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.284 1.434 . . . . 0.0 113.592 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -125.97 20.74 7.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.706 1.603 . . . . 0.0 112.085 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -51.39 144.57 9.79 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.732 1.613 . . . . 0.0 111.526 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -51.32 -52.06 48.8 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 112.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.06 108.66 9.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 126.257 1.823 . . . . 0.0 107.713 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.44 -33.62 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.759 -174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.13 -63.28 1.29 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.803 1.183 . . . . 0.0 111.363 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 m -55.42 -45.73 76.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.768 1.227 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -56.83 -48.85 77.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.818 1.19 . . . . 0.0 110.619 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.4 m -57.09 -31.04 64.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.546 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -64.28 -58.54 6.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 120.303 1.41 . . . . 0.0 108.94 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 80' ' ' VAL . 40.2 m-85 -53.46 -53.34 52.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.023 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.78 -38.77 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.345 0.975 . . . . 0.0 110.93 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -63.65 -46.83 83.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.304 0.502 . . . . 0.0 110.486 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 tp -70.05 -34.96 73.9 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.382 0.673 . . . . 0.0 110.921 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.507 HG22 HD21 ' A' ' 58' ' ' LEU . 77.8 t -58.61 -48.51 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.67 94.38 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.949 0.9 . . . . 0.0 110.621 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -70.66 -25.38 62.97 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.546 1.538 . . . . 0.0 111.631 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.85 -42.26 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 120.702 -1.249 . . . . 0.0 108.466 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -63.72 -40.06 95.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.814 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -50.57 -49.0 57.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.071 0.851 . . . . 0.0 109.49 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -84.8 26.06 0.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.011 2.124 . . . . 0.0 110.763 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.04 22.12 12.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.534 2.734 . . . . 0.0 115.311 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.64 159.41 23.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 122.581 1.101 . . . . 0.0 113.243 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -82.5 163.55 21.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.191 2.197 . . . . 0.0 110.693 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -127.92 153.54 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 120.706 -1.246 . . . . 0.0 108.945 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.1 mmt-85 -141.0 131.88 25.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.692 1.997 . . . . 0.0 106.113 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.6 mm -118.4 107.48 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.86 155.02 19.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -103.11 145.8 29.36 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.7 t -60.55 -34.96 74.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.833 0.708 . . . . 0.0 110.542 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.19 -25.06 67.57 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.347 1.459 . . . . 0.0 112.809 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -83.39 147.62 27.79 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.496 0.718 . . . . 0.0 109.948 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -37.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.982 0.513 . . . . 0.0 110.36 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.6 m -71.04 -20.36 62.39 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.405 1.082 . . . . 0.0 111.838 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.48 -44.54 33.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.84 -34.97 73.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.715 0.758 . . . . 0.0 110.296 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -66.1 -55.65 15.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 111.068 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.61 -30.96 67.65 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.559 1.072 . . . . 0.0 111.803 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 t -60.15 -33.45 72.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.286 1.034 . . . . 0.0 112.128 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -58.76 -21.64 56.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.884 0.765 . . . . 0.0 111.303 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.4 mt -112.27 29.8 7.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.644 2.378 . . . . 0.0 109.412 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.94 0.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.523 2.729 . . . . 0.0 114.427 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.34 13.81 65.07 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 128.87 3.128 . . . . 0.0 113.618 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.2 133.13 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.502 2.151 . . . . 0.0 109.739 171.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -155.17 172.76 17.63 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.775 0.83 . . . . 0.0 110.439 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.44 146.86 22.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.091 -1.006 . . . . 0.0 110.614 173.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.2 mt -84.02 141.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 107.304 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 49' ' ' ALA . 10.1 mt -117.4 141.97 47.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.01 0.924 . . . . 0.0 108.589 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -66.93 -40.48 87.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.32 0.648 . . . . 0.0 110.37 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 17.0 p90 -136.0 156.82 76.83 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.547 1.539 . . . . 0.0 107.725 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 114.48 3.87 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.845 2.364 . . . . 0.0 108.294 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.142 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -33.53 74.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.901 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.5 -11.62 61.04 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.717 2.053 . . . . 0.0 112.741 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.87 -61.74 3.91 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 165.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.79 -43.61 98.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.886 1.274 . . . . 0.0 112.459 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.47 -41.0 80.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 124.0 0.92 . . . . 0.0 109.907 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.41 83.55 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.433 1.015 . . . . 0.0 109.353 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.33 75.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.051 0.541 . . . . 0.0 110.866 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.01 -46.0 89.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.575 0.75 . . . . 0.0 110.456 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -57.2 -52.62 64.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 124.405 1.082 . . . . 0.0 108.765 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -42.15 94.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.219 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.63 -55.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.443 1.497 . . . . 0.0 110.12 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -58.42 -35.54 72.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 118.9 0.773 . . . . 0.0 112.086 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -53.65 -56.34 18.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 1.1 mmm -61.61 -35.81 78.91 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.851 0.75 . . . . 0.0 111.703 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.36 -28.76 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.137 1.335 . . . . 0.0 111.462 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -90.44 -55.96 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.258 0.623 . . . . 0.0 110.827 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.56 -53.8 51.55 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.903 0.774 . . . . 0.0 112.756 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.87 76.41 11.55 Favored Pre-proline 0 N--CA 1.446 -0.654 0 C-N-CA 125.301 1.441 . . . . 0.0 109.059 -172.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -12.44 29.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.531 2.154 . . . . 0.0 112.41 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -61.88 -19.84 63.08 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.893 -1.129 . . . . 0.0 111.729 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.598 ' HA ' HD12 ' A' ' 113' ' ' LEU . 26.5 mtm180 -110.25 6.64 22.71 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.24 1.416 . . . . 0.0 113.118 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.85 95.68 3.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.687 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.3 m-85 -93.29 139.92 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -140.23 156.8 46.35 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 119.382 0.992 . . . . 0.0 112.882 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.24 132.7 1.65 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.73 -51.08 4.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.028 1.731 . . . . 0.0 112.276 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -59.13 -49.46 77.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.472 1.109 . . . . 0.0 110.264 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.87 -55.07 38.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.3 t -53.58 -40.14 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.41 -0.806 . . . . 0.0 111.451 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.34 -41.49 76.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.27 0.941 . . . . 0.0 110.964 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -44.91 83.31 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.082 -1.011 . . . . 0.0 109.647 176.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -62.89 -31.75 72.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -62.72 -45.8 91.08 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.269 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.88 -25.1 66.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.61 -5.6 57.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.771 0.828 . . . . 0.0 111.541 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 58.31 19.96 6.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.509 1.524 . . . . 0.0 111.897 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.14 -5.72 15.86 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.201 -163.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.47 109.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.83 -45.97 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.231 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -146.22 133.46 20.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.06 123.74 50.23 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.347 1.859 . . . . 0.0 106.488 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.29 126.28 46.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 106.719 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -137.02 139.57 44.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.38 131.9 44.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.73 -34.2 67.27 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.99 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.58 -35.83 14.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.471 1.487 . . . . 0.0 113.591 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.8 mt -81.08 -42.43 21.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.023 0.829 . . . . 0.0 110.553 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -55.41 -28.91 57.15 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.069 -1.019 . . . . 0.0 112.218 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -106.45 16.62 24.45 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 127.533 2.333 . . . . 0.0 110.924 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -50.77 139.15 17.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.114 1.324 . . . . 0.0 111.254 -162.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -35.37 74.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.593 1.157 . . . . 0.0 111.74 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.16 119.91 20.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.509 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.405 1.002 . . . . 0.0 109.948 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -56.97 -45.05 83.16 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.637 1.175 . . . . 0.0 111.281 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -51.29 -48.79 62.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.065 1.302 . . . . 0.0 111.817 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -13.62 15.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.243 -1.36 . . . . 0.0 113.961 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -75.2 -63.47 1.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.684 1.584 . . . . 0.0 108.556 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.5 m-85 -49.56 -53.86 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.828 -0.606 . . . . 0.0 112.039 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.59 -36.31 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.76 1.164 . . . . 0.0 111.544 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -64.78 -47.34 78.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 122.028 -0.42 . . . . 0.0 110.941 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.48 -46.63 89.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.712 0.805 . . . . 0.0 110.243 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 58' ' ' LEU . 95.0 t -60.13 -39.09 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.506 1.123 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.23 -43.05 58.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.568 -1.333 . . . . 0.0 110.883 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 t -64.36 -28.26 69.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.454 0.57 . . . . 0.0 111.151 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -65.15 -36.49 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 120.199 -1.563 . . . . 0.0 110.474 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -63.64 -45.62 89.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.365 1.439 . . . . 0.0 109.843 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.41 -37.36 64.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.363 1.065 . . . . 0.0 110.398 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -93.14 20.35 6.98 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.57 1.548 . . . . 0.0 111.215 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.12 27.47 16.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.27 2.228 . . . . 0.0 114.001 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.79 163.06 24.47 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -86.59 145.97 26.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.659 1.583 . . . . 0.0 109.124 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.86 139.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -128.3 121.22 28.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.76 122.09 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -94.46 128.41 41.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 117.4 5.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -58.81 -24.71 62.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.297 1.439 . . . . 0.0 112.415 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.07 -26.16 65.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 111.717 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -81.61 147.32 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.468 1.907 . . . . 0.0 109.436 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.05 -16.06 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.261 1.025 . . . . 0.0 112.262 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -60.19 -35.98 76.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.432 -1.417 . . . . 0.0 111.42 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.92 97.23 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -72.46 -38.24 68.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.11 0.964 . . . . 0.0 111.639 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -57.17 -51.32 69.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.36 -0.838 . . . . 0.0 109.343 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.59 -30.96 71.98 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.7 t -58.04 -37.3 74.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.445 1.898 . . . . 0.0 111.249 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -52.2 -33.45 40.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.61 1.164 . . . . 0.0 110.871 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.7 mt -105.49 31.29 5.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.674 2.79 . . . . 0.0 109.997 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 p 75.11 -14.93 0.71 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.871 2.868 . . . . 0.0 113.479 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.0 14.75 58.8 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.292 2.377 . . . . 0.0 113.13 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.54 132.68 27.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 120.096 1.948 . . . . 0.0 108.976 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.97 175.1 14.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.359 1.063 . . . . 0.0 109.823 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.53 144.46 15.43 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 86.2 mt -83.9 143.11 12.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD13 HG23 ' A' ' 117' ' ' VAL . 13.5 mt -117.09 151.51 36.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 0.0 110.653 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -63.88 -51.91 62.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.735 170.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.08 154.73 80.48 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.256 1.423 . . . . 0.0 110.479 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.24 106.66 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.165 3.243 . . . . 0.0 108.733 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 113' ' ' LEU . 80.7 t . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 122.705 0.402 . . . . 0.0 110.071 -163.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -25.72 66.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.175 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.95 65.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 121.566 1.985 . . . . 0.0 112.056 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.04 16.66 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 172.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.24 -50.31 73.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.289 0.636 . . . . 0.0 111.038 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.99 -47.88 88.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.314 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -55.58 26.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.297 1.408 . . . . 0.0 109.113 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.61 -28.05 66.85 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 127.288 2.235 . . . . 0.0 112.524 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.1 -45.93 17.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.828 1.251 . . . . 0.0 110.218 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -54.45 -48.69 71.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.284 1.834 . . . . 0.0 109.276 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.32 -40.24 67.6 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.183 1.393 . . . . 0.0 109.531 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -59.2 -54.39 47.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.782 1.233 . . . . 0.0 109.891 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -58.28 -38.24 76.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.361 0.665 . . . . 0.0 112.175 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -50.85 -57.2 9.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mmm -59.53 -39.06 82.7 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.4 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -53.36 -25.95 17.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.759 1.224 . . . . 0.0 112.054 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -96.28 -51.63 4.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.167 1.787 . . . . 0.0 111.504 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.75 -64.77 0.86 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.105 -0.997 . . . . 0.0 111.61 -172.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -134.32 81.68 48.96 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.06 -14.42 43.37 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.45 2.1 . . . . 0.0 111.999 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.94 -23.75 7.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.621 1.568 . . . . 0.0 112.087 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 60.9 mtp180 -106.21 13.97 28.19 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.896 1.278 . . . . 0.0 111.995 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.72 90.96 2.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.107 1.322 . . . . 0.0 110.728 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.64 138.75 31.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 109.25 -175.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 13.0 p90 -139.41 158.75 43.6 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.711 0.767 . . . . 0.0 111.308 171.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 134.76 1.33 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -172.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -44.33 -48.05 9.62 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 124.484 1.114 . . . . 0.0 110.84 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -60.7 -44.1 96.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.664 1.186 . . . . 0.0 111.365 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.83 -58.68 6.07 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 t -53.69 -38.8 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.699 0.8 . . . . 0.0 112.195 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.36 -36.94 74.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.749 1.159 . . . . 0.0 110.934 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -46.82 63.2 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.97 0.908 . . . . 0.0 109.557 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -63.59 -35.59 81.0 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -62.2 -44.51 96.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.47 -22.0 66.83 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.44 59.21 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.668 0.787 . . . . 0.0 111.375 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 28.0 mtt 52.06 44.52 29.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.362 1.465 . . . . 0.0 109.581 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -119.93 -9.95 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.246 2.219 . . . . 0.0 111.903 -170.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 49' ' ' ALA . 18.8 mt -80.08 105.95 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.22 -53.07 54.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.812 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 m -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.654 1.181 . . . . 0.0 108.292 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -109.77 137.87 46.96 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.386 1.874 . . . . 0.0 108.029 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.39 128.97 55.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.053 1.741 . . . . 0.0 107.725 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -144.95 143.47 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.402 1.001 . . . . 0.0 110.393 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.17 142.91 50.67 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.366 1.066 . . . . 0.0 109.724 170.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -56.5 -42.65 78.7 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.05 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.27 -20.81 7.74 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.6 -45.33 8.54 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.872 0.869 . . . . 0.0 109.202 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -51.32 -29.93 16.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.842 1.257 . . . . 0.0 112.276 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.91 31.35 5.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 110.841 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -51.68 148.01 5.94 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.666 0.666 . . . . 0.0 111.518 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -68.46 -31.29 70.48 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.413 1.485 . . . . 0.0 112.832 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.57 118.3 28.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.6 -30.63 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.34 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 -54.05 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.9 1.682 . . . . 0.0 109.891 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.4 m -58.2 -51.46 69.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.334 1.854 . . . . 0.0 110.756 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -58.26 -48.9 78.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.351 0.978 . . . . 0.0 110.242 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 m -55.14 -35.41 64.67 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.141 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -60.76 -51.82 67.71 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.46 1.027 . . . . 0.0 111.015 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -60.66 -51.45 69.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.181 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.0 m -63.83 -37.46 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.089 0.859 . . . . 0.0 110.971 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -57.82 -53.8 54.07 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.943 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.08 -48.21 82.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.315 1.009 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.54 -47.34 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.545 1.138 . . . . 0.0 110.526 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 5.3 m-20 -68.08 -43.22 79.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.653 -0.654 . . . . 0.0 110.555 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -72.85 -30.38 63.96 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.038 0.935 . . . . 0.0 110.324 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.29 -42.47 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.85 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 7.0 mtmp? -65.4 -39.24 91.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.898 0.772 . . . . 0.0 111.216 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.37 -25.61 66.87 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.933 -0.479 . . . . 0.0 111.561 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -100.71 44.1 1.03 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.45 5.04 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.447 3.099 . . . . 0.0 116.97 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.75 -174.47 48.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.486 1.517 . . . . 0.0 113.958 -171.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -130.79 149.33 52.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.802 2.441 . . . . 0.0 110.57 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.85 147.12 16.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.264 1.426 . . . . 0.0 108.826 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -147.21 126.59 13.13 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.849 2.06 . . . . 0.0 107.187 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -116.04 123.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.01 164.48 13.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.54 1.536 . . . . 0.0 108.331 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 136.75 42.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 162.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.8 t -51.61 -28.59 14.69 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.118 0.967 . . . . 0.0 111.47 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.18 -26.6 66.71 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 126.649 1.98 . . . . 0.0 113.613 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' A' ' 99' ' ' SER . 6.4 t-80 -84.03 158.85 21.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.669 0.788 . . . . 0.0 110.913 -165.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.44 -40.76 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 118.947 0.794 . . . . 0.0 109.321 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 97' ' ' HIS . 1.6 m -60.06 -23.32 63.67 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.863 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.69 -53.05 10.33 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.955 1.74 . . . . 0.0 110.97 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.19 -27.36 69.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.653 1.727 . . . . 0.0 112.071 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.55 -46.12 73.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.467 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.3 tp -63.26 -34.64 78.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.747 -0.596 . . . . 0.0 111.022 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -57.91 -38.42 75.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.923 1.689 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -55.42 -23.38 24.6 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.344 -0.847 . . . . 0.0 111.085 173.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.53 30.81 7.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.763 2.825 . . . . 0.0 110.238 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.2 p 66.41 19.76 10.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.096 1.358 . . . . 0.0 113.969 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.44 15.65 52.94 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.355 2.407 . . . . 0.0 114.533 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.01 124.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . . . -147.61 174.15 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.52 146.67 8.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.31 -0.869 . . . . 0.0 110.829 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.4 mt -83.83 152.45 3.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.603 HD13 HG23 ' A' ' 117' ' ' VAL . 42.1 mt -115.38 145.74 42.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.783 0.801 . . . . 0.0 109.781 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -64.5 -46.71 81.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.982 1.313 . . . . 0.0 109.906 165.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.3 p90 -138.14 152.85 72.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.428 1.491 . . . . 0.0 108.747 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 124.27 10.62 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.165 2.577 . . . . 0.0 109.105 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 113' ' ' LEU . 86.0 t . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.3 74.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.459 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -56.62 17.24 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.646 1.112 . . . . 0.0 110.928 -172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.3 93.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -50.84 40.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.95 1.3 . . . . 0.0 109.003 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.0 -41.68 83.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 125.204 1.402 . . . . 0.0 109.949 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -59.0 -44.01 91.6 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 119.118 0.872 . . . . 0.0 109.205 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -60.72 -39.0 87.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.968 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.0 tp -64.16 -48.68 75.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.437 1.017 . . . . 0.0 110.571 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -53.28 -50.94 63.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.338 1.455 . . . . 0.0 109.099 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -66.36 -46.89 75.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.413 2.285 . . . . 0.0 109.416 -171.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -54.81 -56.21 21.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.476 1.51 . . . . 0.0 110.375 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.44 -30.68 70.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -50.76 -62.73 1.42 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.659 0.599 . . . . 0.0 109.486 169.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -62.67 -29.49 70.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.048 -0.977 . . . . 0.0 111.613 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.25 -29.58 58.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.102 1.319 . . . . 0.0 111.76 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -92.31 -50.06 5.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.971 0.908 . . . . 0.0 110.367 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -73.37 -48.11 36.76 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -168.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.81 81.1 8.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.803 1.241 . . . . 0.0 109.062 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.83 -12.07 33.6 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.992 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -20.04 10.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 111.604 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 113' ' ' LEU . 81.5 mtp180 -111.7 2.57 17.28 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.831 1.252 . . . . 0.0 113.106 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.06 88.48 2.91 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.583 1.083 . . . . 0.0 108.608 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.6 m-30 -93.78 134.33 36.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.555 0.742 . . . . 0.0 109.011 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -140.74 164.79 29.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.396 0.617 . . . . 0.0 112.619 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.35 126.14 0.51 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -168.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 tp -37.14 -50.04 0.92 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.202 2.201 . . . . 0.0 110.785 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.64 -51.89 52.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 128.671 2.788 . . . . 0.0 114.084 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.22 -50.4 68.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.601 1.191 . . . . 0.0 107.959 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.76 -31.95 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.333 1.053 . . . . 0.0 111.131 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.86 -19.66 65.06 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.933 1.293 . . . . 0.0 112.713 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.74 -42.4 34.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 119.519 -1.988 . . . . 0.0 109.458 165.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.47 71.07 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -60.47 -43.83 96.52 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 119.11 0.868 . . . . 0.0 108.869 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -66.3 -11.17 49.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.57 -5.43 45.91 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.445 1.498 . . . . 0.0 112.078 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 29.1 mmt 55.49 14.15 1.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.85 . . . . 0.0 113.092 -166.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -87.92 -9.64 53.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.87 -1.144 . . . . 0.0 112.909 -162.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.2 mt -72.54 110.6 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.33 -60.19 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.577 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.2 m -144.79 141.79 29.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.592 HD21 HG22 ' A' ' 80' ' ' VAL . 9.5 tp -110.06 133.98 52.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 107.773 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.34 119.49 35.87 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.6 1.56 . . . . 0.0 107.128 175.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 tt -138.85 141.2 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.02 144.47 55.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -59.54 -38.41 80.98 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.094 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -16.53 27.98 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.62 -40.42 9.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.94 1.245 . . . . 0.0 110.042 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.01 -19.19 17.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.72 0.808 . . . . 0.0 111.986 167.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -122.58 21.0 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.973 2.909 . . . . 0.0 111.372 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -56.73 151.96 13.17 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.571 0.749 . . . . 0.0 110.989 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -63.78 -47.18 81.98 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.179 0.591 . . . . 0.0 111.86 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.79 122.73 24.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.83 -32.09 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.684 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.82 -57.78 5.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.919 1.691 . . . . 0.0 110.494 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -53.04 -52.07 59.68 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.037 0.935 . . . . 0.0 109.532 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -57.01 -46.19 82.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.696 -0.628 . . . . 0.0 111.552 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 m -52.72 -42.56 64.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.859 0.754 . . . . 0.0 110.911 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -57.99 -52.6 64.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.918 0.887 . . . . 0.0 109.036 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -60.47 -53.14 61.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.272 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -61.22 -36.78 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.838 1.199 . . . . 0.0 110.758 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -53.15 34.09 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.34 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.05 -37.08 81.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.736 0.698 . . . . 0.0 111.482 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.592 HG22 HD21 ' A' ' 58' ' ' LEU . 25.0 t -53.75 -53.4 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 109.922 168.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -58.81 -47.39 84.94 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.872 1.269 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.8 m -63.0 -33.14 74.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.195 1.798 . . . . 0.0 112.014 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.13 -35.64 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 120.602 -1.311 . . . . 0.0 110.62 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.98 -34.51 77.91 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.47 0.577 . . . . 0.0 109.701 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.37 -34.75 78.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.713 0.688 . . . . 0.0 110.374 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -79.23 3.01 19.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.916 1.287 . . . . 0.0 112.101 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.59 24.53 10.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.381 2.272 . . . . 0.0 113.696 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.24 166.09 29.38 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.4 m -92.56 157.02 16.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.109 0.957 . . . . 0.0 111.126 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.08 147.72 17.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.968 1.707 . . . . 0.0 107.23 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -132.94 121.48 22.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.18 108.11 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HE2' HD13 ' A' ' 25' ' ' LEU . 3.6 m-30 -89.19 156.13 18.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.2 m -103.12 136.12 43.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 t -52.55 -39.5 61.53 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 124.7 1.25 . . . . 0.0 111.895 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.44 -23.58 63.7 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.849 -1.157 . . . . 0.0 113.481 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -85.81 148.98 25.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.182 0.993 . . . . 0.0 109.646 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.47 -17.55 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.922 -1.112 . . . . 0.0 111.697 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 p -57.16 -34.98 68.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.711 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.71 -44.4 57.04 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.31 -38.3 71.08 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.9 0.85 . . . . 0.0 110.916 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -76.8 -37.21 56.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.188 -0.945 . . . . 0.0 112.128 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.41 -32.04 73.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.563 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -56.11 -40.72 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.853 1.661 . . . . 0.0 111.287 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -58.24 -15.71 11.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 112.071 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.36 37.42 4.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 129.073 2.949 . . . . 0.0 108.901 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p 66.54 9.51 6.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.728 2.011 . . . . 0.0 114.72 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.26 15.7 65.93 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.119 2.295 . . . . 0.0 113.385 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.7 111.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.049 0.925 . . . . 0.0 108.708 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.66 174.12 10.93 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.638 1.575 . . . . 0.0 109.258 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.23 146.45 8.94 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.873 -1.142 . . . . 0.0 110.251 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.439 HG23 ' SD ' ' A' ' 31' ' ' MET . 80.6 mt -83.8 152.01 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.232 1.413 . . . . 0.0 107.916 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 117' ' ' VAL . 38.8 mt -117.16 138.45 51.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.996 0.919 . . . . 0.0 110.691 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -60.99 -42.08 97.74 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.035 1.334 . . . . 0.0 110.119 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.5 p90 -139.07 157.1 71.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 125.721 1.609 . . . . 0.0 107.941 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.0 125.07 12.56 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.83 2.354 . . . . 0.0 108.807 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 113' ' ' LEU . 63.2 t . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.01 80.81 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 123.809 0.693 . . . . 0.0 110.363 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.58 -24.5 67.58 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.98 -43.19 74.43 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.48 -51.44 60.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 127.415 2.286 . . . . 0.0 110.528 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.71 -50.42 80.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 119.094 0.861 . . . . 0.0 109.3 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -60.47 -41.93 95.2 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.86 -0.525 . . . . 0.0 110.906 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.42 -48.67 80.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.92 -44.85 94.06 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.136 -0.978 . . . . 0.0 110.184 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.49 -50.8 72.43 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.186 1.795 . . . . 0.0 109.866 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.04 -42.28 80.78 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.083 1.49 . . . . 0.0 108.455 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.42 -58.45 7.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.653 1.181 . . . . 0.0 109.496 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.63 -40.34 75.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.563 0.345 . . . . 0.0 111.626 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.93 -44.2 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.928 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -35.58 62.44 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 119.127 0.876 . . . . 0.0 109.334 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -54.06 -33.41 57.39 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.658 1.117 . . . . 0.0 112.168 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -70.63 -56.84 5.53 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.945 1.698 . . . . 0.0 110.695 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -94.38 -52.93 4.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.395 1.478 . . . . 0.0 113.409 -160.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -138.09 71.69 47.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.713 1.605 . . . . 0.0 107.521 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.35 -10.64 26.82 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 112.488 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.08 -24.04 16.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.334 2.254 . . . . 0.0 111.571 167.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HA ' HD12 ' A' ' 113' ' ' LEU . 82.4 mtp180 -104.46 10.96 35.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.443 1.097 . . . . 0.0 112.063 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.36 96.66 3.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.841 1.2 . . . . 0.0 108.512 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.3 m-30 -93.92 133.19 37.61 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.951 0.9 . . . . 0.0 108.893 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -139.78 160.56 39.6 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.41 133.98 0.52 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -167.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 tp -40.45 -52.89 2.72 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 126.258 1.823 . . . . 0.0 111.576 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -54.56 -46.0 73.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.621 1.568 . . . . 0.0 111.983 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.1 -59.85 4.46 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.69 -39.48 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.596 1.158 . . . . 0.0 112.332 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -54.68 -39.23 67.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.333 1.053 . . . . 0.0 111.505 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.94 -53.21 22.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.799 1.24 . . . . 0.0 110.539 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -55.93 -36.02 67.27 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -58.74 -47.29 85.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.66 -33.8 75.79 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.98 -9.24 57.6 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.164 0.586 . . . . 0.0 111.682 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 44.7 mtt 55.4 24.42 6.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 127.494 2.318 . . . . 0.0 111.839 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -84.86 -13.97 49.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.747 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 mt -66.39 106.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.568 1.147 . . . . 0.0 109.03 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.77 -57.05 4.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.5 m -134.99 131.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.81 132.08 54.47 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.834 2.054 . . . . 0.0 106.522 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 118.88 31.5 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 tt -136.23 139.95 44.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.668 1.122 . . . . 0.0 109.222 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.37 133.12 54.62 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -38.57 75.55 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.247 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.32 -20.48 28.95 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 113.948 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.22 -43.53 10.93 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -50.73 -31.41 16.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 112.157 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.09 46.96 2.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.178 2.191 . . . . 0.0 108.431 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.38 152.52 33.86 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.294 0.638 . . . . 0.0 110.393 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.21 -33.38 63.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.447 1.499 . . . . 0.0 112.874 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -83.61 119.73 25.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.684 1.129 . . . . 0.0 108.858 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -51.85 -44.38 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 117.829 -1.082 . . . . 0.0 112.787 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.02 69.37 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.857 1.662 . . . . 0.0 111.644 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.1 -46.11 82.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.23 1.012 . . . . 0.0 108.748 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -53.87 -50.02 67.22 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.345 0.975 . . . . 0.0 109.417 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 t -52.04 -44.07 64.06 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.11 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -57.65 -55.4 35.28 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.493 1.042 . . . . 0.0 109.349 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -56.45 -50.88 70.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.29 -36.9 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.369 0.986 . . . . 0.0 111.251 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -49.67 75.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.812 0.733 . . . . 0.0 109.044 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 tp -56.21 -51.13 69.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.891 0.877 . . . . 0.0 109.594 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.6 t -54.0 -47.63 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.588 0.755 . . . . 0.0 111.406 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.91 -54.39 22.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.29 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 -11.74 61.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.585 0.754 . . . . 0.0 112.089 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.83 -39.32 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 O-C-N 120.312 -1.493 . . . . 0.0 109.714 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -61.26 -47.78 84.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.036 1.289 . . . . 0.0 108.589 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -51.92 -47.94 64.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.46 1.104 . . . . 0.0 110.086 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -82.25 9.94 7.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.894 0.877 . . . . 0.0 112.264 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 87.91 4.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 130.221 3.408 . . . . 0.0 114.486 166.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.18 162.47 40.42 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.893 -1.129 . . . . 0.0 113.246 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.8 m -87.0 130.4 34.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.501 2.32 . . . . 0.0 109.128 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.04 145.46 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.469 171.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -131.89 132.79 43.93 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 127.163 2.185 . . . . 0.0 106.374 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -118.62 113.42 41.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -90.57 140.35 29.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.076 1.751 . . . . 0.0 109.73 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 m -87.47 130.5 34.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.467 0.707 . . . . 0.0 111.243 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -51.23 -42.01 60.7 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.724 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -70.32 -17.65 63.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.968 1.707 . . . . 0.0 113.511 -171.034 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -93.95 150.15 20.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.204 1.401 . . . . 0.0 110.093 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.89 -31.44 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -53.71 -23.01 10.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.408 0.683 . . . . 0.0 111.311 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 -53.06 5.87 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 118.243 -1.309 . . . . 0.0 112.377 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.74 -29.56 70.19 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.246 1.523 . . . . 0.0 110.69 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.4 -55.26 14.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.498 1.519 . . . . 0.0 110.14 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.29 -37.03 76.68 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 119.449 1.022 . . . . 0.0 110.914 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -58.1 -35.23 71.12 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 111.795 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -60.5 -25.56 66.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.544 -0.722 . . . . 0.0 111.741 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -102.71 20.03 18.06 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.675 2.39 . . . . 0.0 109.656 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.277 17.5 p 78.09 0.92 2.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.471 3.508 . . . . 0.0 113.71 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.88 22.15 62.02 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 127.056 2.265 . . . . 0.0 112.289 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.81 109.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.904 1.352 . . . . 0.0 108.016 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.15 176.36 9.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.513 1.525 . . . . 0.0 111.437 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.37 146.67 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.897 171.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.56 143.76 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 C-N-CA 126.319 1.848 . . . . 0.0 107.634 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.725 HD13 HG23 ' A' ' 117' ' ' VAL . 13.4 mt -117.23 129.32 55.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 124.298 0.999 . . . . 0.0 109.631 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -54.0 -41.14 67.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.49 1.516 . . . . 0.0 110.467 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.1 p90 -137.67 154.76 75.14 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.847 1.659 . . . . 0.0 107.788 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.54 106.6 1.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.044 3.163 . . . . 0.0 108.478 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.725 HG23 HD13 ' A' ' 113' ' ' LEU . 91.6 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.45 98.73 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.325 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.11 -19.42 65.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.008 1.731 . . . . 0.0 112.761 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.83 -53.86 5.17 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 120.958 -1.088 . . . . 0.0 110.46 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.73 -51.71 66.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.943 0.897 . . . . 0.0 110.827 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.88 -48.63 78.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 126.192 1.797 . . . . 0.0 110.576 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -54.55 -48.94 71.43 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 119.56 1.073 . . . . 0.0 109.67 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -42.42 99.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.013 0.82 . . . . 0.0 111.813 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.33 -48.8 78.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.002 0.819 . . . . 0.0 110.716 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -61.47 -52.99 62.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.167 1.787 . . . . 0.0 109.342 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.2 -37.77 86.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.161 0.984 . . . . 0.0 108.886 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -58.94 -57.06 14.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.231 1.012 . . . . 0.0 110.341 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.89 -32.55 72.0 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.94 -59.25 3.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.16 -39.18 85.53 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.978 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.09 -20.27 51.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.857 0.753 . . . . 0.0 111.977 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -96.13 -53.36 3.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.532 1.133 . . . . 0.0 111.551 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -63.65 -66.36 0.55 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.521 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -145.11 80.83 10.9 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 109.616 -172.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.04 -6.52 8.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.228 2.619 . . . . 0.0 114.532 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.37 -25.07 33.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.091 0.86 . . . . 0.0 111.756 165.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HA ' HD12 ' A' ' 113' ' ' LEU . 31.0 mtm-85 -106.91 14.46 26.52 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.441 1.096 . . . . 0.0 112.015 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.56 92.71 3.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.305 0.957 . . . . 0.0 109.214 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.4 m-30 -93.75 132.78 37.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -139.9 163.48 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.497 0.719 . . . . 0.0 109.948 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 123.78 0.93 Allowed Glycine 0 C--N 1.331 0.269 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 -170.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.77 -46.8 2.75 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.726 1.611 . . . . 0.0 111.939 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.15 -55.57 26.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.765 2.826 . . . . 0.0 110.698 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.06 -57.42 13.16 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -50.92 -41.94 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.384 1.473 . . . . 0.0 111.835 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -56.8 -33.5 66.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.494 1.117 . . . . 0.0 111.488 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -77.3 -42.42 36.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 110.498 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -65.6 -32.21 73.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.243 -0.911 . . . . 0.0 112.126 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.09 -51.33 69.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.1 -31.23 70.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -9.22 58.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.875 0.87 . . . . 0.0 111.319 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.2 mmt 62.27 21.44 12.49 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 110.948 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -90.4 -16.21 29.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 112.343 -168.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 mt -70.63 113.71 7.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -80.08 -55.41 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -137.95 128.87 27.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 111' ' ' ALA . 9.8 tp -110.61 131.1 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.96 2.104 . . . . 0.0 108.757 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.16 124.65 52.01 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 108.077 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.05 144.15 27.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 119.785 1.175 . . . . 0.0 108.382 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.29 136.5 53.55 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.39 -35.61 63.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.861 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.71 -16.0 55.41 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.36 1.436 . . . . 0.0 114.287 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.43 -40.8 9.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.607 1.163 . . . . 0.0 109.811 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -52.17 -29.31 21.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.237 1.015 . . . . 0.0 112.55 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 51.07 1.92 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.081 2.552 . . . . 0.0 108.159 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -57.98 148.25 26.57 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.314 -0.866 . . . . 0.0 109.954 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.79 -39.09 87.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.86 117.2 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.587 1.155 . . . . 0.0 108.641 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.51 -33.09 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.267 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.03 60.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 120.782 1.628 . . . . 0.0 109.762 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -59.21 -48.52 81.31 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 111.105 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -52.82 -50.92 62.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.292 0.951 . . . . 0.0 109.873 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -51.71 -42.04 61.94 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -56.8 -55.77 30.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.036 1.289 . . . . 0.0 110.341 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -57.3 -55.04 39.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.147 0.904 . . . . 0.0 111.014 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 t -51.43 -54.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.9 1.28 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -64.52 -40.25 95.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 tp -67.65 -41.39 83.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.413 0.552 . . . . 0.0 111.621 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.44 -48.95 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.622 1.169 . . . . 0.0 108.925 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -42.36 98.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.1 0.96 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 m -66.37 -32.19 73.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.478 1.911 . . . . 0.0 111.956 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.15 -38.03 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 120.34 -1.475 . . . . 0.0 110.467 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -61.77 -44.5 96.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.961 0.801 . . . . 0.0 109.819 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -54.41 -38.03 65.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.229 1.012 . . . . 0.0 110.268 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -93.93 16.82 13.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.842 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 89.77 1.47 0.23 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 128.977 2.911 . . . . 0.0 114.277 168.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.76 152.57 22.52 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.732 1.151 . . . . 0.0 112.775 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -80.35 152.2 29.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.891 2.076 . . . . 0.0 108.491 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.75 139.51 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -130.63 121.67 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.06 108.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 147.85 23.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.188 1.395 . . . . 0.0 109.532 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.98 136.26 45.1 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 171.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.8 t -71.56 4.93 2.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.542 0.737 . . . . 0.0 111.795 167.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.8 mt -121.47 -0.8 9.71 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.614 1.965 . . . . 0.0 112.607 -168.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -106.3 159.56 16.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.333 2.253 . . . . 0.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 m -58.76 -27.46 64.98 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.277 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.87 -54.72 7.97 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-O 119.004 -0.886 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.96 -31.94 73.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.073 0.937 . . . . 0.0 111.721 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.08 -46.15 90.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.989 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.53 -37.89 87.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.318 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.4 m -57.62 -29.15 64.29 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.566 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -66.41 -17.23 64.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 112.856 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -122.59 48.34 1.78 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.797 2.439 . . . . 0.0 107.251 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.5 p 63.03 4.47 1.55 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.69 1.996 . . . . 0.0 114.665 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.27 65.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.144 2.307 . . . . 0.0 112.904 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.7 p -154.32 113.19 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 118.866 1.333 . . . . 0.0 109.668 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.88 176.61 9.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 112.015 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -164.08 147.47 9.63 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.179 -1.576 . . . . 0.0 111.231 174.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -85.72 141.46 14.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.524 1.53 . . . . 0.0 107.68 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' A' ' 40' ' ' PHE . 40.0 mt -108.47 138.7 44.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.832 0.853 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -52.04 -52.6 49.93 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.911 1.685 . . . . 0.0 109.752 168.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.2 p90 -136.02 159.34 71.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 127.448 2.299 . . . . 0.0 107.382 -170.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.81 142.27 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.631 1.554 . . . . 0.0 109.514 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 113' ' ' LEU . 69.1 t . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.77 79.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.965 0.348 . . . . 0.0 110.514 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.15 97.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.503 1.121 . . . . 0.0 112.466 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.49 63.63 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -50.76 54.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.26 1.424 . . . . 0.0 107.856 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.03 -51.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 110.39 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -60.32 -37.97 82.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.403 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.78 -35.48 74.93 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.219 0.918 . . . . 0.0 111.321 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tp -60.8 -49.07 78.96 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.056 0.844 . . . . 0.0 109.314 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -54.17 -56.81 14.64 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.52 1.128 . . . . 0.0 108.635 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -56.82 -43.46 81.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.084 0.865 . . . . 0.0 109.552 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.92 -54.55 40.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.835 0.854 . . . . 0.0 110.882 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.15 -35.73 77.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.795 0.725 . . . . 0.0 112.922 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -47.73 -59.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 108.206 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -62.23 -38.92 91.04 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.552 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.25 -29.28 57.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.044 1.293 . . . . 0.0 111.309 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -94.61 -47.08 6.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -69.39 -58.27 4.22 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.552 0.614 . . . . 0.0 111.658 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HE ' ' A' ' 38' ' ' ARG . 11.0 pt-20 -144.92 79.33 12.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 C-N-CA 124.315 1.046 . . . . 0.0 109.369 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.65 -10.49 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.289 1.993 . . . . 0.0 114.571 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.22 -21.02 61.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.3 1.409 . . . . 0.0 111.23 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HA ' HD12 ' A' ' 113' ' ' LEU . 24.2 mtm180 -102.97 12.33 36.21 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.824 1.193 . . . . 0.0 112.46 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.03 93.6 2.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.922 1.237 . . . . 0.0 109.064 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 3.1 m-30 -97.34 138.26 35.08 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.468 0.707 . . . . 0.0 109.934 -175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -140.3 159.08 42.98 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.31 131.69 0.81 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 tp -43.27 -50.51 6.52 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.999 1.72 . . . . 0.0 112.968 -166.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -52.78 -55.81 20.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.528 1.931 . . . . 0.0 109.952 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -56.84 -57.14 13.78 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 t -47.96 -46.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.975 1.71 . . . . 0.0 111.675 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.36 -43.43 75.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.757 1.162 . . . . 0.0 110.382 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -64.32 -40.51 96.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.067 -1.021 . . . . 0.0 110.349 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -67.6 -33.91 75.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.424 -0.797 . . . . 0.0 112.781 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -68.46 -42.57 78.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.49 -19.98 65.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.943 1.697 . . . . 0.0 113.118 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.58 -13.6 54.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.479 1.111 . . . . 0.0 111.897 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 57.36 24.86 10.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.469 1.908 . . . . 0.0 111.553 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.62 -15.06 31.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.438 -1.268 . . . . 0.0 111.891 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.07 107.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.505 1.048 . . . . 0.0 108.663 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.84 -48.45 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 172.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -143.78 134.31 24.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' VAL . 3.4 tp -110.15 133.95 52.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.863 2.065 . . . . 0.0 107.314 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 124.61 48.54 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.108 1.763 . . . . 0.0 108.175 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 tt -138.64 134.97 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -62.32 125.88 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.743 1.217 . . . . 0.0 107.88 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -57.12 -32.41 66.32 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.017 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -54.13 -25.85 24.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.117 1.326 . . . . 0.0 113.44 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 mt -86.59 -42.15 13.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.51 1.124 . . . . 0.0 109.603 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -52.1 -27.58 14.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.262 1.425 . . . . 0.0 112.481 170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 34.78 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 110.591 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -55.7 146.81 20.05 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.016 -0.428 . . . . 0.0 111.185 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.48 -25.21 64.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.37 120.67 31.69 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.61 -36.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.052 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -56.36 15.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.995 1.725 . . . . 0.0 109.888 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -53.68 -56.11 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.386 1.874 . . . . 0.0 110.232 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.09 -49.88 72.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.943 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -53.32 -41.82 66.07 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.94 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -57.39 -51.76 68.1 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.038 0.836 . . . . 0.0 110.383 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -60.79 -54.44 45.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.286 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.74 -31.79 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.581 1.082 . . . . 0.0 110.758 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -61.08 -58.21 9.32 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 109.075 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.371 1.068 . . . . 0.0 111.689 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 HD21 ' A' ' 58' ' ' LEU . 42.4 t -53.55 -46.22 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.13 . . . . 0.0 110.485 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.14 -37.87 69.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 0.0 111.46 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.2 t -67.01 -38.58 86.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.211 1.804 . . . . 0.0 110.859 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -55.38 -39.59 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 121.557 -0.715 . . . . 0.0 110.659 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.95 -39.3 87.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.794 0.724 . . . . 0.0 110.848 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.58 -28.55 69.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.686 0.794 . . . . 0.0 111.022 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -91.59 12.98 19.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.093 1.757 . . . . 0.0 110.732 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.11 26.4 15.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.471 . . . . 0.0 114.928 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.05 159.9 25.76 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.308 -0.87 . . . . 0.0 111.162 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -93.93 157.22 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.899 1.68 . . . . 0.0 110.184 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.54 148.37 25.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.1 0.96 . . . . 0.0 109.112 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.5 mmt-85 -141.83 121.68 13.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.37 112.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.12 124.57 34.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.1 m -74.02 139.9 45.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.771 0.26 . . . . 0.0 111.034 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 t -61.39 10.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.261 2.625 . . . . 0.0 115.065 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER -118.75 3.63 11.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.61 2.364 . . . . 0.0 113.665 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -114.28 139.41 49.44 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.331 1.452 . . . . 0.0 110.886 -169.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 p -56.2 -28.93 26.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.688 0.795 . . . . 0.0 110.841 172.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.1 m -64.64 -27.72 69.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.726 -0.609 . . . . 0.0 111.529 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.64 52.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.67 -26.89 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.567 0.684 . . . . 0.0 112.002 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.47 -41.37 47.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.303 1.441 . . . . 0.0 110.381 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.38 -26.91 68.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 0.0 112.427 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 t -41.24 -54.9 2.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.176 2.19 . . . . 0.0 110.843 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -61.53 -5.23 1.67 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.638 1.975 . . . . 0.0 113.784 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 mt -131.66 33.97 3.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.784 2.433 . . . . 0.0 109.323 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.8 p 64.37 12.08 6.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.293 1.837 . . . . 0.0 113.671 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.4 17.19 68.24 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.996 2.236 . . . . 0.0 114.182 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.05 115.08 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.919 1.86 . . . . 0.0 108.856 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.97 15.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.343 1.057 . . . . 0.0 111.432 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.71 144.61 13.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.258 -1.526 . . . . 0.0 110.547 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.7 mt -84.12 144.29 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.162 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.684 HD13 HG23 ' A' ' 117' ' ' VAL . 20.8 mt -114.23 146.03 40.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.609 0.764 . . . . 0.0 109.512 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -71.26 -42.84 68.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.685 1.194 . . . . 0.0 110.43 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -129.34 157.39 76.35 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.113 1.365 . . . . 0.0 108.069 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 107.11 1.78 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.824 2.349 . . . . 0.0 106.888 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 HD13 ' A' ' 113' ' ' LEU . 54.5 t . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 tttt . . . . . 0 C--O 1.231 0.099 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.37 -45.83 46.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.795 1.238 . . . . 0.0 111.111 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.25 -32.33 73.94 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.799 0.84 . . . . 0.0 113.227 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.85 77.21 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.19 -51.92 65.86 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.533 1.133 . . . . 0.0 109.519 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.61 -42.35 81.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 124.467 1.107 . . . . 0.0 110.962 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -59.32 -49.59 77.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.659 1.118 . . . . 0.0 109.211 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.5 76.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.236 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 29' ' ' TYR . 15.1 tp -60.86 -50.24 74.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 110.375 173.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -62.31 -33.33 74.45 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.447 1.099 . . . . 0.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -43.72 32.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.665 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.79 -58.03 10.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.279 1.432 . . . . 0.0 110.775 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' A' ' 25' ' ' LEU . 3.8 m-85 -54.55 -39.21 67.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.212 0.914 . . . . 0.0 112.294 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -45.44 -58.29 3.46 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.341 1.056 . . . . 0.0 108.939 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -67.21 -35.77 80.3 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 117.871 -1.062 . . . . 0.0 111.329 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.18 -29.63 46.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.772 1.624 . . . . 0.0 111.498 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.78 -51.15 5.22 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.923 . . . . 0.0 110.878 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -75.96 -33.07 59.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -171.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -168.26 76.76 0.85 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.931 1.693 . . . . 0.0 110.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.8 -10.77 26.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.483 2.122 . . . . 0.0 114.107 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.93 -19.67 61.01 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.888 -1.133 . . . . 0.0 111.43 168.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -98.45 4.68 48.4 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.342 0.974 . . . . 0.0 112.989 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -141.81 95.87 2.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.85 1.205 . . . . 0.0 109.67 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.1 141.39 28.47 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.019 1.328 . . . . 0.0 109.119 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -140.58 160.04 40.88 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.187 0.903 . . . . 0.0 113.07 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.66 131.49 2.66 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.7 tp -44.0 -45.94 8.09 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.688 1.595 . . . . 0.0 111.094 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -58.82 -45.76 89.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.049 1.339 . . . . 0.0 111.953 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -64.08 -59.05 4.93 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -49.64 -42.24 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.468 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -53.6 -40.64 65.85 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.46 1.104 . . . . 0.0 110.905 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.13 -48.08 25.45 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 126.1 1.76 . . . . 0.0 109.746 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.52 -36.15 63.94 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.563 -1.336 . . . . 0.0 112.533 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -68.23 -40.97 81.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.392 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.36 -29.53 69.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.242 1.017 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 -7.0 51.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 111.172 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.8 mmt 54.21 24.69 5.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.688 1.995 . . . . 0.0 111.131 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.5 23.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.615 1.166 . . . . 0.0 111.839 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.54 118.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -97.23 -30.31 13.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.57 0.544 . . . . 0.0 110.946 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 m -139.33 132.77 30.2 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tp -109.87 133.82 52.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.76 125.03 53.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.083 1.753 . . . . 0.0 106.404 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 76' ' ' TYR . 11.9 tt -140.83 148.14 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.7 t -67.92 144.26 55.31 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 1.9 p-10 -59.09 -32.04 69.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.405 165.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.77 -24.73 64.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.433 1.47 . . . . 0.0 113.401 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.45 -45.62 11.67 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.905 1.282 . . . . 0.0 108.941 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.75 -26.49 34.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.234 1.413 . . . . 0.0 114.234 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.35 23.33 9.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.698 1.599 . . . . 0.0 110.807 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -55.63 147.45 18.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.916 0.886 . . . . 0.0 111.193 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -61.25 -45.14 95.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.929 1.291 . . . . 0.0 113.419 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -76.46 113.54 14.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 t -57.53 -32.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 117.514 -1.231 . . . . 0.0 111.139 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 -56.41 10.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 121.043 1.747 . . . . 0.0 110.506 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.9 m -50.81 -57.02 9.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.192 1.397 . . . . 0.0 110.786 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.59 -52.38 59.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.956 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.5 m -54.97 -43.13 73.23 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 117.056 -1.45 . . . . 0.0 111.162 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -51.99 -54.13 33.41 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 121.682 2.037 . . . . 0.0 110.032 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 60' ' ' ILE . 37.3 m-85 -57.99 -49.81 75.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.994 0.517 . . . . 0.0 111.466 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.85 -51.65 69.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.91 1.684 . . . . 0.0 110.983 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -63.88 -40.07 95.67 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.29 -43.84 89.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.05 -44.65 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.334 1.053 . . . . 0.0 109.704 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.57 -44.35 71.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.117 0.967 . . . . 0.0 111.22 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -66.06 -34.92 79.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.155 1.782 . . . . 0.0 110.626 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 t -59.09 -40.56 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.632 1.106 . . . . 0.0 109.952 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -69.68 -40.89 76.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.317 0.962 . . . . 0.0 110.029 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.04 -38.42 70.54 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.2 16.95 5.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.44 2.296 . . . . 0.0 112.193 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.07 10.18 3.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.024 2.93 . . . . 0.0 115.032 168.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.3 158.69 31.63 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.946 -1.096 . . . . 0.0 112.856 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.9 m -81.22 154.26 26.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.315 1.846 . . . . 0.0 109.655 172.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.68 145.55 25.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.037 0.935 . . . . 0.0 108.499 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -136.29 121.67 19.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 mm -112.78 107.74 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.67 155.19 19.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.637 1.175 . . . . 0.0 107.858 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -95.14 129.7 42.15 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -44.33 -46.5 9.31 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.875 1.27 . . . . 0.0 111.062 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -63.58 -17.41 62.81 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.488 1.515 . . . . 0.0 114.735 -173.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -75.93 155.35 35.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 108.759 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.93 -26.94 21.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.98 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -74.83 -18.03 60.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.563 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.93 -49.1 50.47 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 123.106 2.685 . . . . 0.0 107.865 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.57 -33.92 76.67 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.6 -45.22 91.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.2 tp -63.89 -34.32 77.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.814 0.846 . . . . 0.0 110.907 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 m -56.48 -33.59 66.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.401 1.081 . . . . 0.0 113.602 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -60.51 -20.48 60.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.056 -1.028 . . . . 0.0 111.288 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.8 mt -117.72 25.6 10.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 129.313 3.045 . . . . 0.0 108.8 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 p 70.5 11.43 7.34 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.832 2.453 . . . . 0.0 113.807 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.49 76.55 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.955 2.217 . . . . 0.0 113.242 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.33 122.89 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.115 1.457 . . . . 0.0 110.409 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.98 173.97 13.68 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 110.989 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.93 145.97 14.13 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.648 -1.283 . . . . 0.0 111.375 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.53 143.92 10.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.383 1.873 . . . . 0.0 107.615 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.739 HD13 HG23 ' A' ' 117' ' ' VAL . 22.8 mt -117.53 143.44 46.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 110.793 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -62.13 -32.47 73.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.321 1.848 . . . . 0.0 111.716 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.41 161.85 28.46 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 127.26 2.224 . . . . 0.0 107.414 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 107.95 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.274 2.65 . . . . 0.0 109.205 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.739 HG23 HD13 ' A' ' 113' ' ' LEU . 71.4 t . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? . . . . . 0 C--O 1.232 0.181 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.8 -43.98 66.3 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 111.55 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.47 -21.67 63.69 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.11 -44.43 54.16 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.53 -43.83 97.84 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.298 0.639 . . . . 0.0 110.353 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.6 t -58.17 -51.92 65.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 118.117 -0.945 . . . . 0.0 109.366 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -39.22 84.74 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.881 1.219 . . . . 0.0 110.024 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -56.94 -55.89 28.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.46 0.704 . . . . 0.0 110.916 170.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.08 -41.74 79.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.539 1.063 . . . . 0.0 111.673 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.23 -50.09 75.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 126.533 1.933 . . . . 0.0 109.173 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.0 -39.82 87.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.07 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.95 -57.22 12.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.324 1.85 . . . . 0.0 110.24 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -55.78 -38.62 70.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.343 0.657 . . . . 0.0 112.428 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -44.65 -60.18 2.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.226 0.61 . . . . 0.0 110.099 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.448 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.73 -34.68 78.89 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.656 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.67 -30.2 54.83 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.035 1.289 . . . . 0.0 111.519 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -85.63 -65.39 1.02 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.41 0.684 . . . . 0.0 110.34 167.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.52 -38.64 84.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -161.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.99 77.87 3.93 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 30.6 Cg_endo -66.59 -5.76 13.74 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.794 1.663 . . . . 0.0 113.299 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -60.19 -19.47 54.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.616 -1.302 . . . . 0.0 111.094 166.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.3 mtm180 -107.95 9.7 28.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.207 1.403 . . . . 0.0 112.603 172.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -133.97 92.24 2.93 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 120.198 1.363 . . . . 0.0 108.774 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.5 m-30 -94.0 137.77 32.84 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.67 160.26 40.29 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 139.11 1.13 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -39.58 -52.45 2.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.53 1.932 . . . . 0.0 112.026 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -59.64 -44.55 93.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.643 1.977 . . . . 0.0 111.748 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -64.4 -57.26 9.8 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -46.44 -42.6 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.262 1.425 . . . . 0.0 111.686 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -53.44 -43.64 68.22 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.301 0.955 . . . . 0.0 111.391 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.73 -42.21 74.28 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.565 1.146 . . . . 0.0 110.292 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.59 -41.0 96.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -66.11 -36.69 83.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.15 0.281 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.35 -38.4 77.15 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.123 -0.986 . . . . 0.0 111.632 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -3.59 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.299 1.44 . . . . 0.0 111.512 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.7 mmt 63.4 4.39 1.7 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 113.08 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.24 48.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -158.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.9 mt -74.25 110.18 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -168.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.71 -54.23 17.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.405 HG23 ' HE ' ' A' ' 91' ' ' ARG . 28.2 m -146.35 136.32 23.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.455 1.502 . . . . 0.0 107.653 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.8 tp -110.0 142.36 41.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.468 1.907 . . . . 0.0 107.666 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.446 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -128.1 119.52 25.51 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.455 HD11 ' CD1' ' A' ' 76' ' ' TYR . 14.7 tt -139.72 149.77 22.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 120.135 1.334 . . . . 0.0 108.051 175.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 3.9 t -66.51 144.06 56.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -60.33 -36.46 78.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.357 166.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 6.5 pt-20 -56.04 -31.66 63.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.741 1.61 . . . . 0.0 113.65 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 mt -81.71 -42.08 20.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 109.41 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -52.73 -24.99 9.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 113.997 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.55 27.09 6.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.657 1.583 . . . . 0.0 110.819 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -53.52 142.99 20.79 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.716 0.769 . . . . 0.0 111.62 -172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -58.78 -39.82 82.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.366 2.267 . . . . 0.0 113.144 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -85.9 114.9 23.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 t -39.6 -41.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.743 1.617 . . . . 0.0 111.491 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -35.11 62.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.803 1.183 . . . . 0.0 114.065 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -74.36 -45.82 44.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -52.77 -50.9 62.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.3 p -53.17 -46.38 68.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.472 0.709 . . . . 0.0 110.292 -168.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -53.64 -55.58 24.66 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.496 1.918 . . . . 0.0 109.909 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.455 ' CD1' HD11 ' A' ' 60' ' ' ILE . 32.4 m-85 -59.19 -59.37 5.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.621 177.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.53 -36.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.825 1.648 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -57.37 11.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.134 1.374 . . . . 0.0 109.286 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -62.27 -36.78 83.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.297 0.639 . . . . 0.0 111.829 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 t -60.24 -50.48 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.319 1.448 . . . . 0.0 109.012 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.26 -36.72 80.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.504 0.721 . . . . 0.0 110.214 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 t -65.45 -35.0 79.61 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.26 1.424 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.71 -35.53 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 119.422 1.01 . . . . 0.0 110.188 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -69.16 -33.88 74.1 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.38 -25.39 67.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.0 110.914 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -99.09 11.86 37.76 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 127.185 2.194 . . . . 0.0 111.508 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.51 33.37 23.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.398 1.479 . . . . 0.0 113.212 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.75 153.46 20.92 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.204 0.911 . . . . 0.0 111.057 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -74.99 151.12 38.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.031 0.932 . . . . 0.0 108.955 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -121.16 142.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.92 1.288 . . . . 0.0 107.6 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.405 ' HE ' HG23 ' A' ' 57' ' ' THR . 22.7 mmt180 -133.16 120.88 21.78 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.6 mm -94.49 125.21 47.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.42 166.57 13.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.102 0.864 . . . . 0.0 108.788 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.03 110.08 21.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 166.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 t -43.71 -34.3 1.47 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.851 1.26 . . . . 0.0 112.16 173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -65.83 -36.14 82.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.862 2.465 . . . . 0.0 113.748 -176.127 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -72.78 160.3 32.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.133 1.773 . . . . 0.0 111.236 -172.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -36.65 48.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.702 -0.624 . . . . 0.0 110.171 172.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -66.66 -16.73 64.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.483 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.14 10.39 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 171.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.11 -36.96 63.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.949 0.9 . . . . 0.0 110.273 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.04 -63.73 1.2 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.662 169.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.69 -34.15 64.79 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.319 1.418 . . . . 0.0 111.662 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.0 66.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.077 1.351 . . . . 0.0 112.476 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.45 -28.6 68.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 111.055 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.9 mt -104.48 31.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.418 2.287 . . . . 0.0 109.371 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p 69.05 -0.37 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.273 2.229 . . . . 0.0 114.049 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.33 58.88 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.961 2.696 . . . . 0.0 112.538 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.17 118.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.843 1.322 . . . . 0.0 110.306 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.44 9.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.404 1.481 . . . . 0.0 112.567 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -160.16 149.45 17.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 110.772 171.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.13 144.82 9.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.671 1.988 . . . . 0.0 107.029 167.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.714 HD13 HG23 ' A' ' 117' ' ' VAL . 19.4 mt -117.29 136.41 53.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -60.25 -39.0 85.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.979 0.912 . . . . 0.0 110.802 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.31 157.81 75.88 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 128.448 2.699 . . . . 0.0 107.101 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.5 124.69 13.22 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.961 1.774 . . . . 0.0 107.805 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.714 HG23 HD13 ' A' ' 113' ' ' LEU . 65.0 t . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 171.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 mttt . . . . . 0 C--O 1.235 0.302 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.24 79.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.465 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.59 65.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.285 1.034 . . . . 0.0 113.441 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.2 -34.54 54.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.05 -50.5 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.562 0.681 . . . . 0.0 109.783 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.07 -53.54 41.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 125.828 1.651 . . . . 0.0 109.726 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -59.42 -36.29 75.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.425 1.011 . . . . 0.0 110.326 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -63.47 -44.39 94.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.368 0.985 . . . . 0.0 110.995 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.48 -44.82 89.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.035 1.288 . . . . 0.0 110.82 173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -60.6 -47.62 85.38 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.526 1.53 . . . . 0.0 110.289 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -73.3 -35.99 66.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.875 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.61 -59.58 5.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.824 1.65 . . . . 0.0 110.791 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 -37.73 66.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -51.56 -53.1 41.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.703 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.424 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -65.79 -34.08 77.34 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 118.152 -0.928 . . . . 0.0 111.533 174.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.59 -33.65 64.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.976 1.262 . . . . 0.0 110.514 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -76.78 -62.45 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -75.56 -34.56 60.71 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -160.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -157.91 81.48 3.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.987 1.715 . . . . 0.0 109.763 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 -14.03 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.684 2.256 . . . . 0.0 113.916 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.74 -15.28 39.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.657 -1.277 . . . . 0.0 111.871 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -107.52 8.9 29.59 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.957 0.903 . . . . 0.0 112.488 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -139.29 86.74 2.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.789 1.177 . . . . 0.0 108.837 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.8 m-30 -93.19 144.9 24.84 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -172.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.54 164.94 28.81 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.42 134.95 0.57 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 tp -43.05 -47.29 5.88 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.857 1.663 . . . . 0.0 111.806 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -55.72 -43.33 76.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 112.189 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -55.65 13.03 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.72 -42.11 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 111.711 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.26 -24.79 68.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.377 1.471 . . . . 0.0 111.492 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -72.4 -70.31 0.35 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 116.005 -1.95 . . . . 0.0 107.104 161.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.28 -31.19 8.48 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 122.92 2.6 . . . . 0.0 116.135 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.06 -49.21 32.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.416 1.486 . . . . 0.0 112.209 167.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -48.0 -42.15 27.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 128.323 2.649 . . . . 0.0 110.176 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.07 -0.44 57.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.666 1.186 . . . . 0.0 111.116 -169.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 mmt 54.0 31.69 14.05 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.559 1.543 . . . . 0.0 110.425 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.81 -7.81 36.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.094 -166.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -83.08 114.81 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 119.679 1.127 . . . . 0.0 108.043 -166.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.37 -54.79 6.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.337 1.455 . . . . 0.0 108.478 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.6 m -146.52 138.14 24.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.339 1.455 . . . . 0.0 107.336 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.69 139.57 44.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 106.95 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.429 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -122.87 124.17 42.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.048 1.739 . . . . 0.0 106.555 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.7 tt -137.52 142.13 37.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.18 131.06 45.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -53.8 -33.85 57.32 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 117.564 -1.208 . . . . 0.0 111.522 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.84 -37.72 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.944 1.702 . . . . 0.0 112.873 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.48 -42.75 67.72 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.92 0.867 . . . . 0.0 109.752 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.69 -12.14 15.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.057 0.943 . . . . 0.0 112.572 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -123.44 19.96 9.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.898 2.479 . . . . 0.0 111.497 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -61.12 152.93 27.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.353 1.073 . . . . 0.0 111.949 -168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -77.57 -33.76 53.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.903 2.481 . . . . 0.0 112.399 -172.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 50.4 t0 -80.14 120.0 23.68 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.95 -29.98 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.605 0.639 . . . . 0.0 110.455 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.7 -56.05 18.67 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 119.863 -1.773 . . . . 0.0 111.513 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 54.9 m -56.21 -57.44 12.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.938 1.295 . . . . 0.0 108.826 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -54.25 -49.2 70.08 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.412 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.5 m -53.94 -41.17 67.46 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.079 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -57.42 -48.94 77.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.987 1.267 . . . . 0.0 109.812 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -61.91 -56.12 22.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.048 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.85 -36.6 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.532 1.06 . . . . 0.0 110.161 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -57.74 -59.9 4.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.65 0.78 . . . . 0.0 109.486 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 tp -56.07 -44.17 78.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 111.46 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -53.15 -52.16 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.777 1.231 . . . . 0.0 109.991 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -32.73 63.33 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.16 -0.962 . . . . 0.0 112.303 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -62.23 -37.87 87.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.432 1.493 . . . . 0.0 110.985 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.55 -33.34 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.11 0.868 . . . . 0.0 110.008 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -70.48 -29.69 66.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.246 1.385 . . . . 0.0 112.222 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.06 -47.97 75.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -74.69 17.27 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.64 1.976 . . . . 0.0 112.44 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.89 56.46 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.145 2.578 . . . . 0.0 112.369 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.97 155.19 18.49 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.882 1.706 . . . . 0.0 109.822 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.1 m -75.99 148.81 37.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.452 -1.028 . . . . 0.0 110.078 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.0 129.72 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 109.016 169.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -119.64 121.53 39.48 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.42 120.25 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -88.42 162.49 16.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -104.27 113.28 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 117.374 -1.298 . . . . 0.0 107.674 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 t -56.11 -30.0 61.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.662 1.119 . . . . 0.0 112.476 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.06 -38.88 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.025 1.73 . . . . 0.0 111.251 -178.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -75.32 142.02 43.29 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 126.792 2.037 . . . . 0.0 110.655 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.04 -18.34 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.25 1.02 . . . . 0.0 113.331 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.0 m -61.7 -26.46 68.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.501 1.046 . . . . 0.0 111.165 172.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.16 -55.5 29.12 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -56.78 -36.11 69.48 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.06 0.93 . . . . 0.0 112.797 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -67.26 -45.64 76.04 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.576 -0.702 . . . . 0.0 110.184 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.6 tp -61.92 -37.09 83.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.942 176.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.7 m -62.32 -28.54 69.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.563 1.074 . . . . 0.0 112.431 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -69.88 3.89 2.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.086 0.954 . . . . 0.0 112.904 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.8 mt -136.52 33.27 2.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.055 2.942 . . . . 0.0 107.645 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.263 3.2 p 59.74 11.15 2.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.312 2.645 . . . . 0.0 114.845 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.96 17.86 80.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 128.054 2.74 . . . . 0.0 113.03 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.37 120.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 119.706 1.753 . . . . 0.0 108.949 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.47 175.35 10.63 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.933 0.893 . . . . 0.0 109.566 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.85 146.71 11.26 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.614 -1.304 . . . . 0.0 109.454 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.56 139.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 117' ' ' VAL . 30.9 mt -106.07 141.27 37.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -50.02 -61.21 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.943 2.097 . . . . 0.0 108.752 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -130.62 159.46 70.88 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 127.49 2.316 . . . . 0.0 109.278 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 106.68 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.855 2.37 . . . . 0.0 109.577 -176.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 113' ' ' LEU . 96.7 t . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.61 -44.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.398 0.679 . . . . 0.0 111.427 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.19 83.06 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.134 1.373 . . . . 0.0 112.84 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.31 -40.22 98.72 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -45.19 78.39 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.39 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.6 t -54.92 -42.13 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.642 0.777 . . . . 0.0 109.481 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -51.19 70.99 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -57.98 -40.35 80.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.737 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.82 -48.37 79.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.739 1.154 . . . . 0.0 110.907 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.28 -53.4 54.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.557 1.543 . . . . 0.0 109.306 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -66.42 -37.8 86.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.264 1.826 . . . . 0.0 109.169 -171.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -65.1 -56.09 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 111.19 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.88 -37.47 74.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.951 0.796 . . . . 0.0 112.235 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.91 -55.24 12.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.719 0.808 . . . . 0.0 109.731 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -64.11 -34.88 79.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.836 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.11 -17.59 27.87 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.158 0.89 . . . . 0.0 111.86 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -96.55 -57.81 2.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 110.622 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -70.43 -44.48 67.79 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -165.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.33 77.93 6.56 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 119.229 0.922 . . . . 0.0 110.094 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -65.07 -8.76 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.268 1.979 . . . . 0.0 114.208 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.27 -17.86 32.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.91 1.232 . . . . 0.0 111.279 164.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.5 mtm180 -108.42 11.26 27.11 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.311 1.444 . . . . 0.0 112.784 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.55 89.83 2.64 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.876 1.216 . . . . 0.0 108.934 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.619 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -93.81 140.19 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.743 0.817 . . . . 0.0 108.834 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -139.79 158.53 43.95 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.778 0.431 . . . . 0.0 111.214 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 131.72 0.79 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.0 tp -41.21 -49.75 3.58 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.054 2.141 . . . . 0.0 111.456 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.489 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.39 -56.76 15.42 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.526 1.931 . . . . 0.0 110.638 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -59.21 -51.06 71.62 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.16 -42.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.984 1.313 . . . . 0.0 111.962 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -61.06 -30.02 70.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 120.254 1.388 . . . . 0.0 111.261 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -75.0 -45.76 39.74 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 120.098 -1.626 . . . . 0.0 110.579 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -62.46 -30.67 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.77 -1.206 . . . . 0.0 111.94 177.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.45 -52.2 66.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.221 1.409 . . . . 0.0 109.062 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.37 -37.21 72.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.972 0.805 . . . . 0.0 111.65 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.48 -5.01 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.706 0.802 . . . . 0.0 111.282 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.2 mmt 53.97 26.25 6.17 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.195 1.798 . . . . 0.0 111.854 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.11 -11.15 36.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.886 -164.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.584 HG23 ' HB1' ' A' ' 111' ' ' ALA . 64.3 mt -79.39 118.19 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -84.28 -50.09 8.17 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 167.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.3 m -131.99 131.63 42.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 tp -110.15 130.81 55.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.234 1.814 . . . . 0.0 107.579 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.56 131.7 54.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.194 1.797 . . . . 0.0 106.468 177.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.49 146.62 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.39 0.541 . . . . 0.0 109.751 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.16 134.16 51.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 166.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -52.0 -36.6 50.42 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.144 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.61 -33.1 59.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.935 1.243 . . . . 0.0 113.242 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.94 -39.99 20.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.901 0.773 . . . . 0.0 109.347 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -57.57 -16.99 11.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.142 0.977 . . . . 0.0 112.555 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 39.83 3.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.721 2.008 . . . . 0.0 109.241 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -58.5 152.8 17.3 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.625 -0.672 . . . . 0.0 109.535 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -67.73 -55.0 14.8 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.105 1.362 . . . . 0.0 111.725 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -63.6 120.1 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.55 -42.09 80.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.558 1.143 . . . . 0.0 111.521 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.38 -34.3 61.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.95 0.795 . . . . 0.0 111.694 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.0 m -70.92 -45.65 63.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.234 175.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -51.64 -53.47 38.34 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.502 1.046 . . . . 0.0 109.075 167.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.3 t -52.1 -40.44 61.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.98 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -58.8 -57.35 13.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 120.206 1.367 . . . . 0.0 109.725 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -54.18 -50.37 67.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.527 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.37 -38.0 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 118.363 0.528 . . . . 0.0 111.045 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -58.93 -50.75 72.87 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.91 -42.73 97.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.957 0.903 . . . . 0.0 111.226 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -49.89 -52.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.547 1.139 . . . . 0.0 109.571 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 23.7 t70 -65.52 -43.12 91.03 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.436 0.694 . . . . 0.0 111.243 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -37.44 79.01 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.871 1.668 . . . . 0.0 111.769 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.82 -33.89 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.629 1.104 . . . . 0.0 110.115 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 5.7 mtmp? -75.57 -33.35 60.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.853 1.206 . . . . 0.0 111.402 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -56.56 -43.44 79.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -77.53 21.78 0.26 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.482 1.913 . . . . 0.0 111.721 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.73 9.05 0.53 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.794 3.238 . . . . 0.0 115.834 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.48 176.04 52.51 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.79 1.216 . . . . 0.0 112.209 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -108.05 149.36 28.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.173 2.189 . . . . 0.0 109.493 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.9 146.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.269 1.428 . . . . 0.0 107.407 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -139.28 121.75 16.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.32 115.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.19 173.74 7.99 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.365 1.466 . . . . 0.0 108.398 -175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -103.8 132.72 49.79 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -43.21 31.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.343 1.457 . . . . 0.0 111.907 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.653 HD22 ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -71.05 -20.39 62.38 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.096 2.158 . . . . 0.0 112.953 -174.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.61 158.11 34.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.097 -1.002 . . . . 0.0 109.38 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 p -57.58 -37.87 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 m -64.52 -24.15 67.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.279 1.032 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.59 -41.96 28.11 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.67 -41.64 81.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.18 0.99 . . . . 0.0 109.584 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -68.91 -43.74 74.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.544 0.737 . . . . 0.0 111.643 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.48 -31.45 72.67 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.311 0.505 . . . . 0.0 110.172 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.03 -39.59 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.66 1.184 . . . . 0.0 112.637 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -56.54 -14.74 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.594 1.158 . . . . 0.0 112.111 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.1 mt -128.29 33.86 4.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.182 2.993 . . . . 0.0 108.757 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 65.58 10.6 6.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.761 1.624 . . . . 0.0 114.119 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.43 15.11 70.13 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.432 1.968 . . . . 0.0 115.118 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.38 129.65 9.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 119.229 1.515 . . . . 0.0 109.157 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.35 175.91 13.39 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 109.396 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -157.36 145.07 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.53 -0.731 . . . . 0.0 110.526 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 77.0 mt -83.82 135.35 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 117' ' ' VAL . 29.2 mt -105.02 141.23 36.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp-105 -56.54 -56.31 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.708 1.603 . . . . 0.0 109.138 171.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -124.71 157.14 66.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 125.959 1.704 . . . . 0.0 108.493 -172.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.49 115.2 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.359 2.04 . . . . 0.0 107.269 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.743 HG23 HD13 ' A' ' 113' ' ' LEU . 93.6 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -42.03 92.8 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.204 0.456 . . . . 0.0 109.9 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -9.77 34.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.171 1.388 . . . . 0.0 112.88 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.3 -42.68 4.22 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 120.153 1.342 . . . . 0.0 110.988 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.36 -57.37 12.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.59 1.556 . . . . 0.0 108.804 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.98 -50.53 19.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 125.685 1.594 . . . . 0.0 110.407 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -58.15 -50.47 73.4 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.265 0.939 . . . . 0.0 109.58 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.63 75.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.667 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.0 -49.84 64.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.571 1.532 . . . . 0.0 110.451 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.7 -49.12 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.583 1.553 . . . . 0.0 109.178 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -69.48 -34.59 74.55 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.237 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -62.25 -58.54 7.35 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 127.049 2.14 . . . . 0.0 109.647 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -54.43 -39.63 67.54 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.361 0.664 . . . . 0.0 112.248 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -49.9 -48.59 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.475 0.31 . . . . 0.0 111.211 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.2 mtp -71.45 -35.91 71.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.964 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -55.71 -26.97 47.93 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.447 1.021 . . . . 0.0 111.476 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -92.94 -36.39 12.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.73 1.612 . . . . 0.0 112.861 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -86.03 -64.05 1.22 Allowed 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.295 1.038 . . . . 0.0 112.0 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -142.6 80.93 13.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.711 1.604 . . . . 0.0 107.513 -170.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.6 -13.1 38.55 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.769 2.313 . . . . 0.0 112.552 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.8 -20.15 14.01 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 111.892 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HA ' HD12 ' A' ' 113' ' ' LEU . 20.2 mtm180 -103.27 1.83 33.43 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 124.354 1.062 . . . . 0.0 113.543 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.41 90.69 2.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 120.058 1.299 . . . . 0.0 109.915 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.37 140.43 29.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.052 0.941 . . . . 0.0 108.966 -173.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -139.95 160.16 40.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 76.32 143.45 1.39 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -174.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.5 tp -46.64 -49.89 18.46 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.326 1.45 . . . . 0.0 112.356 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -46.41 90.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.682 0.793 . . . . 0.0 109.72 -175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.5 -56.43 18.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 42' ' ' GLY . 10.9 t -50.53 -43.3 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.904 1.282 . . . . 0.0 111.975 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.39 -40.81 68.56 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.577 1.08 . . . . 0.0 110.645 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.19 -46.48 33.78 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.505 1.522 . . . . 0.0 109.838 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.71 -37.54 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.995 -1.065 . . . . 0.0 111.941 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -66.73 -44.34 81.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.391 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.0 -34.63 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.789 1.177 . . . . 0.0 111.758 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.7 -7.15 36.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.978 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mmt 51.29 39.53 24.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.846 2.459 . . . . 0.0 109.362 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -112.0 -10.5 13.93 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.386 1.074 . . . . 0.0 112.923 -164.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.35 111.13 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.49 -59.27 3.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.2 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.458 HG21 ' HE ' ' A' ' 91' ' ' ARG . 53.4 m -146.07 134.73 22.22 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.69 140.96 41.36 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 126.712 2.005 . . . . 0.0 107.201 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.41 129.79 56.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.978 2.111 . . . . 0.0 106.468 176.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.28 131.6 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -63.58 129.97 42.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.73 -33.94 36.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.235 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.32 -22.06 62.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.35 1.432 . . . . 0.0 112.871 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.02 -40.49 11.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.241 1.016 . . . . 0.0 109.191 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -54.23 -21.06 8.09 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 20.05 7.3 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.934 1.243 . . . . 0.0 112.062 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -49.8 145.07 5.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.154 1.382 . . . . 0.0 112.908 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -46.65 89.45 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.05 110.33 5.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.69 -36.47 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.851 -172.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.78 65.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.02 1.282 . . . . 0.0 112.575 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.14 -48.72 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.289 1.036 . . . . 0.0 108.506 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 -55.02 -49.95 70.25 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.394 0.678 . . . . 0.0 109.994 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.2 p -54.61 -43.75 72.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.44 0.696 . . . . 0.0 110.276 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -54.72 -57.34 11.87 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.061 1.344 . . . . 0.0 108.772 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -55.7 -53.19 59.63 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.7 -38.53 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 118.91 0.777 . . . . 0.0 110.281 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -57.57 -52.35 65.76 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.545 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.73 -43.74 98.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.431 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -52.47 -50.43 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.501 1.121 . . . . 0.0 109.758 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.23 96.74 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.146 0.578 . . . . 0.0 109.961 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.8 m -64.7 -30.6 71.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.992 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.66 -44.77 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.138 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -64.01 -34.26 77.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.292 0.951 . . . . 0.0 110.419 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.35 -35.73 81.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.568 0.622 . . . . 0.0 110.454 174.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -91.51 24.29 3.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.9 1.68 . . . . 0.0 111.394 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 28.91 12.84 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.094 1.758 . . . . 0.0 113.861 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.85 145.52 17.82 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 170.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 m -78.06 154.98 30.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.266 1.026 . . . . 0.0 109.017 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.96 149.29 17.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.924 1.29 . . . . 0.0 107.561 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HE ' HG21 ' A' ' 57' ' ' THR . 21.4 mmt180 -137.46 121.31 17.58 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 mm -90.66 119.4 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 m-85 -89.91 125.12 35.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -62.93 109.63 1.52 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 166.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -56.74 -27.41 59.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.455 1.502 . . . . 0.0 112.836 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -67.03 -32.13 73.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.852 2.461 . . . . 0.0 111.758 -178.047 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -71.56 158.5 36.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.626 1.97 . . . . 0.0 110.632 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -19.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.071 -1.018 . . . . 0.0 111.536 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -72.87 -23.32 60.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.177 -1.577 . . . . 0.0 111.003 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.33 -43.05 26.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.637 1.108 . . . . 0.0 110.436 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -52.2 -47.83 65.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.355 1.078 . . . . 0.0 109.876 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.63 -42.26 91.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.167 0.587 . . . . 0.0 111.245 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.12 -33.74 75.04 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 119.018 0.826 . . . . 0.0 111.392 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 m -59.59 -36.54 76.45 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.224 1.409 . . . . 0.0 111.68 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -58.19 -20.65 42.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.711 0.804 . . . . 0.0 112.167 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.48 21.86 15.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.706 2.402 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 p 74.16 -1.68 3.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.551 2.74 . . . . 0.0 113.893 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.42 62.36 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 127.238 2.352 . . . . 0.0 113.462 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.79 133.14 26.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.903 1.852 . . . . 0.0 108.88 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.63 177.35 10.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 110.684 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.83 149.49 16.46 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.797 -1.19 . . . . 0.0 109.738 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 ' SD ' ' A' ' 31' ' ' MET . 81.0 mt -83.46 142.87 12.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.643 HD13 HG23 ' A' ' 117' ' ' VAL . 23.3 mt -108.97 146.14 34.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 109.202 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -59.04 -44.28 91.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.968 169.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 5.0 p90 -142.88 161.71 47.48 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.391 1.476 . . . . 0.0 109.344 -169.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.09 114.04 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 HD13 ' A' ' 113' ' ' LEU . 88.5 t . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 tptp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.99 95.76 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.918 1.287 . . . . 0.0 112.015 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -18.59 65.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.766 0.827 . . . . 0.0 111.382 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.44 51.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -60.66 -50.72 72.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.594 1.158 . . . . 0.0 110.717 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.77 -50.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.213 1.005 . . . . 0.0 110.392 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -53.53 -49.31 67.88 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.057 0.543 . . . . 0.0 110.862 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -62.36 -42.05 99.1 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.297 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.67 -45.28 92.53 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.37 1.441 . . . . 0.0 109.71 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.162 0.985 . . . . 0.0 111.399 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.12 -45.88 46.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.26 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.56 -58.38 6.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.908 1.283 . . . . 0.0 110.267 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.49 -37.8 88.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.864 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -55.97 12.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 ttp -68.64 -30.24 68.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.862 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.25 -44.72 92.36 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 120.473 1.488 . . . . 0.0 111.386 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -65.22 -24.17 67.27 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.744 1.618 . . . . 0.0 111.901 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -117.96 -41.59 2.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -162.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -155.7 83.71 3.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.332 1.853 . . . . 0.0 108.995 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.91 -7.57 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.92 2.413 . . . . 0.0 113.605 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.53 -21.44 52.38 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.889 -1.132 . . . . 0.0 111.579 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.6 mtp180 -103.4 9.23 37.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.006 1.276 . . . . 0.0 112.707 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.15 92.74 2.82 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.411 1.084 . . . . 0.0 109.427 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -93.23 145.59 24.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.06 1.344 . . . . 0.0 107.658 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -140.78 163.56 32.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 77.25 139.43 1.12 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -43.27 -51.0 6.43 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.176 2.19 . . . . 0.0 112.201 -172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -52.82 18.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.011 2.124 . . . . 0.0 111.526 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.5 -53.14 25.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 42' ' ' GLY . 3.9 t -50.5 -44.54 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.876 1.27 . . . . 0.0 111.061 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -53.25 -38.43 63.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.634 1.173 . . . . 0.0 111.65 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -78.63 -43.35 26.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 126.051 1.741 . . . . 0.0 110.632 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -65.81 -30.69 71.36 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 118.497 -1.281 . . . . 0.0 110.629 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.29 -36.69 82.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.473 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -52.52 -35.33 53.09 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.057 0.943 . . . . 0.0 111.503 168.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.54 59.35 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.352 1.461 . . . . 0.0 112.538 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.8 mmt 56.07 39.1 30.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.645 0.778 . . . . 0.0 110.905 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.97 -7.14 14.57 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.116 0.966 . . . . 0.0 112.198 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -78.44 105.19 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.07 -54.89 6.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 123.699 0.624 . . . . 0.0 109.754 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -135.83 124.65 23.99 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -171.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.8 tp -109.07 132.37 54.18 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 107.788 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.59 119.5 35.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.782 1.633 . . . . 0.0 107.66 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.42 141.24 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 137.16 57.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -59.2 -37.66 77.97 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.84 -30.89 62.17 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.686 1.195 . . . . 0.0 112.77 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -82.87 -42.08 18.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.613 1.097 . . . . 0.0 109.618 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -56.74 -18.85 14.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.389 0.675 . . . . 0.0 112.597 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 23.9 9.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.775 2.83 . . . . 0.0 109.881 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -56.45 140.38 46.06 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.689 0.677 . . . . 0.0 110.0 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -59.65 -35.84 75.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.484 1.114 . . . . 0.0 112.638 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -79.68 125.14 29.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 108.61 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.69 -38.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 116.846 -1.55 . . . . 0.0 111.167 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.74 -52.07 41.84 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.921 2.146 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -56.88 -52.42 65.21 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.409 1.884 . . . . 0.0 108.262 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -52.25 -46.48 65.8 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.726 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 p -53.8 -44.16 69.92 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.926 0.89 . . . . 0.0 110.364 -173.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -57.66 -55.48 34.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.273 1.429 . . . . 0.0 108.689 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -57.57 -51.41 69.6 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.587 -1.196 . . . . 0.0 112.629 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.2 -37.63 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.765 1.166 . . . . 0.0 110.937 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.9 mtt-85 -60.17 -51.06 71.19 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.073 0.949 . . . . 0.0 110.238 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.67 -42.83 95.11 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 122.893 0.477 . . . . 0.0 111.221 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.68 -48.55 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.02 0.928 . . . . 0.0 109.986 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.29 -49.13 78.81 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.251 1.02 . . . . 0.0 110.666 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -71.82 -23.54 61.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.683 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.72 -41.67 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 120.058 1.299 . . . . 0.0 108.465 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -65.14 -38.21 89.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.804 1.184 . . . . 0.0 110.327 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.18 -32.67 64.56 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.531 0.605 . . . . 0.0 110.82 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -98.87 24.26 7.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.436 2.294 . . . . 0.0 111.04 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 61.6 19.4 10.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.834 2.054 . . . . 0.0 114.185 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.46 146.71 19.1 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 122.277 0.932 . . . . 0.0 110.792 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.57 149.58 48.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.202 2.201 . . . . 0.0 109.534 170.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.0 t -117.33 150.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.14 1.376 . . . . 0.0 108.861 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -138.54 138.05 37.62 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.679 1.992 . . . . 0.0 106.648 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.72 104.26 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 -170.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.4 m-85 -90.02 124.88 35.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -70.09 128.48 36.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -60.71 10.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.828 2.451 . . . . 0.0 116.148 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.8 mt -129.22 -18.9 3.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.952 2.101 . . . . 0.0 111.393 -175.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -69.67 157.54 37.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.164 1.385 . . . . 0.0 110.532 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.76 -39.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.478 0.581 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 m -63.83 -32.3 73.77 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.198 -0.938 . . . . 0.0 110.489 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -65.93 -50.41 52.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.942 1.258 . . . . 0.0 110.333 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.04 -26.75 65.13 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.298 1.049 . . . . 0.0 112.028 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.62 -46.24 89.16 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.12 -0.988 . . . . 0.0 108.84 170.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.1 tp -60.61 -25.74 66.48 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.488 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t -50.69 -44.08 57.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.572 . . . . 0.0 111.826 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.15 0.56 0.91 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.435 1.094 . . . . 0.0 113.398 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.65 32.75 3.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.742 2.417 . . . . 0.0 108.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p 65.32 -3.45 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.787 2.435 . . . . 0.0 114.174 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.35 18.6 64.08 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.522 2.487 . . . . 0.0 112.884 -170.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.43 129.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 119.638 1.719 . . . . 0.0 110.804 167.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.66 173.49 13.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.456 1.102 . . . . 0.0 109.782 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.09 15.87 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.8 -1.187 . . . . 0.0 110.424 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -98.33 140.5 18.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 126.578 1.951 . . . . 0.0 108.048 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 117' ' ' VAL . 34.6 mt -107.43 145.39 33.06 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.429 0.691 . . . . 0.0 111.266 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -66.25 -39.81 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.928 1.291 . . . . 0.0 110.787 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.55 155.08 57.03 Favored Pre-proline 0 N--CA 1.453 -0.286 0 C-N-CA 123.748 0.819 . . . . 0.0 109.464 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.32 146.4 62.77 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.661 2.24 . . . . 0.0 109.601 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 113' ' ' LEU . 58.8 t . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 125.887 1.675 . . . . 0.0 106.741 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tptm . . . . . 0 N--CA 1.462 0.143 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -25.82 68.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.892 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.17 63.41 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 119.616 1.098 . . . . 0.0 111.491 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.98 -53.0 43.75 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 170.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.21 -58.98 5.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.047 0.939 . . . . 0.0 110.71 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.51 -41.61 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 117.417 -1.278 . . . . 0.0 111.606 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -55.03 -48.35 73.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.802 1.637 . . . . 0.0 109.235 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.61 88.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.892 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.27 -46.9 88.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.064 1.302 . . . . 0.0 110.086 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -56.52 -53.94 51.66 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.75 1.22 . . . . 0.0 109.054 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -66.52 -41.7 88.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.156 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.36 -57.73 10.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.302 1.041 . . . . 0.0 110.933 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.59 -41.25 89.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.166 0.439 . . . . 0.0 111.772 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -50.74 -51.97 45.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 tpp -61.03 -41.04 95.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.714 0.806 . . . . 0.0 111.731 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.44 -29.51 61.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.064 1.746 . . . . 0.0 111.469 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -80.59 -59.37 2.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.993 1.317 . . . . 0.0 108.94 173.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -71.02 -51.64 24.23 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -166.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.13 78.67 9.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.883 1.273 . . . . 0.0 108.305 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.57 -9.19 12.72 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.823 2.349 . . . . 0.0 114.137 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.62 -16.75 51.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 0.0 111.142 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 113' ' ' LEU . 83.0 mtp180 -107.82 9.15 28.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 112.179 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.76 89.57 2.96 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.788 1.235 . . . . 0.0 107.947 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -94.11 133.36 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.028 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -140.25 161.29 38.03 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.32 137.91 0.46 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -168.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 tp -37.16 -53.9 1.02 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.741 2.016 . . . . 0.0 112.862 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -59.56 -49.4 77.9 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.703 1.201 . . . . 0.0 110.943 -174.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -56.24 -58.67 6.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 t -48.93 -45.27 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.474 1.109 . . . . 0.0 112.317 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -58.24 -40.62 82.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.113 1.324 . . . . 0.0 111.205 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -37.85 85.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.63 1.172 . . . . 0.0 109.695 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.25 -35.26 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.17 -38.74 92.36 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.11 -3.6 7.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.745 1.618 . . . . 0.0 114.745 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.61 -5.73 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 112.041 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 mmt 63.26 4.59 1.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.078 2.151 . . . . 0.0 112.596 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -77.68 -10.15 59.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.033 -164.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.96 115.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.28 -65.17 1.04 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 m -125.83 132.64 52.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.91 132.84 53.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.265 1.826 . . . . 0.0 107.127 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 120.95 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.707 1.603 . . . . 0.0 106.961 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.54 145.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -65.02 142.32 58.46 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.718 0.807 . . . . 0.0 109.58 175.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.97 -42.34 89.7 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.6 pt-20 -52.09 -33.34 39.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.99 -43.29 30.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.912 0.778 . . . . 0.0 110.124 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.25 -23.75 16.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.65 1.18 . . . . 0.0 113.624 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.16 27.27 5.66 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.722 1.609 . . . . 0.0 111.29 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -54.43 149.22 10.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.33 1.452 . . . . 0.0 112.687 -174.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -58.58 -26.39 63.57 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.768 2.027 . . . . 0.0 114.51 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -105.21 114.4 28.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -53.13 -39.25 32.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.234 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -34.87 61.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.065 1.302 . . . . 0.0 111.974 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 m -65.95 -53.49 38.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -52.43 -50.51 62.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.41 ' HA ' HG22 ' A' ' 77' ' ' VAL . 24.3 p -56.85 -36.8 70.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.481 0.582 . . . . 0.0 111.523 -174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.74 -53.73 53.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.92 0.782 . . . . 0.0 109.73 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -59.03 -53.76 54.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.05 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 74' ' ' SER . 7.9 m -63.55 -35.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.528 1.058 . . . . 0.0 110.451 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -61.67 -56.07 23.68 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -54.72 -41.31 70.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.82 -50.93 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.993 0.917 . . . . 0.0 110.695 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.37 -46.16 67.61 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.626 0.77 . . . . 0.0 110.022 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.4 m -66.29 -23.8 66.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.395 1.478 . . . . 0.0 112.323 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.95 -38.38 82.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.917 0.78 . . . . 0.0 110.071 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.54 -43.47 89.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.909 0.777 . . . . 0.0 109.493 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.32 -44.41 95.49 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.529 0.518 . . . . 0.0 110.073 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -70.91 6.42 1.55 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 112.231 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.83 54.89 0.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 130.479 3.512 . . . . 0.0 113.093 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.89 163.43 17.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.522 1.058 . . . . 0.0 113.871 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -82.2 146.31 29.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.465 2.306 . . . . 0.0 109.571 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.14 144.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.443 1.497 . . . . 0.0 107.923 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -133.38 121.61 22.56 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.96 110.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.94 124.77 35.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 m -70.04 116.87 10.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -58.61 -17.03 18.7 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.78 -41.52 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.497 1.119 . . . . 0.0 112.181 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.77 153.42 41.86 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 109.591 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.55 -26.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.556 -0.715 . . . . 0.0 111.629 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 p -58.31 -27.51 64.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.221 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.22 -53.0 19.9 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 124.176 0.893 . . . . 0.0 111.034 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -38.93 74.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.653 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.47 -58.31 9.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.219 1.408 . . . . 0.0 109.661 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -56.37 -29.06 60.94 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.61 0.641 . . . . 0.0 111.402 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.02 -36.5 65.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.591 1.557 . . . . 0.0 112.593 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.53 -32.53 68.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.141 0.976 . . . . 0.0 110.705 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -99.79 21.86 11.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.204 2.201 . . . . 0.0 109.692 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p 68.99 9.39 7.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.664 2.386 . . . . 0.0 114.257 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.35 18.97 78.81 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.204 1.859 . . . . 0.0 113.504 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.13 122.02 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.992 1.396 . . . . 0.0 108.977 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.7 170.06 19.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 110.043 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.9 153.68 39.41 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.619 -0.676 . . . . 0.0 110.777 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.9 mt -84.11 141.76 14.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.664 1.585 . . . . 0.0 107.327 168.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 117' ' ' VAL . 26.2 mt -109.36 145.08 36.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.161 0.981 . . . . 0.0 110.167 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -65.68 -38.63 89.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.018 1.327 . . . . 0.0 111.223 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.4 p90 -143.55 157.57 58.78 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 127.309 2.244 . . . . 0.0 106.76 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.13 128.0 15.09 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.883 1.722 . . . . 0.0 108.384 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.737 HG23 HD13 ' A' ' 113' ' ' LEU . 72.6 t . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 174.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.84 94.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.716 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.24 87.39 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.218 0.917 . . . . 0.0 112.353 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.41 61.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 119.292 0.951 . . . . 0.0 111.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -67.12 -44.32 80.2 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.5 -1.0 . . . . 0.0 109.841 172.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.59 -45.93 82.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -60.75 -48.15 83.11 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.924 0.784 . . . . 0.0 109.993 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -59.47 -38.21 80.2 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.46 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -64.76 -50.71 65.75 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.504 1.047 . . . . 0.0 110.435 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -33.81 76.24 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.201 1.0 . . . . 0.0 110.388 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.51 -44.61 67.25 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.209 1.404 . . . . 0.0 110.148 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -58.93 -52.81 64.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.433 1.093 . . . . 0.0 109.944 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.21 -38.81 87.92 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.042 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -45.19 -52.63 9.17 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mmt -63.76 -47.76 79.69 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.198 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.55 -35.38 60.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.362 0.983 . . . . 0.0 111.541 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -78.9 -56.62 4.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.162 0.985 . . . . 0.0 109.569 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -76.46 -70.15 0.47 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.121 1.368 . . . . 0.0 113.307 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.51 71.63 66.03 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.52 -14.35 44.43 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.655 -170.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.03 -21.09 58.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.775 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 78.6 mtp180 -100.59 14.17 32.27 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.133 1.373 . . . . 0.0 113.864 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.33 110.05 12.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.327 1.051 . . . . 0.0 108.757 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.6 m-85 -107.62 130.79 54.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.554 1.142 . . . . 0.0 108.468 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.29 156.6 46.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.728 1.149 . . . . 0.0 114.1 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.97 140.04 0.19 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.633 1.111 . . . . 0.0 110.526 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -47.5 -49.81 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.439 1.096 . . . . 0.0 112.461 -162.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -58.95 -32.7 69.86 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.799 1.64 . . . . 0.0 112.632 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -71.16 -63.31 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -50.74 -41.12 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 0.0 112.233 -170.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -44.68 -49.71 10.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.074 1.75 . . . . 0.0 111.089 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -71.54 -41.92 68.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 109.851 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -66.73 -29.34 69.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.304 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.09 -37.33 78.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.3 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.91 -7.26 10.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.6 0.15 30.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.696 1.599 . . . . 0.0 112.571 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 55.96 8.2 0.35 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 127.025 2.13 . . . . 0.0 112.727 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -18.64 60.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.845 -1.16 . . . . 0.0 112.102 -162.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.28 115.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.82 -55.81 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 165.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -132.72 135.48 45.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 tp -110.25 133.18 53.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.953 2.101 . . . . 0.0 106.547 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.23 129.37 55.5 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.525 1.93 . . . . 0.0 107.115 175.054 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -143.56 136.39 24.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 119.014 0.824 . . . . 0.0 109.585 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.23 128.24 35.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 168.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -34.07 69.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.564 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -43.85 -39.7 4.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.659 1.184 . . . . 0.0 113.473 170.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 mt -77.07 -42.93 36.28 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.486 1.114 . . . . 0.0 109.571 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.53 -20.09 11.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.952 1.301 . . . . 0.0 112.877 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 30.35 4.73 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 119.96 -1.712 . . . . 0.0 110.014 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -56.18 149.39 16.14 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.255 0.55 . . . . 0.0 110.98 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -32.47 65.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.463 1.105 . . . . 0.0 112.439 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.9 113.6 20.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.38 -36.56 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.579 -168.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.61 59.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.596 1.089 . . . . 0.0 112.196 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.1 m -55.7 -52.61 63.28 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.081 1.352 . . . . 0.0 108.406 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -53.07 -53.58 48.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.586 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 77' ' ' VAL . 1.6 t -53.12 -44.81 67.96 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.19 0.596 . . . . 0.0 109.949 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -54.93 -53.87 49.98 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.062 0.945 . . . . 0.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -57.96 -57.37 13.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.197 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.1 m -64.64 -30.41 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.218 0.917 . . . . 0.0 111.102 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -66.25 -59.8 3.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.918 0.887 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 tp -52.74 -39.57 62.26 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.512 0.725 . . . . 0.0 111.445 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.48 -53.25 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.333 1.053 . . . . 0.0 110.235 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.55 -36.03 80.18 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.167 -0.333 . . . . 0.0 111.249 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -69.4 -24.47 63.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.055 0.942 . . . . 0.0 112.435 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.85 -43.85 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -61.16 -43.32 99.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.355 0.98 . . . . 0.0 110.926 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.6 -44.09 62.72 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.345 1.458 . . . . 0.0 110.124 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -85.32 25.44 1.01 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.689 1.195 . . . . 0.0 111.037 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.31 20.57 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.28 2.232 . . . . 0.0 114.064 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.64 -176.44 50.97 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 120.969 -1.082 . . . . 0.0 112.683 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 m -122.05 152.35 39.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.141 2.576 . . . . 0.0 108.499 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.73 124.14 56.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 47.8 mmt-85 -116.17 121.33 41.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -102.68 108.07 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.32 124.0 34.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -71.7 123.57 22.85 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -49.69 -42.73 46.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.329 1.851 . . . . 0.0 112.501 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.93 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.6 -37.21 67.81 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.191 1.796 . . . . 0.0 112.304 -174.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -72.74 152.09 41.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.994 1.318 . . . . 0.0 110.391 -167.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.54 -32.48 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.297 0.639 . . . . 0.0 111.595 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.5 m -65.07 -33.99 77.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.035 -1.041 . . . . 0.0 111.781 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.4 -49.55 77.29 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.1 -38.79 92.35 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.407 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -59.75 -47.26 86.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.21 -29.33 70.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.286 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.5 m -59.82 -34.27 72.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.641 1.11 . . . . 0.0 112.56 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.67 -3.93 7.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.71 1.204 . . . . 0.0 112.428 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -127.47 23.03 6.39 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.354 2.662 . . . . 0.0 108.679 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.7 p 69.75 1.3 3.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 128.449 2.7 . . . . 0.0 114.194 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.61 17.43 70.82 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.299 1.904 . . . . 0.0 113.224 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.03 129.83 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 120.165 1.982 . . . . 0.0 108.879 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.59 173.98 13.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.016 0.926 . . . . 0.0 110.291 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.46 153.92 25.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.193 -0.942 . . . . 0.0 110.874 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.6 mt -99.66 144.94 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.319 1.848 . . . . 0.0 107.911 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CD1' ' A' ' 40' ' ' PHE . 31.4 mt -116.99 131.31 56.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.595 0.758 . . . . 0.0 111.721 -172.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -53.54 -36.93 62.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.643 1.977 . . . . 0.0 111.865 173.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -149.07 157.53 39.81 Favored Pre-proline 0 N--CA 1.444 -0.737 0 C-N-CA 126.621 1.968 . . . . 0.0 106.358 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.43 144.08 66.04 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.233 1.956 . . . . 0.0 109.37 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 113' ' ' LEU . 93.8 t . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -58.33 -41.03 83.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.266 0.626 . . . . 0.0 109.949 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 -26.35 67.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.994 0.815 . . . . 0.0 112.975 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.54 -38.73 86.75 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.674 1.125 . . . . 0.0 111.093 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.67 -52.63 56.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.678 170.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 18' ' ' ALA . 74.7 t -55.02 -49.02 75.04 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 125.117 1.367 . . . . 0.0 110.034 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -49.98 69.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.03 78.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.752 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -64.98 -52.48 55.98 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.253 1.388 . . . . 0.0 110.285 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.61 -43.97 85.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.358 1.063 . . . . 0.0 109.262 -173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.5 -34.54 63.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.811 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.82 -55.08 25.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.629 1.572 . . . . 0.0 109.847 173.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.75 -39.07 73.33 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -53.76 -50.09 66.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.164 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -68.16 -32.15 72.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.564 1.075 . . . . 0.0 111.3 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 tp -55.52 -36.17 66.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.182 1.356 . . . . 0.0 110.665 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -74.22 -57.14 4.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 111.079 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -76.69 -58.78 3.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -166.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -136.91 73.67 52.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.998 1.719 . . . . 0.0 108.283 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.26 -14.13 42.1 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.135 2.557 . . . . 0.0 113.476 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -64.73 -13.73 55.89 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.56 -1.337 . . . . 0.0 111.631 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.56 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.8 mtp180 -103.18 -0.25 30.77 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.377 1.071 . . . . 0.0 112.8 171.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.08 91.17 3.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.299 0.954 . . . . 0.0 108.816 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.7 m-85 -93.35 137.75 32.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.688 1.195 . . . . 0.0 108.707 -175.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -140.33 159.6 41.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.07 134.45 0.63 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.1 tp -42.16 -51.8 4.54 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.473 1.509 . . . . 0.0 112.447 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -56.96 -42.53 80.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.84 1.656 . . . . 0.0 111.708 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -65.25 -55.94 15.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.11 -41.92 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.358 1.063 . . . . 0.0 112.332 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -55.52 -40.38 71.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.245 0.929 . . . . 0.0 110.731 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -71.66 -41.13 69.13 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.681 1.593 . . . . 0.0 110.919 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -68.01 -30.24 69.44 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.179 -0.95 . . . . 0.0 112.085 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.19 -44.15 97.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.38 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.23 -33.33 69.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.253 0.933 . . . . 0.0 112.876 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.6 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.05 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 mmt 47.46 36.61 5.26 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.925 2.09 . . . . 0.0 110.467 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.64 -20.55 13.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.642 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 111' ' ' ALA . 81.3 mt -70.66 113.97 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.31 -42.1 14.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 124.122 0.889 . . . . 0.0 110.177 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.2 m -141.64 124.72 16.3 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 tp -110.07 125.51 53.03 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 127.121 2.168 . . . . 0.0 108.814 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -108.02 126.95 53.33 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.993 1.717 . . . . 0.0 107.857 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -143.17 142.53 25.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -63.33 133.43 54.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 168.359 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.2 -39.91 73.18 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.352 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.9 pt-20 -49.58 -36.46 24.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.592 1.542 . . . . 0.0 113.803 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.3 mt -78.04 -38.56 44.31 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.825 1.193 . . . . 0.0 110.258 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -56.6 -30.25 63.02 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.318 1.047 . . . . 0.0 111.457 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 42.2 3.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.774 2.429 . . . . 0.0 109.055 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -60.99 146.9 45.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.31 -35.74 78.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.162 0.985 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -87.04 114.96 24.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.98 1.312 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.74 -34.61 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.626 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.21 11.77 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 120.093 1.315 . . . . 0.0 110.527 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -62.52 -45.21 94.05 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.637 1.175 . . . . 0.0 110.464 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -51.61 -44.97 63.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.965 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 p -51.61 -46.08 63.46 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.319 0.509 . . . . 0.0 110.083 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.41 -46.23 90.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 109.562 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -59.64 -61.39 2.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.01 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.74 -36.99 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.832 1.196 . . . . 0.0 110.857 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.11 -49.3 78.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.235 1.014 . . . . 0.0 111.297 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.1 -43.15 96.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.132 0.573 . . . . 0.0 109.928 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.33 -55.38 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.761 1.225 . . . . 0.0 110.164 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -39.63 94.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.703 0.801 . . . . 0.0 110.652 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 t -67.14 -36.79 82.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.504 1.122 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.82 -40.24 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.313 0.96 . . . . 0.0 109.273 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -65.29 -41.46 94.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.218 0.917 . . . . 0.0 110.904 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.2 -39.87 73.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.075 0.398 . . . . 0.0 110.501 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -75.39 -2.84 30.42 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 112.92 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 80.51 26.47 0.29 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.72 2.808 . . . . 0.0 113.941 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.75 143.71 16.82 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.499 1.523 . . . . 0.0 112.319 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.0 m -74.77 131.91 41.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.152 2.181 . . . . 0.0 109.778 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.7 t -93.99 148.43 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.989 0.916 . . . . 0.0 109.148 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -140.36 122.01 15.27 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.212 1.805 . . . . 0.0 108.085 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.27 109.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.9 m-85 -89.23 124.33 34.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.9 t -69.75 127.78 34.12 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -31.58 62.84 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.105 0.478 . . . . 0.0 110.355 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.91 -4.78 22.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.839 1.655 . . . . 0.0 113.642 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -109.66 143.42 39.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.867 1.667 . . . . 0.0 110.348 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -22.38 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.757 -0.59 . . . . 0.0 112.154 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -64.8 -20.53 66.43 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.596 -1.315 . . . . 0.0 111.174 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.0 -32.76 13.48 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 119.539 1.063 . . . . 0.0 112.271 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.25 -39.69 79.84 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.137 0.968 . . . . 0.0 108.855 168.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -65.06 -52.36 56.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.649 1.18 . . . . 0.0 110.763 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.32 -30.88 63.13 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.352 0.978 . . . . 0.0 111.713 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.8 t -52.44 -39.93 61.62 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.679 1.592 . . . . 0.0 112.362 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.29 -25.84 59.9 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.466 1.106 . . . . 0.0 111.145 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.1 mt -109.4 23.27 14.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.991 2.116 . . . . 0.0 109.849 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.9 p 73.65 0.23 3.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.321 2.648 . . . . 0.0 113.745 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.14 21.09 63.5 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.402 1.953 . . . . 0.0 113.129 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.48 129.23 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.603 1.702 . . . . 0.0 109.12 171.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.31 177.41 11.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.768 1.227 . . . . 0.0 110.323 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -160.59 150.29 17.55 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.857 -1.152 . . . . 0.0 111.522 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 31' ' ' MET . 78.1 mt -83.76 141.07 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.715 HD13 HG23 ' A' ' 117' ' ' VAL . 21.8 mt -113.03 144.19 43.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -65.57 -25.71 67.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.286 2.234 . . . . 0.0 112.273 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -159.86 161.39 26.47 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 127.141 2.177 . . . . 0.0 106.41 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.32 132.37 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.089 1.859 . . . . 0.0 109.563 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 113' ' ' LEU . 80.5 t . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.27 64.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.679 -163.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.95 -36.43 62.83 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.183 0.902 . . . . 0.0 113.259 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.5 71.1 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 118.987 0.812 . . . . 0.0 111.863 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.66 -53.27 57.04 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.297 0.639 . . . . 0.0 109.328 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.51 -33.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.373 1.069 . . . . 0.0 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -62.96 -47.19 84.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.941 1.7 . . . . 0.0 110.513 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.67 -37.77 82.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.134 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -48.99 79.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.483 1.038 . . . . 0.0 110.111 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -57.52 -53.56 56.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.328 1.451 . . . . 0.0 108.443 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -38.93 83.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.147 0.904 . . . . 0.0 109.77 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.19 -53.13 61.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.815 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.59 -36.29 82.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -53.9 -55.24 28.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.041 0.937 . . . . 0.0 108.721 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 tpp -57.51 -38.81 75.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.8 0.44 . . . . 0.0 110.302 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.02 -19.59 66.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.119 1.768 . . . . 0.0 112.822 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -95.0 -34.89 12.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -90.08 -70.6 0.66 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.1 77.03 68.49 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 109.388 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.99 -8.98 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.597 2.198 . . . . 0.0 114.092 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -57.06 -22.97 43.27 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.046 1.294 . . . . 0.0 111.747 166.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -106.17 8.64 32.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 112.598 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.97 98.19 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.168 0.987 . . . . 0.0 109.521 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.507 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.9 m-30 -100.46 141.74 32.91 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.384 1.074 . . . . 0.0 109.159 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.13 161.09 38.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.749 0.785 . . . . 0.0 112.95 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 148.21 0.68 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 125.242 1.401 . . . . 0.0 111.226 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 tp -49.69 -44.83 48.25 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.31 1.044 . . . . 0.0 110.972 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -61.06 -54.5 43.92 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.263 1.425 . . . . 0.0 111.289 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -61.77 -50.97 70.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 0.0 108.205 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.31 -38.88 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 111.906 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.04 -22.42 64.96 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.209 -0.932 . . . . 0.0 112.742 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -77.98 -43.34 29.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.72 1.145 . . . . 0.0 108.859 167.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.69 -40.23 94.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.005 -0.434 . . . . 0.0 112.02 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.86 -33.53 76.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.503 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.65 -35.01 79.63 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.045 0.839 . . . . 0.0 112.365 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.79 -0.19 29.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 111.991 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 62.19 3.08 0.93 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.88 2.472 . . . . 0.0 114.417 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -81.72 -2.46 50.65 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.696 -1.252 . . . . 0.0 112.629 -162.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.41 110.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.58 -49.36 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 108.121 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -144.41 136.76 26.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.1 tp -109.42 142.1 40.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 125.24 47.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.479 1.911 . . . . 0.0 107.253 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 tt -141.26 143.26 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 119.191 0.905 . . . . 0.0 110.341 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.88 137.26 53.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -37.04 69.8 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.848 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.55 -18.69 42.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.5 -43.18 9.84 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.322 1.049 . . . . 0.0 109.449 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.09 -26.58 11.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 0.0 112.444 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.28 37.39 4.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.554 1.941 . . . . 0.0 110.33 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -56.05 145.79 24.59 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.582 0.753 . . . . 0.0 110.886 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -40.51 96.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.611 0.764 . . . . 0.0 112.699 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.35 120.64 21.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -55.67 -44.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.284 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.31 -53.55 42.22 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 120.223 1.374 . . . . 0.0 111.235 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -51.38 -53.32 37.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.763 1.625 . . . . 0.0 109.878 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -55.73 -48.57 74.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.513 0.597 . . . . 0.0 109.773 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -39.23 58.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.624 0.77 . . . . 0.0 110.802 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -62.44 -56.55 17.12 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.634 1.106 . . . . 0.0 109.049 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -55.19 -50.23 69.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.762 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.62 -40.82 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 119.432 1.014 . . . . 0.0 110.479 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -62.33 -52.76 62.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.18 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.79 -42.62 75.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.521 1.055 . . . . 0.0 111.126 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -58.07 -51.23 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.194 0.597 . . . . 0.0 110.315 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.47 -33.12 74.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.843 1.657 . . . . 0.0 111.085 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -71.49 -30.12 65.6 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.954 1.701 . . . . 0.0 110.866 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.23 -37.79 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.718 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE2' HG21 ' A' ' 90' ' ' VAL . 36.4 mttt -61.73 -46.01 91.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.159 1.345 . . . . 0.0 110.295 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.11 -43.73 87.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.428 0.691 . . . . 0.0 111.842 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -77.48 10.52 2.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.992 0.917 . . . . 0.0 111.247 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.44 19.21 11.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.499 3.119 . . . . 0.0 115.143 174.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.3 168.37 51.7 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.435 1.016 . . . . 0.0 111.918 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -83.42 159.45 21.78 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.904 1.682 . . . . 0.0 109.846 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 84' ' ' LYS . 39.1 t -124.59 146.73 29.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.653 1.181 . . . . 0.0 109.127 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -143.85 121.28 11.68 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.26 0.624 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 mm -110.61 110.09 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.28 151.94 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.717 1.607 . . . . 0.0 108.985 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -103.08 132.27 49.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.338 0.655 . . . . 0.0 110.648 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.3 p -65.36 10.43 0.09 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.805 2.042 . . . . 0.0 114.715 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.28 0.71 10.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.394 1.877 . . . . 0.0 112.463 -166.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -139.62 160.38 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.606 1.962 . . . . 0.0 107.041 -172.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.33 -24.69 28.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.326 0.65 . . . . 0.0 112.41 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.3 p -68.47 -31.99 71.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.722 -1.236 . . . . 0.0 110.285 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.32 -39.14 70.97 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -66.39 -28.96 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.143 1.472 . . . . 0.0 110.92 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.04 -51.23 26.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.251 1.021 . . . . 0.0 109.311 170.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -60.03 -28.8 68.04 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.818 1.19 . . . . 0.0 111.954 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -58.85 -36.15 74.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.565 1.146 . . . . 0.0 111.811 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -68.23 -0.68 4.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.1 1.76 . . . . 0.0 112.162 173.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.77 28.22 3.58 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.422 2.289 . . . . 0.0 108.79 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 p 70.87 2.38 4.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.829 2.051 . . . . 0.0 114.521 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.04 17.07 70.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 129.03 3.205 . . . . 0.0 114.238 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.66 134.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.299 1.55 . . . . 0.0 109.477 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.69 177.97 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.218 1.407 . . . . 0.0 110.488 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -162.3 144.35 10.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.465 1.03 . . . . 0.0 110.338 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.8 mt -84.11 144.84 9.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 125.081 1.352 . . . . 0.0 107.607 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD13 HG23 ' A' ' 117' ' ' VAL . 9.7 mt -117.71 139.25 51.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.145 0.978 . . . . 0.0 109.874 -176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.73 -24.24 65.35 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.093 1.357 . . . . 0.0 111.98 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.9 p90 -151.44 157.31 34.91 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.929 1.292 . . . . 0.0 108.799 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.91 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.414 2.743 . . . . 0.0 108.406 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 113' ' ' LEU . 62.2 t . . . . . 0 C--O 1.237 0.414 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 -65.31 0.14 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 p -70.34 -179.71 2.13 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.96 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.51 -161.32 42.59 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -170.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 m 63.05 97.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.962 1.705 . . . . 0.0 110.943 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.7 m 35.2 90.68 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.548 1.939 . . . . 0.0 115.577 167.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.6 151.48 23.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 t -138.37 -174.61 3.86 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.115 1.366 . . . . 0.0 109.325 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.38 118.29 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.79 41.11 0.33 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.47 1.508 . . . . 0.0 112.33 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -55.72 138.04 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.768 0.827 . . . . 0.0 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -161.93 149.52 14.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.313 2.245 . . . . 0.0 106.263 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.14 156.85 36.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.805 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.47 -174.65 5.05 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.261 1.024 . . . . 0.0 109.339 166.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.33 131.14 49.77 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.085 0.954 . . . . 0.0 108.435 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.2 m -60.2 -38.08 82.2 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.261 0.937 . . . . 0.0 111.341 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.05 -52.08 66.46 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.706 1.139 . . . . 0.0 108.451 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.9 85.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.434 0.561 . . . . 0.0 112.291 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.11 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.3 1.44 . . . . 0.0 112.812 -169.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.06 -49.74 32.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -55.31 -51.21 67.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.714 0.805 . . . . 0.0 110.205 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.9 -42.21 88.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 119.223 0.92 . . . . 0.0 111.2 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -59.85 -47.75 84.47 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.85 1.659 . . . . 0.0 109.075 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.64 95.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.095 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.6 -43.9 80.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.269 0.94 . . . . 0.0 110.164 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.54 -48.38 60.62 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.522 1.129 . . . . 0.0 111.029 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.05 -41.11 95.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -57.43 -60.0 4.3 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.22 1.408 . . . . 0.0 110.32 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -35.94 74.94 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.59 -56.36 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.453 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -64.94 -37.78 88.77 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.142 0.577 . . . . 0.0 109.933 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.52 -36.53 69.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.332 0.969 . . . . 0.0 111.725 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -67.98 -61.26 1.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -64.97 -85.55 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.47 1.908 . . . . 0.0 112.44 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.21 93.87 47.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.29 1.436 . . . . 0.0 109.929 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -67.45 -5.36 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.894 1.729 . . . . 0.0 112.087 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.75 -33.07 60.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.134 0.879 . . . . 0.0 110.039 165.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -97.33 7.72 46.0 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -137.18 90.68 2.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.253 1.842 . . . . 0.0 110.347 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.7 m-30 -93.3 137.28 32.77 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.495 0.718 . . . . 0.0 109.756 -174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.56 164.94 28.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.77 0.795 . . . . 0.0 112.017 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.58 126.69 0.85 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -170.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -35.66 -53.66 0.7 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.907 2.083 . . . . 0.0 112.422 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.05 83.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.037 0.935 . . . . 0.0 111.767 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -59.04 -57.23 13.98 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 t -49.64 -43.87 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.26 -31.99 69.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.805 1.184 . . . . 0.0 111.727 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -44.71 30.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.617 1.567 . . . . 0.0 110.477 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -57.85 -32.51 67.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.925 -1.11 . . . . 0.0 112.37 172.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.52 -41.93 92.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.549 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.02 -35.4 69.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.25 0.932 . . . . 0.0 111.544 172.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.61 -2.81 40.8 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.847 1.259 . . . . 0.0 112.706 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.6 mmt 51.96 14.91 0.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.462 1.905 . . . . 0.0 113.148 -170.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.53 -4.97 58.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.143 -0.973 . . . . 0.0 112.362 -162.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -76.55 108.72 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -169.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.4 -62.48 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.557 -1.202 . . . . 0.0 107.849 168.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.4 m -139.01 133.69 32.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 111' ' ' ALA . 8.2 tp -110.51 124.25 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.3 1.84 . . . . 0.0 108.582 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -101.67 137.56 39.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.591 1.556 . . . . 0.0 107.806 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 tt -151.94 139.75 13.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 134.24 50.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 166.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -34.52 69.45 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.6 -25.22 62.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.743 1.156 . . . . 0.0 113.212 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.72 -37.06 19.78 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.531 1.059 . . . . 0.0 110.378 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -56.55 -19.55 16.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.682 1.193 . . . . 0.0 112.352 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.66 49.72 2.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.626 -1.297 . . . . 0.0 108.863 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -62.09 151.59 35.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.882 0.873 . . . . 0.0 109.617 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -69.22 -42.81 75.2 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.217 0.607 . . . . 0.0 112.415 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.17 119.15 19.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.5 -49.43 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 117.532 -1.223 . . . . 0.0 110.676 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.04 -52.38 66.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.366 1.439 . . . . 0.0 110.945 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -52.94 -53.12 54.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 110.809 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -55.89 -52.7 63.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -46.47 -50.6 16.69 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 126.256 1.822 . . . . 0.0 110.575 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.13 -57.3 11.62 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.972 0.909 . . . . 0.0 110.048 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -56.18 -51.68 67.14 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.152 -0.928 . . . . 0.0 112.113 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.12 -38.61 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 120.058 1.299 . . . . 0.0 110.824 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -60.22 -52.58 64.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.356 1.062 . . . . 0.0 109.026 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.12 -44.17 92.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.006 0.922 . . . . 0.0 111.205 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -53.29 -57.42 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.263 1.025 . . . . 0.0 110.138 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -34.73 78.63 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -16.82 63.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.028 . . . . 0.0 112.809 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.35 -37.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 O-C-N 120.472 -1.393 . . . . 0.0 109.135 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.98 -39.44 92.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.306 0.957 . . . . 0.0 108.899 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -57.25 -36.13 70.58 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.274 0.63 . . . . 0.0 111.269 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -87.62 13.37 10.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.856 1.262 . . . . 0.0 112.065 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.26 19.34 4.89 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.887 2.475 . . . . 0.0 114.535 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.33 170.03 50.84 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.282 0.946 . . . . 0.0 110.956 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -92.99 153.4 18.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.293 1.437 . . . . 0.0 108.691 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.6 142.1 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.333 1.453 . . . . 0.0 107.73 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -134.5 122.4 22.39 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.537 1.535 . . . . 0.0 108.011 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.75 105.55 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 10.2 m-85 -88.49 155.42 19.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -172.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 m -103.84 147.32 27.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.318 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 t -60.64 -35.85 77.19 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.149 0.906 . . . . 0.0 108.809 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.13 -56.25 16.18 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.976 1.71 . . . . 0.0 111.514 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -66.46 145.21 55.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.79 -26.46 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.586 0.63 . . . . 0.0 111.247 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 p -56.38 -17.98 9.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.184 0.994 . . . . 0.0 112.664 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.91 -55.58 4.08 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 125.348 1.452 . . . . 0.0 110.449 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.06 -29.19 67.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.312 1.056 . . . . 0.0 111.103 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -60.81 -58.13 9.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.48 -28.06 63.07 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.391 1.077 . . . . 0.0 112.238 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 m -56.34 -34.35 66.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.25 1.02 . . . . 0.0 113.196 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -64.44 -9.17 16.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.822 1.249 . . . . 0.0 111.755 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.1 mt -131.03 32.88 4.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.816 2.846 . . . . 0.0 108.711 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p 56.99 18.4 3.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.003 2.121 . . . . 0.0 114.482 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.64 69.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.801 2.143 . . . . 0.0 113.072 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.48 121.82 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.791 1.796 . . . . 0.0 110.59 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 179.48 8.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.506 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -161.67 145.44 12.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.903 1.281 . . . . 0.0 110.502 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.44 146.34 7.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.529 1.531 . . . . 0.0 106.898 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 117' ' ' VAL . 18.1 mt -117.46 145.57 44.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.452 0.701 . . . . 0.0 109.725 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -77.6 -24.6 49.62 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.689 1.596 . . . . 0.0 111.913 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -148.22 154.83 42.88 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 126.2 1.8 . . . . 0.0 106.324 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.34 114.75 3.56 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 123.163 2.576 . . . . 0.0 107.586 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 113' ' ' LEU . 55.7 t -61.6 142.23 94.43 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.65 66.19 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.504 2.803 . . . . 0.0 112.32 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.9 m -139.78 5.47 2.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.398 1.879 . . . . 0.0 111.837 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.04 -177.64 54.21 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.964 0.802 . . . . 0.0 113.088 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.33 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.08 2.52 . . . . 0.0 110.896 -167.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -155.29 175.92 13.23 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 128.795 2.838 . . . . 0.0 105.462 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 t -141.95 169.65 17.2 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.059 0.933 . . . . 0.0 110.692 -172.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 C-N-CA 127.851 2.644 . . . . 0.0 106.847 169.491 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -155.85 171.72 19.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.269 1.828 . . . . 0.0 108.592 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -162.72 -173.09 3.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.729 2.412 . . . . 0.0 109.005 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.17 126.16 3.47 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.882 1.229 . . . . 0.0 111.806 165.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.1 p -153.12 142.48 21.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.782 0.833 . . . . 0.0 109.009 168.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 143.71 16.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.583 1.553 . . . . 0.0 109.585 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.05 159.24 14.25 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.969 0.795 . . . . 0.0 112.061 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.3 t -163.31 133.11 4.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.739 1.216 . . . . 0.0 109.489 165.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -138.2 161.53 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.78 1.632 . . . . 0.0 106.676 166.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.69 100.1 0.32 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.337 1.055 . . . . 0.0 109.767 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -117.89 151.39 37.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.082 0.953 . . . . 0.0 109.941 167.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.45 153.45 39.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.419 1.887 . . . . 0.0 107.528 167.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.58 179.26 4.32 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.834 1.254 . . . . 0.0 109.996 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 m -96.36 60.69 1.95 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.893 1.677 . . . . 0.0 108.259 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.66 109.63 4.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.0 m -54.47 -48.89 71.24 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.267 1.027 . . . . 0.0 111.29 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -66.71 -52.56 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.423 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.7 76.3 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.982 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.95 -23.99 61.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.496 1.044 . . . . 0.0 112.231 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.79 -43.44 22.98 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.71 93.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.009 0.924 . . . . 0.0 110.54 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 t -69.03 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.197 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -53.38 -44.1 68.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.077 1.762 . . . . 0.0 109.87 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.563 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -65.61 -46.32 79.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.794 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.1 -45.32 79.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.38 0.991 . . . . 0.0 111.106 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.26 -54.38 44.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.33 1.852 . . . . 0.0 108.465 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -66.39 -38.15 86.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.819 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 90.8 t80 -58.22 -59.7 4.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 110.285 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -61.71 -31.04 71.17 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -50.37 -62.94 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -58.9 -38.75 79.62 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.29 -30.32 59.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.983 1.265 . . . . 0.0 112.23 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -96.16 -35.45 11.31 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.463 -0.773 . . . . 0.0 111.945 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -76.88 -56.42 4.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.207 1.003 . . . . 0.0 112.857 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.27 81.06 7.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.606 1.963 . . . . 0.0 108.891 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.11 -14.03 39.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.126 2.551 . . . . 0.0 112.762 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.41 -20.98 61.64 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.104 -0.998 . . . . 0.0 111.301 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -101.08 11.35 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 123.835 0.854 . . . . 0.0 112.665 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -146.26 91.03 2.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.43 1.014 . . . . 0.0 109.837 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 4.3 m-30 -92.33 144.5 25.32 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.64 164.66 29.59 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.57 130.8 2.86 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 -171.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.0 tp -43.95 -47.6 8.51 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.27 -46.73 89.12 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.307 1.043 . . . . 0.0 111.618 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.14 -58.4 8.69 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.532 1.06 . . . . 0.0 108.412 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 t -53.08 -36.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.684 1.194 . . . . 0.0 111.637 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.04 -21.62 66.29 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.02 . . . . 0.0 112.767 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -87.6 -43.49 11.94 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 125.836 1.654 . . . . 0.0 110.459 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -54.87 -36.55 65.22 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.251 -0.906 . . . . 0.0 111.898 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.89 -45.18 87.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.576 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -60.0 -28.75 67.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.388 0.994 . . . . 0.0 113.132 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -0.11 29.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.186 1.394 . . . . 0.0 111.829 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.1 mmt 52.26 23.31 2.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.309 2.244 . . . . 0.0 112.775 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -100.92 -8.26 22.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.333 1.053 . . . . 0.0 112.694 -161.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.3 mt -70.5 117.48 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.05 -61.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.57 1.148 . . . . 0.0 108.518 165.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.7 m -138.0 139.84 39.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 80' ' ' VAL . 12.1 tp -110.53 133.4 53.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.186 1.794 . . . . 0.0 108.107 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.563 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -109.62 134.47 51.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.199 1.799 . . . . 0.0 107.326 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.53 142.83 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -72.7 131.73 42.75 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.58 -32.85 65.62 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 123.05 0.54 . . . . 0.0 111.537 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.52 -41.87 22.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.6 -40.24 35.08 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.114 0.966 . . . . 0.0 108.998 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.32 -20.05 10.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.372 0.669 . . . . 0.0 111.694 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -118.61 21.27 12.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.847 2.059 . . . . 0.0 111.773 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -55.07 144.85 22.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.369 0.986 . . . . 0.0 111.421 -168.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.21 -21.78 56.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.99 108.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.0 -26.09 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 111.592 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.36 -54.39 12.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.16 0.891 . . . . 0.0 111.195 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.0 m -53.86 -49.03 69.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.145 1.778 . . . . 0.0 109.635 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.91 -47.28 71.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.089 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -50.13 -43.5 51.91 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.886 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.79 -56.74 18.27 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.271 1.028 . . . . 0.0 108.671 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -54.4 -55.61 26.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.757 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 m -64.96 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.901 1.228 . . . . 0.0 111.666 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -62.11 -53.36 56.49 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.0 tp -58.06 -43.28 86.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.197 0.999 . . . . 0.0 111.461 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 49.3 t -57.08 -33.02 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.094 0.958 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.24 -35.1 15.51 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.478 -0.764 . . . . 0.0 112.073 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 t -64.93 -16.3 63.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.069 1.747 . . . . 0.0 111.643 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.06 -35.3 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 119.513 -1.992 . . . . 0.0 109.679 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.85 -39.5 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.654 1.115 . . . . 0.0 110.37 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -48.93 -43.18 39.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.479 1.112 . . . . 0.0 110.325 171.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -94.37 17.65 12.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.161 1.384 . . . . 0.0 111.054 -168.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 27.69 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.57 2.348 . . . . 0.0 113.658 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.48 -170.79 46.72 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.127 0.87 . . . . 0.0 111.293 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -124.93 156.34 38.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.136 2.174 . . . . 0.0 109.14 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.66 140.92 44.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.969 0.89 . . . . 0.0 108.826 -173.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -137.07 120.81 17.37 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.25 109.93 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 -175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -89.66 138.12 31.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 t -69.07 122.43 18.71 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 p -55.88 -15.0 2.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.226 1.41 . . . . 0.0 113.38 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.95 -33.93 44.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.158 0.89 . . . . 0.0 111.297 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -67.44 151.49 47.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.78 -18.18 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.752 -0.592 . . . . 0.0 111.905 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.7 p -68.04 -27.9 66.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.105 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.07 -26.32 72.66 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.66 1.118 . . . . 0.0 110.756 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.49 -49.86 37.05 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.289 1.045 . . . . 0.0 108.811 165.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -61.14 -35.65 77.65 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.203 -0.936 . . . . 0.0 111.885 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -70.64 -29.79 66.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.646 172.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 t -52.94 -41.47 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.984 1.314 . . . . 0.0 110.973 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.0 4.03 0.73 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.017 2.127 . . . . 0.0 114.115 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -137.81 27.98 2.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.539 2.736 . . . . 0.0 108.793 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p 66.29 2.08 2.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.249 2.62 . . . . 0.0 114.801 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.34 73.32 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 128.32 2.867 . . . . 0.0 113.94 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.56 132.67 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.016 1.908 . . . . 0.0 109.904 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.93 168.56 24.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.519 1.127 . . . . 0.0 110.269 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.06 145.28 23.91 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.309 0.958 . . . . 0.0 111.137 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.1 mt -83.95 148.87 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 127.029 2.132 . . . . 0.0 106.687 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 49' ' ' ALA . 24.2 mt -117.56 147.38 42.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.118 0.967 . . . . 0.0 111.718 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mtt85 -70.34 -32.09 69.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 168.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 10.4 p90 -151.23 154.0 33.32 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 118.245 0.475 . . . . 0.0 110.356 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.3 113.44 3.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.783 2.988 . . . . 0.0 109.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.506 HG23 HD13 ' A' ' 113' ' ' LEU . 98.0 t -73.02 122.62 88.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.83 82.31 2.35 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.804 3.003 . . . . 0.0 111.682 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 m -140.43 -165.57 1.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.704 2.002 . . . . 0.0 107.845 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 127.86 2.56 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 172.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.24 155.74 63.67 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.152 1.901 . . . . 0.0 109.333 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 p -86.52 -66.28 0.92 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.124 1.369 . . . . 0.0 110.673 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.3 t -131.83 -179.32 5.32 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.686 1.995 . . . . 0.0 107.251 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.295 0 CA-C-O 117.519 -1.711 . . . . 0.0 110.087 -177.974 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.6 p -155.62 168.13 28.15 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.51 -170.72 0.1 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.299 0.64 . . . . 0.0 112.469 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.17 -163.87 16.41 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m 67.33 103.58 0.05 OUTLIER 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.442 1.897 . . . . 0.0 111.908 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 t -154.87 141.22 18.66 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.754 1.622 . . . . 0.0 107.371 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.24 140.82 3.09 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -166.1 135.55 3.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.68 72.43 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 110.964 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.45 11.53 13.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.738 2.415 . . . . 0.0 111.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -66.24 110.6 3.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.081 1.752 . . . . 0.0 110.009 -169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -148.97 -66.42 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.209 -0.932 . . . . 0.0 110.892 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.01 -163.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.101 1.36 . . . . 0.0 112.259 -157.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 m -141.35 170.9 14.86 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.175 1.79 . . . . 0.0 108.944 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t0 63.12 105.41 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 130.074 3.35 . . . . 0.0 110.471 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -42.16 -41.79 2.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.83 1.652 . . . . 0.0 114.503 -165.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -68.78 -51.94 35.68 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.806 -1.184 . . . . 0.0 110.153 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.07 -54.43 46.02 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.637 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.72 -40.37 54.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.537 1.135 . . . . 0.0 112.447 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.39 -47.61 34.74 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.962 0.801 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -48.68 76.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.946 0.873 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.23 -42.5 66.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 124.7 1.2 . . . . 0.0 109.606 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -57.13 -50.04 74.03 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.909 1.231 . . . . 0.0 109.533 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.45 -43.64 98.52 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.855 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.91 -47.93 81.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.865 1.211 . . . . 0.0 110.233 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.18 -51.95 65.77 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 126.701 2.0 . . . . 0.0 109.477 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.03 -42.15 73.31 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -173.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.98 -56.82 11.88 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.198 0.999 . . . . 0.0 108.567 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -44.89 89.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 124.123 0.889 . . . . 0.0 112.247 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.08 -57.73 4.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ttp -66.27 -33.14 75.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.374 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.18 -50.94 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.732 1.606 . . . . 0.0 110.814 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -65.33 -40.16 93.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.221 0.208 . . . . 0.0 110.562 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.88 -57.95 3.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 111.41 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -149.97 76.9 8.63 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.431 2.292 . . . . 0.0 108.29 -167.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.81 -5.94 14.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.749 2.299 . . . . 0.0 112.151 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -27.19 2.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.003 2.121 . . . . 0.0 110.99 163.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HA ' HD12 ' A' ' 113' ' ' LEU . 76.1 mtp180 -110.22 0.8 18.32 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.208 1.403 . . . . 0.0 113.922 175.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.74 95.21 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.669 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.5 m-30 -93.55 133.62 36.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -140.38 159.91 41.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.16 0.981 . . . . 0.0 113.522 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 135.94 0.69 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.8 tp -44.97 -49.8 10.96 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.801 1.641 . . . . 0.0 112.27 -169.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -56.16 -43.27 78.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.432 1.493 . . . . 0.0 110.367 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -66.69 -57.82 6.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.18 -36.65 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.218 -0.926 . . . . 0.0 111.924 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -56.4 -38.84 72.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.914 0.885 . . . . 0.0 112.21 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -47.11 53.29 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.155 1.382 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -58.77 -32.83 69.64 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.577 -0.702 . . . . 0.0 112.537 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.53 -43.61 89.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.906 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.64 -28.16 66.98 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.04 0.836 . . . . 0.0 112.548 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.18 -6.12 57.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.46 0.704 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 60.26 9.5 1.96 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.624 1.97 . . . . 0.0 112.491 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.56 -7.19 59.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.167 -0.958 . . . . 0.0 113.027 -162.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.0 114.35 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 119.167 0.894 . . . . 0.0 108.86 -170.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.74 -52.37 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.166 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.6 m -140.99 132.93 27.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.27 132.71 53.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.467 2.307 . . . . 0.0 106.797 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.481 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -110.96 126.68 55.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.16 1.784 . . . . 0.0 106.918 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.11 136.31 29.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 118.931 0.787 . . . . 0.0 109.469 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -65.75 138.55 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.55 -39.35 70.5 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 122.928 0.491 . . . . 0.0 110.208 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -60.65 -16.7 41.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.39 -42.59 10.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.875 1.216 . . . . 0.0 110.091 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -50.28 -32.56 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.554 1.142 . . . . 0.0 112.379 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.55 38.85 4.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.511 1.924 . . . . 0.0 109.709 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.97 151.82 17.62 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -68.73 -41.49 78.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.583 0.753 . . . . 0.0 111.785 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 23.9 t70 -75.89 120.48 21.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.191 1.396 . . . . 0.0 108.23 -172.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.84 -39.44 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.404 -174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -60.27 4.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.976 0.807 . . . . 0.0 109.289 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 89.1 m -58.93 -51.24 70.88 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.089 0.956 . . . . 0.0 110.061 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -52.62 -52.31 56.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.017 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.3 t -52.2 -46.87 65.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 119.227 0.922 . . . . 0.0 109.245 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -51.73 -50.73 59.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.106 0.866 . . . . 0.0 109.668 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -57.82 -60.4 3.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.722 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 m -61.94 -37.84 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.328 1.422 . . . . 0.0 111.151 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -57.55 -53.16 61.34 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.809 1.644 . . . . 0.0 108.721 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.72 -46.63 88.53 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.808 0.843 . . . . 0.0 111.252 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 58' ' ' LEU . 41.6 t -54.67 -49.88 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 124.311 1.045 . . . . 0.0 109.348 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.02 -37.8 78.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -64.65 -30.49 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.76 0.824 . . . . 0.0 111.856 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.28 -39.77 79.46 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 O-C-N 120.952 -1.092 . . . . 0.0 109.623 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.01 -46.69 89.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.985 0.811 . . . . 0.0 110.114 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -59.14 -31.27 68.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.979 0.512 . . . . 0.0 112.189 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.81 26.6 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.829 1.252 . . . . 0.0 111.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.64 6.75 2.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.872 2.869 . . . . 0.0 115.225 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.99 -176.18 47.91 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.177 0.899 . . . . 0.0 112.015 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -123.42 157.5 33.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.897 1.679 . . . . 0.0 109.935 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.3 t -122.66 139.66 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 108.232 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -129.36 121.45 27.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.1 mm -100.74 109.34 25.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 5.6 m-85 -89.62 156.76 18.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 108.697 -177.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -104.76 139.4 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 t -62.4 9.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.691 2.396 . . . . 0.0 114.155 170.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -129.3 -14.47 4.27 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.27 1.828 . . . . 0.0 113.689 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -87.69 148.38 24.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.565 1.075 . . . . 0.0 109.214 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.6 p -57.02 -32.63 40.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 O-C-N 121.721 -0.612 . . . . 0.0 110.129 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.0 m -65.3 -27.36 68.56 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.307 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.65 -53.8 25.99 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 167.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.34 -31.33 67.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.29 1.045 . . . . 0.0 112.196 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.96 -47.53 65.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.953 0.901 . . . . 0.0 109.697 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.86 -31.91 65.28 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 122.948 0.499 . . . . 0.0 111.39 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -58.33 -33.88 70.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.648 1.179 . . . . 0.0 112.926 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.14 -6.77 14.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.452 1.501 . . . . 0.0 112.053 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.0 mt -129.7 23.04 5.42 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.537 2.735 . . . . 0.0 108.218 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p 77.57 -12.12 1.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.263 3.425 . . . . 0.0 114.122 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.36 15.76 46.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.962 2.22 . . . . 0.0 113.133 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.17 133.48 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 118.933 1.366 . . . . 0.0 108.962 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.09 13.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.669 1.188 . . . . 0.0 110.05 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.18 142.01 9.82 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.241 0.928 . . . . 0.0 110.918 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -83.88 141.84 14.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.203 1.401 . . . . 0.0 107.715 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.732 HD13 HG23 ' A' ' 117' ' ' VAL . 30.2 mt -112.9 139.91 48.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.311 1.045 . . . . 0.0 111.249 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -66.86 -25.54 66.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.052 1.741 . . . . 0.0 112.374 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -151.61 157.47 34.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.507 1.523 . . . . 0.0 107.254 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.69 128.92 15.81 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.992 1.795 . . . . 0.0 108.384 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.732 HG23 HD13 ' A' ' 113' ' ' LEU . 79.4 t -78.88 129.39 73.62 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.85 104.87 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.869 2.379 . . . . 0.0 110.334 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.8 t -158.9 -74.98 0.08 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.35 170.49 34.74 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.7 169.64 15.59 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.945 2.43 . . . . 0.0 109.783 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.2 p -157.4 164.62 37.32 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.292 0.637 . . . . 0.0 110.095 171.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -167.38 -164.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.741 2.016 . . . . 0.0 108.384 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 117.62 -1.656 . . . . 0.0 110.683 178.055 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m 61.68 141.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.063 1.745 . . . . 0.0 109.73 -152.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -145.49 155.88 43.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.45 160.72 53.62 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.7 t -153.18 126.25 8.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t 61.12 -164.91 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.729 1.212 . . . . 0.0 112.812 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.2 -170.76 43.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 128.548 2.975 . . . . 0.0 107.655 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 154.66 41.18 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.619 1.209 . . . . 0.0 108.775 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.23 165.5 19.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.99 0.916 . . . . 0.0 110.845 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.3 146.53 43.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 161.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.5 p -140.57 162.42 35.42 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.978 0.911 . . . . 0.0 109.021 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -139.79 164.78 29.05 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 123.859 0.863 . . . . 0.0 109.084 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.63 -59.6 4.94 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 167.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t 47.03 83.52 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.35 1.86 . . . . 0.0 113.155 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.05 96.26 0.07 Allowed 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 126.7 2.0 . . . . 0.0 113.087 153.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 m -35.3 -50.68 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.808 2.043 . . . . 0.0 115.489 -162.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -65.97 -51.76 55.61 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.732 0.413 . . . . 0.0 110.216 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.95 80.54 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.524 0.73 . . . . 0.0 110.007 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.14 69.14 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.416 1.007 . . . . 0.0 113.367 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.67 -39.27 18.11 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 119.423 1.011 . . . . 0.0 111.115 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -50.42 68.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.881 2.072 . . . . 0.0 108.139 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.44 -51.52 48.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 126.013 1.725 . . . . 0.0 109.677 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.06 -45.01 67.92 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.558 1.072 . . . . 0.0 109.769 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.6 -50.72 71.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 123.854 0.721 . . . . 0.0 111.383 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -55.74 -46.75 77.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.977 1.262 . . . . 0.0 111.361 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.04 -46.53 88.0 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.543 1.537 . . . . 0.0 110.073 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.72 -35.65 65.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.135 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 61.4 t80 -61.46 -57.39 12.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.444 2.298 . . . . 0.0 109.995 173.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -58.79 -35.4 72.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.739 0.7 . . . . 0.0 112.073 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -50.0 -53.65 25.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.482 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.1 mmt -59.86 -44.44 94.13 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.57 0.623 . . . . 0.0 110.286 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.1 -25.31 45.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.056 0.844 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -86.65 -62.35 1.53 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -68.11 -59.39 3.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.927 1.291 . . . . 0.0 113.826 -168.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.98 80.63 47.93 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 124.975 1.31 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.48 -7.65 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.273 1.982 . . . . 0.0 113.752 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.99 -55.24 25.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.889 1.222 . . . . 0.0 108.195 164.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -76.08 10.97 1.63 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.278 0.945 . . . . 0.0 112.526 -168.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -128.3 96.51 4.46 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.77 1.228 . . . . 0.0 109.69 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.73 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.37 140.64 29.34 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.27 159.67 41.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 142.13 0.73 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 tp -45.24 -51.81 10.31 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.361 1.464 . . . . 0.0 112.673 -165.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' O ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -57.56 -49.59 75.89 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.648 1.579 . . . . 0.0 110.272 -175.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.12 -56.44 22.22 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -49.22 -40.59 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.666 1.186 . . . . 0.0 112.29 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -59.61 -35.65 74.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.688 1.586 . . . . 0.0 111.56 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -49.32 16.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.236 1.415 . . . . 0.0 109.348 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.73 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -56.06 -39.36 71.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.748 -0.595 . . . . 0.0 111.126 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -54.93 -50.37 69.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.5 0.72 . . . . 0.0 109.114 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.88 -16.01 47.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.891 1.277 . . . . 0.0 114.355 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.17 -10.51 54.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.806 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 51.91 52.45 14.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.164 1.385 . . . . 0.0 109.573 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 115' ' ' PHE . . . -124.76 -18.73 5.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.334 2.254 . . . . 0.0 111.528 -171.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.48 117.61 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.7 -57.65 2.68 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.459 1.103 . . . . 0.0 108.973 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -129.98 126.42 37.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 108.099 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 HG22 ' A' ' 80' ' ' VAL . 9.3 tp -109.52 137.2 47.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.874 2.07 . . . . 0.0 106.958 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -119.23 126.17 50.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.486 1.914 . . . . 0.0 107.076 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.83 141.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.3 m -71.22 134.13 46.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.268 1.027 . . . . 0.0 108.682 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -56.19 -35.0 66.76 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.04 -22.27 10.28 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.64 -45.41 9.87 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 120.85 -1.157 . . . . 0.0 110.081 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -54.85 -20.49 8.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.284 1.434 . . . . 0.0 113.592 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -125.97 20.74 7.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.706 1.603 . . . . 0.0 112.085 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -51.39 144.57 9.79 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.732 1.613 . . . . 0.0 111.526 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -51.32 -52.06 48.8 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 112.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.06 108.66 9.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 126.257 1.823 . . . . 0.0 107.713 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.44 -33.62 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.759 -174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.13 -63.28 1.29 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.803 1.183 . . . . 0.0 111.363 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 m -55.42 -45.73 76.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.768 1.227 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -56.83 -48.85 77.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.818 1.19 . . . . 0.0 110.619 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.4 m -57.09 -31.04 64.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.546 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -64.28 -58.54 6.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 120.303 1.41 . . . . 0.0 108.94 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 80' ' ' VAL . 40.2 m-85 -53.46 -53.34 52.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.023 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.78 -38.77 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.345 0.975 . . . . 0.0 110.93 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -63.65 -46.83 83.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.304 0.502 . . . . 0.0 110.486 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 tp -70.05 -34.96 73.9 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.382 0.673 . . . . 0.0 110.921 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.507 HG22 HD21 ' A' ' 58' ' ' LEU . 77.8 t -58.61 -48.51 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.67 94.38 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.949 0.9 . . . . 0.0 110.621 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -70.66 -25.38 62.97 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.546 1.538 . . . . 0.0 111.631 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.85 -42.26 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 120.702 -1.249 . . . . 0.0 108.466 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -63.72 -40.06 95.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.814 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -50.57 -49.0 57.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.071 0.851 . . . . 0.0 109.49 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -84.8 26.06 0.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.011 2.124 . . . . 0.0 110.763 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.04 22.12 12.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.534 2.734 . . . . 0.0 115.311 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.64 159.41 23.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 122.581 1.101 . . . . 0.0 113.243 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -82.5 163.55 21.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.191 2.197 . . . . 0.0 110.693 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -127.92 153.54 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 120.706 -1.246 . . . . 0.0 108.945 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.1 mmt-85 -141.0 131.88 25.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.692 1.997 . . . . 0.0 106.113 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.6 mm -118.4 107.48 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.86 155.02 19.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -103.11 145.8 29.36 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.7 t -60.55 -34.96 74.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.833 0.708 . . . . 0.0 110.542 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.19 -25.06 67.57 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.347 1.459 . . . . 0.0 112.809 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -83.39 147.62 27.79 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.496 0.718 . . . . 0.0 109.948 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -37.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.982 0.513 . . . . 0.0 110.36 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.6 m -71.04 -20.36 62.39 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.405 1.082 . . . . 0.0 111.838 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.48 -44.54 33.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.84 -34.97 73.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.715 0.758 . . . . 0.0 110.296 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -66.1 -55.65 15.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 111.068 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.61 -30.96 67.65 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.559 1.072 . . . . 0.0 111.803 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 t -60.15 -33.45 72.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.286 1.034 . . . . 0.0 112.128 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -58.76 -21.64 56.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.884 0.765 . . . . 0.0 111.303 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.4 mt -112.27 29.8 7.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.644 2.378 . . . . 0.0 109.412 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.94 0.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.523 2.729 . . . . 0.0 114.427 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.34 13.81 65.07 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 128.87 3.128 . . . . 0.0 113.618 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.2 133.13 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.502 2.151 . . . . 0.0 109.739 171.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -155.17 172.76 17.63 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.775 0.83 . . . . 0.0 110.439 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.44 146.86 22.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.091 -1.006 . . . . 0.0 110.614 173.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.2 mt -84.02 141.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 107.304 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 49' ' ' ALA . 10.1 mt -117.4 141.97 47.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.01 0.924 . . . . 0.0 108.589 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -66.93 -40.48 87.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.32 0.648 . . . . 0.0 110.37 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 17.0 p90 -136.0 156.82 76.83 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.547 1.539 . . . . 0.0 107.725 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 114.48 3.87 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.845 2.364 . . . . 0.0 108.294 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.14 133.71 94.72 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.12 98.87 0.33 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.888 2.392 . . . . 0.0 109.017 170.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.4 m -161.33 -179.98 7.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.849 2.46 . . . . 0.0 107.593 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.0 29.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.53 -15.81 24.48 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.409 2.739 . . . . 0.0 113.523 -170.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.34 -21.67 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.093 0.86 . . . . 0.0 110.864 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 p -95.63 53.92 1.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.13 1.372 . . . . 0.0 111.811 -171.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 167.622 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -105.73 -1.24 24.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.895 1.278 . . . . 0.0 112.75 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 m -63.17 156.15 26.05 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.33 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.81 25.83 69.48 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.08 162.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.9 t -93.34 -97.57 0.14 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.416 1.608 . . . . 0.0 109.957 -173.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.3 m -61.85 144.28 55.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.842 1.257 . . . . 0.0 110.906 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.99 -178.15 40.24 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.791 -0.568 . . . . 0.0 111.883 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -120.1 120.11 35.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.464 1.106 . . . . 0.0 109.631 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -114.41 67.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 140.98 47.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.52 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 p -139.38 141.16 37.59 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.435 0.636 . . . . 0.0 110.716 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -126.5 103.04 7.39 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.91 1.684 . . . . 0.0 108.312 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.74 94.79 5.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.9 m -127.99 -8.24 5.46 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 19.0 t70 -163.14 141.5 8.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.76 1.164 . . . . 0.0 109.131 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -62.19 -43.14 99.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.375 1.443 . . . . 0.0 111.48 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -52.91 5.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -68.48 -33.53 74.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.901 -172.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.5 -11.62 61.04 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.717 2.053 . . . . 0.0 112.741 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.87 -61.74 3.91 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 165.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.79 -43.61 98.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.886 1.274 . . . . 0.0 112.459 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.47 -41.0 80.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 124.0 0.92 . . . . 0.0 109.907 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.41 83.55 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.433 1.015 . . . . 0.0 109.353 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.33 75.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.051 0.541 . . . . 0.0 110.866 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.01 -46.0 89.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.575 0.75 . . . . 0.0 110.456 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -57.2 -52.62 64.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 124.405 1.082 . . . . 0.0 108.765 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -42.15 94.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.219 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.63 -55.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.443 1.497 . . . . 0.0 110.12 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -58.42 -35.54 72.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 118.9 0.773 . . . . 0.0 112.086 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -53.65 -56.34 18.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 1.1 mmm -61.61 -35.81 78.91 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.851 0.75 . . . . 0.0 111.703 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.36 -28.76 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.137 1.335 . . . . 0.0 111.462 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -90.44 -55.96 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.258 0.623 . . . . 0.0 110.827 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.56 -53.8 51.55 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.903 0.774 . . . . 0.0 112.756 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.87 76.41 11.55 Favored Pre-proline 0 N--CA 1.446 -0.654 0 C-N-CA 125.301 1.441 . . . . 0.0 109.059 -172.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -12.44 29.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.531 2.154 . . . . 0.0 112.41 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -61.88 -19.84 63.08 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.893 -1.129 . . . . 0.0 111.729 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.598 ' HA ' HD12 ' A' ' 113' ' ' LEU . 26.5 mtm180 -110.25 6.64 22.71 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.24 1.416 . . . . 0.0 113.118 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.85 95.68 3.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.687 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.3 m-85 -93.29 139.92 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -140.23 156.8 46.35 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 119.382 0.992 . . . . 0.0 112.882 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.24 132.7 1.65 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.73 -51.08 4.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.028 1.731 . . . . 0.0 112.276 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -59.13 -49.46 77.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.472 1.109 . . . . 0.0 110.264 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.87 -55.07 38.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.3 t -53.58 -40.14 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.41 -0.806 . . . . 0.0 111.451 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.34 -41.49 76.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.27 0.941 . . . . 0.0 110.964 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -44.91 83.31 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.082 -1.011 . . . . 0.0 109.647 176.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -62.89 -31.75 72.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -62.72 -45.8 91.08 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.269 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.88 -25.1 66.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.61 -5.6 57.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.771 0.828 . . . . 0.0 111.541 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 58.31 19.96 6.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.509 1.524 . . . . 0.0 111.897 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.14 -5.72 15.86 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.201 -163.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.47 109.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.83 -45.97 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.231 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -146.22 133.46 20.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.06 123.74 50.23 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.347 1.859 . . . . 0.0 106.488 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.29 126.28 46.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 106.719 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -137.02 139.57 44.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.38 131.9 44.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.73 -34.2 67.27 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.99 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.58 -35.83 14.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.471 1.487 . . . . 0.0 113.591 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.8 mt -81.08 -42.43 21.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.023 0.829 . . . . 0.0 110.553 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -55.41 -28.91 57.15 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.069 -1.019 . . . . 0.0 112.218 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -106.45 16.62 24.45 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 127.533 2.333 . . . . 0.0 110.924 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -50.77 139.15 17.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.114 1.324 . . . . 0.0 111.254 -162.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -35.37 74.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.593 1.157 . . . . 0.0 111.74 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.16 119.91 20.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.509 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.405 1.002 . . . . 0.0 109.948 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -56.97 -45.05 83.16 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.637 1.175 . . . . 0.0 111.281 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -51.29 -48.79 62.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.065 1.302 . . . . 0.0 111.817 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -13.62 15.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.243 -1.36 . . . . 0.0 113.961 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -75.2 -63.47 1.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.684 1.584 . . . . 0.0 108.556 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.5 m-85 -49.56 -53.86 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.828 -0.606 . . . . 0.0 112.039 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.59 -36.31 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.76 1.164 . . . . 0.0 111.544 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -64.78 -47.34 78.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 122.028 -0.42 . . . . 0.0 110.941 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.48 -46.63 89.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.712 0.805 . . . . 0.0 110.243 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 58' ' ' LEU . 95.0 t -60.13 -39.09 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.506 1.123 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.23 -43.05 58.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.568 -1.333 . . . . 0.0 110.883 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 t -64.36 -28.26 69.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.454 0.57 . . . . 0.0 111.151 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -65.15 -36.49 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 120.199 -1.563 . . . . 0.0 110.474 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -63.64 -45.62 89.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.365 1.439 . . . . 0.0 109.843 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.41 -37.36 64.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.363 1.065 . . . . 0.0 110.398 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -93.14 20.35 6.98 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.57 1.548 . . . . 0.0 111.215 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.12 27.47 16.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.27 2.228 . . . . 0.0 114.001 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.79 163.06 24.47 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -86.59 145.97 26.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.659 1.583 . . . . 0.0 109.124 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.86 139.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -128.3 121.22 28.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.76 122.09 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -94.46 128.41 41.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 117.4 5.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -58.81 -24.71 62.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.297 1.439 . . . . 0.0 112.415 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.07 -26.16 65.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 111.717 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -81.61 147.32 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.468 1.907 . . . . 0.0 109.436 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.05 -16.06 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.261 1.025 . . . . 0.0 112.262 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -60.19 -35.98 76.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.432 -1.417 . . . . 0.0 111.42 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.92 97.23 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -72.46 -38.24 68.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.11 0.964 . . . . 0.0 111.639 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -57.17 -51.32 69.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.36 -0.838 . . . . 0.0 109.343 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.59 -30.96 71.98 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.7 t -58.04 -37.3 74.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.445 1.898 . . . . 0.0 111.249 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -52.2 -33.45 40.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.61 1.164 . . . . 0.0 110.871 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.7 mt -105.49 31.29 5.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.674 2.79 . . . . 0.0 109.997 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 p 75.11 -14.93 0.71 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.871 2.868 . . . . 0.0 113.479 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.0 14.75 58.8 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.292 2.377 . . . . 0.0 113.13 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.54 132.68 27.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 120.096 1.948 . . . . 0.0 108.976 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.97 175.1 14.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.359 1.063 . . . . 0.0 109.823 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.53 144.46 15.43 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 86.2 mt -83.9 143.11 12.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD13 HG23 ' A' ' 117' ' ' VAL . 13.5 mt -117.09 151.51 36.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 0.0 110.653 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -63.88 -51.91 62.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.735 170.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.08 154.73 80.48 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.256 1.423 . . . . 0.0 110.479 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.24 106.66 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.165 3.243 . . . . 0.0 108.733 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 113' ' ' LEU . 80.7 t -63.25 135.48 96.26 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.705 0.402 . . . . 0.0 110.071 -163.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.13 91.7 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.172 3.248 . . . . 0.0 109.885 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.0 m -150.22 -171.03 3.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.803 1.241 . . . . 0.0 109.417 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.13 -178.0 15.32 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.502 1.525 . . . . 0.0 110.324 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.3 163.25 39.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.861 2.374 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -135.67 -62.96 0.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.508 0.723 . . . . 0.0 109.601 163.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 m -66.6 175.8 2.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.021 1.328 . . . . 0.0 110.936 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.749 -1.584 . . . . 0.0 110.628 166.237 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.45 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.724 2.009 . . . . 0.0 112.303 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -139.44 115.08 10.01 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.905 1.282 . . . . 0.0 108.36 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.71 -167.11 34.15 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 168.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m 110.65 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.846 3.659 . . . . 0.0 107.621 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 83.1 p -153.25 176.41 11.99 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.255 0.622 . . . . 0.0 111.165 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.58 76.83 1.14 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -154.29 133.2 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.36 21.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.072 0.549 . . . . 0.0 110.929 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.29 134.98 49.96 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.959 -1.088 . . . . 0.0 111.49 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -132.53 -58.53 0.93 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.569 2.347 . . . . 0.0 110.819 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.42 91.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.888 2.475 . . . . 0.0 113.186 -170.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -77.74 156.37 30.63 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 164.074 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.64 -53.05 0.31 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.528 1.531 . . . . 0.0 110.119 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.15 176.25 4.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.206 0.602 . . . . 0.0 111.802 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -67.44 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.498 -1.376 . . . . 0.0 109.085 152.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -51.77 41.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -161.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -25.72 66.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.175 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.95 65.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 121.566 1.985 . . . . 0.0 112.056 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.04 16.66 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 172.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.24 -50.31 73.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.289 0.636 . . . . 0.0 111.038 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.99 -47.88 88.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.314 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -55.58 26.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.297 1.408 . . . . 0.0 109.113 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.61 -28.05 66.85 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 127.288 2.235 . . . . 0.0 112.524 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.1 -45.93 17.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.828 1.251 . . . . 0.0 110.218 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -54.45 -48.69 71.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.284 1.834 . . . . 0.0 109.276 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.32 -40.24 67.6 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.183 1.393 . . . . 0.0 109.531 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -59.2 -54.39 47.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.782 1.233 . . . . 0.0 109.891 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -58.28 -38.24 76.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.361 0.665 . . . . 0.0 112.175 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -50.85 -57.2 9.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mmm -59.53 -39.06 82.7 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.4 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -53.36 -25.95 17.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.759 1.224 . . . . 0.0 112.054 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -96.28 -51.63 4.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.167 1.787 . . . . 0.0 111.504 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.75 -64.77 0.86 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.105 -0.997 . . . . 0.0 111.61 -172.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -134.32 81.68 48.96 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.06 -14.42 43.37 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.45 2.1 . . . . 0.0 111.999 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.94 -23.75 7.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.621 1.568 . . . . 0.0 112.087 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 60.9 mtp180 -106.21 13.97 28.19 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.896 1.278 . . . . 0.0 111.995 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.72 90.96 2.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.107 1.322 . . . . 0.0 110.728 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.64 138.75 31.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 109.25 -175.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 13.0 p90 -139.41 158.75 43.6 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.711 0.767 . . . . 0.0 111.308 171.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 134.76 1.33 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -172.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -44.33 -48.05 9.62 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 124.484 1.114 . . . . 0.0 110.84 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -60.7 -44.1 96.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.664 1.186 . . . . 0.0 111.365 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.83 -58.68 6.07 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 t -53.69 -38.8 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.699 0.8 . . . . 0.0 112.195 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.36 -36.94 74.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.749 1.159 . . . . 0.0 110.934 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -46.82 63.2 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.97 0.908 . . . . 0.0 109.557 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -63.59 -35.59 81.0 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -62.2 -44.51 96.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.47 -22.0 66.83 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.44 59.21 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.668 0.787 . . . . 0.0 111.375 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 28.0 mtt 52.06 44.52 29.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.362 1.465 . . . . 0.0 109.581 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -119.93 -9.95 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.246 2.219 . . . . 0.0 111.903 -170.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 49' ' ' ALA . 18.8 mt -80.08 105.95 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.22 -53.07 54.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.812 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 m -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.654 1.181 . . . . 0.0 108.292 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -109.77 137.87 46.96 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.386 1.874 . . . . 0.0 108.029 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.39 128.97 55.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.053 1.741 . . . . 0.0 107.725 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -144.95 143.47 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.402 1.001 . . . . 0.0 110.393 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.17 142.91 50.67 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.366 1.066 . . . . 0.0 109.724 170.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -56.5 -42.65 78.7 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.05 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.27 -20.81 7.74 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.6 -45.33 8.54 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.872 0.869 . . . . 0.0 109.202 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -51.32 -29.93 16.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.842 1.257 . . . . 0.0 112.276 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.91 31.35 5.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 110.841 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -51.68 148.01 5.94 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.666 0.666 . . . . 0.0 111.518 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -68.46 -31.29 70.48 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.413 1.485 . . . . 0.0 112.832 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.57 118.3 28.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.6 -30.63 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.34 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 -54.05 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.9 1.682 . . . . 0.0 109.891 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.4 m -58.2 -51.46 69.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.334 1.854 . . . . 0.0 110.756 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -58.26 -48.9 78.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.351 0.978 . . . . 0.0 110.242 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 m -55.14 -35.41 64.67 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.141 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -60.76 -51.82 67.71 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.46 1.027 . . . . 0.0 111.015 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -60.66 -51.45 69.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.181 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.0 m -63.83 -37.46 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.089 0.859 . . . . 0.0 110.971 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -57.82 -53.8 54.07 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.943 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.08 -48.21 82.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.315 1.009 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.54 -47.34 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.545 1.138 . . . . 0.0 110.526 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 5.3 m-20 -68.08 -43.22 79.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.653 -0.654 . . . . 0.0 110.555 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -72.85 -30.38 63.96 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.038 0.935 . . . . 0.0 110.324 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.29 -42.47 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.85 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 7.0 mtmp? -65.4 -39.24 91.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.898 0.772 . . . . 0.0 111.216 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.37 -25.61 66.87 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.933 -0.479 . . . . 0.0 111.561 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -100.71 44.1 1.03 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.45 5.04 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.447 3.099 . . . . 0.0 116.97 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.75 -174.47 48.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.486 1.517 . . . . 0.0 113.958 -171.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -130.79 149.33 52.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.802 2.441 . . . . 0.0 110.57 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.85 147.12 16.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.264 1.426 . . . . 0.0 108.826 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -147.21 126.59 13.13 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.849 2.06 . . . . 0.0 107.187 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -116.04 123.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.01 164.48 13.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.54 1.536 . . . . 0.0 108.331 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 136.75 42.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 162.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.8 t -51.61 -28.59 14.69 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.118 0.967 . . . . 0.0 111.47 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.18 -26.6 66.71 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 126.649 1.98 . . . . 0.0 113.613 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' A' ' 99' ' ' SER . 6.4 t-80 -84.03 158.85 21.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.669 0.788 . . . . 0.0 110.913 -165.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.44 -40.76 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 118.947 0.794 . . . . 0.0 109.321 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 97' ' ' HIS . 1.6 m -60.06 -23.32 63.67 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.863 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.69 -53.05 10.33 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.955 1.74 . . . . 0.0 110.97 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.19 -27.36 69.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.653 1.727 . . . . 0.0 112.071 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.55 -46.12 73.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.467 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.3 tp -63.26 -34.64 78.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.747 -0.596 . . . . 0.0 111.022 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -57.91 -38.42 75.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.923 1.689 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -55.42 -23.38 24.6 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.344 -0.847 . . . . 0.0 111.085 173.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.53 30.81 7.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.763 2.825 . . . . 0.0 110.238 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.2 p 66.41 19.76 10.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.096 1.358 . . . . 0.0 113.969 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.44 15.65 52.94 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.355 2.407 . . . . 0.0 114.533 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.01 124.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . . . -147.61 174.15 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.52 146.67 8.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.31 -0.869 . . . . 0.0 110.829 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.4 mt -83.83 152.45 3.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.603 HD13 HG23 ' A' ' 117' ' ' VAL . 42.1 mt -115.38 145.74 42.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.783 0.801 . . . . 0.0 109.781 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -64.5 -46.71 81.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.982 1.313 . . . . 0.0 109.906 165.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.3 p90 -138.14 152.85 72.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.428 1.491 . . . . 0.0 108.747 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 124.27 10.62 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.165 2.577 . . . . 0.0 109.105 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 113' ' ' LEU . 86.0 t -78.29 131.45 68.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.03 49.06 2.68 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.021 3.147 . . . . 0.0 111.764 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -152.88 89.3 1.38 Allowed 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -163.94 139.17 5.7 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.46 -35.45 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.656 2.237 . . . . 0.0 112.065 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 t -162.3 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.969 1.708 . . . . 0.0 108.507 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.9 m 68.08 -64.13 0.3 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.673 1.989 . . . . 0.0 111.113 -173.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 106.115 -2.794 . . . . 0.0 106.115 162.207 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m 64.55 -20.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.62 2.368 . . . . 0.0 115.975 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 47.93 65.22 1.36 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.392 2.277 . . . . 0.0 114.259 162.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.9 -162.43 46.71 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.7 m -165.74 -67.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.726 1.611 . . . . 0.0 108.869 167.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -159.67 159.64 33.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.367 2.667 . . . . 0.0 104.489 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.37 151.53 12.16 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.3 t -143.56 153.78 42.92 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.195 0.998 . . . . 0.0 108.94 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.71 156.52 9.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 127.204 2.202 . . . . 0.0 107.441 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.26 173.71 13.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.092 1.757 . . . . 0.0 109.251 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 m -156.85 106.22 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -156.89 0.59 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 154.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.3 mm? -51.72 112.76 0.82 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.343 0.974 . . . . 0.0 110.505 -172.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -107.08 140.63 39.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.09 154.12 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 160.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -53.22 -46.38 69.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.182 0.993 . . . . 0.0 110.945 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.29 -51.02 69.37 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.862 0.755 . . . . 0.0 109.364 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.3 74.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.459 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -56.62 17.24 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.646 1.112 . . . . 0.0 110.928 -172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.3 93.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -50.84 40.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.95 1.3 . . . . 0.0 109.003 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.0 -41.68 83.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 125.204 1.402 . . . . 0.0 109.949 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -59.0 -44.01 91.6 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 119.118 0.872 . . . . 0.0 109.205 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -60.72 -39.0 87.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.968 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.0 tp -64.16 -48.68 75.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.437 1.017 . . . . 0.0 110.571 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -53.28 -50.94 63.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.338 1.455 . . . . 0.0 109.099 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -66.36 -46.89 75.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.413 2.285 . . . . 0.0 109.416 -171.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -54.81 -56.21 21.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.476 1.51 . . . . 0.0 110.375 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.44 -30.68 70.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -50.76 -62.73 1.42 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.659 0.599 . . . . 0.0 109.486 169.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -62.67 -29.49 70.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.048 -0.977 . . . . 0.0 111.613 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.25 -29.58 58.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.102 1.319 . . . . 0.0 111.76 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -92.31 -50.06 5.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.971 0.908 . . . . 0.0 110.367 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -73.37 -48.11 36.76 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -168.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.81 81.1 8.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.803 1.241 . . . . 0.0 109.062 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.83 -12.07 33.6 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.992 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -20.04 10.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 111.604 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 113' ' ' LEU . 81.5 mtp180 -111.7 2.57 17.28 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.831 1.252 . . . . 0.0 113.106 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.06 88.48 2.91 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.583 1.083 . . . . 0.0 108.608 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.6 m-30 -93.78 134.33 36.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.555 0.742 . . . . 0.0 109.011 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -140.74 164.79 29.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.396 0.617 . . . . 0.0 112.619 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.35 126.14 0.51 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -168.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 tp -37.14 -50.04 0.92 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.202 2.201 . . . . 0.0 110.785 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.64 -51.89 52.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 128.671 2.788 . . . . 0.0 114.084 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.22 -50.4 68.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.601 1.191 . . . . 0.0 107.959 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.76 -31.95 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.333 1.053 . . . . 0.0 111.131 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.86 -19.66 65.06 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.933 1.293 . . . . 0.0 112.713 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.74 -42.4 34.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 119.519 -1.988 . . . . 0.0 109.458 165.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.47 71.07 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -60.47 -43.83 96.52 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 119.11 0.868 . . . . 0.0 108.869 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -66.3 -11.17 49.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.57 -5.43 45.91 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.445 1.498 . . . . 0.0 112.078 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 29.1 mmt 55.49 14.15 1.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.85 . . . . 0.0 113.092 -166.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -87.92 -9.64 53.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.87 -1.144 . . . . 0.0 112.909 -162.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.2 mt -72.54 110.6 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.33 -60.19 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.577 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.2 m -144.79 141.79 29.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.592 HD21 HG22 ' A' ' 80' ' ' VAL . 9.5 tp -110.06 133.98 52.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 107.773 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.34 119.49 35.87 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.6 1.56 . . . . 0.0 107.128 175.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 tt -138.85 141.2 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.02 144.47 55.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -59.54 -38.41 80.98 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.094 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -16.53 27.98 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.62 -40.42 9.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.94 1.245 . . . . 0.0 110.042 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.01 -19.19 17.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.72 0.808 . . . . 0.0 111.986 167.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -122.58 21.0 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.973 2.909 . . . . 0.0 111.372 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -56.73 151.96 13.17 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.571 0.749 . . . . 0.0 110.989 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -63.78 -47.18 81.98 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.179 0.591 . . . . 0.0 111.86 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.79 122.73 24.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.83 -32.09 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.684 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.82 -57.78 5.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.919 1.691 . . . . 0.0 110.494 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -53.04 -52.07 59.68 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.037 0.935 . . . . 0.0 109.532 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -57.01 -46.19 82.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.696 -0.628 . . . . 0.0 111.552 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 m -52.72 -42.56 64.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.859 0.754 . . . . 0.0 110.911 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -57.99 -52.6 64.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.918 0.887 . . . . 0.0 109.036 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -60.47 -53.14 61.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.272 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -61.22 -36.78 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.838 1.199 . . . . 0.0 110.758 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -53.15 34.09 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.34 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.05 -37.08 81.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.736 0.698 . . . . 0.0 111.482 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.592 HG22 HD21 ' A' ' 58' ' ' LEU . 25.0 t -53.75 -53.4 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 109.922 168.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -58.81 -47.39 84.94 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.872 1.269 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.8 m -63.0 -33.14 74.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.195 1.798 . . . . 0.0 112.014 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.13 -35.64 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 120.602 -1.311 . . . . 0.0 110.62 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.98 -34.51 77.91 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.47 0.577 . . . . 0.0 109.701 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.37 -34.75 78.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.713 0.688 . . . . 0.0 110.374 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -79.23 3.01 19.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.916 1.287 . . . . 0.0 112.101 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.59 24.53 10.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.381 2.272 . . . . 0.0 113.696 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.24 166.09 29.38 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.4 m -92.56 157.02 16.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.109 0.957 . . . . 0.0 111.126 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.08 147.72 17.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.968 1.707 . . . . 0.0 107.23 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -132.94 121.48 22.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.18 108.11 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HE2' HD13 ' A' ' 25' ' ' LEU . 3.6 m-30 -89.19 156.13 18.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.2 m -103.12 136.12 43.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 t -52.55 -39.5 61.53 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 124.7 1.25 . . . . 0.0 111.895 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.44 -23.58 63.7 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.849 -1.157 . . . . 0.0 113.481 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -85.81 148.98 25.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.182 0.993 . . . . 0.0 109.646 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.47 -17.55 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.922 -1.112 . . . . 0.0 111.697 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 p -57.16 -34.98 68.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.711 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.71 -44.4 57.04 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.31 -38.3 71.08 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.9 0.85 . . . . 0.0 110.916 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -76.8 -37.21 56.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.188 -0.945 . . . . 0.0 112.128 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.41 -32.04 73.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.563 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -56.11 -40.72 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.853 1.661 . . . . 0.0 111.287 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -58.24 -15.71 11.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 112.071 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.36 37.42 4.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 129.073 2.949 . . . . 0.0 108.901 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p 66.54 9.51 6.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.728 2.011 . . . . 0.0 114.72 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.26 15.7 65.93 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.119 2.295 . . . . 0.0 113.385 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.7 111.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.049 0.925 . . . . 0.0 108.708 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.66 174.12 10.93 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.638 1.575 . . . . 0.0 109.258 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.23 146.45 8.94 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.873 -1.142 . . . . 0.0 110.251 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.439 HG23 ' SD ' ' A' ' 31' ' ' MET . 80.6 mt -83.8 152.01 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.232 1.413 . . . . 0.0 107.916 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 117' ' ' VAL . 38.8 mt -117.16 138.45 51.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.996 0.919 . . . . 0.0 110.691 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -60.99 -42.08 97.74 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.035 1.334 . . . . 0.0 110.119 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.5 p90 -139.07 157.1 71.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 125.721 1.609 . . . . 0.0 107.941 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.0 125.07 12.56 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.83 2.354 . . . . 0.0 108.807 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 113' ' ' LEU . 63.2 t -78.45 129.09 75.74 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.53 87.29 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.46 2.107 . . . . 0.0 109.767 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 p -143.04 146.31 33.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 160.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.29 168.64 51.98 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.09 124.51 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.007 2.472 . . . . 0.0 108.664 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 t -153.22 89.89 1.39 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -153.91 92.47 1.55 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.426 -1.764 . . . . 0.0 110.316 -169.661 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.099 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -149.18 164.56 34.4 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -154.97 175.78 13.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.013 2.125 . . . . 0.0 106.663 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.68 89.43 1.9 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 t -149.07 -82.19 0.11 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m 47.55 46.16 17.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.334 1.054 . . . . 0.0 110.501 -170.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 165.7 33.31 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 m -153.52 139.59 18.31 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.41 142.5 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.26 85.05 1.45 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 p -136.64 94.77 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.71 1.204 . . . . 0.0 109.456 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.93 139.7 38.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 159.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 13' ' ' LEU . 1.5 pt? -162.61 142.71 9.56 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.707 1.603 . . . . 0.0 107.685 169.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 t -155.06 -58.44 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.315 1.046 . . . . 0.0 108.191 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.79 163.02 14.91 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -91.2 -73.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -51.25 19.09 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.862 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.01 80.81 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 123.809 0.693 . . . . 0.0 110.363 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.58 -24.5 67.58 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.98 -43.19 74.43 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.48 -51.44 60.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 127.415 2.286 . . . . 0.0 110.528 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.71 -50.42 80.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 119.094 0.861 . . . . 0.0 109.3 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -60.47 -41.93 95.2 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.86 -0.525 . . . . 0.0 110.906 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.42 -48.67 80.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.92 -44.85 94.06 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.136 -0.978 . . . . 0.0 110.184 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.49 -50.8 72.43 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.186 1.795 . . . . 0.0 109.866 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.04 -42.28 80.78 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.083 1.49 . . . . 0.0 108.455 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.42 -58.45 7.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.653 1.181 . . . . 0.0 109.496 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.63 -40.34 75.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.563 0.345 . . . . 0.0 111.626 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.93 -44.2 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.928 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -35.58 62.44 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 119.127 0.876 . . . . 0.0 109.334 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -54.06 -33.41 57.39 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.658 1.117 . . . . 0.0 112.168 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -70.63 -56.84 5.53 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.945 1.698 . . . . 0.0 110.695 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -94.38 -52.93 4.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.395 1.478 . . . . 0.0 113.409 -160.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -138.09 71.69 47.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.713 1.605 . . . . 0.0 107.521 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.35 -10.64 26.82 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 112.488 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.08 -24.04 16.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.334 2.254 . . . . 0.0 111.571 167.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HA ' HD12 ' A' ' 113' ' ' LEU . 82.4 mtp180 -104.46 10.96 35.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.443 1.097 . . . . 0.0 112.063 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.36 96.66 3.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.841 1.2 . . . . 0.0 108.512 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.3 m-30 -93.92 133.19 37.61 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.951 0.9 . . . . 0.0 108.893 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -139.78 160.56 39.6 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.41 133.98 0.52 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -167.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 tp -40.45 -52.89 2.72 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 126.258 1.823 . . . . 0.0 111.576 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -54.56 -46.0 73.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.621 1.568 . . . . 0.0 111.983 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.1 -59.85 4.46 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.69 -39.48 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.596 1.158 . . . . 0.0 112.332 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -54.68 -39.23 67.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.333 1.053 . . . . 0.0 111.505 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.94 -53.21 22.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.799 1.24 . . . . 0.0 110.539 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -55.93 -36.02 67.27 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -58.74 -47.29 85.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.66 -33.8 75.79 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.98 -9.24 57.6 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.164 0.586 . . . . 0.0 111.682 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 44.7 mtt 55.4 24.42 6.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 127.494 2.318 . . . . 0.0 111.839 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -84.86 -13.97 49.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.747 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 mt -66.39 106.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.568 1.147 . . . . 0.0 109.03 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.77 -57.05 4.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.5 m -134.99 131.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.81 132.08 54.47 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.834 2.054 . . . . 0.0 106.522 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 118.88 31.5 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 tt -136.23 139.95 44.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.668 1.122 . . . . 0.0 109.222 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.37 133.12 54.62 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -38.57 75.55 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.247 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.32 -20.48 28.95 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 113.948 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.22 -43.53 10.93 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -50.73 -31.41 16.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 112.157 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.09 46.96 2.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.178 2.191 . . . . 0.0 108.431 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.38 152.52 33.86 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.294 0.638 . . . . 0.0 110.393 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.21 -33.38 63.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.447 1.499 . . . . 0.0 112.874 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -83.61 119.73 25.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.684 1.129 . . . . 0.0 108.858 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -51.85 -44.38 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 117.829 -1.082 . . . . 0.0 112.787 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.02 69.37 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.857 1.662 . . . . 0.0 111.644 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.1 -46.11 82.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.23 1.012 . . . . 0.0 108.748 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -53.87 -50.02 67.22 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.345 0.975 . . . . 0.0 109.417 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 t -52.04 -44.07 64.06 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.11 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -57.65 -55.4 35.28 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.493 1.042 . . . . 0.0 109.349 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -56.45 -50.88 70.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.29 -36.9 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.369 0.986 . . . . 0.0 111.251 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -49.67 75.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.812 0.733 . . . . 0.0 109.044 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 tp -56.21 -51.13 69.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.891 0.877 . . . . 0.0 109.594 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.6 t -54.0 -47.63 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.588 0.755 . . . . 0.0 111.406 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.91 -54.39 22.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.29 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 -11.74 61.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.585 0.754 . . . . 0.0 112.089 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.83 -39.32 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 O-C-N 120.312 -1.493 . . . . 0.0 109.714 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -61.26 -47.78 84.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.036 1.289 . . . . 0.0 108.589 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -51.92 -47.94 64.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.46 1.104 . . . . 0.0 110.086 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -82.25 9.94 7.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.894 0.877 . . . . 0.0 112.264 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 87.91 4.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 130.221 3.408 . . . . 0.0 114.486 166.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.18 162.47 40.42 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.893 -1.129 . . . . 0.0 113.246 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.8 m -87.0 130.4 34.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.501 2.32 . . . . 0.0 109.128 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.04 145.46 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.469 171.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -131.89 132.79 43.93 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 127.163 2.185 . . . . 0.0 106.374 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -118.62 113.42 41.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -90.57 140.35 29.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.076 1.751 . . . . 0.0 109.73 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 m -87.47 130.5 34.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.467 0.707 . . . . 0.0 111.243 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -51.23 -42.01 60.7 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.724 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -70.32 -17.65 63.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.968 1.707 . . . . 0.0 113.511 -171.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -93.95 150.15 20.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.204 1.401 . . . . 0.0 110.093 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.89 -31.44 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -53.71 -23.01 10.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.408 0.683 . . . . 0.0 111.311 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 -53.06 5.87 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 118.243 -1.309 . . . . 0.0 112.377 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.74 -29.56 70.19 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.246 1.523 . . . . 0.0 110.69 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.4 -55.26 14.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.498 1.519 . . . . 0.0 110.14 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.29 -37.03 76.68 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 119.449 1.022 . . . . 0.0 110.914 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -58.1 -35.23 71.12 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 111.795 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -60.5 -25.56 66.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.544 -0.722 . . . . 0.0 111.741 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -102.71 20.03 18.06 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.675 2.39 . . . . 0.0 109.656 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.277 17.5 p 78.09 0.92 2.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.471 3.508 . . . . 0.0 113.71 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.88 22.15 62.02 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 127.056 2.265 . . . . 0.0 112.289 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.81 109.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.904 1.352 . . . . 0.0 108.016 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.15 176.36 9.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.513 1.525 . . . . 0.0 111.437 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.37 146.67 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.897 171.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.56 143.76 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 C-N-CA 126.319 1.848 . . . . 0.0 107.634 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.725 HD13 HG23 ' A' ' 117' ' ' VAL . 13.4 mt -117.23 129.32 55.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 124.298 0.999 . . . . 0.0 109.631 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -54.0 -41.14 67.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.49 1.516 . . . . 0.0 110.467 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.1 p90 -137.67 154.76 75.14 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.847 1.659 . . . . 0.0 107.788 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.54 106.6 1.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.044 3.163 . . . . 0.0 108.478 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.725 HG23 HD13 ' A' ' 113' ' ' LEU . 91.6 t -64.14 137.16 97.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.35 90.3 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.276 2.651 . . . . 0.0 109.751 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -133.26 162.14 32.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.179 1.392 . . . . 0.0 108.577 165.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.75 169.56 22.78 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 161.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.39 158.59 2.49 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.588 2.858 . . . . 0.0 110.511 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.67 161.81 41.81 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.153 -0.967 . . . . 0.0 109.528 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 t -72.41 -166.83 0.28 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.302 1.041 . . . . 0.0 109.808 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 O-C-N 120.223 -1.548 . . . . 0.0 109.298 165.892 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -134.01 172.82 12.3 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 111.838 -167.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -139.87 169.79 17.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.204 1.802 . . . . 0.0 108.705 171.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.64 91.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.555 1.55 . . . . 0.0 113.482 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -55.05 -50.86 68.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.908 0.854 . . . . 0.0 109.411 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p 47.45 65.46 1.26 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.88 1.672 . . . . 0.0 112.474 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.0 147.48 41.4 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.8 m -68.4 -34.86 76.78 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.261 -0.876 . . . . 0.0 112.121 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 t 40.72 68.18 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.765 2.026 . . . . 0.0 111.049 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.71 -73.16 0.51 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.65 0.78 . . . . 0.0 109.359 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -74.41 177.04 6.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.606 1.162 . . . . 0.0 111.674 -174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -71.62 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.012 -0.994 . . . . 0.0 112.382 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 144.88 28.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 121.044 1.747 . . . . 0.0 110.801 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 t -140.31 -56.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.448 0.699 . . . . 0.0 109.926 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.19 160.58 23.5 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.462 -0.774 . . . . 0.0 110.685 -163.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -61.06 -51.73 67.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.926 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -58.08 -53.24 60.49 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.45 98.73 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.325 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.11 -19.42 65.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.008 1.731 . . . . 0.0 112.761 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.83 -53.86 5.17 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 120.958 -1.088 . . . . 0.0 110.46 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.73 -51.71 66.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.943 0.897 . . . . 0.0 110.827 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.88 -48.63 78.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 126.192 1.797 . . . . 0.0 110.576 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -54.55 -48.94 71.43 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 119.56 1.073 . . . . 0.0 109.67 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -42.42 99.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.013 0.82 . . . . 0.0 111.813 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.33 -48.8 78.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.002 0.819 . . . . 0.0 110.716 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -61.47 -52.99 62.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.167 1.787 . . . . 0.0 109.342 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.2 -37.77 86.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.161 0.984 . . . . 0.0 108.886 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -58.94 -57.06 14.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.231 1.012 . . . . 0.0 110.341 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.89 -32.55 72.0 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.94 -59.25 3.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.16 -39.18 85.53 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.978 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.09 -20.27 51.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.857 0.753 . . . . 0.0 111.977 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -96.13 -53.36 3.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.532 1.133 . . . . 0.0 111.551 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -63.65 -66.36 0.55 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.521 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -145.11 80.83 10.9 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 109.616 -172.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.04 -6.52 8.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.228 2.619 . . . . 0.0 114.532 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.37 -25.07 33.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.091 0.86 . . . . 0.0 111.756 165.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HA ' HD12 ' A' ' 113' ' ' LEU . 31.0 mtm-85 -106.91 14.46 26.52 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.441 1.096 . . . . 0.0 112.015 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.56 92.71 3.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.305 0.957 . . . . 0.0 109.214 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.4 m-30 -93.75 132.78 37.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -139.9 163.48 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.497 0.719 . . . . 0.0 109.948 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 123.78 0.93 Allowed Glycine 0 C--N 1.331 0.269 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 -170.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.77 -46.8 2.75 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.726 1.611 . . . . 0.0 111.939 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.15 -55.57 26.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.765 2.826 . . . . 0.0 110.698 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.06 -57.42 13.16 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -50.92 -41.94 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.384 1.473 . . . . 0.0 111.835 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -56.8 -33.5 66.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.494 1.117 . . . . 0.0 111.488 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -77.3 -42.42 36.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 110.498 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -65.6 -32.21 73.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.243 -0.911 . . . . 0.0 112.126 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.09 -51.33 69.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.1 -31.23 70.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -9.22 58.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.875 0.87 . . . . 0.0 111.319 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.2 mmt 62.27 21.44 12.49 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 110.948 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -90.4 -16.21 29.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 112.343 -168.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 mt -70.63 113.71 7.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -80.08 -55.41 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -137.95 128.87 27.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 111' ' ' ALA . 9.8 tp -110.61 131.1 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.96 2.104 . . . . 0.0 108.757 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.16 124.65 52.01 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 108.077 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.05 144.15 27.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 119.785 1.175 . . . . 0.0 108.382 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.29 136.5 53.55 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.39 -35.61 63.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.861 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.71 -16.0 55.41 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.36 1.436 . . . . 0.0 114.287 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.43 -40.8 9.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.607 1.163 . . . . 0.0 109.811 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -52.17 -29.31 21.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.237 1.015 . . . . 0.0 112.55 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 51.07 1.92 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.081 2.552 . . . . 0.0 108.159 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -57.98 148.25 26.57 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.314 -0.866 . . . . 0.0 109.954 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.79 -39.09 87.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.86 117.2 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.587 1.155 . . . . 0.0 108.641 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.51 -33.09 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.267 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.03 60.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 120.782 1.628 . . . . 0.0 109.762 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -59.21 -48.52 81.31 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 111.105 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -52.82 -50.92 62.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.292 0.951 . . . . 0.0 109.873 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -51.71 -42.04 61.94 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -56.8 -55.77 30.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.036 1.289 . . . . 0.0 110.341 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -57.3 -55.04 39.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.147 0.904 . . . . 0.0 111.014 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 t -51.43 -54.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.9 1.28 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -64.52 -40.25 95.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 tp -67.65 -41.39 83.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.413 0.552 . . . . 0.0 111.621 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.44 -48.95 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.622 1.169 . . . . 0.0 108.925 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -42.36 98.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.1 0.96 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 m -66.37 -32.19 73.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.478 1.911 . . . . 0.0 111.956 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.15 -38.03 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 120.34 -1.475 . . . . 0.0 110.467 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -61.77 -44.5 96.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.961 0.801 . . . . 0.0 109.819 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -54.41 -38.03 65.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.229 1.012 . . . . 0.0 110.268 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -93.93 16.82 13.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.842 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 89.77 1.47 0.23 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 128.977 2.911 . . . . 0.0 114.277 168.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.76 152.57 22.52 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.732 1.151 . . . . 0.0 112.775 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -80.35 152.2 29.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.891 2.076 . . . . 0.0 108.491 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.75 139.51 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -130.63 121.67 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.06 108.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 147.85 23.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.188 1.395 . . . . 0.0 109.532 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.98 136.26 45.1 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 171.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.8 t -71.56 4.93 2.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.542 0.737 . . . . 0.0 111.795 167.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.8 mt -121.47 -0.8 9.71 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.614 1.965 . . . . 0.0 112.607 -168.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -106.3 159.56 16.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.333 2.253 . . . . 0.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 m -58.76 -27.46 64.98 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.277 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.87 -54.72 7.97 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-O 119.004 -0.886 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.96 -31.94 73.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.073 0.937 . . . . 0.0 111.721 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.08 -46.15 90.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.989 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.53 -37.89 87.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.318 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.4 m -57.62 -29.15 64.29 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.566 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -66.41 -17.23 64.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 112.856 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -122.59 48.34 1.78 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.797 2.439 . . . . 0.0 107.251 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.5 p 63.03 4.47 1.55 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.69 1.996 . . . . 0.0 114.665 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.27 65.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.144 2.307 . . . . 0.0 112.904 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.7 p -154.32 113.19 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 118.866 1.333 . . . . 0.0 109.668 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.88 176.61 9.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 112.015 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -164.08 147.47 9.63 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.179 -1.576 . . . . 0.0 111.231 174.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -85.72 141.46 14.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.524 1.53 . . . . 0.0 107.68 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' A' ' 40' ' ' PHE . 40.0 mt -108.47 138.7 44.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.832 0.853 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -52.04 -52.6 49.93 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.911 1.685 . . . . 0.0 109.752 168.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.2 p90 -136.02 159.34 71.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 127.448 2.299 . . . . 0.0 107.382 -170.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.81 142.27 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.631 1.554 . . . . 0.0 109.514 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 113' ' ' LEU . 69.1 t -89.4 136.89 29.38 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.95 65.54 8.28 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.451 2.768 . . . . 0.0 112.454 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.9 m -132.09 3.35 4.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.267 1.427 . . . . 0.0 112.255 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 65.13 163.09 0.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.205 1.383 . . . . 0.0 111.935 -172.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.02 -177.51 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.184 2.589 . . . . 0.0 112.207 -174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 m -75.91 157.12 33.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 157.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t -118.89 -25.16 6.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.262 1.425 . . . . 0.0 110.166 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 O-C-N 120.549 -1.345 . . . . 0.0 111.028 172.542 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -87.86 -169.4 2.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.32 1.448 . . . . 0.0 110.449 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t 47.3 -145.65 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.525 2.33 . . . . 0.0 112.886 161.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.61 163.58 12.14 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 158.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -137.29 -6.76 1.78 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.326 1.05 . . . . 0.0 113.418 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -89.58 142.46 27.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.367 1.439 . . . . 0.0 109.18 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.18 99.75 0.65 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.674 1.13 . . . . 0.0 110.659 -165.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -131.61 -0.9 3.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 111.96 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.85 -168.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 169.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 45.23 60.69 2.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.44 1.896 . . . . 0.0 111.926 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -135.32 95.25 3.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -129.94 -95.58 0.39 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 159.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.62 168.98 17.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 110.656 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 m -73.63 -70.35 0.38 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.787 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 46.76 77.32 0.09 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.948 1.699 . . . . 0.0 111.878 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -49.64 -42.9 46.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.736 1.614 . . . . 0.0 112.995 -168.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -66.13 -52.71 45.89 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.174 0.897 . . . . 0.0 110.135 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.77 79.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.965 0.348 . . . . 0.0 110.514 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.15 97.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.503 1.121 . . . . 0.0 112.466 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.49 63.63 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -50.76 54.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.26 1.424 . . . . 0.0 107.856 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.03 -51.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 110.39 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -60.32 -37.97 82.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.403 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.78 -35.48 74.93 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.219 0.918 . . . . 0.0 111.321 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tp -60.8 -49.07 78.96 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.056 0.844 . . . . 0.0 109.314 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -54.17 -56.81 14.64 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.52 1.128 . . . . 0.0 108.635 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -56.82 -43.46 81.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.084 0.865 . . . . 0.0 109.552 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.92 -54.55 40.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.835 0.854 . . . . 0.0 110.882 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.15 -35.73 77.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.795 0.725 . . . . 0.0 112.922 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -47.73 -59.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 108.206 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -62.23 -38.92 91.04 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.552 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.25 -29.28 57.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.044 1.293 . . . . 0.0 111.309 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -94.61 -47.08 6.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -69.39 -58.27 4.22 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.552 0.614 . . . . 0.0 111.658 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HE ' ' A' ' 38' ' ' ARG . 11.0 pt-20 -144.92 79.33 12.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 C-N-CA 124.315 1.046 . . . . 0.0 109.369 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.65 -10.49 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.289 1.993 . . . . 0.0 114.571 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.22 -21.02 61.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.3 1.409 . . . . 0.0 111.23 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HA ' HD12 ' A' ' 113' ' ' LEU . 24.2 mtm180 -102.97 12.33 36.21 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.824 1.193 . . . . 0.0 112.46 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.03 93.6 2.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.922 1.237 . . . . 0.0 109.064 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 3.1 m-30 -97.34 138.26 35.08 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.468 0.707 . . . . 0.0 109.934 -175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -140.3 159.08 42.98 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.31 131.69 0.81 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 tp -43.27 -50.51 6.52 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.999 1.72 . . . . 0.0 112.968 -166.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -52.78 -55.81 20.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.528 1.931 . . . . 0.0 109.952 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -56.84 -57.14 13.78 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 t -47.96 -46.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.975 1.71 . . . . 0.0 111.675 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.36 -43.43 75.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.757 1.162 . . . . 0.0 110.382 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -64.32 -40.51 96.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.067 -1.021 . . . . 0.0 110.349 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -67.6 -33.91 75.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.424 -0.797 . . . . 0.0 112.781 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -68.46 -42.57 78.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.49 -19.98 65.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.943 1.697 . . . . 0.0 113.118 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.58 -13.6 54.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.479 1.111 . . . . 0.0 111.897 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 57.36 24.86 10.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.469 1.908 . . . . 0.0 111.553 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.62 -15.06 31.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.438 -1.268 . . . . 0.0 111.891 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.07 107.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.505 1.048 . . . . 0.0 108.663 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.84 -48.45 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 172.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -143.78 134.31 24.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' VAL . 3.4 tp -110.15 133.95 52.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.863 2.065 . . . . 0.0 107.314 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 124.61 48.54 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.108 1.763 . . . . 0.0 108.175 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 tt -138.64 134.97 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -62.32 125.88 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.743 1.217 . . . . 0.0 107.88 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -57.12 -32.41 66.32 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.017 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -54.13 -25.85 24.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.117 1.326 . . . . 0.0 113.44 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 mt -86.59 -42.15 13.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.51 1.124 . . . . 0.0 109.603 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -52.1 -27.58 14.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.262 1.425 . . . . 0.0 112.481 170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 34.78 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 110.591 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -55.7 146.81 20.05 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.016 -0.428 . . . . 0.0 111.185 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.48 -25.21 64.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.37 120.67 31.69 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.61 -36.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.052 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -56.36 15.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.995 1.725 . . . . 0.0 109.888 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -53.68 -56.11 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.386 1.874 . . . . 0.0 110.232 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.09 -49.88 72.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.943 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -53.32 -41.82 66.07 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.94 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -57.39 -51.76 68.1 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.038 0.836 . . . . 0.0 110.383 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -60.79 -54.44 45.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.286 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.74 -31.79 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.581 1.082 . . . . 0.0 110.758 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -61.08 -58.21 9.32 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 109.075 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.371 1.068 . . . . 0.0 111.689 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 HD21 ' A' ' 58' ' ' LEU . 42.4 t -53.55 -46.22 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.13 . . . . 0.0 110.485 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.14 -37.87 69.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 0.0 111.46 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.2 t -67.01 -38.58 86.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.211 1.804 . . . . 0.0 110.859 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -55.38 -39.59 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 121.557 -0.715 . . . . 0.0 110.659 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.95 -39.3 87.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.794 0.724 . . . . 0.0 110.848 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.58 -28.55 69.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.686 0.794 . . . . 0.0 111.022 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -91.59 12.98 19.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.093 1.757 . . . . 0.0 110.732 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.11 26.4 15.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.471 . . . . 0.0 114.928 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.05 159.9 25.76 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.308 -0.87 . . . . 0.0 111.162 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -93.93 157.22 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.899 1.68 . . . . 0.0 110.184 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.54 148.37 25.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.1 0.96 . . . . 0.0 109.112 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.5 mmt-85 -141.83 121.68 13.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.37 112.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.12 124.57 34.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.1 m -74.02 139.9 45.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.771 0.26 . . . . 0.0 111.034 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 t -61.39 10.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.261 2.625 . . . . 0.0 115.065 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER -118.75 3.63 11.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.61 2.364 . . . . 0.0 113.665 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -114.28 139.41 49.44 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.331 1.452 . . . . 0.0 110.886 -169.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 p -56.2 -28.93 26.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.688 0.795 . . . . 0.0 110.841 172.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.1 m -64.64 -27.72 69.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.726 -0.609 . . . . 0.0 111.529 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.64 52.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.67 -26.89 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.567 0.684 . . . . 0.0 112.002 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.47 -41.37 47.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.303 1.441 . . . . 0.0 110.381 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.38 -26.91 68.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 0.0 112.427 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 t -41.24 -54.9 2.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.176 2.19 . . . . 0.0 110.843 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -61.53 -5.23 1.67 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.638 1.975 . . . . 0.0 113.784 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 mt -131.66 33.97 3.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.784 2.433 . . . . 0.0 109.323 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.8 p 64.37 12.08 6.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.293 1.837 . . . . 0.0 113.671 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.4 17.19 68.24 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.996 2.236 . . . . 0.0 114.182 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.05 115.08 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.919 1.86 . . . . 0.0 108.856 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.97 15.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.343 1.057 . . . . 0.0 111.432 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.71 144.61 13.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.258 -1.526 . . . . 0.0 110.547 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.7 mt -84.12 144.29 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.162 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.684 HD13 HG23 ' A' ' 117' ' ' VAL . 20.8 mt -114.23 146.03 40.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.609 0.764 . . . . 0.0 109.512 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -71.26 -42.84 68.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.685 1.194 . . . . 0.0 110.43 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -129.34 157.39 76.35 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.113 1.365 . . . . 0.0 108.069 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 107.11 1.78 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.824 2.349 . . . . 0.0 106.888 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 HD13 ' A' ' 113' ' ' LEU . 54.5 t -57.58 138.03 81.97 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 97.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.037 2.492 . . . . 0.0 109.563 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.91 -52.31 0.03 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.798 0.839 . . . . 0.0 110.791 166.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 150.69 167.94 15.03 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 127.241 2.353 . . . . 0.0 111.307 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.57 166.47 13.72 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.076 3.184 . . . . 0.0 111.262 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -149.62 102.66 3.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.9 m -129.99 177.71 7.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.568 1.947 . . . . 0.0 108.003 161.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 CA-C-O 117.473 -1.737 . . . . 0.0 108.859 178.033 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.0 p -62.44 -36.22 81.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.296 1.048 . . . . 0.0 112.294 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.6 m 51.5 -155.59 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.903 1.281 . . . . 0.0 111.579 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.8 -76.56 0.22 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 m 69.56 87.34 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 127.82 2.448 . . . . 0.0 109.877 -172.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.7 p -132.72 -160.23 1.03 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.148 1.779 . . . . 0.0 108.867 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.53 174.99 13.9 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.1 m -124.26 176.38 6.46 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.671 1.588 . . . . 0.0 107.031 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.88 53.42 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 123.064 1.412 . . . . 0.0 108.379 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.32 142.19 58.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.269 1.428 . . . . 0.0 111.05 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.1 p -143.02 156.02 44.76 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.006 0.923 . . . . 0.0 109.817 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -160.13 133.72 7.03 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 52.32 -167.89 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.542 0.737 . . . . 0.0 110.57 -172.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.8 t -148.05 -53.79 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.28 -166.34 0.22 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.29 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.1 m -91.8 -74.48 0.51 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 111.106 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -66.82 -44.07 82.11 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -171.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.37 -45.83 46.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.795 1.238 . . . . 0.0 111.111 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.25 -32.33 73.94 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.799 0.84 . . . . 0.0 113.227 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.85 77.21 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.19 -51.92 65.86 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.533 1.133 . . . . 0.0 109.519 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.61 -42.35 81.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 124.467 1.107 . . . . 0.0 110.962 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -59.32 -49.59 77.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.659 1.118 . . . . 0.0 109.211 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.5 76.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.236 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 29' ' ' TYR . 15.1 tp -60.86 -50.24 74.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 110.375 173.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -62.31 -33.33 74.45 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.447 1.099 . . . . 0.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -43.72 32.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.665 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.79 -58.03 10.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.279 1.432 . . . . 0.0 110.775 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' A' ' 25' ' ' LEU . 3.8 m-85 -54.55 -39.21 67.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.212 0.914 . . . . 0.0 112.294 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -45.44 -58.29 3.46 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.341 1.056 . . . . 0.0 108.939 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -67.21 -35.77 80.3 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 117.871 -1.062 . . . . 0.0 111.329 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.18 -29.63 46.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.772 1.624 . . . . 0.0 111.498 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.78 -51.15 5.22 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.923 . . . . 0.0 110.878 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -75.96 -33.07 59.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -171.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -168.26 76.76 0.85 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.931 1.693 . . . . 0.0 110.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.8 -10.77 26.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.483 2.122 . . . . 0.0 114.107 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.93 -19.67 61.01 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.888 -1.133 . . . . 0.0 111.43 168.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -98.45 4.68 48.4 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.342 0.974 . . . . 0.0 112.989 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -141.81 95.87 2.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.85 1.205 . . . . 0.0 109.67 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.1 141.39 28.47 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.019 1.328 . . . . 0.0 109.119 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -140.58 160.04 40.88 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.187 0.903 . . . . 0.0 113.07 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.66 131.49 2.66 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.7 tp -44.0 -45.94 8.09 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.688 1.595 . . . . 0.0 111.094 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -58.82 -45.76 89.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.049 1.339 . . . . 0.0 111.953 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -64.08 -59.05 4.93 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -49.64 -42.24 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.468 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -53.6 -40.64 65.85 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.46 1.104 . . . . 0.0 110.905 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.13 -48.08 25.45 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 126.1 1.76 . . . . 0.0 109.746 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.52 -36.15 63.94 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.563 -1.336 . . . . 0.0 112.533 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -68.23 -40.97 81.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.392 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.36 -29.53 69.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.242 1.017 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 -7.0 51.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 111.172 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.8 mmt 54.21 24.69 5.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.688 1.995 . . . . 0.0 111.131 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.5 23.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.615 1.166 . . . . 0.0 111.839 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.54 118.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -97.23 -30.31 13.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.57 0.544 . . . . 0.0 110.946 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 m -139.33 132.77 30.2 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tp -109.87 133.82 52.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.76 125.03 53.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.083 1.753 . . . . 0.0 106.404 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 76' ' ' TYR . 11.9 tt -140.83 148.14 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.7 t -67.92 144.26 55.31 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 1.9 p-10 -59.09 -32.04 69.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.405 165.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.77 -24.73 64.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.433 1.47 . . . . 0.0 113.401 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.45 -45.62 11.67 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.905 1.282 . . . . 0.0 108.941 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.75 -26.49 34.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.234 1.413 . . . . 0.0 114.234 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.35 23.33 9.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.698 1.599 . . . . 0.0 110.807 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -55.63 147.45 18.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.916 0.886 . . . . 0.0 111.193 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -61.25 -45.14 95.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.929 1.291 . . . . 0.0 113.419 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -76.46 113.54 14.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 t -57.53 -32.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 117.514 -1.231 . . . . 0.0 111.139 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 -56.41 10.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 121.043 1.747 . . . . 0.0 110.506 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.9 m -50.81 -57.02 9.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.192 1.397 . . . . 0.0 110.786 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.59 -52.38 59.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.956 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.5 m -54.97 -43.13 73.23 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 117.056 -1.45 . . . . 0.0 111.162 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -51.99 -54.13 33.41 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 121.682 2.037 . . . . 0.0 110.032 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 60' ' ' ILE . 37.3 m-85 -57.99 -49.81 75.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.994 0.517 . . . . 0.0 111.466 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.85 -51.65 69.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.91 1.684 . . . . 0.0 110.983 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -63.88 -40.07 95.67 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.29 -43.84 89.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.05 -44.65 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.334 1.053 . . . . 0.0 109.704 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.57 -44.35 71.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.117 0.967 . . . . 0.0 111.22 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -66.06 -34.92 79.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.155 1.782 . . . . 0.0 110.626 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 t -59.09 -40.56 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.632 1.106 . . . . 0.0 109.952 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -69.68 -40.89 76.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.317 0.962 . . . . 0.0 110.029 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.04 -38.42 70.54 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.2 16.95 5.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.44 2.296 . . . . 0.0 112.193 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.07 10.18 3.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.024 2.93 . . . . 0.0 115.032 168.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.3 158.69 31.63 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.946 -1.096 . . . . 0.0 112.856 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.9 m -81.22 154.26 26.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.315 1.846 . . . . 0.0 109.655 172.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.68 145.55 25.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.037 0.935 . . . . 0.0 108.499 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -136.29 121.67 19.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 mm -112.78 107.74 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.67 155.19 19.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.637 1.175 . . . . 0.0 107.858 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -95.14 129.7 42.15 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -44.33 -46.5 9.31 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.875 1.27 . . . . 0.0 111.062 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -63.58 -17.41 62.81 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.488 1.515 . . . . 0.0 114.735 -173.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -75.93 155.35 35.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 108.759 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.93 -26.94 21.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.98 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -74.83 -18.03 60.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.563 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.93 -49.1 50.47 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 123.106 2.685 . . . . 0.0 107.865 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.57 -33.92 76.67 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.6 -45.22 91.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.2 tp -63.89 -34.32 77.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.814 0.846 . . . . 0.0 110.907 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 m -56.48 -33.59 66.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.401 1.081 . . . . 0.0 113.602 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -60.51 -20.48 60.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.056 -1.028 . . . . 0.0 111.288 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.8 mt -117.72 25.6 10.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 129.313 3.045 . . . . 0.0 108.8 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 p 70.5 11.43 7.34 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.832 2.453 . . . . 0.0 113.807 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.49 76.55 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.955 2.217 . . . . 0.0 113.242 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.33 122.89 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.115 1.457 . . . . 0.0 110.409 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.98 173.97 13.68 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 110.989 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.93 145.97 14.13 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.648 -1.283 . . . . 0.0 111.375 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.53 143.92 10.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.383 1.873 . . . . 0.0 107.615 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.739 HD13 HG23 ' A' ' 117' ' ' VAL . 22.8 mt -117.53 143.44 46.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 110.793 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -62.13 -32.47 73.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.321 1.848 . . . . 0.0 111.716 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.41 161.85 28.46 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 127.26 2.224 . . . . 0.0 107.414 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 107.95 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.274 2.65 . . . . 0.0 109.205 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.739 HG23 HD13 ' A' ' 113' ' ' LEU . 71.4 t -59.93 127.48 85.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.75 87.81 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.439 2.76 . . . . 0.0 110.103 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 m -147.48 170.23 17.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.092 2.557 . . . . 0.0 107.504 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.96 119.18 5.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 163.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.47 162.26 39.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.161 1.907 . . . . 0.0 109.205 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t -161.37 122.03 2.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.0 m -64.86 168.25 6.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 152.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 157.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p -148.2 155.96 42.0 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.301 1.05 . . . . 0.0 110.49 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 m -137.91 177.36 7.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.753 1.621 . . . . 0.0 110.156 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.43 -177.79 15.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.489 2.471 . . . . 0.0 107.26 166.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m 38.05 78.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.506 1.923 . . . . 0.0 115.615 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 p -139.75 159.49 42.05 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.695 -0.628 . . . . 0.0 110.183 159.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 35.58 51.38 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.4 p -86.3 -154.67 0.22 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.673 1.189 . . . . 0.0 109.225 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -44.7 121.2 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.938 1.695 . . . . 0.0 110.551 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 84.18 6.38 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.72 0.808 . . . . 0.0 109.897 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.64 174.68 10.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.864 1.666 . . . . 0.0 107.857 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -149.32 -65.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 109.347 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' C ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.46 149.36 23.95 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.258 1.823 . . . . 0.0 109.299 172.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 m -141.74 -9.48 0.93 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.843 0.857 . . . . 0.0 112.726 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -163.12 168.87 20.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.551 1.941 . . . . 0.0 106.557 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.9 m -68.38 -59.31 3.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.779 1.232 . . . . 0.0 111.007 169.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -64.54 -51.76 61.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.8 -43.98 66.3 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 111.55 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.47 -21.67 63.69 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.11 -44.43 54.16 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.53 -43.83 97.84 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.298 0.639 . . . . 0.0 110.353 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.6 t -58.17 -51.92 65.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 118.117 -0.945 . . . . 0.0 109.366 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -39.22 84.74 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.881 1.219 . . . . 0.0 110.024 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -56.94 -55.89 28.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.46 0.704 . . . . 0.0 110.916 170.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.08 -41.74 79.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.539 1.063 . . . . 0.0 111.673 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.23 -50.09 75.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 126.533 1.933 . . . . 0.0 109.173 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.0 -39.82 87.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.07 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.95 -57.22 12.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.324 1.85 . . . . 0.0 110.24 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -55.78 -38.62 70.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.343 0.657 . . . . 0.0 112.428 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -44.65 -60.18 2.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.226 0.61 . . . . 0.0 110.099 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.448 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.73 -34.68 78.89 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.656 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.67 -30.2 54.83 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.035 1.289 . . . . 0.0 111.519 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -85.63 -65.39 1.02 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.41 0.684 . . . . 0.0 110.34 167.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.52 -38.64 84.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -161.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.99 77.87 3.93 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 30.6 Cg_endo -66.59 -5.76 13.74 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.794 1.663 . . . . 0.0 113.299 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -60.19 -19.47 54.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.616 -1.302 . . . . 0.0 111.094 166.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.3 mtm180 -107.95 9.7 28.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.207 1.403 . . . . 0.0 112.603 172.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -133.97 92.24 2.93 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 120.198 1.363 . . . . 0.0 108.774 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.5 m-30 -94.0 137.77 32.84 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.67 160.26 40.29 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 139.11 1.13 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -39.58 -52.45 2.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.53 1.932 . . . . 0.0 112.026 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -59.64 -44.55 93.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.643 1.977 . . . . 0.0 111.748 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -64.4 -57.26 9.8 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -46.44 -42.6 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.262 1.425 . . . . 0.0 111.686 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -53.44 -43.64 68.22 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.301 0.955 . . . . 0.0 111.391 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.73 -42.21 74.28 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.565 1.146 . . . . 0.0 110.292 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.59 -41.0 96.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -66.11 -36.69 83.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.15 0.281 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.35 -38.4 77.15 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.123 -0.986 . . . . 0.0 111.632 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -3.59 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.299 1.44 . . . . 0.0 111.512 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.7 mmt 63.4 4.39 1.7 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 113.08 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.24 48.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -158.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.9 mt -74.25 110.18 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -168.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.71 -54.23 17.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.405 HG23 ' HE ' ' A' ' 91' ' ' ARG . 28.2 m -146.35 136.32 23.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.455 1.502 . . . . 0.0 107.653 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.8 tp -110.0 142.36 41.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.468 1.907 . . . . 0.0 107.666 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.446 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -128.1 119.52 25.51 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.455 HD11 ' CD1' ' A' ' 76' ' ' TYR . 14.7 tt -139.72 149.77 22.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 120.135 1.334 . . . . 0.0 108.051 175.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 3.9 t -66.51 144.06 56.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -60.33 -36.46 78.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.357 166.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 6.5 pt-20 -56.04 -31.66 63.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.741 1.61 . . . . 0.0 113.65 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 mt -81.71 -42.08 20.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 109.41 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -52.73 -24.99 9.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 113.997 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.55 27.09 6.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.657 1.583 . . . . 0.0 110.819 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -53.52 142.99 20.79 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.716 0.769 . . . . 0.0 111.62 -172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -58.78 -39.82 82.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.366 2.267 . . . . 0.0 113.144 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -85.9 114.9 23.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 t -39.6 -41.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.743 1.617 . . . . 0.0 111.491 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -35.11 62.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.803 1.183 . . . . 0.0 114.065 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -74.36 -45.82 44.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -52.77 -50.9 62.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.3 p -53.17 -46.38 68.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.472 0.709 . . . . 0.0 110.292 -168.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -53.64 -55.58 24.66 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.496 1.918 . . . . 0.0 109.909 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.455 ' CD1' HD11 ' A' ' 60' ' ' ILE . 32.4 m-85 -59.19 -59.37 5.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.621 177.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.53 -36.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.825 1.648 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -57.37 11.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.134 1.374 . . . . 0.0 109.286 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -62.27 -36.78 83.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.297 0.639 . . . . 0.0 111.829 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 t -60.24 -50.48 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.319 1.448 . . . . 0.0 109.012 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.26 -36.72 80.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.504 0.721 . . . . 0.0 110.214 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 t -65.45 -35.0 79.61 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.26 1.424 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.71 -35.53 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 119.422 1.01 . . . . 0.0 110.188 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -69.16 -33.88 74.1 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.38 -25.39 67.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.0 110.914 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -99.09 11.86 37.76 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 127.185 2.194 . . . . 0.0 111.508 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.51 33.37 23.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.398 1.479 . . . . 0.0 113.212 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.75 153.46 20.92 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.204 0.911 . . . . 0.0 111.057 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -74.99 151.12 38.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.031 0.932 . . . . 0.0 108.955 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -121.16 142.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.92 1.288 . . . . 0.0 107.6 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.405 ' HE ' HG23 ' A' ' 57' ' ' THR . 22.7 mmt180 -133.16 120.88 21.78 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.6 mm -94.49 125.21 47.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.42 166.57 13.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.102 0.864 . . . . 0.0 108.788 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.03 110.08 21.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 166.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 t -43.71 -34.3 1.47 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.851 1.26 . . . . 0.0 112.16 173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -65.83 -36.14 82.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.862 2.465 . . . . 0.0 113.748 -176.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -72.78 160.3 32.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.133 1.773 . . . . 0.0 111.236 -172.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -36.65 48.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.702 -0.624 . . . . 0.0 110.171 172.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -66.66 -16.73 64.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.483 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.14 10.39 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 171.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.11 -36.96 63.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.949 0.9 . . . . 0.0 110.273 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.04 -63.73 1.2 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.662 169.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.69 -34.15 64.79 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.319 1.418 . . . . 0.0 111.662 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.0 66.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.077 1.351 . . . . 0.0 112.476 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.45 -28.6 68.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 111.055 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.9 mt -104.48 31.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.418 2.287 . . . . 0.0 109.371 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p 69.05 -0.37 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.273 2.229 . . . . 0.0 114.049 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.33 58.88 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.961 2.696 . . . . 0.0 112.538 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.17 118.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.843 1.322 . . . . 0.0 110.306 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.44 9.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.404 1.481 . . . . 0.0 112.567 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -160.16 149.45 17.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 110.772 171.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.13 144.82 9.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.671 1.988 . . . . 0.0 107.029 167.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.714 HD13 HG23 ' A' ' 117' ' ' VAL . 19.4 mt -117.29 136.41 53.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -60.25 -39.0 85.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.979 0.912 . . . . 0.0 110.802 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.31 157.81 75.88 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 128.448 2.699 . . . . 0.0 107.101 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.5 124.69 13.22 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.961 1.774 . . . . 0.0 107.805 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.714 HG23 HD13 ' A' ' 113' ' ' LEU . 65.0 t -75.31 122.02 86.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.19 142.69 81.22 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.46 1.44 . . . . 0.0 109.349 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.6 p -163.57 168.99 19.32 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.09 165.81 24.31 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 162.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.42 166.61 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.663 2.909 . . . . 0.0 113.27 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.0 m -141.07 50.4 1.63 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.7 2.0 . . . . 0.0 109.628 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 t -128.63 -87.09 0.55 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 104.864 -3.294 . . . . 0.0 104.864 162.074 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -163.31 -49.34 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.315 1.046 . . . . 0.0 108.584 162.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t -143.89 -177.06 5.24 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.284 1.034 . . . . 0.0 109.326 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.07 179.17 18.11 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 125.993 1.759 . . . . 0.0 111.038 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -128.69 175.88 8.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 108.595 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -177.5 -172.42 0.37 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.183 2.993 . . . . 0.0 104.71 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.48 166.65 19.32 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 171.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -142.89 162.62 34.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.23 1.812 . . . . 0.0 106.655 -176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.0 t -131.94 91.07 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.37 166.12 23.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.167 1.787 . . . . 0.0 109.375 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -163.05 -172.18 2.94 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 107.281 163.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -156.4 168.95 25.75 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.682 1.593 . . . . 0.0 108.112 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.2 tp -149.98 134.55 17.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.782 0.833 . . . . 0.0 108.94 173.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.58 131.1 9.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 29.4 t70 58.87 -177.96 0.08 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 112.45 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -92.55 -53.18 4.3 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.112 -2.243 . . . . 0.0 111.48 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -69.11 -51.3 39.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -56.55 -43.24 79.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.465 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.59 65.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.285 1.034 . . . . 0.0 113.441 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.2 -34.54 54.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.05 -50.5 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.562 0.681 . . . . 0.0 109.783 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.07 -53.54 41.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 125.828 1.651 . . . . 0.0 109.726 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -59.42 -36.29 75.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.425 1.011 . . . . 0.0 110.326 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -63.47 -44.39 94.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.368 0.985 . . . . 0.0 110.995 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.48 -44.82 89.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.035 1.288 . . . . 0.0 110.82 173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -60.6 -47.62 85.38 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.526 1.53 . . . . 0.0 110.289 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -73.3 -35.99 66.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.875 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.61 -59.58 5.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.824 1.65 . . . . 0.0 110.791 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 -37.73 66.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -51.56 -53.1 41.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.703 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.424 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -65.79 -34.08 77.34 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 118.152 -0.928 . . . . 0.0 111.533 174.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.59 -33.65 64.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.976 1.262 . . . . 0.0 110.514 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -76.78 -62.45 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -75.56 -34.56 60.71 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -160.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -157.91 81.48 3.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.987 1.715 . . . . 0.0 109.763 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 -14.03 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.684 2.256 . . . . 0.0 113.916 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.74 -15.28 39.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.657 -1.277 . . . . 0.0 111.871 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -107.52 8.9 29.59 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.957 0.903 . . . . 0.0 112.488 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -139.29 86.74 2.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.789 1.177 . . . . 0.0 108.837 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.8 m-30 -93.19 144.9 24.84 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -172.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.54 164.94 28.81 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.42 134.95 0.57 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 tp -43.05 -47.29 5.88 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.857 1.663 . . . . 0.0 111.806 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -55.72 -43.33 76.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 112.189 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -55.65 13.03 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.72 -42.11 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 111.711 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.26 -24.79 68.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.377 1.471 . . . . 0.0 111.492 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -72.4 -70.31 0.35 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 116.005 -1.95 . . . . 0.0 107.104 161.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.28 -31.19 8.48 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 122.92 2.6 . . . . 0.0 116.135 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.06 -49.21 32.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.416 1.486 . . . . 0.0 112.209 167.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -48.0 -42.15 27.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 128.323 2.649 . . . . 0.0 110.176 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.07 -0.44 57.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.666 1.186 . . . . 0.0 111.116 -169.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 mmt 54.0 31.69 14.05 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.559 1.543 . . . . 0.0 110.425 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.81 -7.81 36.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.094 -166.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -83.08 114.81 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 119.679 1.127 . . . . 0.0 108.043 -166.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.37 -54.79 6.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.337 1.455 . . . . 0.0 108.478 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.6 m -146.52 138.14 24.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.339 1.455 . . . . 0.0 107.336 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.69 139.57 44.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 106.95 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -122.87 124.17 42.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.048 1.739 . . . . 0.0 106.555 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.7 tt -137.52 142.13 37.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.18 131.06 45.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -53.8 -33.85 57.32 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 117.564 -1.208 . . . . 0.0 111.522 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.84 -37.72 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.944 1.702 . . . . 0.0 112.873 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.48 -42.75 67.72 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.92 0.867 . . . . 0.0 109.752 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.69 -12.14 15.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.057 0.943 . . . . 0.0 112.572 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -123.44 19.96 9.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.898 2.479 . . . . 0.0 111.497 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -61.12 152.93 27.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.353 1.073 . . . . 0.0 111.949 -168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -77.57 -33.76 53.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.903 2.481 . . . . 0.0 112.399 -172.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 50.4 t0 -80.14 120.0 23.68 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.95 -29.98 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.605 0.639 . . . . 0.0 110.455 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.7 -56.05 18.67 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 119.863 -1.773 . . . . 0.0 111.513 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 54.9 m -56.21 -57.44 12.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.938 1.295 . . . . 0.0 108.826 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -54.25 -49.2 70.08 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.412 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.5 m -53.94 -41.17 67.46 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.079 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -57.42 -48.94 77.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.987 1.267 . . . . 0.0 109.812 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -61.91 -56.12 22.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.048 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.85 -36.6 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.532 1.06 . . . . 0.0 110.161 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -57.74 -59.9 4.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.65 0.78 . . . . 0.0 109.486 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 tp -56.07 -44.17 78.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 111.46 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -53.15 -52.16 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.777 1.231 . . . . 0.0 109.991 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -32.73 63.33 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.16 -0.962 . . . . 0.0 112.303 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -62.23 -37.87 87.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.432 1.493 . . . . 0.0 110.985 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.55 -33.34 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.11 0.868 . . . . 0.0 110.008 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -70.48 -29.69 66.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.246 1.385 . . . . 0.0 112.222 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.06 -47.97 75.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -74.69 17.27 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.64 1.976 . . . . 0.0 112.44 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.89 56.46 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.145 2.578 . . . . 0.0 112.369 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.97 155.19 18.49 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.882 1.706 . . . . 0.0 109.822 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.1 m -75.99 148.81 37.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.452 -1.028 . . . . 0.0 110.078 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.0 129.72 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 109.016 169.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -119.64 121.53 39.48 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.42 120.25 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -88.42 162.49 16.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -104.27 113.28 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 117.374 -1.298 . . . . 0.0 107.674 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 t -56.11 -30.0 61.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.662 1.119 . . . . 0.0 112.476 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.06 -38.88 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.025 1.73 . . . . 0.0 111.251 -178.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -75.32 142.02 43.29 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 126.792 2.037 . . . . 0.0 110.655 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.04 -18.34 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.25 1.02 . . . . 0.0 113.331 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.0 m -61.7 -26.46 68.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.501 1.046 . . . . 0.0 111.165 172.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.16 -55.5 29.12 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -56.78 -36.11 69.48 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.06 0.93 . . . . 0.0 112.797 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -67.26 -45.64 76.04 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.576 -0.702 . . . . 0.0 110.184 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.6 tp -61.92 -37.09 83.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.942 176.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.7 m -62.32 -28.54 69.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.563 1.074 . . . . 0.0 112.431 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -69.88 3.89 2.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.086 0.954 . . . . 0.0 112.904 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.8 mt -136.52 33.27 2.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.055 2.942 . . . . 0.0 107.645 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.263 3.2 p 59.74 11.15 2.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.312 2.645 . . . . 0.0 114.845 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.96 17.86 80.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 128.054 2.74 . . . . 0.0 113.03 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.37 120.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 119.706 1.753 . . . . 0.0 108.949 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.47 175.35 10.63 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.933 0.893 . . . . 0.0 109.566 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.85 146.71 11.26 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.614 -1.304 . . . . 0.0 109.454 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.56 139.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 117' ' ' VAL . 30.9 mt -106.07 141.27 37.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -50.02 -61.21 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.943 2.097 . . . . 0.0 108.752 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -130.62 159.46 70.88 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 127.49 2.316 . . . . 0.0 109.278 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 106.68 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.855 2.37 . . . . 0.0 109.577 -176.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 113' ' ' LEU . 96.7 t -59.01 136.54 87.74 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 170.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.41 112.73 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.563 2.175 . . . . 0.0 108.532 169.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.69 -52.01 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.47 157.77 7.29 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.22 -24.34 32.26 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.027 1.818 . . . . 0.0 111.134 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 m 44.3 63.09 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.427 1.891 . . . . 0.0 111.05 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.4 m -53.23 148.09 9.04 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.512 1.525 . . . . 0.0 113.551 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.818 0 CA-C-O 117.907 -1.496 . . . . 0.0 111.566 -168.03 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.966 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 m -140.63 -13.15 0.99 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t 48.5 -129.89 1.81 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.95 1.25 . . . . 0.0 111.131 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.93 -151.03 45.21 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.802 1.668 . . . . 0.0 113.476 171.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t 95.46 20.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.671 2.788 . . . . 0.0 113.063 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -127.14 76.44 1.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.035 1.288 . . . . 0.0 110.6 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.97 175.32 42.0 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -103.94 160.39 14.86 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.324 1.05 . . . . 0.0 109.899 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.19 84.62 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.245 1.818 . . . . 0.0 106.228 165.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.89 156.0 26.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.742 0.817 . . . . 0.0 109.94 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.0 t -172.89 114.93 0.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -141.22 172.59 12.47 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.695 1.598 . . . . 0.0 109.151 171.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.89 -75.61 0.56 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.313 1.845 . . . . 0.0 108.244 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.9 t 72.34 -54.82 0.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.191 2.196 . . . . 0.0 110.775 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -150.17 156.25 41.27 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.818 1.247 . . . . 0.0 109.523 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -54.93 -56.06 23.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.988 1.715 . . . . 0.0 112.421 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -67.13 -48.44 68.07 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.61 -44.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.398 0.679 . . . . 0.0 111.427 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.19 83.06 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.134 1.373 . . . . 0.0 112.84 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.31 -40.22 98.72 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -45.19 78.39 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.39 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.6 t -54.92 -42.13 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.642 0.777 . . . . 0.0 109.481 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -51.19 70.99 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -57.98 -40.35 80.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.737 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.82 -48.37 79.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.739 1.154 . . . . 0.0 110.907 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.28 -53.4 54.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.557 1.543 . . . . 0.0 109.306 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -66.42 -37.8 86.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.264 1.826 . . . . 0.0 109.169 -171.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -65.1 -56.09 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 111.19 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.88 -37.47 74.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.951 0.796 . . . . 0.0 112.235 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.91 -55.24 12.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.719 0.808 . . . . 0.0 109.731 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -64.11 -34.88 79.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.836 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.11 -17.59 27.87 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.158 0.89 . . . . 0.0 111.86 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -96.55 -57.81 2.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 110.622 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -70.43 -44.48 67.79 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -165.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.33 77.93 6.56 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 119.229 0.922 . . . . 0.0 110.094 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -65.07 -8.76 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.268 1.979 . . . . 0.0 114.208 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.27 -17.86 32.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.91 1.232 . . . . 0.0 111.279 164.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.5 mtm180 -108.42 11.26 27.11 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.311 1.444 . . . . 0.0 112.784 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.55 89.83 2.64 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.876 1.216 . . . . 0.0 108.934 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.619 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -93.81 140.19 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.743 0.817 . . . . 0.0 108.834 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -139.79 158.53 43.95 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.778 0.431 . . . . 0.0 111.214 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 131.72 0.79 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.0 tp -41.21 -49.75 3.58 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.054 2.141 . . . . 0.0 111.456 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.489 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.39 -56.76 15.42 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.526 1.931 . . . . 0.0 110.638 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -59.21 -51.06 71.62 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.16 -42.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.984 1.313 . . . . 0.0 111.962 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -61.06 -30.02 70.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 120.254 1.388 . . . . 0.0 111.261 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -75.0 -45.76 39.74 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 120.098 -1.626 . . . . 0.0 110.579 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -62.46 -30.67 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.77 -1.206 . . . . 0.0 111.94 177.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.45 -52.2 66.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.221 1.409 . . . . 0.0 109.062 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.37 -37.21 72.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.972 0.805 . . . . 0.0 111.65 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.48 -5.01 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.706 0.802 . . . . 0.0 111.282 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.2 mmt 53.97 26.25 6.17 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.195 1.798 . . . . 0.0 111.854 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.11 -11.15 36.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.886 -164.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.584 HG23 ' HB1' ' A' ' 111' ' ' ALA . 64.3 mt -79.39 118.19 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -84.28 -50.09 8.17 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 167.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.3 m -131.99 131.63 42.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 tp -110.15 130.81 55.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.234 1.814 . . . . 0.0 107.579 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.56 131.7 54.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.194 1.797 . . . . 0.0 106.468 177.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.49 146.62 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.39 0.541 . . . . 0.0 109.751 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.16 134.16 51.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 166.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -52.0 -36.6 50.42 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.144 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.61 -33.1 59.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.935 1.243 . . . . 0.0 113.242 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.94 -39.99 20.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.901 0.773 . . . . 0.0 109.347 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -57.57 -16.99 11.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.142 0.977 . . . . 0.0 112.555 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 39.83 3.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.721 2.008 . . . . 0.0 109.241 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -58.5 152.8 17.3 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.625 -0.672 . . . . 0.0 109.535 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -67.73 -55.0 14.8 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.105 1.362 . . . . 0.0 111.725 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -63.6 120.1 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.55 -42.09 80.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.558 1.143 . . . . 0.0 111.521 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.38 -34.3 61.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.95 0.795 . . . . 0.0 111.694 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.0 m -70.92 -45.65 63.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.234 175.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -51.64 -53.47 38.34 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.502 1.046 . . . . 0.0 109.075 167.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.3 t -52.1 -40.44 61.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.98 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -58.8 -57.35 13.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 120.206 1.367 . . . . 0.0 109.725 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -54.18 -50.37 67.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.527 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.37 -38.0 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 118.363 0.528 . . . . 0.0 111.045 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -58.93 -50.75 72.87 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.91 -42.73 97.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.957 0.903 . . . . 0.0 111.226 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -49.89 -52.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.547 1.139 . . . . 0.0 109.571 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 23.7 t70 -65.52 -43.12 91.03 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.436 0.694 . . . . 0.0 111.243 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -37.44 79.01 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.871 1.668 . . . . 0.0 111.769 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.82 -33.89 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.629 1.104 . . . . 0.0 110.115 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 5.7 mtmp? -75.57 -33.35 60.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.853 1.206 . . . . 0.0 111.402 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -56.56 -43.44 79.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -77.53 21.78 0.26 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.482 1.913 . . . . 0.0 111.721 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.73 9.05 0.53 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.794 3.238 . . . . 0.0 115.834 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.48 176.04 52.51 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.79 1.216 . . . . 0.0 112.209 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -108.05 149.36 28.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.173 2.189 . . . . 0.0 109.493 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.9 146.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.269 1.428 . . . . 0.0 107.407 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -139.28 121.75 16.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.32 115.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.19 173.74 7.99 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.365 1.466 . . . . 0.0 108.398 -175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -103.8 132.72 49.79 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -43.21 31.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.343 1.457 . . . . 0.0 111.907 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.653 HD22 ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -71.05 -20.39 62.38 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.096 2.158 . . . . 0.0 112.953 -174.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.61 158.11 34.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.097 -1.002 . . . . 0.0 109.38 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 p -57.58 -37.87 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 m -64.52 -24.15 67.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.279 1.032 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.59 -41.96 28.11 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.67 -41.64 81.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.18 0.99 . . . . 0.0 109.584 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -68.91 -43.74 74.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.544 0.737 . . . . 0.0 111.643 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.48 -31.45 72.67 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.311 0.505 . . . . 0.0 110.172 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.03 -39.59 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.66 1.184 . . . . 0.0 112.637 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -56.54 -14.74 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.594 1.158 . . . . 0.0 112.111 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.1 mt -128.29 33.86 4.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.182 2.993 . . . . 0.0 108.757 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 65.58 10.6 6.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.761 1.624 . . . . 0.0 114.119 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.43 15.11 70.13 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.432 1.968 . . . . 0.0 115.118 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.38 129.65 9.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 119.229 1.515 . . . . 0.0 109.157 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.35 175.91 13.39 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 109.396 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -157.36 145.07 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.53 -0.731 . . . . 0.0 110.526 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 77.0 mt -83.82 135.35 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 117' ' ' VAL . 29.2 mt -105.02 141.23 36.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp-105 -56.54 -56.31 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.708 1.603 . . . . 0.0 109.138 171.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -124.71 157.14 66.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 125.959 1.704 . . . . 0.0 108.493 -172.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.49 115.2 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.359 2.04 . . . . 0.0 107.269 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.743 HG23 HD13 ' A' ' 113' ' ' LEU . 93.6 t -68.99 119.89 72.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.18 111.2 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -56.49 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.762 0.825 . . . . 0.0 110.035 -171.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.64 141.35 7.31 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.265 1.888 . . . . 0.0 110.292 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.34 -23.83 27.69 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.997 3.131 . . . . 0.0 113.632 -166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.0 m 48.8 65.81 1.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.73 1.612 . . . . 0.0 113.915 163.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.0 t -63.12 -10.16 13.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.414 2.286 . . . . 0.0 114.432 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 116.597 -2.224 . . . . 0.0 109.459 178.097 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m -136.93 165.47 25.91 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.538 1.535 . . . . 0.0 107.333 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -150.88 -83.88 0.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.45 10.96 71.41 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.778 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 p -67.19 87.93 0.17 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.989 2.115 . . . . 0.0 110.479 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.0 p -144.26 -167.73 2.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.889 0.876 . . . . 0.0 110.671 -171.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.63 -174.53 20.99 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -140.79 151.93 44.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.64 42.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.1 1.36 . . . . 0.0 108.573 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.08 159.85 5.41 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.648 1.179 . . . . 0.0 110.462 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.2 t -143.82 162.14 36.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.681 0.753 . . . . 0.0 109.82 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -143.05 168.02 20.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.237 2.215 . . . . 0.0 106.608 165.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.45 -166.53 2.44 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.187 0.595 . . . . 0.0 109.598 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.3 m 53.8 -142.69 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.335 1.854 . . . . 0.0 109.851 -159.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -40.02 103.35 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.004 2.522 . . . . 0.0 112.126 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -59.14 -33.41 70.86 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.512 1.125 . . . . 0.0 112.233 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -71.15 -52.39 19.52 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.925 0.784 . . . . 0.0 111.212 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -42.03 92.8 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.204 0.456 . . . . 0.0 109.9 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -9.77 34.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.171 1.388 . . . . 0.0 112.88 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.3 -42.68 4.22 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 120.153 1.342 . . . . 0.0 110.988 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.36 -57.37 12.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.59 1.556 . . . . 0.0 108.804 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.98 -50.53 19.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 125.685 1.594 . . . . 0.0 110.407 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -58.15 -50.47 73.4 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.265 0.939 . . . . 0.0 109.58 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.63 75.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.667 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.0 -49.84 64.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.571 1.532 . . . . 0.0 110.451 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.7 -49.12 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.583 1.553 . . . . 0.0 109.178 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -69.48 -34.59 74.55 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.237 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -62.25 -58.54 7.35 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 127.049 2.14 . . . . 0.0 109.647 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -54.43 -39.63 67.54 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.361 0.664 . . . . 0.0 112.248 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -49.9 -48.59 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.475 0.31 . . . . 0.0 111.211 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.2 mtp -71.45 -35.91 71.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.964 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -55.71 -26.97 47.93 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.447 1.021 . . . . 0.0 111.476 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -92.94 -36.39 12.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.73 1.612 . . . . 0.0 112.861 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -86.03 -64.05 1.22 Allowed 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.295 1.038 . . . . 0.0 112.0 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -142.6 80.93 13.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.711 1.604 . . . . 0.0 107.513 -170.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.6 -13.1 38.55 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.769 2.313 . . . . 0.0 112.552 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.8 -20.15 14.01 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 111.892 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HA ' HD12 ' A' ' 113' ' ' LEU . 20.2 mtm180 -103.27 1.83 33.43 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 124.354 1.062 . . . . 0.0 113.543 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.41 90.69 2.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 120.058 1.299 . . . . 0.0 109.915 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.37 140.43 29.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.052 0.941 . . . . 0.0 108.966 -173.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -139.95 160.16 40.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 76.32 143.45 1.39 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -174.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.5 tp -46.64 -49.89 18.46 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.326 1.45 . . . . 0.0 112.356 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -46.41 90.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.682 0.793 . . . . 0.0 109.72 -175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.5 -56.43 18.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 42' ' ' GLY . 10.9 t -50.53 -43.3 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.904 1.282 . . . . 0.0 111.975 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.39 -40.81 68.56 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.577 1.08 . . . . 0.0 110.645 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.19 -46.48 33.78 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.505 1.522 . . . . 0.0 109.838 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.71 -37.54 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.995 -1.065 . . . . 0.0 111.941 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -66.73 -44.34 81.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.391 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.0 -34.63 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.789 1.177 . . . . 0.0 111.758 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.7 -7.15 36.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.978 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mmt 51.29 39.53 24.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.846 2.459 . . . . 0.0 109.362 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -112.0 -10.5 13.93 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.386 1.074 . . . . 0.0 112.923 -164.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.35 111.13 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.49 -59.27 3.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.2 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.458 HG21 ' HE ' ' A' ' 91' ' ' ARG . 53.4 m -146.07 134.73 22.22 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.69 140.96 41.36 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 126.712 2.005 . . . . 0.0 107.201 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.45 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.41 129.79 56.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.978 2.111 . . . . 0.0 106.468 176.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.28 131.6 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -63.58 129.97 42.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.73 -33.94 36.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.235 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.32 -22.06 62.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.35 1.432 . . . . 0.0 112.871 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.02 -40.49 11.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.241 1.016 . . . . 0.0 109.191 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -54.23 -21.06 8.09 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 20.05 7.3 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.934 1.243 . . . . 0.0 112.062 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -49.8 145.07 5.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.154 1.382 . . . . 0.0 112.908 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -46.65 89.45 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.05 110.33 5.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.69 -36.47 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.851 -172.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.78 65.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.02 1.282 . . . . 0.0 112.575 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.14 -48.72 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.289 1.036 . . . . 0.0 108.506 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 -55.02 -49.95 70.25 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.394 0.678 . . . . 0.0 109.994 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.2 p -54.61 -43.75 72.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.44 0.696 . . . . 0.0 110.276 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -54.72 -57.34 11.87 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.061 1.344 . . . . 0.0 108.772 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -55.7 -53.19 59.63 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.7 -38.53 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 118.91 0.777 . . . . 0.0 110.281 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -57.57 -52.35 65.76 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.545 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.73 -43.74 98.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.431 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -52.47 -50.43 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.501 1.121 . . . . 0.0 109.758 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.23 96.74 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.146 0.578 . . . . 0.0 109.961 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.8 m -64.7 -30.6 71.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.992 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.66 -44.77 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.138 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -64.01 -34.26 77.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.292 0.951 . . . . 0.0 110.419 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.35 -35.73 81.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.568 0.622 . . . . 0.0 110.454 174.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -91.51 24.29 3.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.9 1.68 . . . . 0.0 111.394 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 28.91 12.84 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.094 1.758 . . . . 0.0 113.861 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.85 145.52 17.82 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 170.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 m -78.06 154.98 30.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.266 1.026 . . . . 0.0 109.017 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.96 149.29 17.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.924 1.29 . . . . 0.0 107.561 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HE ' HG21 ' A' ' 57' ' ' THR . 21.4 mmt180 -137.46 121.31 17.58 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 mm -90.66 119.4 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 m-85 -89.91 125.12 35.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -62.93 109.63 1.52 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 166.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -56.74 -27.41 59.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.455 1.502 . . . . 0.0 112.836 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -67.03 -32.13 73.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.852 2.461 . . . . 0.0 111.758 -178.047 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -71.56 158.5 36.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.626 1.97 . . . . 0.0 110.632 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -19.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.071 -1.018 . . . . 0.0 111.536 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -72.87 -23.32 60.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.177 -1.577 . . . . 0.0 111.003 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.33 -43.05 26.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.637 1.108 . . . . 0.0 110.436 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -52.2 -47.83 65.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.355 1.078 . . . . 0.0 109.876 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.63 -42.26 91.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.167 0.587 . . . . 0.0 111.245 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.12 -33.74 75.04 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 119.018 0.826 . . . . 0.0 111.392 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 m -59.59 -36.54 76.45 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.224 1.409 . . . . 0.0 111.68 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -58.19 -20.65 42.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.711 0.804 . . . . 0.0 112.167 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.48 21.86 15.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.706 2.402 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 p 74.16 -1.68 3.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.551 2.74 . . . . 0.0 113.893 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.42 62.36 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 127.238 2.352 . . . . 0.0 113.462 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.79 133.14 26.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.903 1.852 . . . . 0.0 108.88 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.63 177.35 10.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 110.684 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.83 149.49 16.46 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.797 -1.19 . . . . 0.0 109.738 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 ' SD ' ' A' ' 31' ' ' MET . 81.0 mt -83.46 142.87 12.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.643 HD13 HG23 ' A' ' 117' ' ' VAL . 23.3 mt -108.97 146.14 34.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 109.202 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -59.04 -44.28 91.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.968 169.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 5.0 p90 -142.88 161.71 47.48 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.391 1.476 . . . . 0.0 109.344 -169.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.09 114.04 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 HD13 ' A' ' 113' ' ' LEU . 88.5 t -69.12 124.22 89.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.19 24.66 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.394 3.396 . . . . 0.0 113.635 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.0 t -149.83 121.23 7.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -166.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.41 178.61 43.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.6 11.04 3.05 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.671 4.247 . . . . 0.0 114.795 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.69 147.72 8.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.411 1.005 . . . . 0.0 110.117 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.0 p -143.94 99.02 3.32 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.853 0.861 . . . . 0.0 109.911 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.305 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.837 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.46 173.01 3.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.42 1.11 . . . . 0.0 111.352 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 t -150.47 -167.02 2.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.506 2.323 . . . . 0.0 106.544 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.38 81.65 0.16 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.21 102.36 2.45 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 172.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -156.24 112.88 3.11 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.56 155.48 26.7 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.4 m -147.64 127.62 13.62 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.6 94.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.07 140.39 28.04 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.034 0.934 . . . . 0.0 109.38 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 m -163.44 -178.04 5.64 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.221 3.008 . . . . 0.0 105.914 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 60.0 179.82 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 0.0 111.565 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.22 165.56 27.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.98 167.57 23.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.76 0.791 . . . . 0.0 109.68 160.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.1 160.64 23.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.351 1.06 . . . . 0.0 110.249 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 t -53.76 -44.85 70.34 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.111 0.564 . . . . 0.0 111.41 -168.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -70.94 -53.08 16.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.99 95.76 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.918 1.287 . . . . 0.0 112.015 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -18.59 65.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.766 0.827 . . . . 0.0 111.382 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.44 51.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -60.66 -50.72 72.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.594 1.158 . . . . 0.0 110.717 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.77 -50.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.213 1.005 . . . . 0.0 110.392 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -53.53 -49.31 67.88 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.057 0.543 . . . . 0.0 110.862 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -62.36 -42.05 99.1 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.297 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.67 -45.28 92.53 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.37 1.441 . . . . 0.0 109.71 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.162 0.985 . . . . 0.0 111.399 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.12 -45.88 46.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.26 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.56 -58.38 6.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.908 1.283 . . . . 0.0 110.267 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.49 -37.8 88.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.864 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -55.97 12.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 ttp -68.64 -30.24 68.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.862 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.25 -44.72 92.36 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 120.473 1.488 . . . . 0.0 111.386 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -65.22 -24.17 67.27 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.744 1.618 . . . . 0.0 111.901 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -117.96 -41.59 2.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -162.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -155.7 83.71 3.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.332 1.853 . . . . 0.0 108.995 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.91 -7.57 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.92 2.413 . . . . 0.0 113.605 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.53 -21.44 52.38 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.889 -1.132 . . . . 0.0 111.579 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.6 mtp180 -103.4 9.23 37.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.006 1.276 . . . . 0.0 112.707 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.15 92.74 2.82 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.411 1.084 . . . . 0.0 109.427 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -93.23 145.59 24.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.06 1.344 . . . . 0.0 107.658 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -140.78 163.56 32.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 77.25 139.43 1.12 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -43.27 -51.0 6.43 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.176 2.19 . . . . 0.0 112.201 -172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -52.82 18.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.011 2.124 . . . . 0.0 111.526 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.5 -53.14 25.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 42' ' ' GLY . 3.9 t -50.5 -44.54 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.876 1.27 . . . . 0.0 111.061 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -53.25 -38.43 63.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.634 1.173 . . . . 0.0 111.65 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -78.63 -43.35 26.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 126.051 1.741 . . . . 0.0 110.632 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -65.81 -30.69 71.36 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 118.497 -1.281 . . . . 0.0 110.629 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.29 -36.69 82.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.473 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -52.52 -35.33 53.09 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.057 0.943 . . . . 0.0 111.503 168.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.54 59.35 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.352 1.461 . . . . 0.0 112.538 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.8 mmt 56.07 39.1 30.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.645 0.778 . . . . 0.0 110.905 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.97 -7.14 14.57 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.116 0.966 . . . . 0.0 112.198 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -78.44 105.19 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.07 -54.89 6.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 123.699 0.624 . . . . 0.0 109.754 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -135.83 124.65 23.99 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -171.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.8 tp -109.07 132.37 54.18 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 107.788 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.59 119.5 35.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.782 1.633 . . . . 0.0 107.66 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.42 141.24 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 137.16 57.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -59.2 -37.66 77.97 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.84 -30.89 62.17 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.686 1.195 . . . . 0.0 112.77 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -82.87 -42.08 18.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.613 1.097 . . . . 0.0 109.618 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -56.74 -18.85 14.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.389 0.675 . . . . 0.0 112.597 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 23.9 9.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.775 2.83 . . . . 0.0 109.881 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -56.45 140.38 46.06 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.689 0.677 . . . . 0.0 110.0 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -59.65 -35.84 75.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.484 1.114 . . . . 0.0 112.638 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -79.68 125.14 29.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 108.61 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.69 -38.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 116.846 -1.55 . . . . 0.0 111.167 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.74 -52.07 41.84 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.921 2.146 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -56.88 -52.42 65.21 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.409 1.884 . . . . 0.0 108.262 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -52.25 -46.48 65.8 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.726 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 p -53.8 -44.16 69.92 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.926 0.89 . . . . 0.0 110.364 -173.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -57.66 -55.48 34.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.273 1.429 . . . . 0.0 108.689 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -57.57 -51.41 69.6 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.587 -1.196 . . . . 0.0 112.629 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.2 -37.63 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.765 1.166 . . . . 0.0 110.937 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.9 mtt-85 -60.17 -51.06 71.19 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.073 0.949 . . . . 0.0 110.238 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.67 -42.83 95.11 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 122.893 0.477 . . . . 0.0 111.221 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.68 -48.55 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.02 0.928 . . . . 0.0 109.986 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.29 -49.13 78.81 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.251 1.02 . . . . 0.0 110.666 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -71.82 -23.54 61.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.683 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.72 -41.67 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 120.058 1.299 . . . . 0.0 108.465 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -65.14 -38.21 89.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.804 1.184 . . . . 0.0 110.327 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.18 -32.67 64.56 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.531 0.605 . . . . 0.0 110.82 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -98.87 24.26 7.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.436 2.294 . . . . 0.0 111.04 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 61.6 19.4 10.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.834 2.054 . . . . 0.0 114.185 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.46 146.71 19.1 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 122.277 0.932 . . . . 0.0 110.792 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.57 149.58 48.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.202 2.201 . . . . 0.0 109.534 170.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.0 t -117.33 150.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.14 1.376 . . . . 0.0 108.861 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -138.54 138.05 37.62 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.679 1.992 . . . . 0.0 106.648 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.72 104.26 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 -170.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.4 m-85 -90.02 124.88 35.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -70.09 128.48 36.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -60.71 10.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.828 2.451 . . . . 0.0 116.148 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.8 mt -129.22 -18.9 3.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.952 2.101 . . . . 0.0 111.393 -175.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -69.67 157.54 37.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.164 1.385 . . . . 0.0 110.532 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.76 -39.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.478 0.581 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 m -63.83 -32.3 73.77 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.198 -0.938 . . . . 0.0 110.489 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -65.93 -50.41 52.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.942 1.258 . . . . 0.0 110.333 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.04 -26.75 65.13 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.298 1.049 . . . . 0.0 112.028 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.62 -46.24 89.16 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.12 -0.988 . . . . 0.0 108.84 170.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.1 tp -60.61 -25.74 66.48 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.488 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t -50.69 -44.08 57.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.572 . . . . 0.0 111.826 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.15 0.56 0.91 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.435 1.094 . . . . 0.0 113.398 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.65 32.75 3.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.742 2.417 . . . . 0.0 108.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p 65.32 -3.45 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.787 2.435 . . . . 0.0 114.174 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.35 18.6 64.08 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.522 2.487 . . . . 0.0 112.884 -170.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.43 129.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 119.638 1.719 . . . . 0.0 110.804 167.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.66 173.49 13.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.456 1.102 . . . . 0.0 109.782 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.09 15.87 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.8 -1.187 . . . . 0.0 110.424 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -98.33 140.5 18.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 126.578 1.951 . . . . 0.0 108.048 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 117' ' ' VAL . 34.6 mt -107.43 145.39 33.06 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.429 0.691 . . . . 0.0 111.266 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -66.25 -39.81 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.928 1.291 . . . . 0.0 110.787 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.55 155.08 57.03 Favored Pre-proline 0 N--CA 1.453 -0.286 0 C-N-CA 123.748 0.819 . . . . 0.0 109.464 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.32 146.4 62.77 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.661 2.24 . . . . 0.0 109.601 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 113' ' ' LEU . 58.8 t -108.46 132.22 21.26 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.887 1.675 . . . . 0.0 106.741 -170.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.36 102.71 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.974 2.449 . . . . 0.0 109.186 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 t -170.6 -175.8 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.923 1.689 . . . . 0.0 108.162 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.63 164.43 18.09 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 161.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.87 175.39 6.45 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.565 2.843 . . . . 0.0 110.548 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -126.4 123.98 39.14 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.9 t 51.33 -103.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.096 1.358 . . . . 0.0 108.275 -157.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.97 0 CA-C-O 116.963 -2.021 . . . . 0.0 110.744 -178.152 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 p -160.34 148.7 16.72 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.02 0.928 . . . . 0.0 108.887 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -97.93 170.32 9.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.451 1.1 . . . . 0.0 109.758 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.49 -96.1 0.1 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 151.21 41.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.15 1.38 . . . . 0.0 110.287 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.2 m 62.09 -175.05 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.078 0.951 . . . . 0.0 112.87 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.65 -88.49 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 O-C-N 121.14 -0.975 . . . . 0.0 112.25 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -70.17 138.33 51.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.583 0.691 . . . . 0.0 109.856 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.36 99.37 9.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.7 62.24 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 t 51.23 -169.82 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.521 1.928 . . . . 0.0 111.651 -166.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -151.23 166.84 29.67 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 127.102 2.161 . . . . 0.0 106.902 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -145.77 154.35 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 159.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 m -151.19 -61.47 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.1 -1.0 . . . . 0.0 109.498 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.7 149.28 43.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -60.91 -44.21 97.5 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.17 0.896 . . . . 0.0 111.172 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -71.76 -49.16 41.51 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.629 0.649 . . . . 0.0 109.748 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -25.82 68.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.892 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.17 63.41 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 119.616 1.098 . . . . 0.0 111.491 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.98 -53.0 43.75 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 170.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.21 -58.98 5.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.047 0.939 . . . . 0.0 110.71 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.51 -41.61 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 117.417 -1.278 . . . . 0.0 111.606 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -55.03 -48.35 73.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.802 1.637 . . . . 0.0 109.235 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.61 88.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.892 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.27 -46.9 88.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.064 1.302 . . . . 0.0 110.086 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -56.52 -53.94 51.66 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.75 1.22 . . . . 0.0 109.054 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -66.52 -41.7 88.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.156 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.36 -57.73 10.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.302 1.041 . . . . 0.0 110.933 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.59 -41.25 89.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.166 0.439 . . . . 0.0 111.772 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -50.74 -51.97 45.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 tpp -61.03 -41.04 95.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.714 0.806 . . . . 0.0 111.731 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.44 -29.51 61.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.064 1.746 . . . . 0.0 111.469 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -80.59 -59.37 2.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.993 1.317 . . . . 0.0 108.94 173.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -71.02 -51.64 24.23 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -166.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.13 78.67 9.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.883 1.273 . . . . 0.0 108.305 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.57 -9.19 12.72 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.823 2.349 . . . . 0.0 114.137 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.62 -16.75 51.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 0.0 111.142 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 113' ' ' LEU . 83.0 mtp180 -107.82 9.15 28.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 112.179 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.76 89.57 2.96 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.788 1.235 . . . . 0.0 107.947 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -94.11 133.36 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.028 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -140.25 161.29 38.03 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.32 137.91 0.46 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -168.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 tp -37.16 -53.9 1.02 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.741 2.016 . . . . 0.0 112.862 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -59.56 -49.4 77.9 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.703 1.201 . . . . 0.0 110.943 -174.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -56.24 -58.67 6.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 t -48.93 -45.27 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.474 1.109 . . . . 0.0 112.317 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -58.24 -40.62 82.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.113 1.324 . . . . 0.0 111.205 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -37.85 85.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.63 1.172 . . . . 0.0 109.695 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.25 -35.26 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.17 -38.74 92.36 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.11 -3.6 7.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.745 1.618 . . . . 0.0 114.745 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.61 -5.73 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 112.041 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 mmt 63.26 4.59 1.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.078 2.151 . . . . 0.0 112.596 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -77.68 -10.15 59.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.033 -164.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.96 115.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.28 -65.17 1.04 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 m -125.83 132.64 52.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.91 132.84 53.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.265 1.826 . . . . 0.0 107.127 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 120.95 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.707 1.603 . . . . 0.0 106.961 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.54 145.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -65.02 142.32 58.46 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.718 0.807 . . . . 0.0 109.58 175.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.97 -42.34 89.7 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.6 pt-20 -52.09 -33.34 39.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.99 -43.29 30.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.912 0.778 . . . . 0.0 110.124 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.25 -23.75 16.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.65 1.18 . . . . 0.0 113.624 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.16 27.27 5.66 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.722 1.609 . . . . 0.0 111.29 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -54.43 149.22 10.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.33 1.452 . . . . 0.0 112.687 -174.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -58.58 -26.39 63.57 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.768 2.027 . . . . 0.0 114.51 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -105.21 114.4 28.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -53.13 -39.25 32.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.234 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -34.87 61.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.065 1.302 . . . . 0.0 111.974 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 m -65.95 -53.49 38.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -52.43 -50.51 62.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.41 ' HA ' HG22 ' A' ' 77' ' ' VAL . 24.3 p -56.85 -36.8 70.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.481 0.582 . . . . 0.0 111.523 -174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.74 -53.73 53.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.92 0.782 . . . . 0.0 109.73 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -59.03 -53.76 54.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.05 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 74' ' ' SER . 7.9 m -63.55 -35.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.528 1.058 . . . . 0.0 110.451 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -61.67 -56.07 23.68 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -54.72 -41.31 70.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.82 -50.93 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.993 0.917 . . . . 0.0 110.695 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.37 -46.16 67.61 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.626 0.77 . . . . 0.0 110.022 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.4 m -66.29 -23.8 66.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.395 1.478 . . . . 0.0 112.323 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.95 -38.38 82.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.917 0.78 . . . . 0.0 110.071 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.54 -43.47 89.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.909 0.777 . . . . 0.0 109.493 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.32 -44.41 95.49 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.529 0.518 . . . . 0.0 110.073 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -70.91 6.42 1.55 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 112.231 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.83 54.89 0.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 130.479 3.512 . . . . 0.0 113.093 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.89 163.43 17.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.522 1.058 . . . . 0.0 113.871 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -82.2 146.31 29.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.465 2.306 . . . . 0.0 109.571 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.14 144.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.443 1.497 . . . . 0.0 107.923 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -133.38 121.61 22.56 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.96 110.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.94 124.77 35.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 m -70.04 116.87 10.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -58.61 -17.03 18.7 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.78 -41.52 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.497 1.119 . . . . 0.0 112.181 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.77 153.42 41.86 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 109.591 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.55 -26.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.556 -0.715 . . . . 0.0 111.629 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 p -58.31 -27.51 64.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.221 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.22 -53.0 19.9 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 124.176 0.893 . . . . 0.0 111.034 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -38.93 74.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.653 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.47 -58.31 9.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.219 1.408 . . . . 0.0 109.661 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -56.37 -29.06 60.94 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.61 0.641 . . . . 0.0 111.402 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.02 -36.5 65.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.591 1.557 . . . . 0.0 112.593 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.53 -32.53 68.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.141 0.976 . . . . 0.0 110.705 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -99.79 21.86 11.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.204 2.201 . . . . 0.0 109.692 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p 68.99 9.39 7.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.664 2.386 . . . . 0.0 114.257 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.35 18.97 78.81 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.204 1.859 . . . . 0.0 113.504 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.13 122.02 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.992 1.396 . . . . 0.0 108.977 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.7 170.06 19.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 110.043 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.9 153.68 39.41 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.619 -0.676 . . . . 0.0 110.777 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.9 mt -84.11 141.76 14.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.664 1.585 . . . . 0.0 107.327 168.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 117' ' ' VAL . 26.2 mt -109.36 145.08 36.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.161 0.981 . . . . 0.0 110.167 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -65.68 -38.63 89.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.018 1.327 . . . . 0.0 111.223 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.4 p90 -143.55 157.57 58.78 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 127.309 2.244 . . . . 0.0 106.76 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.13 128.0 15.09 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.883 1.722 . . . . 0.0 108.384 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.737 HG23 HD13 ' A' ' 113' ' ' LEU . 72.6 t -80.5 119.58 76.73 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 60.19 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.297 3.332 . . . . 0.0 112.087 -169.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.0 m -127.54 -18.48 4.38 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.024 2.13 . . . . 0.0 111.043 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.49 -178.57 31.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.681 0.657 . . . . 0.0 112.444 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.09 160.68 48.45 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.119 2.546 . . . . 0.0 108.809 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -81.99 -16.39 50.48 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.12 -0.988 . . . . 0.0 112.284 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.09 173.62 4.29 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.274 1.43 . . . . 0.0 108.39 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 105.904 -2.878 . . . . 0.0 105.904 165.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 m -149.38 -12.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.14 -0.933 . . . . 0.0 113.457 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p 51.56 -177.63 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.261 1.424 . . . . 0.0 111.783 -162.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.2 -177.17 30.96 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 121.082 -1.011 . . . . 0.0 113.19 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m 52.35 164.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.08 2.152 . . . . 0.0 113.662 -162.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -170.83 -174.25 1.52 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.447 2.699 . . . . 0.0 105.792 157.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.36 108.59 0.56 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -162.63 86.27 0.57 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.415 1.102 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.89 170.29 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.582 -1.324 . . . . 0.0 108.864 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.17 168.03 20.77 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.728 1.611 . . . . 0.0 107.972 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m -153.34 93.63 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.804 -1.185 . . . . 0.0 109.306 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 75.1 158.06 0.2 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 129.488 3.115 . . . . 0.0 111.081 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.99 150.08 33.34 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.468 1.507 . . . . 0.0 108.833 156.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -150.21 -66.12 0.2 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -55.91 136.44 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.859 1.264 . . . . 0.0 109.278 165.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 m -93.63 -47.55 6.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.859 1.263 . . . . 0.0 112.229 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -63.58 -52.04 62.72 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.336 -0.853 . . . . 0.0 108.954 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.84 94.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.716 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.24 87.39 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.218 0.917 . . . . 0.0 112.353 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.41 61.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 119.292 0.951 . . . . 0.0 111.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -67.12 -44.32 80.2 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.5 -1.0 . . . . 0.0 109.841 172.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.59 -45.93 82.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -60.75 -48.15 83.11 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.924 0.784 . . . . 0.0 109.993 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -59.47 -38.21 80.2 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.46 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -64.76 -50.71 65.75 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.504 1.047 . . . . 0.0 110.435 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -33.81 76.24 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.201 1.0 . . . . 0.0 110.388 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.51 -44.61 67.25 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.209 1.404 . . . . 0.0 110.148 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -58.93 -52.81 64.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.433 1.093 . . . . 0.0 109.944 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.21 -38.81 87.92 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.042 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -45.19 -52.63 9.17 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mmt -63.76 -47.76 79.69 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.198 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.55 -35.38 60.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.362 0.983 . . . . 0.0 111.541 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -78.9 -56.62 4.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.162 0.985 . . . . 0.0 109.569 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -76.46 -70.15 0.47 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.121 1.368 . . . . 0.0 113.307 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.51 71.63 66.03 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.52 -14.35 44.43 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.655 -170.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.03 -21.09 58.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.775 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 78.6 mtp180 -100.59 14.17 32.27 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.133 1.373 . . . . 0.0 113.864 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.33 110.05 12.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.327 1.051 . . . . 0.0 108.757 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.6 m-85 -107.62 130.79 54.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.554 1.142 . . . . 0.0 108.468 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.29 156.6 46.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.728 1.149 . . . . 0.0 114.1 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.97 140.04 0.19 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.633 1.111 . . . . 0.0 110.526 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -47.5 -49.81 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.439 1.096 . . . . 0.0 112.461 -162.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -58.95 -32.7 69.86 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.799 1.64 . . . . 0.0 112.632 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -71.16 -63.31 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -50.74 -41.12 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 0.0 112.233 -170.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -44.68 -49.71 10.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.074 1.75 . . . . 0.0 111.089 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -71.54 -41.92 68.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 109.851 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -66.73 -29.34 69.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.304 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.09 -37.33 78.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.3 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.91 -7.26 10.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.6 0.15 30.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.696 1.599 . . . . 0.0 112.571 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 55.96 8.2 0.35 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 127.025 2.13 . . . . 0.0 112.727 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -18.64 60.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.845 -1.16 . . . . 0.0 112.102 -162.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.28 115.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.82 -55.81 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 165.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -132.72 135.48 45.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 tp -110.25 133.18 53.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.953 2.101 . . . . 0.0 106.547 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.23 129.37 55.5 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.525 1.93 . . . . 0.0 107.115 175.054 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -143.56 136.39 24.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 119.014 0.824 . . . . 0.0 109.585 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.23 128.24 35.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 168.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -34.07 69.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.564 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -43.85 -39.7 4.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.659 1.184 . . . . 0.0 113.473 170.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 mt -77.07 -42.93 36.28 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.486 1.114 . . . . 0.0 109.571 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.53 -20.09 11.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.952 1.301 . . . . 0.0 112.877 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 30.35 4.73 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 119.96 -1.712 . . . . 0.0 110.014 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -56.18 149.39 16.14 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.255 0.55 . . . . 0.0 110.98 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -32.47 65.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.463 1.105 . . . . 0.0 112.439 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.9 113.6 20.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.38 -36.56 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.579 -168.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.61 59.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.596 1.089 . . . . 0.0 112.196 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.1 m -55.7 -52.61 63.28 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.081 1.352 . . . . 0.0 108.406 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -53.07 -53.58 48.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.586 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 77' ' ' VAL . 1.6 t -53.12 -44.81 67.96 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.19 0.596 . . . . 0.0 109.949 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -54.93 -53.87 49.98 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.062 0.945 . . . . 0.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -57.96 -57.37 13.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.197 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.1 m -64.64 -30.41 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.218 0.917 . . . . 0.0 111.102 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -66.25 -59.8 3.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.918 0.887 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 tp -52.74 -39.57 62.26 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.512 0.725 . . . . 0.0 111.445 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.48 -53.25 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.333 1.053 . . . . 0.0 110.235 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.55 -36.03 80.18 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.167 -0.333 . . . . 0.0 111.249 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -69.4 -24.47 63.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.055 0.942 . . . . 0.0 112.435 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.85 -43.85 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -61.16 -43.32 99.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.355 0.98 . . . . 0.0 110.926 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.6 -44.09 62.72 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.345 1.458 . . . . 0.0 110.124 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -85.32 25.44 1.01 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.689 1.195 . . . . 0.0 111.037 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.31 20.57 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.28 2.232 . . . . 0.0 114.064 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.64 -176.44 50.97 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 120.969 -1.082 . . . . 0.0 112.683 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 m -122.05 152.35 39.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.141 2.576 . . . . 0.0 108.499 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.73 124.14 56.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 47.8 mmt-85 -116.17 121.33 41.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -102.68 108.07 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.32 124.0 34.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -71.7 123.57 22.85 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -49.69 -42.73 46.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.329 1.851 . . . . 0.0 112.501 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.93 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.6 -37.21 67.81 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.191 1.796 . . . . 0.0 112.304 -174.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -72.74 152.09 41.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.994 1.318 . . . . 0.0 110.391 -167.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.54 -32.48 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.297 0.639 . . . . 0.0 111.595 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.5 m -65.07 -33.99 77.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.035 -1.041 . . . . 0.0 111.781 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.4 -49.55 77.29 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.1 -38.79 92.35 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.407 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -59.75 -47.26 86.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.21 -29.33 70.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.286 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.5 m -59.82 -34.27 72.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.641 1.11 . . . . 0.0 112.56 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.67 -3.93 7.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.71 1.204 . . . . 0.0 112.428 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -127.47 23.03 6.39 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.354 2.662 . . . . 0.0 108.679 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.7 p 69.75 1.3 3.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 128.449 2.7 . . . . 0.0 114.194 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.61 17.43 70.82 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.299 1.904 . . . . 0.0 113.224 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.03 129.83 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 120.165 1.982 . . . . 0.0 108.879 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.59 173.98 13.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.016 0.926 . . . . 0.0 110.291 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.46 153.92 25.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.193 -0.942 . . . . 0.0 110.874 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.6 mt -99.66 144.94 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.319 1.848 . . . . 0.0 107.911 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CD1' ' A' ' 40' ' ' PHE . 31.4 mt -116.99 131.31 56.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.595 0.758 . . . . 0.0 111.721 -172.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -53.54 -36.93 62.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.643 1.977 . . . . 0.0 111.865 173.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -149.07 157.53 39.81 Favored Pre-proline 0 N--CA 1.444 -0.737 0 C-N-CA 126.621 1.968 . . . . 0.0 106.358 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.43 144.08 66.04 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.233 1.956 . . . . 0.0 109.37 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 113' ' ' LEU . 93.8 t -94.9 124.11 55.49 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.7 120.14 6.98 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.298 1.999 . . . . 0.0 109.361 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -139.76 -77.12 0.33 Allowed 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.79 -169.25 40.06 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.26 155.54 56.19 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.063 1.842 . . . . 0.0 111.045 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -141.74 -38.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.352 1.461 . . . . 0.0 111.359 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.8 t -166.83 -35.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.968 0.804 . . . . 0.0 111.159 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 CA-C-O 116.561 -2.244 . . . . 0.0 112.567 170.753 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -67.33 162.84 21.95 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.733 0.778 . . . . 0.0 110.798 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -126.88 -179.97 5.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.386 1.874 . . . . 0.0 107.367 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.74 -80.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 p -157.46 20.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -163.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.49 82.93 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.066 -1.646 . . . . 0.0 110.195 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.29 47.42 0.4 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.665 0.65 . . . . 0.0 114.16 -172.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -150.97 133.45 15.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.456 1.128 . . . . 0.0 109.445 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.22 132.65 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.406 1.082 . . . . 0.0 108.87 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 33.97 58.52 0.59 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 129.411 3.085 . . . . 0.0 114.826 169.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -124.74 171.88 9.75 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.521 0.728 . . . . 0.0 112.001 172.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -130.63 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.887 2.075 . . . . 0.0 108.202 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.8 tp -134.72 -52.86 0.81 Allowed 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.801 0.841 . . . . 0.0 108.887 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m 52.22 66.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.556 1.169 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 33.9 t70 -137.89 151.91 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 152.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -90.48 -41.17 11.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.884 0.766 . . . . 0.0 110.967 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.34 -52.24 24.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -58.33 -41.03 83.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.266 0.626 . . . . 0.0 109.949 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 -26.35 67.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.994 0.815 . . . . 0.0 112.975 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.54 -38.73 86.75 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.674 1.125 . . . . 0.0 111.093 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.67 -52.63 56.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.678 170.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 18' ' ' ALA . 74.7 t -55.02 -49.02 75.04 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 125.117 1.367 . . . . 0.0 110.034 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -49.98 69.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.03 78.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.752 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -64.98 -52.48 55.98 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.253 1.388 . . . . 0.0 110.285 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.61 -43.97 85.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.358 1.063 . . . . 0.0 109.262 -173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.5 -34.54 63.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.811 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.82 -55.08 25.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.629 1.572 . . . . 0.0 109.847 173.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.75 -39.07 73.33 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -53.76 -50.09 66.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.164 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -68.16 -32.15 72.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.564 1.075 . . . . 0.0 111.3 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 tp -55.52 -36.17 66.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.182 1.356 . . . . 0.0 110.665 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -74.22 -57.14 4.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 111.079 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -76.69 -58.78 3.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -166.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -136.91 73.67 52.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.998 1.719 . . . . 0.0 108.283 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.26 -14.13 42.1 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.135 2.557 . . . . 0.0 113.476 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -64.73 -13.73 55.89 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.56 -1.337 . . . . 0.0 111.631 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.8 mtp180 -103.18 -0.25 30.77 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.377 1.071 . . . . 0.0 112.8 171.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.08 91.17 3.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.299 0.954 . . . . 0.0 108.816 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.7 m-85 -93.35 137.75 32.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.688 1.195 . . . . 0.0 108.707 -175.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -140.33 159.6 41.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.07 134.45 0.63 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.1 tp -42.16 -51.8 4.54 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.473 1.509 . . . . 0.0 112.447 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -56.96 -42.53 80.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.84 1.656 . . . . 0.0 111.708 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -65.25 -55.94 15.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.11 -41.92 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.358 1.063 . . . . 0.0 112.332 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -55.52 -40.38 71.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.245 0.929 . . . . 0.0 110.731 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -71.66 -41.13 69.13 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.681 1.593 . . . . 0.0 110.919 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -68.01 -30.24 69.44 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.179 -0.95 . . . . 0.0 112.085 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.19 -44.15 97.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.38 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.23 -33.33 69.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.253 0.933 . . . . 0.0 112.876 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.6 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.05 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 mmt 47.46 36.61 5.26 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.925 2.09 . . . . 0.0 110.467 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.64 -20.55 13.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.642 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 111' ' ' ALA . 81.3 mt -70.66 113.97 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.31 -42.1 14.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 124.122 0.889 . . . . 0.0 110.177 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.2 m -141.64 124.72 16.3 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 tp -110.07 125.51 53.03 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 127.121 2.168 . . . . 0.0 108.814 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -108.02 126.95 53.33 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.993 1.717 . . . . 0.0 107.857 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -143.17 142.53 25.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -63.33 133.43 54.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 168.359 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.2 -39.91 73.18 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.352 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.9 pt-20 -49.58 -36.46 24.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.592 1.542 . . . . 0.0 113.803 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.3 mt -78.04 -38.56 44.31 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.825 1.193 . . . . 0.0 110.258 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -56.6 -30.25 63.02 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.318 1.047 . . . . 0.0 111.457 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 42.2 3.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.774 2.429 . . . . 0.0 109.055 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -60.99 146.9 45.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.31 -35.74 78.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.162 0.985 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -87.04 114.96 24.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.98 1.312 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.74 -34.61 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.626 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.21 11.77 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 120.093 1.315 . . . . 0.0 110.527 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -62.52 -45.21 94.05 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.637 1.175 . . . . 0.0 110.464 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -51.61 -44.97 63.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.965 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 p -51.61 -46.08 63.46 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.319 0.509 . . . . 0.0 110.083 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.41 -46.23 90.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 109.562 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -59.64 -61.39 2.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.01 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.74 -36.99 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.832 1.196 . . . . 0.0 110.857 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.11 -49.3 78.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.235 1.014 . . . . 0.0 111.297 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.1 -43.15 96.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.132 0.573 . . . . 0.0 109.928 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.33 -55.38 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.761 1.225 . . . . 0.0 110.164 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -39.63 94.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.703 0.801 . . . . 0.0 110.652 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 t -67.14 -36.79 82.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.504 1.122 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.82 -40.24 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.313 0.96 . . . . 0.0 109.273 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -65.29 -41.46 94.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.218 0.917 . . . . 0.0 110.904 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.2 -39.87 73.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.075 0.398 . . . . 0.0 110.501 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -75.39 -2.84 30.42 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 112.92 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 80.51 26.47 0.29 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.72 2.808 . . . . 0.0 113.941 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.75 143.71 16.82 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.499 1.523 . . . . 0.0 112.319 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.0 m -74.77 131.91 41.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.152 2.181 . . . . 0.0 109.778 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.7 t -93.99 148.43 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.989 0.916 . . . . 0.0 109.148 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -140.36 122.01 15.27 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.212 1.805 . . . . 0.0 108.085 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.27 109.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.9 m-85 -89.23 124.33 34.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.9 t -69.75 127.78 34.12 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -31.58 62.84 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.105 0.478 . . . . 0.0 110.355 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.91 -4.78 22.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.839 1.655 . . . . 0.0 113.642 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -109.66 143.42 39.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.867 1.667 . . . . 0.0 110.348 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -22.38 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.757 -0.59 . . . . 0.0 112.154 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -64.8 -20.53 66.43 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.596 -1.315 . . . . 0.0 111.174 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.0 -32.76 13.48 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 119.539 1.063 . . . . 0.0 112.271 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.25 -39.69 79.84 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.137 0.968 . . . . 0.0 108.855 168.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -65.06 -52.36 56.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.649 1.18 . . . . 0.0 110.763 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.32 -30.88 63.13 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.352 0.978 . . . . 0.0 111.713 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.8 t -52.44 -39.93 61.62 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.679 1.592 . . . . 0.0 112.362 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.29 -25.84 59.9 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.466 1.106 . . . . 0.0 111.145 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.1 mt -109.4 23.27 14.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.991 2.116 . . . . 0.0 109.849 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.9 p 73.65 0.23 3.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.321 2.648 . . . . 0.0 113.745 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.14 21.09 63.5 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.402 1.953 . . . . 0.0 113.129 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.48 129.23 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.603 1.702 . . . . 0.0 109.12 171.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.31 177.41 11.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.768 1.227 . . . . 0.0 110.323 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -160.59 150.29 17.55 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.857 -1.152 . . . . 0.0 111.522 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 31' ' ' MET . 78.1 mt -83.76 141.07 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.715 HD13 HG23 ' A' ' 117' ' ' VAL . 21.8 mt -113.03 144.19 43.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -65.57 -25.71 67.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.286 2.234 . . . . 0.0 112.273 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -159.86 161.39 26.47 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 127.141 2.177 . . . . 0.0 106.41 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.32 132.37 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.089 1.859 . . . . 0.0 109.563 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 113' ' ' LEU . 80.5 t -87.51 131.46 43.84 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.0 111.74 2.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.143 2.562 . . . . 0.0 107.91 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -161.48 125.28 3.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.18 166.3 33.7 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.48 -65.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.363 2.709 . . . . 0.0 110.908 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.1 t -163.82 110.46 1.11 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m 56.4 -169.1 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.452 1.501 . . . . 0.0 111.829 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 116.289 -2.395 . . . . 0.0 111.265 174.478 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 t -143.43 99.23 3.39 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -119.6 26.1 9.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.683 1.193 . . . . 0.0 111.356 -167.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.23 -164.62 52.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -163.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.62 156.17 36.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 117.708 0.754 . . . . 0.0 109.548 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -148.8 179.56 7.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.201 1.001 . . . . 0.0 110.747 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.97 161.69 34.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.011 2.243 . . . . 0.0 108.869 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -153.17 148.43 26.91 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.29 106.44 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.696 0.798 . . . . 0.0 109.091 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.89 157.72 45.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 108.259 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -164.65 173.38 11.97 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.969 2.508 . . . . 0.0 107.13 171.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -38.03 0.39 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.772 -1.109 . . . . 0.0 112.296 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 43.3 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.022 2.529 . . . . 0.0 112.137 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 t -146.73 150.91 36.29 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 53.7 154.51 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 130.431 3.492 . . . . 0.0 115.577 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 m -76.71 -33.85 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.122 -0.986 . . . . 0.0 110.643 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -52.9 17.67 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.497 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.27 64.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.679 -163.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.95 -36.43 62.83 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.183 0.902 . . . . 0.0 113.259 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.5 71.1 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 118.987 0.812 . . . . 0.0 111.863 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.66 -53.27 57.04 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.297 0.639 . . . . 0.0 109.328 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.51 -33.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.373 1.069 . . . . 0.0 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -62.96 -47.19 84.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.941 1.7 . . . . 0.0 110.513 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.67 -37.77 82.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.134 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -48.99 79.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.483 1.038 . . . . 0.0 110.111 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -57.52 -53.56 56.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.328 1.451 . . . . 0.0 108.443 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -38.93 83.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.147 0.904 . . . . 0.0 109.77 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.19 -53.13 61.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.815 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.59 -36.29 82.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -53.9 -55.24 28.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.041 0.937 . . . . 0.0 108.721 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 tpp -57.51 -38.81 75.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.8 0.44 . . . . 0.0 110.302 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.02 -19.59 66.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.119 1.768 . . . . 0.0 112.822 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -95.0 -34.89 12.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -90.08 -70.6 0.66 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.1 77.03 68.49 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 109.388 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.99 -8.98 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.597 2.198 . . . . 0.0 114.092 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -57.06 -22.97 43.27 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.046 1.294 . . . . 0.0 111.747 166.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -106.17 8.64 32.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 112.598 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.97 98.19 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.168 0.987 . . . . 0.0 109.521 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.507 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.9 m-30 -100.46 141.74 32.91 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.384 1.074 . . . . 0.0 109.159 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.13 161.09 38.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.749 0.785 . . . . 0.0 112.95 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 148.21 0.68 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 125.242 1.401 . . . . 0.0 111.226 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 tp -49.69 -44.83 48.25 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.31 1.044 . . . . 0.0 110.972 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -61.06 -54.5 43.92 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.263 1.425 . . . . 0.0 111.289 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -61.77 -50.97 70.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 0.0 108.205 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.31 -38.88 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 111.906 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.04 -22.42 64.96 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.209 -0.932 . . . . 0.0 112.742 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -77.98 -43.34 29.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.72 1.145 . . . . 0.0 108.859 167.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.69 -40.23 94.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.005 -0.434 . . . . 0.0 112.02 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.86 -33.53 76.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.503 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.65 -35.01 79.63 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.045 0.839 . . . . 0.0 112.365 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.79 -0.19 29.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 111.991 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 62.19 3.08 0.93 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.88 2.472 . . . . 0.0 114.417 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -81.72 -2.46 50.65 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.696 -1.252 . . . . 0.0 112.629 -162.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.41 110.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.58 -49.36 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 108.121 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -144.41 136.76 26.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.1 tp -109.42 142.1 40.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 125.24 47.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.479 1.911 . . . . 0.0 107.253 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 tt -141.26 143.26 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 119.191 0.905 . . . . 0.0 110.341 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.88 137.26 53.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -37.04 69.8 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.848 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.55 -18.69 42.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.5 -43.18 9.84 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.322 1.049 . . . . 0.0 109.449 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.09 -26.58 11.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 0.0 112.444 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.28 37.39 4.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.554 1.941 . . . . 0.0 110.33 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -56.05 145.79 24.59 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.582 0.753 . . . . 0.0 110.886 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -40.51 96.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.611 0.764 . . . . 0.0 112.699 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.35 120.64 21.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -55.67 -44.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.284 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.31 -53.55 42.22 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 120.223 1.374 . . . . 0.0 111.235 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -51.38 -53.32 37.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.763 1.625 . . . . 0.0 109.878 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -55.73 -48.57 74.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.513 0.597 . . . . 0.0 109.773 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -39.23 58.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.624 0.77 . . . . 0.0 110.802 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -62.44 -56.55 17.12 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.634 1.106 . . . . 0.0 109.049 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -55.19 -50.23 69.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.762 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.62 -40.82 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 119.432 1.014 . . . . 0.0 110.479 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -62.33 -52.76 62.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.18 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.79 -42.62 75.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.521 1.055 . . . . 0.0 111.126 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -58.07 -51.23 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.194 0.597 . . . . 0.0 110.315 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.47 -33.12 74.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.843 1.657 . . . . 0.0 111.085 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -71.49 -30.12 65.6 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.954 1.701 . . . . 0.0 110.866 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.23 -37.79 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.718 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE2' HG21 ' A' ' 90' ' ' VAL . 36.4 mttt -61.73 -46.01 91.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.159 1.345 . . . . 0.0 110.295 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.11 -43.73 87.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.428 0.691 . . . . 0.0 111.842 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -77.48 10.52 2.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.992 0.917 . . . . 0.0 111.247 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.44 19.21 11.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.499 3.119 . . . . 0.0 115.143 174.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.3 168.37 51.7 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.435 1.016 . . . . 0.0 111.918 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -83.42 159.45 21.78 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.904 1.682 . . . . 0.0 109.846 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 84' ' ' LYS . 39.1 t -124.59 146.73 29.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.653 1.181 . . . . 0.0 109.127 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -143.85 121.28 11.68 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.26 0.624 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 mm -110.61 110.09 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.28 151.94 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.717 1.607 . . . . 0.0 108.985 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -103.08 132.27 49.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.338 0.655 . . . . 0.0 110.648 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.3 p -65.36 10.43 0.09 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.805 2.042 . . . . 0.0 114.715 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.28 0.71 10.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.394 1.877 . . . . 0.0 112.463 -166.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -139.62 160.38 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.606 1.962 . . . . 0.0 107.041 -172.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.33 -24.69 28.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.326 0.65 . . . . 0.0 112.41 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.3 p -68.47 -31.99 71.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.722 -1.236 . . . . 0.0 110.285 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.32 -39.14 70.97 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -66.39 -28.96 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.143 1.472 . . . . 0.0 110.92 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.04 -51.23 26.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.251 1.021 . . . . 0.0 109.311 170.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -60.03 -28.8 68.04 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.818 1.19 . . . . 0.0 111.954 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -58.85 -36.15 74.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.565 1.146 . . . . 0.0 111.811 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -68.23 -0.68 4.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.1 1.76 . . . . 0.0 112.162 173.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.77 28.22 3.58 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.422 2.289 . . . . 0.0 108.79 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 p 70.87 2.38 4.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.829 2.051 . . . . 0.0 114.521 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.04 17.07 70.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 129.03 3.205 . . . . 0.0 114.238 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.66 134.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.299 1.55 . . . . 0.0 109.477 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.69 177.97 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.218 1.407 . . . . 0.0 110.488 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -162.3 144.35 10.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.465 1.03 . . . . 0.0 110.338 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.8 mt -84.11 144.84 9.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 125.081 1.352 . . . . 0.0 107.607 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.543 HD13 HG23 ' A' ' 117' ' ' VAL . 9.7 mt -117.71 139.25 51.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.145 0.978 . . . . 0.0 109.874 -176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.73 -24.24 65.35 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.093 1.357 . . . . 0.0 111.98 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.9 p90 -151.44 157.31 34.91 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.929 1.292 . . . . 0.0 108.799 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.91 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.414 2.743 . . . . 0.0 108.406 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 113' ' ' LEU . 62.2 t -76.12 117.76 66.36 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.45 121.14 8.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.132 1.888 . . . . 0.0 108.188 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -165.46 -161.05 0.5 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.531 2.732 . . . . 0.0 105.034 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.62 179.84 31.27 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.629 -1.295 . . . . 0.0 110.856 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 122.72 9.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.882 2.388 . . . . 0.0 109.42 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m -139.55 -18.41 0.97 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.822 1.249 . . . . 0.0 113.445 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 p -91.01 -29.18 17.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.868 1.213 . . . . 0.0 112.209 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.374 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -145.423 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.9 85.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.434 0.561 . . . . 0.0 112.291 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.11 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.3 1.44 . . . . 0.0 112.812 -169.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.06 -49.74 32.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -55.31 -51.21 67.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.714 0.805 . . . . 0.0 110.205 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.9 -42.21 88.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 119.223 0.92 . . . . 0.0 111.2 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -59.85 -47.75 84.47 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.85 1.659 . . . . 0.0 109.075 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.64 95.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.095 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.6 -43.9 80.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.269 0.94 . . . . 0.0 110.164 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.54 -48.38 60.62 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.522 1.129 . . . . 0.0 111.029 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.05 -41.11 95.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -57.43 -60.0 4.3 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.22 1.408 . . . . 0.0 110.32 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -35.94 74.94 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.59 -56.36 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.453 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -64.94 -37.78 88.77 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.142 0.577 . . . . 0.0 109.933 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.52 -36.53 69.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.332 0.969 . . . . 0.0 111.725 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -67.98 -61.26 1.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -64.97 -85.55 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.47 1.908 . . . . 0.0 112.44 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.21 93.87 47.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.29 1.436 . . . . 0.0 109.929 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -67.45 -5.36 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.894 1.729 . . . . 0.0 112.087 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.75 -33.07 60.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.134 0.879 . . . . 0.0 110.039 165.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -97.33 7.72 46.0 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -137.18 90.68 2.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.253 1.842 . . . . 0.0 110.347 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.7 m-30 -93.3 137.28 32.77 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.495 0.718 . . . . 0.0 109.756 -174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.56 164.94 28.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.77 0.795 . . . . 0.0 112.017 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.58 126.69 0.85 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -170.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -35.66 -53.66 0.7 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.907 2.083 . . . . 0.0 112.422 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.05 83.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.037 0.935 . . . . 0.0 111.767 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -59.04 -57.23 13.98 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 t -49.64 -43.87 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.26 -31.99 69.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.805 1.184 . . . . 0.0 111.727 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -44.71 30.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.617 1.567 . . . . 0.0 110.477 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -57.85 -32.51 67.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.925 -1.11 . . . . 0.0 112.37 172.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.52 -41.93 92.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.549 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.02 -35.4 69.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.25 0.932 . . . . 0.0 111.544 172.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.61 -2.81 40.8 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.847 1.259 . . . . 0.0 112.706 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.6 mmt 51.96 14.91 0.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.462 1.905 . . . . 0.0 113.148 -170.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.53 -4.97 58.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.143 -0.973 . . . . 0.0 112.362 -162.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -76.55 108.72 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -169.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.4 -62.48 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.557 -1.202 . . . . 0.0 107.849 168.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.4 m -139.01 133.69 32.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 111' ' ' ALA . 8.2 tp -110.51 124.25 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.3 1.84 . . . . 0.0 108.582 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -101.67 137.56 39.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.591 1.556 . . . . 0.0 107.806 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 tt -151.94 139.75 13.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 134.24 50.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 166.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -34.52 69.45 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.6 -25.22 62.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.743 1.156 . . . . 0.0 113.212 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.72 -37.06 19.78 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.531 1.059 . . . . 0.0 110.378 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -56.55 -19.55 16.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.682 1.193 . . . . 0.0 112.352 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.66 49.72 2.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.626 -1.297 . . . . 0.0 108.863 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -62.09 151.59 35.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.882 0.873 . . . . 0.0 109.617 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -69.22 -42.81 75.2 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.217 0.607 . . . . 0.0 112.415 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.17 119.15 19.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.5 -49.43 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 117.532 -1.223 . . . . 0.0 110.676 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.04 -52.38 66.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.366 1.439 . . . . 0.0 110.945 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -52.94 -53.12 54.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 110.809 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -55.89 -52.7 63.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -46.47 -50.6 16.69 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 126.256 1.822 . . . . 0.0 110.575 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.13 -57.3 11.62 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.972 0.909 . . . . 0.0 110.048 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -56.18 -51.68 67.14 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.152 -0.928 . . . . 0.0 112.113 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.12 -38.61 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 120.058 1.299 . . . . 0.0 110.824 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -60.22 -52.58 64.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.356 1.062 . . . . 0.0 109.026 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.12 -44.17 92.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.006 0.922 . . . . 0.0 111.205 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -53.29 -57.42 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.263 1.025 . . . . 0.0 110.138 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -34.73 78.63 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -16.82 63.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.028 . . . . 0.0 112.809 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.35 -37.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 O-C-N 120.472 -1.393 . . . . 0.0 109.135 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.98 -39.44 92.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.306 0.957 . . . . 0.0 108.899 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -57.25 -36.13 70.58 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.274 0.63 . . . . 0.0 111.269 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -87.62 13.37 10.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.856 1.262 . . . . 0.0 112.065 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.26 19.34 4.89 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.887 2.475 . . . . 0.0 114.535 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.33 170.03 50.84 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.282 0.946 . . . . 0.0 110.956 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -92.99 153.4 18.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.293 1.437 . . . . 0.0 108.691 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.6 142.1 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.333 1.453 . . . . 0.0 107.73 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -134.5 122.4 22.39 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.537 1.535 . . . . 0.0 108.011 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.75 105.55 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 10.2 m-85 -88.49 155.42 19.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -172.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 m -103.84 147.32 27.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.318 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 t -60.64 -35.85 77.19 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.149 0.906 . . . . 0.0 108.809 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.13 -56.25 16.18 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.976 1.71 . . . . 0.0 111.514 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -66.46 145.21 55.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.79 -26.46 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.586 0.63 . . . . 0.0 111.247 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 p -56.38 -17.98 9.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.184 0.994 . . . . 0.0 112.664 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.91 -55.58 4.08 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 125.348 1.452 . . . . 0.0 110.449 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.06 -29.19 67.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.312 1.056 . . . . 0.0 111.103 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -60.81 -58.13 9.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.48 -28.06 63.07 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.391 1.077 . . . . 0.0 112.238 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 m -56.34 -34.35 66.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.25 1.02 . . . . 0.0 113.196 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -64.44 -9.17 16.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.822 1.249 . . . . 0.0 111.755 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.1 mt -131.03 32.88 4.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.816 2.846 . . . . 0.0 108.711 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p 56.99 18.4 3.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.003 2.121 . . . . 0.0 114.482 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.64 69.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.801 2.143 . . . . 0.0 113.072 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.48 121.82 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.791 1.796 . . . . 0.0 110.59 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 179.48 8.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.506 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -161.67 145.44 12.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.903 1.281 . . . . 0.0 110.502 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.44 146.34 7.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.529 1.531 . . . . 0.0 106.898 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 117' ' ' VAL . 18.1 mt -117.46 145.57 44.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.452 0.701 . . . . 0.0 109.725 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -77.6 -24.6 49.62 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.689 1.596 . . . . 0.0 111.913 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -148.22 154.83 42.88 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 126.2 1.8 . . . . 0.0 106.324 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.34 114.75 3.56 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 123.163 2.576 . . . . 0.0 107.586 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 113' ' ' LEU . 55.7 t . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt . . . . . 0 C--O 1.237 0.395 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.7 76.3 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.982 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.95 -23.99 61.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.496 1.044 . . . . 0.0 112.231 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.79 -43.44 22.98 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.71 93.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.009 0.924 . . . . 0.0 110.54 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 t -69.03 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.197 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -53.38 -44.1 68.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.077 1.762 . . . . 0.0 109.87 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.563 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -65.61 -46.32 79.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.794 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.1 -45.32 79.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.38 0.991 . . . . 0.0 111.106 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.26 -54.38 44.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.33 1.852 . . . . 0.0 108.465 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -66.39 -38.15 86.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.819 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 90.8 t80 -58.22 -59.7 4.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 110.285 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -61.71 -31.04 71.17 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -50.37 -62.94 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -58.9 -38.75 79.62 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.29 -30.32 59.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.983 1.265 . . . . 0.0 112.23 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -35.45 11.31 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.463 -0.773 . . . . 0.0 111.945 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -76.88 -56.42 4.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.207 1.003 . . . . 0.0 112.857 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.27 81.06 7.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.606 1.963 . . . . 0.0 108.891 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.11 -14.03 39.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.126 2.551 . . . . 0.0 112.762 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.41 -20.98 61.64 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.104 -0.998 . . . . 0.0 111.301 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -101.08 11.35 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 123.835 0.854 . . . . 0.0 112.665 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -146.26 91.03 2.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.43 1.014 . . . . 0.0 109.837 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 4.3 m-30 -92.33 144.5 25.32 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.64 164.66 29.59 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.57 130.8 2.86 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 -171.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.0 tp -43.95 -47.6 8.51 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.27 -46.73 89.12 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.307 1.043 . . . . 0.0 111.618 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.14 -58.4 8.69 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.532 1.06 . . . . 0.0 108.412 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 t -53.08 -36.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.684 1.194 . . . . 0.0 111.637 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.04 -21.62 66.29 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.02 . . . . 0.0 112.767 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -87.6 -43.49 11.94 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 125.836 1.654 . . . . 0.0 110.459 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -54.87 -36.55 65.22 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.251 -0.906 . . . . 0.0 111.898 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.89 -45.18 87.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.576 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -60.0 -28.75 67.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.388 0.994 . . . . 0.0 113.132 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -0.11 29.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.186 1.394 . . . . 0.0 111.829 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.1 mmt 52.26 23.31 2.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.309 2.244 . . . . 0.0 112.775 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -100.92 -8.26 22.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.333 1.053 . . . . 0.0 112.694 -161.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.3 mt -70.5 117.48 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.05 -61.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.57 1.148 . . . . 0.0 108.518 165.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.7 m -138.0 139.84 39.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 80' ' ' VAL . 12.1 tp -110.53 133.4 53.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.186 1.794 . . . . 0.0 108.107 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.563 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -109.62 134.47 51.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.199 1.799 . . . . 0.0 107.326 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.53 142.83 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -72.7 131.73 42.75 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.58 -32.85 65.62 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 123.05 0.54 . . . . 0.0 111.537 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.52 -41.87 22.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.6 -40.24 35.08 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.114 0.966 . . . . 0.0 108.998 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.32 -20.05 10.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.372 0.669 . . . . 0.0 111.694 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -118.61 21.27 12.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.847 2.059 . . . . 0.0 111.773 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -55.07 144.85 22.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.369 0.986 . . . . 0.0 111.421 -168.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.21 -21.78 56.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.99 108.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.0 -26.09 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 111.592 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.36 -54.39 12.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.16 0.891 . . . . 0.0 111.195 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.0 m -53.86 -49.03 69.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.145 1.778 . . . . 0.0 109.635 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.91 -47.28 71.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.089 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -50.13 -43.5 51.91 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.886 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.79 -56.74 18.27 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.271 1.028 . . . . 0.0 108.671 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -54.4 -55.61 26.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.757 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 m -64.96 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.901 1.228 . . . . 0.0 111.666 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -62.11 -53.36 56.49 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.0 tp -58.06 -43.28 86.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.197 0.999 . . . . 0.0 111.461 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 49.3 t -57.08 -33.02 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.094 0.958 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.24 -35.1 15.51 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.478 -0.764 . . . . 0.0 112.073 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 t -64.93 -16.3 63.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.069 1.747 . . . . 0.0 111.643 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.06 -35.3 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 119.513 -1.992 . . . . 0.0 109.679 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.85 -39.5 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.654 1.115 . . . . 0.0 110.37 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -48.93 -43.18 39.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.479 1.112 . . . . 0.0 110.325 171.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -94.37 17.65 12.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.161 1.384 . . . . 0.0 111.054 -168.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 27.69 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.57 2.348 . . . . 0.0 113.658 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.48 -170.79 46.72 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.127 0.87 . . . . 0.0 111.293 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -124.93 156.34 38.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.136 2.174 . . . . 0.0 109.14 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.66 140.92 44.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.969 0.89 . . . . 0.0 108.826 -173.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -137.07 120.81 17.37 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.25 109.93 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 -175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -89.66 138.12 31.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 t -69.07 122.43 18.71 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 p -55.88 -15.0 2.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.226 1.41 . . . . 0.0 113.38 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.95 -33.93 44.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.158 0.89 . . . . 0.0 111.297 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -67.44 151.49 47.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.78 -18.18 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.752 -0.592 . . . . 0.0 111.905 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.7 p -68.04 -27.9 66.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.105 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.07 -26.32 72.66 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.66 1.118 . . . . 0.0 110.756 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.49 -49.86 37.05 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.289 1.045 . . . . 0.0 108.811 165.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -61.14 -35.65 77.65 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.203 -0.936 . . . . 0.0 111.885 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -70.64 -29.79 66.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.646 172.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 t -52.94 -41.47 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.984 1.314 . . . . 0.0 110.973 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.0 4.03 0.73 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.017 2.127 . . . . 0.0 114.115 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -137.81 27.98 2.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.539 2.736 . . . . 0.0 108.793 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p 66.29 2.08 2.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.249 2.62 . . . . 0.0 114.801 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.34 73.32 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 128.32 2.867 . . . . 0.0 113.94 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.56 132.67 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.016 1.908 . . . . 0.0 109.904 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.93 168.56 24.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.519 1.127 . . . . 0.0 110.269 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.06 145.28 23.91 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.309 0.958 . . . . 0.0 111.137 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.1 mt -83.95 148.87 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 127.029 2.132 . . . . 0.0 106.687 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 49' ' ' ALA . 24.2 mt -117.56 147.38 42.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.118 0.967 . . . . 0.0 111.718 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mtt85 -70.34 -32.09 69.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 168.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 10.4 p90 -151.23 154.0 33.32 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 118.245 0.475 . . . . 0.0 110.356 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.3 113.44 3.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.783 2.988 . . . . 0.0 109.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.506 HG23 HD13 ' A' ' 113' ' ' LEU . 98.0 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 119.061 -0.495 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.07 -54.43 46.02 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.637 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.72 -40.37 54.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.537 1.135 . . . . 0.0 112.447 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.39 -47.61 34.74 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.962 0.801 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -48.68 76.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.946 0.873 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.23 -42.5 66.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 124.7 1.2 . . . . 0.0 109.606 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -57.13 -50.04 74.03 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.909 1.231 . . . . 0.0 109.533 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.45 -43.64 98.52 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.855 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.91 -47.93 81.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.865 1.211 . . . . 0.0 110.233 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.18 -51.95 65.77 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 126.701 2.0 . . . . 0.0 109.477 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.03 -42.15 73.31 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -173.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.98 -56.82 11.88 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.198 0.999 . . . . 0.0 108.567 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -44.89 89.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 124.123 0.889 . . . . 0.0 112.247 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.08 -57.73 4.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ttp -66.27 -33.14 75.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.374 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.18 -50.94 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.732 1.606 . . . . 0.0 110.814 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -65.33 -40.16 93.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.221 0.208 . . . . 0.0 110.562 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -78.88 -57.95 3.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 111.41 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -149.97 76.9 8.63 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.431 2.292 . . . . 0.0 108.29 -167.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.81 -5.94 14.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.749 2.299 . . . . 0.0 112.151 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -27.19 2.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.003 2.121 . . . . 0.0 110.99 163.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HA ' HD12 ' A' ' 113' ' ' LEU . 76.1 mtp180 -110.22 0.8 18.32 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.208 1.403 . . . . 0.0 113.922 175.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.74 95.21 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.669 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.5 m-30 -93.55 133.62 36.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -140.38 159.91 41.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.16 0.981 . . . . 0.0 113.522 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 135.94 0.69 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.8 tp -44.97 -49.8 10.96 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.801 1.641 . . . . 0.0 112.27 -169.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -56.16 -43.27 78.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.432 1.493 . . . . 0.0 110.367 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -66.69 -57.82 6.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.18 -36.65 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.218 -0.926 . . . . 0.0 111.924 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -56.4 -38.84 72.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.914 0.885 . . . . 0.0 112.21 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -47.11 53.29 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.155 1.382 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -58.77 -32.83 69.64 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.577 -0.702 . . . . 0.0 112.537 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -65.53 -43.61 89.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.906 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.64 -28.16 66.98 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.04 0.836 . . . . 0.0 112.548 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.18 -6.12 57.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.46 0.704 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 60.26 9.5 1.96 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.624 1.97 . . . . 0.0 112.491 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.56 -7.19 59.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.167 -0.958 . . . . 0.0 113.027 -162.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.0 114.35 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 119.167 0.894 . . . . 0.0 108.86 -170.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.74 -52.37 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.166 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.6 m -140.99 132.93 27.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.27 132.71 53.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.467 2.307 . . . . 0.0 106.797 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.481 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -110.96 126.68 55.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.16 1.784 . . . . 0.0 106.918 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.11 136.31 29.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 118.931 0.787 . . . . 0.0 109.469 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -65.75 138.55 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.55 -39.35 70.5 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 122.928 0.491 . . . . 0.0 110.208 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -60.65 -16.7 41.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.39 -42.59 10.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.875 1.216 . . . . 0.0 110.091 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -50.28 -32.56 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.554 1.142 . . . . 0.0 112.379 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.55 38.85 4.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.511 1.924 . . . . 0.0 109.709 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.97 151.82 17.62 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -68.73 -41.49 78.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.583 0.753 . . . . 0.0 111.785 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 23.9 t70 -75.89 120.48 21.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.191 1.396 . . . . 0.0 108.23 -172.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.84 -39.44 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.404 -174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -60.27 4.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.976 0.807 . . . . 0.0 109.289 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 89.1 m -58.93 -51.24 70.88 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.089 0.956 . . . . 0.0 110.061 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -52.62 -52.31 56.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.017 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.3 t -52.2 -46.87 65.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 119.227 0.922 . . . . 0.0 109.245 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -51.73 -50.73 59.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.106 0.866 . . . . 0.0 109.668 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -57.82 -60.4 3.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.722 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 m -61.94 -37.84 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.328 1.422 . . . . 0.0 111.151 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -57.55 -53.16 61.34 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.809 1.644 . . . . 0.0 108.721 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.72 -46.63 88.53 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.808 0.843 . . . . 0.0 111.252 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 58' ' ' LEU . 41.6 t -54.67 -49.88 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 124.311 1.045 . . . . 0.0 109.348 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.02 -37.8 78.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -64.65 -30.49 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.76 0.824 . . . . 0.0 111.856 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.28 -39.77 79.46 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 O-C-N 120.952 -1.092 . . . . 0.0 109.623 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.01 -46.69 89.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.985 0.811 . . . . 0.0 110.114 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -59.14 -31.27 68.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.979 0.512 . . . . 0.0 112.189 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.81 26.6 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.829 1.252 . . . . 0.0 111.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.64 6.75 2.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.872 2.869 . . . . 0.0 115.225 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.99 -176.18 47.91 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.177 0.899 . . . . 0.0 112.015 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -123.42 157.5 33.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.897 1.679 . . . . 0.0 109.935 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.3 t -122.66 139.66 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 108.232 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -129.36 121.45 27.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.1 mm -100.74 109.34 25.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 5.6 m-85 -89.62 156.76 18.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 108.697 -177.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -104.76 139.4 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 t -62.4 9.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.691 2.396 . . . . 0.0 114.155 170.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -129.3 -14.47 4.27 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.27 1.828 . . . . 0.0 113.689 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -87.69 148.38 24.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.565 1.075 . . . . 0.0 109.214 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.6 p -57.02 -32.63 40.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 O-C-N 121.721 -0.612 . . . . 0.0 110.129 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.0 m -65.3 -27.36 68.56 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.307 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.65 -53.8 25.99 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 167.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.34 -31.33 67.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.29 1.045 . . . . 0.0 112.196 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.96 -47.53 65.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.953 0.901 . . . . 0.0 109.697 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.86 -31.91 65.28 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 122.948 0.499 . . . . 0.0 111.39 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -58.33 -33.88 70.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.648 1.179 . . . . 0.0 112.926 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.14 -6.77 14.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.452 1.501 . . . . 0.0 112.053 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.0 mt -129.7 23.04 5.42 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.537 2.735 . . . . 0.0 108.218 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p 77.57 -12.12 1.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.263 3.425 . . . . 0.0 114.122 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.36 15.76 46.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.962 2.22 . . . . 0.0 113.133 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.17 133.48 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 118.933 1.366 . . . . 0.0 108.962 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.09 13.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.669 1.188 . . . . 0.0 110.05 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.18 142.01 9.82 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.241 0.928 . . . . 0.0 110.918 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -83.88 141.84 14.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.203 1.401 . . . . 0.0 107.715 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.732 HD13 HG23 ' A' ' 117' ' ' VAL . 30.2 mt -112.9 139.91 48.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.311 1.045 . . . . 0.0 111.249 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -66.86 -25.54 66.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.052 1.741 . . . . 0.0 112.374 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -151.61 157.47 34.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.507 1.523 . . . . 0.0 107.254 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.69 128.92 15.81 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.992 1.795 . . . . 0.0 108.384 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.732 HG23 HD13 ' A' ' 113' ' ' LEU . 79.4 t . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tptm . . . . . 0 C--O 1.232 0.147 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.95 80.54 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.524 0.73 . . . . 0.0 110.007 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.14 69.14 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.416 1.007 . . . . 0.0 113.367 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.67 -39.27 18.11 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 119.423 1.011 . . . . 0.0 111.115 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -50.42 68.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.881 2.072 . . . . 0.0 108.139 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.44 -51.52 48.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 126.013 1.725 . . . . 0.0 109.677 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.06 -45.01 67.92 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.558 1.072 . . . . 0.0 109.769 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.6 -50.72 71.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 123.854 0.721 . . . . 0.0 111.383 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -55.74 -46.75 77.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.977 1.262 . . . . 0.0 111.361 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.04 -46.53 88.0 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.543 1.537 . . . . 0.0 110.073 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.72 -35.65 65.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.135 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 61.4 t80 -61.46 -57.39 12.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.444 2.298 . . . . 0.0 109.995 173.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -58.79 -35.4 72.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.739 0.7 . . . . 0.0 112.073 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -50.0 -53.65 25.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.482 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.1 mmt -59.86 -44.44 94.13 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.57 0.623 . . . . 0.0 110.286 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.1 -25.31 45.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.056 0.844 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -86.65 -62.35 1.53 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -68.11 -59.39 3.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.927 1.291 . . . . 0.0 113.826 -168.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.98 80.63 47.93 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 124.975 1.31 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.48 -7.65 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.273 1.982 . . . . 0.0 113.752 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.99 -55.24 25.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.889 1.222 . . . . 0.0 108.195 164.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -76.08 10.97 1.63 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.278 0.945 . . . . 0.0 112.526 -168.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -128.3 96.51 4.46 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.77 1.228 . . . . 0.0 109.69 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.73 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.37 140.64 29.34 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.27 159.67 41.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 142.13 0.73 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 tp -45.24 -51.81 10.31 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.361 1.464 . . . . 0.0 112.673 -165.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -57.56 -49.59 75.89 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.648 1.579 . . . . 0.0 110.272 -175.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.12 -56.44 22.22 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -49.22 -40.59 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.666 1.186 . . . . 0.0 112.29 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -59.61 -35.65 74.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.688 1.586 . . . . 0.0 111.56 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -49.32 16.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.236 1.415 . . . . 0.0 109.348 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.73 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -56.06 -39.36 71.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.748 -0.595 . . . . 0.0 111.126 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.93 -50.37 69.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.5 0.72 . . . . 0.0 109.114 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.88 -16.01 47.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.891 1.277 . . . . 0.0 114.355 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.17 -10.51 54.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.806 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 51.91 52.45 14.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.164 1.385 . . . . 0.0 109.573 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 115' ' ' PHE . . . -124.76 -18.73 5.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.334 2.254 . . . . 0.0 111.528 -171.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.48 117.61 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.7 -57.65 2.68 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.459 1.103 . . . . 0.0 108.973 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -129.98 126.42 37.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 108.099 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 HG22 ' A' ' 80' ' ' VAL . 9.3 tp -109.52 137.2 47.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.874 2.07 . . . . 0.0 106.958 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -119.23 126.17 50.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.486 1.914 . . . . 0.0 107.076 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.83 141.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.3 m -71.22 134.13 46.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.268 1.027 . . . . 0.0 108.682 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -56.19 -35.0 66.76 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.04 -22.27 10.28 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.64 -45.41 9.87 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 120.85 -1.157 . . . . 0.0 110.081 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -54.85 -20.49 8.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.284 1.434 . . . . 0.0 113.592 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -125.97 20.74 7.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.706 1.603 . . . . 0.0 112.085 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -51.39 144.57 9.79 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.732 1.613 . . . . 0.0 111.526 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -51.32 -52.06 48.8 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 112.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.06 108.66 9.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 126.257 1.823 . . . . 0.0 107.713 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.44 -33.62 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.759 -174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.13 -63.28 1.29 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.803 1.183 . . . . 0.0 111.363 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 m -55.42 -45.73 76.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.768 1.227 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -56.83 -48.85 77.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.818 1.19 . . . . 0.0 110.619 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.4 m -57.09 -31.04 64.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.546 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -64.28 -58.54 6.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 120.303 1.41 . . . . 0.0 108.94 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 80' ' ' VAL . 40.2 m-85 -53.46 -53.34 52.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.023 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.78 -38.77 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.345 0.975 . . . . 0.0 110.93 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -63.65 -46.83 83.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.304 0.502 . . . . 0.0 110.486 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 tp -70.05 -34.96 73.9 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.382 0.673 . . . . 0.0 110.921 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.507 HG22 HD21 ' A' ' 58' ' ' LEU . 77.8 t -58.61 -48.51 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.67 94.38 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.949 0.9 . . . . 0.0 110.621 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -70.66 -25.38 62.97 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.546 1.538 . . . . 0.0 111.631 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.85 -42.26 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 120.702 -1.249 . . . . 0.0 108.466 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -63.72 -40.06 95.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.814 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -50.57 -49.0 57.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.071 0.851 . . . . 0.0 109.49 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -84.8 26.06 0.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.011 2.124 . . . . 0.0 110.763 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.04 22.12 12.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.534 2.734 . . . . 0.0 115.311 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.64 159.41 23.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 122.581 1.101 . . . . 0.0 113.243 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -82.5 163.55 21.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.191 2.197 . . . . 0.0 110.693 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -127.92 153.54 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 120.706 -1.246 . . . . 0.0 108.945 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.1 mmt-85 -141.0 131.88 25.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.692 1.997 . . . . 0.0 106.113 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.6 mm -118.4 107.48 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.86 155.02 19.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -103.11 145.8 29.36 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.7 t -60.55 -34.96 74.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.833 0.708 . . . . 0.0 110.542 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.19 -25.06 67.57 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.347 1.459 . . . . 0.0 112.809 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -83.39 147.62 27.79 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.496 0.718 . . . . 0.0 109.948 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -37.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.982 0.513 . . . . 0.0 110.36 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.6 m -71.04 -20.36 62.39 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.405 1.082 . . . . 0.0 111.838 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.48 -44.54 33.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.84 -34.97 73.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.715 0.758 . . . . 0.0 110.296 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -66.1 -55.65 15.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 111.068 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.61 -30.96 67.65 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.559 1.072 . . . . 0.0 111.803 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 t -60.15 -33.45 72.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.286 1.034 . . . . 0.0 112.128 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -58.76 -21.64 56.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.884 0.765 . . . . 0.0 111.303 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.4 mt -112.27 29.8 7.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.644 2.378 . . . . 0.0 109.412 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.94 0.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.523 2.729 . . . . 0.0 114.427 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.34 13.81 65.07 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 128.87 3.128 . . . . 0.0 113.618 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.2 133.13 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.502 2.151 . . . . 0.0 109.739 171.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -155.17 172.76 17.63 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.775 0.83 . . . . 0.0 110.439 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.44 146.86 22.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.091 -1.006 . . . . 0.0 110.614 173.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.2 mt -84.02 141.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 107.304 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 49' ' ' ALA . 10.1 mt -117.4 141.97 47.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.01 0.924 . . . . 0.0 108.589 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -66.93 -40.48 87.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.32 0.648 . . . . 0.0 110.37 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 17.0 p90 -136.0 156.82 76.83 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.547 1.539 . . . . 0.0 107.725 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 114.48 3.87 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.845 2.364 . . . . 0.0 108.294 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.142 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -33.53 74.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.901 -172.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.5 -11.62 61.04 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.717 2.053 . . . . 0.0 112.741 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.87 -61.74 3.91 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 165.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.79 -43.61 98.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.886 1.274 . . . . 0.0 112.459 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.47 -41.0 80.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 124.0 0.92 . . . . 0.0 109.907 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.41 83.55 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.433 1.015 . . . . 0.0 109.353 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.33 75.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.051 0.541 . . . . 0.0 110.866 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.01 -46.0 89.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.575 0.75 . . . . 0.0 110.456 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -57.2 -52.62 64.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 124.405 1.082 . . . . 0.0 108.765 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -42.15 94.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.219 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.63 -55.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.443 1.497 . . . . 0.0 110.12 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -58.42 -35.54 72.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 118.9 0.773 . . . . 0.0 112.086 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -53.65 -56.34 18.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 1.1 mmm -61.61 -35.81 78.91 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.851 0.75 . . . . 0.0 111.703 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.36 -28.76 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.137 1.335 . . . . 0.0 111.462 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -90.44 -55.96 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.258 0.623 . . . . 0.0 110.827 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.56 -53.8 51.55 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.903 0.774 . . . . 0.0 112.756 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.87 76.41 11.55 Favored Pre-proline 0 N--CA 1.446 -0.654 0 C-N-CA 125.301 1.441 . . . . 0.0 109.059 -172.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -12.44 29.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.531 2.154 . . . . 0.0 112.41 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -61.88 -19.84 63.08 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.893 -1.129 . . . . 0.0 111.729 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.598 ' HA ' HD12 ' A' ' 113' ' ' LEU . 26.5 mtm180 -110.25 6.64 22.71 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.24 1.416 . . . . 0.0 113.118 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.85 95.68 3.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.687 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.3 m-85 -93.29 139.92 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -140.23 156.8 46.35 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 119.382 0.992 . . . . 0.0 112.882 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.24 132.7 1.65 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.73 -51.08 4.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.028 1.731 . . . . 0.0 112.276 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -59.13 -49.46 77.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.472 1.109 . . . . 0.0 110.264 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.87 -55.07 38.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.3 t -53.58 -40.14 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.41 -0.806 . . . . 0.0 111.451 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.34 -41.49 76.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.27 0.941 . . . . 0.0 110.964 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -44.91 83.31 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.082 -1.011 . . . . 0.0 109.647 176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -62.89 -31.75 72.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -62.72 -45.8 91.08 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.269 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.88 -25.1 66.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.61 -5.6 57.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.771 0.828 . . . . 0.0 111.541 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 58.31 19.96 6.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.509 1.524 . . . . 0.0 111.897 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.14 -5.72 15.86 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.201 -163.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.47 109.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.83 -45.97 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.231 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -146.22 133.46 20.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.06 123.74 50.23 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.347 1.859 . . . . 0.0 106.488 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.29 126.28 46.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 106.719 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -137.02 139.57 44.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.38 131.9 44.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.73 -34.2 67.27 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.99 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.58 -35.83 14.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.471 1.487 . . . . 0.0 113.591 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.8 mt -81.08 -42.43 21.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.023 0.829 . . . . 0.0 110.553 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -55.41 -28.91 57.15 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.069 -1.019 . . . . 0.0 112.218 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -106.45 16.62 24.45 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 127.533 2.333 . . . . 0.0 110.924 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -50.77 139.15 17.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.114 1.324 . . . . 0.0 111.254 -162.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -35.37 74.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.593 1.157 . . . . 0.0 111.74 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.16 119.91 20.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.509 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.405 1.002 . . . . 0.0 109.948 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -56.97 -45.05 83.16 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.637 1.175 . . . . 0.0 111.281 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -51.29 -48.79 62.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.065 1.302 . . . . 0.0 111.817 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -13.62 15.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.243 -1.36 . . . . 0.0 113.961 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -75.2 -63.47 1.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.684 1.584 . . . . 0.0 108.556 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.5 m-85 -49.56 -53.86 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.828 -0.606 . . . . 0.0 112.039 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.59 -36.31 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.76 1.164 . . . . 0.0 111.544 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -64.78 -47.34 78.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 122.028 -0.42 . . . . 0.0 110.941 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.48 -46.63 89.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.712 0.805 . . . . 0.0 110.243 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 58' ' ' LEU . 95.0 t -60.13 -39.09 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.506 1.123 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.23 -43.05 58.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.568 -1.333 . . . . 0.0 110.883 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 t -64.36 -28.26 69.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.454 0.57 . . . . 0.0 111.151 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -65.15 -36.49 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 120.199 -1.563 . . . . 0.0 110.474 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -63.64 -45.62 89.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.365 1.439 . . . . 0.0 109.843 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.41 -37.36 64.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.363 1.065 . . . . 0.0 110.398 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -93.14 20.35 6.98 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.57 1.548 . . . . 0.0 111.215 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.12 27.47 16.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.27 2.228 . . . . 0.0 114.001 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.79 163.06 24.47 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -86.59 145.97 26.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.659 1.583 . . . . 0.0 109.124 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.86 139.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -128.3 121.22 28.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.76 122.09 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -94.46 128.41 41.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 117.4 5.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -58.81 -24.71 62.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.297 1.439 . . . . 0.0 112.415 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.07 -26.16 65.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 111.717 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -81.61 147.32 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.468 1.907 . . . . 0.0 109.436 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.05 -16.06 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.261 1.025 . . . . 0.0 112.262 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -60.19 -35.98 76.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.432 -1.417 . . . . 0.0 111.42 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.92 97.23 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -72.46 -38.24 68.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.11 0.964 . . . . 0.0 111.639 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -57.17 -51.32 69.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.36 -0.838 . . . . 0.0 109.343 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.59 -30.96 71.98 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.7 t -58.04 -37.3 74.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.445 1.898 . . . . 0.0 111.249 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -52.2 -33.45 40.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.61 1.164 . . . . 0.0 110.871 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.7 mt -105.49 31.29 5.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.674 2.79 . . . . 0.0 109.997 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 p 75.11 -14.93 0.71 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.871 2.868 . . . . 0.0 113.479 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.0 14.75 58.8 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.292 2.377 . . . . 0.0 113.13 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.54 132.68 27.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 120.096 1.948 . . . . 0.0 108.976 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.97 175.1 14.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.359 1.063 . . . . 0.0 109.823 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.53 144.46 15.43 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 86.2 mt -83.9 143.11 12.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD13 HG23 ' A' ' 117' ' ' VAL . 13.5 mt -117.09 151.51 36.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 0.0 110.653 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -63.88 -51.91 62.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.735 170.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.08 154.73 80.48 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.256 1.423 . . . . 0.0 110.479 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.24 106.66 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.165 3.243 . . . . 0.0 108.733 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 113' ' ' LEU . 80.7 t . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 122.705 0.402 . . . . 0.0 110.071 -163.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -25.72 66.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.175 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.95 65.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 121.566 1.985 . . . . 0.0 112.056 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.04 16.66 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 172.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.24 -50.31 73.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.289 0.636 . . . . 0.0 111.038 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.99 -47.88 88.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.314 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -55.58 26.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.297 1.408 . . . . 0.0 109.113 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.61 -28.05 66.85 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 127.288 2.235 . . . . 0.0 112.524 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.1 -45.93 17.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.828 1.251 . . . . 0.0 110.218 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -54.45 -48.69 71.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.284 1.834 . . . . 0.0 109.276 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.32 -40.24 67.6 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.183 1.393 . . . . 0.0 109.531 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -59.2 -54.39 47.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.782 1.233 . . . . 0.0 109.891 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -58.28 -38.24 76.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.361 0.665 . . . . 0.0 112.175 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -50.85 -57.2 9.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mmm -59.53 -39.06 82.7 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.4 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -53.36 -25.95 17.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.759 1.224 . . . . 0.0 112.054 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -96.28 -51.63 4.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.167 1.787 . . . . 0.0 111.504 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.75 -64.77 0.86 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.105 -0.997 . . . . 0.0 111.61 -172.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -134.32 81.68 48.96 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.06 -14.42 43.37 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.45 2.1 . . . . 0.0 111.999 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.94 -23.75 7.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.621 1.568 . . . . 0.0 112.087 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 60.9 mtp180 -106.21 13.97 28.19 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.896 1.278 . . . . 0.0 111.995 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.72 90.96 2.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.107 1.322 . . . . 0.0 110.728 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.64 138.75 31.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 109.25 -175.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 13.0 p90 -139.41 158.75 43.6 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.711 0.767 . . . . 0.0 111.308 171.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 134.76 1.33 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -172.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -44.33 -48.05 9.62 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 124.484 1.114 . . . . 0.0 110.84 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -60.7 -44.1 96.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.664 1.186 . . . . 0.0 111.365 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.83 -58.68 6.07 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 t -53.69 -38.8 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.699 0.8 . . . . 0.0 112.195 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.36 -36.94 74.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.749 1.159 . . . . 0.0 110.934 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -46.82 63.2 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.97 0.908 . . . . 0.0 109.557 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -63.59 -35.59 81.0 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -62.2 -44.51 96.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.47 -22.0 66.83 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.44 59.21 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.668 0.787 . . . . 0.0 111.375 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 28.0 mtt 52.06 44.52 29.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.362 1.465 . . . . 0.0 109.581 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -119.93 -9.95 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.246 2.219 . . . . 0.0 111.903 -170.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 49' ' ' ALA . 18.8 mt -80.08 105.95 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.22 -53.07 54.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.812 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 m -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.654 1.181 . . . . 0.0 108.292 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -109.77 137.87 46.96 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.386 1.874 . . . . 0.0 108.029 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.39 128.97 55.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.053 1.741 . . . . 0.0 107.725 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -144.95 143.47 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.402 1.001 . . . . 0.0 110.393 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.17 142.91 50.67 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.366 1.066 . . . . 0.0 109.724 170.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -56.5 -42.65 78.7 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.05 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.27 -20.81 7.74 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.6 -45.33 8.54 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.872 0.869 . . . . 0.0 109.202 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -51.32 -29.93 16.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.842 1.257 . . . . 0.0 112.276 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.91 31.35 5.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 110.841 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -51.68 148.01 5.94 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.666 0.666 . . . . 0.0 111.518 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -68.46 -31.29 70.48 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.413 1.485 . . . . 0.0 112.832 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.57 118.3 28.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.6 -30.63 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.34 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 -54.05 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.9 1.682 . . . . 0.0 109.891 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.4 m -58.2 -51.46 69.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.334 1.854 . . . . 0.0 110.756 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -58.26 -48.9 78.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.351 0.978 . . . . 0.0 110.242 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 m -55.14 -35.41 64.67 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.141 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -60.76 -51.82 67.71 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.46 1.027 . . . . 0.0 111.015 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -60.66 -51.45 69.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.181 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.0 m -63.83 -37.46 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.089 0.859 . . . . 0.0 110.971 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -57.82 -53.8 54.07 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.943 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.08 -48.21 82.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.315 1.009 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.54 -47.34 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.545 1.138 . . . . 0.0 110.526 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 5.3 m-20 -68.08 -43.22 79.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.653 -0.654 . . . . 0.0 110.555 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -72.85 -30.38 63.96 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.038 0.935 . . . . 0.0 110.324 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.29 -42.47 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.85 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 7.0 mtmp? -65.4 -39.24 91.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.898 0.772 . . . . 0.0 111.216 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.37 -25.61 66.87 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.933 -0.479 . . . . 0.0 111.561 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -100.71 44.1 1.03 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.45 5.04 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.447 3.099 . . . . 0.0 116.97 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.75 -174.47 48.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.486 1.517 . . . . 0.0 113.958 -171.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -130.79 149.33 52.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.802 2.441 . . . . 0.0 110.57 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.85 147.12 16.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.264 1.426 . . . . 0.0 108.826 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -147.21 126.59 13.13 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.849 2.06 . . . . 0.0 107.187 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -116.04 123.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.01 164.48 13.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.54 1.536 . . . . 0.0 108.331 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 136.75 42.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 162.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.8 t -51.61 -28.59 14.69 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.118 0.967 . . . . 0.0 111.47 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.18 -26.6 66.71 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 126.649 1.98 . . . . 0.0 113.613 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' A' ' 99' ' ' SER . 6.4 t-80 -84.03 158.85 21.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.669 0.788 . . . . 0.0 110.913 -165.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.44 -40.76 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 118.947 0.794 . . . . 0.0 109.321 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 97' ' ' HIS . 1.6 m -60.06 -23.32 63.67 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.863 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.69 -53.05 10.33 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.955 1.74 . . . . 0.0 110.97 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.19 -27.36 69.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.653 1.727 . . . . 0.0 112.071 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.55 -46.12 73.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.467 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.3 tp -63.26 -34.64 78.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.747 -0.596 . . . . 0.0 111.022 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -57.91 -38.42 75.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.923 1.689 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -55.42 -23.38 24.6 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.344 -0.847 . . . . 0.0 111.085 173.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.53 30.81 7.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.763 2.825 . . . . 0.0 110.238 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.2 p 66.41 19.76 10.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.096 1.358 . . . . 0.0 113.969 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.44 15.65 52.94 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.355 2.407 . . . . 0.0 114.533 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.01 124.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . . . -147.61 174.15 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.52 146.67 8.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.31 -0.869 . . . . 0.0 110.829 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.4 mt -83.83 152.45 3.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.603 HD13 HG23 ' A' ' 117' ' ' VAL . 42.1 mt -115.38 145.74 42.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.783 0.801 . . . . 0.0 109.781 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -64.5 -46.71 81.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.982 1.313 . . . . 0.0 109.906 165.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.3 p90 -138.14 152.85 72.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.428 1.491 . . . . 0.0 108.747 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 124.27 10.62 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.165 2.577 . . . . 0.0 109.105 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 113' ' ' LEU . 86.0 t . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.3 74.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.459 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -56.62 17.24 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.646 1.112 . . . . 0.0 110.928 -172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.3 93.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -50.84 40.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.95 1.3 . . . . 0.0 109.003 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.0 -41.68 83.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 125.204 1.402 . . . . 0.0 109.949 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -59.0 -44.01 91.6 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 119.118 0.872 . . . . 0.0 109.205 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -60.72 -39.0 87.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.968 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.0 tp -64.16 -48.68 75.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.437 1.017 . . . . 0.0 110.571 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -53.28 -50.94 63.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.338 1.455 . . . . 0.0 109.099 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -66.36 -46.89 75.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.413 2.285 . . . . 0.0 109.416 -171.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -54.81 -56.21 21.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.476 1.51 . . . . 0.0 110.375 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.44 -30.68 70.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -50.76 -62.73 1.42 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.659 0.599 . . . . 0.0 109.486 169.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -62.67 -29.49 70.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.048 -0.977 . . . . 0.0 111.613 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.25 -29.58 58.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.102 1.319 . . . . 0.0 111.76 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -92.31 -50.06 5.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.971 0.908 . . . . 0.0 110.367 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -73.37 -48.11 36.76 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -168.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.81 81.1 8.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.803 1.241 . . . . 0.0 109.062 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.83 -12.07 33.6 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.992 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -20.04 10.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 111.604 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 113' ' ' LEU . 81.5 mtp180 -111.7 2.57 17.28 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.831 1.252 . . . . 0.0 113.106 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.06 88.48 2.91 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.583 1.083 . . . . 0.0 108.608 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.6 m-30 -93.78 134.33 36.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.555 0.742 . . . . 0.0 109.011 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -140.74 164.79 29.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.396 0.617 . . . . 0.0 112.619 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.35 126.14 0.51 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -168.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 tp -37.14 -50.04 0.92 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.202 2.201 . . . . 0.0 110.785 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.64 -51.89 52.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 128.671 2.788 . . . . 0.0 114.084 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.22 -50.4 68.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.601 1.191 . . . . 0.0 107.959 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.76 -31.95 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.333 1.053 . . . . 0.0 111.131 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.86 -19.66 65.06 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.933 1.293 . . . . 0.0 112.713 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.74 -42.4 34.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 119.519 -1.988 . . . . 0.0 109.458 165.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.47 71.07 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -60.47 -43.83 96.52 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 119.11 0.868 . . . . 0.0 108.869 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -66.3 -11.17 49.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.57 -5.43 45.91 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.445 1.498 . . . . 0.0 112.078 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 29.1 mmt 55.49 14.15 1.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.85 . . . . 0.0 113.092 -166.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -87.92 -9.64 53.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.87 -1.144 . . . . 0.0 112.909 -162.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.2 mt -72.54 110.6 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.33 -60.19 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.577 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.2 m -144.79 141.79 29.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.592 HD21 HG22 ' A' ' 80' ' ' VAL . 9.5 tp -110.06 133.98 52.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 107.773 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.34 119.49 35.87 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.6 1.56 . . . . 0.0 107.128 175.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 tt -138.85 141.2 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.02 144.47 55.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -59.54 -38.41 80.98 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.094 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -16.53 27.98 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.62 -40.42 9.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.94 1.245 . . . . 0.0 110.042 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.01 -19.19 17.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.72 0.808 . . . . 0.0 111.986 167.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -122.58 21.0 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.973 2.909 . . . . 0.0 111.372 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -56.73 151.96 13.17 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.571 0.749 . . . . 0.0 110.989 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -63.78 -47.18 81.98 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.179 0.591 . . . . 0.0 111.86 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.79 122.73 24.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.83 -32.09 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.684 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.82 -57.78 5.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.919 1.691 . . . . 0.0 110.494 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -53.04 -52.07 59.68 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.037 0.935 . . . . 0.0 109.532 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -57.01 -46.19 82.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.696 -0.628 . . . . 0.0 111.552 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 m -52.72 -42.56 64.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.859 0.754 . . . . 0.0 110.911 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -57.99 -52.6 64.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.918 0.887 . . . . 0.0 109.036 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -60.47 -53.14 61.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.272 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -61.22 -36.78 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.838 1.199 . . . . 0.0 110.758 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -53.15 34.09 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.34 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.05 -37.08 81.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.736 0.698 . . . . 0.0 111.482 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.592 HG22 HD21 ' A' ' 58' ' ' LEU . 25.0 t -53.75 -53.4 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 109.922 168.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -58.81 -47.39 84.94 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.872 1.269 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.8 m -63.0 -33.14 74.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.195 1.798 . . . . 0.0 112.014 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.13 -35.64 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 120.602 -1.311 . . . . 0.0 110.62 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.98 -34.51 77.91 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.47 0.577 . . . . 0.0 109.701 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.37 -34.75 78.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.713 0.688 . . . . 0.0 110.374 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -79.23 3.01 19.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.916 1.287 . . . . 0.0 112.101 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.59 24.53 10.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.381 2.272 . . . . 0.0 113.696 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.24 166.09 29.38 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.4 m -92.56 157.02 16.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.109 0.957 . . . . 0.0 111.126 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.08 147.72 17.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.968 1.707 . . . . 0.0 107.23 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -132.94 121.48 22.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.18 108.11 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HE2' HD13 ' A' ' 25' ' ' LEU . 3.6 m-30 -89.19 156.13 18.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.2 m -103.12 136.12 43.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 t -52.55 -39.5 61.53 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 124.7 1.25 . . . . 0.0 111.895 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.44 -23.58 63.7 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.849 -1.157 . . . . 0.0 113.481 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -85.81 148.98 25.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.182 0.993 . . . . 0.0 109.646 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.47 -17.55 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.922 -1.112 . . . . 0.0 111.697 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 p -57.16 -34.98 68.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.711 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.71 -44.4 57.04 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.31 -38.3 71.08 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.9 0.85 . . . . 0.0 110.916 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -76.8 -37.21 56.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.188 -0.945 . . . . 0.0 112.128 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.41 -32.04 73.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.563 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -56.11 -40.72 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.853 1.661 . . . . 0.0 111.287 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -58.24 -15.71 11.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 112.071 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.36 37.42 4.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 129.073 2.949 . . . . 0.0 108.901 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p 66.54 9.51 6.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.728 2.011 . . . . 0.0 114.72 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.26 15.7 65.93 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.119 2.295 . . . . 0.0 113.385 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.7 111.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.049 0.925 . . . . 0.0 108.708 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.66 174.12 10.93 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.638 1.575 . . . . 0.0 109.258 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.23 146.45 8.94 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.873 -1.142 . . . . 0.0 110.251 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.439 HG23 ' SD ' ' A' ' 31' ' ' MET . 80.6 mt -83.8 152.01 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.232 1.413 . . . . 0.0 107.916 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 117' ' ' VAL . 38.8 mt -117.16 138.45 51.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.996 0.919 . . . . 0.0 110.691 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -60.99 -42.08 97.74 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.035 1.334 . . . . 0.0 110.119 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.5 p90 -139.07 157.1 71.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 125.721 1.609 . . . . 0.0 107.941 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.0 125.07 12.56 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.83 2.354 . . . . 0.0 108.807 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 113' ' ' LEU . 63.2 t . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.01 80.81 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 123.809 0.693 . . . . 0.0 110.363 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.58 -24.5 67.58 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.98 -43.19 74.43 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.48 -51.44 60.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 127.415 2.286 . . . . 0.0 110.528 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.71 -50.42 80.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 119.094 0.861 . . . . 0.0 109.3 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -60.47 -41.93 95.2 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.86 -0.525 . . . . 0.0 110.906 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.42 -48.67 80.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.92 -44.85 94.06 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.136 -0.978 . . . . 0.0 110.184 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.49 -50.8 72.43 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.186 1.795 . . . . 0.0 109.866 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.04 -42.28 80.78 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.083 1.49 . . . . 0.0 108.455 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.42 -58.45 7.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.653 1.181 . . . . 0.0 109.496 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.63 -40.34 75.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.563 0.345 . . . . 0.0 111.626 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.93 -44.2 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.928 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -35.58 62.44 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 119.127 0.876 . . . . 0.0 109.334 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -54.06 -33.41 57.39 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.658 1.117 . . . . 0.0 112.168 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -70.63 -56.84 5.53 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.945 1.698 . . . . 0.0 110.695 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -94.38 -52.93 4.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.395 1.478 . . . . 0.0 113.409 -160.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -138.09 71.69 47.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.713 1.605 . . . . 0.0 107.521 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.35 -10.64 26.82 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 112.488 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.08 -24.04 16.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.334 2.254 . . . . 0.0 111.571 167.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HA ' HD12 ' A' ' 113' ' ' LEU . 82.4 mtp180 -104.46 10.96 35.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.443 1.097 . . . . 0.0 112.063 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.36 96.66 3.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.841 1.2 . . . . 0.0 108.512 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.3 m-30 -93.92 133.19 37.61 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.951 0.9 . . . . 0.0 108.893 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -139.78 160.56 39.6 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.41 133.98 0.52 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -167.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 tp -40.45 -52.89 2.72 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 126.258 1.823 . . . . 0.0 111.576 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -54.56 -46.0 73.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.621 1.568 . . . . 0.0 111.983 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.1 -59.85 4.46 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.69 -39.48 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.596 1.158 . . . . 0.0 112.332 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -54.68 -39.23 67.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.333 1.053 . . . . 0.0 111.505 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.94 -53.21 22.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.799 1.24 . . . . 0.0 110.539 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -55.93 -36.02 67.27 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -58.74 -47.29 85.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.66 -33.8 75.79 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.98 -9.24 57.6 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.164 0.586 . . . . 0.0 111.682 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 44.7 mtt 55.4 24.42 6.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 127.494 2.318 . . . . 0.0 111.839 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -84.86 -13.97 49.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.747 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 mt -66.39 106.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.568 1.147 . . . . 0.0 109.03 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.77 -57.05 4.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.5 m -134.99 131.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.81 132.08 54.47 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.834 2.054 . . . . 0.0 106.522 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 118.88 31.5 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 tt -136.23 139.95 44.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.668 1.122 . . . . 0.0 109.222 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.37 133.12 54.62 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -38.57 75.55 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.247 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.32 -20.48 28.95 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 113.948 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.22 -43.53 10.93 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -50.73 -31.41 16.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 112.157 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.09 46.96 2.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.178 2.191 . . . . 0.0 108.431 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.38 152.52 33.86 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.294 0.638 . . . . 0.0 110.393 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.21 -33.38 63.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.447 1.499 . . . . 0.0 112.874 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -83.61 119.73 25.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.684 1.129 . . . . 0.0 108.858 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -51.85 -44.38 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 117.829 -1.082 . . . . 0.0 112.787 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.02 69.37 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.857 1.662 . . . . 0.0 111.644 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.1 -46.11 82.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.23 1.012 . . . . 0.0 108.748 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -53.87 -50.02 67.22 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.345 0.975 . . . . 0.0 109.417 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 t -52.04 -44.07 64.06 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.11 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -57.65 -55.4 35.28 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.493 1.042 . . . . 0.0 109.349 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -56.45 -50.88 70.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.29 -36.9 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.369 0.986 . . . . 0.0 111.251 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -49.67 75.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.812 0.733 . . . . 0.0 109.044 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 tp -56.21 -51.13 69.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.891 0.877 . . . . 0.0 109.594 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.6 t -54.0 -47.63 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.588 0.755 . . . . 0.0 111.406 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.91 -54.39 22.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.29 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 -11.74 61.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.585 0.754 . . . . 0.0 112.089 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.83 -39.32 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 O-C-N 120.312 -1.493 . . . . 0.0 109.714 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -61.26 -47.78 84.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.036 1.289 . . . . 0.0 108.589 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -51.92 -47.94 64.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.46 1.104 . . . . 0.0 110.086 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -82.25 9.94 7.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.894 0.877 . . . . 0.0 112.264 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 87.91 4.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 130.221 3.408 . . . . 0.0 114.486 166.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.18 162.47 40.42 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.893 -1.129 . . . . 0.0 113.246 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.8 m -87.0 130.4 34.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.501 2.32 . . . . 0.0 109.128 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.04 145.46 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.469 171.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -131.89 132.79 43.93 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 127.163 2.185 . . . . 0.0 106.374 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -118.62 113.42 41.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -90.57 140.35 29.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.076 1.751 . . . . 0.0 109.73 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 m -87.47 130.5 34.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.467 0.707 . . . . 0.0 111.243 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -51.23 -42.01 60.7 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.724 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -70.32 -17.65 63.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.968 1.707 . . . . 0.0 113.511 -171.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -93.95 150.15 20.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.204 1.401 . . . . 0.0 110.093 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.89 -31.44 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -53.71 -23.01 10.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.408 0.683 . . . . 0.0 111.311 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 -53.06 5.87 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 118.243 -1.309 . . . . 0.0 112.377 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.74 -29.56 70.19 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.246 1.523 . . . . 0.0 110.69 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.4 -55.26 14.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.498 1.519 . . . . 0.0 110.14 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.29 -37.03 76.68 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 119.449 1.022 . . . . 0.0 110.914 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -58.1 -35.23 71.12 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 111.795 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -60.5 -25.56 66.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.544 -0.722 . . . . 0.0 111.741 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -102.71 20.03 18.06 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.675 2.39 . . . . 0.0 109.656 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.277 17.5 p 78.09 0.92 2.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.471 3.508 . . . . 0.0 113.71 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.88 22.15 62.02 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 127.056 2.265 . . . . 0.0 112.289 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.81 109.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.904 1.352 . . . . 0.0 108.016 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.15 176.36 9.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.513 1.525 . . . . 0.0 111.437 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.37 146.67 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.897 171.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.56 143.76 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 C-N-CA 126.319 1.848 . . . . 0.0 107.634 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.725 HD13 HG23 ' A' ' 117' ' ' VAL . 13.4 mt -117.23 129.32 55.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 124.298 0.999 . . . . 0.0 109.631 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -54.0 -41.14 67.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.49 1.516 . . . . 0.0 110.467 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.1 p90 -137.67 154.76 75.14 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.847 1.659 . . . . 0.0 107.788 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.54 106.6 1.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.044 3.163 . . . . 0.0 108.478 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.725 HG23 HD13 ' A' ' 113' ' ' LEU . 91.6 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.45 98.73 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.325 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.11 -19.42 65.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.008 1.731 . . . . 0.0 112.761 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.83 -53.86 5.17 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 120.958 -1.088 . . . . 0.0 110.46 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.73 -51.71 66.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.943 0.897 . . . . 0.0 110.827 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.88 -48.63 78.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 126.192 1.797 . . . . 0.0 110.576 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -54.55 -48.94 71.43 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 119.56 1.073 . . . . 0.0 109.67 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -42.42 99.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.013 0.82 . . . . 0.0 111.813 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.33 -48.8 78.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.002 0.819 . . . . 0.0 110.716 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -61.47 -52.99 62.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.167 1.787 . . . . 0.0 109.342 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.2 -37.77 86.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.161 0.984 . . . . 0.0 108.886 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -58.94 -57.06 14.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.231 1.012 . . . . 0.0 110.341 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.89 -32.55 72.0 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.94 -59.25 3.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.16 -39.18 85.53 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.978 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.09 -20.27 51.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.857 0.753 . . . . 0.0 111.977 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -96.13 -53.36 3.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.532 1.133 . . . . 0.0 111.551 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -63.65 -66.36 0.55 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.521 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -145.11 80.83 10.9 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 109.616 -172.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.04 -6.52 8.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.228 2.619 . . . . 0.0 114.532 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.37 -25.07 33.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.091 0.86 . . . . 0.0 111.756 165.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HA ' HD12 ' A' ' 113' ' ' LEU . 31.0 mtm-85 -106.91 14.46 26.52 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.441 1.096 . . . . 0.0 112.015 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.56 92.71 3.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.305 0.957 . . . . 0.0 109.214 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.4 m-30 -93.75 132.78 37.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -139.9 163.48 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.497 0.719 . . . . 0.0 109.948 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 123.78 0.93 Allowed Glycine 0 C--N 1.331 0.269 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 -170.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.77 -46.8 2.75 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.726 1.611 . . . . 0.0 111.939 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.15 -55.57 26.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.765 2.826 . . . . 0.0 110.698 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.06 -57.42 13.16 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -50.92 -41.94 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.384 1.473 . . . . 0.0 111.835 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -56.8 -33.5 66.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.494 1.117 . . . . 0.0 111.488 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -77.3 -42.42 36.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 110.498 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -65.6 -32.21 73.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.243 -0.911 . . . . 0.0 112.126 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -57.09 -51.33 69.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.1 -31.23 70.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -9.22 58.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.875 0.87 . . . . 0.0 111.319 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.2 mmt 62.27 21.44 12.49 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 110.948 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -90.4 -16.21 29.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 112.343 -168.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 mt -70.63 113.71 7.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -80.08 -55.41 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -137.95 128.87 27.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 111' ' ' ALA . 9.8 tp -110.61 131.1 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.96 2.104 . . . . 0.0 108.757 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.16 124.65 52.01 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 108.077 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.05 144.15 27.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 119.785 1.175 . . . . 0.0 108.382 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.29 136.5 53.55 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.39 -35.61 63.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.861 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.71 -16.0 55.41 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.36 1.436 . . . . 0.0 114.287 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.43 -40.8 9.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.607 1.163 . . . . 0.0 109.811 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -52.17 -29.31 21.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.237 1.015 . . . . 0.0 112.55 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 51.07 1.92 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.081 2.552 . . . . 0.0 108.159 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -57.98 148.25 26.57 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.314 -0.866 . . . . 0.0 109.954 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.79 -39.09 87.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.86 117.2 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.587 1.155 . . . . 0.0 108.641 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.51 -33.09 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.267 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.03 60.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 120.782 1.628 . . . . 0.0 109.762 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -59.21 -48.52 81.31 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 111.105 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -52.82 -50.92 62.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.292 0.951 . . . . 0.0 109.873 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -51.71 -42.04 61.94 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -56.8 -55.77 30.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.036 1.289 . . . . 0.0 110.341 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -57.3 -55.04 39.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.147 0.904 . . . . 0.0 111.014 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 t -51.43 -54.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.9 1.28 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -64.52 -40.25 95.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 tp -67.65 -41.39 83.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.413 0.552 . . . . 0.0 111.621 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.44 -48.95 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.622 1.169 . . . . 0.0 108.925 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -42.36 98.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.1 0.96 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 m -66.37 -32.19 73.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.478 1.911 . . . . 0.0 111.956 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.15 -38.03 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 120.34 -1.475 . . . . 0.0 110.467 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -61.77 -44.5 96.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.961 0.801 . . . . 0.0 109.819 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -54.41 -38.03 65.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.229 1.012 . . . . 0.0 110.268 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -93.93 16.82 13.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.842 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 89.77 1.47 0.23 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 128.977 2.911 . . . . 0.0 114.277 168.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.76 152.57 22.52 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.732 1.151 . . . . 0.0 112.775 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -80.35 152.2 29.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.891 2.076 . . . . 0.0 108.491 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.75 139.51 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -130.63 121.67 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.06 108.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 147.85 23.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.188 1.395 . . . . 0.0 109.532 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.98 136.26 45.1 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 171.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.8 t -71.56 4.93 2.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.542 0.737 . . . . 0.0 111.795 167.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.8 mt -121.47 -0.8 9.71 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.614 1.965 . . . . 0.0 112.607 -168.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -106.3 159.56 16.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.333 2.253 . . . . 0.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 m -58.76 -27.46 64.98 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.277 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.87 -54.72 7.97 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-O 119.004 -0.886 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.96 -31.94 73.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.073 0.937 . . . . 0.0 111.721 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.08 -46.15 90.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.989 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.53 -37.89 87.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.318 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.4 m -57.62 -29.15 64.29 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.566 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -66.41 -17.23 64.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 112.856 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -122.59 48.34 1.78 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.797 2.439 . . . . 0.0 107.251 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.5 p 63.03 4.47 1.55 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.69 1.996 . . . . 0.0 114.665 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.27 65.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.144 2.307 . . . . 0.0 112.904 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.7 p -154.32 113.19 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 118.866 1.333 . . . . 0.0 109.668 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.88 176.61 9.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 112.015 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -164.08 147.47 9.63 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.179 -1.576 . . . . 0.0 111.231 174.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -85.72 141.46 14.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.524 1.53 . . . . 0.0 107.68 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' A' ' 40' ' ' PHE . 40.0 mt -108.47 138.7 44.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.832 0.853 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -52.04 -52.6 49.93 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.911 1.685 . . . . 0.0 109.752 168.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.2 p90 -136.02 159.34 71.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 127.448 2.299 . . . . 0.0 107.382 -170.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.81 142.27 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.631 1.554 . . . . 0.0 109.514 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 113' ' ' LEU . 69.1 t . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.77 79.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.965 0.348 . . . . 0.0 110.514 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.15 97.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.503 1.121 . . . . 0.0 112.466 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.49 63.63 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -50.76 54.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.26 1.424 . . . . 0.0 107.856 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.03 -51.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 110.39 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -60.32 -37.97 82.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.403 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.78 -35.48 74.93 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.219 0.918 . . . . 0.0 111.321 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tp -60.8 -49.07 78.96 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.056 0.844 . . . . 0.0 109.314 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -54.17 -56.81 14.64 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.52 1.128 . . . . 0.0 108.635 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -56.82 -43.46 81.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.084 0.865 . . . . 0.0 109.552 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.92 -54.55 40.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.835 0.854 . . . . 0.0 110.882 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.15 -35.73 77.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.795 0.725 . . . . 0.0 112.922 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -47.73 -59.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 108.206 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -62.23 -38.92 91.04 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.552 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.25 -29.28 57.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.044 1.293 . . . . 0.0 111.309 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -94.61 -47.08 6.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -69.39 -58.27 4.22 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.552 0.614 . . . . 0.0 111.658 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HE ' ' A' ' 38' ' ' ARG . 11.0 pt-20 -144.92 79.33 12.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 C-N-CA 124.315 1.046 . . . . 0.0 109.369 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.65 -10.49 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.289 1.993 . . . . 0.0 114.571 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.22 -21.02 61.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.3 1.409 . . . . 0.0 111.23 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HA ' HD12 ' A' ' 113' ' ' LEU . 24.2 mtm180 -102.97 12.33 36.21 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.824 1.193 . . . . 0.0 112.46 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.03 93.6 2.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.922 1.237 . . . . 0.0 109.064 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 3.1 m-30 -97.34 138.26 35.08 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.468 0.707 . . . . 0.0 109.934 -175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -140.3 159.08 42.98 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.31 131.69 0.81 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 tp -43.27 -50.51 6.52 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.999 1.72 . . . . 0.0 112.968 -166.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -52.78 -55.81 20.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.528 1.931 . . . . 0.0 109.952 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -56.84 -57.14 13.78 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 t -47.96 -46.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.975 1.71 . . . . 0.0 111.675 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.36 -43.43 75.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.757 1.162 . . . . 0.0 110.382 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -64.32 -40.51 96.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.067 -1.021 . . . . 0.0 110.349 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -67.6 -33.91 75.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.424 -0.797 . . . . 0.0 112.781 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -68.46 -42.57 78.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.49 -19.98 65.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.943 1.697 . . . . 0.0 113.118 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.58 -13.6 54.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.479 1.111 . . . . 0.0 111.897 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 57.36 24.86 10.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.469 1.908 . . . . 0.0 111.553 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.62 -15.06 31.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.438 -1.268 . . . . 0.0 111.891 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.07 107.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.505 1.048 . . . . 0.0 108.663 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.84 -48.45 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 172.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -143.78 134.31 24.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' VAL . 3.4 tp -110.15 133.95 52.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.863 2.065 . . . . 0.0 107.314 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 124.61 48.54 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.108 1.763 . . . . 0.0 108.175 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 tt -138.64 134.97 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -62.32 125.88 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.743 1.217 . . . . 0.0 107.88 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -57.12 -32.41 66.32 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.017 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -54.13 -25.85 24.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.117 1.326 . . . . 0.0 113.44 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 mt -86.59 -42.15 13.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.51 1.124 . . . . 0.0 109.603 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -52.1 -27.58 14.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.262 1.425 . . . . 0.0 112.481 170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 34.78 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 110.591 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -55.7 146.81 20.05 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.016 -0.428 . . . . 0.0 111.185 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.412 HE21 ' C ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -68.48 -25.21 64.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.37 120.67 31.69 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.61 -36.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.052 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -56.36 15.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.995 1.725 . . . . 0.0 109.888 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -53.68 -56.11 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.386 1.874 . . . . 0.0 110.232 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.09 -49.88 72.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.943 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -53.32 -41.82 66.07 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.94 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -57.39 -51.76 68.1 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.038 0.836 . . . . 0.0 110.383 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -60.79 -54.44 45.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.286 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.74 -31.79 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.581 1.082 . . . . 0.0 110.758 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -61.08 -58.21 9.32 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 109.075 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.371 1.068 . . . . 0.0 111.689 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 HD21 ' A' ' 58' ' ' LEU . 42.4 t -53.55 -46.22 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.13 . . . . 0.0 110.485 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.14 -37.87 69.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 0.0 111.46 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.2 t -67.01 -38.58 86.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.211 1.804 . . . . 0.0 110.859 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -55.38 -39.59 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 121.557 -0.715 . . . . 0.0 110.659 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.95 -39.3 87.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.794 0.724 . . . . 0.0 110.848 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.58 -28.55 69.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.686 0.794 . . . . 0.0 111.022 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -91.59 12.98 19.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.093 1.757 . . . . 0.0 110.732 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.11 26.4 15.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.471 . . . . 0.0 114.928 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.05 159.9 25.76 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.308 -0.87 . . . . 0.0 111.162 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -93.93 157.22 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.899 1.68 . . . . 0.0 110.184 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.54 148.37 25.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.1 0.96 . . . . 0.0 109.112 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.5 mmt-85 -141.83 121.68 13.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.37 112.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.12 124.57 34.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.1 m -74.02 139.9 45.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.771 0.26 . . . . 0.0 111.034 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 t -61.39 10.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.261 2.625 . . . . 0.0 115.065 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER -118.75 3.63 11.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.61 2.364 . . . . 0.0 113.665 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -114.28 139.41 49.44 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.331 1.452 . . . . 0.0 110.886 -169.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 p -56.2 -28.93 26.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.688 0.795 . . . . 0.0 110.841 172.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.1 m -64.64 -27.72 69.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.726 -0.609 . . . . 0.0 111.529 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.64 52.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.67 -26.89 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.567 0.684 . . . . 0.0 112.002 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.47 -41.37 47.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.303 1.441 . . . . 0.0 110.381 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.38 -26.91 68.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 0.0 112.427 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 t -41.24 -54.9 2.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.176 2.19 . . . . 0.0 110.843 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -61.53 -5.23 1.67 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.638 1.975 . . . . 0.0 113.784 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 mt -131.66 33.97 3.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.784 2.433 . . . . 0.0 109.323 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.8 p 64.37 12.08 6.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.293 1.837 . . . . 0.0 113.671 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.4 17.19 68.24 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.996 2.236 . . . . 0.0 114.182 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.05 115.08 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.919 1.86 . . . . 0.0 108.856 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.97 15.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.343 1.057 . . . . 0.0 111.432 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.71 144.61 13.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.258 -1.526 . . . . 0.0 110.547 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.7 mt -84.12 144.29 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.162 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.684 HD13 HG23 ' A' ' 117' ' ' VAL . 20.8 mt -114.23 146.03 40.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.609 0.764 . . . . 0.0 109.512 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -71.26 -42.84 68.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.685 1.194 . . . . 0.0 110.43 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -129.34 157.39 76.35 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.113 1.365 . . . . 0.0 108.069 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 107.11 1.78 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.824 2.349 . . . . 0.0 106.888 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 HD13 ' A' ' 113' ' ' LEU . 54.5 t . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 tttt . . . . . 0 C--O 1.231 0.099 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.37 -45.83 46.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.795 1.238 . . . . 0.0 111.111 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.25 -32.33 73.94 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.799 0.84 . . . . 0.0 113.227 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.85 77.21 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.19 -51.92 65.86 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.533 1.133 . . . . 0.0 109.519 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.61 -42.35 81.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 124.467 1.107 . . . . 0.0 110.962 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -59.32 -49.59 77.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.659 1.118 . . . . 0.0 109.211 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.5 76.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.236 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 29' ' ' TYR . 15.1 tp -60.86 -50.24 74.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 110.375 173.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -62.31 -33.33 74.45 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.447 1.099 . . . . 0.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -43.72 32.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.665 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.79 -58.03 10.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.279 1.432 . . . . 0.0 110.775 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' A' ' 25' ' ' LEU . 3.8 m-85 -54.55 -39.21 67.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.212 0.914 . . . . 0.0 112.294 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -45.44 -58.29 3.46 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.341 1.056 . . . . 0.0 108.939 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -67.21 -35.77 80.3 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 117.871 -1.062 . . . . 0.0 111.329 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.18 -29.63 46.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.772 1.624 . . . . 0.0 111.498 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.78 -51.15 5.22 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.923 . . . . 0.0 110.878 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -75.96 -33.07 59.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -171.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -168.26 76.76 0.85 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.931 1.693 . . . . 0.0 110.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.8 -10.77 26.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.483 2.122 . . . . 0.0 114.107 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.93 -19.67 61.01 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.888 -1.133 . . . . 0.0 111.43 168.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -98.45 4.68 48.4 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.342 0.974 . . . . 0.0 112.989 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -141.81 95.87 2.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.85 1.205 . . . . 0.0 109.67 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.1 141.39 28.47 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.019 1.328 . . . . 0.0 109.119 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -140.58 160.04 40.88 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.187 0.903 . . . . 0.0 113.07 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.66 131.49 2.66 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.7 tp -44.0 -45.94 8.09 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.688 1.595 . . . . 0.0 111.094 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -58.82 -45.76 89.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.049 1.339 . . . . 0.0 111.953 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -64.08 -59.05 4.93 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -49.64 -42.24 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.468 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -53.6 -40.64 65.85 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.46 1.104 . . . . 0.0 110.905 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.13 -48.08 25.45 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 126.1 1.76 . . . . 0.0 109.746 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.52 -36.15 63.94 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.563 -1.336 . . . . 0.0 112.533 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -68.23 -40.97 81.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.392 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.36 -29.53 69.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.242 1.017 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 -7.0 51.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 111.172 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.8 mmt 54.21 24.69 5.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.688 1.995 . . . . 0.0 111.131 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.5 23.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.615 1.166 . . . . 0.0 111.839 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.54 118.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -97.23 -30.31 13.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.57 0.544 . . . . 0.0 110.946 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 m -139.33 132.77 30.2 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tp -109.87 133.82 52.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.76 125.03 53.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.083 1.753 . . . . 0.0 106.404 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 76' ' ' TYR . 11.9 tt -140.83 148.14 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.7 t -67.92 144.26 55.31 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 1.9 p-10 -59.09 -32.04 69.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.405 165.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.77 -24.73 64.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.433 1.47 . . . . 0.0 113.401 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.45 -45.62 11.67 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.905 1.282 . . . . 0.0 108.941 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.75 -26.49 34.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.234 1.413 . . . . 0.0 114.234 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.35 23.33 9.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.698 1.599 . . . . 0.0 110.807 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -55.63 147.45 18.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.916 0.886 . . . . 0.0 111.193 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -61.25 -45.14 95.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.929 1.291 . . . . 0.0 113.419 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -76.46 113.54 14.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 t -57.53 -32.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 117.514 -1.231 . . . . 0.0 111.139 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 -56.41 10.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 121.043 1.747 . . . . 0.0 110.506 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.9 m -50.81 -57.02 9.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.192 1.397 . . . . 0.0 110.786 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.59 -52.38 59.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.956 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.5 m -54.97 -43.13 73.23 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 117.056 -1.45 . . . . 0.0 111.162 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -51.99 -54.13 33.41 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 121.682 2.037 . . . . 0.0 110.032 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 60' ' ' ILE . 37.3 m-85 -57.99 -49.81 75.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.994 0.517 . . . . 0.0 111.466 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.85 -51.65 69.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.91 1.684 . . . . 0.0 110.983 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -63.88 -40.07 95.67 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.29 -43.84 89.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.05 -44.65 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.334 1.053 . . . . 0.0 109.704 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.57 -44.35 71.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.117 0.967 . . . . 0.0 111.22 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -66.06 -34.92 79.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.155 1.782 . . . . 0.0 110.626 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 t -59.09 -40.56 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.632 1.106 . . . . 0.0 109.952 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -69.68 -40.89 76.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.317 0.962 . . . . 0.0 110.029 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.04 -38.42 70.54 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.2 16.95 5.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.44 2.296 . . . . 0.0 112.193 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.07 10.18 3.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.024 2.93 . . . . 0.0 115.032 168.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.3 158.69 31.63 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.946 -1.096 . . . . 0.0 112.856 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.9 m -81.22 154.26 26.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.315 1.846 . . . . 0.0 109.655 172.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.68 145.55 25.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.037 0.935 . . . . 0.0 108.499 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -136.29 121.67 19.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 mm -112.78 107.74 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.67 155.19 19.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.637 1.175 . . . . 0.0 107.858 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -95.14 129.7 42.15 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -44.33 -46.5 9.31 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.875 1.27 . . . . 0.0 111.062 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -63.58 -17.41 62.81 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.488 1.515 . . . . 0.0 114.735 -173.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -75.93 155.35 35.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 108.759 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.93 -26.94 21.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.98 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -74.83 -18.03 60.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.563 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.93 -49.1 50.47 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 123.106 2.685 . . . . 0.0 107.865 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.57 -33.92 76.67 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.6 -45.22 91.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.2 tp -63.89 -34.32 77.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.814 0.846 . . . . 0.0 110.907 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 m -56.48 -33.59 66.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.401 1.081 . . . . 0.0 113.602 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -60.51 -20.48 60.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.056 -1.028 . . . . 0.0 111.288 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.8 mt -117.72 25.6 10.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 129.313 3.045 . . . . 0.0 108.8 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 p 70.5 11.43 7.34 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.832 2.453 . . . . 0.0 113.807 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.49 76.55 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.955 2.217 . . . . 0.0 113.242 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.33 122.89 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.115 1.457 . . . . 0.0 110.409 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.98 173.97 13.68 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 110.989 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.93 145.97 14.13 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.648 -1.283 . . . . 0.0 111.375 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.53 143.92 10.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.383 1.873 . . . . 0.0 107.615 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.739 HD13 HG23 ' A' ' 117' ' ' VAL . 22.8 mt -117.53 143.44 46.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 110.793 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -62.13 -32.47 73.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.321 1.848 . . . . 0.0 111.716 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.41 161.85 28.46 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 127.26 2.224 . . . . 0.0 107.414 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 107.95 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.274 2.65 . . . . 0.0 109.205 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.739 HG23 HD13 ' A' ' 113' ' ' LEU . 71.4 t . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? . . . . . 0 C--O 1.232 0.181 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.8 -43.98 66.3 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 111.55 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.47 -21.67 63.69 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.11 -44.43 54.16 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.53 -43.83 97.84 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.298 0.639 . . . . 0.0 110.353 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.6 t -58.17 -51.92 65.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 118.117 -0.945 . . . . 0.0 109.366 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -39.22 84.74 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.881 1.219 . . . . 0.0 110.024 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -56.94 -55.89 28.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.46 0.704 . . . . 0.0 110.916 170.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.08 -41.74 79.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.539 1.063 . . . . 0.0 111.673 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.23 -50.09 75.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 126.533 1.933 . . . . 0.0 109.173 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.0 -39.82 87.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.07 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.95 -57.22 12.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.324 1.85 . . . . 0.0 110.24 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -55.78 -38.62 70.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.343 0.657 . . . . 0.0 112.428 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -44.65 -60.18 2.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.226 0.61 . . . . 0.0 110.099 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.448 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.73 -34.68 78.89 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.656 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.67 -30.2 54.83 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.035 1.289 . . . . 0.0 111.519 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -85.63 -65.39 1.02 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.41 0.684 . . . . 0.0 110.34 167.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.52 -38.64 84.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -161.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.99 77.87 3.93 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 30.6 Cg_endo -66.59 -5.76 13.74 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.794 1.663 . . . . 0.0 113.299 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -60.19 -19.47 54.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.616 -1.302 . . . . 0.0 111.094 166.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.3 mtm180 -107.95 9.7 28.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.207 1.403 . . . . 0.0 112.603 172.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -133.97 92.24 2.93 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 120.198 1.363 . . . . 0.0 108.774 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.5 m-30 -94.0 137.77 32.84 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.67 160.26 40.29 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 139.11 1.13 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -39.58 -52.45 2.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.53 1.932 . . . . 0.0 112.026 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -59.64 -44.55 93.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.643 1.977 . . . . 0.0 111.748 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -64.4 -57.26 9.8 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -46.44 -42.6 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.262 1.425 . . . . 0.0 111.686 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -53.44 -43.64 68.22 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.301 0.955 . . . . 0.0 111.391 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.73 -42.21 74.28 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.565 1.146 . . . . 0.0 110.292 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.59 -41.0 96.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -66.11 -36.69 83.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.15 0.281 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.35 -38.4 77.15 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.123 -0.986 . . . . 0.0 111.632 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -3.59 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.299 1.44 . . . . 0.0 111.512 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.7 mmt 63.4 4.39 1.7 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 113.08 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.24 48.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -158.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.9 mt -74.25 110.18 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -168.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.71 -54.23 17.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.405 HG23 ' HE ' ' A' ' 91' ' ' ARG . 28.2 m -146.35 136.32 23.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.455 1.502 . . . . 0.0 107.653 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.8 tp -110.0 142.36 41.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.468 1.907 . . . . 0.0 107.666 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.446 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -128.1 119.52 25.51 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.455 HD11 ' CD1' ' A' ' 76' ' ' TYR . 14.7 tt -139.72 149.77 22.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 120.135 1.334 . . . . 0.0 108.051 175.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 3.9 t -66.51 144.06 56.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -60.33 -36.46 78.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.357 166.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 6.5 pt-20 -56.04 -31.66 63.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.741 1.61 . . . . 0.0 113.65 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 mt -81.71 -42.08 20.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 109.41 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -52.73 -24.99 9.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 113.997 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.55 27.09 6.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.657 1.583 . . . . 0.0 110.819 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -53.52 142.99 20.79 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.716 0.769 . . . . 0.0 111.62 -172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -58.78 -39.82 82.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.366 2.267 . . . . 0.0 113.144 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -85.9 114.9 23.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 t -39.6 -41.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.743 1.617 . . . . 0.0 111.491 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -35.11 62.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.803 1.183 . . . . 0.0 114.065 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -74.36 -45.82 44.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -52.77 -50.9 62.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.3 p -53.17 -46.38 68.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.472 0.709 . . . . 0.0 110.292 -168.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -53.64 -55.58 24.66 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.496 1.918 . . . . 0.0 109.909 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.455 ' CD1' HD11 ' A' ' 60' ' ' ILE . 32.4 m-85 -59.19 -59.37 5.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.621 177.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.53 -36.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.825 1.648 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -57.37 11.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.134 1.374 . . . . 0.0 109.286 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -62.27 -36.78 83.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.297 0.639 . . . . 0.0 111.829 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 t -60.24 -50.48 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.319 1.448 . . . . 0.0 109.012 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.26 -36.72 80.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.504 0.721 . . . . 0.0 110.214 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 t -65.45 -35.0 79.61 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.26 1.424 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.71 -35.53 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 119.422 1.01 . . . . 0.0 110.188 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -69.16 -33.88 74.1 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.38 -25.39 67.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.0 110.914 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -99.09 11.86 37.76 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 127.185 2.194 . . . . 0.0 111.508 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.51 33.37 23.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.398 1.479 . . . . 0.0 113.212 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.75 153.46 20.92 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.204 0.911 . . . . 0.0 111.057 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -74.99 151.12 38.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.031 0.932 . . . . 0.0 108.955 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -121.16 142.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.92 1.288 . . . . 0.0 107.6 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.405 ' HE ' HG23 ' A' ' 57' ' ' THR . 22.7 mmt180 -133.16 120.88 21.78 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.6 mm -94.49 125.21 47.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.42 166.57 13.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.102 0.864 . . . . 0.0 108.788 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.03 110.08 21.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 166.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 t -43.71 -34.3 1.47 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.851 1.26 . . . . 0.0 112.16 173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -65.83 -36.14 82.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.862 2.465 . . . . 0.0 113.748 -176.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -72.78 160.3 32.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.133 1.773 . . . . 0.0 111.236 -172.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -36.65 48.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.702 -0.624 . . . . 0.0 110.171 172.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -66.66 -16.73 64.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.483 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.14 10.39 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 171.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.11 -36.96 63.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.949 0.9 . . . . 0.0 110.273 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.04 -63.73 1.2 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.662 169.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.69 -34.15 64.79 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.319 1.418 . . . . 0.0 111.662 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.0 66.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.077 1.351 . . . . 0.0 112.476 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.45 -28.6 68.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 111.055 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.9 mt -104.48 31.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.418 2.287 . . . . 0.0 109.371 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p 69.05 -0.37 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.273 2.229 . . . . 0.0 114.049 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.33 58.88 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.961 2.696 . . . . 0.0 112.538 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.17 118.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.843 1.322 . . . . 0.0 110.306 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.44 9.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.404 1.481 . . . . 0.0 112.567 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -160.16 149.45 17.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 110.772 171.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.13 144.82 9.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.671 1.988 . . . . 0.0 107.029 167.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.714 HD13 HG23 ' A' ' 117' ' ' VAL . 19.4 mt -117.29 136.41 53.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -60.25 -39.0 85.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.979 0.912 . . . . 0.0 110.802 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.31 157.81 75.88 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 128.448 2.699 . . . . 0.0 107.101 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.5 124.69 13.22 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.961 1.774 . . . . 0.0 107.805 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.714 HG23 HD13 ' A' ' 113' ' ' LEU . 65.0 t . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 171.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 mttt . . . . . 0 C--O 1.235 0.302 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.24 79.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.465 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.59 65.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.285 1.034 . . . . 0.0 113.441 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.2 -34.54 54.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.05 -50.5 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.562 0.681 . . . . 0.0 109.783 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.07 -53.54 41.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 125.828 1.651 . . . . 0.0 109.726 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -59.42 -36.29 75.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.425 1.011 . . . . 0.0 110.326 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -63.47 -44.39 94.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.368 0.985 . . . . 0.0 110.995 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.48 -44.82 89.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.035 1.288 . . . . 0.0 110.82 173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -60.6 -47.62 85.38 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.526 1.53 . . . . 0.0 110.289 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -73.3 -35.99 66.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.875 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.61 -59.58 5.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.824 1.65 . . . . 0.0 110.791 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 -37.73 66.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -51.56 -53.1 41.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.703 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.424 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -65.79 -34.08 77.34 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 118.152 -0.928 . . . . 0.0 111.533 174.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.59 -33.65 64.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.976 1.262 . . . . 0.0 110.514 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -76.78 -62.45 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -75.56 -34.56 60.71 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -160.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -157.91 81.48 3.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.987 1.715 . . . . 0.0 109.763 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 -14.03 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.684 2.256 . . . . 0.0 113.916 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.74 -15.28 39.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.657 -1.277 . . . . 0.0 111.871 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -107.52 8.9 29.59 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.957 0.903 . . . . 0.0 112.488 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -139.29 86.74 2.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.789 1.177 . . . . 0.0 108.837 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.8 m-30 -93.19 144.9 24.84 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -172.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.54 164.94 28.81 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.42 134.95 0.57 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 tp -43.05 -47.29 5.88 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.857 1.663 . . . . 0.0 111.806 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -55.72 -43.33 76.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 112.189 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -55.65 13.03 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.72 -42.11 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 111.711 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.26 -24.79 68.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.377 1.471 . . . . 0.0 111.492 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -72.4 -70.31 0.35 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 116.005 -1.95 . . . . 0.0 107.104 161.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.28 -31.19 8.48 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 122.92 2.6 . . . . 0.0 116.135 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.06 -49.21 32.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.416 1.486 . . . . 0.0 112.209 167.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -48.0 -42.15 27.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 128.323 2.649 . . . . 0.0 110.176 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.07 -0.44 57.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.666 1.186 . . . . 0.0 111.116 -169.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 mmt 54.0 31.69 14.05 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.559 1.543 . . . . 0.0 110.425 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.81 -7.81 36.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.094 -166.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -83.08 114.81 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 119.679 1.127 . . . . 0.0 108.043 -166.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.37 -54.79 6.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.337 1.455 . . . . 0.0 108.478 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.6 m -146.52 138.14 24.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.339 1.455 . . . . 0.0 107.336 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.69 139.57 44.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 106.95 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.429 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -122.87 124.17 42.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.048 1.739 . . . . 0.0 106.555 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.7 tt -137.52 142.13 37.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.18 131.06 45.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -53.8 -33.85 57.32 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 117.564 -1.208 . . . . 0.0 111.522 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.84 -37.72 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.944 1.702 . . . . 0.0 112.873 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.48 -42.75 67.72 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.92 0.867 . . . . 0.0 109.752 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.69 -12.14 15.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.057 0.943 . . . . 0.0 112.572 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -123.44 19.96 9.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.898 2.479 . . . . 0.0 111.497 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -61.12 152.93 27.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.353 1.073 . . . . 0.0 111.949 -168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -77.57 -33.76 53.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.903 2.481 . . . . 0.0 112.399 -172.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 50.4 t0 -80.14 120.0 23.68 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.95 -29.98 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.605 0.639 . . . . 0.0 110.455 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.7 -56.05 18.67 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 119.863 -1.773 . . . . 0.0 111.513 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 54.9 m -56.21 -57.44 12.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.938 1.295 . . . . 0.0 108.826 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -54.25 -49.2 70.08 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.412 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.5 m -53.94 -41.17 67.46 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.079 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -57.42 -48.94 77.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.987 1.267 . . . . 0.0 109.812 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -61.91 -56.12 22.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.048 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.85 -36.6 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.532 1.06 . . . . 0.0 110.161 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -57.74 -59.9 4.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.65 0.78 . . . . 0.0 109.486 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 tp -56.07 -44.17 78.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 111.46 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -53.15 -52.16 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.777 1.231 . . . . 0.0 109.991 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -32.73 63.33 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.16 -0.962 . . . . 0.0 112.303 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -62.23 -37.87 87.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.432 1.493 . . . . 0.0 110.985 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.55 -33.34 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.11 0.868 . . . . 0.0 110.008 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -70.48 -29.69 66.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.246 1.385 . . . . 0.0 112.222 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.06 -47.97 75.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -74.69 17.27 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.64 1.976 . . . . 0.0 112.44 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.89 56.46 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.145 2.578 . . . . 0.0 112.369 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.97 155.19 18.49 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.882 1.706 . . . . 0.0 109.822 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.1 m -75.99 148.81 37.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.452 -1.028 . . . . 0.0 110.078 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.0 129.72 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 109.016 169.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -119.64 121.53 39.48 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.42 120.25 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -88.42 162.49 16.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -104.27 113.28 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 117.374 -1.298 . . . . 0.0 107.674 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 t -56.11 -30.0 61.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.662 1.119 . . . . 0.0 112.476 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.06 -38.88 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.025 1.73 . . . . 0.0 111.251 -178.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -75.32 142.02 43.29 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 126.792 2.037 . . . . 0.0 110.655 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.04 -18.34 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.25 1.02 . . . . 0.0 113.331 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.0 m -61.7 -26.46 68.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.501 1.046 . . . . 0.0 111.165 172.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.16 -55.5 29.12 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -56.78 -36.11 69.48 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.06 0.93 . . . . 0.0 112.797 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -67.26 -45.64 76.04 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.576 -0.702 . . . . 0.0 110.184 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.6 tp -61.92 -37.09 83.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.942 176.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.7 m -62.32 -28.54 69.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.563 1.074 . . . . 0.0 112.431 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -69.88 3.89 2.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.086 0.954 . . . . 0.0 112.904 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.8 mt -136.52 33.27 2.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.055 2.942 . . . . 0.0 107.645 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.263 3.2 p 59.74 11.15 2.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.312 2.645 . . . . 0.0 114.845 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.96 17.86 80.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 128.054 2.74 . . . . 0.0 113.03 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.37 120.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 119.706 1.753 . . . . 0.0 108.949 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.47 175.35 10.63 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.933 0.893 . . . . 0.0 109.566 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.85 146.71 11.26 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.614 -1.304 . . . . 0.0 109.454 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.56 139.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 117' ' ' VAL . 30.9 mt -106.07 141.27 37.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -50.02 -61.21 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.943 2.097 . . . . 0.0 108.752 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -130.62 159.46 70.88 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 127.49 2.316 . . . . 0.0 109.278 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 106.68 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.855 2.37 . . . . 0.0 109.577 -176.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 113' ' ' LEU . 96.7 t . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.61 -44.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.398 0.679 . . . . 0.0 111.427 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.19 83.06 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.134 1.373 . . . . 0.0 112.84 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.31 -40.22 98.72 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -45.19 78.39 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.39 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.6 t -54.92 -42.13 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.642 0.777 . . . . 0.0 109.481 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -51.19 70.99 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -57.98 -40.35 80.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.737 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.82 -48.37 79.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.739 1.154 . . . . 0.0 110.907 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.28 -53.4 54.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.557 1.543 . . . . 0.0 109.306 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -66.42 -37.8 86.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.264 1.826 . . . . 0.0 109.169 -171.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -65.1 -56.09 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 111.19 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.88 -37.47 74.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.951 0.796 . . . . 0.0 112.235 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.91 -55.24 12.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.719 0.808 . . . . 0.0 109.731 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -64.11 -34.88 79.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.836 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.11 -17.59 27.87 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.158 0.89 . . . . 0.0 111.86 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -96.55 -57.81 2.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 110.622 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -70.43 -44.48 67.79 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -165.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.33 77.93 6.56 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 119.229 0.922 . . . . 0.0 110.094 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -65.07 -8.76 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.268 1.979 . . . . 0.0 114.208 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.27 -17.86 32.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.91 1.232 . . . . 0.0 111.279 164.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.5 mtm180 -108.42 11.26 27.11 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.311 1.444 . . . . 0.0 112.784 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.55 89.83 2.64 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.876 1.216 . . . . 0.0 108.934 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.619 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -93.81 140.19 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.743 0.817 . . . . 0.0 108.834 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -139.79 158.53 43.95 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.778 0.431 . . . . 0.0 111.214 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 131.72 0.79 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.0 tp -41.21 -49.75 3.58 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.054 2.141 . . . . 0.0 111.456 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.489 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.39 -56.76 15.42 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.526 1.931 . . . . 0.0 110.638 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -59.21 -51.06 71.62 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.16 -42.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.984 1.313 . . . . 0.0 111.962 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -61.06 -30.02 70.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 120.254 1.388 . . . . 0.0 111.261 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -75.0 -45.76 39.74 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 120.098 -1.626 . . . . 0.0 110.579 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -62.46 -30.67 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.77 -1.206 . . . . 0.0 111.94 177.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.45 -52.2 66.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.221 1.409 . . . . 0.0 109.062 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.37 -37.21 72.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.972 0.805 . . . . 0.0 111.65 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.48 -5.01 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.706 0.802 . . . . 0.0 111.282 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.2 mmt 53.97 26.25 6.17 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.195 1.798 . . . . 0.0 111.854 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.11 -11.15 36.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.886 -164.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.584 HG23 ' HB1' ' A' ' 111' ' ' ALA . 64.3 mt -79.39 118.19 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -84.28 -50.09 8.17 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 167.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.3 m -131.99 131.63 42.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 tp -110.15 130.81 55.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.234 1.814 . . . . 0.0 107.579 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.56 131.7 54.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.194 1.797 . . . . 0.0 106.468 177.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.49 146.62 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.39 0.541 . . . . 0.0 109.751 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.16 134.16 51.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 166.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -52.0 -36.6 50.42 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.144 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.61 -33.1 59.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.935 1.243 . . . . 0.0 113.242 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.94 -39.99 20.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.901 0.773 . . . . 0.0 109.347 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -57.57 -16.99 11.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.142 0.977 . . . . 0.0 112.555 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 39.83 3.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.721 2.008 . . . . 0.0 109.241 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -58.5 152.8 17.3 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.625 -0.672 . . . . 0.0 109.535 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -67.73 -55.0 14.8 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.105 1.362 . . . . 0.0 111.725 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -63.6 120.1 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.55 -42.09 80.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.558 1.143 . . . . 0.0 111.521 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.38 -34.3 61.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.95 0.795 . . . . 0.0 111.694 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.0 m -70.92 -45.65 63.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.234 175.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -51.64 -53.47 38.34 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.502 1.046 . . . . 0.0 109.075 167.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.3 t -52.1 -40.44 61.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.98 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -58.8 -57.35 13.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 120.206 1.367 . . . . 0.0 109.725 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -54.18 -50.37 67.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.527 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.37 -38.0 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 118.363 0.528 . . . . 0.0 111.045 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -58.93 -50.75 72.87 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.91 -42.73 97.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.957 0.903 . . . . 0.0 111.226 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -49.89 -52.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.547 1.139 . . . . 0.0 109.571 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 23.7 t70 -65.52 -43.12 91.03 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.436 0.694 . . . . 0.0 111.243 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -37.44 79.01 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.871 1.668 . . . . 0.0 111.769 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.82 -33.89 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.629 1.104 . . . . 0.0 110.115 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 5.7 mtmp? -75.57 -33.35 60.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.853 1.206 . . . . 0.0 111.402 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -56.56 -43.44 79.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -77.53 21.78 0.26 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.482 1.913 . . . . 0.0 111.721 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.73 9.05 0.53 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.794 3.238 . . . . 0.0 115.834 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.48 176.04 52.51 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.79 1.216 . . . . 0.0 112.209 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -108.05 149.36 28.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.173 2.189 . . . . 0.0 109.493 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.9 146.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.269 1.428 . . . . 0.0 107.407 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -139.28 121.75 16.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.32 115.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.19 173.74 7.99 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.365 1.466 . . . . 0.0 108.398 -175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -103.8 132.72 49.79 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -43.21 31.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.343 1.457 . . . . 0.0 111.907 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.653 HD22 ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -71.05 -20.39 62.38 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.096 2.158 . . . . 0.0 112.953 -174.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.61 158.11 34.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.097 -1.002 . . . . 0.0 109.38 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 p -57.58 -37.87 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 m -64.52 -24.15 67.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.279 1.032 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.59 -41.96 28.11 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.67 -41.64 81.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.18 0.99 . . . . 0.0 109.584 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -68.91 -43.74 74.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.544 0.737 . . . . 0.0 111.643 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.48 -31.45 72.67 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.311 0.505 . . . . 0.0 110.172 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.03 -39.59 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.66 1.184 . . . . 0.0 112.637 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -56.54 -14.74 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.594 1.158 . . . . 0.0 112.111 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.1 mt -128.29 33.86 4.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.182 2.993 . . . . 0.0 108.757 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 65.58 10.6 6.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.761 1.624 . . . . 0.0 114.119 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.43 15.11 70.13 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.432 1.968 . . . . 0.0 115.118 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.38 129.65 9.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 119.229 1.515 . . . . 0.0 109.157 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.35 175.91 13.39 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 109.396 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -157.36 145.07 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.53 -0.731 . . . . 0.0 110.526 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 77.0 mt -83.82 135.35 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 117' ' ' VAL . 29.2 mt -105.02 141.23 36.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp-105 -56.54 -56.31 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.708 1.603 . . . . 0.0 109.138 171.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -124.71 157.14 66.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 125.959 1.704 . . . . 0.0 108.493 -172.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.49 115.2 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.359 2.04 . . . . 0.0 107.269 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.743 HG23 HD13 ' A' ' 113' ' ' LEU . 93.6 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -42.03 92.8 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.204 0.456 . . . . 0.0 109.9 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -9.77 34.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.171 1.388 . . . . 0.0 112.88 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.3 -42.68 4.22 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 120.153 1.342 . . . . 0.0 110.988 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.36 -57.37 12.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.59 1.556 . . . . 0.0 108.804 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.98 -50.53 19.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 125.685 1.594 . . . . 0.0 110.407 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -58.15 -50.47 73.4 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.265 0.939 . . . . 0.0 109.58 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.63 75.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.667 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.0 -49.84 64.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.571 1.532 . . . . 0.0 110.451 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.7 -49.12 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.583 1.553 . . . . 0.0 109.178 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -69.48 -34.59 74.55 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.237 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -62.25 -58.54 7.35 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 127.049 2.14 . . . . 0.0 109.647 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -54.43 -39.63 67.54 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.361 0.664 . . . . 0.0 112.248 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -49.9 -48.59 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.475 0.31 . . . . 0.0 111.211 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.2 mtp -71.45 -35.91 71.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.964 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -55.71 -26.97 47.93 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.447 1.021 . . . . 0.0 111.476 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -92.94 -36.39 12.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.73 1.612 . . . . 0.0 112.861 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -86.03 -64.05 1.22 Allowed 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.295 1.038 . . . . 0.0 112.0 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -142.6 80.93 13.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.711 1.604 . . . . 0.0 107.513 -170.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.6 -13.1 38.55 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.769 2.313 . . . . 0.0 112.552 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.8 -20.15 14.01 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 111.892 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HA ' HD12 ' A' ' 113' ' ' LEU . 20.2 mtm180 -103.27 1.83 33.43 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 124.354 1.062 . . . . 0.0 113.543 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.41 90.69 2.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 120.058 1.299 . . . . 0.0 109.915 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.37 140.43 29.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.052 0.941 . . . . 0.0 108.966 -173.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -139.95 160.16 40.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 76.32 143.45 1.39 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -174.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.5 tp -46.64 -49.89 18.46 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.326 1.45 . . . . 0.0 112.356 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -46.41 90.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.682 0.793 . . . . 0.0 109.72 -175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.5 -56.43 18.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 42' ' ' GLY . 10.9 t -50.53 -43.3 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.904 1.282 . . . . 0.0 111.975 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.39 -40.81 68.56 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.577 1.08 . . . . 0.0 110.645 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.19 -46.48 33.78 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.505 1.522 . . . . 0.0 109.838 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.71 -37.54 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.995 -1.065 . . . . 0.0 111.941 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -66.73 -44.34 81.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.391 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.0 -34.63 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.789 1.177 . . . . 0.0 111.758 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.7 -7.15 36.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.978 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mmt 51.29 39.53 24.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.846 2.459 . . . . 0.0 109.362 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -112.0 -10.5 13.93 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.386 1.074 . . . . 0.0 112.923 -164.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.35 111.13 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.49 -59.27 3.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.2 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.458 HG21 ' HE ' ' A' ' 91' ' ' ARG . 53.4 m -146.07 134.73 22.22 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.69 140.96 41.36 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 126.712 2.005 . . . . 0.0 107.201 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.41 129.79 56.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.978 2.111 . . . . 0.0 106.468 176.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.28 131.6 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -63.58 129.97 42.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.73 -33.94 36.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.235 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.32 -22.06 62.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.35 1.432 . . . . 0.0 112.871 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.02 -40.49 11.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.241 1.016 . . . . 0.0 109.191 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -54.23 -21.06 8.09 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 20.05 7.3 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.934 1.243 . . . . 0.0 112.062 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -49.8 145.07 5.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.154 1.382 . . . . 0.0 112.908 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -46.65 89.45 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.05 110.33 5.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.69 -36.47 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.851 -172.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.78 65.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.02 1.282 . . . . 0.0 112.575 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.14 -48.72 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.289 1.036 . . . . 0.0 108.506 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 -55.02 -49.95 70.25 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.394 0.678 . . . . 0.0 109.994 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.2 p -54.61 -43.75 72.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.44 0.696 . . . . 0.0 110.276 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -54.72 -57.34 11.87 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.061 1.344 . . . . 0.0 108.772 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -55.7 -53.19 59.63 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.7 -38.53 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 118.91 0.777 . . . . 0.0 110.281 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -57.57 -52.35 65.76 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.545 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.73 -43.74 98.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.431 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -52.47 -50.43 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.501 1.121 . . . . 0.0 109.758 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.23 96.74 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.146 0.578 . . . . 0.0 109.961 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.8 m -64.7 -30.6 71.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.992 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.66 -44.77 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.138 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -64.01 -34.26 77.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.292 0.951 . . . . 0.0 110.419 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.35 -35.73 81.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.568 0.622 . . . . 0.0 110.454 174.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -91.51 24.29 3.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.9 1.68 . . . . 0.0 111.394 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 28.91 12.84 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.094 1.758 . . . . 0.0 113.861 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.85 145.52 17.82 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 170.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 m -78.06 154.98 30.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.266 1.026 . . . . 0.0 109.017 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.96 149.29 17.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.924 1.29 . . . . 0.0 107.561 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HE ' HG21 ' A' ' 57' ' ' THR . 21.4 mmt180 -137.46 121.31 17.58 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 mm -90.66 119.4 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 m-85 -89.91 125.12 35.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -62.93 109.63 1.52 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 166.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -56.74 -27.41 59.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.455 1.502 . . . . 0.0 112.836 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -67.03 -32.13 73.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.852 2.461 . . . . 0.0 111.758 -178.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -71.56 158.5 36.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.626 1.97 . . . . 0.0 110.632 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -19.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.071 -1.018 . . . . 0.0 111.536 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -72.87 -23.32 60.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.177 -1.577 . . . . 0.0 111.003 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.33 -43.05 26.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.637 1.108 . . . . 0.0 110.436 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -52.2 -47.83 65.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.355 1.078 . . . . 0.0 109.876 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.63 -42.26 91.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.167 0.587 . . . . 0.0 111.245 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.12 -33.74 75.04 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 119.018 0.826 . . . . 0.0 111.392 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 m -59.59 -36.54 76.45 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.224 1.409 . . . . 0.0 111.68 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -58.19 -20.65 42.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.711 0.804 . . . . 0.0 112.167 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.48 21.86 15.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.706 2.402 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 p 74.16 -1.68 3.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.551 2.74 . . . . 0.0 113.893 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.42 62.36 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 127.238 2.352 . . . . 0.0 113.462 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.79 133.14 26.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.903 1.852 . . . . 0.0 108.88 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.63 177.35 10.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 110.684 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.83 149.49 16.46 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.797 -1.19 . . . . 0.0 109.738 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 ' SD ' ' A' ' 31' ' ' MET . 81.0 mt -83.46 142.87 12.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.643 HD13 HG23 ' A' ' 117' ' ' VAL . 23.3 mt -108.97 146.14 34.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 109.202 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -59.04 -44.28 91.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.968 169.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 5.0 p90 -142.88 161.71 47.48 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.391 1.476 . . . . 0.0 109.344 -169.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.09 114.04 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 HD13 ' A' ' 113' ' ' LEU . 88.5 t . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 tptp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.99 95.76 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.918 1.287 . . . . 0.0 112.015 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -18.59 65.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.766 0.827 . . . . 0.0 111.382 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.44 51.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -60.66 -50.72 72.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.594 1.158 . . . . 0.0 110.717 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.77 -50.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.213 1.005 . . . . 0.0 110.392 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -53.53 -49.31 67.88 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.057 0.543 . . . . 0.0 110.862 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -62.36 -42.05 99.1 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.297 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.67 -45.28 92.53 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.37 1.441 . . . . 0.0 109.71 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.162 0.985 . . . . 0.0 111.399 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.12 -45.88 46.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.26 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.56 -58.38 6.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.908 1.283 . . . . 0.0 110.267 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.49 -37.8 88.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.864 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -55.97 12.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 ttp -68.64 -30.24 68.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.862 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.25 -44.72 92.36 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 120.473 1.488 . . . . 0.0 111.386 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -65.22 -24.17 67.27 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.744 1.618 . . . . 0.0 111.901 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -117.96 -41.59 2.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -162.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -155.7 83.71 3.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.332 1.853 . . . . 0.0 108.995 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.91 -7.57 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.92 2.413 . . . . 0.0 113.605 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.53 -21.44 52.38 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.889 -1.132 . . . . 0.0 111.579 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.6 mtp180 -103.4 9.23 37.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.006 1.276 . . . . 0.0 112.707 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.15 92.74 2.82 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.411 1.084 . . . . 0.0 109.427 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -93.23 145.59 24.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.06 1.344 . . . . 0.0 107.658 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -140.78 163.56 32.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 77.25 139.43 1.12 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -43.27 -51.0 6.43 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.176 2.19 . . . . 0.0 112.201 -172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -52.82 18.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.011 2.124 . . . . 0.0 111.526 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.5 -53.14 25.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 42' ' ' GLY . 3.9 t -50.5 -44.54 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.876 1.27 . . . . 0.0 111.061 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -53.25 -38.43 63.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.634 1.173 . . . . 0.0 111.65 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -78.63 -43.35 26.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 126.051 1.741 . . . . 0.0 110.632 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -65.81 -30.69 71.36 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 118.497 -1.281 . . . . 0.0 110.629 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.29 -36.69 82.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.473 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -52.52 -35.33 53.09 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.057 0.943 . . . . 0.0 111.503 168.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.54 59.35 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.352 1.461 . . . . 0.0 112.538 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.8 mmt 56.07 39.1 30.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.645 0.778 . . . . 0.0 110.905 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.97 -7.14 14.57 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.116 0.966 . . . . 0.0 112.198 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -78.44 105.19 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.07 -54.89 6.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 123.699 0.624 . . . . 0.0 109.754 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -135.83 124.65 23.99 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -171.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.8 tp -109.07 132.37 54.18 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 107.788 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.59 119.5 35.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.782 1.633 . . . . 0.0 107.66 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.42 141.24 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 137.16 57.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -59.2 -37.66 77.97 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.84 -30.89 62.17 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.686 1.195 . . . . 0.0 112.77 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -82.87 -42.08 18.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.613 1.097 . . . . 0.0 109.618 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -56.74 -18.85 14.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.389 0.675 . . . . 0.0 112.597 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 23.9 9.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.775 2.83 . . . . 0.0 109.881 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -56.45 140.38 46.06 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.689 0.677 . . . . 0.0 110.0 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -59.65 -35.84 75.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.484 1.114 . . . . 0.0 112.638 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -79.68 125.14 29.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 108.61 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.69 -38.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 116.846 -1.55 . . . . 0.0 111.167 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.74 -52.07 41.84 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.921 2.146 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -56.88 -52.42 65.21 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.409 1.884 . . . . 0.0 108.262 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -52.25 -46.48 65.8 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.726 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 p -53.8 -44.16 69.92 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.926 0.89 . . . . 0.0 110.364 -173.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -57.66 -55.48 34.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.273 1.429 . . . . 0.0 108.689 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -57.57 -51.41 69.6 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.587 -1.196 . . . . 0.0 112.629 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.2 -37.63 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.765 1.166 . . . . 0.0 110.937 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.9 mtt-85 -60.17 -51.06 71.19 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.073 0.949 . . . . 0.0 110.238 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.67 -42.83 95.11 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 122.893 0.477 . . . . 0.0 111.221 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.68 -48.55 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.02 0.928 . . . . 0.0 109.986 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.29 -49.13 78.81 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.251 1.02 . . . . 0.0 110.666 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -71.82 -23.54 61.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.683 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.72 -41.67 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 120.058 1.299 . . . . 0.0 108.465 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -65.14 -38.21 89.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.804 1.184 . . . . 0.0 110.327 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.18 -32.67 64.56 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.531 0.605 . . . . 0.0 110.82 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -98.87 24.26 7.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.436 2.294 . . . . 0.0 111.04 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 61.6 19.4 10.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.834 2.054 . . . . 0.0 114.185 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.46 146.71 19.1 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 122.277 0.932 . . . . 0.0 110.792 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.57 149.58 48.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.202 2.201 . . . . 0.0 109.534 170.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.0 t -117.33 150.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.14 1.376 . . . . 0.0 108.861 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -138.54 138.05 37.62 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.679 1.992 . . . . 0.0 106.648 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.72 104.26 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 -170.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.4 m-85 -90.02 124.88 35.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -70.09 128.48 36.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -60.71 10.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.828 2.451 . . . . 0.0 116.148 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.8 mt -129.22 -18.9 3.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.952 2.101 . . . . 0.0 111.393 -175.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -69.67 157.54 37.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.164 1.385 . . . . 0.0 110.532 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.76 -39.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.478 0.581 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 m -63.83 -32.3 73.77 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.198 -0.938 . . . . 0.0 110.489 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -65.93 -50.41 52.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.942 1.258 . . . . 0.0 110.333 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.04 -26.75 65.13 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.298 1.049 . . . . 0.0 112.028 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.62 -46.24 89.16 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.12 -0.988 . . . . 0.0 108.84 170.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.1 tp -60.61 -25.74 66.48 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.488 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t -50.69 -44.08 57.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.572 . . . . 0.0 111.826 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.15 0.56 0.91 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.435 1.094 . . . . 0.0 113.398 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.65 32.75 3.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.742 2.417 . . . . 0.0 108.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p 65.32 -3.45 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.787 2.435 . . . . 0.0 114.174 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.35 18.6 64.08 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.522 2.487 . . . . 0.0 112.884 -170.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.43 129.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 119.638 1.719 . . . . 0.0 110.804 167.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.66 173.49 13.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.456 1.102 . . . . 0.0 109.782 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.09 15.87 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.8 -1.187 . . . . 0.0 110.424 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -98.33 140.5 18.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 126.578 1.951 . . . . 0.0 108.048 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 117' ' ' VAL . 34.6 mt -107.43 145.39 33.06 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.429 0.691 . . . . 0.0 111.266 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -66.25 -39.81 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.928 1.291 . . . . 0.0 110.787 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.55 155.08 57.03 Favored Pre-proline 0 N--CA 1.453 -0.286 0 C-N-CA 123.748 0.819 . . . . 0.0 109.464 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.32 146.4 62.77 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.661 2.24 . . . . 0.0 109.601 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 113' ' ' LEU . 58.8 t . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 125.887 1.675 . . . . 0.0 106.741 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tptm . . . . . 0 N--CA 1.462 0.143 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -25.82 68.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.892 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.17 63.41 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 119.616 1.098 . . . . 0.0 111.491 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.98 -53.0 43.75 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 170.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.21 -58.98 5.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.047 0.939 . . . . 0.0 110.71 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.51 -41.61 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 117.417 -1.278 . . . . 0.0 111.606 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -55.03 -48.35 73.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.802 1.637 . . . . 0.0 109.235 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.61 88.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.892 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.27 -46.9 88.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.064 1.302 . . . . 0.0 110.086 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -56.52 -53.94 51.66 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.75 1.22 . . . . 0.0 109.054 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -66.52 -41.7 88.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.156 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.36 -57.73 10.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.302 1.041 . . . . 0.0 110.933 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.59 -41.25 89.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.166 0.439 . . . . 0.0 111.772 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -50.74 -51.97 45.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 tpp -61.03 -41.04 95.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.714 0.806 . . . . 0.0 111.731 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.44 -29.51 61.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.064 1.746 . . . . 0.0 111.469 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -80.59 -59.37 2.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.993 1.317 . . . . 0.0 108.94 173.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -71.02 -51.64 24.23 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -166.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.13 78.67 9.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.883 1.273 . . . . 0.0 108.305 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.57 -9.19 12.72 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.823 2.349 . . . . 0.0 114.137 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.62 -16.75 51.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 0.0 111.142 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 113' ' ' LEU . 83.0 mtp180 -107.82 9.15 28.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 112.179 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.76 89.57 2.96 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.788 1.235 . . . . 0.0 107.947 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -94.11 133.36 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.028 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -140.25 161.29 38.03 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.32 137.91 0.46 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -168.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 tp -37.16 -53.9 1.02 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.741 2.016 . . . . 0.0 112.862 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -59.56 -49.4 77.9 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.703 1.201 . . . . 0.0 110.943 -174.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -56.24 -58.67 6.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 t -48.93 -45.27 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.474 1.109 . . . . 0.0 112.317 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -58.24 -40.62 82.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.113 1.324 . . . . 0.0 111.205 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -37.85 85.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.63 1.172 . . . . 0.0 109.695 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.25 -35.26 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.17 -38.74 92.36 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.11 -3.6 7.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.745 1.618 . . . . 0.0 114.745 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.61 -5.73 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 112.041 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 mmt 63.26 4.59 1.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.078 2.151 . . . . 0.0 112.596 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -77.68 -10.15 59.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.033 -164.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.96 115.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.28 -65.17 1.04 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 m -125.83 132.64 52.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.91 132.84 53.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.265 1.826 . . . . 0.0 107.127 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 120.95 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.707 1.603 . . . . 0.0 106.961 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.54 145.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -65.02 142.32 58.46 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.718 0.807 . . . . 0.0 109.58 175.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.97 -42.34 89.7 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.6 pt-20 -52.09 -33.34 39.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.99 -43.29 30.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.912 0.778 . . . . 0.0 110.124 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.25 -23.75 16.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.65 1.18 . . . . 0.0 113.624 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.16 27.27 5.66 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.722 1.609 . . . . 0.0 111.29 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -54.43 149.22 10.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.33 1.452 . . . . 0.0 112.687 -174.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -58.58 -26.39 63.57 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.768 2.027 . . . . 0.0 114.51 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -105.21 114.4 28.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -53.13 -39.25 32.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.234 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -34.87 61.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.065 1.302 . . . . 0.0 111.974 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 m -65.95 -53.49 38.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -52.43 -50.51 62.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.41 ' HA ' HG22 ' A' ' 77' ' ' VAL . 24.3 p -56.85 -36.8 70.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.481 0.582 . . . . 0.0 111.523 -174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.74 -53.73 53.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.92 0.782 . . . . 0.0 109.73 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -59.03 -53.76 54.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.05 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 74' ' ' SER . 7.9 m -63.55 -35.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.528 1.058 . . . . 0.0 110.451 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -61.67 -56.07 23.68 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -54.72 -41.31 70.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.82 -50.93 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.993 0.917 . . . . 0.0 110.695 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.37 -46.16 67.61 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.626 0.77 . . . . 0.0 110.022 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.4 m -66.29 -23.8 66.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.395 1.478 . . . . 0.0 112.323 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.95 -38.38 82.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.917 0.78 . . . . 0.0 110.071 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.54 -43.47 89.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.909 0.777 . . . . 0.0 109.493 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.32 -44.41 95.49 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.529 0.518 . . . . 0.0 110.073 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -70.91 6.42 1.55 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 112.231 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.83 54.89 0.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 130.479 3.512 . . . . 0.0 113.093 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.89 163.43 17.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.522 1.058 . . . . 0.0 113.871 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -82.2 146.31 29.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.465 2.306 . . . . 0.0 109.571 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.14 144.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.443 1.497 . . . . 0.0 107.923 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -133.38 121.61 22.56 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.96 110.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.94 124.77 35.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 m -70.04 116.87 10.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -58.61 -17.03 18.7 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.78 -41.52 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.497 1.119 . . . . 0.0 112.181 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.77 153.42 41.86 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 109.591 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.55 -26.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.556 -0.715 . . . . 0.0 111.629 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 p -58.31 -27.51 64.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.221 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.22 -53.0 19.9 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 124.176 0.893 . . . . 0.0 111.034 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -38.93 74.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.653 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.47 -58.31 9.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.219 1.408 . . . . 0.0 109.661 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -56.37 -29.06 60.94 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.61 0.641 . . . . 0.0 111.402 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.02 -36.5 65.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.591 1.557 . . . . 0.0 112.593 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.53 -32.53 68.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.141 0.976 . . . . 0.0 110.705 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -99.79 21.86 11.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.204 2.201 . . . . 0.0 109.692 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p 68.99 9.39 7.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.664 2.386 . . . . 0.0 114.257 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.35 18.97 78.81 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.204 1.859 . . . . 0.0 113.504 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.13 122.02 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.992 1.396 . . . . 0.0 108.977 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.7 170.06 19.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 110.043 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.9 153.68 39.41 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.619 -0.676 . . . . 0.0 110.777 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.9 mt -84.11 141.76 14.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.664 1.585 . . . . 0.0 107.327 168.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 117' ' ' VAL . 26.2 mt -109.36 145.08 36.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.161 0.981 . . . . 0.0 110.167 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -65.68 -38.63 89.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.018 1.327 . . . . 0.0 111.223 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.4 p90 -143.55 157.57 58.78 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 127.309 2.244 . . . . 0.0 106.76 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.13 128.0 15.09 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.883 1.722 . . . . 0.0 108.384 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.737 HG23 HD13 ' A' ' 113' ' ' LEU . 72.6 t . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 174.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.84 94.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.716 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.24 87.39 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.218 0.917 . . . . 0.0 112.353 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.41 61.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 119.292 0.951 . . . . 0.0 111.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -67.12 -44.32 80.2 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.5 -1.0 . . . . 0.0 109.841 172.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.59 -45.93 82.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -60.75 -48.15 83.11 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.924 0.784 . . . . 0.0 109.993 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -59.47 -38.21 80.2 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.46 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -64.76 -50.71 65.75 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.504 1.047 . . . . 0.0 110.435 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -33.81 76.24 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.201 1.0 . . . . 0.0 110.388 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.51 -44.61 67.25 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.209 1.404 . . . . 0.0 110.148 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -58.93 -52.81 64.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.433 1.093 . . . . 0.0 109.944 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.21 -38.81 87.92 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.042 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -45.19 -52.63 9.17 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mmt -63.76 -47.76 79.69 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.198 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.55 -35.38 60.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.362 0.983 . . . . 0.0 111.541 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -78.9 -56.62 4.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.162 0.985 . . . . 0.0 109.569 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -76.46 -70.15 0.47 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.121 1.368 . . . . 0.0 113.307 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.51 71.63 66.03 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.52 -14.35 44.43 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.655 -170.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.03 -21.09 58.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.775 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 78.6 mtp180 -100.59 14.17 32.27 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.133 1.373 . . . . 0.0 113.864 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.33 110.05 12.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.327 1.051 . . . . 0.0 108.757 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.6 m-85 -107.62 130.79 54.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.554 1.142 . . . . 0.0 108.468 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.29 156.6 46.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.728 1.149 . . . . 0.0 114.1 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.97 140.04 0.19 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.633 1.111 . . . . 0.0 110.526 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -47.5 -49.81 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.439 1.096 . . . . 0.0 112.461 -162.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -58.95 -32.7 69.86 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.799 1.64 . . . . 0.0 112.632 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -71.16 -63.31 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -50.74 -41.12 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 0.0 112.233 -170.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -44.68 -49.71 10.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.074 1.75 . . . . 0.0 111.089 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -71.54 -41.92 68.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 109.851 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -66.73 -29.34 69.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.304 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.09 -37.33 78.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.3 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.91 -7.26 10.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.6 0.15 30.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.696 1.599 . . . . 0.0 112.571 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 55.96 8.2 0.35 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 127.025 2.13 . . . . 0.0 112.727 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -18.64 60.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.845 -1.16 . . . . 0.0 112.102 -162.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.28 115.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.82 -55.81 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 165.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -132.72 135.48 45.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 tp -110.25 133.18 53.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.953 2.101 . . . . 0.0 106.547 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.23 129.37 55.5 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.525 1.93 . . . . 0.0 107.115 175.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -143.56 136.39 24.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 119.014 0.824 . . . . 0.0 109.585 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.23 128.24 35.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 168.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -34.07 69.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.564 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -43.85 -39.7 4.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.659 1.184 . . . . 0.0 113.473 170.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 mt -77.07 -42.93 36.28 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.486 1.114 . . . . 0.0 109.571 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.53 -20.09 11.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.952 1.301 . . . . 0.0 112.877 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 30.35 4.73 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 119.96 -1.712 . . . . 0.0 110.014 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -56.18 149.39 16.14 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.255 0.55 . . . . 0.0 110.98 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -32.47 65.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.463 1.105 . . . . 0.0 112.439 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.9 113.6 20.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.38 -36.56 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.579 -168.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.61 59.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.596 1.089 . . . . 0.0 112.196 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.1 m -55.7 -52.61 63.28 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.081 1.352 . . . . 0.0 108.406 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -53.07 -53.58 48.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.586 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 77' ' ' VAL . 1.6 t -53.12 -44.81 67.96 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.19 0.596 . . . . 0.0 109.949 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -54.93 -53.87 49.98 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.062 0.945 . . . . 0.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -57.96 -57.37 13.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.197 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.1 m -64.64 -30.41 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.218 0.917 . . . . 0.0 111.102 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -66.25 -59.8 3.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.918 0.887 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 tp -52.74 -39.57 62.26 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.512 0.725 . . . . 0.0 111.445 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.48 -53.25 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.333 1.053 . . . . 0.0 110.235 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.55 -36.03 80.18 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.167 -0.333 . . . . 0.0 111.249 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -69.4 -24.47 63.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.055 0.942 . . . . 0.0 112.435 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.85 -43.85 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -61.16 -43.32 99.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.355 0.98 . . . . 0.0 110.926 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.6 -44.09 62.72 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.345 1.458 . . . . 0.0 110.124 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -85.32 25.44 1.01 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.689 1.195 . . . . 0.0 111.037 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.31 20.57 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.28 2.232 . . . . 0.0 114.064 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.64 -176.44 50.97 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 120.969 -1.082 . . . . 0.0 112.683 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 m -122.05 152.35 39.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.141 2.576 . . . . 0.0 108.499 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.73 124.14 56.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 47.8 mmt-85 -116.17 121.33 41.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -102.68 108.07 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.32 124.0 34.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -71.7 123.57 22.85 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -49.69 -42.73 46.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.329 1.851 . . . . 0.0 112.501 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.93 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.6 -37.21 67.81 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.191 1.796 . . . . 0.0 112.304 -174.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -72.74 152.09 41.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.994 1.318 . . . . 0.0 110.391 -167.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.54 -32.48 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.297 0.639 . . . . 0.0 111.595 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.5 m -65.07 -33.99 77.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.035 -1.041 . . . . 0.0 111.781 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.4 -49.55 77.29 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.1 -38.79 92.35 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.407 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -59.75 -47.26 86.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.21 -29.33 70.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.286 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.5 m -59.82 -34.27 72.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.641 1.11 . . . . 0.0 112.56 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.67 -3.93 7.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.71 1.204 . . . . 0.0 112.428 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -127.47 23.03 6.39 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.354 2.662 . . . . 0.0 108.679 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.7 p 69.75 1.3 3.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 128.449 2.7 . . . . 0.0 114.194 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.61 17.43 70.82 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.299 1.904 . . . . 0.0 113.224 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.03 129.83 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 120.165 1.982 . . . . 0.0 108.879 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.59 173.98 13.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.016 0.926 . . . . 0.0 110.291 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.46 153.92 25.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.193 -0.942 . . . . 0.0 110.874 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.6 mt -99.66 144.94 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.319 1.848 . . . . 0.0 107.911 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CD1' ' A' ' 40' ' ' PHE . 31.4 mt -116.99 131.31 56.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.595 0.758 . . . . 0.0 111.721 -172.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -53.54 -36.93 62.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.643 1.977 . . . . 0.0 111.865 173.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -149.07 157.53 39.81 Favored Pre-proline 0 N--CA 1.444 -0.737 0 C-N-CA 126.621 1.968 . . . . 0.0 106.358 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.43 144.08 66.04 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.233 1.956 . . . . 0.0 109.37 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 113' ' ' LEU . 93.8 t . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -58.33 -41.03 83.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.266 0.626 . . . . 0.0 109.949 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 -26.35 67.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.994 0.815 . . . . 0.0 112.975 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.54 -38.73 86.75 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.674 1.125 . . . . 0.0 111.093 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.67 -52.63 56.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.678 170.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 18' ' ' ALA . 74.7 t -55.02 -49.02 75.04 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 125.117 1.367 . . . . 0.0 110.034 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -49.98 69.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.03 78.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.752 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -64.98 -52.48 55.98 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.253 1.388 . . . . 0.0 110.285 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.61 -43.97 85.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.358 1.063 . . . . 0.0 109.262 -173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.5 -34.54 63.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.811 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.82 -55.08 25.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.629 1.572 . . . . 0.0 109.847 173.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.75 -39.07 73.33 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -53.76 -50.09 66.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.164 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -68.16 -32.15 72.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.564 1.075 . . . . 0.0 111.3 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 tp -55.52 -36.17 66.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.182 1.356 . . . . 0.0 110.665 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -74.22 -57.14 4.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 111.079 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -76.69 -58.78 3.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -166.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -136.91 73.67 52.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.998 1.719 . . . . 0.0 108.283 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.26 -14.13 42.1 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.135 2.557 . . . . 0.0 113.476 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -64.73 -13.73 55.89 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.56 -1.337 . . . . 0.0 111.631 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.56 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.8 mtp180 -103.18 -0.25 30.77 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.377 1.071 . . . . 0.0 112.8 171.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.08 91.17 3.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.299 0.954 . . . . 0.0 108.816 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.7 m-85 -93.35 137.75 32.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.688 1.195 . . . . 0.0 108.707 -175.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -140.33 159.6 41.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.07 134.45 0.63 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.1 tp -42.16 -51.8 4.54 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.473 1.509 . . . . 0.0 112.447 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -56.96 -42.53 80.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.84 1.656 . . . . 0.0 111.708 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -65.25 -55.94 15.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.11 -41.92 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.358 1.063 . . . . 0.0 112.332 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -55.52 -40.38 71.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.245 0.929 . . . . 0.0 110.731 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -71.66 -41.13 69.13 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.681 1.593 . . . . 0.0 110.919 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -68.01 -30.24 69.44 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.179 -0.95 . . . . 0.0 112.085 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.19 -44.15 97.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.38 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.23 -33.33 69.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.253 0.933 . . . . 0.0 112.876 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.6 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.05 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 mmt 47.46 36.61 5.26 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.925 2.09 . . . . 0.0 110.467 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.64 -20.55 13.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.642 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 111' ' ' ALA . 81.3 mt -70.66 113.97 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.31 -42.1 14.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 124.122 0.889 . . . . 0.0 110.177 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.2 m -141.64 124.72 16.3 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 tp -110.07 125.51 53.03 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 127.121 2.168 . . . . 0.0 108.814 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -108.02 126.95 53.33 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.993 1.717 . . . . 0.0 107.857 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -143.17 142.53 25.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -63.33 133.43 54.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 168.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.2 -39.91 73.18 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.352 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.9 pt-20 -49.58 -36.46 24.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.592 1.542 . . . . 0.0 113.803 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.3 mt -78.04 -38.56 44.31 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.825 1.193 . . . . 0.0 110.258 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -56.6 -30.25 63.02 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.318 1.047 . . . . 0.0 111.457 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 42.2 3.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.774 2.429 . . . . 0.0 109.055 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -60.99 146.9 45.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.31 -35.74 78.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.162 0.985 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -87.04 114.96 24.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.98 1.312 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.74 -34.61 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.626 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.21 11.77 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 120.093 1.315 . . . . 0.0 110.527 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -62.52 -45.21 94.05 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.637 1.175 . . . . 0.0 110.464 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -51.61 -44.97 63.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.965 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 p -51.61 -46.08 63.46 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.319 0.509 . . . . 0.0 110.083 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.41 -46.23 90.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 109.562 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -59.64 -61.39 2.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.01 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.74 -36.99 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.832 1.196 . . . . 0.0 110.857 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.11 -49.3 78.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.235 1.014 . . . . 0.0 111.297 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.1 -43.15 96.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.132 0.573 . . . . 0.0 109.928 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.33 -55.38 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.761 1.225 . . . . 0.0 110.164 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -39.63 94.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.703 0.801 . . . . 0.0 110.652 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 t -67.14 -36.79 82.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.504 1.122 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.82 -40.24 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.313 0.96 . . . . 0.0 109.273 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -65.29 -41.46 94.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.218 0.917 . . . . 0.0 110.904 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.2 -39.87 73.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.075 0.398 . . . . 0.0 110.501 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -75.39 -2.84 30.42 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 112.92 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 80.51 26.47 0.29 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.72 2.808 . . . . 0.0 113.941 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.75 143.71 16.82 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.499 1.523 . . . . 0.0 112.319 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.0 m -74.77 131.91 41.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.152 2.181 . . . . 0.0 109.778 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.7 t -93.99 148.43 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.989 0.916 . . . . 0.0 109.148 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -140.36 122.01 15.27 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.212 1.805 . . . . 0.0 108.085 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.27 109.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.9 m-85 -89.23 124.33 34.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.9 t -69.75 127.78 34.12 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -31.58 62.84 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.105 0.478 . . . . 0.0 110.355 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.91 -4.78 22.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.839 1.655 . . . . 0.0 113.642 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -109.66 143.42 39.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.867 1.667 . . . . 0.0 110.348 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -22.38 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.757 -0.59 . . . . 0.0 112.154 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -64.8 -20.53 66.43 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.596 -1.315 . . . . 0.0 111.174 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.0 -32.76 13.48 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 119.539 1.063 . . . . 0.0 112.271 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.25 -39.69 79.84 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.137 0.968 . . . . 0.0 108.855 168.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.06 -52.36 56.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.649 1.18 . . . . 0.0 110.763 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.32 -30.88 63.13 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.352 0.978 . . . . 0.0 111.713 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.8 t -52.44 -39.93 61.62 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.679 1.592 . . . . 0.0 112.362 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.29 -25.84 59.9 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.466 1.106 . . . . 0.0 111.145 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.1 mt -109.4 23.27 14.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.991 2.116 . . . . 0.0 109.849 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.9 p 73.65 0.23 3.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.321 2.648 . . . . 0.0 113.745 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.14 21.09 63.5 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.402 1.953 . . . . 0.0 113.129 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.48 129.23 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.603 1.702 . . . . 0.0 109.12 171.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.31 177.41 11.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.768 1.227 . . . . 0.0 110.323 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -160.59 150.29 17.55 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.857 -1.152 . . . . 0.0 111.522 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 31' ' ' MET . 78.1 mt -83.76 141.07 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.715 HD13 HG23 ' A' ' 117' ' ' VAL . 21.8 mt -113.03 144.19 43.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -65.57 -25.71 67.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.286 2.234 . . . . 0.0 112.273 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -159.86 161.39 26.47 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 127.141 2.177 . . . . 0.0 106.41 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.32 132.37 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.089 1.859 . . . . 0.0 109.563 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 113' ' ' LEU . 80.5 t . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.27 64.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.679 -163.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.95 -36.43 62.83 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.183 0.902 . . . . 0.0 113.259 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.5 71.1 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 118.987 0.812 . . . . 0.0 111.863 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.66 -53.27 57.04 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.297 0.639 . . . . 0.0 109.328 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.51 -33.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.373 1.069 . . . . 0.0 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -62.96 -47.19 84.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.941 1.7 . . . . 0.0 110.513 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.67 -37.77 82.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.134 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -48.99 79.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.483 1.038 . . . . 0.0 110.111 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -57.52 -53.56 56.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.328 1.451 . . . . 0.0 108.443 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -38.93 83.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.147 0.904 . . . . 0.0 109.77 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.19 -53.13 61.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.815 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.59 -36.29 82.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -53.9 -55.24 28.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.041 0.937 . . . . 0.0 108.721 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 tpp -57.51 -38.81 75.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.8 0.44 . . . . 0.0 110.302 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.02 -19.59 66.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.119 1.768 . . . . 0.0 112.822 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -95.0 -34.89 12.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -90.08 -70.6 0.66 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.1 77.03 68.49 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 109.388 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.99 -8.98 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.597 2.198 . . . . 0.0 114.092 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -57.06 -22.97 43.27 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.046 1.294 . . . . 0.0 111.747 166.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -106.17 8.64 32.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 112.598 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.97 98.19 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.168 0.987 . . . . 0.0 109.521 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.507 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.9 m-30 -100.46 141.74 32.91 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.384 1.074 . . . . 0.0 109.159 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.13 161.09 38.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.749 0.785 . . . . 0.0 112.95 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 148.21 0.68 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 125.242 1.401 . . . . 0.0 111.226 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 tp -49.69 -44.83 48.25 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.31 1.044 . . . . 0.0 110.972 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -61.06 -54.5 43.92 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.263 1.425 . . . . 0.0 111.289 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -61.77 -50.97 70.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 0.0 108.205 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.31 -38.88 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 111.906 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.04 -22.42 64.96 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.209 -0.932 . . . . 0.0 112.742 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -77.98 -43.34 29.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.72 1.145 . . . . 0.0 108.859 167.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.69 -40.23 94.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.005 -0.434 . . . . 0.0 112.02 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.86 -33.53 76.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.503 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.65 -35.01 79.63 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.045 0.839 . . . . 0.0 112.365 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.79 -0.19 29.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 111.991 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 62.19 3.08 0.93 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.88 2.472 . . . . 0.0 114.417 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -81.72 -2.46 50.65 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.696 -1.252 . . . . 0.0 112.629 -162.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.41 110.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.58 -49.36 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 108.121 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -144.41 136.76 26.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.1 tp -109.42 142.1 40.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 125.24 47.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.479 1.911 . . . . 0.0 107.253 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 tt -141.26 143.26 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 119.191 0.905 . . . . 0.0 110.341 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.88 137.26 53.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -37.04 69.8 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.848 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.55 -18.69 42.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.5 -43.18 9.84 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.322 1.049 . . . . 0.0 109.449 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.09 -26.58 11.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 0.0 112.444 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.28 37.39 4.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.554 1.941 . . . . 0.0 110.33 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -56.05 145.79 24.59 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.582 0.753 . . . . 0.0 110.886 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -40.51 96.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.611 0.764 . . . . 0.0 112.699 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.35 120.64 21.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -55.67 -44.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.284 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.31 -53.55 42.22 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 120.223 1.374 . . . . 0.0 111.235 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -51.38 -53.32 37.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.763 1.625 . . . . 0.0 109.878 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -55.73 -48.57 74.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.513 0.597 . . . . 0.0 109.773 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -39.23 58.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.624 0.77 . . . . 0.0 110.802 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -62.44 -56.55 17.12 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.634 1.106 . . . . 0.0 109.049 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -55.19 -50.23 69.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.762 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.62 -40.82 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 119.432 1.014 . . . . 0.0 110.479 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -62.33 -52.76 62.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.18 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.79 -42.62 75.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.521 1.055 . . . . 0.0 111.126 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -58.07 -51.23 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.194 0.597 . . . . 0.0 110.315 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.47 -33.12 74.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.843 1.657 . . . . 0.0 111.085 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -71.49 -30.12 65.6 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.954 1.701 . . . . 0.0 110.866 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.23 -37.79 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.718 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE2' HG21 ' A' ' 90' ' ' VAL . 36.4 mttt -61.73 -46.01 91.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.159 1.345 . . . . 0.0 110.295 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.11 -43.73 87.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.428 0.691 . . . . 0.0 111.842 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -77.48 10.52 2.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.992 0.917 . . . . 0.0 111.247 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.44 19.21 11.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.499 3.119 . . . . 0.0 115.143 174.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.3 168.37 51.7 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.435 1.016 . . . . 0.0 111.918 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -83.42 159.45 21.78 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.904 1.682 . . . . 0.0 109.846 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 84' ' ' LYS . 39.1 t -124.59 146.73 29.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.653 1.181 . . . . 0.0 109.127 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -143.85 121.28 11.68 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.26 0.624 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 mm -110.61 110.09 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.28 151.94 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.717 1.607 . . . . 0.0 108.985 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -103.08 132.27 49.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.338 0.655 . . . . 0.0 110.648 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.3 p -65.36 10.43 0.09 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.805 2.042 . . . . 0.0 114.715 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.28 0.71 10.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.394 1.877 . . . . 0.0 112.463 -166.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -139.62 160.38 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.606 1.962 . . . . 0.0 107.041 -172.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.33 -24.69 28.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.326 0.65 . . . . 0.0 112.41 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.3 p -68.47 -31.99 71.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.722 -1.236 . . . . 0.0 110.285 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.32 -39.14 70.97 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -66.39 -28.96 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.143 1.472 . . . . 0.0 110.92 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.04 -51.23 26.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.251 1.021 . . . . 0.0 109.311 170.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -60.03 -28.8 68.04 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.818 1.19 . . . . 0.0 111.954 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -58.85 -36.15 74.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.565 1.146 . . . . 0.0 111.811 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -68.23 -0.68 4.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.1 1.76 . . . . 0.0 112.162 173.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.77 28.22 3.58 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.422 2.289 . . . . 0.0 108.79 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 p 70.87 2.38 4.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.829 2.051 . . . . 0.0 114.521 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.04 17.07 70.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 129.03 3.205 . . . . 0.0 114.238 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.66 134.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.299 1.55 . . . . 0.0 109.477 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.69 177.97 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.218 1.407 . . . . 0.0 110.488 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -162.3 144.35 10.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.465 1.03 . . . . 0.0 110.338 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.8 mt -84.11 144.84 9.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 125.081 1.352 . . . . 0.0 107.607 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD13 HG23 ' A' ' 117' ' ' VAL . 9.7 mt -117.71 139.25 51.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.145 0.978 . . . . 0.0 109.874 -176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.73 -24.24 65.35 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.093 1.357 . . . . 0.0 111.98 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.9 p90 -151.44 157.31 34.91 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.929 1.292 . . . . 0.0 108.799 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.91 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.414 2.743 . . . . 0.0 108.406 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 113' ' ' LEU . 62.2 t . . . . . 0 C--O 1.237 0.414 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.16 -65.31 0.14 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 p -70.34 -179.71 2.13 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.46 0.573 . . . . 0.0 111.96 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.51 -161.32 42.59 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -170.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 m 63.05 97.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.962 1.705 . . . . 0.0 110.943 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.7 m 35.2 90.68 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.548 1.939 . . . . 0.0 115.577 167.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.6 151.48 23.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 t -138.37 -174.61 3.86 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.115 1.366 . . . . 0.0 109.325 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.38 118.29 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.79 41.11 0.33 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.47 1.508 . . . . 0.0 112.33 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -55.72 138.04 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.768 0.827 . . . . 0.0 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -161.93 149.52 14.47 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.313 2.245 . . . . 0.0 106.263 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.14 156.85 36.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.805 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.47 -174.65 5.05 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.261 1.024 . . . . 0.0 109.339 166.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.33 131.14 49.77 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 124.085 0.954 . . . . 0.0 108.435 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.2 m -60.2 -38.08 82.2 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.261 0.937 . . . . 0.0 111.341 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.05 -52.08 66.46 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.706 1.139 . . . . 0.0 108.451 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.9 85.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.434 0.561 . . . . 0.0 112.291 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.11 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.3 1.44 . . . . 0.0 112.812 -169.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.06 -49.74 32.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -55.31 -51.21 67.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.714 0.805 . . . . 0.0 110.205 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.9 -42.21 88.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 119.223 0.92 . . . . 0.0 111.2 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -59.85 -47.75 84.47 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.85 1.659 . . . . 0.0 109.075 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.64 95.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.095 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.6 -43.9 80.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.269 0.94 . . . . 0.0 110.164 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.54 -48.38 60.62 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.522 1.129 . . . . 0.0 111.029 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.05 -41.11 95.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -57.43 -60.0 4.3 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.22 1.408 . . . . 0.0 110.32 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -35.94 74.94 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.59 -56.36 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.453 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -64.94 -37.78 88.77 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.142 0.577 . . . . 0.0 109.933 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.52 -36.53 69.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.332 0.969 . . . . 0.0 111.725 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -67.98 -61.26 1.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -64.97 -85.55 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.47 1.908 . . . . 0.0 112.44 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.21 93.87 47.58 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.29 1.436 . . . . 0.0 109.929 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -67.45 -5.36 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.894 1.729 . . . . 0.0 112.087 174.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.75 -33.07 60.77 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.134 0.879 . . . . 0.0 110.039 165.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -97.33 7.72 46.0 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -137.18 90.68 2.55 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.253 1.842 . . . . 0.0 110.347 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.7 m-30 -93.3 137.28 32.77 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.495 0.718 . . . . 0.0 109.756 -174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.56 164.94 28.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.77 0.795 . . . . 0.0 112.017 168.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.58 126.69 0.85 Allowed Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -170.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -35.66 -53.66 0.7 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.907 2.083 . . . . 0.0 112.422 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.05 83.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.037 0.935 . . . . 0.0 111.767 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -59.04 -57.23 13.98 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 t -49.64 -43.87 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.785 1.234 . . . . 0.0 111.895 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.26 -31.99 69.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.805 1.184 . . . . 0.0 111.727 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -44.71 30.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.617 1.567 . . . . 0.0 110.477 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -57.85 -32.51 67.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.925 -1.11 . . . . 0.0 112.37 172.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -65.52 -41.93 92.57 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.549 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.02 -35.4 69.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.25 0.932 . . . . 0.0 111.544 172.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.61 -2.81 40.8 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.847 1.259 . . . . 0.0 112.706 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.6 mmt 51.96 14.91 0.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.462 1.905 . . . . 0.0 113.148 -170.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.53 -4.97 58.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.143 -0.973 . . . . 0.0 112.362 -162.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.3 mt -76.55 108.72 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -169.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.4 -62.48 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.557 -1.202 . . . . 0.0 107.849 168.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.4 m -139.01 133.69 32.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 111' ' ' ALA . 8.2 tp -110.51 124.25 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.3 1.84 . . . . 0.0 108.582 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -101.67 137.56 39.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.591 1.556 . . . . 0.0 107.806 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 tt -151.94 139.75 13.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 134.24 50.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 166.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -34.52 69.45 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.041 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.6 -25.22 62.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.743 1.156 . . . . 0.0 113.212 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.72 -37.06 19.78 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.531 1.059 . . . . 0.0 110.378 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -56.55 -19.55 16.28 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.682 1.193 . . . . 0.0 112.352 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.66 49.72 2.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 120.626 -1.297 . . . . 0.0 108.863 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -62.09 151.59 35.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.882 0.873 . . . . 0.0 109.617 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -69.22 -42.81 75.2 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.217 0.607 . . . . 0.0 112.415 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.17 119.15 19.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.5 -49.43 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 117.532 -1.223 . . . . 0.0 110.676 -172.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.04 -52.38 66.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.366 1.439 . . . . 0.0 110.945 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -52.94 -53.12 54.32 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 110.809 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -55.89 -52.7 63.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -46.47 -50.6 16.69 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 126.256 1.822 . . . . 0.0 110.575 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.13 -57.3 11.62 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.972 0.909 . . . . 0.0 110.048 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -56.18 -51.68 67.14 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.152 -0.928 . . . . 0.0 112.113 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.12 -38.61 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 120.058 1.299 . . . . 0.0 110.824 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -60.22 -52.58 64.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.356 1.062 . . . . 0.0 109.026 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.12 -44.17 92.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.006 0.922 . . . . 0.0 111.205 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -53.29 -57.42 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.263 1.025 . . . . 0.0 110.138 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -34.73 78.63 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -69.45 -16.82 63.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.028 . . . . 0.0 112.809 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -79.35 -37.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 O-C-N 120.472 -1.393 . . . . 0.0 109.135 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.98 -39.44 92.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.306 0.957 . . . . 0.0 108.899 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -57.25 -36.13 70.58 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.274 0.63 . . . . 0.0 111.269 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -87.62 13.37 10.45 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.856 1.262 . . . . 0.0 112.065 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.26 19.34 4.89 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.887 2.475 . . . . 0.0 114.535 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.33 170.03 50.84 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.282 0.946 . . . . 0.0 110.956 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -92.99 153.4 18.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.293 1.437 . . . . 0.0 108.691 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.6 142.1 40.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.333 1.453 . . . . 0.0 107.73 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -134.5 122.4 22.39 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.537 1.535 . . . . 0.0 108.011 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.75 105.55 19.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 10.2 m-85 -88.49 155.42 19.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -172.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 m -103.84 147.32 27.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.318 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.9 t -60.64 -35.85 77.19 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.149 0.906 . . . . 0.0 108.809 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.13 -56.25 16.18 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.976 1.71 . . . . 0.0 111.514 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -66.46 145.21 55.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.79 -26.46 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.586 0.63 . . . . 0.0 111.247 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 p -56.38 -17.98 9.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.184 0.994 . . . . 0.0 112.664 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.91 -55.58 4.08 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 125.348 1.452 . . . . 0.0 110.449 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.06 -29.19 67.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.312 1.056 . . . . 0.0 111.103 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -60.81 -58.13 9.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -57.48 -28.06 63.07 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.391 1.077 . . . . 0.0 112.238 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 m -56.34 -34.35 66.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.25 1.02 . . . . 0.0 113.196 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -64.44 -9.17 16.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.822 1.249 . . . . 0.0 111.755 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.1 mt -131.03 32.88 4.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.816 2.846 . . . . 0.0 108.711 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p 56.99 18.4 3.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.003 2.121 . . . . 0.0 114.482 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.64 69.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.801 2.143 . . . . 0.0 113.072 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.48 121.82 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.791 1.796 . . . . 0.0 110.59 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 179.48 8.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.577 0.751 . . . . 0.0 111.506 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -161.67 145.44 12.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.903 1.281 . . . . 0.0 110.502 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.44 146.34 7.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.529 1.531 . . . . 0.0 106.898 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 117' ' ' VAL . 18.1 mt -117.46 145.57 44.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.452 0.701 . . . . 0.0 109.725 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -77.6 -24.6 49.62 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.689 1.596 . . . . 0.0 111.913 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -148.22 154.83 42.88 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 126.2 1.8 . . . . 0.0 106.324 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.34 114.75 3.56 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 123.163 2.576 . . . . 0.0 107.586 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 113' ' ' LEU . 55.7 t -61.6 142.23 94.43 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.65 66.19 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.504 2.803 . . . . 0.0 112.32 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.9 m -139.78 5.47 2.18 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.398 1.879 . . . . 0.0 111.837 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.04 -177.64 54.21 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.964 0.802 . . . . 0.0 113.088 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.33 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.08 2.52 . . . . 0.0 110.896 -167.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -155.29 175.92 13.23 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 128.795 2.838 . . . . 0.0 105.462 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 t -141.95 169.65 17.2 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.059 0.933 . . . . 0.0 110.692 -172.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 C-N-CA 127.851 2.644 . . . . 0.0 106.847 169.491 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -155.85 171.72 19.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.269 1.828 . . . . 0.0 108.592 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -162.72 -173.09 3.36 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.729 2.412 . . . . 0.0 109.005 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.17 126.16 3.47 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 124.882 1.229 . . . . 0.0 111.806 165.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.1 p -153.12 142.48 21.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.782 0.833 . . . . 0.0 109.009 168.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 143.71 16.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.583 1.553 . . . . 0.0 109.585 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.05 159.24 14.25 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.969 0.795 . . . . 0.0 112.061 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.3 t -163.31 133.11 4.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.739 1.216 . . . . 0.0 109.489 165.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -138.2 161.53 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.78 1.632 . . . . 0.0 106.676 166.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.69 100.1 0.32 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.337 1.055 . . . . 0.0 109.767 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -117.89 151.39 37.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.082 0.953 . . . . 0.0 109.941 167.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.45 153.45 39.59 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.419 1.887 . . . . 0.0 107.528 167.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.58 179.26 4.32 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.834 1.254 . . . . 0.0 109.996 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.2 m -96.36 60.69 1.95 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.893 1.677 . . . . 0.0 108.259 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.66 109.63 4.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.0 m -54.47 -48.89 71.24 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.267 1.027 . . . . 0.0 111.29 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -66.71 -52.56 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.423 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.4 -33.7 76.3 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.982 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.95 -23.99 61.54 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.496 1.044 . . . . 0.0 112.231 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.79 -43.44 22.98 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.71 93.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.009 0.924 . . . . 0.0 110.54 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 t -69.03 -35.39 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.197 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -53.38 -44.1 68.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.077 1.762 . . . . 0.0 109.87 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.563 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -65.61 -46.32 79.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.794 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.1 -45.32 79.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.38 0.991 . . . . 0.0 111.106 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.26 -54.38 44.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.33 1.852 . . . . 0.0 108.465 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -66.39 -38.15 86.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.819 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 90.8 t80 -58.22 -59.7 4.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 110.285 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -61.71 -31.04 71.17 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -50.37 -62.94 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmm -58.9 -38.75 79.62 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.975 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -55.29 -30.32 59.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.983 1.265 . . . . 0.0 112.23 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -35.45 11.31 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.463 -0.773 . . . . 0.0 111.945 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -76.88 -56.42 4.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.207 1.003 . . . . 0.0 112.857 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.27 81.06 7.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.606 1.963 . . . . 0.0 108.891 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.11 -14.03 39.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.126 2.551 . . . . 0.0 112.762 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.41 -20.98 61.64 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.104 -0.998 . . . . 0.0 111.301 172.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -101.08 11.35 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 123.835 0.854 . . . . 0.0 112.665 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -146.26 91.03 2.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 119.43 1.014 . . . . 0.0 109.837 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 4.3 m-30 -92.33 144.5 25.32 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.64 164.66 29.59 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.57 130.8 2.86 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.879 -2.089 . . . . 0.0 107.879 -171.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.0 tp -43.95 -47.6 8.51 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -61.27 -46.73 89.12 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.307 1.043 . . . . 0.0 111.618 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.14 -58.4 8.69 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 119.532 1.06 . . . . 0.0 108.412 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 t -53.08 -36.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.684 1.194 . . . . 0.0 111.637 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.04 -21.62 66.29 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.067 -1.02 . . . . 0.0 112.767 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -87.6 -43.49 11.94 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 125.836 1.654 . . . . 0.0 110.459 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -54.87 -36.55 65.22 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.251 -0.906 . . . . 0.0 111.898 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -64.89 -45.18 87.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.576 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -60.0 -28.75 67.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.388 0.994 . . . . 0.0 113.132 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -0.11 29.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.186 1.394 . . . . 0.0 111.829 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.1 mmt 52.26 23.31 2.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.309 2.244 . . . . 0.0 112.775 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -100.92 -8.26 22.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.333 1.053 . . . . 0.0 112.694 -161.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.3 mt -70.5 117.48 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.05 -61.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.57 1.148 . . . . 0.0 108.518 165.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.7 m -138.0 139.84 39.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 80' ' ' VAL . 12.1 tp -110.53 133.4 53.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.186 1.794 . . . . 0.0 108.107 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.563 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -109.62 134.47 51.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.199 1.799 . . . . 0.0 107.326 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.53 142.83 23.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -72.7 131.73 42.75 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.58 -32.85 65.62 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 123.05 0.54 . . . . 0.0 111.537 -174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -47.52 -41.87 22.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.6 -40.24 35.08 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.114 0.966 . . . . 0.0 108.998 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.32 -20.05 10.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.372 0.669 . . . . 0.0 111.694 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -118.61 21.27 12.63 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.847 2.059 . . . . 0.0 111.773 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -55.07 144.85 22.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.369 0.986 . . . . 0.0 111.421 -168.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.21 -21.78 56.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -88.99 108.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.0 -26.09 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.983 0.913 . . . . 0.0 111.592 -172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.36 -54.39 12.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.16 0.891 . . . . 0.0 111.195 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.0 m -53.86 -49.03 69.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.145 1.778 . . . . 0.0 109.635 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -53.91 -47.28 71.32 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.089 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -50.13 -43.5 51.91 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.886 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.79 -56.74 18.27 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.271 1.028 . . . . 0.0 108.671 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -54.4 -55.61 26.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.788 -0.625 . . . . 0.0 111.757 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 m -64.96 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.901 1.228 . . . . 0.0 111.666 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -62.11 -53.36 56.49 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.0 tp -58.06 -43.28 86.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.197 0.999 . . . . 0.0 111.461 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 49.3 t -57.08 -33.02 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.094 0.958 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.24 -35.1 15.51 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.478 -0.764 . . . . 0.0 112.073 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 t -64.93 -16.3 63.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.069 1.747 . . . . 0.0 111.643 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -78.06 -35.3 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 119.513 -1.992 . . . . 0.0 109.679 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.85 -39.5 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.654 1.115 . . . . 0.0 110.37 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -48.93 -43.18 39.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.479 1.112 . . . . 0.0 110.325 171.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -94.37 17.65 12.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.161 1.384 . . . . 0.0 111.054 -168.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 27.69 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.57 2.348 . . . . 0.0 113.658 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.48 -170.79 46.72 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.127 0.87 . . . . 0.0 111.293 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -124.93 156.34 38.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.136 2.174 . . . . 0.0 109.14 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.66 140.92 44.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.969 0.89 . . . . 0.0 108.826 -173.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -137.07 120.81 17.37 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.2 mm -115.25 109.93 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 -175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -89.66 138.12 31.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.4 t -69.07 122.43 18.71 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 165.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 p -55.88 -15.0 2.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.226 1.41 . . . . 0.0 113.38 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.95 -33.93 44.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.158 0.89 . . . . 0.0 111.297 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -67.44 151.49 47.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.78 -18.18 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.752 -0.592 . . . . 0.0 111.905 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.7 p -68.04 -27.9 66.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.105 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -72.07 -26.32 72.66 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.66 1.118 . . . . 0.0 110.756 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.49 -49.86 37.05 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.289 1.045 . . . . 0.0 108.811 165.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -61.14 -35.65 77.65 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.203 -0.936 . . . . 0.0 111.885 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -70.64 -29.79 66.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.646 172.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 t -52.94 -41.47 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.984 1.314 . . . . 0.0 110.973 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.0 4.03 0.73 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.017 2.127 . . . . 0.0 114.115 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -137.81 27.98 2.68 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.539 2.736 . . . . 0.0 108.793 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p 66.29 2.08 2.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.249 2.62 . . . . 0.0 114.801 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.66 17.34 73.32 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 128.32 2.867 . . . . 0.0 113.94 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.56 132.67 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.016 1.908 . . . . 0.0 109.904 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.93 168.56 24.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.519 1.127 . . . . 0.0 110.269 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.06 145.28 23.91 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.309 0.958 . . . . 0.0 111.137 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 89.1 mt -83.95 148.87 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 127.029 2.132 . . . . 0.0 106.687 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 49' ' ' ALA . 24.2 mt -117.56 147.38 42.86 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.118 0.967 . . . . 0.0 111.718 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mtt85 -70.34 -32.09 69.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 168.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 10.4 p90 -151.23 154.0 33.32 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 118.245 0.475 . . . . 0.0 110.356 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.3 113.44 3.7 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.783 2.988 . . . . 0.0 109.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.506 HG23 HD13 ' A' ' 113' ' ' LEU . 98.0 t -73.02 122.62 88.13 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.83 82.31 2.35 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.804 3.003 . . . . 0.0 111.682 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 m -140.43 -165.57 1.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.704 2.002 . . . . 0.0 107.845 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.64 127.86 2.56 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 172.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.24 155.74 63.67 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.152 1.901 . . . . 0.0 109.333 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.1 p -86.52 -66.28 0.92 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.124 1.369 . . . . 0.0 110.673 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.3 t -131.83 -179.32 5.32 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.686 1.995 . . . . 0.0 107.251 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.295 0 CA-C-O 117.519 -1.711 . . . . 0.0 110.087 -177.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.6 p -155.62 168.13 28.15 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.51 -170.72 0.1 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.299 0.64 . . . . 0.0 112.469 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.17 -163.87 16.41 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.6 m 67.33 103.58 0.05 OUTLIER 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.442 1.897 . . . . 0.0 111.908 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 t -154.87 141.22 18.66 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.754 1.622 . . . . 0.0 107.371 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.24 140.82 3.09 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -166.1 135.55 3.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.68 72.43 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 110.964 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.45 11.53 13.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.738 2.415 . . . . 0.0 111.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -66.24 110.6 3.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.081 1.752 . . . . 0.0 110.009 -169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -148.97 -66.42 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.209 -0.932 . . . . 0.0 110.892 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.01 -163.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.101 1.36 . . . . 0.0 112.259 -157.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 m -141.35 170.9 14.86 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.175 1.79 . . . . 0.0 108.944 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t0 63.12 105.41 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 130.074 3.35 . . . . 0.0 110.471 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -42.16 -41.79 2.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.83 1.652 . . . . 0.0 114.503 -165.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -68.78 -51.94 35.68 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.806 -1.184 . . . . 0.0 110.153 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.07 -54.43 46.02 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.89 -0.576 . . . . 0.0 109.637 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.72 -40.37 54.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.537 1.135 . . . . 0.0 112.447 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.39 -47.61 34.74 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.962 0.801 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -48.68 76.35 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.946 0.873 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.23 -42.5 66.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 124.7 1.2 . . . . 0.0 109.606 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -57.13 -50.04 74.03 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.909 1.231 . . . . 0.0 109.533 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.45 -43.64 98.52 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.855 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 tp -57.91 -47.93 81.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.865 1.211 . . . . 0.0 110.233 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.18 -51.95 65.77 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 126.701 2.0 . . . . 0.0 109.477 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -70.03 -42.15 73.31 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -173.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -51.98 -56.82 11.88 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.198 0.999 . . . . 0.0 108.567 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -44.89 89.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 124.123 0.889 . . . . 0.0 112.247 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.08 -57.73 4.76 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ttp -66.27 -33.14 75.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.374 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.18 -50.94 60.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.732 1.606 . . . . 0.0 110.814 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -65.33 -40.16 93.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.221 0.208 . . . . 0.0 110.562 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -78.88 -57.95 3.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 111.41 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -149.97 76.9 8.63 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.431 2.292 . . . . 0.0 108.29 -167.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.81 -5.94 14.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.749 2.299 . . . . 0.0 112.151 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -27.19 2.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.003 2.121 . . . . 0.0 110.99 163.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HA ' HD12 ' A' ' 113' ' ' LEU . 76.1 mtp180 -110.22 0.8 18.32 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.208 1.403 . . . . 0.0 113.922 175.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.74 95.21 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.669 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.5 m-30 -93.55 133.62 36.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -140.38 159.91 41.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.16 0.981 . . . . 0.0 113.522 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 135.94 0.69 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.8 tp -44.97 -49.8 10.96 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.801 1.641 . . . . 0.0 112.27 -169.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -56.16 -43.27 78.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.432 1.493 . . . . 0.0 110.367 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -66.69 -57.82 6.37 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.18 -36.65 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.218 -0.926 . . . . 0.0 111.924 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -56.4 -38.84 72.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.914 0.885 . . . . 0.0 112.21 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -47.11 53.29 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.155 1.382 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -58.77 -32.83 69.64 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.577 -0.702 . . . . 0.0 112.537 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -65.53 -43.61 89.47 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.906 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.64 -28.16 66.98 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.04 0.836 . . . . 0.0 112.548 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.18 -6.12 57.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.46 0.704 . . . . 0.0 111.746 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 60.26 9.5 1.96 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.624 1.97 . . . . 0.0 112.491 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -83.56 -7.19 59.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.167 -0.958 . . . . 0.0 113.027 -162.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.0 114.35 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 119.167 0.894 . . . . 0.0 108.86 -170.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.74 -52.37 10.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.166 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.6 m -140.99 132.93 27.66 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.27 132.71 53.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.467 2.307 . . . . 0.0 106.797 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.481 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -110.96 126.68 55.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.16 1.784 . . . . 0.0 106.918 176.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.11 136.31 29.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 118.931 0.787 . . . . 0.0 109.469 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -65.75 138.55 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -55.55 -39.35 70.5 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 122.928 0.491 . . . . 0.0 110.208 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -60.65 -16.7 41.52 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.39 -42.59 10.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.875 1.216 . . . . 0.0 110.091 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -50.28 -32.56 17.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.554 1.142 . . . . 0.0 112.379 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.55 38.85 4.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.511 1.924 . . . . 0.0 109.709 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.97 151.82 17.62 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -68.73 -41.49 78.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.583 0.753 . . . . 0.0 111.785 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 23.9 t70 -75.89 120.48 21.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.191 1.396 . . . . 0.0 108.23 -172.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.84 -39.44 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.404 -174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.91 -60.27 4.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.976 0.807 . . . . 0.0 109.289 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 89.1 m -58.93 -51.24 70.88 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.089 0.956 . . . . 0.0 110.061 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -52.62 -52.31 56.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.017 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.3 t -52.2 -46.87 65.77 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 119.227 0.922 . . . . 0.0 109.245 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -51.73 -50.73 59.99 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.106 0.866 . . . . 0.0 109.668 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -57.82 -60.4 3.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.722 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 m -61.94 -37.84 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.328 1.422 . . . . 0.0 111.151 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -57.55 -53.16 61.34 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.809 1.644 . . . . 0.0 108.721 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.72 -46.63 88.53 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.808 0.843 . . . . 0.0 111.252 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 58' ' ' LEU . 41.6 t -54.67 -49.88 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 124.311 1.045 . . . . 0.0 109.348 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.02 -37.8 78.85 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -64.65 -30.49 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.76 0.824 . . . . 0.0 111.856 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.28 -39.77 79.46 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 O-C-N 120.952 -1.092 . . . . 0.0 109.623 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.01 -46.69 89.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.985 0.811 . . . . 0.0 110.114 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -59.14 -31.27 68.8 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.979 0.512 . . . . 0.0 112.189 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.81 26.6 2.34 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.829 1.252 . . . . 0.0 111.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.64 6.75 2.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.872 2.869 . . . . 0.0 115.225 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.99 -176.18 47.91 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.177 0.899 . . . . 0.0 112.015 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -123.42 157.5 33.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.897 1.679 . . . . 0.0 109.935 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.3 t -122.66 139.66 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 108.232 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -129.36 121.45 27.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.1 mm -100.74 109.34 25.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 5.6 m-85 -89.62 156.76 18.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 108.697 -177.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -104.76 139.4 39.61 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 t -62.4 9.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.691 2.396 . . . . 0.0 114.155 170.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.7 mt -129.3 -14.47 4.27 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.27 1.828 . . . . 0.0 113.689 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -87.69 148.38 24.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.565 1.075 . . . . 0.0 109.214 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.6 p -57.02 -32.63 40.38 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 O-C-N 121.721 -0.612 . . . . 0.0 110.129 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.0 m -65.3 -27.36 68.56 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.307 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.65 -53.8 25.99 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 167.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.34 -31.33 67.48 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.29 1.045 . . . . 0.0 112.196 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.96 -47.53 65.42 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.953 0.901 . . . . 0.0 109.697 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.86 -31.91 65.28 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 122.948 0.499 . . . . 0.0 111.39 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -58.33 -33.88 70.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.648 1.179 . . . . 0.0 112.926 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.14 -6.77 14.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.452 1.501 . . . . 0.0 112.053 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.0 mt -129.7 23.04 5.42 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.537 2.735 . . . . 0.0 108.218 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.9 p 77.57 -12.12 1.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 130.263 3.425 . . . . 0.0 114.122 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.36 15.76 46.12 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.962 2.22 . . . . 0.0 113.133 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.17 133.48 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 118.933 1.366 . . . . 0.0 108.962 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.74 175.09 13.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.669 1.188 . . . . 0.0 110.05 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.18 142.01 9.82 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.241 0.928 . . . . 0.0 110.918 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 72.2 mt -83.88 141.84 14.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.203 1.401 . . . . 0.0 107.715 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.732 HD13 HG23 ' A' ' 117' ' ' VAL . 30.2 mt -112.9 139.91 48.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.311 1.045 . . . . 0.0 111.249 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -66.86 -25.54 66.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.052 1.741 . . . . 0.0 112.374 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -151.61 157.47 34.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 125.507 1.523 . . . . 0.0 107.254 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -70.69 128.92 15.81 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.992 1.795 . . . . 0.0 108.384 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.732 HG23 HD13 ' A' ' 113' ' ' LEU . 79.4 t -78.88 129.39 73.62 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.85 104.87 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.869 2.379 . . . . 0.0 110.334 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.8 t -158.9 -74.98 0.08 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.35 170.49 34.74 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.7 169.64 15.59 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.945 2.43 . . . . 0.0 109.783 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.2 p -157.4 164.62 37.32 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.292 0.637 . . . . 0.0 110.095 171.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -167.38 -164.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.741 2.016 . . . . 0.0 108.384 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 117.62 -1.656 . . . . 0.0 110.683 178.055 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m 61.68 141.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.063 1.745 . . . . 0.0 109.73 -152.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -145.49 155.88 43.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.45 160.72 53.62 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.7 t -153.18 126.25 8.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t 61.12 -164.91 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.729 1.212 . . . . 0.0 112.812 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.2 -170.76 43.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 128.548 2.975 . . . . 0.0 107.655 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 154.66 41.18 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.619 1.209 . . . . 0.0 108.775 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.23 165.5 19.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.99 0.916 . . . . 0.0 110.845 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.3 146.53 43.64 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 161.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.5 p -140.57 162.42 35.42 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.978 0.911 . . . . 0.0 109.021 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -139.79 164.78 29.05 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 123.859 0.863 . . . . 0.0 109.084 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.63 -59.6 4.94 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 167.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 t 47.03 83.52 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.35 1.86 . . . . 0.0 113.155 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 74.05 96.26 0.07 Allowed 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 126.7 2.0 . . . . 0.0 113.087 153.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.2 m -35.3 -50.68 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.808 2.043 . . . . 0.0 115.489 -162.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -65.97 -51.76 55.61 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.732 0.413 . . . . 0.0 110.216 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.26 -39.95 80.54 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.524 0.73 . . . . 0.0 110.007 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.14 69.14 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.416 1.007 . . . . 0.0 113.367 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.67 -39.27 18.11 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 119.423 1.011 . . . . 0.0 111.115 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -50.42 68.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.881 2.072 . . . . 0.0 108.139 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.44 -51.52 48.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 126.013 1.725 . . . . 0.0 109.677 172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.06 -45.01 67.92 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.558 1.072 . . . . 0.0 109.769 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -61.6 -50.72 71.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 123.854 0.721 . . . . 0.0 111.383 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -55.74 -46.75 77.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.977 1.262 . . . . 0.0 111.361 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.04 -46.53 88.0 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.543 1.537 . . . . 0.0 110.073 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.72 -35.65 65.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.135 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' CE1' ' HB1' ' A' ' 39' ' ' ALA . 61.4 t80 -61.46 -57.39 12.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.444 2.298 . . . . 0.0 109.995 173.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -58.79 -35.4 72.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.739 0.7 . . . . 0.0 112.073 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -50.0 -53.65 25.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.482 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.1 mmt -59.86 -44.44 94.13 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.57 0.623 . . . . 0.0 110.286 174.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.1 -25.31 45.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.056 0.844 . . . . 0.0 112.688 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -86.65 -62.35 1.53 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -68.11 -59.39 3.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.927 1.291 . . . . 0.0 113.826 -168.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.98 80.63 47.93 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 124.975 1.31 . . . . 0.0 109.015 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.48 -7.65 18.44 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.273 1.982 . . . . 0.0 113.752 -171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.99 -55.24 25.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.889 1.222 . . . . 0.0 108.195 164.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -76.08 10.97 1.63 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.278 0.945 . . . . 0.0 112.526 -168.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -128.3 96.51 4.46 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.77 1.228 . . . . 0.0 109.69 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.73 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.37 140.64 29.34 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.27 159.67 41.68 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 142.13 0.73 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 tp -45.24 -51.81 10.31 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.361 1.464 . . . . 0.0 112.673 -165.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -57.56 -49.59 75.89 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.648 1.579 . . . . 0.0 110.272 -175.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -59.12 -56.44 22.22 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -49.22 -40.59 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.666 1.186 . . . . 0.0 112.29 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -59.61 -35.65 74.76 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.688 1.586 . . . . 0.0 111.56 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -49.32 16.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 125.236 1.415 . . . . 0.0 109.348 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.73 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -56.06 -39.36 71.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.748 -0.595 . . . . 0.0 111.126 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.93 -50.37 69.01 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.5 0.72 . . . . 0.0 109.114 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.88 -16.01 47.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.891 1.277 . . . . 0.0 114.355 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.17 -10.51 54.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.806 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 51.91 52.45 14.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.164 1.385 . . . . 0.0 109.573 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 115' ' ' PHE . . . -124.76 -18.73 5.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.334 2.254 . . . . 0.0 111.528 -171.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.8 mt -71.48 117.61 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -91.7 -57.65 2.68 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.459 1.103 . . . . 0.0 108.973 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -129.98 126.42 37.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 108.099 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 HG22 ' A' ' 80' ' ' VAL . 9.3 tp -109.52 137.2 47.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.874 2.07 . . . . 0.0 106.958 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -119.23 126.17 50.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.486 1.914 . . . . 0.0 107.076 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.83 141.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.3 m -71.22 134.13 46.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.268 1.027 . . . . 0.0 108.682 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -56.19 -35.0 66.76 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.737 -1.125 . . . . 0.0 110.055 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -54.04 -22.27 10.28 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.64 -45.41 9.87 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 120.85 -1.157 . . . . 0.0 110.081 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -54.85 -20.49 8.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.284 1.434 . . . . 0.0 113.592 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -125.97 20.74 7.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.706 1.603 . . . . 0.0 112.085 178.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -51.39 144.57 9.79 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.732 1.613 . . . . 0.0 111.526 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -51.32 -52.06 48.8 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.416 1.886 . . . . 0.0 112.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.06 108.66 9.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 126.257 1.823 . . . . 0.0 107.713 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -54.44 -33.62 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.759 -174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.13 -63.28 1.29 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.803 1.183 . . . . 0.0 111.363 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 m -55.42 -45.73 76.7 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.768 1.227 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -56.83 -48.85 77.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.818 1.19 . . . . 0.0 110.619 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.4 m -57.09 -31.04 64.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.546 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -64.28 -58.54 6.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 120.303 1.41 . . . . 0.0 108.94 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 80' ' ' VAL . 40.2 m-85 -53.46 -53.34 52.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.023 -177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.78 -38.77 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.345 0.975 . . . . 0.0 110.93 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -63.65 -46.83 83.82 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.304 0.502 . . . . 0.0 110.486 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 tp -70.05 -34.96 73.9 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.382 0.673 . . . . 0.0 110.921 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.507 HG22 HD21 ' A' ' 58' ' ' LEU . 77.8 t -58.61 -48.51 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.67 94.38 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.949 0.9 . . . . 0.0 110.621 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -70.66 -25.38 62.97 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.546 1.538 . . . . 0.0 111.631 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.85 -42.26 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 120.702 -1.249 . . . . 0.0 108.466 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -63.72 -40.06 95.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.814 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -50.57 -49.0 57.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.071 0.851 . . . . 0.0 109.49 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -84.8 26.06 0.87 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.011 2.124 . . . . 0.0 110.763 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.04 22.12 12.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.534 2.734 . . . . 0.0 115.311 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.64 159.41 23.93 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 122.581 1.101 . . . . 0.0 113.243 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -82.5 163.55 21.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.191 2.197 . . . . 0.0 110.693 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.1 t -127.92 153.54 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 120.706 -1.246 . . . . 0.0 108.945 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.1 mmt-85 -141.0 131.88 25.95 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.692 1.997 . . . . 0.0 106.113 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.6 mm -118.4 107.48 21.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.86 155.02 19.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -103.11 145.8 29.36 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.7 t -60.55 -34.96 74.91 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.833 0.708 . . . . 0.0 110.542 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.19 -25.06 67.57 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.347 1.459 . . . . 0.0 112.809 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -83.39 147.62 27.79 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.496 0.718 . . . . 0.0 109.948 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -37.71 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.982 0.513 . . . . 0.0 110.36 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.6 m -71.04 -20.36 62.39 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.405 1.082 . . . . 0.0 111.838 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.48 -44.54 33.03 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.84 -34.97 73.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 117.715 0.758 . . . . 0.0 110.296 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -66.1 -55.65 15.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.552 0.741 . . . . 0.0 111.068 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.61 -30.96 67.65 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.559 1.072 . . . . 0.0 111.803 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.4 t -60.15 -33.45 72.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.286 1.034 . . . . 0.0 112.128 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -58.76 -21.64 56.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.884 0.765 . . . . 0.0 111.303 171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.4 mt -112.27 29.8 7.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.644 2.378 . . . . 0.0 109.412 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.94 0.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.523 2.729 . . . . 0.0 114.427 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.34 13.81 65.07 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 128.87 3.128 . . . . 0.0 113.618 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.2 133.13 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.502 2.151 . . . . 0.0 109.739 171.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -155.17 172.76 17.63 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.775 0.83 . . . . 0.0 110.439 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.44 146.86 22.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.091 -1.006 . . . . 0.0 110.614 173.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.2 mt -84.02 141.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 107.304 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 49' ' ' ALA . 10.1 mt -117.4 141.97 47.69 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.01 0.924 . . . . 0.0 108.589 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -66.93 -40.48 87.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.32 0.648 . . . . 0.0 110.37 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 17.0 p90 -136.0 156.82 76.83 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 125.547 1.539 . . . . 0.0 107.725 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 114.48 3.87 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.845 2.364 . . . . 0.0 108.294 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.2 t -66.14 133.71 94.72 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.12 98.87 0.33 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.888 2.392 . . . . 0.0 109.017 170.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.4 m -161.33 -179.98 7.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.849 2.46 . . . . 0.0 107.593 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.0 29.83 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.53 -15.81 24.48 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.409 2.739 . . . . 0.0 113.523 -170.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.34 -21.67 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.093 0.86 . . . . 0.0 110.864 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 p -95.63 53.92 1.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.13 1.372 . . . . 0.0 111.811 -171.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 167.622 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -105.73 -1.24 24.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.895 1.278 . . . . 0.0 112.75 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 m -63.17 156.15 26.05 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.141 1.376 . . . . 0.0 112.33 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.81 25.83 69.48 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.268 -1.296 . . . . 0.0 115.08 162.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.9 t -93.34 -97.57 0.14 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.416 1.608 . . . . 0.0 109.957 -173.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.3 m -61.85 144.28 55.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.842 1.257 . . . . 0.0 110.906 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.99 -178.15 40.24 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 121.791 -0.568 . . . . 0.0 111.883 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -120.1 120.11 35.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.464 1.106 . . . . 0.0 109.631 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -114.41 67.99 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 140.98 47.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.52 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 p -139.38 141.16 37.59 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.435 0.636 . . . . 0.0 110.716 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -126.5 103.04 7.39 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.91 1.684 . . . . 0.0 108.312 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.74 94.79 5.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.9 m -127.99 -8.24 5.46 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 19.0 t70 -163.14 141.5 8.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.76 1.164 . . . . 0.0 109.131 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -62.19 -43.14 99.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.375 1.443 . . . . 0.0 111.48 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -52.91 5.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -68.48 -33.53 74.32 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.901 -172.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.5 -11.62 61.04 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.717 2.053 . . . . 0.0 112.741 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.87 -61.74 3.91 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 165.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -62.79 -43.61 98.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.886 1.274 . . . . 0.0 112.459 -173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.47 -41.0 80.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 124.0 0.92 . . . . 0.0 109.907 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.41 83.55 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.433 1.015 . . . . 0.0 109.353 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.33 75.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.051 0.541 . . . . 0.0 110.866 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.01 -46.0 89.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.575 0.75 . . . . 0.0 110.456 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -57.2 -52.62 64.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 124.405 1.082 . . . . 0.0 108.765 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -42.15 94.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.219 -172.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.63 -55.27 36.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.443 1.497 . . . . 0.0 110.12 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -58.42 -35.54 72.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 118.9 0.773 . . . . 0.0 112.086 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -53.65 -56.34 18.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 1.1 mmm -61.61 -35.81 78.91 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.851 0.75 . . . . 0.0 111.703 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.36 -28.76 60.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.137 1.335 . . . . 0.0 111.462 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -90.44 -55.96 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.258 0.623 . . . . 0.0 110.827 169.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.56 -53.8 51.55 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.903 0.774 . . . . 0.0 112.756 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.87 76.41 11.55 Favored Pre-proline 0 N--CA 1.446 -0.654 0 C-N-CA 125.301 1.441 . . . . 0.0 109.059 -172.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -12.44 29.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.531 2.154 . . . . 0.0 112.41 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -61.88 -19.84 63.08 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.893 -1.129 . . . . 0.0 111.729 167.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.598 ' HA ' HD12 ' A' ' 113' ' ' LEU . 26.5 mtm180 -110.25 6.64 22.71 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.24 1.416 . . . . 0.0 113.118 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.85 95.68 3.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.687 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.3 m-85 -93.29 139.92 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -140.23 156.8 46.35 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 119.382 0.992 . . . . 0.0 112.882 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.24 132.7 1.65 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.73 -51.08 4.22 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.028 1.731 . . . . 0.0 112.276 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -59.13 -49.46 77.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.472 1.109 . . . . 0.0 110.264 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -59.87 -55.07 38.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.3 t -53.58 -40.14 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.41 -0.806 . . . . 0.0 111.451 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.34 -41.49 76.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.27 0.941 . . . . 0.0 110.964 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -44.91 83.31 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.082 -1.011 . . . . 0.0 109.647 176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -62.89 -31.75 72.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -62.72 -45.8 91.08 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.269 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.88 -25.1 66.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.61 -5.6 57.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.771 0.828 . . . . 0.0 111.541 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.1 mmt 58.31 19.96 6.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.509 1.524 . . . . 0.0 111.897 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.14 -5.72 15.86 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.201 -163.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.47 109.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -74.83 -45.97 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.231 170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -146.22 133.46 20.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 80' ' ' VAL . 8.1 tp -110.06 123.74 50.23 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.347 1.859 . . . . 0.0 106.488 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.29 126.28 46.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.879 1.672 . . . . 0.0 106.719 175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -137.02 139.57 44.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.38 131.9 44.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.73 -34.2 67.27 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.99 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.58 -35.83 14.32 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.471 1.487 . . . . 0.0 113.591 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 73.8 mt -81.08 -42.43 21.03 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.023 0.829 . . . . 0.0 110.553 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -55.41 -28.91 57.15 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.069 -1.019 . . . . 0.0 112.218 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -106.45 16.62 24.45 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 127.533 2.333 . . . . 0.0 110.924 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -50.77 139.15 17.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.114 1.324 . . . . 0.0 111.254 -162.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -35.37 74.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.593 1.157 . . . . 0.0 111.74 -174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -76.16 119.91 20.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 170.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.509 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.405 1.002 . . . . 0.0 109.948 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -56.97 -45.05 83.16 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.637 1.175 . . . . 0.0 111.281 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -51.29 -48.79 62.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.065 1.302 . . . . 0.0 111.817 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -13.62 15.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 117.243 -1.36 . . . . 0.0 113.961 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -75.2 -63.47 1.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.684 1.584 . . . . 0.0 108.556 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 80' ' ' VAL . 53.5 m-85 -49.56 -53.86 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.828 -0.606 . . . . 0.0 112.039 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.59 -36.31 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.76 1.164 . . . . 0.0 111.544 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 -64.78 -47.34 78.49 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 122.028 -0.42 . . . . 0.0 110.941 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.48 -46.63 89.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.712 0.805 . . . . 0.0 110.243 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 58' ' ' LEU . 95.0 t -60.13 -39.09 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.506 1.123 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.23 -43.05 58.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.568 -1.333 . . . . 0.0 110.883 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 t -64.36 -28.26 69.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.454 0.57 . . . . 0.0 111.151 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -65.15 -36.49 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 120.199 -1.563 . . . . 0.0 110.474 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -63.64 -45.62 89.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.365 1.439 . . . . 0.0 109.843 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -54.41 -37.36 64.98 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.363 1.065 . . . . 0.0 110.398 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -93.14 20.35 6.98 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.57 1.548 . . . . 0.0 111.215 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.12 27.47 16.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.27 2.228 . . . . 0.0 114.001 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.79 163.06 24.47 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -86.59 145.97 26.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.659 1.583 . . . . 0.0 109.124 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -99.86 139.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -128.3 121.22 28.73 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.76 122.09 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -94.46 128.41 41.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 117.4 5.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -58.81 -24.71 62.32 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.297 1.439 . . . . 0.0 112.415 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.07 -26.16 65.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 111.717 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -81.61 147.32 29.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.468 1.907 . . . . 0.0 109.436 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.05 -16.06 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.261 1.025 . . . . 0.0 112.262 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -60.19 -35.98 76.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.432 -1.417 . . . . 0.0 111.42 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.92 97.23 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -72.46 -38.24 68.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.11 0.964 . . . . 0.0 111.639 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -57.17 -51.32 69.81 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.36 -0.838 . . . . 0.0 109.343 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.59 -30.96 71.98 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.7 t -58.04 -37.3 74.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.445 1.898 . . . . 0.0 111.249 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -52.2 -33.45 40.97 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.61 1.164 . . . . 0.0 110.871 171.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.7 mt -105.49 31.29 5.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 128.674 2.79 . . . . 0.0 109.997 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 p 75.11 -14.93 0.71 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 128.871 2.868 . . . . 0.0 113.479 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.0 14.75 58.8 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.292 2.377 . . . . 0.0 113.13 -171.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.54 132.68 27.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 120.096 1.948 . . . . 0.0 108.976 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.97 175.1 14.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.359 1.063 . . . . 0.0 109.823 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.53 144.46 15.43 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 86.2 mt -83.9 143.11 12.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD13 HG23 ' A' ' 117' ' ' VAL . 13.5 mt -117.09 151.51 36.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 0.0 110.653 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -63.88 -51.91 62.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.735 170.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.08 154.73 80.48 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.256 1.423 . . . . 0.0 110.479 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.24 106.66 2.32 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.165 3.243 . . . . 0.0 108.733 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 113' ' ' LEU . 80.7 t -63.25 135.48 96.26 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.705 0.402 . . . . 0.0 110.071 -163.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.13 91.7 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 124.172 3.248 . . . . 0.0 109.885 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.0 m -150.22 -171.03 3.81 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.803 1.241 . . . . 0.0 109.417 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.13 -178.0 15.32 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.502 1.525 . . . . 0.0 110.324 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.3 163.25 39.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.861 2.374 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -135.67 -62.96 0.68 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.508 0.723 . . . . 0.0 109.601 163.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 m -66.6 175.8 2.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.021 1.328 . . . . 0.0 110.936 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.749 -1.584 . . . . 0.0 110.628 166.237 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.45 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.724 2.009 . . . . 0.0 112.303 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -139.44 115.08 10.01 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.905 1.282 . . . . 0.0 108.36 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.71 -167.11 34.15 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 168.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m 110.65 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 130.846 3.659 . . . . 0.0 107.621 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 83.1 p -153.25 176.41 11.99 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.255 0.622 . . . . 0.0 111.165 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.58 76.83 1.14 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 t -154.29 133.2 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.36 21.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.072 0.549 . . . . 0.0 110.929 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.29 134.98 49.96 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.959 -1.088 . . . . 0.0 111.49 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -132.53 -58.53 0.93 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.569 2.347 . . . . 0.0 110.819 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.42 91.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.888 2.475 . . . . 0.0 113.186 -170.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -77.74 156.37 30.63 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 164.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.64 -53.05 0.31 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.528 1.531 . . . . 0.0 110.119 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -71.15 176.25 4.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.206 0.602 . . . . 0.0 111.802 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -67.44 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.498 -1.376 . . . . 0.0 109.085 152.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -68.22 -51.77 41.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -161.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -25.72 66.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.005 -1.474 . . . . 0.0 113.175 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.25 -27.95 65.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 121.566 1.985 . . . . 0.0 112.056 172.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.71 -58.04 16.66 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 172.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.24 -50.31 73.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.289 0.636 . . . . 0.0 111.038 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.99 -47.88 88.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.314 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -55.58 26.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.297 1.408 . . . . 0.0 109.113 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.61 -28.05 66.85 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 127.288 2.235 . . . . 0.0 112.524 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tp -80.1 -45.93 17.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.828 1.251 . . . . 0.0 110.218 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -54.45 -48.69 71.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.284 1.834 . . . . 0.0 109.276 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.32 -40.24 67.6 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.183 1.393 . . . . 0.0 109.531 -172.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -59.2 -54.39 47.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.782 1.233 . . . . 0.0 109.891 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -58.28 -38.24 76.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.361 0.665 . . . . 0.0 112.175 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -50.85 -57.2 9.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mmm -59.53 -39.06 82.7 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.4 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -53.36 -25.95 17.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.759 1.224 . . . . 0.0 112.054 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -96.28 -51.63 4.31 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.167 1.787 . . . . 0.0 111.504 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.75 -64.77 0.86 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.105 -0.997 . . . . 0.0 111.61 -172.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -134.32 81.68 48.96 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.06 -14.42 43.37 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.45 2.1 . . . . 0.0 111.999 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.94 -23.75 7.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.621 1.568 . . . . 0.0 112.087 167.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 60.9 mtp180 -106.21 13.97 28.19 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.896 1.278 . . . . 0.0 111.995 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.72 90.96 2.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.107 1.322 . . . . 0.0 110.728 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 m-30 -93.64 138.75 31.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 109.25 -175.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 13.0 p90 -139.41 158.75 43.6 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.711 0.767 . . . . 0.0 111.308 171.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.18 134.76 1.33 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -172.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 tp -44.33 -48.05 9.62 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 124.484 1.114 . . . . 0.0 110.84 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -60.7 -44.1 96.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.664 1.186 . . . . 0.0 111.365 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.83 -58.68 6.07 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 t -53.69 -38.8 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.699 0.8 . . . . 0.0 112.195 -177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.36 -36.94 74.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.749 1.159 . . . . 0.0 110.934 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -46.82 63.2 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.97 0.908 . . . . 0.0 109.557 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -63.59 -35.59 81.0 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -62.2 -44.51 96.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -64.47 -22.0 66.83 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.44 59.21 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.668 0.787 . . . . 0.0 111.375 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 28.0 mtt 52.06 44.52 29.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.362 1.465 . . . . 0.0 109.581 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -119.93 -9.95 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.246 2.219 . . . . 0.0 111.903 -170.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 49' ' ' ALA . 18.8 mt -80.08 105.95 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.22 -53.07 54.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.812 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 m -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.654 1.181 . . . . 0.0 108.292 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -109.77 137.87 46.96 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.386 1.874 . . . . 0.0 108.029 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.39 128.97 55.13 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.053 1.741 . . . . 0.0 107.725 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -144.95 143.47 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.402 1.001 . . . . 0.0 110.393 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.17 142.91 50.67 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.366 1.066 . . . . 0.0 109.724 170.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -56.5 -42.65 78.7 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.05 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -54.27 -20.81 7.74 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 mt -91.6 -45.33 8.54 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.872 0.869 . . . . 0.0 109.202 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -51.32 -29.93 16.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.842 1.257 . . . . 0.0 112.276 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.91 31.35 5.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 110.841 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -51.68 148.01 5.94 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.666 0.666 . . . . 0.0 111.518 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -68.46 -31.29 70.48 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.413 1.485 . . . . 0.0 112.832 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -88.57 118.3 28.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.6 -30.63 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.34 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 -54.05 38.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.9 1.682 . . . . 0.0 109.891 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.4 m -58.2 -51.46 69.65 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.334 1.854 . . . . 0.0 110.756 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -58.26 -48.9 78.98 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.351 0.978 . . . . 0.0 110.242 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.403 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 m -55.14 -35.41 64.67 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.141 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.7 mtt85 -60.76 -51.82 67.71 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.46 1.027 . . . . 0.0 111.015 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -60.66 -51.45 69.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.181 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.0 m -63.83 -37.46 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.089 0.859 . . . . 0.0 110.971 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -57.82 -53.8 54.07 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.943 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.08 -48.21 82.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 124.315 1.009 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.54 -47.34 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.545 1.138 . . . . 0.0 110.526 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 5.3 m-20 -68.08 -43.22 79.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.653 -0.654 . . . . 0.0 110.555 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -72.85 -30.38 63.96 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.038 0.935 . . . . 0.0 110.324 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.29 -42.47 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.85 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 7.0 mtmp? -65.4 -39.24 91.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.898 0.772 . . . . 0.0 111.216 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.37 -25.61 66.87 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.933 -0.479 . . . . 0.0 111.561 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -100.71 44.1 1.03 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.71 1.604 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.45 5.04 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.447 3.099 . . . . 0.0 116.97 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.75 -174.47 48.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.486 1.517 . . . . 0.0 113.958 -171.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -130.79 149.33 52.48 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.802 2.441 . . . . 0.0 110.57 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.85 147.12 16.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.264 1.426 . . . . 0.0 108.826 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 mmt-85 -147.21 126.59 13.13 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.849 2.06 . . . . 0.0 107.187 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -116.04 123.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -91.01 164.48 13.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.54 1.536 . . . . 0.0 108.331 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 136.75 42.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 162.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.8 t -51.61 -28.59 14.69 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.118 0.967 . . . . 0.0 111.47 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.18 -26.6 66.71 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 126.649 1.98 . . . . 0.0 113.613 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' A' ' 99' ' ' SER . 6.4 t-80 -84.03 158.85 21.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.669 0.788 . . . . 0.0 110.913 -165.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.44 -40.76 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 118.947 0.794 . . . . 0.0 109.321 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 97' ' ' HIS . 1.6 m -60.06 -23.32 63.67 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.863 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.69 -53.05 10.33 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.955 1.74 . . . . 0.0 110.97 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.19 -27.36 69.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.653 1.727 . . . . 0.0 112.071 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.55 -46.12 73.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.467 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.3 tp -63.26 -34.64 78.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.747 -0.596 . . . . 0.0 111.022 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.6 t -57.91 -38.42 75.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.923 1.689 . . . . 0.0 111.192 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -55.42 -23.38 24.6 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.344 -0.847 . . . . 0.0 111.085 173.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.53 30.81 7.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.763 2.825 . . . . 0.0 110.238 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.2 p 66.41 19.76 10.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.096 1.358 . . . . 0.0 113.969 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.44 15.65 52.94 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.355 2.407 . . . . 0.0 114.533 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.2 p -143.01 124.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' TYR . . . -147.61 174.15 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.52 146.67 8.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.31 -0.869 . . . . 0.0 110.829 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.4 mt -83.83 152.45 3.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.603 HD13 HG23 ' A' ' 117' ' ' VAL . 42.1 mt -115.38 145.74 42.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.783 0.801 . . . . 0.0 109.781 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -64.5 -46.71 81.78 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.982 1.313 . . . . 0.0 109.906 165.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.3 p90 -138.14 152.85 72.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 125.428 1.491 . . . . 0.0 108.747 -169.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.5 124.27 10.62 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 123.165 2.577 . . . . 0.0 109.105 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 113' ' ' LEU . 86.0 t -78.29 131.45 68.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.03 49.06 2.68 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.021 3.147 . . . . 0.0 111.764 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t -152.88 89.3 1.38 Allowed 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.095 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -163.94 139.17 5.7 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.46 -35.45 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.656 2.237 . . . . 0.0 112.065 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.0 t -162.3 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.969 1.708 . . . . 0.0 108.507 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.9 m 68.08 -64.13 0.3 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.673 1.989 . . . . 0.0 111.113 -173.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 106.115 -2.794 . . . . 0.0 106.115 162.207 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m 64.55 -20.74 0.07 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.62 2.368 . . . . 0.0 115.975 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 47.93 65.22 1.36 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.392 2.277 . . . . 0.0 114.259 162.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.9 -162.43 46.71 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.7 m -165.74 -67.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.726 1.611 . . . . 0.0 108.869 167.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -159.67 159.64 33.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.367 2.667 . . . . 0.0 104.489 171.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.37 151.53 12.16 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.3 t -143.56 153.78 42.92 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.195 0.998 . . . . 0.0 108.94 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.71 156.52 9.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 127.204 2.202 . . . . 0.0 107.441 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.26 173.71 13.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.092 1.757 . . . . 0.0 109.251 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 m -156.85 106.22 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -156.89 0.59 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 154.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.3 mm? -51.72 112.76 0.82 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.343 0.974 . . . . 0.0 110.505 -172.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -107.08 140.63 39.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 167.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.09 154.12 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 160.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -53.22 -46.38 69.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.182 0.993 . . . . 0.0 110.945 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.29 -51.02 69.37 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.862 0.755 . . . . 0.0 109.364 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.3 74.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.459 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -56.62 17.24 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.646 1.112 . . . . 0.0 110.928 -172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.3 93.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -50.84 40.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.95 1.3 . . . . 0.0 109.003 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.0 -41.68 83.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.199 0 C-N-CA 125.204 1.402 . . . . 0.0 109.949 173.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -59.0 -44.01 91.6 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 119.118 0.872 . . . . 0.0 109.205 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -60.72 -39.0 87.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.968 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD13 ' HE2' ' A' ' 93' ' ' PHE . 3.0 tp -64.16 -48.68 75.05 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.437 1.017 . . . . 0.0 110.571 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -53.28 -50.94 63.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.338 1.455 . . . . 0.0 109.099 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -66.36 -46.89 75.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.413 2.285 . . . . 0.0 109.416 -171.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -54.81 -56.21 21.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.476 1.51 . . . . 0.0 110.375 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.44 -30.68 70.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -50.76 -62.73 1.42 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.659 0.599 . . . . 0.0 109.486 169.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.439 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -62.67 -29.49 70.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.048 -0.977 . . . . 0.0 111.613 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.25 -29.58 58.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.102 1.319 . . . . 0.0 111.76 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -92.31 -50.06 5.84 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.971 0.908 . . . . 0.0 110.367 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -73.37 -48.11 36.76 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -168.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.81 81.1 8.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.803 1.241 . . . . 0.0 109.062 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.83 -12.07 33.6 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.992 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -20.04 10.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.457 1.503 . . . . 0.0 111.604 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HA ' HD12 ' A' ' 113' ' ' LEU . 81.5 mtp180 -111.7 2.57 17.28 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.831 1.252 . . . . 0.0 113.106 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.06 88.48 2.91 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.583 1.083 . . . . 0.0 108.608 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.6 m-30 -93.78 134.33 36.24 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.555 0.742 . . . . 0.0 109.011 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -140.74 164.79 29.25 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.396 0.617 . . . . 0.0 112.619 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.35 126.14 0.51 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -168.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 tp -37.14 -50.04 0.92 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.202 2.201 . . . . 0.0 110.785 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.64 -51.89 52.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 128.671 2.788 . . . . 0.0 114.084 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -64.22 -50.4 68.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.601 1.191 . . . . 0.0 107.959 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.76 -31.95 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.333 1.053 . . . . 0.0 111.131 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.86 -19.66 65.06 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.933 1.293 . . . . 0.0 112.713 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.74 -42.4 34.36 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 119.519 -1.988 . . . . 0.0 109.458 165.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.47 71.07 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -60.47 -43.83 96.52 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 119.11 0.868 . . . . 0.0 108.869 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -66.3 -11.17 49.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.57 -5.43 45.91 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.445 1.498 . . . . 0.0 112.078 174.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 29.1 mmt 55.49 14.15 1.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.85 . . . . 0.0 113.092 -166.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -87.92 -9.64 53.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.87 -1.144 . . . . 0.0 112.909 -162.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.2 mt -72.54 110.6 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.33 -60.19 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.577 172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.2 m -144.79 141.79 29.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.592 HD21 HG22 ' A' ' 80' ' ' VAL . 9.5 tp -110.06 133.98 52.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 107.773 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.464 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.34 119.49 35.87 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.6 1.56 . . . . 0.0 107.128 175.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 tt -138.85 141.2 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.02 144.47 55.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -59.54 -38.41 80.98 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.094 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -16.53 27.98 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.62 -40.42 9.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.94 1.245 . . . . 0.0 110.042 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.01 -19.19 17.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.72 0.808 . . . . 0.0 111.986 167.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -122.58 21.0 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.973 2.909 . . . . 0.0 111.372 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -56.73 151.96 13.17 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.571 0.749 . . . . 0.0 110.989 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -63.78 -47.18 81.98 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.179 0.591 . . . . 0.0 111.86 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.79 122.73 24.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.83 -32.09 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.684 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.82 -57.78 5.11 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 120.919 1.691 . . . . 0.0 110.494 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -53.04 -52.07 59.68 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.037 0.935 . . . . 0.0 109.532 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -57.01 -46.19 82.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.696 -0.628 . . . . 0.0 111.552 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 m -52.72 -42.56 64.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.859 0.754 . . . . 0.0 110.911 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.2 mtt-85 -57.99 -52.6 64.82 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 123.918 0.887 . . . . 0.0 109.036 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -60.47 -53.14 61.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 118.129 -0.938 . . . . 0.0 112.272 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -61.22 -36.78 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 119.838 1.199 . . . . 0.0 110.758 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -53.15 34.09 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.34 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.05 -37.08 81.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 118.736 0.698 . . . . 0.0 111.482 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.592 HG22 HD21 ' A' ' 58' ' ' LEU . 25.0 t -53.75 -53.4 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 109.922 168.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -58.81 -47.39 84.94 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.872 1.269 . . . . 0.0 110.84 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.8 m -63.0 -33.14 74.78 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.195 1.798 . . . . 0.0 112.014 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.13 -35.64 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 120.602 -1.311 . . . . 0.0 110.62 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.98 -34.51 77.91 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.47 0.577 . . . . 0.0 109.701 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.37 -34.75 78.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.713 0.688 . . . . 0.0 110.374 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -79.23 3.01 19.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.916 1.287 . . . . 0.0 112.101 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.59 24.53 10.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.381 2.272 . . . . 0.0 113.696 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.24 166.09 29.38 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.4 m -92.56 157.02 16.74 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.109 0.957 . . . . 0.0 111.126 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.08 147.72 17.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.968 1.707 . . . . 0.0 107.23 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -132.94 121.48 22.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.18 108.11 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HE2' HD13 ' A' ' 25' ' ' LEU . 3.6 m-30 -89.19 156.13 18.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.2 m -103.12 136.12 43.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 t -52.55 -39.5 61.53 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 124.7 1.25 . . . . 0.0 111.895 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.44 -23.58 63.7 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.849 -1.157 . . . . 0.0 113.481 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -85.81 148.98 25.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.182 0.993 . . . . 0.0 109.646 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.47 -17.55 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 120.922 -1.112 . . . . 0.0 111.697 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 p -57.16 -34.98 68.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.711 172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.71 -44.4 57.04 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -56.31 -38.3 71.08 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.9 0.85 . . . . 0.0 110.916 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -76.8 -37.21 56.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 121.188 -0.945 . . . . 0.0 112.128 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.41 -32.04 73.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.446 -0.788 . . . . 0.0 110.563 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -56.11 -40.72 74.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.853 1.661 . . . . 0.0 111.287 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -58.24 -15.71 11.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.635 1.174 . . . . 0.0 112.071 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.36 37.42 4.41 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 129.073 2.949 . . . . 0.0 108.901 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p 66.54 9.51 6.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.728 2.011 . . . . 0.0 114.72 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.26 15.7 65.93 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.119 2.295 . . . . 0.0 113.385 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.7 111.89 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.049 0.925 . . . . 0.0 108.708 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.66 174.12 10.93 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.638 1.575 . . . . 0.0 109.258 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.23 146.45 8.94 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.873 -1.142 . . . . 0.0 110.251 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.439 HG23 ' SD ' ' A' ' 31' ' ' MET . 80.6 mt -83.8 152.01 3.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.232 1.413 . . . . 0.0 107.916 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 117' ' ' VAL . 38.8 mt -117.16 138.45 51.65 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.996 0.919 . . . . 0.0 110.691 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -60.99 -42.08 97.74 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.035 1.334 . . . . 0.0 110.119 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.5 p90 -139.07 157.1 71.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 125.721 1.609 . . . . 0.0 107.941 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.0 125.07 12.56 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.83 2.354 . . . . 0.0 108.807 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG23 HD13 ' A' ' 113' ' ' LEU . 63.2 t -78.45 129.09 75.74 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.53 87.29 1.11 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.46 2.107 . . . . 0.0 109.767 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 p -143.04 146.31 33.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 160.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.29 168.64 51.98 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.09 124.51 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.007 2.472 . . . . 0.0 108.664 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 t -153.22 89.89 1.39 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -153.91 92.47 1.55 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.426 -1.764 . . . . 0.0 110.316 -169.661 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.099 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -149.18 164.56 34.4 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -154.97 175.78 13.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.013 2.125 . . . . 0.0 106.663 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.68 89.43 1.9 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 t -149.07 -82.19 0.11 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m 47.55 46.16 17.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.334 1.054 . . . . 0.0 110.501 -170.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 165.7 33.31 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 m -153.52 139.59 18.31 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.41 142.5 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 166.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.26 85.05 1.45 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 p -136.64 94.77 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.71 1.204 . . . . 0.0 109.456 -168.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.93 139.7 38.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 159.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' N ' HD23 ' A' ' 13' ' ' LEU . 1.5 pt? -162.61 142.71 9.56 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.707 1.603 . . . . 0.0 107.685 169.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 t -155.06 -58.44 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.315 1.046 . . . . 0.0 108.191 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.79 163.02 14.91 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.518 . . . . 0.0 110.801 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.9 m -91.2 -73.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -51.25 19.09 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.862 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.01 80.81 Favored 'General case' 0 C--N 1.341 0.223 0 O-C-N 123.809 0.693 . . . . 0.0 110.363 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.58 -24.5 67.58 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.98 -43.19 74.43 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.48 -51.44 60.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 127.415 2.286 . . . . 0.0 110.528 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.71 -50.42 80.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 119.094 0.861 . . . . 0.0 109.3 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -60.47 -41.93 95.2 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 121.86 -0.525 . . . . 0.0 110.906 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.42 -48.67 80.74 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.92 -44.85 94.06 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.136 -0.978 . . . . 0.0 110.184 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.49 -50.8 72.43 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.186 1.795 . . . . 0.0 109.866 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.04 -42.28 80.78 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 125.083 1.49 . . . . 0.0 108.455 -172.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.42 -58.45 7.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.653 1.181 . . . . 0.0 109.496 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.63 -40.34 75.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.563 0.345 . . . . 0.0 111.626 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.93 -44.2 63.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.928 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -35.58 62.44 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 119.127 0.876 . . . . 0.0 109.334 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -54.06 -33.41 57.39 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.658 1.117 . . . . 0.0 112.168 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -70.63 -56.84 5.53 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.945 1.698 . . . . 0.0 110.695 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -94.38 -52.93 4.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.395 1.478 . . . . 0.0 113.409 -160.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -138.09 71.69 47.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.713 1.605 . . . . 0.0 107.521 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.35 -10.64 26.82 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 112.488 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.08 -24.04 16.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.334 2.254 . . . . 0.0 111.571 167.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HA ' HD12 ' A' ' 113' ' ' LEU . 82.4 mtp180 -104.46 10.96 35.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.443 1.097 . . . . 0.0 112.063 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.36 96.66 3.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.841 1.2 . . . . 0.0 108.512 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.3 m-30 -93.92 133.19 37.61 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.951 0.9 . . . . 0.0 108.893 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -139.78 160.56 39.6 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 169.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.41 133.98 0.52 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -167.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 tp -40.45 -52.89 2.72 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 126.258 1.823 . . . . 0.0 111.576 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -54.56 -46.0 73.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.621 1.568 . . . . 0.0 111.983 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -62.1 -59.85 4.46 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.69 -39.48 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.596 1.158 . . . . 0.0 112.332 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -54.68 -39.23 67.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.333 1.053 . . . . 0.0 111.505 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.94 -53.21 22.13 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.799 1.24 . . . . 0.0 110.539 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -55.93 -36.02 67.27 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -58.74 -47.29 85.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.66 -33.8 75.79 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.98 -9.24 57.6 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.164 0.586 . . . . 0.0 111.682 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 44.7 mtt 55.4 24.42 6.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 127.494 2.318 . . . . 0.0 111.839 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -84.86 -13.97 49.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.747 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 mt -66.39 106.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.568 1.147 . . . . 0.0 109.03 -175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -72.77 -57.05 4.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.5 m -134.99 131.35 37.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.81 132.08 54.47 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.834 2.054 . . . . 0.0 106.522 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.38 118.88 31.5 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 tt -136.23 139.95 44.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.668 1.122 . . . . 0.0 109.222 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.37 133.12 54.62 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -38.57 75.55 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.247 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.32 -20.48 28.95 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 113.948 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.22 -43.53 10.93 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -50.73 -31.41 16.53 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.107 0.963 . . . . 0.0 112.157 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.09 46.96 2.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.178 2.191 . . . . 0.0 108.431 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.38 152.52 33.86 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.294 0.638 . . . . 0.0 110.393 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.21 -33.38 63.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.447 1.499 . . . . 0.0 112.874 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -83.61 119.73 25.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.684 1.129 . . . . 0.0 108.858 174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -51.85 -44.38 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 117.829 -1.082 . . . . 0.0 112.787 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.25 -42.02 69.37 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.857 1.662 . . . . 0.0 111.644 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -65.1 -46.11 82.4 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.23 1.012 . . . . 0.0 108.748 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -53.87 -50.02 67.22 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.345 0.975 . . . . 0.0 109.417 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 t -52.04 -44.07 64.06 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.11 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -57.65 -55.4 35.28 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.493 1.042 . . . . 0.0 109.349 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -56.45 -50.88 70.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.29 -36.9 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 119.369 0.986 . . . . 0.0 111.251 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -49.67 75.0 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 118.812 0.733 . . . . 0.0 109.044 176.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 tp -56.21 -51.13 69.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.891 0.877 . . . . 0.0 109.594 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.6 t -54.0 -47.63 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.588 0.755 . . . . 0.0 111.406 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.91 -54.39 22.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.815 0.846 . . . . 0.0 110.29 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 -11.74 61.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.585 0.754 . . . . 0.0 112.089 -175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 t -70.83 -39.32 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 O-C-N 120.312 -1.493 . . . . 0.0 109.714 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -61.26 -47.78 84.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.036 1.289 . . . . 0.0 108.589 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -51.92 -47.94 64.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.46 1.104 . . . . 0.0 110.086 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -82.25 9.94 7.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.894 0.877 . . . . 0.0 112.264 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 87.91 4.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 130.221 3.408 . . . . 0.0 114.486 166.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.18 162.47 40.42 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.893 -1.129 . . . . 0.0 113.246 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.8 m -87.0 130.4 34.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.501 2.32 . . . . 0.0 109.128 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.04 145.46 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.266 -0.896 . . . . 0.0 109.469 171.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -131.89 132.79 43.93 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 127.163 2.185 . . . . 0.0 106.374 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 mm -118.62 113.42 41.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -90.57 140.35 29.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.076 1.751 . . . . 0.0 109.73 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 m -87.47 130.5 34.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.467 0.707 . . . . 0.0 111.243 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.3 m -51.23 -42.01 60.7 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.724 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -70.32 -17.65 63.08 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.968 1.707 . . . . 0.0 113.511 -171.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -93.95 150.15 20.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.204 1.401 . . . . 0.0 110.093 -174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 p -59.89 -31.44 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -53.71 -23.01 10.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.408 0.683 . . . . 0.0 111.311 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 -53.06 5.87 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 118.243 -1.309 . . . . 0.0 112.377 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.74 -29.56 70.19 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.246 1.523 . . . . 0.0 110.69 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -67.4 -55.26 14.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.498 1.519 . . . . 0.0 110.14 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.29 -37.03 76.68 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 119.449 1.022 . . . . 0.0 110.914 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.2 t -58.1 -35.23 71.12 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.04 1.736 . . . . 0.0 111.795 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -60.5 -25.56 66.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.544 -0.722 . . . . 0.0 111.741 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.9 mt -102.71 20.03 18.06 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.675 2.39 . . . . 0.0 109.656 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.277 17.5 p 78.09 0.92 2.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.471 3.508 . . . . 0.0 113.71 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.88 22.15 62.02 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 127.056 2.265 . . . . 0.0 112.289 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.81 109.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.904 1.352 . . . . 0.0 108.016 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.15 176.36 9.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.513 1.525 . . . . 0.0 111.437 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.37 146.67 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.897 171.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.0 mt -83.56 143.76 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 C-N-CA 126.319 1.848 . . . . 0.0 107.634 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.725 HD13 HG23 ' A' ' 117' ' ' VAL . 13.4 mt -117.23 129.32 55.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 O-C-N 124.298 0.999 . . . . 0.0 109.631 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -54.0 -41.14 67.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.49 1.516 . . . . 0.0 110.467 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 12.1 p90 -137.67 154.76 75.14 Favored Pre-proline 0 N--CA 1.445 -0.715 0 C-N-CA 125.847 1.659 . . . . 0.0 107.788 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.54 106.6 1.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 124.044 3.163 . . . . 0.0 108.478 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.725 HG23 HD13 ' A' ' 113' ' ' LEU . 91.6 t -64.14 137.16 97.03 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.35 90.3 1.02 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.276 2.651 . . . . 0.0 109.751 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -133.26 162.14 32.6 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.179 1.392 . . . . 0.0 108.577 165.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.75 169.56 22.78 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 161.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.39 158.59 2.49 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.588 2.858 . . . . 0.0 110.511 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.67 161.81 41.81 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.153 -0.967 . . . . 0.0 109.528 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.9 t -72.41 -166.83 0.28 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.302 1.041 . . . . 0.0 109.808 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 O-C-N 120.223 -1.548 . . . . 0.0 109.298 165.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -134.01 172.82 12.3 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 111.838 -167.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -139.87 169.79 17.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.204 1.802 . . . . 0.0 108.705 171.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.64 91.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.555 1.55 . . . . 0.0 113.482 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -55.05 -50.86 68.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.908 0.854 . . . . 0.0 109.411 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p 47.45 65.46 1.26 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.88 1.672 . . . . 0.0 112.474 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.0 147.48 41.4 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 168.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.8 m -68.4 -34.86 76.78 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.261 -0.876 . . . . 0.0 112.121 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 t 40.72 68.18 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.765 2.026 . . . . 0.0 111.049 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.71 -73.16 0.51 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.65 0.78 . . . . 0.0 109.359 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -74.41 177.04 6.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.606 1.162 . . . . 0.0 111.674 -174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -71.62 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.012 -0.994 . . . . 0.0 112.382 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 144.88 28.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 121.044 1.747 . . . . 0.0 110.801 -176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 t -140.31 -56.76 0.54 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.448 0.699 . . . . 0.0 109.926 168.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.19 160.58 23.5 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.462 -0.774 . . . . 0.0 110.685 -163.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -61.06 -51.73 67.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.926 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -58.08 -53.24 60.49 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.45 98.73 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 117.704 -1.141 . . . . 0.0 111.325 -174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.11 -19.42 65.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.008 1.731 . . . . 0.0 112.761 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.83 -53.86 5.17 Favored Glycine 0 CA--C 1.524 0.64 0 O-C-N 120.958 -1.088 . . . . 0.0 110.46 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.73 -51.71 66.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.943 0.897 . . . . 0.0 110.827 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.88 -48.63 78.13 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 C-N-CA 126.192 1.797 . . . . 0.0 110.576 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -54.55 -48.94 71.43 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 119.56 1.073 . . . . 0.0 109.67 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -42.42 99.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.013 0.82 . . . . 0.0 111.813 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.33 -48.8 78.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.002 0.819 . . . . 0.0 110.716 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -61.47 -52.99 62.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.167 1.787 . . . . 0.0 109.342 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.2 -37.77 86.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.161 0.984 . . . . 0.0 108.886 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -58.94 -57.06 14.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.231 1.012 . . . . 0.0 110.341 170.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.89 -32.55 72.0 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.94 -59.25 3.76 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.16 -39.18 85.53 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.978 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.09 -20.27 51.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.857 0.753 . . . . 0.0 111.977 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -96.13 -53.36 3.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.532 1.133 . . . . 0.0 111.551 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -63.65 -66.36 0.55 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.461 1.105 . . . . 0.0 111.521 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -145.11 80.83 10.9 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.802 0.841 . . . . 0.0 109.616 -172.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.04 -6.52 8.08 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.228 2.619 . . . . 0.0 114.532 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.37 -25.07 33.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.091 0.86 . . . . 0.0 111.756 165.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HA ' HD12 ' A' ' 113' ' ' LEU . 31.0 mtm-85 -106.91 14.46 26.52 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.441 1.096 . . . . 0.0 112.015 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.56 92.71 3.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.305 0.957 . . . . 0.0 109.214 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 2.4 m-30 -93.75 132.78 37.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -139.9 163.48 32.55 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.497 0.719 . . . . 0.0 109.948 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.4 123.78 0.93 Allowed Glycine 0 C--N 1.331 0.269 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 -170.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.77 -46.8 2.75 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.726 1.611 . . . . 0.0 111.939 -177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.15 -55.57 26.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.765 2.826 . . . . 0.0 110.698 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -59.06 -57.42 13.16 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 t -50.92 -41.94 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.384 1.473 . . . . 0.0 111.835 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -56.8 -33.5 66.75 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.494 1.117 . . . . 0.0 111.488 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -77.3 -42.42 36.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 110.498 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -65.6 -32.21 73.67 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 121.243 -0.911 . . . . 0.0 112.126 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -57.09 -51.33 69.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -61.1 -31.23 70.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -9.22 58.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.875 0.87 . . . . 0.0 111.319 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.2 mmt 62.27 21.44 12.49 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.351 2.26 . . . . 0.0 110.948 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -90.4 -16.21 29.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.836 1.254 . . . . 0.0 112.343 -168.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.7 mt -70.63 113.71 7.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -80.08 -55.41 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.071 0.948 . . . . 0.0 108.698 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -137.95 128.87 27.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 111' ' ' ALA . 9.8 tp -110.61 131.1 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.96 2.104 . . . . 0.0 108.757 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.16 124.65 52.01 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 108.077 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.05 144.15 27.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 119.785 1.175 . . . . 0.0 108.382 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.29 136.5 53.55 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.39 -35.61 63.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.861 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.71 -16.0 55.41 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.36 1.436 . . . . 0.0 114.287 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.6 mt -94.43 -40.8 9.73 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.607 1.163 . . . . 0.0 109.811 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -52.17 -29.31 21.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.237 1.015 . . . . 0.0 112.55 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 51.07 1.92 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.081 2.552 . . . . 0.0 108.159 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -57.98 148.25 26.57 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.314 -0.866 . . . . 0.0 109.954 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -60.79 -39.09 87.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.86 117.2 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.587 1.155 . . . . 0.0 108.641 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.51 -33.09 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.267 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.03 60.61 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 120.782 1.628 . . . . 0.0 109.762 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -59.21 -48.52 81.31 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.212 1.405 . . . . 0.0 111.105 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -52.82 -50.92 62.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.292 0.951 . . . . 0.0 109.873 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -51.71 -42.04 61.94 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -56.8 -55.77 30.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.036 1.289 . . . . 0.0 110.341 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -57.3 -55.04 39.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 124.147 0.904 . . . . 0.0 111.014 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 t -51.43 -54.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.9 1.28 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -64.52 -40.25 95.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 tp -67.65 -41.39 83.88 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.413 0.552 . . . . 0.0 111.621 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.44 -48.95 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.622 1.169 . . . . 0.0 108.925 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -42.36 98.67 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.1 0.96 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 m -66.37 -32.19 73.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.478 1.911 . . . . 0.0 111.956 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.15 -38.03 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 120.34 -1.475 . . . . 0.0 110.467 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -61.77 -44.5 96.77 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.961 0.801 . . . . 0.0 109.819 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -54.41 -38.03 65.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.229 1.012 . . . . 0.0 110.268 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -93.93 16.82 13.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.842 -174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 89.77 1.47 0.23 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 128.977 2.911 . . . . 0.0 114.277 168.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.76 152.57 22.52 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.732 1.151 . . . . 0.0 112.775 -167.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -80.35 152.2 29.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.891 2.076 . . . . 0.0 108.491 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.75 139.51 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -130.63 121.67 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.06 108.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 147.85 23.38 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.188 1.395 . . . . 0.0 109.532 -170.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.98 136.26 45.1 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 171.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.8 t -71.56 4.93 2.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.542 0.737 . . . . 0.0 111.795 167.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.8 mt -121.47 -0.8 9.71 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.614 1.965 . . . . 0.0 112.607 -168.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -106.3 159.56 16.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.333 2.253 . . . . 0.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.15 -38.95 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 m -58.76 -27.46 64.98 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.277 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -71.87 -54.72 7.97 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-O 119.004 -0.886 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.96 -31.94 73.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.073 0.937 . . . . 0.0 111.721 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.08 -46.15 90.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.989 171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.53 -37.89 87.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.318 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.4 m -57.62 -29.15 64.29 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.242 1.017 . . . . 0.0 112.566 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -66.41 -17.23 64.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 112.856 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -122.59 48.34 1.78 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.797 2.439 . . . . 0.0 107.251 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.5 p 63.03 4.47 1.55 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.69 1.996 . . . . 0.0 114.665 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.27 65.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 127.144 2.307 . . . . 0.0 112.904 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.7 p -154.32 113.19 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 118.866 1.333 . . . . 0.0 109.668 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.88 176.61 9.76 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 112.015 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -164.08 147.47 9.63 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.179 -1.576 . . . . 0.0 111.231 174.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.6 mt -85.72 141.46 14.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 125.524 1.53 . . . . 0.0 107.68 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' A' ' 40' ' ' PHE . 40.0 mt -108.47 138.7 44.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.832 0.853 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -52.04 -52.6 49.93 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.911 1.685 . . . . 0.0 109.752 168.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.2 p90 -136.02 159.34 71.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 127.448 2.299 . . . . 0.0 107.382 -170.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.81 142.27 51.78 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.631 1.554 . . . . 0.0 109.514 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 113' ' ' LEU . 69.1 t -89.4 136.89 29.38 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 172.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.95 65.54 8.28 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.451 2.768 . . . . 0.0 112.454 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.9 m -132.09 3.35 4.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.267 1.427 . . . . 0.0 112.255 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 65.13 163.09 0.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.205 1.383 . . . . 0.0 111.935 -172.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.02 -177.51 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.184 2.589 . . . . 0.0 112.207 -174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 m -75.91 157.12 33.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 157.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t -118.89 -25.16 6.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.262 1.425 . . . . 0.0 110.166 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 O-C-N 120.549 -1.345 . . . . 0.0 111.028 172.542 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -87.86 -169.4 2.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.32 1.448 . . . . 0.0 110.449 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t 47.3 -145.65 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.525 2.33 . . . . 0.0 112.886 161.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.61 163.58 12.14 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 158.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -137.29 -6.76 1.78 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.326 1.05 . . . . 0.0 113.418 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -89.58 142.46 27.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.367 1.439 . . . . 0.0 109.18 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.18 99.75 0.65 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.674 1.13 . . . . 0.0 110.659 -165.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -131.61 -0.9 3.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.285 1.034 . . . . 0.0 111.96 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.85 -168.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 120.838 -1.164 . . . . 0.0 109.567 169.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 45.23 60.69 2.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.44 1.896 . . . . 0.0 111.926 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -135.32 95.25 3.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -129.94 -95.58 0.39 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 159.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.62 168.98 17.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.386 0.539 . . . . 0.0 110.656 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 m -73.63 -70.35 0.38 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.787 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 46.76 77.32 0.09 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.948 1.699 . . . . 0.0 111.878 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -49.64 -42.9 46.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.736 1.614 . . . . 0.0 112.995 -168.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -66.13 -52.71 45.89 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.174 0.897 . . . . 0.0 110.135 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.77 79.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 117.965 0.348 . . . . 0.0 110.514 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.15 97.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.503 1.121 . . . . 0.0 112.466 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.49 63.63 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -50.76 54.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.26 1.424 . . . . 0.0 107.856 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.03 -51.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 110.39 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -60.32 -37.97 82.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.403 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.78 -35.48 74.93 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.219 0.918 . . . . 0.0 111.321 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tp -60.8 -49.07 78.96 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.056 0.844 . . . . 0.0 109.314 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -54.17 -56.81 14.64 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 124.52 1.128 . . . . 0.0 108.635 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -56.82 -43.46 81.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.084 0.865 . . . . 0.0 109.552 -172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.92 -54.55 40.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.835 0.854 . . . . 0.0 110.882 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.15 -35.73 77.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.795 0.725 . . . . 0.0 112.922 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -47.73 -59.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 108.206 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -62.23 -38.92 91.04 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.029 -0.986 . . . . 0.0 111.552 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 tp -55.25 -29.28 57.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.044 1.293 . . . . 0.0 111.309 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -94.61 -47.08 6.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -69.39 -58.27 4.22 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.552 0.614 . . . . 0.0 111.658 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HE ' ' A' ' 38' ' ' ARG . 11.0 pt-20 -144.92 79.33 12.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 C-N-CA 124.315 1.046 . . . . 0.0 109.369 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.65 -10.49 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.289 1.993 . . . . 0.0 114.571 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.22 -21.02 61.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.3 1.409 . . . . 0.0 111.23 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HA ' HD12 ' A' ' 113' ' ' LEU . 24.2 mtm180 -102.97 12.33 36.21 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.824 1.193 . . . . 0.0 112.46 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.03 93.6 2.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.922 1.237 . . . . 0.0 109.064 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 3.1 m-30 -97.34 138.26 35.08 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.468 0.707 . . . . 0.0 109.934 -175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -140.3 159.08 42.98 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.31 131.69 0.81 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.6 tp -43.27 -50.51 6.52 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.999 1.72 . . . . 0.0 112.968 -166.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -52.78 -55.81 20.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.528 1.931 . . . . 0.0 109.952 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -56.84 -57.14 13.78 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 t -47.96 -46.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.975 1.71 . . . . 0.0 111.675 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.36 -43.43 75.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.757 1.162 . . . . 0.0 110.382 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -64.32 -40.51 96.05 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.067 -1.021 . . . . 0.0 110.349 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -67.6 -33.91 75.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.424 -0.797 . . . . 0.0 112.781 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -68.46 -42.57 78.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.49 -19.98 65.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.943 1.697 . . . . 0.0 113.118 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.58 -13.6 54.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.479 1.111 . . . . 0.0 111.897 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 57.36 24.86 10.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.469 1.908 . . . . 0.0 111.553 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.62 -15.06 31.2 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.438 -1.268 . . . . 0.0 111.891 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 mt -69.07 107.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.505 1.048 . . . . 0.0 108.663 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.84 -48.45 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 172.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.7 m -143.78 134.31 24.84 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' VAL . 3.4 tp -110.15 133.95 52.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.863 2.065 . . . . 0.0 107.314 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 124.61 48.54 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.108 1.763 . . . . 0.0 108.175 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 tt -138.64 134.97 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -62.32 125.88 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.743 1.217 . . . . 0.0 107.88 168.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -57.12 -32.41 66.32 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 118.564 -0.731 . . . . 0.0 111.017 -177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -54.13 -25.85 24.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.117 1.326 . . . . 0.0 113.44 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 mt -86.59 -42.15 13.71 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.51 1.124 . . . . 0.0 109.603 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -52.1 -27.58 14.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.262 1.425 . . . . 0.0 112.481 170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 34.78 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.352 1.861 . . . . 0.0 110.591 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -55.7 146.81 20.05 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.016 -0.428 . . . . 0.0 111.185 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.412 HE21 ' C ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -68.48 -25.21 64.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.37 120.67 31.69 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -57.61 -36.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.052 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -56.36 15.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.995 1.725 . . . . 0.0 109.888 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.6 m -53.68 -56.11 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.386 1.874 . . . . 0.0 110.232 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.09 -49.88 72.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.943 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -53.32 -41.82 66.07 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.94 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -57.39 -51.76 68.1 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.038 0.836 . . . . 0.0 110.383 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -60.79 -54.44 45.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.286 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -64.74 -31.79 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.581 1.082 . . . . 0.0 110.758 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -61.08 -58.21 9.32 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 109.075 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.371 1.068 . . . . 0.0 111.689 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 HD21 ' A' ' 58' ' ' LEU . 42.4 t -53.55 -46.22 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.13 . . . . 0.0 110.485 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -72.14 -37.87 69.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 0.0 111.46 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.2 t -67.01 -38.58 86.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.211 1.804 . . . . 0.0 110.859 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -55.38 -39.59 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 121.557 -0.715 . . . . 0.0 110.659 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.95 -39.3 87.24 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.794 0.724 . . . . 0.0 110.848 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.58 -28.55 69.71 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.686 0.794 . . . . 0.0 111.022 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -91.59 12.98 19.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.093 1.757 . . . . 0.0 110.732 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.11 26.4 15.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.471 . . . . 0.0 114.928 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.05 159.9 25.76 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.308 -0.87 . . . . 0.0 111.162 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -93.93 157.22 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.899 1.68 . . . . 0.0 110.184 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.54 148.37 25.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.1 0.96 . . . . 0.0 109.112 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.5 mmt-85 -141.83 121.68 13.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.37 112.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -90.12 124.57 34.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.1 m -74.02 139.9 45.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.771 0.26 . . . . 0.0 111.034 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 t -61.39 10.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.261 2.625 . . . . 0.0 115.065 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER -118.75 3.63 11.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.61 2.364 . . . . 0.0 113.665 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -114.28 139.41 49.44 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.331 1.452 . . . . 0.0 110.886 -169.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 p -56.2 -28.93 26.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.688 0.795 . . . . 0.0 110.841 172.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.1 m -64.64 -27.72 69.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.726 -0.609 . . . . 0.0 111.529 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.64 52.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -60.67 -26.89 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.567 0.684 . . . . 0.0 112.002 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -76.47 -41.37 47.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.303 1.441 . . . . 0.0 110.381 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.38 -26.91 68.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 0.0 112.427 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 t -41.24 -54.9 2.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.176 2.19 . . . . 0.0 110.843 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -61.53 -5.23 1.67 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.638 1.975 . . . . 0.0 113.784 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 mt -131.66 33.97 3.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.784 2.433 . . . . 0.0 109.323 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.8 p 64.37 12.08 6.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.293 1.837 . . . . 0.0 113.671 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.4 17.19 68.24 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.996 2.236 . . . . 0.0 114.182 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.05 115.08 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.919 1.86 . . . . 0.0 108.856 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.97 15.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.343 1.057 . . . . 0.0 111.432 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.71 144.61 13.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 120.258 -1.526 . . . . 0.0 110.547 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 84.7 mt -84.12 144.29 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.162 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.684 HD13 HG23 ' A' ' 117' ' ' VAL . 20.8 mt -114.23 146.03 40.95 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.609 0.764 . . . . 0.0 109.512 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -71.26 -42.84 68.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.685 1.194 . . . . 0.0 110.43 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -129.34 157.39 76.35 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 125.113 1.365 . . . . 0.0 108.069 -177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 107.11 1.78 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.824 2.349 . . . . 0.0 106.888 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 HD13 ' A' ' 113' ' ' LEU . 54.5 t -57.58 138.03 81.97 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 97.7 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.037 2.492 . . . . 0.0 109.563 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.91 -52.31 0.03 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.798 0.839 . . . . 0.0 110.791 166.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 150.69 167.94 15.03 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 127.241 2.353 . . . . 0.0 111.307 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.57 166.47 13.72 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.076 3.184 . . . . 0.0 111.262 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -149.62 102.66 3.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.9 m -129.99 177.71 7.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.568 1.947 . . . . 0.0 108.003 161.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 CA-C-O 117.473 -1.737 . . . . 0.0 108.859 178.033 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.0 p -62.44 -36.22 81.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.296 1.048 . . . . 0.0 112.294 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.6 m 51.5 -155.59 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.903 1.281 . . . . 0.0 111.579 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.8 -76.56 0.22 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 m 69.56 87.34 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 127.82 2.448 . . . . 0.0 109.877 -172.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.7 p -132.72 -160.23 1.03 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.148 1.779 . . . . 0.0 108.867 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.53 174.99 13.9 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 56.1 m -124.26 176.38 6.46 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.671 1.588 . . . . 0.0 107.031 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.88 53.42 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 123.064 1.412 . . . . 0.0 108.379 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.32 142.19 58.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.269 1.428 . . . . 0.0 111.05 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.1 p -143.02 156.02 44.76 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.006 0.923 . . . . 0.0 109.817 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -160.13 133.72 7.03 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mm? 52.32 -167.89 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.542 0.737 . . . . 0.0 110.57 -172.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.8 t -148.05 -53.79 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.28 -166.34 0.22 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.29 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.1 m -91.8 -74.48 0.51 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 111.106 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -66.82 -44.07 82.11 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -171.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.37 -45.83 46.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.795 1.238 . . . . 0.0 111.111 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.25 -32.33 73.94 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.799 0.84 . . . . 0.0 113.227 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.85 77.21 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.19 -51.92 65.86 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.533 1.133 . . . . 0.0 109.519 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.61 -42.35 81.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 124.467 1.107 . . . . 0.0 110.962 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -59.32 -49.59 77.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.659 1.118 . . . . 0.0 109.211 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.5 76.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.236 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 29' ' ' TYR . 15.1 tp -60.86 -50.24 74.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.613 1.097 . . . . 0.0 110.375 173.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -62.31 -33.33 74.45 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.447 1.099 . . . . 0.0 110.707 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -43.72 32.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.665 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.79 -58.03 10.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.279 1.432 . . . . 0.0 110.775 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' A' ' 25' ' ' LEU . 3.8 m-85 -54.55 -39.21 67.48 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.212 0.914 . . . . 0.0 112.294 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -45.44 -58.29 3.46 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.341 1.056 . . . . 0.0 108.939 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -67.21 -35.77 80.3 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 117.871 -1.062 . . . . 0.0 111.329 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.18 -29.63 46.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.772 1.624 . . . . 0.0 111.498 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.78 -51.15 5.22 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.923 . . . . 0.0 110.878 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -75.96 -33.07 59.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -171.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -168.26 76.76 0.85 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.931 1.693 . . . . 0.0 110.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.8 -10.77 26.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.483 2.122 . . . . 0.0 114.107 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.93 -19.67 61.01 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.888 -1.133 . . . . 0.0 111.43 168.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -98.45 4.68 48.4 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.342 0.974 . . . . 0.0 112.989 171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -141.81 95.87 2.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.85 1.205 . . . . 0.0 109.67 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.1 141.39 28.47 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.019 1.328 . . . . 0.0 109.119 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -140.58 160.04 40.88 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.187 0.903 . . . . 0.0 113.07 170.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.66 131.49 2.66 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.7 tp -44.0 -45.94 8.09 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 125.688 1.595 . . . . 0.0 111.094 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -58.82 -45.76 89.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.049 1.339 . . . . 0.0 111.953 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -64.08 -59.05 4.93 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.0 t -49.64 -42.24 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.468 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -53.6 -40.64 65.85 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.46 1.104 . . . . 0.0 110.905 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.13 -48.08 25.45 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 126.1 1.76 . . . . 0.0 109.746 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.52 -36.15 63.94 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.563 -1.336 . . . . 0.0 112.533 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -68.23 -40.97 81.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.392 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.36 -29.53 69.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.242 1.017 . . . . 0.0 112.586 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.76 -7.0 51.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 111.172 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.8 mmt 54.21 24.69 5.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.688 1.995 . . . . 0.0 111.131 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.33 -17.5 23.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.615 1.166 . . . . 0.0 111.839 -165.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.54 118.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -97.23 -30.31 13.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.57 0.544 . . . . 0.0 110.946 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 m -139.33 132.77 30.2 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 tp -109.87 133.82 52.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.76 125.03 53.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.083 1.753 . . . . 0.0 106.404 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 76' ' ' TYR . 11.9 tt -140.83 148.14 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.7 t -67.92 144.26 55.31 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 1.9 p-10 -59.09 -32.04 69.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.405 165.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.77 -24.73 64.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.433 1.47 . . . . 0.0 113.401 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -85.45 -45.62 11.67 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.905 1.282 . . . . 0.0 108.941 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -54.75 -26.49 34.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.234 1.413 . . . . 0.0 114.234 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.35 23.33 9.07 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.698 1.599 . . . . 0.0 110.807 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -55.63 147.45 18.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.916 0.886 . . . . 0.0 111.193 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -61.25 -45.14 95.75 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.929 1.291 . . . . 0.0 113.419 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -76.46 113.54 14.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 t -57.53 -32.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 117.514 -1.231 . . . . 0.0 111.139 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 -56.41 10.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 121.043 1.747 . . . . 0.0 110.506 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.9 m -50.81 -57.02 9.43 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.192 1.397 . . . . 0.0 110.786 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.59 -52.38 59.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.956 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.5 m -54.97 -43.13 73.23 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 117.056 -1.45 . . . . 0.0 111.162 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -51.99 -54.13 33.41 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 121.682 2.037 . . . . 0.0 110.032 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 60' ' ' ILE . 37.3 m-85 -57.99 -49.81 75.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.994 0.517 . . . . 0.0 111.466 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.85 -51.65 69.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.91 1.684 . . . . 0.0 110.983 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -63.88 -40.07 95.67 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.29 -43.84 89.87 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.05 -44.65 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.334 1.053 . . . . 0.0 109.704 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.57 -44.35 71.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.117 0.967 . . . . 0.0 111.22 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -66.06 -34.92 79.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.155 1.782 . . . . 0.0 110.626 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 t -59.09 -40.56 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.632 1.106 . . . . 0.0 109.952 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -69.68 -40.89 76.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.317 0.962 . . . . 0.0 110.029 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.04 -38.42 70.54 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.2 16.95 5.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.44 2.296 . . . . 0.0 112.193 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.07 10.18 3.78 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.024 2.93 . . . . 0.0 115.032 168.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.3 158.69 31.63 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.946 -1.096 . . . . 0.0 112.856 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.9 m -81.22 154.26 26.73 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.315 1.846 . . . . 0.0 109.655 172.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.68 145.55 25.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.037 0.935 . . . . 0.0 108.499 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -136.29 121.67 19.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 mm -112.78 107.74 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.67 155.19 19.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.637 1.175 . . . . 0.0 107.858 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -95.14 129.7 42.15 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -44.33 -46.5 9.31 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.875 1.27 . . . . 0.0 111.062 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -63.58 -17.41 62.81 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.488 1.515 . . . . 0.0 114.735 -173.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -75.93 155.35 35.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.24 0.927 . . . . 0.0 108.759 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.93 -26.94 21.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.98 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -74.83 -18.03 60.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 117.983 -1.008 . . . . 0.0 111.563 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.93 -49.1 50.47 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 123.106 2.685 . . . . 0.0 107.865 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.57 -33.92 76.67 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.6 -45.22 91.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.2 tp -63.89 -34.32 77.68 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.814 0.846 . . . . 0.0 110.907 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.5 m -56.48 -33.59 66.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.401 1.081 . . . . 0.0 113.602 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -60.51 -20.48 60.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.056 -1.028 . . . . 0.0 111.288 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.8 mt -117.72 25.6 10.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 129.313 3.045 . . . . 0.0 108.8 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 p 70.5 11.43 7.34 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.832 2.453 . . . . 0.0 113.807 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.64 19.49 76.55 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.955 2.217 . . . . 0.0 113.242 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.33 122.89 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 119.115 1.457 . . . . 0.0 110.409 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.98 173.97 13.68 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 110.989 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.93 145.97 14.13 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.648 -1.283 . . . . 0.0 111.375 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -90.53 143.92 10.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.383 1.873 . . . . 0.0 107.615 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.739 HD13 HG23 ' A' ' 117' ' ' VAL . 22.8 mt -117.53 143.44 46.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 110.793 -172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -62.13 -32.47 73.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.321 1.848 . . . . 0.0 111.716 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.41 161.85 28.46 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 127.26 2.224 . . . . 0.0 107.414 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 107.95 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.274 2.65 . . . . 0.0 109.205 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.739 HG23 HD13 ' A' ' 113' ' ' LEU . 71.4 t -59.93 127.48 85.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.75 87.81 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.439 2.76 . . . . 0.0 110.103 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 m -147.48 170.23 17.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.092 2.557 . . . . 0.0 107.504 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.96 119.18 5.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 163.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.47 162.26 39.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.161 1.907 . . . . 0.0 109.205 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t -161.37 122.03 2.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.0 m -64.86 168.25 6.55 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 152.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 105.801 -2.92 . . . . 0.0 105.801 157.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p -148.2 155.96 42.0 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.301 1.05 . . . . 0.0 110.49 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.3 m -137.91 177.36 7.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.753 1.621 . . . . 0.0 110.156 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.43 -177.79 15.62 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.489 2.471 . . . . 0.0 107.26 166.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m 38.05 78.92 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.506 1.923 . . . . 0.0 115.615 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 p -139.75 159.49 42.05 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.695 -0.628 . . . . 0.0 110.183 159.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 35.58 51.38 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.4 p -86.3 -154.67 0.22 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.673 1.189 . . . . 0.0 109.225 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -44.7 121.2 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.938 1.695 . . . . 0.0 110.551 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 84.18 6.38 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.72 0.808 . . . . 0.0 109.897 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.64 174.68 10.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.864 1.666 . . . . 0.0 107.857 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -149.32 -65.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 109.347 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.46 149.36 23.95 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.258 1.823 . . . . 0.0 109.299 172.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 m -141.74 -9.48 0.93 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.843 0.857 . . . . 0.0 112.726 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -163.12 168.87 20.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.551 1.941 . . . . 0.0 106.557 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.9 m -68.38 -59.31 3.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.779 1.232 . . . . 0.0 111.007 169.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -64.54 -51.76 61.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.8 -43.98 66.3 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 111.55 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.47 -21.67 63.69 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.11 -44.43 54.16 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.53 -43.83 97.84 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.298 0.639 . . . . 0.0 110.353 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.6 t -58.17 -51.92 65.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 118.117 -0.945 . . . . 0.0 109.366 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -39.22 84.74 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.881 1.219 . . . . 0.0 110.024 -174.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -56.94 -55.89 28.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.46 0.704 . . . . 0.0 110.916 170.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.08 -41.74 79.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.539 1.063 . . . . 0.0 111.673 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.23 -50.09 75.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 126.533 1.933 . . . . 0.0 109.173 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.0 -39.82 87.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.07 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.95 -57.22 12.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.324 1.85 . . . . 0.0 110.24 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -55.78 -38.62 70.14 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.343 0.657 . . . . 0.0 112.428 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -44.65 -60.18 2.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.226 0.61 . . . . 0.0 110.099 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.448 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.73 -34.68 78.89 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.656 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.67 -30.2 54.83 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.035 1.289 . . . . 0.0 111.519 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -85.63 -65.39 1.02 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.41 0.684 . . . . 0.0 110.34 167.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -67.52 -38.64 84.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -161.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.99 77.87 3.93 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.755 1.622 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 30.6 Cg_endo -66.59 -5.76 13.74 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.794 1.663 . . . . 0.0 113.299 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -60.19 -19.47 54.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.616 -1.302 . . . . 0.0 111.094 166.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.3 mtm180 -107.95 9.7 28.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.207 1.403 . . . . 0.0 112.603 172.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -133.97 92.24 2.93 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 120.198 1.363 . . . . 0.0 108.774 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.5 m-30 -94.0 137.77 32.84 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.67 160.26 40.29 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 139.11 1.13 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.6 tp -39.58 -52.45 2.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.53 1.932 . . . . 0.0 112.026 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -59.64 -44.55 93.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.643 1.977 . . . . 0.0 111.748 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -64.4 -57.26 9.8 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -46.44 -42.6 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.262 1.425 . . . . 0.0 111.686 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -53.44 -43.64 68.22 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.301 0.955 . . . . 0.0 111.391 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -69.73 -42.21 74.28 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.565 1.146 . . . . 0.0 110.292 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.56 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.59 -41.0 96.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -66.11 -36.69 83.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 123.15 0.281 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.35 -38.4 77.15 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.123 -0.986 . . . . 0.0 111.632 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -3.59 37.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.299 1.44 . . . . 0.0 111.512 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.7 mmt 63.4 4.39 1.7 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 113.08 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.4 -6.24 48.99 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -158.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 56.9 mt -74.25 110.18 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -168.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.71 -54.23 17.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.405 HG23 ' HE ' ' A' ' 91' ' ' ARG . 28.2 m -146.35 136.32 23.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.455 1.502 . . . . 0.0 107.653 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.8 tp -110.0 142.36 41.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.468 1.907 . . . . 0.0 107.666 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.446 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -128.1 119.52 25.51 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.455 HD11 ' CD1' ' A' ' 76' ' ' TYR . 14.7 tt -139.72 149.77 22.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 120.135 1.334 . . . . 0.0 108.051 175.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 3.9 t -66.51 144.06 56.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -60.33 -36.46 78.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.357 166.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 6.5 pt-20 -56.04 -31.66 63.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.741 1.61 . . . . 0.0 113.65 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 mt -81.71 -42.08 20.38 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 109.41 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -52.73 -24.99 9.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 113.997 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.55 27.09 6.19 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.657 1.583 . . . . 0.0 110.819 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -53.52 142.99 20.79 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.716 0.769 . . . . 0.0 111.62 -172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -58.78 -39.82 82.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.366 2.267 . . . . 0.0 113.144 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -85.9 114.9 23.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 t -39.6 -41.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.743 1.617 . . . . 0.0 111.491 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -35.11 62.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.803 1.183 . . . . 0.0 114.065 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -74.36 -45.82 44.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -52.77 -50.9 62.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.117 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.3 p -53.17 -46.38 68.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.472 0.709 . . . . 0.0 110.292 -168.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -53.64 -55.58 24.66 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 126.496 1.918 . . . . 0.0 109.909 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.455 ' CD1' HD11 ' A' ' 60' ' ' ILE . 32.4 m-85 -59.19 -59.37 5.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.621 177.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.53 -36.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.825 1.648 . . . . 0.0 111.681 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -57.37 11.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.134 1.374 . . . . 0.0 109.286 176.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -62.27 -36.78 83.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.297 0.639 . . . . 0.0 111.829 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 t -60.24 -50.48 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.319 1.448 . . . . 0.0 109.012 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -61.26 -36.72 80.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.504 0.721 . . . . 0.0 110.214 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 t -65.45 -35.0 79.61 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.26 1.424 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.1 t -62.71 -35.53 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 119.422 1.01 . . . . 0.0 110.188 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -69.16 -33.88 74.1 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.38 -25.39 67.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.0 110.914 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -99.09 11.86 37.76 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 127.185 2.194 . . . . 0.0 111.508 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.51 33.37 23.18 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.398 1.479 . . . . 0.0 113.212 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.75 153.46 20.92 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.204 0.911 . . . . 0.0 111.057 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -74.99 151.12 38.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.031 0.932 . . . . 0.0 108.955 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -121.16 142.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.92 1.288 . . . . 0.0 107.6 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.405 ' HE ' HG23 ' A' ' 57' ' ' THR . 22.7 mmt180 -133.16 120.88 21.78 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.6 mm -94.49 125.21 47.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.42 166.57 13.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.102 0.864 . . . . 0.0 108.788 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.03 110.08 21.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 166.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 t -43.71 -34.3 1.47 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.851 1.26 . . . . 0.0 112.16 173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -65.83 -36.14 82.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.862 2.465 . . . . 0.0 113.748 -176.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -72.78 160.3 32.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.133 1.773 . . . . 0.0 111.236 -172.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -36.65 48.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.702 -0.624 . . . . 0.0 110.171 172.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.7 m -66.66 -16.73 64.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.483 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.14 10.39 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 171.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.11 -36.96 63.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.949 0.9 . . . . 0.0 110.273 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.04 -63.73 1.2 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.662 169.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.69 -34.15 64.79 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.319 1.418 . . . . 0.0 111.662 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.0 66.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.077 1.351 . . . . 0.0 112.476 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.45 -28.6 68.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.848 0.859 . . . . 0.0 111.055 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.9 mt -104.48 31.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.418 2.287 . . . . 0.0 109.371 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p 69.05 -0.37 2.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.273 2.229 . . . . 0.0 114.049 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.33 58.88 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.961 2.696 . . . . 0.0 112.538 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -151.17 118.51 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 118.843 1.322 . . . . 0.0 110.306 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.44 9.5 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.404 1.481 . . . . 0.0 112.567 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -160.16 149.45 17.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.165 1.786 . . . . 0.0 110.772 171.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.13 144.82 9.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.671 1.988 . . . . 0.0 107.029 167.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.714 HD13 HG23 ' A' ' 117' ' ' VAL . 19.4 mt -117.29 136.41 53.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -60.25 -39.0 85.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.979 0.912 . . . . 0.0 110.802 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -135.31 157.81 75.88 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 128.448 2.699 . . . . 0.0 107.101 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -65.5 124.69 13.22 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.961 1.774 . . . . 0.0 107.805 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.714 HG23 HD13 ' A' ' 113' ' ' LEU . 65.0 t -75.31 122.02 86.43 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 171.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.19 142.69 81.22 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.46 1.44 . . . . 0.0 109.349 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 11.6 p -163.57 168.99 19.32 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.09 165.81 24.31 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 162.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.42 166.61 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.663 2.909 . . . . 0.0 113.27 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.0 m -141.07 50.4 1.63 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.7 2.0 . . . . 0.0 109.628 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 t -128.63 -87.09 0.55 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 104.864 -3.294 . . . . 0.0 104.864 162.074 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.635 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -163.31 -49.34 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.315 1.046 . . . . 0.0 108.584 162.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t -143.89 -177.06 5.24 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.284 1.034 . . . . 0.0 109.326 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.07 179.17 18.11 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 125.993 1.759 . . . . 0.0 111.038 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -128.69 175.88 8.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 108.595 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -177.5 -172.42 0.37 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.183 2.993 . . . . 0.0 104.71 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.48 166.65 19.32 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 171.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -142.89 162.62 34.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.23 1.812 . . . . 0.0 106.655 -176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.0 t -131.94 91.07 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.37 166.12 23.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.167 1.787 . . . . 0.0 109.375 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -163.05 -172.18 2.94 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 107.281 163.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -156.4 168.95 25.75 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.682 1.593 . . . . 0.0 108.112 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.2 tp -149.98 134.55 17.5 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.782 0.833 . . . . 0.0 108.94 173.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.58 131.1 9.69 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 29.4 t70 58.87 -177.96 0.08 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 112.45 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -92.55 -53.18 4.3 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 119.112 -2.243 . . . . 0.0 111.48 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -69.11 -51.3 39.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -56.55 -43.24 79.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.465 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.59 65.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.285 1.034 . . . . 0.0 113.441 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.2 -34.54 54.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.05 -50.5 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.562 0.681 . . . . 0.0 109.783 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.07 -53.54 41.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 125.828 1.651 . . . . 0.0 109.726 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -59.42 -36.29 75.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.425 1.011 . . . . 0.0 110.326 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -63.47 -44.39 94.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.368 0.985 . . . . 0.0 110.995 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tp -58.48 -44.82 89.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.035 1.288 . . . . 0.0 110.82 173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -60.6 -47.62 85.38 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.526 1.53 . . . . 0.0 110.289 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -73.3 -35.99 66.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.875 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.61 -59.58 5.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.824 1.65 . . . . 0.0 110.791 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -54.92 -37.73 66.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -51.56 -53.1 41.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.703 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.424 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -65.79 -34.08 77.34 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 118.152 -0.928 . . . . 0.0 111.533 174.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.59 -33.65 64.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.976 1.262 . . . . 0.0 110.514 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -76.78 -62.45 1.64 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.687 -0.633 . . . . 0.0 110.249 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -75.56 -34.56 60.71 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -160.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -157.91 81.48 3.02 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.987 1.715 . . . . 0.0 109.763 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.11 -14.03 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.684 2.256 . . . . 0.0 113.916 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.74 -15.28 39.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.657 -1.277 . . . . 0.0 111.871 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -107.52 8.9 29.59 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.957 0.903 . . . . 0.0 112.488 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -139.29 86.74 2.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 119.789 1.177 . . . . 0.0 108.837 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.8 m-30 -93.19 144.9 24.84 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -172.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.54 164.94 28.81 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.42 134.95 0.57 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 tp -43.05 -47.29 5.88 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.857 1.663 . . . . 0.0 111.806 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -55.72 -43.33 76.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.886 1.275 . . . . 0.0 112.189 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -55.65 13.03 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.72 -42.11 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 111.711 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.26 -24.79 68.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.377 1.471 . . . . 0.0 111.492 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -72.4 -70.31 0.35 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 116.005 -1.95 . . . . 0.0 107.104 161.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.28 -31.19 8.48 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 122.92 2.6 . . . . 0.0 116.135 -164.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.06 -49.21 32.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.416 1.486 . . . . 0.0 112.209 167.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -48.0 -42.15 27.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 128.323 2.649 . . . . 0.0 110.176 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.07 -0.44 57.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.666 1.186 . . . . 0.0 111.116 -169.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.9 mmt 54.0 31.69 14.05 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.559 1.543 . . . . 0.0 110.425 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.81 -7.81 36.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.094 -166.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -83.08 114.81 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 119.679 1.127 . . . . 0.0 108.043 -166.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.37 -54.79 6.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.337 1.455 . . . . 0.0 108.478 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.6 m -146.52 138.14 24.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.339 1.455 . . . . 0.0 107.336 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.69 139.57 44.58 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 106.95 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -122.87 124.17 42.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.048 1.739 . . . . 0.0 106.555 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.7 tt -137.52 142.13 37.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.18 131.06 45.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 169.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -53.8 -33.85 57.32 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 117.564 -1.208 . . . . 0.0 111.522 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.84 -37.72 69.1 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.944 1.702 . . . . 0.0 112.873 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.2 mt -71.48 -42.75 67.72 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.92 0.867 . . . . 0.0 109.752 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.69 -12.14 15.05 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.057 0.943 . . . . 0.0 112.572 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -123.44 19.96 9.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.898 2.479 . . . . 0.0 111.497 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -61.12 152.93 27.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.353 1.073 . . . . 0.0 111.949 -168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -77.57 -33.76 53.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.903 2.481 . . . . 0.0 112.399 -172.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 50.4 t0 -80.14 120.0 23.68 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.95 -29.98 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.605 0.639 . . . . 0.0 110.455 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.7 -56.05 18.67 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 119.863 -1.773 . . . . 0.0 111.513 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 54.9 m -56.21 -57.44 12.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.938 1.295 . . . . 0.0 108.826 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -54.25 -49.2 70.08 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.412 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.5 m -53.94 -41.17 67.46 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.551 -1.214 . . . . 0.0 111.079 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -57.42 -48.94 77.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.987 1.267 . . . . 0.0 109.812 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -61.91 -56.12 22.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.048 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 m -62.85 -36.6 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.532 1.06 . . . . 0.0 110.161 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -57.74 -59.9 4.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 123.65 0.78 . . . . 0.0 109.486 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 tp -56.07 -44.17 78.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 111.46 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -53.15 -52.16 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.777 1.231 . . . . 0.0 109.991 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.11 -32.73 63.33 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.16 -0.962 . . . . 0.0 112.303 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -62.23 -37.87 87.04 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.432 1.493 . . . . 0.0 110.985 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.55 -33.34 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.11 0.868 . . . . 0.0 110.008 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -70.48 -29.69 66.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.246 1.385 . . . . 0.0 112.222 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.06 -47.97 75.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -74.69 17.27 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.64 1.976 . . . . 0.0 112.44 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.89 56.46 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.145 2.578 . . . . 0.0 112.369 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.97 155.19 18.49 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.882 1.706 . . . . 0.0 109.822 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.1 m -75.99 148.81 37.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.452 -1.028 . . . . 0.0 110.078 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.0 129.72 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 109.016 169.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -119.64 121.53 39.48 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.42 120.25 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -88.42 162.49 16.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -104.27 113.28 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 117.374 -1.298 . . . . 0.0 107.674 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 t -56.11 -30.0 61.43 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.662 1.119 . . . . 0.0 112.476 -170.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.06 -38.88 92.25 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.025 1.73 . . . . 0.0 111.251 -178.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -75.32 142.02 43.29 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 126.792 2.037 . . . . 0.0 110.655 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.04 -18.34 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.25 1.02 . . . . 0.0 113.331 -172.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.0 m -61.7 -26.46 68.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.501 1.046 . . . . 0.0 111.165 172.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.16 -55.5 29.12 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -56.78 -36.11 69.48 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.06 0.93 . . . . 0.0 112.797 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -67.26 -45.64 76.04 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.576 -0.702 . . . . 0.0 110.184 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.6 tp -61.92 -37.09 83.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.942 176.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.7 m -62.32 -28.54 69.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.563 1.074 . . . . 0.0 112.431 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -69.88 3.89 2.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.086 0.954 . . . . 0.0 112.904 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.8 mt -136.52 33.27 2.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 129.055 2.942 . . . . 0.0 107.645 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.263 3.2 p 59.74 11.15 2.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.312 2.645 . . . . 0.0 114.845 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.96 17.86 80.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 128.054 2.74 . . . . 0.0 113.03 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.37 120.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 119.706 1.753 . . . . 0.0 108.949 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.47 175.35 10.63 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.933 0.893 . . . . 0.0 109.566 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.85 146.71 11.26 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.614 -1.304 . . . . 0.0 109.454 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.56 139.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 170.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 117' ' ' VAL . 30.9 mt -106.07 141.27 37.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -50.02 -61.21 2.28 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.943 2.097 . . . . 0.0 108.752 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -130.62 159.46 70.88 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 127.49 2.316 . . . . 0.0 109.278 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 106.68 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.855 2.37 . . . . 0.0 109.577 -176.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.552 HG23 HD13 ' A' ' 113' ' ' LEU . 96.7 t -59.01 136.54 87.74 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 170.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.41 112.73 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.563 2.175 . . . . 0.0 108.532 169.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.69 -52.01 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.47 157.77 7.29 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.22 -24.34 32.26 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.027 1.818 . . . . 0.0 111.134 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 m 44.3 63.09 1.76 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.427 1.891 . . . . 0.0 111.05 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.4 m -53.23 148.09 9.04 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.512 1.525 . . . . 0.0 113.551 -169.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.818 0 CA-C-O 117.907 -1.496 . . . . 0.0 111.566 -168.03 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.966 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 m -140.63 -13.15 0.99 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t 48.5 -129.89 1.81 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.95 1.25 . . . . 0.0 111.131 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.93 -151.03 45.21 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.802 1.668 . . . . 0.0 113.476 171.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t 95.46 20.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.671 2.788 . . . . 0.0 113.063 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -127.14 76.44 1.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.035 1.288 . . . . 0.0 110.6 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.97 175.32 42.0 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -103.94 160.39 14.86 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.324 1.05 . . . . 0.0 109.899 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.19 84.62 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.245 1.818 . . . . 0.0 106.228 165.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.89 156.0 26.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.742 0.817 . . . . 0.0 109.94 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.0 t -172.89 114.93 0.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -141.22 172.59 12.47 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.695 1.598 . . . . 0.0 109.151 171.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.89 -75.61 0.56 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.313 1.845 . . . . 0.0 108.244 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.9 t 72.34 -54.82 0.68 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.191 2.196 . . . . 0.0 110.775 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -150.17 156.25 41.27 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.818 1.247 . . . . 0.0 109.523 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 m -54.93 -56.06 23.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.988 1.715 . . . . 0.0 112.421 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -67.13 -48.44 68.07 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.61 -44.81 62.99 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.398 0.679 . . . . 0.0 111.427 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.27 -37.19 83.06 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 125.134 1.373 . . . . 0.0 112.84 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.31 -40.22 98.72 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -45.19 78.39 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.39 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.6 t -54.92 -42.13 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.642 0.777 . . . . 0.0 109.481 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -51.19 70.99 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -57.98 -40.35 80.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.737 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.82 -48.37 79.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.739 1.154 . . . . 0.0 110.907 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.28 -53.4 54.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.557 1.543 . . . . 0.0 109.306 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -66.42 -37.8 86.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.264 1.826 . . . . 0.0 109.169 -171.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -65.1 -56.09 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.299 1.84 . . . . 0.0 111.19 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.88 -37.47 74.02 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.951 0.796 . . . . 0.0 112.235 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.91 -55.24 12.37 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.719 0.808 . . . . 0.0 109.731 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.8 mmt -64.11 -34.88 79.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.813 -0.613 . . . . 0.0 111.836 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tp -59.11 -17.59 27.87 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.158 0.89 . . . . 0.0 111.86 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -96.55 -57.81 2.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.326 1.05 . . . . 0.0 110.622 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -70.43 -44.48 67.79 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -165.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.33 77.93 6.56 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 119.229 0.922 . . . . 0.0 110.094 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -65.07 -8.76 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.268 1.979 . . . . 0.0 114.208 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.27 -17.86 32.29 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.91 1.232 . . . . 0.0 111.279 164.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 113' ' ' LEU . 28.5 mtm180 -108.42 11.26 27.11 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.311 1.444 . . . . 0.0 112.784 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.55 89.83 2.64 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.876 1.216 . . . . 0.0 108.934 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.619 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -93.81 140.19 29.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.743 0.817 . . . . 0.0 108.834 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -139.79 158.53 43.95 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 122.778 0.431 . . . . 0.0 111.214 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 131.72 0.79 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.0 tp -41.21 -49.75 3.58 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.054 2.141 . . . . 0.0 111.456 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.489 ' O ' ' HE2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -54.39 -56.76 15.42 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.526 1.931 . . . . 0.0 110.638 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -59.21 -51.06 71.62 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.7 t -50.16 -42.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.984 1.313 . . . . 0.0 111.962 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -61.06 -30.02 70.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 120.254 1.388 . . . . 0.0 111.261 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -75.0 -45.76 39.74 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 120.098 -1.626 . . . . 0.0 110.579 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -62.46 -30.67 71.42 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.77 -1.206 . . . . 0.0 111.94 177.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.45 -52.2 66.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.221 1.409 . . . . 0.0 109.062 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -57.37 -37.21 72.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.972 0.805 . . . . 0.0 111.65 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.48 -5.01 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.706 0.802 . . . . 0.0 111.282 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 11.2 mmt 53.97 26.25 6.17 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.195 1.798 . . . . 0.0 111.854 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.11 -11.15 36.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.886 -164.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.584 HG23 ' HB1' ' A' ' 111' ' ' ALA . 64.3 mt -79.39 118.19 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -84.28 -50.09 8.17 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 167.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.3 m -131.99 131.63 42.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 tp -110.15 130.81 55.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.234 1.814 . . . . 0.0 107.579 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.56 131.7 54.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.194 1.797 . . . . 0.0 106.468 177.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.49 146.62 19.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.39 0.541 . . . . 0.0 109.751 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.16 134.16 51.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 166.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -52.0 -36.6 50.42 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.144 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.61 -33.1 59.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.935 1.243 . . . . 0.0 113.242 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.94 -39.99 20.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.901 0.773 . . . . 0.0 109.347 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -57.57 -16.99 11.7 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.142 0.977 . . . . 0.0 112.555 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 39.83 3.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.721 2.008 . . . . 0.0 109.241 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -58.5 152.8 17.3 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.625 -0.672 . . . . 0.0 109.535 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -67.73 -55.0 14.8 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.105 1.362 . . . . 0.0 111.725 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -63.6 120.1 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.55 -42.09 80.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.558 1.143 . . . . 0.0 111.521 -173.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.38 -34.3 61.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.95 0.795 . . . . 0.0 111.694 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.0 m -70.92 -45.65 63.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.234 175.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -51.64 -53.47 38.34 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.502 1.046 . . . . 0.0 109.075 167.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.3 t -52.1 -40.44 61.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.98 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -58.8 -57.35 13.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 120.206 1.367 . . . . 0.0 109.725 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -54.18 -50.37 67.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 119.238 -0.411 . . . . 0.0 111.527 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -70.37 -38.0 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 118.363 0.528 . . . . 0.0 111.045 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -58.93 -50.75 72.87 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.91 -42.73 97.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.957 0.903 . . . . 0.0 111.226 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 t -49.89 -52.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.547 1.139 . . . . 0.0 109.571 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 23.7 t70 -65.52 -43.12 91.03 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.436 0.694 . . . . 0.0 111.243 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -37.44 79.01 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.871 1.668 . . . . 0.0 111.769 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.82 -33.89 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.629 1.104 . . . . 0.0 110.115 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' A' ' 81' ' ' ASP . 5.7 mtmp? -75.57 -33.35 60.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.853 1.206 . . . . 0.0 111.402 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -56.56 -43.44 79.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -77.53 21.78 0.26 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.482 1.913 . . . . 0.0 111.721 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.73 9.05 0.53 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.794 3.238 . . . . 0.0 115.834 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.48 176.04 52.51 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 122.79 1.216 . . . . 0.0 112.209 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -108.05 149.36 28.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.173 2.189 . . . . 0.0 109.493 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.9 146.6 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.269 1.428 . . . . 0.0 107.407 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -139.28 121.75 16.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.32 115.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.19 173.74 7.99 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.365 1.466 . . . . 0.0 108.398 -175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -103.8 132.72 49.79 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.18 -43.21 31.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.343 1.457 . . . . 0.0 111.907 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.653 HD22 ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -71.05 -20.39 62.38 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.096 2.158 . . . . 0.0 112.953 -174.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -68.61 158.11 34.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 121.097 -1.002 . . . . 0.0 109.38 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 p -57.58 -37.87 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.7 m -64.52 -24.15 67.51 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.279 1.032 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.59 -41.96 28.11 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.67 -41.64 81.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.18 0.99 . . . . 0.0 109.584 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -68.91 -43.74 74.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.544 0.737 . . . . 0.0 111.643 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.48 -31.45 72.67 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.311 0.505 . . . . 0.0 110.172 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.03 -39.59 75.09 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.66 1.184 . . . . 0.0 112.637 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -56.54 -14.74 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.594 1.158 . . . . 0.0 112.111 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.1 mt -128.29 33.86 4.65 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 129.182 2.993 . . . . 0.0 108.757 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 65.58 10.6 6.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.761 1.624 . . . . 0.0 114.119 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.43 15.11 70.13 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.432 1.968 . . . . 0.0 115.118 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 p -146.38 129.65 9.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 119.229 1.515 . . . . 0.0 109.157 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.35 175.91 13.39 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 109.396 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -157.36 145.07 18.87 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.53 -0.731 . . . . 0.0 110.526 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 77.0 mt -83.82 135.35 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 117' ' ' VAL . 29.2 mt -105.02 141.23 36.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp-105 -56.54 -56.31 22.93 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.708 1.603 . . . . 0.0 109.138 171.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -124.71 157.14 66.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 125.959 1.704 . . . . 0.0 108.493 -172.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.49 115.2 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.359 2.04 . . . . 0.0 107.269 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.743 HG23 HD13 ' A' ' 113' ' ' LEU . 93.6 t -68.99 119.89 72.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.18 111.2 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -56.49 0.03 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.762 0.825 . . . . 0.0 110.035 -171.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.64 141.35 7.31 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.265 1.888 . . . . 0.0 110.292 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.34 -23.83 27.69 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.997 3.131 . . . . 0.0 113.632 -166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.0 m 48.8 65.81 1.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.73 1.612 . . . . 0.0 113.915 163.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.0 t -63.12 -10.16 13.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.414 2.286 . . . . 0.0 114.432 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 116.597 -2.224 . . . . 0.0 109.459 178.097 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m -136.93 165.47 25.91 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.538 1.535 . . . . 0.0 107.333 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -150.88 -83.88 0.09 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.45 10.96 71.41 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.778 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 p -67.19 87.93 0.17 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.989 2.115 . . . . 0.0 110.479 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.0 p -144.26 -167.73 2.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.889 0.876 . . . . 0.0 110.671 -171.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.63 -174.53 20.99 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -140.79 151.93 44.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 173.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.64 42.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.1 1.36 . . . . 0.0 108.573 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.08 159.85 5.41 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.648 1.179 . . . . 0.0 110.462 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.2 t -143.82 162.14 36.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.681 0.753 . . . . 0.0 109.82 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -143.05 168.02 20.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.237 2.215 . . . . 0.0 106.608 165.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.45 -166.53 2.44 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.187 0.595 . . . . 0.0 109.598 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.3 m 53.8 -142.69 0.78 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.335 1.854 . . . . 0.0 109.851 -159.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -40.02 103.35 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.004 2.522 . . . . 0.0 112.126 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -59.14 -33.41 70.86 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.512 1.125 . . . . 0.0 112.233 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -71.15 -52.39 19.52 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.925 0.784 . . . . 0.0 111.212 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -42.03 92.8 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.204 0.456 . . . . 0.0 109.9 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 -9.77 34.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.171 1.388 . . . . 0.0 112.88 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.3 -42.68 4.22 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 120.153 1.342 . . . . 0.0 110.988 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.36 -57.37 12.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.59 1.556 . . . . 0.0 108.804 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.98 -50.53 19.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 125.685 1.594 . . . . 0.0 110.407 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -58.15 -50.47 73.4 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.265 0.939 . . . . 0.0 109.58 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.63 75.29 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.667 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -67.0 -49.84 64.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.571 1.532 . . . . 0.0 110.451 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.7 -49.12 78.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.583 1.553 . . . . 0.0 109.178 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -69.48 -34.59 74.55 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.237 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -62.25 -58.54 7.35 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 127.049 2.14 . . . . 0.0 109.647 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -54.43 -39.63 67.54 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.361 0.664 . . . . 0.0 112.248 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -49.9 -48.59 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 122.475 0.31 . . . . 0.0 111.211 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 3.2 mtp -71.45 -35.91 71.04 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.272 -0.871 . . . . 0.0 109.964 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -55.71 -26.97 47.93 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.447 1.021 . . . . 0.0 111.476 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -92.94 -36.39 12.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.73 1.612 . . . . 0.0 112.861 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -86.03 -64.05 1.22 Allowed 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.295 1.038 . . . . 0.0 112.0 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -142.6 80.93 13.91 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.711 1.604 . . . . 0.0 107.513 -170.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.6 -13.1 38.55 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.769 2.313 . . . . 0.0 112.552 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.8 -20.15 14.01 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 111.892 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HA ' HD12 ' A' ' 113' ' ' LEU . 20.2 mtm180 -103.27 1.83 33.43 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 124.354 1.062 . . . . 0.0 113.543 174.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 31' ' ' MET . . . -131.41 90.69 2.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 120.058 1.299 . . . . 0.0 109.915 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.8 m-30 -93.37 140.43 29.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.052 0.941 . . . . 0.0 108.966 -173.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -139.95 160.16 40.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 76.32 143.45 1.39 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -174.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.5 tp -46.64 -49.89 18.46 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.326 1.45 . . . . 0.0 112.356 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -46.41 90.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 123.682 0.793 . . . . 0.0 109.72 -175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.5 -56.43 18.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 42' ' ' GLY . 10.9 t -50.53 -43.3 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.904 1.282 . . . . 0.0 111.975 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.39 -40.81 68.56 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.577 1.08 . . . . 0.0 110.645 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.19 -46.48 33.78 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 125.505 1.522 . . . . 0.0 109.838 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -54.71 -37.54 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.995 -1.065 . . . . 0.0 111.941 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -66.73 -44.34 81.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.391 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.0 -34.63 68.33 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.789 1.177 . . . . 0.0 111.758 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.7 -7.15 36.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.006 0.922 . . . . 0.0 110.978 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.9 mmt 51.29 39.53 24.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.846 2.459 . . . . 0.0 109.362 -173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -112.0 -10.5 13.93 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.386 1.074 . . . . 0.0 112.923 -164.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.35 111.13 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.49 -59.27 3.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.2 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.458 HG21 ' HE ' ' A' ' 91' ' ' ARG . 53.4 m -146.07 134.73 22.22 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.69 140.96 41.36 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 126.712 2.005 . . . . 0.0 107.201 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.45 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.41 129.79 56.42 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.978 2.111 . . . . 0.0 106.468 176.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.28 131.6 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 m -63.58 129.97 42.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.73 -33.94 36.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.235 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.32 -22.06 62.75 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.35 1.432 . . . . 0.0 112.871 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.02 -40.49 11.62 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.241 1.016 . . . . 0.0 109.191 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -54.23 -21.06 8.09 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 20.05 7.3 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.934 1.243 . . . . 0.0 112.062 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -49.8 145.07 5.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.154 1.382 . . . . 0.0 112.908 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -46.65 89.45 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.05 110.33 5.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.69 -36.47 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.851 -172.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -29.78 65.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.02 1.282 . . . . 0.0 112.575 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.14 -48.72 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.289 1.036 . . . . 0.0 108.506 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 -55.02 -49.95 70.25 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.394 0.678 . . . . 0.0 109.994 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 53.2 p -54.61 -43.75 72.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.44 0.696 . . . . 0.0 110.276 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -54.72 -57.34 11.87 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.061 1.344 . . . . 0.0 108.772 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -55.7 -53.19 59.63 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -65.7 -38.53 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 118.91 0.777 . . . . 0.0 110.281 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -57.57 -52.35 65.76 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.545 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -61.73 -43.74 98.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.431 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -52.47 -50.43 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 124.501 1.121 . . . . 0.0 109.758 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.23 96.74 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.146 0.578 . . . . 0.0 109.961 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.8 m -64.7 -30.6 71.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.992 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.66 -44.77 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.138 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -64.01 -34.26 77.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.292 0.951 . . . . 0.0 110.419 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.35 -35.73 81.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.568 0.622 . . . . 0.0 110.454 174.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -91.51 24.29 3.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.9 1.68 . . . . 0.0 111.394 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 28.91 12.84 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.094 1.758 . . . . 0.0 113.861 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.85 145.52 17.82 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 170.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 m -78.06 154.98 30.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.266 1.026 . . . . 0.0 109.017 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.96 149.29 17.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.924 1.29 . . . . 0.0 107.561 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HE ' HG21 ' A' ' 57' ' ' THR . 21.4 mmt180 -137.46 121.31 17.58 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 mm -90.66 119.4 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.1 m-85 -89.91 125.12 35.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.5 m -62.93 109.63 1.52 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 166.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 m -56.74 -27.41 59.31 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.455 1.502 . . . . 0.0 112.836 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -67.03 -32.13 73.13 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.852 2.461 . . . . 0.0 111.758 -178.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -71.56 158.5 36.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.626 1.97 . . . . 0.0 110.632 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -19.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.071 -1.018 . . . . 0.0 111.536 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -72.87 -23.32 60.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.177 -1.577 . . . . 0.0 111.003 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.33 -43.05 26.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 119.637 1.108 . . . . 0.0 110.436 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -52.2 -47.83 65.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.355 1.078 . . . . 0.0 109.876 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.63 -42.26 91.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.167 0.587 . . . . 0.0 111.245 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.12 -33.74 75.04 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 119.018 0.826 . . . . 0.0 111.392 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.7 m -59.59 -36.54 76.45 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.224 1.409 . . . . 0.0 111.68 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -58.19 -20.65 42.89 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.711 0.804 . . . . 0.0 112.167 171.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt -112.48 21.86 15.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.706 2.402 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 p 74.16 -1.68 3.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.551 2.74 . . . . 0.0 113.893 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.42 62.36 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 127.238 2.352 . . . . 0.0 113.462 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.79 133.14 26.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.903 1.852 . . . . 0.0 108.88 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.63 177.35 10.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 110.684 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.83 149.49 16.46 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.797 -1.19 . . . . 0.0 109.738 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.5 HG23 ' SD ' ' A' ' 31' ' ' MET . 81.0 mt -83.46 142.87 12.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.643 HD13 HG23 ' A' ' 117' ' ' VAL . 23.3 mt -108.97 146.14 34.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 109.202 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 mtp85 -59.04 -44.28 91.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.968 169.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 5.0 p90 -142.88 161.71 47.48 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.391 1.476 . . . . 0.0 109.344 -169.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.09 114.04 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.505 2.803 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 HD13 ' A' ' 113' ' ' LEU . 88.5 t -69.12 124.22 89.93 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.19 24.66 0.54 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.394 3.396 . . . . 0.0 113.635 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.0 t -149.83 121.23 7.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -166.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.41 178.61 43.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.6 11.04 3.05 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.671 4.247 . . . . 0.0 114.795 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.69 147.72 8.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.411 1.005 . . . . 0.0 110.117 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.0 p -143.94 99.02 3.32 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.853 0.861 . . . . 0.0 109.911 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.305 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.837 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.46 173.01 3.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.42 1.11 . . . . 0.0 111.352 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 t -150.47 -167.02 2.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.506 2.323 . . . . 0.0 106.544 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.38 81.65 0.16 Allowed Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.21 102.36 2.45 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 172.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -156.24 112.88 3.11 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.56 155.48 26.7 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.4 m -147.64 127.62 13.62 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.6 94.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.07 140.39 28.04 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 124.034 0.934 . . . . 0.0 109.38 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 m -163.44 -178.04 5.64 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.221 3.008 . . . . 0.0 105.914 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 60.0 179.82 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.257 1.423 . . . . 0.0 111.565 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.1 tp -140.22 165.56 27.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.98 167.57 23.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.76 0.791 . . . . 0.0 109.68 160.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.1 160.64 23.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.351 1.06 . . . . 0.0 110.249 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 t -53.76 -44.85 70.34 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.111 0.564 . . . . 0.0 111.41 -168.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -70.94 -53.08 16.24 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.99 95.76 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.918 1.287 . . . . 0.0 112.015 -169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -18.59 65.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.766 0.827 . . . . 0.0 111.382 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.44 51.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -60.66 -50.72 72.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.594 1.158 . . . . 0.0 110.717 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.77 -50.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.213 1.005 . . . . 0.0 110.392 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -53.53 -49.31 67.88 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.057 0.543 . . . . 0.0 110.862 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -62.36 -42.05 99.1 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.297 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.67 -45.28 92.53 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.37 1.441 . . . . 0.0 109.71 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.162 0.985 . . . . 0.0 111.399 -173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.12 -45.88 46.18 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.26 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.56 -58.38 6.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.908 1.283 . . . . 0.0 110.267 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.49 -37.8 88.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 118.388 -0.815 . . . . 0.0 112.864 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -55.97 12.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.3 ttp -68.64 -30.24 68.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.862 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 tp -59.25 -44.72 92.36 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 120.473 1.488 . . . . 0.0 111.386 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -65.22 -24.17 67.27 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.744 1.618 . . . . 0.0 111.901 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -117.96 -41.59 2.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -162.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -155.7 83.71 3.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.332 1.853 . . . . 0.0 108.995 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.91 -7.57 13.61 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.92 2.413 . . . . 0.0 113.605 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.53 -21.44 52.38 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.889 -1.132 . . . . 0.0 111.579 168.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.6 mtp180 -103.4 9.23 37.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.006 1.276 . . . . 0.0 112.707 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.15 92.74 2.82 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.411 1.084 . . . . 0.0 109.427 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -93.23 145.59 24.32 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.06 1.344 . . . . 0.0 107.658 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -140.78 163.56 32.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' VAL . . . 77.25 139.43 1.12 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -43.27 -51.0 6.43 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.176 2.19 . . . . 0.0 112.201 -172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -52.82 18.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.011 2.124 . . . . 0.0 111.526 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.5 -53.14 25.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 42' ' ' GLY . 3.9 t -50.5 -44.54 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.876 1.27 . . . . 0.0 111.061 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -53.25 -38.43 63.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.634 1.173 . . . . 0.0 111.65 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -78.63 -43.35 26.49 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 126.051 1.741 . . . . 0.0 110.632 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 113' ' ' LEU . . . -65.81 -30.69 71.36 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 118.497 -1.281 . . . . 0.0 110.629 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -67.29 -36.69 82.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.473 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -52.52 -35.33 53.09 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.057 0.943 . . . . 0.0 111.503 168.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.54 59.35 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.352 1.461 . . . . 0.0 112.538 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.8 mmt 56.07 39.1 30.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.645 0.778 . . . . 0.0 110.905 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.97 -7.14 14.57 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.116 0.966 . . . . 0.0 112.198 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -78.44 105.19 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.07 -54.89 6.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 123.699 0.624 . . . . 0.0 109.754 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -135.83 124.65 23.99 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -171.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.8 tp -109.07 132.37 54.18 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 107.788 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.59 119.5 35.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.782 1.633 . . . . 0.0 107.66 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 tt -135.42 141.24 43.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 137.16 57.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 170.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -59.2 -37.66 77.97 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.476 -0.765 . . . . 0.0 109.009 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -55.84 -30.89 62.17 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.686 1.195 . . . . 0.0 112.77 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.8 mt -82.87 -42.08 18.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.613 1.097 . . . . 0.0 109.618 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -56.74 -18.85 14.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.389 0.675 . . . . 0.0 112.597 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 23.9 9.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.775 2.83 . . . . 0.0 109.881 -177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -56.45 140.38 46.06 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.689 0.677 . . . . 0.0 110.0 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -59.65 -35.84 75.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.484 1.114 . . . . 0.0 112.638 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -79.68 125.14 29.25 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 108.61 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -59.69 -38.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 116.846 -1.55 . . . . 0.0 111.167 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.74 -52.07 41.84 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.921 2.146 . . . . 0.0 111.744 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -56.88 -52.42 65.21 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.409 1.884 . . . . 0.0 108.262 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -52.25 -46.48 65.8 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.726 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 p -53.8 -44.16 69.92 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.926 0.89 . . . . 0.0 110.364 -173.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -57.66 -55.48 34.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.273 1.429 . . . . 0.0 108.689 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -57.57 -51.41 69.6 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 117.587 -1.196 . . . . 0.0 112.629 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.2 -37.63 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.765 1.166 . . . . 0.0 110.937 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.9 mtt-85 -60.17 -51.06 71.19 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.073 0.949 . . . . 0.0 110.238 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.67 -42.83 95.11 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 122.893 0.477 . . . . 0.0 111.221 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.68 -48.55 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.02 0.928 . . . . 0.0 109.986 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -60.29 -49.13 78.81 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.251 1.02 . . . . 0.0 110.666 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -71.82 -23.54 61.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.683 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.72 -41.67 93.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 120.058 1.299 . . . . 0.0 108.465 169.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -65.14 -38.21 89.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.804 1.184 . . . . 0.0 110.327 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.18 -32.67 64.56 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.531 0.605 . . . . 0.0 110.82 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -98.87 24.26 7.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.436 2.294 . . . . 0.0 111.04 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 61.6 19.4 10.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.834 2.054 . . . . 0.0 114.185 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.46 146.71 19.1 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 122.277 0.932 . . . . 0.0 110.792 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.57 149.58 48.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.202 2.201 . . . . 0.0 109.534 170.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.0 t -117.33 150.05 19.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.14 1.376 . . . . 0.0 108.861 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -138.54 138.05 37.62 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.679 1.992 . . . . 0.0 106.648 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.72 104.26 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 -170.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.4 m-85 -90.02 124.88 35.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -70.09 128.48 36.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -60.71 10.04 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.828 2.451 . . . . 0.0 116.148 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.8 mt -129.22 -18.9 3.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.952 2.101 . . . . 0.0 111.393 -175.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -69.67 157.54 37.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.164 1.385 . . . . 0.0 110.532 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.76 -39.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 118.478 0.581 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.3 m -63.83 -32.3 73.77 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.198 -0.938 . . . . 0.0 110.489 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -65.93 -50.41 52.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.942 1.258 . . . . 0.0 110.333 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -69.04 -26.75 65.13 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 118.298 1.049 . . . . 0.0 112.028 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.62 -46.24 89.16 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.12 -0.988 . . . . 0.0 108.84 170.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 103' ' ' LEU . 8.1 tp -60.61 -25.74 66.48 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.488 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t -50.69 -44.08 57.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.572 . . . . 0.0 111.826 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.15 0.56 0.91 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.435 1.094 . . . . 0.0 113.398 175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.65 32.75 3.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.742 2.417 . . . . 0.0 108.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p 65.32 -3.45 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.787 2.435 . . . . 0.0 114.174 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.35 18.6 64.08 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.522 2.487 . . . . 0.0 112.884 -170.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.43 129.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 119.638 1.719 . . . . 0.0 110.804 167.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.66 173.49 13.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.456 1.102 . . . . 0.0 109.782 175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.09 15.87 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.8 -1.187 . . . . 0.0 110.424 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -98.33 140.5 18.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 126.578 1.951 . . . . 0.0 108.048 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 117' ' ' VAL . 34.6 mt -107.43 145.39 33.06 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.429 0.691 . . . . 0.0 111.266 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -66.25 -39.81 89.74 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.928 1.291 . . . . 0.0 110.787 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.55 155.08 57.03 Favored Pre-proline 0 N--CA 1.453 -0.286 0 C-N-CA 123.748 0.819 . . . . 0.0 109.464 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.32 146.4 62.77 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.661 2.24 . . . . 0.0 109.601 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.455 HG23 HD13 ' A' ' 113' ' ' LEU . 58.8 t -108.46 132.22 21.26 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.887 1.675 . . . . 0.0 106.741 -170.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.36 102.71 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.974 2.449 . . . . 0.0 109.186 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 t -170.6 -175.8 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.923 1.689 . . . . 0.0 108.162 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.63 164.43 18.09 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 161.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.87 175.39 6.45 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.565 2.843 . . . . 0.0 110.548 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.8 t -126.4 123.98 39.14 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.9 t 51.33 -103.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.096 1.358 . . . . 0.0 108.275 -157.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.97 0 CA-C-O 116.963 -2.021 . . . . 0.0 110.744 -178.152 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 p -160.34 148.7 16.72 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.02 0.928 . . . . 0.0 108.887 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.1 p -97.93 170.32 9.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.451 1.1 . . . . 0.0 109.758 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.49 -96.1 0.1 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 151.21 41.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.15 1.38 . . . . 0.0 110.287 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.2 m 62.09 -175.05 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.078 0.951 . . . . 0.0 112.87 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.65 -88.49 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 O-C-N 121.14 -0.975 . . . . 0.0 112.25 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -70.17 138.33 51.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.583 0.691 . . . . 0.0 109.856 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.36 99.37 9.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.7 62.24 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 t 51.23 -169.82 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.521 1.928 . . . . 0.0 111.651 -166.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -151.23 166.84 29.67 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 127.102 2.161 . . . . 0.0 106.902 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -145.77 154.35 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 159.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 m -151.19 -61.47 0.18 Allowed 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.1 -1.0 . . . . 0.0 109.498 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -139.7 149.28 43.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -60.91 -44.21 97.5 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.17 0.896 . . . . 0.0 111.172 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -71.76 -49.16 41.51 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.629 0.649 . . . . 0.0 109.748 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -25.82 68.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.892 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.17 63.41 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 119.616 1.098 . . . . 0.0 111.491 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.98 -53.0 43.75 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 170.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -53.21 -58.98 5.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.047 0.939 . . . . 0.0 110.71 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.51 -41.61 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 117.417 -1.278 . . . . 0.0 111.606 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -55.03 -48.35 73.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.802 1.637 . . . . 0.0 109.235 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.61 88.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.892 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.27 -46.9 88.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.064 1.302 . . . . 0.0 110.086 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -56.52 -53.94 51.66 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.75 1.22 . . . . 0.0 109.054 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -66.52 -41.7 88.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.156 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.36 -57.73 10.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.302 1.041 . . . . 0.0 110.933 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.59 -41.25 89.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.166 0.439 . . . . 0.0 111.772 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -50.74 -51.97 45.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.8 tpp -61.03 -41.04 95.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.714 0.806 . . . . 0.0 111.731 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 tp -56.44 -29.51 61.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.064 1.746 . . . . 0.0 111.469 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -80.59 -59.37 2.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.993 1.317 . . . . 0.0 108.94 173.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -71.02 -51.64 24.23 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -166.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.13 78.67 9.44 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.883 1.273 . . . . 0.0 108.305 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.57 -9.19 12.72 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.823 2.349 . . . . 0.0 114.137 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.62 -16.75 51.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 0.0 111.142 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 113' ' ' LEU . 83.0 mtp180 -107.82 9.15 28.98 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 112.179 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.76 89.57 2.96 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.788 1.235 . . . . 0.0 107.947 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 113' ' ' LEU . 2.0 m-30 -94.11 133.36 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.028 -172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -140.25 161.29 38.03 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.32 137.91 0.46 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -168.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.3 tp -37.16 -53.9 1.02 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.741 2.016 . . . . 0.0 112.862 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -59.56 -49.4 77.9 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.703 1.201 . . . . 0.0 110.943 -174.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -56.24 -58.67 6.96 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 t -48.93 -45.27 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.474 1.109 . . . . 0.0 112.317 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -58.24 -40.62 82.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.113 1.324 . . . . 0.0 111.205 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -37.85 85.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.63 1.172 . . . . 0.0 109.695 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.25 -35.26 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.17 -38.74 92.36 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.11 -3.6 7.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.745 1.618 . . . . 0.0 114.745 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.61 -5.73 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.046 1.738 . . . . 0.0 112.041 171.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.5 mmt 63.26 4.59 1.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.078 2.151 . . . . 0.0 112.596 -171.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -77.68 -10.15 59.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.877 -1.059 . . . . 0.0 113.033 -164.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.96 115.66 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.28 -65.17 1.04 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 m -125.83 132.64 52.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.91 132.84 53.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.265 1.826 . . . . 0.0 107.127 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.02 120.95 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.707 1.603 . . . . 0.0 106.961 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.54 145.06 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -65.02 142.32 58.46 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.718 0.807 . . . . 0.0 109.58 175.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.97 -42.34 89.7 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.6 pt-20 -52.09 -33.34 39.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.99 -43.29 30.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.912 0.778 . . . . 0.0 110.124 174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.25 -23.75 16.03 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.65 1.18 . . . . 0.0 113.624 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.16 27.27 5.66 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.722 1.609 . . . . 0.0 111.29 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -54.43 149.22 10.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.33 1.452 . . . . 0.0 112.687 -174.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -58.58 -26.39 63.57 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.768 2.027 . . . . 0.0 114.51 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -105.21 114.4 28.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -53.13 -39.25 32.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-O 117.447 -1.263 . . . . 0.0 111.234 -174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -34.87 61.11 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.065 1.302 . . . . 0.0 111.974 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 m -65.95 -53.49 38.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -52.43 -50.51 62.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.41 ' HA ' HG22 ' A' ' 77' ' ' VAL . 24.3 p -56.85 -36.8 70.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.481 0.582 . . . . 0.0 111.523 -174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.74 -53.73 53.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.92 0.782 . . . . 0.0 109.73 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -59.03 -53.76 54.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.05 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 74' ' ' SER . 7.9 m -63.55 -35.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.528 1.058 . . . . 0.0 110.451 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -61.67 -56.07 23.68 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -54.72 -41.31 70.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.82 -50.93 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.993 0.917 . . . . 0.0 110.695 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.37 -46.16 67.61 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.626 0.77 . . . . 0.0 110.022 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.4 m -66.29 -23.8 66.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.395 1.478 . . . . 0.0 112.323 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.95 -38.38 82.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 118.917 0.78 . . . . 0.0 110.071 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.54 -43.47 89.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.909 0.777 . . . . 0.0 109.493 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.32 -44.41 95.49 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.529 0.518 . . . . 0.0 110.073 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -70.91 6.42 1.55 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 112.231 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.83 54.89 0.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 130.479 3.512 . . . . 0.0 113.093 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.89 163.43 17.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.522 1.058 . . . . 0.0 113.871 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -82.2 146.31 29.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.465 2.306 . . . . 0.0 109.571 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.14 144.93 18.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.443 1.497 . . . . 0.0 107.923 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -133.38 121.61 22.56 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.96 110.65 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -89.94 124.77 35.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 m -70.04 116.87 10.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -58.61 -17.03 18.7 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.78 -41.52 62.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.497 1.119 . . . . 0.0 112.181 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.77 153.42 41.86 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.963 0.801 . . . . 0.0 109.591 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.55 -26.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.556 -0.715 . . . . 0.0 111.629 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.7 p -58.31 -27.51 64.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.221 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -69.22 -53.0 19.9 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 124.176 0.893 . . . . 0.0 111.034 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -38.93 74.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.653 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.47 -58.31 9.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.219 1.408 . . . . 0.0 109.661 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.8 tp -56.37 -29.06 60.94 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.61 0.641 . . . . 0.0 111.402 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.02 -36.5 65.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.591 1.557 . . . . 0.0 112.593 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.53 -32.53 68.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.141 0.976 . . . . 0.0 110.705 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -99.79 21.86 11.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.204 2.201 . . . . 0.0 109.692 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p 68.99 9.39 7.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.664 2.386 . . . . 0.0 114.257 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.35 18.97 78.81 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.204 1.859 . . . . 0.0 113.504 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.13 122.02 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.992 1.396 . . . . 0.0 108.977 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.7 170.06 19.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 110.043 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.9 153.68 39.41 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.619 -0.676 . . . . 0.0 110.777 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.9 mt -84.11 141.76 14.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.664 1.585 . . . . 0.0 107.327 168.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.737 HD13 HG23 ' A' ' 117' ' ' VAL . 26.2 mt -109.36 145.08 36.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.161 0.981 . . . . 0.0 110.167 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -65.68 -38.63 89.8 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.018 1.327 . . . . 0.0 111.223 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 17.4 p90 -143.55 157.57 58.78 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 127.309 2.244 . . . . 0.0 106.76 -175.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.13 128.0 15.09 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.883 1.722 . . . . 0.0 108.384 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.737 HG23 HD13 ' A' ' 113' ' ' LEU . 72.6 t -80.5 119.58 76.73 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 60.19 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.297 3.332 . . . . 0.0 112.087 -169.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.0 m -127.54 -18.48 4.38 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.024 2.13 . . . . 0.0 111.043 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.49 -178.57 31.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.681 0.657 . . . . 0.0 112.444 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.09 160.68 48.45 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.119 2.546 . . . . 0.0 108.809 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -81.99 -16.39 50.48 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.12 -0.988 . . . . 0.0 112.284 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.09 173.62 4.29 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.274 1.43 . . . . 0.0 108.39 173.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 105.904 -2.878 . . . . 0.0 105.904 165.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 m -149.38 -12.02 0.3 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.14 -0.933 . . . . 0.0 113.457 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p 51.56 -177.63 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.261 1.424 . . . . 0.0 111.783 -162.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.2 -177.17 30.96 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 121.082 -1.011 . . . . 0.0 113.19 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m 52.35 164.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.08 2.152 . . . . 0.0 113.662 -162.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -170.83 -174.25 1.52 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.447 2.699 . . . . 0.0 105.792 157.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.36 108.59 0.56 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.039 -2.424 . . . . 0.0 107.039 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -162.63 86.27 0.57 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 122.415 1.102 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 p -141.89 170.29 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.582 -1.324 . . . . 0.0 108.864 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.17 168.03 20.77 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.728 1.611 . . . . 0.0 107.972 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m -153.34 93.63 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.804 -1.185 . . . . 0.0 109.306 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 75.1 158.06 0.2 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 129.488 3.115 . . . . 0.0 111.081 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.99 150.08 33.34 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.468 1.507 . . . . 0.0 108.833 156.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -150.21 -66.12 0.2 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -55.91 136.44 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.859 1.264 . . . . 0.0 109.278 165.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 m -93.63 -47.55 6.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.859 1.263 . . . . 0.0 112.229 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -63.58 -52.04 62.72 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.336 -0.853 . . . . 0.0 108.954 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.84 94.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.716 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.24 87.39 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.218 0.917 . . . . 0.0 112.353 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.41 61.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 119.292 0.951 . . . . 0.0 111.481 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -67.12 -44.32 80.2 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.5 -1.0 . . . . 0.0 109.841 172.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.59 -45.93 82.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -60.75 -48.15 83.11 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.924 0.784 . . . . 0.0 109.993 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -59.47 -38.21 80.2 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.46 175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 tp -64.76 -50.71 65.75 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.504 1.047 . . . . 0.0 110.435 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -33.81 76.24 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.201 1.0 . . . . 0.0 110.388 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.51 -44.61 67.25 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.209 1.404 . . . . 0.0 110.148 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -58.93 -52.81 64.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.433 1.093 . . . . 0.0 109.944 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.21 -38.81 87.92 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.042 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -45.19 -52.63 9.17 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.4 mmt -63.76 -47.76 79.69 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.198 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.55 -35.38 60.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.362 0.983 . . . . 0.0 111.541 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -78.9 -56.62 4.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.162 0.985 . . . . 0.0 109.569 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -76.46 -70.15 0.47 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.121 1.368 . . . . 0.0 113.307 -171.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.51 71.63 66.03 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.52 -14.35 44.43 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.655 -170.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.03 -21.09 58.53 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.308 -0.87 . . . . 0.0 110.775 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' HA ' HD12 ' A' ' 113' ' ' LEU . 78.6 mtp180 -100.59 14.17 32.27 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.133 1.373 . . . . 0.0 113.864 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.33 110.05 12.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.327 1.051 . . . . 0.0 108.757 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.6 m-85 -107.62 130.79 54.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.554 1.142 . . . . 0.0 108.468 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -140.29 156.6 46.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.728 1.149 . . . . 0.0 114.1 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.97 140.04 0.19 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.633 1.111 . . . . 0.0 110.526 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -47.5 -49.81 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.439 1.096 . . . . 0.0 112.461 -162.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -58.95 -32.7 69.86 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.799 1.64 . . . . 0.0 112.632 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -71.16 -63.31 1.13 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -50.74 -41.12 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.395 1.078 . . . . 0.0 112.233 -170.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -44.68 -49.71 10.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.074 1.75 . . . . 0.0 111.089 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -71.54 -41.92 68.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 109.851 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -66.73 -29.34 69.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.304 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.09 -37.33 78.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.3 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.91 -7.26 10.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.6 0.15 30.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.696 1.599 . . . . 0.0 112.571 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.3 mmt 55.96 8.2 0.35 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 127.025 2.13 . . . . 0.0 112.727 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -18.64 60.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.845 -1.16 . . . . 0.0 112.102 -162.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.28 115.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.82 -55.81 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 165.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.9 m -132.72 135.48 45.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 tp -110.25 133.18 53.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.953 2.101 . . . . 0.0 106.547 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.433 HD22 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.23 129.37 55.5 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.525 1.93 . . . . 0.0 107.115 175.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 tt -143.56 136.39 24.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 119.014 0.824 . . . . 0.0 109.585 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.23 128.24 35.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 168.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -34.07 69.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.564 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -43.85 -39.7 4.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.659 1.184 . . . . 0.0 113.473 170.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.2 mt -77.07 -42.93 36.28 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.486 1.114 . . . . 0.0 109.571 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.53 -20.09 11.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.952 1.301 . . . . 0.0 112.877 171.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 30.35 4.73 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 119.96 -1.712 . . . . 0.0 110.014 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -56.18 149.39 16.14 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.255 0.55 . . . . 0.0 110.98 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -32.47 65.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.463 1.105 . . . . 0.0 112.439 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.9 113.6 20.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.38 -36.56 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.579 -168.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.61 59.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.596 1.089 . . . . 0.0 112.196 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.1 m -55.7 -52.61 63.28 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.081 1.352 . . . . 0.0 108.406 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -53.07 -53.58 48.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.668 -0.682 . . . . 0.0 109.586 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 77' ' ' VAL . 1.6 t -53.12 -44.81 67.96 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.19 0.596 . . . . 0.0 109.949 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -54.93 -53.87 49.98 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.062 0.945 . . . . 0.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -57.96 -57.37 13.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.197 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 74' ' ' SER . 6.1 m -64.64 -30.41 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.218 0.917 . . . . 0.0 111.102 -173.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -66.25 -59.8 3.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.918 0.887 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 tp -52.74 -39.57 62.26 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 123.512 0.725 . . . . 0.0 111.445 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -54.48 -53.25 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.333 1.053 . . . . 0.0 110.235 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.55 -36.03 80.18 Favored 'General case' 0 C--O 1.224 -0.277 0 O-C-N 122.167 -0.333 . . . . 0.0 111.249 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -69.4 -24.47 63.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.055 0.942 . . . . 0.0 112.435 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.5 t -71.85 -43.85 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -61.16 -43.32 99.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.355 0.98 . . . . 0.0 110.926 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.6 -44.09 62.72 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.345 1.458 . . . . 0.0 110.124 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -85.32 25.44 1.01 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.689 1.195 . . . . 0.0 111.037 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.31 20.57 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.28 2.232 . . . . 0.0 114.064 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.64 -176.44 50.97 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 120.969 -1.082 . . . . 0.0 112.683 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.1 m -122.05 152.35 39.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.141 2.576 . . . . 0.0 108.499 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.73 124.14 56.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 47.8 mmt-85 -116.17 121.33 41.78 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.0 mm -102.68 108.07 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.32 124.0 34.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.5 m -71.7 123.57 22.85 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -49.69 -42.73 46.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.329 1.851 . . . . 0.0 112.501 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.93 HD22 ' H ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.6 -37.21 67.81 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 126.191 1.796 . . . . 0.0 112.304 -174.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -72.74 152.09 41.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.994 1.318 . . . . 0.0 110.391 -167.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.54 -32.48 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.297 0.639 . . . . 0.0 111.595 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.5 m -65.07 -33.99 77.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.035 -1.041 . . . . 0.0 111.781 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.4 -49.55 77.29 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.1 -38.79 92.35 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.047 0.939 . . . . 0.0 111.407 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -59.75 -47.26 86.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 171.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.21 -29.33 70.69 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.286 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.5 m -59.82 -34.27 72.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.641 1.11 . . . . 0.0 112.56 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.67 -3.93 7.68 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.71 1.204 . . . . 0.0 112.428 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -127.47 23.03 6.39 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.354 2.662 . . . . 0.0 108.679 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.7 p 69.75 1.3 3.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 128.449 2.7 . . . . 0.0 114.194 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.61 17.43 70.82 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.299 1.904 . . . . 0.0 113.224 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.03 129.83 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 120.165 1.982 . . . . 0.0 108.879 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.59 173.98 13.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.016 0.926 . . . . 0.0 110.291 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.46 153.92 25.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.193 -0.942 . . . . 0.0 110.874 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 81.6 mt -99.66 144.94 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.319 1.848 . . . . 0.0 107.911 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CD1' ' A' ' 40' ' ' PHE . 31.4 mt -116.99 131.31 56.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.595 0.758 . . . . 0.0 111.721 -172.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -53.54 -36.93 62.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.643 1.977 . . . . 0.0 111.865 173.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -149.07 157.53 39.81 Favored Pre-proline 0 N--CA 1.444 -0.737 0 C-N-CA 126.621 1.968 . . . . 0.0 106.358 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.43 144.08 66.04 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.233 1.956 . . . . 0.0 109.37 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 113' ' ' LEU . 93.8 t -94.9 124.11 55.49 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.7 120.14 6.98 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.298 1.999 . . . . 0.0 109.361 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -139.76 -77.12 0.33 Allowed 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 179.79 -169.25 40.06 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.26 155.54 56.19 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.063 1.842 . . . . 0.0 111.045 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -141.74 -38.08 0.4 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.352 1.461 . . . . 0.0 111.359 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.8 t -166.83 -35.11 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.968 0.804 . . . . 0.0 111.159 -168.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 CA-C-O 116.561 -2.244 . . . . 0.0 112.567 170.753 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -67.33 162.84 21.95 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.733 0.778 . . . . 0.0 110.798 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -126.88 -179.97 5.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.386 1.874 . . . . 0.0 107.367 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.74 -80.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 p -157.46 20.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -163.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.49 82.93 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.066 -1.646 . . . . 0.0 110.195 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.29 47.42 0.4 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.665 0.65 . . . . 0.0 114.16 -172.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -150.97 133.45 15.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.456 1.128 . . . . 0.0 109.445 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.22 132.65 60.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.406 1.082 . . . . 0.0 108.87 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 33.97 58.52 0.59 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 129.411 3.085 . . . . 0.0 114.826 169.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -124.74 171.88 9.75 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.521 0.728 . . . . 0.0 112.001 172.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -130.63 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.887 2.075 . . . . 0.0 108.202 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.8 tp -134.72 -52.86 0.81 Allowed 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.801 0.841 . . . . 0.0 108.887 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m 52.22 66.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.556 1.169 . . . . 0.0 111.599 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 33.9 t70 -137.89 151.91 48.5 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 152.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.6 m -90.48 -41.17 11.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.884 0.766 . . . . 0.0 110.967 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.34 -52.24 24.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -58.33 -41.03 83.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.266 0.626 . . . . 0.0 109.949 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 -26.35 67.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.994 0.815 . . . . 0.0 112.975 178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.54 -38.73 86.75 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.674 1.125 . . . . 0.0 111.093 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.67 -52.63 56.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.379 1.072 . . . . 0.0 110.678 170.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 18' ' ' ALA . 74.7 t -55.02 -49.02 75.04 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 125.117 1.367 . . . . 0.0 110.034 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -49.98 69.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.03 78.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.752 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 tp -64.98 -52.48 55.98 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.253 1.388 . . . . 0.0 110.285 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.61 -43.97 85.13 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.358 1.063 . . . . 0.0 109.262 -173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.5 -34.54 63.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.811 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.82 -55.08 25.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.629 1.572 . . . . 0.0 109.847 173.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.75 -39.07 73.33 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -53.76 -50.09 66.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.164 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -68.16 -32.15 72.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.564 1.075 . . . . 0.0 111.3 175.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 tp -55.52 -36.17 66.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.182 1.356 . . . . 0.0 110.665 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -74.22 -57.14 4.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 111.079 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -76.69 -58.78 3.08 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -166.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -136.91 73.67 52.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.998 1.719 . . . . 0.0 108.283 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.26 -14.13 42.1 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.135 2.557 . . . . 0.0 113.476 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -64.73 -13.73 55.89 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.56 -1.337 . . . . 0.0 111.631 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' HA ' HD12 ' A' ' 113' ' ' LEU . 75.8 mtp180 -103.18 -0.25 30.77 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.377 1.071 . . . . 0.0 112.8 171.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.08 91.17 3.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.299 0.954 . . . . 0.0 108.816 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 1.7 m-85 -93.35 137.75 32.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.688 1.195 . . . . 0.0 108.707 -175.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -140.33 159.6 41.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.07 134.45 0.63 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.1 tp -42.16 -51.8 4.54 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.473 1.509 . . . . 0.0 112.447 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -56.96 -42.53 80.3 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 125.84 1.656 . . . . 0.0 111.708 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -65.25 -55.94 15.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.11 -41.92 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.358 1.063 . . . . 0.0 112.332 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -55.52 -40.38 71.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.245 0.929 . . . . 0.0 110.731 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -71.66 -41.13 69.13 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.681 1.593 . . . . 0.0 110.919 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -68.01 -30.24 69.44 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.179 -0.95 . . . . 0.0 112.085 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.19 -44.15 97.23 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.38 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.23 -33.33 69.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.253 0.933 . . . . 0.0 112.876 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.6 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.05 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 mmt 47.46 36.61 5.26 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.925 2.09 . . . . 0.0 110.467 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.64 -20.55 13.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.642 -165.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 111' ' ' ALA . 81.3 mt -70.66 113.97 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -86.31 -42.1 14.0 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 124.122 0.889 . . . . 0.0 110.177 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.2 m -141.64 124.72 16.3 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.6 tp -110.07 125.51 53.03 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 127.121 2.168 . . . . 0.0 108.814 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -108.02 126.95 53.33 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.993 1.717 . . . . 0.0 107.857 -179.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 tt -143.17 142.53 25.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -63.33 133.43 54.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 168.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.2 -39.91 73.18 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.352 174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 12.9 pt-20 -49.58 -36.46 24.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.592 1.542 . . . . 0.0 113.803 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.3 mt -78.04 -38.56 44.31 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.825 1.193 . . . . 0.0 110.258 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -56.6 -30.25 63.02 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.318 1.047 . . . . 0.0 111.457 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 42.2 3.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.774 2.429 . . . . 0.0 109.055 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -60.99 146.9 45.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.31 -35.74 78.18 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.162 0.985 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -87.04 114.96 24.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.98 1.312 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.74 -34.61 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.626 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.21 11.77 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 120.093 1.315 . . . . 0.0 110.527 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -62.52 -45.21 94.05 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.637 1.175 . . . . 0.0 110.464 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -51.61 -44.97 63.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.965 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 p -51.61 -46.08 63.46 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 118.319 0.509 . . . . 0.0 110.083 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.41 -46.23 90.99 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 109.562 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -59.64 -61.39 2.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.312 -0.851 . . . . 0.0 111.01 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.74 -36.99 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.832 1.196 . . . . 0.0 110.857 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.11 -49.3 78.17 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.235 1.014 . . . . 0.0 111.297 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.1 -43.15 96.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.132 0.573 . . . . 0.0 109.928 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.33 -55.38 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.761 1.225 . . . . 0.0 110.164 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.72 -39.63 94.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.703 0.801 . . . . 0.0 110.652 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 t -67.14 -36.79 82.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.504 1.122 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.82 -40.24 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.313 0.96 . . . . 0.0 109.273 172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -65.29 -41.46 94.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.218 0.917 . . . . 0.0 110.904 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.2 -39.87 73.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.075 0.398 . . . . 0.0 110.501 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -75.39 -2.84 30.42 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 112.92 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 80.51 26.47 0.29 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.72 2.808 . . . . 0.0 113.941 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -95.75 143.71 16.82 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.499 1.523 . . . . 0.0 112.319 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.0 m -74.77 131.91 41.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.152 2.181 . . . . 0.0 109.778 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.7 t -93.99 148.43 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.989 0.916 . . . . 0.0 109.148 172.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -140.36 122.01 15.27 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.212 1.805 . . . . 0.0 108.085 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.27 109.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 59' ' ' LEU . 3.9 m-85 -89.23 124.33 34.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.9 t -69.75 127.78 34.12 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -31.58 62.84 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.105 0.478 . . . . 0.0 110.355 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.5 mt -69.91 -4.78 22.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.839 1.655 . . . . 0.0 113.642 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -109.66 143.42 39.44 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 125.867 1.667 . . . . 0.0 110.348 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -22.38 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 O-C-N 121.757 -0.59 . . . . 0.0 112.154 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -64.8 -20.53 66.43 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.596 -1.315 . . . . 0.0 111.174 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.0 -32.76 13.48 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 119.539 1.063 . . . . 0.0 112.271 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.25 -39.69 79.84 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.137 0.968 . . . . 0.0 108.855 168.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -65.06 -52.36 56.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.649 1.18 . . . . 0.0 110.763 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 tp -56.32 -30.88 63.13 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.352 0.978 . . . . 0.0 111.713 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.8 t -52.44 -39.93 61.62 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.679 1.592 . . . . 0.0 112.362 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.29 -25.84 59.9 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.466 1.106 . . . . 0.0 111.145 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.1 mt -109.4 23.27 14.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.991 2.116 . . . . 0.0 109.849 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.9 p 73.65 0.23 3.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.321 2.648 . . . . 0.0 113.745 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.14 21.09 63.5 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.402 1.953 . . . . 0.0 113.129 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.48 129.23 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.603 1.702 . . . . 0.0 109.12 171.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.31 177.41 11.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.768 1.227 . . . . 0.0 110.323 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 55' ' ' ILE . . . -160.59 150.29 17.55 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.857 -1.152 . . . . 0.0 111.522 173.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 31' ' ' MET . 78.1 mt -83.76 141.07 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.715 HD13 HG23 ' A' ' 117' ' ' VAL . 21.8 mt -113.03 144.19 43.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -65.57 -25.71 67.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 127.286 2.234 . . . . 0.0 112.273 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -159.86 161.39 26.47 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 127.141 2.177 . . . . 0.0 106.41 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.32 132.37 23.89 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.089 1.859 . . . . 0.0 109.563 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 113' ' ' LEU . 80.5 t -87.51 131.46 43.84 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.0 111.74 2.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.143 2.562 . . . . 0.0 107.91 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -161.48 125.28 3.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.18 166.3 33.7 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.48 -65.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.363 2.709 . . . . 0.0 110.908 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.1 t -163.82 110.46 1.11 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m 56.4 -169.1 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.452 1.501 . . . . 0.0 111.829 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 116.289 -2.395 . . . . 0.0 111.265 174.478 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 t -143.43 99.23 3.39 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -119.6 26.1 9.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.683 1.193 . . . . 0.0 111.356 -167.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.23 -164.62 52.09 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -163.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.62 156.17 36.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 117.708 0.754 . . . . 0.0 109.548 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -148.8 179.56 7.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.201 1.001 . . . . 0.0 110.747 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.97 161.69 34.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.011 2.243 . . . . 0.0 108.869 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -153.17 148.43 26.91 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.29 106.44 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.696 0.798 . . . . 0.0 109.091 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.89 157.72 45.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.525 1.53 . . . . 0.0 108.259 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -164.65 173.38 11.97 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.969 2.508 . . . . 0.0 107.13 171.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 -38.03 0.39 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.772 -1.109 . . . . 0.0 112.296 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 43.3 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.022 2.529 . . . . 0.0 112.137 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.5 t -146.73 150.91 36.29 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 53.7 154.51 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 130.431 3.492 . . . . 0.0 115.577 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 m -76.71 -33.85 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.122 -0.986 . . . . 0.0 110.643 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -52.9 17.67 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.497 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.27 64.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.679 -163.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.95 -36.43 62.83 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.183 0.902 . . . . 0.0 113.259 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.5 71.1 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 118.987 0.812 . . . . 0.0 111.863 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.66 -53.27 57.04 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.297 0.639 . . . . 0.0 109.328 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.51 -33.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.373 1.069 . . . . 0.0 110.877 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -62.96 -47.19 84.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.941 1.7 . . . . 0.0 110.513 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.67 -37.77 82.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.134 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -61.06 -48.99 79.18 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.483 1.038 . . . . 0.0 110.111 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -57.52 -53.56 56.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 125.328 1.451 . . . . 0.0 108.443 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -38.93 83.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.147 0.904 . . . . 0.0 109.77 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.19 -53.13 61.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.475 0.71 . . . . 0.0 109.815 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.59 -36.29 82.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -53.9 -55.24 28.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.041 0.937 . . . . 0.0 108.721 169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 tpp -57.51 -38.81 75.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.8 0.44 . . . . 0.0 110.302 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.02 -19.59 66.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.119 1.768 . . . . 0.0 112.822 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -95.0 -34.89 12.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.079 1.352 . . . . 0.0 111.335 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -90.08 -70.6 0.66 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.1 77.03 68.49 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 109.388 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.99 -8.98 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.597 2.198 . . . . 0.0 114.092 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -57.06 -22.97 43.27 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.046 1.294 . . . . 0.0 111.747 166.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -106.17 8.64 32.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 112.598 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.97 98.19 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.168 0.987 . . . . 0.0 109.521 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.507 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.9 m-30 -100.46 141.74 32.91 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.384 1.074 . . . . 0.0 109.159 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.13 161.09 38.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.749 0.785 . . . . 0.0 112.95 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 148.21 0.68 Allowed Glycine 0 CA--C 1.523 0.533 0 C-N-CA 125.242 1.401 . . . . 0.0 111.226 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.4 tp -49.69 -44.83 48.25 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.31 1.044 . . . . 0.0 110.972 -169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -61.06 -54.5 43.92 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.263 1.425 . . . . 0.0 111.289 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -61.77 -50.97 70.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 0.0 108.205 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -51.31 -38.88 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 111.906 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.04 -22.42 64.96 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.209 -0.932 . . . . 0.0 112.742 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -77.98 -43.34 29.9 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.72 1.145 . . . . 0.0 108.859 167.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 40' ' ' PHE . . . -61.69 -40.23 94.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.005 -0.434 . . . . 0.0 112.02 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -64.86 -33.53 76.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.503 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.65 -35.01 79.63 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.045 0.839 . . . . 0.0 112.365 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.79 -0.19 29.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 111.991 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.8 mmt 62.19 3.08 0.93 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.88 2.472 . . . . 0.0 114.417 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 115' ' ' PHE . . . -81.72 -2.46 50.65 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.696 -1.252 . . . . 0.0 112.629 -162.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.41 110.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.58 -49.36 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.574 1.55 . . . . 0.0 108.121 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.9 m -144.41 136.76 26.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 111' ' ' ALA . 11.1 tp -109.42 142.1 40.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 125.24 47.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.479 1.911 . . . . 0.0 107.253 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 tt -141.26 143.26 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 119.191 0.905 . . . . 0.0 110.341 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.88 137.26 53.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -37.04 69.8 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.848 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.55 -18.69 42.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.5 -43.18 9.84 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.322 1.049 . . . . 0.0 109.449 171.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.09 -26.58 11.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 0.0 112.444 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.28 37.39 4.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.554 1.941 . . . . 0.0 110.33 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -56.05 145.79 24.59 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.582 0.753 . . . . 0.0 110.886 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -40.51 96.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.611 0.764 . . . . 0.0 112.699 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.35 120.64 21.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -55.67 -44.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.284 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.31 -53.55 42.22 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 120.223 1.374 . . . . 0.0 111.235 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -51.38 -53.32 37.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.763 1.625 . . . . 0.0 109.878 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -55.73 -48.57 74.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.513 0.597 . . . . 0.0 109.773 177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.97 -39.23 58.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.624 0.77 . . . . 0.0 110.802 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -62.44 -56.55 17.12 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.634 1.106 . . . . 0.0 109.049 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -55.19 -50.23 69.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.643 -0.694 . . . . 0.0 112.762 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.62 -40.82 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 119.432 1.014 . . . . 0.0 110.479 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -62.33 -52.76 62.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.18 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -55.79 -42.62 75.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.521 1.055 . . . . 0.0 111.126 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -58.07 -51.23 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.194 0.597 . . . . 0.0 110.315 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.47 -33.12 74.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.843 1.657 . . . . 0.0 111.085 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 m -71.49 -30.12 65.6 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.954 1.701 . . . . 0.0 110.866 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 t -69.23 -37.79 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.718 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE2' HG21 ' A' ' 90' ' ' VAL . 36.4 mttt -61.73 -46.01 91.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.159 1.345 . . . . 0.0 110.295 174.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.11 -43.73 87.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.428 0.691 . . . . 0.0 111.842 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -77.48 10.52 2.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.992 0.917 . . . . 0.0 111.247 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.44 19.21 11.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 129.499 3.119 . . . . 0.0 115.143 174.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.3 168.37 51.7 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 119.435 1.016 . . . . 0.0 111.918 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -83.42 159.45 21.78 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.904 1.682 . . . . 0.0 109.846 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 84' ' ' LYS . 39.1 t -124.59 146.73 29.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.653 1.181 . . . . 0.0 109.127 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -143.85 121.28 11.68 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.26 0.624 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 mm -110.61 110.09 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.28 151.94 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.717 1.607 . . . . 0.0 108.985 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -103.08 132.27 49.46 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.338 0.655 . . . . 0.0 110.648 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.3 p -65.36 10.43 0.09 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.805 2.042 . . . . 0.0 114.715 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.28 0.71 10.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.394 1.877 . . . . 0.0 112.463 -166.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -139.62 160.38 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.606 1.962 . . . . 0.0 107.041 -172.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.33 -24.69 28.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 123.326 0.65 . . . . 0.0 112.41 -172.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.3 p -68.47 -31.99 71.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 120.722 -1.236 . . . . 0.0 110.285 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.32 -39.14 70.97 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -66.39 -28.96 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.143 1.472 . . . . 0.0 110.92 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.04 -51.23 26.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.251 1.021 . . . . 0.0 109.311 170.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 103' ' ' LEU . 7.2 tp -60.03 -28.8 68.04 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.818 1.19 . . . . 0.0 111.954 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.6 m -58.85 -36.15 74.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.565 1.146 . . . . 0.0 111.811 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -68.23 -0.68 4.95 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.1 1.76 . . . . 0.0 112.162 173.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -134.77 28.22 3.58 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.422 2.289 . . . . 0.0 108.79 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.3 p 70.87 2.38 4.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.829 2.051 . . . . 0.0 114.521 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.04 17.07 70.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 129.03 3.205 . . . . 0.0 114.238 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.1 p -145.66 134.51 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.299 1.55 . . . . 0.0 109.477 170.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.69 177.97 10.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.218 1.407 . . . . 0.0 110.488 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 58' ' ' LEU . . . -162.3 144.35 10.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.465 1.03 . . . . 0.0 110.338 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 78.8 mt -84.11 144.84 9.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 125.081 1.352 . . . . 0.0 107.607 170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.543 HD13 HG23 ' A' ' 117' ' ' VAL . 9.7 mt -117.71 139.25 51.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.145 0.978 . . . . 0.0 109.874 -176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.73 -24.24 65.35 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.093 1.357 . . . . 0.0 111.98 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 54' ' ' ALA . 9.9 p90 -151.44 157.31 34.91 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.929 1.292 . . . . 0.0 108.799 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.91 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.414 2.743 . . . . 0.0 108.406 -176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.543 HG23 HD13 ' A' ' 113' ' ' LEU . 62.2 t -76.12 117.76 66.36 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -67.45 121.14 8.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.132 1.888 . . . . 0.0 108.188 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.9 t -165.46 -161.05 0.5 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.531 2.732 . . . . 0.0 105.034 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.62 179.84 31.27 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.629 -1.295 . . . . 0.0 110.856 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 122.72 9.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.882 2.388 . . . . 0.0 109.42 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.2 m -139.55 -18.41 0.97 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.822 1.249 . . . . 0.0 113.445 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 p -91.01 -29.18 17.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.868 1.213 . . . . 0.0 112.209 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.374 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -145.423 . . . . . . . . 0 0 . 1 stop_ save_